data_6mg9_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6mg9 _Structure_validation_residue.Date_analyzed 2019-02-01 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.56 ' CD ' ' H ' ' A' ' 4' ' ' GLU . 1.5 pm0 . . . . . 0 CA--C 1.529 0.136 0 CA-C-O 120.637 0.256 . . . . 0.0 110.333 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.9 t -84.6 120.12 34.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 80.8 m -84.89 125.58 32.76 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 119.415 -0.914 . . . . 0.0 109.274 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.8 mm -104.54 94.13 2.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.094 0.473 . . . . 0.0 110.802 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 53.4 tp -124.66 79.48 1.77 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.037 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.535 ' C ' ' H ' ' A' ' 11' ' ' LEU . 1.4 pt-20 -122.99 89.06 50.79 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.853 -178.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -69.03 16.7 0.17 Allowed 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 121.988 1.792 . . . . 0.0 111.602 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.535 ' H ' ' C ' ' A' ' 9' ' ' GLU . 64.2 mt -72.46 61.97 0.51 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.433 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -71.08 -40.6 71.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.597 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -172.0 132.38 0.68 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 81.8 t -124.96 132.08 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 120.895 0.378 . . . . 0.0 110.671 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -128.88 138.44 52.02 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.901 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.7 pp -157.03 135.06 11.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.997 0.427 . . . . 0.0 110.889 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 42.4 t -64.49 146.65 54.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.792 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.427 ' CD ' ' N ' ' A' ' 19' ' ' GLY . 14.5 tm-20 -61.02 143.12 55.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.607 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.427 ' N ' ' CD ' ' A' ' 18' ' ' GLU . . . 98.86 -14.26 61.73 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 20.2 mp0 -98.68 147.57 24.72 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.878 0.37 . . . . 0.0 110.736 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -71.93 153.3 41.93 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.741 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -129.87 146.32 51.59 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.857 0.361 . . . . 0.0 110.918 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 36.4 m -146.22 145.03 30.27 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.41 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -119.58 150.24 40.61 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -146.02 131.46 18.67 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.555 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 10.9 p -151.73 140.53 20.92 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.599 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -100.44 118.19 36.15 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.38 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.453 ' O ' ' CG2' ' A' ' 59' ' ' THR . 79.9 mt -129.25 106.16 8.63 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 110.332 -0.248 . . . . 0.0 110.332 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.531 ' HG ' ' H ' ' A' ' 30' ' ' ARG . 22.2 t -62.39 164.4 7.3 Favored 'General case' 0 CA--C 1.515 -0.381 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.026 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.531 ' H ' ' HG ' ' A' ' 29' ' ' SER . 9.5 ptm180 -54.96 162.37 1.31 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.225 -178.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.464 ' O ' ' NH1' ' A' ' 30' ' ' ARG . . . -94.11 -174.11 3.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.411 -179.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.2 m -149.96 -50.59 0.14 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.503 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -89.28 -75.58 1.3 Allowed Glycine 0 CA--C 1.522 0.487 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 178.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -124.83 154.28 41.25 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.824 0.345 . . . . 0.0 110.486 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.9 tp10 -89.97 147.23 23.83 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.976 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.79 147.93 48.42 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.917 0.389 . . . . 0.0 110.364 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -108.15 139.72 42.4 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.644 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 10.1 t-105 -102.45 134.21 46.14 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.448 -0.797 . . . . 0.0 108.901 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -163.19 154.23 16.85 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.083 -0.647 . . . . 0.0 111.587 -178.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.1 tt -128.19 127.72 43.44 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.759 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.32 10.77 84.23 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.29 -16.64 59.32 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 16.8 m -109.21 148.54 38.2 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -56.18 143.9 82.91 Favored 'Trans proline' 0 N--CA 1.488 1.19 0 C-N-CA 121.103 1.202 . . . . 0.0 110.468 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.42 ' H ' ' CD2' ' A' ' 45' ' ' LEU . 0.8 OUTLIER -101.15 -177.46 3.45 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.246 -179.01 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -141.55 124.22 15.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.907 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.84 81.36 0.11 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.932 0.396 . . . . 0.0 110.611 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.442 ' O ' ' O ' ' A' ' 51' ' ' ASN . 85.4 m-20 -66.46 -168.63 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.098 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.44 -52.17 59.43 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.622 -0.431 . . . . 0.0 109.885 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 62.4 ttp -67.01 -39.82 87.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.805 178.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.442 ' O ' ' O ' ' A' ' 48' ' ' ASN . 1.3 t-20 -94.46 102.26 14.21 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.924 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -116.67 140.17 49.71 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 87.8 mt -123.34 132.67 70.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.801 0.334 . . . . 0.0 110.481 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.7 t -130.98 140.77 50.19 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.077 0.465 . . . . 0.0 110.852 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 72.6 t -120.89 131.8 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.534 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -118.84 179.77 4.05 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.759 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -59.87 167.91 2.0 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.997 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.07 15.24 74.23 Favored Glycine 0 CA--C 1.519 0.343 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.453 ' CG2' ' O ' ' A' ' 28' ' ' LEU . 0.6 OUTLIER 54.89 35.44 24.37 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.204 0.526 . . . . 0.0 110.379 -179.771 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 81.1 mt -79.11 139.08 38.16 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.438 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -118.82 147.89 43.44 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.418 ' C ' ' CD2' ' A' ' 62' ' ' LEU . 5.4 tt -155.38 115.2 3.7 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 120.499 -0.481 . . . . 0.0 111.432 -178.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -86.73 106.66 17.81 Favored 'General case' 0 N--CA 1.461 0.11 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 89.9 m -90.21 105.64 17.95 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.898 0.38 . . . . 0.0 110.304 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 80.3 mt -109.82 118.03 35.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.732 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.712 ' HD1' ' N ' ' A' ' 67' ' ' LYS . 24.9 t-80 -77.75 -136.39 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 120.549 -0.461 . . . . 0.0 110.63 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.712 ' N ' ' HD1' ' A' ' 66' ' ' HIS . 15.8 ptmt -53.3 96.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.209 0.528 . . . . 0.0 110.694 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.1 p -69.72 159.29 5.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.874 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 70.6 p -136.95 161.24 36.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.334 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.56 -27.26 66.08 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -71.4 -32.83 68.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.157 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -62.45 -36.52 82.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.026 -178.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -47.43 143.8 3.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.841 0.353 . . . . 0.0 110.438 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 172.86 -175.14 45.91 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 98.1 m -106.81 126.18 51.96 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.654 0.264 . . . . 0.0 111.403 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.3 t -98.51 133.25 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.6 m -122.71 154.01 38.66 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.084 0.469 . . . . 0.0 111.186 -178.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -134.46 144.7 48.26 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.28 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 61.7 m80 -133.44 113.92 13.07 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.74 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.51 ' C ' ' H ' ' A' ' 82' ' ' THR . 2.1 t -122.1 133.76 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.53 -5.07 0.29 Allowed Glycine 0 CA--C 1.528 0.905 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.564 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.51 ' H ' ' C ' ' A' ' 80' ' ' VAL . 5.1 p -109.39 -43.71 4.06 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.854 0.327 . . . . 0.0 111.165 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.591 ' SG ' ' N ' ' A' ' 84' ' ' SER . 44.4 t -152.85 166.05 33.49 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.709 0.29 . . . . 0.0 111.259 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.591 ' N ' ' SG ' ' A' ' 83' ' ' CYS . 60.0 m -129.01 151.35 49.8 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.859 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 37.6 p -158.63 166.61 31.64 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.925 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.43 ' N ' ' CD ' ' A' ' 86' ' ' GLU . 2.4 pm0 -154.24 169.86 22.64 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.943 0.401 . . . . 0.0 110.743 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -154.37 151.62 29.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.976 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -115.29 123.88 49.89 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.025 0.441 . . . . 0.0 111.14 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.8 tt -107.09 115.1 29.59 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -111.85 153.69 26.25 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.54 0.686 . . . . 0.0 111.737 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 43.8 t -120.8 129.89 75.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.396 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 29.5 m . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.526 -179.827 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 . . . . . 0 N--CA 1.464 0.236 0 CA-C-O 120.798 0.332 . . . . 0.0 110.509 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.9 p -58.8 128.68 19.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.461 ' OG1' ' CB ' ' A' ' 29' ' ' SER . 53.8 p -86.6 131.17 34.23 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 119.719 -0.792 . . . . 0.0 110.2 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 24.9 mm -99.87 73.0 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.052 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 79.6 mt -112.36 81.36 1.46 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -118.15 88.0 30.89 Favored Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.986 -177.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -73.48 -5.0 16.38 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 121.999 1.799 . . . . 0.0 110.229 178.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.25 90.62 0.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.668 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -97.3 -124.15 0.13 Allowed 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.404 ' O ' ' OD2' ' A' ' 13' ' ' ASP . 47.5 p-10 -109.01 137.5 46.83 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.798 0.333 . . . . 0.0 110.959 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.6 m -130.8 156.71 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -121.38 134.86 55.12 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.866 0.365 . . . . 0.0 110.782 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.9 pp -147.71 135.73 21.24 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.736 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.6 p -75.73 158.21 32.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.497 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -65.64 142.28 58.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.887 0.375 . . . . 0.0 110.022 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.3 -6.67 78.35 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -97.79 156.85 16.39 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 51.1 p30 -78.43 162.32 26.49 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.908 0.385 . . . . 0.0 110.964 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -147.2 150.74 35.49 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.52 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.4 p -160.04 159.07 31.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.346 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -131.8 152.42 50.99 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.951 0.405 . . . . 0.0 110.694 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -142.43 128.33 19.47 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 50.6 m -131.6 155.38 47.63 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.183 0.516 . . . . 0.0 111.577 -179.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -121.85 94.6 4.36 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.68 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 85.5 mt -127.15 112.53 15.26 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.745 -0.207 . . . . 0.0 110.691 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.461 ' CB ' ' OG1' ' A' ' 6' ' ' THR . 46.0 t -62.54 158.02 19.04 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 53.0 ptt85 -55.3 158.46 3.12 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.723 -177.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -86.28 -179.13 6.64 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.84 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 30.9 t -157.77 -49.61 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.141 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -86.15 -75.17 1.26 Allowed Glycine 0 CA--C 1.52 0.366 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -122.84 142.81 50.36 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.103 0.477 . . . . 0.0 111.051 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -75.02 144.02 43.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.768 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -81.54 170.28 16.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.666 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.6 mtm180 -132.46 137.28 47.19 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.355 0.598 . . . . 0.0 111.916 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 76.5 t-105 -117.93 137.49 52.79 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -169.96 165.96 9.44 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 119.474 -0.89 . . . . 0.0 112.484 -177.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.0 tt -136.79 122.5 19.83 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.227 178.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.27 14.6 82.04 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.98 4.17 87.23 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 111.62 -0.592 . . . . 0.0 111.62 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.1 t -113.27 130.26 23.8 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-O 119.491 -0.29 . . . . 0.0 110.467 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -58.34 144.94 95.48 Favored 'Trans proline' 0 N--CA 1.491 1.35 0 C-N-CA 120.919 1.08 . . . . 0.0 110.34 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.2 mt -77.53 150.76 34.78 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.681 -179.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -129.01 153.91 47.12 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.382 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.24 80.88 0.35 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.474 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -77.7 169.08 18.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.716 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -66.79 -37.17 84.04 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.137 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 25.8 ptt? -86.83 -21.23 26.56 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.651 0.262 . . . . 0.0 111.266 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.464 ' OD1' ' N ' ' A' ' 52' ' ' ASP . 58.9 t-20 -103.1 146.33 28.54 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.417 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.464 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 98.3 m-20 -138.84 115.18 10.41 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 48.1 mt -107.95 125.9 64.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.2 t -144.75 153.15 41.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.049 0.452 . . . . 0.0 110.912 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.6 p -104.15 130.89 54.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.501 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -111.77 -179.19 3.63 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.485 -179.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -63.38 152.07 39.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.533 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.14 9.32 86.85 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 -179.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.3 m 67.27 38.75 3.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.866 0.365 . . . . 0.0 110.646 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.9 mp -94.39 130.59 40.66 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.674 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 64.0 m80 -91.38 158.0 16.77 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 48.2 tp -156.77 111.24 2.75 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 120.247 -0.581 . . . . 0.0 111.623 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.44 ' CD1' ' N ' ' A' ' 63' ' ' LEU . 6.5 mp -96.73 115.7 27.88 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.816 178.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 63.7 m -109.94 95.47 5.61 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.4 tt -107.53 121.5 44.76 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 79.3 t60 -80.34 -86.05 0.09 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -178.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? -76.05 106.88 7.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.91 0.386 . . . . 0.0 110.428 -178.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.9 p -88.59 155.11 3.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.906 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 72.8 p -130.95 156.69 44.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.324 -0.398 . . . . 0.0 109.948 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 93.4 mt -59.54 -29.8 68.16 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -67.58 -35.36 78.85 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.959 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -61.72 -32.16 72.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.575 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.27 140.23 39.86 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.625 -0.43 . . . . 0.0 109.893 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 172.55 -171.64 44.44 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 87.8 m -101.53 120.87 40.97 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.735 0.303 . . . . 0.0 111.281 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 10.6 t -86.4 130.91 35.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.2 m -118.2 148.83 41.99 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.109 0.48 . . . . 0.0 110.918 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -136.95 124.96 22.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.453 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 63.4 t-80 -137.62 125.45 22.55 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.831 0.348 . . . . 0.0 111.568 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.411 ' O ' ' C ' ' A' ' 81' ' ' GLY . 5.8 p -141.47 134.3 29.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.579 178.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.411 ' C ' ' O ' ' A' ' 80' ' ' VAL . . . -26.36 -51.94 0.06 OUTLIER Glycine 0 CA--C 1.53 0.977 0 CA-C-N 115.573 -0.739 . . . . 0.0 113.248 -178.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 68.3 p -61.52 -77.27 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 7.3 m -125.56 -166.7 1.59 Allowed 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.06 0.457 . . . . 0.0 111.136 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 28.6 m -149.93 147.06 27.44 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.308 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 50.0 m -126.99 155.42 43.21 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.745 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -129.65 147.2 51.42 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.103 0.478 . . . . 0.0 111.126 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.63 151.92 30.26 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.762 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -130.96 138.51 49.75 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.982 0.42 . . . . 0.0 111.301 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.422 ' CD2' ' C ' ' A' ' 89' ' ' LEU . 2.2 tt -112.49 111.31 22.06 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -117.71 155.1 30.54 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.996 0.427 . . . . 0.0 111.391 -178.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 34.4 m -113.48 133.26 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.461 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 81.2 m . . . . . 0 N--CA 1.468 0.436 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.525 -179.919 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 . . . . . 0 CA--C 1.529 0.165 0 N-CA-C 110.213 -0.292 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.4 t -67.54 133.2 31.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.545 ' OG1' ' N ' ' A' ' 29' ' ' SER . 71.0 p -90.14 127.16 36.03 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 118.633 -1.227 . . . . 0.0 110.42 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 20.7 mm -104.81 49.46 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.811 -178.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 89.5 mt -88.07 81.02 7.52 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.552 ' C ' ' H ' ' A' ' 11' ' ' LEU . 27.8 mt-10 -111.9 97.07 36.51 Favored Pre-proline 0 CA--C 1.536 0.413 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.695 -179.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -68.9 25.82 0.15 Allowed 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.656 1.571 . . . . 0.0 111.53 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.552 ' H ' ' C ' ' A' ' 9' ' ' GLU . 3.8 mm? -72.82 125.76 28.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.244 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -133.38 -152.65 0.5 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.22 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.443 ' OD2' ' N ' ' A' ' 13' ' ' ASP . 23.0 p-10 -106.32 131.4 53.58 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.796 0.331 . . . . 0.0 110.238 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 26.9 m -133.07 154.74 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-O 121.052 0.453 . . . . 0.0 110.904 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -126.86 112.99 15.98 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 58.3 mt -110.69 132.9 53.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.444 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 55.7 p -73.05 161.86 30.15 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -63.64 142.94 58.21 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.352 -0.539 . . . . 0.0 110.308 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.93 -3.32 77.23 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 111.119 -0.793 . . . . 0.0 111.119 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -103.4 140.8 36.97 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.028 0.442 . . . . 0.0 110.911 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -78.25 173.76 11.93 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.399 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.85 149.9 36.18 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.722 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 41.8 t -162.78 155.36 19.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.027 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -135.83 155.01 51.0 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.075 -0.512 . . . . 0.0 109.643 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -139.37 114.18 9.35 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 179.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -110.91 150.2 29.55 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.181 -178.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 96.3 mtt-85 -114.32 93.37 4.31 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 85.8 mt -119.35 118.65 31.75 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -178.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.545 ' N ' ' OG1' ' A' ' 6' ' ' THR . 88.3 p -76.41 161.11 28.95 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 177.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 12.0 ptp85 -50.64 163.54 0.18 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -176.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -83.32 167.53 17.51 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 113.635 -1.62 . . . . 0.0 110.777 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.2 p -152.22 -59.75 0.15 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -90.99 -70.99 1.21 Allowed Glycine 0 CA--C 1.524 0.621 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 178.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 10.6 tp-100 -122.08 136.27 54.9 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -83.5 148.66 27.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.863 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.49 152.88 39.33 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.91 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 15.4 tpt180 -123.19 123.5 40.94 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.057 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.57 ' CZ2' ' CE1' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -83.59 157.93 22.11 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.151 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -166.78 146.12 5.49 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 119.028 -1.069 . . . . 0.0 112.674 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.7 tt -142.26 128.13 19.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.631 178.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.11 4.27 89.7 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -178.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.56 -24.92 29.9 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 111.941 -0.464 . . . . 0.0 111.941 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 16.7 m -109.41 148.58 38.36 Favored Pre-proline 0 N--CA 1.471 0.607 0 CA-C-N 117.048 0.424 . . . . 0.0 111.37 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -54.97 137.78 76.78 Favored 'Trans proline' 0 N--CA 1.487 1.132 0 C-N-CA 121.449 1.432 . . . . 0.0 110.752 178.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.54 -176.83 3.74 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.03 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -140.52 161.26 38.16 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.648 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.83 81.69 0.89 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.959 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.45 ' O ' ' O ' ' A' ' 51' ' ' ASN . 65.0 t30 -82.0 171.97 13.79 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.984 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -63.82 -35.7 81.49 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.934 0.397 . . . . 0.0 110.108 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 3.2 ppp? -86.96 -3.18 59.06 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.329 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.45 ' O ' ' O ' ' A' ' 48' ' ' ASN . 56.4 t30 -138.51 109.08 6.56 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.554 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -109.67 124.12 50.66 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.121 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.2 mt -110.78 132.15 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.228 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.4 t -144.42 150.5 37.78 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.154 0.502 . . . . 0.0 111.122 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 46.2 t -100.76 116.39 44.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.276 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -88.76 172.73 9.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.309 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -63.15 158.68 19.24 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.784 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.35 17.73 76.31 Favored Glycine 0 CA--C 1.518 0.276 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 66.66 27.9 9.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.95 0.405 . . . . 0.0 110.794 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.7 mp -85.37 131.09 34.45 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.893 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 75.5 m80 -94.49 163.62 13.33 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -155.23 113.17 3.42 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.717 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -94.01 114.61 26.82 Favored 'General case' 0 C--N 1.341 0.215 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 63.9 m -102.2 103.88 14.42 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 38.4 tp -110.58 126.88 54.9 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.724 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -127.94 162.49 26.63 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.596 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt 53.57 72.49 0.43 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.085 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.6 p -91.27 140.92 15.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.067 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.455 ' O ' ' N ' ' A' ' 71' ' ' GLU . 26.9 m -125.39 131.03 53.02 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.4 pp -45.04 -19.22 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.88 0.371 . . . . 0.0 110.757 -178.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.455 ' N ' ' O ' ' A' ' 69' ' ' THR . 98.6 mt-10 -70.66 -32.91 70.36 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.948 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.433 ' O ' ' O ' ' A' ' 73' ' ' ALA . 51.5 t0 -54.16 -70.28 0.1 Allowed 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.373 -178.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.433 ' O ' ' O ' ' A' ' 72' ' ' ASP . . . 33.66 94.19 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.785 0.326 . . . . 0.0 111.019 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -136.73 170.83 23.25 Favored Glycine 0 N--CA 1.463 0.463 0 N-CA-C 111.389 -0.685 . . . . 0.0 111.389 -179.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 28.6 m -117.96 117.49 29.39 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.632 -0.284 . . . . 0.0 110.273 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 11.1 t -93.49 132.99 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 11.3 p -138.17 158.18 44.82 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.012 0.434 . . . . 0.0 111.299 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.57 ' CE1' ' CZ2' ' A' ' 38' ' ' TRP . 4.7 m-85 -130.85 144.95 51.83 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 62.7 t-80 -138.8 115.38 10.59 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.842 0.353 . . . . 0.0 111.601 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.536 ' O ' ' N ' ' A' ' 82' ' ' THR . 2.0 t -123.41 129.88 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -39.2 -20.84 0.01 OUTLIER Glycine 0 CA--C 1.527 0.838 0 CA-C-N 116.339 -0.391 . . . . 0.0 112.214 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.536 ' N ' ' O ' ' A' ' 80' ' ' VAL . 18.4 p -83.5 -74.81 0.35 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.996 0.427 . . . . 0.0 110.162 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 36.6 m -125.53 162.53 24.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.287 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 62.3 m -129.95 155.37 46.19 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.783 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 96.0 p -156.8 162.54 39.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.329 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.51 ' OE2' ' N ' ' A' ' 86' ' ' GLU . 56.7 mp0 -138.14 152.9 49.16 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.111 0.482 . . . . 0.0 111.061 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -139.19 149.58 44.58 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.388 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -119.84 126.57 51.3 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.992 0.425 . . . . 0.0 111.647 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 59.5 tp -113.56 116.13 29.05 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -127.89 147.52 50.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.383 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.7 t -106.52 125.72 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 120.91 0.386 . . . . 0.0 110.029 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 C--N 1.331 -0.215 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.85 -179.621 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.444 ' N ' ' CD ' ' A' ' 4' ' ' GLU . 2.6 pm0 . . . . . 0 N--CA 1.465 0.298 0 CA-C-O 120.769 0.319 . . . . 0.0 110.235 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.3 p -74.65 131.69 34.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.836 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 95.6 m -119.73 128.51 53.84 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.881 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.2 mp -121.62 112.72 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-O 121.121 0.486 . . . . 0.0 111.531 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.6 mt -105.25 93.72 4.84 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 177.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.422 ' OE2' ' CE1' ' A' ' 78' ' ' PHE . 3.4 pt-20 -116.94 89.99 31.31 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.321 -178.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -70.43 -12.59 31.87 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 122.296 1.997 . . . . 0.0 111.792 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.1 68.6 2.7 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.09 0.472 . . . . 0.0 109.737 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -77.99 -2.36 36.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.152 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 39.9 p-10 -172.89 143.36 1.2 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.189 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.8 m -134.93 155.93 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 120.891 0.377 . . . . 0.0 111.338 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -137.25 120.43 16.74 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.189 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 pp -152.14 138.56 18.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.947 0.403 . . . . 0.0 110.828 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.6 m -74.74 150.32 39.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.235 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -56.97 147.49 23.79 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.36 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.92 -9.17 78.55 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.769 -0.533 . . . . 0.0 111.769 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -97.09 156.23 16.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.853 0.358 . . . . 0.0 110.719 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.433 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 19.6 p-10 -75.33 148.91 38.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.495 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -134.54 149.51 50.66 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.814 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 38.2 t -163.17 159.88 23.5 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.567 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -129.47 143.11 50.7 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.383 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -142.39 119.93 11.73 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.905 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 1.2 p -149.6 157.67 43.47 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.078 0.466 . . . . 0.0 111.028 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 96.3 mtt-85 -99.68 143.34 30.03 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.564 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.463 ' O ' ' OG1' ' A' ' 59' ' ' THR . 2.1 tt -145.55 96.41 2.82 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.602 -179.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.7 p -59.97 159.72 8.89 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.805 0.336 . . . . 0.0 110.24 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -57.37 156.3 7.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.868 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -100.05 -173.28 2.4 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.646 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.3 t -141.68 -58.25 0.48 Allowed 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -82.96 -77.07 1.11 Allowed Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -123.91 143.28 50.46 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.797 0.332 . . . . 0.0 110.802 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -92.1 146.21 23.91 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.121 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.86 151.81 43.11 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.373 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 -130.99 151.89 50.9 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.236 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -74.49 178.33 5.37 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.85 125.65 3.66 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.402 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 58.1 tp -129.8 115.91 17.95 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.8 16.67 72.51 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.1 -24.29 25.5 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.5 m -103.4 150.47 38.04 Favored Pre-proline 0 N--CA 1.468 0.448 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -53.93 143.17 61.83 Favored 'Trans proline' 0 C--N 1.315 -1.201 0 C-N-CA 121.455 1.437 . . . . 0.0 110.757 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.08 175.72 7.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.484 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 67.6 tp60 -144.89 153.76 41.91 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.23 72.85 1.26 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.829 0.347 . . . . 0.0 111.539 -178.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' A' ' 51' ' ' ASN . 70.8 m-20 -64.9 -177.16 0.32 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.406 ' OE1' ' N ' ' A' ' 49' ' ' GLU . 56.2 mp0 -68.29 -46.17 71.04 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.469 -0.493 . . . . 0.0 110.685 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 76.6 mtm -67.61 -39.32 84.76 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.943 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' A' ' 48' ' ' ASN . 1.9 m-80 -93.56 143.03 26.68 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.733 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -135.89 136.83 40.84 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.0 mm -107.39 122.5 61.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 95.3 m -129.85 129.49 44.03 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.073 0.463 . . . . 0.0 111.31 -178.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.5 m -121.3 136.88 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.425 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -137.56 -177.26 4.71 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.823 0.344 . . . . 0.0 110.521 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -51.23 157.58 0.92 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.575 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.08 30.29 77.35 Favored Glycine 0 CA--C 1.519 0.322 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.463 ' OG1' ' O ' ' A' ' 28' ' ' LEU . 65.3 p 41.63 39.64 1.19 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.095 0.474 . . . . 0.0 110.263 -179.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 55.5 mt -71.28 131.86 44.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.013 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -107.11 135.71 48.19 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.963 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -146.52 97.32 2.9 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 27.9 tp -96.61 106.97 19.33 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.113 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 26.5 m -89.7 114.59 26.26 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.109 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.402 ' C ' ' CD1' ' A' ' 65' ' ' LEU . 0.3 OUTLIER -105.47 118.37 36.39 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.457 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -110.77 147.02 35.33 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.261 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 65.5 mttm 54.82 58.58 4.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.97 179.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.1 p -56.57 149.02 3.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.343 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.437 ' HG1' ' H ' ' A' ' 72' ' ' ASP . 79.6 p -133.13 155.48 49.19 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.457 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 90.4 mt -60.32 -24.72 65.24 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -68.66 -36.12 78.13 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.145 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.437 ' H ' ' HG1' ' A' ' 69' ' ' THR . 66.2 t0 -62.01 -41.24 97.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.043 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.24 141.54 50.44 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 172.01 -99.28 0.14 Allowed Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.245 -0.979 . . . . 0.0 111.737 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 31.7 m -159.11 117.06 2.82 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.826 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 82.0 t -107.39 129.47 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 57.7 m -138.42 178.77 6.89 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.906 0.384 . . . . 0.0 111.236 -178.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.422 ' CE1' ' OE2' ' A' ' 9' ' ' GLU . 97.4 m-85 -128.53 141.02 51.51 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.101 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -116.99 102.53 9.42 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.451 ' O ' ' O ' ' A' ' 83' ' ' CYS . 2.1 t -118.9 134.38 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.241 -179.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.52 -23.91 61.13 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 121.159 -0.544 . . . . 0.0 111.885 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 43.2 p -98.8 -21.79 16.17 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 117.188 0.494 . . . . 0.0 112.124 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.451 ' O ' ' O ' ' A' ' 80' ' ' VAL . 27.6 p -154.17 -177.83 6.7 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.057 0.456 . . . . 0.0 111.205 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 31.4 t -148.79 150.51 33.2 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 49.2 m -154.13 168.11 27.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.923 0.392 . . . . 0.0 110.871 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -151.14 157.71 43.07 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.645 -179.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.88 146.44 25.66 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.274 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -116.85 131.39 56.96 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.28 0.562 . . . . 0.0 111.605 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.46 ' CD1' ' N ' ' A' ' 89' ' ' LEU . 9.4 mp -101.74 115.81 31.35 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.34 -0.846 . . . . 0.0 108.969 178.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -120.5 152.88 37.45 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.63 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.5 m -113.72 135.62 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 39.9 m . . . . . 0 C--N 1.323 -0.572 0 CA-C-O 121.037 0.446 . . . . 0.0 111.29 -179.134 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.413 ' OE2' ' OG1' ' A' ' 82' ' ' THR . 79.8 tt0 . . . . . 0 C--O 1.233 0.187 0 CA-C-O 120.716 0.293 . . . . 0.0 110.269 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.453 ' O ' ' CG1' ' A' ' 5' ' ' VAL . 5.6 p -61.88 122.01 11.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.426 ' HB ' ' H ' ' A' ' 29' ' ' SER . 38.2 m -67.82 131.55 45.74 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 119.284 -0.966 . . . . 0.0 109.091 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.404 ' CG2' ' O ' ' A' ' 7' ' ' ILE . 9.7 tp -110.47 101.22 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-O 122.057 0.932 . . . . 0.0 112.072 -178.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.6 mt -129.99 82.06 2.05 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.44 -1.254 . . . . 0.0 109.581 178.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 49.0 tt0 -119.71 86.2 34.79 Favored Pre-proline 0 N--CA 1.468 0.448 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.561 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.445 ' O ' ' N ' ' A' ' 12' ' ' GLN . 3.4 Cg_exo -71.55 -7.68 21.71 Favored 'Trans proline' 0 C--N 1.314 -1.273 0 C-N-CA 122.279 1.986 . . . . 0.0 111.409 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 29.3 mt -64.4 75.2 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.853 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.445 ' N ' ' O ' ' A' ' 10' ' ' PRO . 87.6 mt-30 -76.65 -67.63 0.68 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.119 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.444 ' OD2' ' O ' ' A' ' 12' ' ' GLN . 63.6 m-20 -157.42 127.3 6.18 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.514 -178.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.3 m -129.24 156.9 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 121.362 0.601 . . . . 0.0 111.305 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -120.71 129.33 53.61 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.136 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 74.8 mt -118.88 129.27 55.11 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.053 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.6 m -78.76 148.35 33.02 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 177.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -63.81 134.16 54.73 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.953 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.79 -2.09 64.08 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -112.24 134.5 53.75 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.006 0.431 . . . . 0.0 110.717 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -83.21 167.66 17.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.122 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -159.73 174.87 13.87 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.226 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 29.9 t -156.87 148.62 22.62 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.071 0.463 . . . . 0.0 110.915 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -103.0 141.09 36.39 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -129.39 119.1 23.27 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.118 0.485 . . . . 0.0 110.384 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 2.7 m -126.56 163.95 22.27 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.581 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 77.5 ttt-85 -142.65 115.76 8.87 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.9 mt -127.69 100.91 6.15 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 121.095 -0.242 . . . . 0.0 110.995 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.426 ' H ' ' HB ' ' A' ' 6' ' ' THR . 14.2 t -60.05 177.61 0.23 Allowed 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 119.991 -0.684 . . . . 0.0 109.5 179.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -54.41 136.95 43.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.481 0.658 . . . . 0.0 111.866 -178.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.05 -172.86 3.28 Favored 'General case' 0 CA--C 1.521 -0.136 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.937 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.2 t -147.53 -65.34 0.26 Allowed 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.493 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.84 -88.46 0.22 Allowed Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 178.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -124.13 141.0 52.43 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.234 0.54 . . . . 0.0 111.368 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.4 tp10 -83.63 152.91 24.55 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.246 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.38 139.34 51.88 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.197 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 86.2 mtm-85 -115.97 138.59 51.06 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.763 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 80.8 m95 -76.21 169.16 18.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.008 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -165.1 119.83 1.31 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.809 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.424 ' C ' ' CD2' ' A' ' 40' ' ' LEU . 6.7 tt -118.96 114.75 23.04 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.97 14.7 81.51 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.64 -23.57 35.37 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 16.7 m -104.94 146.52 32.82 Favored Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -54.62 142.12 73.0 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 121.547 1.498 . . . . 0.0 111.892 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.409 ' H ' ' CD2' ' A' ' 45' ' ' LEU . 1.0 OUTLIER -82.4 171.54 14.06 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.279 179.154 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 71.3 tp60 -144.92 142.01 29.51 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.187 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.38 141.57 58.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.82 0.343 . . . . 0.0 110.274 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.456 ' O ' ' O ' ' A' ' 51' ' ' ASN . 45.4 t30 -155.66 -164.89 1.84 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 53.8 mp0 -66.03 -48.49 70.92 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 119.924 -0.71 . . . . 0.0 110.167 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 66.4 ttp -68.35 -43.43 77.47 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.466 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.456 ' O ' ' O ' ' A' ' 48' ' ' ASN . 99.1 m-20 -107.39 137.84 44.7 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.892 0.377 . . . . 0.0 110.84 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 48' ' ' ASN . 96.7 m-20 -139.31 146.74 40.69 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.423 HG21 HD13 ' A' ' 53' ' ' ILE . 98.6 mt -124.06 127.05 73.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 88.5 m -125.43 131.47 52.9 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.886 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.6 t -87.69 128.06 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.209 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -116.1 154.26 30.28 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.545 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -56.36 155.73 6.67 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.583 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.85 12.39 84.48 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 68.77 22.92 7.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.619 -0.291 . . . . 0.0 111.758 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.9 mp -79.28 144.28 34.45 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 178.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 66.1 m170 -110.96 156.18 21.59 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.416 ' CD1' ' C ' ' A' ' 62' ' ' LEU . 0.4 OUTLIER -153.22 108.9 3.28 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.385 -179.208 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.3 mp -95.94 109.58 21.92 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 95.3 m -87.44 113.87 23.54 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.432 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 74.8 mt -99.63 104.13 15.87 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.718 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -97.96 134.79 40.59 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.037 0.446 . . . . 0.0 111.579 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt 52.79 65.68 1.45 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.991 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.1 p -61.84 153.04 6.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.389 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.2 t -135.77 163.34 30.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.735 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 62.8 mt -60.31 -29.01 68.57 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.256 0.551 . . . . 0.0 109.867 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -66.69 -24.11 66.22 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.587 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.4 ' O ' ' C ' ' A' ' 73' ' ' ALA . 55.7 t0 -61.99 -40.76 96.73 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.36 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 72' ' ' ASP . . . -38.9 122.08 1.14 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.518 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -174.97 177.25 47.08 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 52.9 m -103.93 127.61 51.45 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.033 0.444 . . . . 0.0 111.436 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 74.0 t -117.15 129.42 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.242 178.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 36.2 t -144.5 171.68 14.01 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -150.96 150.51 30.89 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.047 0.451 . . . . 0.0 110.996 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -117.26 127.86 54.5 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.62 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.427 ' O ' ' O ' ' A' ' 83' ' ' CYS . 2.5 t -118.36 130.14 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.03 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -48.0 -19.26 0.95 Allowed Glycine 0 CA--C 1.53 1.006 0 CA-C-N 115.962 -0.563 . . . . 0.0 113.061 -178.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.413 ' OG1' ' OE2' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -107.01 -33.63 7.43 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 117.725 0.762 . . . . 0.0 111.549 -179.014 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.427 ' O ' ' O ' ' A' ' 80' ' ' VAL . 33.1 m -144.93 -175.56 4.73 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 96.0 p -159.38 157.95 31.28 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.778 0.323 . . . . 0.0 110.912 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.625 ' HG ' ' H ' ' A' ' 86' ' ' GLU . 48.2 t -167.27 168.33 13.41 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.085 0.469 . . . . 0.0 111.022 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.625 ' H ' ' HG ' ' A' ' 85' ' ' SER . 98.1 mt-10 -133.95 163.27 29.92 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.956 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -149.15 154.04 38.6 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -124.72 132.84 53.35 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.262 0.553 . . . . 0.0 111.512 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 60.7 tp -116.92 103.69 10.55 Favored 'General case' 0 C--N 1.334 -0.094 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.691 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -103.98 147.39 27.41 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 13.2 t -120.01 99.26 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.4 t . . . . . 0 N--CA 1.468 0.471 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.4 -179.931 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 . . . . . 0 N--CA 1.456 -0.158 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.6 t -64.32 135.95 27.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.425 ' HB ' ' H ' ' A' ' 29' ' ' SER . 20.4 m -104.14 135.8 44.95 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.767 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.8 mp -121.25 116.25 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 121.379 0.609 . . . . 0.0 111.222 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 96.5 mt -128.35 98.11 4.96 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.073 -0.967 . . . . 0.0 108.581 177.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -122.59 90.14 49.7 Favored Pre-proline 0 N--CA 1.468 0.449 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -178.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -74.23 -5.06 16.41 Favored 'Trans proline' 0 N--CA 1.489 1.231 0 C-N-CA 122.024 1.816 . . . . 0.0 110.068 178.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 65.7 mt -66.45 74.85 0.1 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.353 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -71.6 -49.61 38.67 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.957 0.408 . . . . 0.0 111.775 -179.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -173.7 137.76 0.62 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.989 -178.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 53.0 t -125.11 133.48 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 120.84 0.352 . . . . 0.0 110.578 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -134.24 99.68 4.47 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.126 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 87.4 mt -124.9 139.92 53.39 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.939 0.399 . . . . 0.0 111.309 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.3 t -68.32 141.92 55.66 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.447 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -51.21 149.16 4.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.306 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.95 16.98 78.03 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -115.58 147.48 40.69 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.96 136.59 50.68 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.331 -0.548 . . . . 0.0 109.593 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -132.23 154.92 49.13 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.234 -179.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.9 m -158.63 159.62 35.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.981 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -136.99 148.65 47.02 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.225 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -145.15 122.82 11.82 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.042 0.449 . . . . 0.0 110.935 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 5.9 t -135.56 139.59 44.01 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.248 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 64.6 ttp85 -122.71 127.98 49.96 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.111 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.6 pp -143.69 133.46 23.83 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.22 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.425 ' H ' ' HB ' ' A' ' 6' ' ' THR . 44.7 t -66.22 158.85 27.77 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.008 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 38.4 ptt-85 -51.48 163.93 0.24 Allowed 'General case' 0 C--N 1.32 -0.716 0 O-C-N 123.665 0.603 . . . . 0.0 111.972 -177.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.56 174.8 2.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.322 -178.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.65 ' HG ' ' H ' ' A' ' 33' ' ' GLY . 18.4 p -138.46 -56.82 0.64 Allowed 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.65 ' H ' ' HG ' ' A' ' 32' ' ' SER . . . -104.89 -66.85 0.69 Allowed Glycine 0 CA--C 1.523 0.592 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 178.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.488 HE21 ' H ' ' A' ' 81' ' ' GLY . 14.1 pt20 -122.7 143.08 50.03 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.783 0.325 . . . . 0.0 110.315 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.547 ' CD ' ' H ' ' A' ' 35' ' ' GLU . 1.2 pm0 -70.57 146.46 50.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.528 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.89 157.05 38.21 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -123.97 133.86 53.61 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.337 0.589 . . . . 0.0 111.683 -178.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 22.0 t-105 -99.02 147.87 24.59 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.084 -0.962 . . . . 0.0 108.919 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -172.68 147.6 1.81 Allowed 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 119.883 -0.727 . . . . 0.0 112.419 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.6 tp -124.96 119.03 27.59 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.89 8.52 84.78 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.42 -1.36 58.69 Favored Glycine 0 CA--C 1.531 1.066 0 N-CA-C 111.954 -0.458 . . . . 0.0 111.954 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.9 m -115.87 147.25 38.7 Favored Pre-proline 0 CA--C 1.549 0.93 0 CA-C-N 117.384 0.592 . . . . 0.0 111.618 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -58.45 145.82 92.82 Favored 'Trans proline' 0 N--CA 1.502 2.022 0 C-N-CA 122.008 1.806 . . . . 0.0 112.359 178.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.0 mp -90.29 144.84 25.47 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.084 178.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.437 ' O ' ' N ' ' A' ' 48' ' ' ASN . 1.0 OUTLIER -122.89 153.14 40.05 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.396 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.64 76.57 0.02 OUTLIER 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.489 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.463 ' OD1' ' N ' ' A' ' 49' ' ' GLU . 24.3 t-20 -74.25 165.7 24.72 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.607 179.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.463 ' N ' ' OD1' ' A' ' 48' ' ' ASN . 97.5 mt-10 -62.12 -40.34 95.59 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.616 -0.433 . . . . 0.0 110.885 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 12.4 ptt? -85.6 -15.33 42.9 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 121.032 -0.267 . . . . 0.0 111.173 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.461 ' O ' ' O ' ' A' ' 48' ' ' ASN . 35.1 t-20 -126.11 122.45 35.79 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.594 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -124.5 128.1 48.46 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 75.5 mt -107.1 129.56 60.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.951 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.442 ' HG1' ' N ' ' A' ' 55' ' ' VAL . 1.9 t -143.93 147.98 34.73 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.853 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.442 ' N ' ' HG1' ' A' ' 54' ' ' THR . 6.9 m -110.92 131.32 62.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.371 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.446 ' O ' ' C ' ' A' ' 57' ' ' GLN . 98.8 mt-10 -112.11 -173.51 2.26 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.382 -179.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.446 ' C ' ' O ' ' A' ' 56' ' ' GLU . 45.6 tp60 -25.62 144.07 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 O-C-N 123.834 0.709 . . . . 0.0 111.854 -179.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 58.12 -97.31 0.07 OUTLIER Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 17.9 m -162.5 62.31 0.21 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.991 0.424 . . . . 0.0 110.364 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 8.3 tt -104.31 120.66 41.67 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.915 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -90.8 148.53 22.47 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.202 -0.453 . . . . 0.0 109.833 178.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.3 tt -151.57 114.66 4.73 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.86 0.362 . . . . 0.0 110.409 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.6 mp -97.0 114.94 26.59 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.882 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.6 m -94.11 109.37 21.15 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 62.3 mt -101.06 132.31 46.56 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.545 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 49.7 p-80 -153.25 155.46 36.63 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.76 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt 50.97 55.49 9.48 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 120.889 0.376 . . . . 0.0 110.091 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.5 m -110.49 130.1 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.777 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 64.1 p -86.35 -157.49 0.36 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.052 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 40.5 tp -59.88 -15.96 25.42 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.876 0.369 . . . . 0.0 110.442 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -67.6 -5.45 15.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.966 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 72' ' ' ASP . 25.2 p-10 -53.37 -30.0 37.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.394 -179.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.1 135.02 56.96 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.101 -0.64 . . . . 0.0 109.667 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -174.54 166.83 38.89 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -122.95 108.6 13.14 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.57 0.224 . . . . 0.0 110.707 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 8.6 t -101.15 120.6 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 33.9 t -137.13 152.09 49.57 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.334 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -135.73 147.8 48.58 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.86 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.545 ' ND1' ' OG ' ' A' ' 84' ' ' SER . 93.7 m-70 -125.22 123.83 40.42 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.209 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.508 ' O ' ' N ' ' A' ' 82' ' ' THR . 2.9 p -128.41 130.35 69.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.488 ' H ' HE21 ' A' ' 34' ' ' GLN . . . -31.7 -31.39 0.01 OUTLIER Glycine 0 CA--C 1.529 0.913 0 CA-C-N 115.671 -0.695 . . . . 0.0 113.1 -178.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.703 ' HG1' ' H ' ' A' ' 83' ' ' CYS . 82.5 p -79.04 -75.68 0.23 Allowed 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.659 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.703 ' H ' ' HG1' ' A' ' 82' ' ' THR . 46.2 t -111.56 163.81 13.67 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 120.829 0.347 . . . . 0.0 111.315 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.545 ' OG ' ' ND1' ' A' ' 79' ' ' HIS . 23.3 t -140.74 134.36 30.15 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 13.9 m -160.27 167.91 26.49 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.272 0.558 . . . . 0.0 111.999 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -140.22 164.11 30.96 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.963 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -134.33 148.36 50.72 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -113.61 127.49 56.08 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.267 -179.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.2 tt -112.02 112.34 23.9 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 17.7 ttpt -113.29 170.12 8.46 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.078 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.0 t -111.0 125.58 68.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.476 -179.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 97.8 m . . . . . 0 C--N 1.333 -0.135 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.999 -179.608 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.487 ' HG2' ' H ' ' A' ' 5' ' ' VAL . 39.3 tt0 . . . . . 0 N--CA 1.464 0.241 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.487 ' H ' ' HG2' ' A' ' 4' ' ' GLU . 9.8 p -52.65 136.49 13.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 110.431 -0.211 . . . . 0.0 110.431 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.632 ' H ' ' HG ' ' A' ' 29' ' ' SER . 7.1 m -115.96 125.3 52.36 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.42 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.534 ' CD1' ' N ' ' A' ' 7' ' ' ILE . 3.0 mp -108.41 111.43 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 121.144 0.497 . . . . 0.0 111.046 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.8 mp -122.31 84.27 2.23 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.44 ' O ' ' CG ' ' A' ' 9' ' ' GLU . 0.2 OUTLIER -110.74 98.93 39.84 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.806 -178.246 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -73.9 -7.16 19.65 Favored 'Trans proline' 0 N--CA 1.489 1.238 0 C-N-CA 121.454 1.436 . . . . 0.0 110.136 178.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 52.3 mt -61.17 80.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.425 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -79.32 -67.15 0.78 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.422 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -171.78 128.26 0.63 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.651 -0.25 . . . . 0.0 110.37 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.8 m -126.15 162.1 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-O 120.926 0.394 . . . . 0.0 110.978 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -116.95 128.74 55.5 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.127 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 74.6 mt -123.01 129.34 51.39 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.058 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.4 p -76.55 164.18 26.19 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -61.83 128.68 37.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.828 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 77.34 19.53 76.48 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.068 178.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -103.41 138.47 40.1 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.85 0.357 . . . . 0.0 110.963 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 49.5 p30 -82.39 164.89 20.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.044 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -161.89 168.98 22.05 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.914 0.388 . . . . 0.0 110.213 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 73.1 m -147.76 140.85 25.01 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.961 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -111.8 129.85 56.0 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 23.8 tm0? -132.11 127.09 35.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.201 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -149.47 163.94 36.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.333 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -120.28 120.89 37.38 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.09 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.7 tt -132.14 104.78 6.98 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.632 ' HG ' ' H ' ' A' ' 6' ' ' THR . 10.1 p -62.68 153.12 33.45 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.167 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -53.31 153.25 4.0 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.592 -177.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.78 -175.17 3.66 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.848 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 44.9 t -142.44 -49.62 0.36 Allowed 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -91.77 -76.2 1.32 Allowed Glycine 0 CA--C 1.52 0.353 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -124.91 135.49 52.9 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.075 0.464 . . . . 0.0 111.864 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.461 ' O ' ' NH1' ' A' ' 37' ' ' ARG . 22.5 pt-20 -83.6 154.61 23.67 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.978 179.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.59 151.97 42.06 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.783 0.325 . . . . 0.0 110.692 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.461 ' NH1' ' O ' ' A' ' 35' ' ' GLU . 87.4 mmt-85 -106.72 148.24 28.64 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.068 0.461 . . . . 0.0 111.277 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 2.9 t-105 -107.71 148.52 29.31 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 179.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -173.31 155.26 2.85 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 119.864 -0.734 . . . . 0.0 111.73 -178.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 32.9 tp -134.22 124.72 26.42 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.707 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.51 6.14 88.06 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.653 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.73 -16.09 57.87 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 121.278 -0.487 . . . . 0.0 112.068 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.8 m -112.21 141.82 25.74 Favored Pre-proline 0 N--CA 1.472 0.671 0 CA-C-N 117.134 0.467 . . . . 0.0 110.43 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -56.87 143.12 92.43 Favored 'Trans proline' 0 N--CA 1.488 1.202 0 C-N-CA 120.826 1.018 . . . . 0.0 110.873 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.17 -166.69 1.33 Allowed 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.537 ' O ' ' N ' ' A' ' 48' ' ' ASN . 2.3 pm0 -153.28 153.99 33.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.927 0.394 . . . . 0.0 111.02 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -55.4 76.31 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.318 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.537 ' N ' ' O ' ' A' ' 46' ' ' GLN . 10.3 t-20 -75.04 171.37 14.23 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.884 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -62.13 -33.98 75.49 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.883 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 14.8 ptp -94.02 -19.63 20.7 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.772 0.32 . . . . 0.0 110.986 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -120.29 118.98 31.82 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.152 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -121.26 142.42 49.95 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.77 0.319 . . . . 0.0 110.63 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.408 HD13 HG22 ' A' ' 53' ' ' ILE . 15.5 mm -115.6 118.35 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.4 p -138.85 159.61 41.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.934 0.397 . . . . 0.0 111.183 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 55.8 t -117.51 129.04 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.659 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -107.4 167.46 9.91 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.517 ' NE2' ' H ' ' A' ' 58' ' ' GLY . 71.1 tp60 -58.42 152.77 17.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.947 0.403 . . . . 0.0 110.5 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.517 ' H ' ' NE2' ' A' ' 57' ' ' GLN . . . 79.5 11.29 85.0 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 69.15 27.37 5.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.402 -0.399 . . . . 0.0 110.809 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.413 ' N ' ' CD1' ' A' ' 60' ' ' LEU . 10.6 mp -87.09 129.69 34.81 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.32 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -97.51 131.12 44.43 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.425 ' CD1' ' C ' ' A' ' 62' ' ' LEU . 0.5 OUTLIER -123.48 115.57 21.79 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.875 -179.481 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.8 mp -103.01 114.04 28.01 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 25.9 m -88.8 117.01 27.48 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.179 0.514 . . . . 0.0 110.387 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 36.9 tp -107.31 127.13 53.27 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.253 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -85.23 -170.1 2.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.888 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -72.36 71.31 0.9 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.672 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 23.9 m -69.21 -172.54 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.488 0.661 . . . . 0.0 112.069 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.553 ' HG1' ' H ' ' A' ' 71' ' ' GLU . 69.8 p -130.6 -165.31 1.53 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.764 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 53.6 mt -64.23 -15.94 61.02 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.738 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.553 ' H ' ' HG1' ' A' ' 69' ' ' THR . 97.4 mt-10 -65.25 -38.11 89.31 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -66.63 -36.29 82.22 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.744 0.307 . . . . 0.0 111.316 -179.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -40.28 112.79 0.3 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.17 0.51 . . . . 0.0 111.268 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -168.83 -179.65 41.1 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 109.704 -1.359 . . . . 0.0 109.704 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 99.0 m -105.19 120.54 41.79 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.907 0.354 . . . . 0.0 111.413 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 12.0 t -93.59 134.55 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.9 p -140.9 146.62 37.7 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.132 0.491 . . . . 0.0 110.916 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -150.95 147.59 27.36 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.483 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 53.5 p-80 -159.78 163.4 34.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.58 0.705 . . . . 0.0 111.96 -178.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.556 ' O ' ' N ' ' A' ' 82' ' ' THR . 2.5 p -131.59 140.4 48.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.254 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -35.54 -24.5 0.01 OUTLIER Glycine 0 CA--C 1.528 0.897 0 CA-C-N 115.67 -0.695 . . . . 0.0 112.604 -178.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.556 ' N ' ' O ' ' A' ' 80' ' ' VAL . 43.9 p -85.97 -72.73 0.48 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.058 0.456 . . . . 0.0 110.864 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.513 ' N ' ' OG1' ' A' ' 82' ' ' THR . 35.3 m -108.55 -171.56 1.88 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.794 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 83.2 p -156.85 153.95 29.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.896 0.379 . . . . 0.0 111.097 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 47.8 t -152.89 153.79 33.74 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.342 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -134.54 150.96 50.81 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.51 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -139.85 148.37 42.0 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -124.13 125.6 44.75 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.996 0.426 . . . . 0.0 111.793 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.8 tp -113.28 100.84 8.87 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.678 178.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 13.4 ptpt -107.91 172.07 7.04 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 179.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.4 m -128.77 158.6 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 121.328 0.585 . . . . 0.0 111.478 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 N--CA 1.466 0.344 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.745 -179.828 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.483 ' O ' ' OG ' ' A' ' 29' ' ' SER . 88.5 tt0 . . . . . 0 N--CA 1.454 -0.252 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.6 m -58.28 122.22 7.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.545 ' OG1' ' N ' ' A' ' 29' ' ' SER . 41.7 p -88.5 138.73 31.17 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 118.81 -1.156 . . . . 0.0 110.189 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 18.8 mm -110.55 62.4 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.643 -179.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -102.09 74.2 1.43 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.346 0.593 . . . . 0.0 109.948 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -122.99 84.32 50.72 Favored Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.921 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -70.9 50.83 1.16 Allowed 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 122.275 1.983 . . . . 0.0 112.25 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.6 mt -79.93 127.39 32.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.169 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 27.3 pt20 -118.81 -145.05 0.37 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.342 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -104.36 130.88 52.19 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.949 0.404 . . . . 0.0 110.426 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.4 m -123.41 138.1 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.2 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -113.32 115.31 27.93 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.264 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 73.3 mt -119.35 135.08 54.89 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.04 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.42 ' HG ' ' N ' ' A' ' 18' ' ' GLU . 31.0 t -63.6 151.39 41.74 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.42 ' N ' ' HG ' ' A' ' 17' ' ' SER . 81.5 tt0 -55.55 144.42 26.35 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.052 0.453 . . . . 0.0 111.504 -179.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.18 19.2 75.09 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -114.68 144.97 42.59 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.281 0.563 . . . . 0.0 111.152 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 51.3 p-10 -75.5 168.24 20.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.305 -0.862 . . . . 0.0 110.028 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -140.79 142.65 34.65 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.69 0.281 . . . . 0.0 110.913 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 60.6 m -136.25 152.54 50.84 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.857 0.361 . . . . 0.0 111.087 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -135.4 152.24 51.23 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.379 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.422 ' C ' ' SG ' ' A' ' 26' ' ' CYS . 58.4 tt0 -134.33 143.49 47.72 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.698 0.285 . . . . 0.0 110.364 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.422 ' SG ' ' C ' ' A' ' 25' ' ' GLN . 30.0 m -150.34 164.34 36.05 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.254 0.55 . . . . 0.0 111.506 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -134.4 99.8 4.48 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 115.427 -0.806 . . . . 0.0 108.859 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.469 ' O ' ' OG1' ' A' ' 59' ' ' THR . 50.1 mt -118.91 128.79 54.76 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.205 -178.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.545 ' N ' ' OG1' ' A' ' 6' ' ' THR . 24.1 p -73.65 158.66 34.32 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 51.7 ptt85 -58.11 169.47 0.81 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 -176.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.8 151.08 45.2 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 113.826 -1.534 . . . . 0.0 111.56 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 73.4 m -139.48 -54.95 0.57 Allowed 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.037 179.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -100.49 -65.81 0.81 Allowed Glycine 0 CA--C 1.52 0.372 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 178.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -123.39 145.27 48.9 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 178.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.608 ' CD ' ' H ' ' A' ' 35' ' ' GLU . 1.7 pm0 -76.17 143.73 40.95 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.092 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.52 152.71 37.78 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.536 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 84.2 mtm180 -128.56 139.74 52.14 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.236 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.532 ' CZ2' ' CE2' ' A' ' 78' ' ' PHE . 10.6 t-105 -101.46 150.96 22.51 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -171.37 157.33 4.89 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 119.498 -0.881 . . . . 0.0 111.914 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.2 tt -123.72 124.94 43.84 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.415 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.27 21.99 76.04 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.98 7.72 88.27 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 71.7 t -113.69 128.77 25.36 Favored Pre-proline 0 N--CA 1.47 0.537 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -57.34 143.56 93.56 Favored 'Trans proline' 0 N--CA 1.488 1.203 0 CA-C-N 120.004 1.037 . . . . 0.0 111.03 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -106.73 179.66 4.2 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.035 0.445 . . . . 0.0 111.245 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -145.86 150.63 36.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.988 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.99 139.26 48.51 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.035 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.431 ' OD1' ' O ' ' A' ' 51' ' ' ASN . 32.8 p-10 -166.54 -175.01 3.02 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.884 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -66.45 -41.79 88.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.576 -0.283 . . . . 0.0 111.66 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 54.4 ttp -67.95 -42.7 80.52 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.431 ' O ' ' OD1' ' A' ' 48' ' ' ASN . 86.7 m-20 -135.31 115.41 13.23 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.392 178.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.481 ' OD1' ' O ' ' A' ' 64' ' ' THR . 12.2 p-10 -111.63 147.41 35.57 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 178.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.1 mm -113.26 126.25 70.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 98.4 m -127.82 134.31 49.44 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.757 0.313 . . . . 0.0 110.9 -178.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.6 p -111.17 133.86 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 57' ' ' GLN . 95.9 mt-10 -116.09 -177.33 3.14 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.035 0.445 . . . . 0.0 111.766 -178.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.449 ' O ' ' N ' ' A' ' 59' ' ' THR . 77.8 mt-30 -24.92 144.11 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.069 -0.969 . . . . 0.0 112.784 -179.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.426 ' O ' ' CG2' ' A' ' 59' ' ' THR . . . 52.91 -89.44 0.01 OUTLIER Glycine 0 CA--C 1.519 0.284 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.469 ' OG1' ' O ' ' A' ' 28' ' ' LEU . 19.7 p -160.33 42.82 0.19 Allowed 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.484 -179.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.6 mp -86.01 112.66 21.43 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 49.1 m170 -86.49 150.93 23.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.874 -179.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.2 tp -149.41 105.91 3.53 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.537 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.469 ' CD2' ' N ' ' A' ' 63' ' ' LEU . 1.3 mm? -83.15 111.41 18.89 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.072 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.481 ' O ' ' OD1' ' A' ' 52' ' ' ASP . 70.9 m -101.79 94.82 6.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.108 0.48 . . . . 0.0 111.206 -178.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.5 mp -95.65 136.37 36.14 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.613 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.626 ' CG ' ' H ' ' A' ' 67' ' ' LYS . 45.7 t60 -70.93 -176.07 1.27 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.587 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.626 ' H ' ' CG ' ' A' ' 66' ' ' HIS . 97.7 mttt -63.47 100.39 0.26 Allowed 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.3 m -100.02 134.36 39.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.258 -178.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 30.9 p -79.28 -148.54 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.247 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.532 ' C ' ' H ' ' A' ' 72' ' ' ASP . 88.4 mt -54.48 -37.31 65.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.598 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -50.25 -8.38 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.661 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.532 ' H ' ' C ' ' A' ' 70' ' ' LEU . 37.1 p-10 -65.64 -35.73 81.66 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.821 0.343 . . . . 0.0 110.839 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -47.45 111.43 0.41 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -173.84 166.55 38.78 Favored Glycine 0 CA--C 1.522 0.496 0 C-N-CA 120.638 -0.792 . . . . 0.0 111.388 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 10.3 m -118.84 126.43 51.82 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.723 -0.239 . . . . 0.0 110.448 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.5 t -103.88 130.76 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 93.9 p -121.92 160.43 24.82 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.171 0.51 . . . . 0.0 110.43 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.532 ' CE2' ' CZ2' ' A' ' 38' ' ' TRP . 12.0 m-85 -135.32 138.31 43.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.172 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 72.6 t60 -127.89 127.52 43.53 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.184 0.516 . . . . 0.0 111.225 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.48 ' O ' ' C ' ' A' ' 81' ' ' GLY . 2.6 p -148.7 116.63 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.337 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.48 ' C ' ' O ' ' A' ' 80' ' ' VAL . . . -5.75 -67.34 0.01 OUTLIER Glycine 0 N--CA 1.473 1.116 0 O-C-N 123.927 0.767 . . . . 0.0 113.877 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.605 ' HG1' ' H ' ' A' ' 83' ' ' CYS . 65.1 p -48.6 -86.59 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -178.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.605 ' H ' ' HG1' ' A' ' 82' ' ' THR . 92.5 m -125.48 -168.71 1.88 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.384 -179.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 51.6 p -153.79 168.71 25.4 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.709 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.676 ' HG ' ' N ' ' A' ' 86' ' ' GLU . 39.1 t -152.11 169.99 21.06 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.723 -179.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.676 ' N ' ' HG ' ' A' ' 85' ' ' SER . 17.6 pt-20 -150.19 164.11 36.51 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 120.973 0.416 . . . . 0.0 111.184 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.0 152.1 38.05 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.114 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -119.5 129.96 54.97 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.215 0.531 . . . . 0.0 111.066 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 8.2 tt -117.53 122.68 44.35 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.399 -0.818 . . . . 0.0 109.684 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -120.23 159.51 24.79 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.015 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.7 p -109.56 126.91 66.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-O 120.889 0.375 . . . . 0.0 110.154 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 31.6 m . . . . . 0 C--N 1.325 -0.461 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.539 -179.579 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 . . . . . 0 N--CA 1.466 0.359 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.6 p -72.09 127.22 33.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.805 ' H ' ' HG ' ' A' ' 29' ' ' SER . 26.2 p -101.0 135.56 42.25 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.721 -179.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.524 ' CD1' ' N ' ' A' ' 7' ' ' ILE . 1.9 mp -107.78 115.16 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 121.492 0.663 . . . . 0.0 111.687 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.455 ' CD2' ' NH1' ' A' ' 27' ' ' ARG . 49.2 tp -126.95 110.77 13.35 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 114.537 -1.211 . . . . 0.0 109.141 178.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.498 ' OE1' ' SG ' ' A' ' 26' ' ' CYS . 24.9 mm-40 -125.15 91.8 48.52 Favored Pre-proline 0 N--CA 1.471 0.598 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -178.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -71.69 -9.32 24.76 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 C-N-CA 121.747 1.632 . . . . 0.0 111.619 177.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.84 87.75 3.43 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.613 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 95.9 mm-40 -69.61 -32.79 71.71 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.097 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 43.6 p-10 -176.96 142.58 0.38 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.904 0.383 . . . . 0.0 110.576 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 51.8 t -119.72 133.1 67.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.557 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.436 HE21 ' CE ' ' A' ' 90' ' ' LYS . 98.1 mt-30 -135.85 108.61 7.53 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -115.13 133.22 56.23 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 120.563 0.221 . . . . 0.0 110.427 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.9 t -68.1 149.52 49.52 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.877 0.37 . . . . 0.0 110.732 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -52.3 132.28 33.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.779 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.94 16.48 56.1 Favored Glycine 0 CA--C 1.534 1.256 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.972 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -125.06 155.87 39.1 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.913 0.387 . . . . 0.0 110.273 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 43.9 p-10 -85.72 169.36 13.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.555 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -134.44 147.36 50.41 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.042 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 44.5 t -134.87 141.21 46.29 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.884 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -119.96 146.38 45.88 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.127 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -128.71 104.89 7.9 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.224 179.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.498 ' SG ' ' OE1' ' A' ' 9' ' ' GLU . 6.6 t -124.45 141.81 51.79 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.455 ' NH1' ' CD2' ' A' ' 8' ' ' LEU . 60.1 ttp180 -124.99 119.52 28.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.922 0.391 . . . . 0.0 110.634 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 84.0 mt -123.4 121.01 34.67 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.383 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.805 ' HG ' ' H ' ' A' ' 6' ' ' THR . 66.3 p -71.6 161.33 31.17 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 18.5 ptp180 -53.9 147.74 11.66 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.377 0.608 . . . . 0.0 112.329 -178.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.29 -173.78 3.33 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.611 -178.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.7 t -163.68 -43.67 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.933 -1.03 . . . . 0.0 109.166 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -98.23 -71.41 1.02 Allowed Glycine 0 CA--C 1.521 0.409 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 179.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 -124.93 135.78 53.15 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.109 0.481 . . . . 0.0 111.926 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -90.12 151.98 21.34 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.211 178.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.2 167.62 15.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.358 -179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -149.65 159.51 44.28 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.195 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.409 ' CZ3' ' CZ ' ' A' ' 78' ' ' PHE . 92.7 m95 -84.63 176.56 8.51 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.922 0.391 . . . . 0.0 110.222 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -166.12 106.32 0.69 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.676 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.1 tt -114.88 118.0 32.26 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.59 21.37 68.87 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.7 -9.29 74.49 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 47.2 t -115.1 134.94 22.45 Favored Pre-proline 0 N--CA 1.471 0.618 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -56.71 142.21 91.55 Favored 'Trans proline' 0 N--CA 1.489 1.227 0 C-N-CA 121.378 1.386 . . . . 0.0 111.589 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.53 159.64 17.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.199 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -139.93 162.22 35.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.011 0.434 . . . . 0.0 110.389 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.99 76.3 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.362 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.505 ' CG ' ' H ' ' A' ' 49' ' ' GLU . 47.9 t30 -71.03 -174.89 1.03 Allowed 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.505 ' H ' ' CG ' ' A' ' 48' ' ' ASN . 86.5 tt0 -62.85 -44.63 95.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.153 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.9 ptt? -90.13 -16.24 29.98 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.02 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -105.32 142.2 35.5 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.092 0.472 . . . . 0.0 111.353 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.487 ' OD2' ' N ' ' A' ' 53' ' ' ILE . 63.3 t0 -148.03 146.47 28.9 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.429 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.487 ' N ' ' OD2' ' A' ' 52' ' ' ASP . 97.9 mt -125.25 130.77 72.93 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 CA-C-O 120.727 0.298 . . . . 0.0 110.616 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.3 p -135.47 157.91 45.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.11 0.481 . . . . 0.0 110.966 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 50.6 t -117.63 131.63 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.221 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.448 ' O ' ' O ' ' A' ' 57' ' ' GLN . 97.1 mt-10 -108.31 177.63 4.74 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.448 ' O ' ' O ' ' A' ' 56' ' ' GLU . 55.5 tt0 -28.15 148.77 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 O-C-N 123.795 0.684 . . . . 0.0 112.137 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 60.6 -98.14 0.14 Allowed Glycine 0 C--N 1.329 0.178 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.2 m -163.27 48.19 0.14 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.327 0.584 . . . . 0.0 110.535 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 8.2 tt -92.19 116.77 29.24 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.264 0.554 . . . . 0.0 110.339 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 -79.07 146.64 33.15 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.264 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.406 ' C ' ' CD2' ' A' ' 62' ' ' LEU . 6.3 tt -143.38 114.57 7.87 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -90.62 106.17 18.32 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 90.9 m -92.45 107.78 19.47 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.695 -178.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 83.2 mt -103.28 124.08 47.98 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.276 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.466 ' O ' ' N ' ' A' ' 68' ' ' VAL . 13.2 t60 -72.72 156.7 38.66 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 66' ' ' HIS . 15.8 ptpt -27.45 89.15 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.599 0.714 . . . . 0.0 112.495 -179.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.466 ' N ' ' O ' ' A' ' 66' ' ' HIS . 28.0 m -82.33 167.45 2.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.031 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.445 ' OG1' ' N ' ' A' ' 70' ' ' LEU . 6.7 t -130.77 -149.68 0.4 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.335 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.515 ' C ' ' H ' ' A' ' 72' ' ' ASP . 3.3 mm? -51.24 -36.35 41.38 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.293 -0.563 . . . . 0.0 109.684 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -60.96 -0.39 0.3 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.481 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.515 ' H ' ' C ' ' A' ' 70' ' ' LEU . 42.8 t0 -63.53 -36.97 85.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.913 -179.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.93 141.25 40.12 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.211 0.529 . . . . 0.0 111.324 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 173.52 153.49 9.71 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.523 -1.031 . . . . 0.0 110.523 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 16.0 p -97.25 111.35 23.63 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.954 0.407 . . . . 0.0 110.91 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 25.2 t -107.59 128.28 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.884 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.695 ' HG ' ' H ' ' A' ' 78' ' ' PHE . 17.5 t -144.29 175.8 9.82 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.28 -179.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.695 ' H ' ' HG ' ' A' ' 77' ' ' SER . 57.9 m-85 -127.07 144.27 51.07 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -131.57 115.3 15.93 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.968 0.413 . . . . 0.0 110.84 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.486 ' O ' ' N ' ' A' ' 82' ' ' THR . 6.0 p -141.23 125.49 17.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.404 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -39.85 -20.38 0.02 OUTLIER Glycine 0 CA--C 1.531 1.068 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.863 -178.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.486 ' N ' ' O ' ' A' ' 80' ' ' VAL . 68.3 p -80.65 -75.19 0.28 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.054 0.454 . . . . 0.0 111.084 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.417 ' N ' ' OG1' ' A' ' 82' ' ' THR . 61.8 m -121.0 179.6 4.33 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.427 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 73.5 m -131.57 151.81 51.3 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 11.4 t -153.07 164.39 38.09 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -148.37 162.07 40.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.065 0.46 . . . . 0.0 111.214 -178.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.2 155.69 34.34 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.933 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -122.45 128.59 51.07 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.424 -179.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.3 tt -121.1 117.55 27.47 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.436 ' CE ' HE21 ' A' ' 15' ' ' GLN . 20.5 pttp -144.57 166.38 25.34 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 120.904 0.383 . . . . 0.0 111.679 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.6 p -104.08 133.22 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.184 0.516 . . . . 0.0 110.137 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.0 t . . . . . 0 C--N 1.332 -0.195 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.994 -179.3 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 . . . . . 0 N--CA 1.458 -0.071 0 CA-C-O 120.931 0.396 . . . . 0.0 110.519 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.0 p -54.37 130.22 16.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.402 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.599 ' CG2' ' HG ' ' A' ' 29' ' ' SER . 16.6 p -101.23 124.95 47.74 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 22.9 mm -100.8 111.17 29.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.102 0.477 . . . . 0.0 110.948 -178.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.435 ' O ' ' O ' ' A' ' 27' ' ' ARG . 91.6 mt -120.02 106.07 11.65 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.501 178.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.496 ' CD ' ' HG ' ' A' ' 26' ' ' CYS . 34.0 mm-40 -124.81 89.39 52.54 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.957 -179.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -71.79 -3.51 13.29 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 121.622 1.548 . . . . 0.0 110.694 178.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 67.4 mt -69.24 141.5 54.41 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.982 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -124.77 -46.84 1.84 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.174 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 37.3 p30 -176.72 146.43 0.57 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.136 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 65.1 t -125.28 129.31 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.043 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -137.66 135.93 36.97 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.023 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -160.87 160.56 31.15 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.995 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.532 ' HG ' ' NE2' ' A' ' 20' ' ' GLN . 13.0 p -74.69 156.53 36.56 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.978 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -67.91 138.59 56.12 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.21 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.45 -3.38 65.92 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.532 ' NE2' ' HG ' ' A' ' 17' ' ' SER . 86.8 mt-30 -103.33 151.52 22.64 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.871 0.367 . . . . 0.0 110.878 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -76.07 155.23 34.99 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.97 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -135.39 146.29 48.17 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.523 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.5 m -133.43 148.8 51.79 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.31 0.576 . . . . 0.0 111.112 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -128.19 147.35 50.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.608 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -136.38 116.09 13.02 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.452 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.496 ' HG ' ' CD ' ' A' ' 9' ' ' GLU . 3.0 t -131.48 127.99 38.49 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.398 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.435 ' O ' ' O ' ' A' ' 8' ' ' LEU . 99.6 mtt180 -96.76 125.81 41.48 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 178.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 18.8 tp -145.34 112.24 5.96 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.599 ' HG ' ' CG2' ' A' ' 6' ' ' THR . 6.6 p -79.08 155.24 28.86 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 18.1 ptp180 -54.22 157.96 2.46 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -177.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.69 -173.86 2.46 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 114.649 -1.16 . . . . 0.0 111.374 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.8 t -154.85 -44.93 0.09 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.231 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -86.51 -72.12 1.29 Allowed Glycine 0 CA--C 1.522 0.482 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 178.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -122.41 143.39 49.7 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.833 0.349 . . . . 0.0 110.632 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.515 ' OE1' ' N ' ' A' ' 35' ' ' GLU . 56.4 mp0 -91.72 129.64 37.66 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.463 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.48 145.98 48.88 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -129.92 151.86 50.02 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.747 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 62.5 m95 -74.38 176.32 6.85 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -163.24 114.5 1.44 Allowed 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.896 178.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 41.1 tp -124.25 121.27 34.59 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.18 3.21 64.51 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.94 -17.21 58.51 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.9 m -107.08 149.68 38.93 Favored Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -58.76 145.11 97.33 Favored 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 120.885 1.056 . . . . 0.0 111.641 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.13 178.25 6.42 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.687 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -151.22 140.42 21.26 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.007 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.35 142.65 58.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.625 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.456 ' CG ' ' H ' ' A' ' 49' ' ' GLU . 48.4 t30 -169.01 -173.5 1.81 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.798 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.456 ' H ' ' CG ' ' A' ' 48' ' ' ASN . 82.4 tt0 -64.0 -42.25 97.24 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.526 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 97.2 mmm -66.28 -40.18 89.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.513 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.477 ' OD1' ' CD1' ' A' ' 63' ' ' LEU . 46.5 t30 -120.81 119.83 33.83 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.71 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -113.79 136.77 52.49 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 70.9 mt -120.07 129.87 74.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 110.11 -0.329 . . . . 0.0 110.11 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 86.8 m -132.5 142.04 49.04 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.203 0.525 . . . . 0.0 111.182 -178.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 42.1 t -110.58 132.9 57.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.438 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -124.6 -174.66 3.07 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.204 0.526 . . . . 0.0 110.543 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -28.41 137.99 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.466 -179.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.7 -99.63 0.69 Allowed Glycine 0 CA--C 1.52 0.367 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 25.3 p -159.94 51.51 0.32 Allowed 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 52.1 tp -87.22 119.14 27.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.467 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 53.6 m170 -100.97 124.84 47.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.673 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 76.2 mt -119.01 123.81 45.44 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.173 0.511 . . . . 0.0 111.18 -179.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.477 ' CD1' ' OD1' ' A' ' 51' ' ' ASN . 0.3 OUTLIER -97.89 105.69 17.87 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 177.954 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 58.7 m -104.97 105.2 15.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.173 0.511 . . . . 0.0 111.297 -177.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.6 mt -96.42 131.17 43.26 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.019 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -112.84 144.62 42.08 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.986 0.422 . . . . 0.0 111.114 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 74.7 tttt 50.92 57.04 7.08 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.475 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -44.98 152.08 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.087 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 43.7 p -134.5 164.4 27.56 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.9 -33.93 73.88 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -65.06 -22.22 66.94 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.592 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -60.3 -34.6 74.0 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -44.63 118.33 1.55 Allowed 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.594 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -170.74 -179.34 41.98 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 52.6 m -108.63 122.99 48.24 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.833 0.349 . . . . 0.0 110.781 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.14 131.46 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 29.0 t -144.18 175.15 10.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.885 0.374 . . . . 0.0 110.584 -179.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -127.34 138.16 52.97 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.904 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 -120.72 112.0 18.31 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.455 ' C ' ' H ' ' A' ' 82' ' ' THR . 2.4 t -126.67 129.66 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 120.966 0.412 . . . . 0.0 110.336 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -57.18 -7.48 2.66 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.623 ' HG1' ' N ' ' A' ' 83' ' ' CYS . 16.4 p -108.7 -40.53 5.04 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.656 0.265 . . . . 0.0 110.963 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.623 ' N ' ' HG1' ' A' ' 82' ' ' THR . 26.2 m -148.04 -166.37 2.51 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.328 -179.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 91.0 p -160.04 167.02 28.8 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.046 0.45 . . . . 0.0 111.229 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 31.5 t -158.87 166.8 31.04 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.331 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -134.63 153.53 51.93 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.21 0.528 . . . . 0.0 110.969 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.93 151.31 23.41 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.489 -0.778 . . . . 0.0 108.917 178.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -133.66 132.57 40.86 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.846 0.355 . . . . 0.0 111.693 -178.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.406 ' CD2' ' C ' ' A' ' 89' ' ' LEU . 5.3 tt -114.57 118.46 33.8 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -128.17 134.84 49.11 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.912 0.387 . . . . 0.0 110.677 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.2 p -114.94 108.24 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 27.4 m . . . . . 0 N--CA 1.464 0.246 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.324 -179.7 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 . . . . . 0 N--CA 1.464 0.252 0 CA-C-O 120.91 0.386 . . . . 0.0 110.994 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.2 t -59.99 132.73 25.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.536 ' N ' ' OG ' ' A' ' 29' ' ' SER . 89.6 m -87.15 121.13 29.19 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 119.032 -1.067 . . . . 0.0 110.486 -179.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.423 HG23 HD13 ' A' ' 7' ' ' ILE . 18.2 mm -105.2 100.5 10.69 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.926 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 60.6 mt -128.41 90.26 3.04 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.494 ' OE2' ' CE2' ' A' ' 78' ' ' PHE . 7.6 pt-20 -120.14 84.27 33.38 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.933 -178.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.402 ' O ' ' N ' ' A' ' 12' ' ' GLN . 3.1 Cg_exo -71.23 11.67 0.55 Allowed 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 122.204 1.936 . . . . 0.0 111.491 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.45 ' CD1' ' N ' ' A' ' 11' ' ' LEU . 8.4 mp -70.54 67.07 0.34 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.402 ' N ' ' O ' ' A' ' 10' ' ' PRO . 99.4 mm-40 -69.94 -43.17 72.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.365 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.574 ' CG ' HE21 ' A' ' 15' ' ' GLN . 54.9 t0 -175.04 138.64 0.45 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.916 0.389 . . . . 0.0 110.992 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.424 ' N ' ' OD2' ' A' ' 13' ' ' ASP . 54.7 t -127.0 131.69 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.574 HE21 ' CG ' ' A' ' 13' ' ' ASP . 7.9 mp0 -136.43 102.64 5.02 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.734 0.302 . . . . 0.0 111.035 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -119.68 146.36 45.66 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.239 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.514 ' HG ' ' H ' ' A' ' 18' ' ' GLU . 45.0 t -82.06 162.91 22.4 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.14 179.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.514 ' H ' ' HG ' ' A' ' 17' ' ' SER . 79.2 tt0 -61.61 137.68 58.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.162 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.21 2.29 85.74 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 111.761 -0.535 . . . . 0.0 111.761 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -96.73 166.79 11.48 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.87 0.367 . . . . 0.0 110.72 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 21' ' ' ASP . 39.9 p30 -79.46 151.56 30.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.625 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.07 142.19 29.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.271 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 96.5 p -162.48 161.17 26.96 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.943 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -132.59 150.69 52.12 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.944 0.402 . . . . 0.0 110.644 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -136.45 123.85 22.03 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 8.5 t -134.38 132.9 39.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.277 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 90.6 mtm-85 -104.44 104.72 14.63 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.763 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 85.7 mt -123.81 121.05 34.4 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.0 0.428 . . . . 0.0 111.682 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.536 ' OG ' ' N ' ' A' ' 6' ' ' THR . 85.2 p -75.33 163.68 27.21 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 177.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 35.5 ptt-85 -50.87 149.02 3.68 Favored 'General case' 0 C--N 1.322 -0.618 0 O-C-N 124.181 0.926 . . . . 0.0 113.331 -177.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -75.46 176.43 7.54 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 114.177 -1.374 . . . . 0.0 111.135 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 50.0 m -151.25 -63.51 0.19 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.695 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -88.44 -75.36 1.29 Allowed Glycine 0 CA--C 1.521 0.409 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 178.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -122.43 129.96 52.59 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.711 0.291 . . . . 0.0 110.332 178.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -73.35 145.46 45.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.712 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.34 146.83 48.57 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.587 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 24.2 mmt85 -104.85 132.74 50.72 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.908 179.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -113.0 138.62 49.59 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -176.43 155.53 1.43 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 119.727 -0.789 . . . . 0.0 111.52 -178.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.5 tt -123.06 121.85 37.04 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 86.05 6.04 82.49 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -178.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.33 0.84 79.42 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 112.028 -0.429 . . . . 0.0 112.028 179.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 23.1 m -113.13 143.98 30.26 Favored Pre-proline 0 N--CA 1.47 0.551 0 CA-C-N 116.777 0.289 . . . . 0.0 110.884 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -56.41 144.87 81.88 Favored 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 121.411 1.407 . . . . 0.0 110.449 178.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 14.2 mt -80.87 156.97 25.82 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.034 0.445 . . . . 0.0 111.384 -179.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.465 ' O ' ' N ' ' A' ' 48' ' ' ASN . 89.9 mt-30 -126.6 131.48 51.49 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.21 179.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.01 70.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.943 0.401 . . . . 0.0 111.566 -178.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.465 ' N ' ' O ' ' A' ' 46' ' ' GLN . 87.4 m-20 -76.93 163.21 26.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.645 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -59.26 -46.57 88.15 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 95.2 mtp -66.91 -40.24 87.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.236 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.425 ' O ' ' O ' ' A' ' 48' ' ' ASN . 66.0 m-20 -117.6 107.77 14.65 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.769 179.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -109.82 158.51 18.08 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.7 mt -122.09 130.25 74.71 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-O 120.916 0.389 . . . . 0.0 110.084 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 97.1 m -128.27 129.38 46.27 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.905 -178.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.4 p -111.03 129.25 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.879 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.411 ' O ' ' C ' ' A' ' 57' ' ' GLN . 98.0 mt-10 -112.38 -174.57 2.49 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.144 0.497 . . . . 0.0 111.114 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.411 ' C ' ' O ' ' A' ' 56' ' ' GLU . 63.1 tp60 -24.78 144.56 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 114.791 -1.095 . . . . 0.0 112.462 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 58.52 -94.48 0.05 OUTLIER Glycine 0 CA--C 1.522 0.512 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.672 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 37.5 m -163.7 65.06 0.17 Allowed 'General case' 0 C--O 1.239 0.516 0 CA-C-O 121.324 0.583 . . . . 0.0 110.635 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 91.4 mt -95.8 126.3 40.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.426 178.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 48.7 m170 -107.84 120.61 42.77 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.22 118.39 14.49 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.083 0.468 . . . . 0.0 110.8 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -86.58 118.05 25.75 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 94.9 m -105.64 95.94 6.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.278 -179.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.88 140.84 39.06 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 21.3 p80 -139.19 159.02 43.14 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.575 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 79.2 tttt 47.74 73.17 0.21 Allowed 'General case' 0 C--O 1.231 0.109 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -179.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.7 p -116.47 131.83 67.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.959 -179.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.6 p -79.08 -157.41 0.12 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.523 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.581 ' C ' ' H ' ' A' ' 72' ' ' ASP . 55.4 tp -57.72 -33.74 68.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.421 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -51.28 -2.33 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.235 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.581 ' H ' ' C ' ' A' ' 70' ' ' LEU . 29.1 t0 -53.57 -39.24 64.64 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.697 0.284 . . . . 0.0 110.474 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.65 137.89 57.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.181 0.515 . . . . 0.0 111.068 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 179.99 176.8 47.65 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 110.076 -1.209 . . . . 0.0 110.076 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 94.4 m -126.15 117.26 22.76 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 117.088 0.444 . . . . 0.0 111.003 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.1 t -89.63 131.64 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.1 p -132.04 149.5 52.4 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.149 0.5 . . . . 0.0 110.891 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.494 ' CE2' ' OE2' ' A' ' 9' ' ' GLU . 0.2 OUTLIER -153.52 150.24 28.52 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.826 179.911 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -145.07 141.43 28.84 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.222 0.534 . . . . 0.0 111.112 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.507 ' C ' ' H ' ' A' ' 82' ' ' THR . 2.3 t -130.07 131.53 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.893 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -46.76 -11.89 0.06 OUTLIER Glycine 0 CA--C 1.528 0.896 0 C-N-CA 121.067 -0.587 . . . . 0.0 111.693 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.507 ' H ' ' C ' ' A' ' 80' ' ' VAL . 22.7 p -99.92 -54.01 3.01 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 122.722 -0.281 . . . . 0.0 110.696 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 38.8 t -139.58 162.5 34.93 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.115 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 30.9 p -134.68 155.13 51.06 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.964 0.412 . . . . 0.0 111.254 -179.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.0 t -162.87 166.87 23.53 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.948 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -142.34 165.06 28.44 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.66 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.82 155.69 41.93 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.139 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -125.25 135.89 52.99 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.344 0.592 . . . . 0.0 111.773 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 48.2 tp -109.66 97.68 7.18 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.783 179.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -94.62 166.82 11.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.312 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 53.1 t -119.51 128.37 75.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.256 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.63 -179.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 . . . . . 0 N--CA 1.47 0.556 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.7 t -61.28 130.53 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 C-N-CA 120.221 -0.591 . . . . 0.0 109.413 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.543 ' N ' ' OG ' ' A' ' 29' ' ' SER . 72.4 m -91.94 130.21 37.74 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 119.962 -0.695 . . . . 0.0 111.457 -178.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.42 HG22 HD12 ' A' ' 7' ' ' ILE . 33.8 mm -111.86 102.52 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-O 121.275 0.559 . . . . 0.0 111.017 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 39.4 tp -126.3 87.51 2.68 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.08 -0.963 . . . . 0.0 108.768 178.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.513 ' OE2' ' CE2' ' A' ' 78' ' ' PHE . 28.9 mt-10 -120.61 85.03 37.73 Favored Pre-proline 0 N--CA 1.464 0.267 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.354 -179.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -72.2 8.85 1.29 Allowed 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 121.819 1.679 . . . . 0.0 111.557 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.405 ' H ' ' C ' ' A' ' 9' ' ' GLU . 65.2 mt -61.56 84.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.903 179.099 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.408 ' CG ' ' H ' ' A' ' 13' ' ' ASP . 40.5 tp60 -72.86 -133.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.408 ' H ' ' CG ' ' A' ' 12' ' ' GLN . 95.2 m-20 -109.02 138.3 45.58 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.5 m -127.95 156.16 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -136.61 104.51 5.57 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.546 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 78.4 mt -118.45 139.97 50.58 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.249 -178.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 91.5 p -69.26 153.81 43.04 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.996 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -65.94 146.6 54.53 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.085 0.469 . . . . 0.0 111.065 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.43 8.82 65.63 Favored Glycine 0 CA--C 1.53 0.976 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.501 HE21 ' C ' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -112.29 156.78 21.84 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 120.976 0.417 . . . . 0.0 110.366 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.501 ' C ' HE21 ' A' ' 20' ' ' GLN . 87.1 m-20 -78.05 144.81 36.29 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.063 178.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -126.07 146.74 49.79 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.072 0.463 . . . . 0.0 110.594 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 41.5 t -156.77 154.74 30.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.927 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -132.81 152.13 51.87 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.809 0.337 . . . . 0.0 110.641 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.405 ' CD ' ' N ' ' A' ' 25' ' ' GLN . 0.5 OUTLIER -124.9 111.25 15.24 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.125 -0.488 . . . . 0.0 109.755 179.48 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 6.7 t -115.84 137.7 51.84 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 82.1 mtm180 -123.47 125.1 44.3 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.8 pp -147.98 141.17 25.07 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 119.974 -0.691 . . . . 0.0 111.438 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.543 ' OG ' ' N ' ' A' ' 6' ' ' THR . 98.5 p -74.31 162.65 28.68 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 178.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -52.24 162.53 0.49 Allowed 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -177.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.14 157.07 38.28 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 114.018 -1.447 . . . . 0.0 111.401 -179.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.5 t -141.44 -61.34 0.47 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.399 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -101.27 -67.24 0.81 Allowed Glycine 0 N--CA 1.459 0.22 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -123.55 137.72 54.7 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 179.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -79.8 147.58 31.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.589 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.44 152.21 40.85 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.188 179.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 61.3 mtp85 -126.09 147.04 49.68 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.292 -179.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 2.3 t-105 -104.45 151.29 23.72 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.597 -179.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -165.62 148.47 7.72 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.066 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.0 tt -124.99 126.27 45.18 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.65 7.69 88.3 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.87 -12.74 62.5 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.4 m -112.17 150.76 42.96 Favored Pre-proline 0 N--CA 1.468 0.466 0 C-N-CA 121.975 0.11 . . . . 0.0 110.756 -179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -57.71 144.33 93.31 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 121.39 1.393 . . . . 0.0 110.666 178.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.66 171.78 7.43 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.691 0.281 . . . . 0.0 111.069 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -130.58 134.24 46.84 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.952 0.406 . . . . 0.0 110.247 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.01 96.29 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.273 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -75.17 169.67 17.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.997 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -58.43 -45.21 88.96 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 20.6 mmt -67.58 -38.83 84.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.639 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 62.8 t-20 -98.89 106.9 19.21 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.765 -178.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.474 ' O ' ' OG1' ' A' ' 64' ' ' THR . 67.0 m-20 -109.0 108.29 18.97 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 38.4 mt -100.74 133.74 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -179.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.544 ' HG1' ' N ' ' A' ' 55' ' ' VAL . 4.9 t -146.11 159.17 43.65 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -179.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.544 ' N ' ' HG1' ' A' ' 54' ' ' THR . 59.0 t -109.25 137.44 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.268 179.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 57' ' ' GLN . 79.4 mm-40 -116.11 -178.6 3.44 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.438 ' C ' ' O ' ' A' ' 56' ' ' GLU . 56.1 tt0 -26.19 144.98 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 O-C-N 123.889 0.743 . . . . 0.0 112.102 -179.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 59.05 -94.7 0.06 OUTLIER Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.446 ' OG1' ' O ' ' A' ' 59' ' ' THR . 0.0 OUTLIER -166.75 59.49 0.09 Allowed 'General case' 0 C--O 1.24 0.594 0 CA-C-O 121.541 0.686 . . . . 0.0 110.962 -179.797 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.47 ' CD2' ' N ' ' A' ' 60' ' ' LEU . 3.1 mm? -99.55 130.56 45.81 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.099 179.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -107.27 142.96 36.2 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 120.869 0.366 . . . . 0.0 110.261 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.2 mp -137.89 118.92 14.37 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.293 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.33 108.2 19.89 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.474 ' OG1' ' O ' ' A' ' 52' ' ' ASP . 82.1 p -102.75 96.93 7.18 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 121.138 0.494 . . . . 0.0 109.908 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 36.6 tp -103.34 124.65 49.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.513 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.651 ' CG ' ' H ' ' A' ' 67' ' ' LYS . 1.0 OUTLIER -71.13 -152.71 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.41 -179.465 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.651 ' H ' ' CG ' ' A' ' 66' ' ' HIS . 5.4 mtmp? -53.99 97.09 0.02 OUTLIER 'General case' 0 CA--C 1.522 -0.108 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.376 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.0 p -58.19 168.35 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.819 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.451 ' HG1' ' H ' ' A' ' 72' ' ' ASP . 58.2 p -134.41 159.79 39.96 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 47.2 tp -58.54 -40.81 84.02 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -69.9 -33.02 71.64 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.677 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.451 ' H ' ' HG1' ' A' ' 69' ' ' THR . 55.3 m-20 -64.27 -40.27 95.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.86 -178.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.74 140.05 57.68 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.649 -0.421 . . . . 0.0 110.24 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -175.39 -108.02 0.22 Allowed Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 -179.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 97.0 m -156.5 109.69 2.63 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.412 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.5 t -89.07 127.9 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 31.9 t -133.03 146.23 51.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.283 0.563 . . . . 0.0 111.542 -178.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.513 ' CE2' ' OE2' ' A' ' 9' ' ' GLU . 0.1 OUTLIER -140.7 159.2 42.73 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.476 179.585 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.433 ' CD2' ' N ' ' A' ' 79' ' ' HIS . 5.3 p80 -143.41 146.39 33.44 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.973 -179.186 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.48 ' O ' ' N ' ' A' ' 82' ' ' THR . 2.2 t -134.32 134.46 54.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.557 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -43.06 -20.32 0.09 OUTLIER Glycine 0 CA--C 1.533 1.165 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.676 ' HG1' ' N ' ' A' ' 83' ' ' CYS . 33.1 p -82.6 -72.38 0.45 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.839 0.352 . . . . 0.0 110.657 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.676 ' N ' ' HG1' ' A' ' 82' ' ' THR . 7.8 t -128.02 -178.26 4.45 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.699 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.506 ' H ' ' HG ' ' A' ' 83' ' ' CYS . 35.5 m -127.74 149.69 50.12 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.244 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 52.9 p -156.63 162.85 39.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.611 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -160.06 168.14 26.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.983 0.42 . . . . 0.0 111.024 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.78 140.11 28.26 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.865 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 25.1 mp0 -109.7 122.04 46.59 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.098 0.475 . . . . 0.0 111.005 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 53.6 tp -108.54 106.29 16.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.929 179.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -110.02 171.03 7.69 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 24.3 m -113.8 128.7 70.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 120.77 0.319 . . . . 0.0 110.242 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.9 m . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.247 -179.894 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.0 tp10 . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.973 0.416 . . . . 0.0 110.411 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.8 t -58.76 132.89 23.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.494 ' OG1' ' N ' ' A' ' 29' ' ' SER . 51.8 p -94.55 133.91 37.66 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 119.177 -1.009 . . . . 0.0 110.936 -179.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.3 mm -112.45 56.93 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.181 -178.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 48.0 tp -90.1 78.03 6.71 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.537 ' OE1' ' CZ ' ' A' ' 78' ' ' PHE . 16.3 tt0 -121.7 83.82 42.66 Favored Pre-proline 0 N--CA 1.466 0.369 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.286 -179.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -71.46 47.14 0.83 Allowed 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.447 2.098 . . . . 0.0 112.067 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -81.69 82.47 7.4 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.418 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -74.12 -86.08 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.811 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.431 ' O ' ' OD2' ' A' ' 13' ' ' ASP . 44.0 p-10 -172.7 133.83 0.6 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.328 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.0 m -131.03 156.5 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-O 120.975 0.417 . . . . 0.0 110.697 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.87 121.66 30.6 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.33 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 53.4 mt -124.66 141.02 52.4 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.319 -179.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.2 t -83.92 155.55 22.8 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 -52.27 143.33 14.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.015 0.436 . . . . 0.0 111.426 -179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.42 2.1 85.42 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.844 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -101.08 146.76 27.04 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.003 0.43 . . . . 0.0 111.219 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -73.79 153.87 39.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.588 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.462 ' C ' ' HG ' ' A' ' 23' ' ' SER . . . -134.8 138.92 44.7 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.986 0.422 . . . . 0.0 110.049 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.462 ' HG ' ' C ' ' A' ' 22' ' ' ALA . 71.0 m -161.51 158.05 25.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.235 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -135.41 151.08 50.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.158 179.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -124.09 135.31 53.46 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.532 ' SG ' ' N ' ' A' ' 27' ' ' ARG . 53.8 t -149.8 163.62 37.5 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.043 0.449 . . . . 0.0 111.441 -179.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.532 ' N ' ' SG ' ' A' ' 26' ' ' CYS . 80.2 mtp85 -129.91 96.52 4.23 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.085 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.426 ' O ' ' CG2' ' A' ' 59' ' ' THR . 76.2 mt -113.32 113.66 25.57 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.728 -0.214 . . . . 0.0 111.384 -179.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.541 ' HG ' ' N ' ' A' ' 30' ' ' ARG . 44.2 t -68.04 156.2 37.87 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 178.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.541 ' N ' ' HG ' ' A' ' 29' ' ' SER . 16.2 ptm180 -53.33 167.03 0.22 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -177.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.24 159.88 16.87 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 113.691 -1.595 . . . . 0.0 111.799 -179.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.7 t -140.87 -58.19 0.51 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.49 -69.71 0.7 Allowed Glycine 0 CA--C 1.521 0.437 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 177.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -121.75 144.48 48.77 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.05 0.452 . . . . 0.0 110.652 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -83.85 142.12 30.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.57 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.29 152.68 41.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.443 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -124.15 126.72 46.64 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.199 0.523 . . . . 0.0 110.683 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 40.8 t-105 -93.73 148.05 22.47 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.951 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -167.37 154.99 8.96 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 119.632 -0.827 . . . . 0.0 112.123 -179.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 67.2 tp -118.17 117.03 28.05 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.74 8.7 82.38 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.9 3.93 79.39 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.5 t -113.48 134.8 21.9 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-O 119.224 -0.417 . . . . 0.0 110.357 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -50.83 138.49 41.88 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 121.022 1.148 . . . . 0.0 110.57 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -114.25 174.16 6.09 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.923 0.392 . . . . 0.0 111.792 -178.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -136.98 150.25 48.03 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.294 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.19 78.43 0.05 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.624 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.427 ' O ' ' O ' ' A' ' 51' ' ' ASN . 7.9 m120 -71.41 178.89 3.19 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.021 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.407 ' OE2' ' N ' ' A' ' 49' ' ' GLU . 56.8 mp0 -61.31 -44.88 96.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.228 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 25.9 ptm -83.69 -17.15 42.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.074 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.427 ' O ' ' O ' ' A' ' 48' ' ' ASN . 77.1 m-20 -114.16 105.07 12.75 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.29 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -115.12 130.41 56.92 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 42.7 mt -123.78 133.99 67.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.2 t -137.61 153.23 49.92 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.024 0.44 . . . . 0.0 110.781 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 53.4 t -111.85 131.87 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.254 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -108.12 162.0 14.45 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.932 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -49.87 150.76 2.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.787 -179.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.31 13.09 82.35 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.426 ' CG2' ' O ' ' A' ' 28' ' ' LEU . 1.0 OUTLIER 67.38 26.68 8.35 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.835 0.35 . . . . 0.0 110.629 -179.76 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.6 mp -77.47 136.36 38.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.14 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 5.6 t-160 -104.97 153.39 21.49 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.213 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.1 tp -152.77 110.68 3.63 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 121.01 0.434 . . . . 0.0 109.969 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.416 ' C ' ' CD1' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -86.14 107.54 17.91 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.517 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 60.3 m -99.93 99.93 10.76 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.262 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 41.0 tp -110.94 120.66 43.14 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.452 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.519 ' CG ' ' H ' ' A' ' 67' ' ' LYS . 26.8 t60 -138.55 175.46 9.55 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.215 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.519 ' H ' ' CG ' ' A' ' 66' ' ' HIS . 64.1 mttp 55.18 57.09 5.8 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -179.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 28.2 m -108.28 156.3 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-O 121.448 0.642 . . . . 0.0 111.5 -179.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 36.5 p -135.69 -149.6 0.34 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.69 178.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 16.7 mt -56.52 -23.68 41.44 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -71.45 -1.15 12.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.693 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -56.89 -39.74 74.94 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.711 -0.395 . . . . 0.0 109.945 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.61 147.45 18.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.653 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 171.38 -161.14 33.51 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 87.5 m -153.5 109.28 3.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.719 0.295 . . . . 0.0 110.31 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.0 m -80.3 136.29 23.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.577 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.9 t -144.8 145.82 31.82 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.029 0.442 . . . . 0.0 110.904 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.537 ' CZ ' ' OE1' ' A' ' 9' ' ' GLU . 38.9 p90 -150.07 151.7 33.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.07 179.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.543 ' ND1' ' OG ' ' A' ' 84' ' ' SER . 64.9 t60 -134.86 131.22 37.12 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.906 -179.161 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.529 ' O ' ' N ' ' A' ' 82' ' ' THR . 2.4 t -127.87 130.89 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.22 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -39.91 -21.33 0.03 OUTLIER Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.775 -0.53 . . . . 0.0 111.775 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.529 ' N ' ' O ' ' A' ' 80' ' ' VAL . 19.0 p -88.54 -71.93 0.56 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.87 0.367 . . . . 0.0 110.233 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 4.1 t -132.04 160.1 36.88 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.939 179.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.543 ' OG ' ' ND1' ' A' ' 79' ' ' HIS . 20.4 m -133.91 154.88 50.77 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.157 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.5 m -160.28 161.65 33.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.116 0.484 . . . . 0.0 111.26 -179.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -143.05 150.13 39.15 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.424 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -135.01 153.24 52.16 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.303 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -108.43 135.74 49.22 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 121.365 0.603 . . . . 0.0 111.412 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 50.0 tp -115.59 96.42 5.62 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.103 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.5 ttmt -94.28 169.74 10.01 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.536 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.8 t -118.38 131.37 71.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.471 0.6 0 CA-C-O 120.719 0.295 . . . . 0.0 110.798 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 . . . . . 0 N--CA 1.461 0.099 0 CA-C-O 121.479 0.657 . . . . 0.0 111.71 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.7 p -65.1 133.85 30.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.401 179.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.87 ' HG1' ' H ' ' A' ' 29' ' ' SER . 59.7 p -92.77 136.48 33.21 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.337 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.497 ' O ' ' CG2' ' A' ' 7' ' ' ILE . 2.4 tp -118.21 107.0 20.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-O 122.487 1.137 . . . . 0.0 111.455 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.7 mp -126.14 79.94 1.88 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 113.996 -1.456 . . . . 0.0 108.418 178.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -120.62 87.8 42.27 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.652 -178.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.45 ' O ' ' N ' ' A' ' 12' ' ' GLN . 2.5 Cg_endo -73.75 -7.0 19.54 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 C-N-CA 122.109 1.873 . . . . 0.0 110.727 178.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 98.2 mt -56.23 83.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.233 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.45 ' N ' ' O ' ' A' ' 10' ' ' PRO . 59.5 tt0 -85.64 -64.76 1.1 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.594 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 14' ' ' VAL . 60.1 t0 -170.64 142.88 2.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.721 -178.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.545 ' N ' ' OD1' ' A' ' 13' ' ' ASP . 29.3 m -132.82 161.68 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.984 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.422 ' CD ' ' N ' ' A' ' 15' ' ' GLN . 0.6 OUTLIER -128.47 115.71 18.59 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.883 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 60.4 mt -122.16 143.78 49.35 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.949 0.404 . . . . 0.0 111.465 -179.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 92' ' ' THR . 17.7 m -80.74 157.86 25.7 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.003 178.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -65.9 148.53 51.65 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.585 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.8 10.16 84.53 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 111.071 -0.811 . . . . 0.0 111.071 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -121.16 145.14 48.13 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -74.29 162.25 29.09 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.403 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -131.22 162.24 30.42 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 28.1 p -159.39 158.51 32.32 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.196 -0.602 . . . . 0.0 111.476 -179.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -139.75 148.22 41.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.294 179.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -136.33 126.99 27.14 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.595 ' SG ' ' N ' ' A' ' 27' ' ' ARG . 8.2 t -130.13 162.47 28.76 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.472 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.595 ' N ' ' SG ' ' A' ' 26' ' ' CYS . 79.4 ttt180 -143.41 116.01 8.65 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.4 pp -146.06 123.47 11.67 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 119.846 -0.742 . . . . 0.0 111.71 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.87 ' H ' ' HG1' ' A' ' 6' ' ' THR . 92.4 p -62.25 160.23 13.49 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -53.52 155.84 2.81 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 122.015 0.912 . . . . 0.0 113.388 -177.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -53.47 179.57 0.02 OUTLIER 'General case' 0 C--O 1.232 0.163 0 CA-C-N 113.875 -1.511 . . . . 0.0 112.044 -179.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.4 p -156.56 -50.39 0.08 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.406 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -101.69 -66.87 0.79 Allowed Glycine 0 CA--C 1.522 0.507 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 178.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -122.69 157.46 32.21 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.726 0.298 . . . . 0.0 110.34 179.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -79.85 141.64 35.98 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.798 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.42 145.84 36.93 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.332 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -128.95 144.27 51.13 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.268 0.556 . . . . 0.0 111.062 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 18.8 t-105 -100.67 155.7 17.74 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.797 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -164.56 151.3 11.07 Favored 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 119.774 -0.77 . . . . 0.0 111.913 -179.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.403 ' CD1' ' C ' ' A' ' 40' ' ' LEU . 0.5 OUTLIER -129.32 116.63 19.37 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.057 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.85 19.07 69.23 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -178.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.13 4.11 84.43 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.966 -0.853 . . . . 0.0 110.966 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.2 t -111.02 128.38 25.41 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-O 119.491 -0.29 . . . . 0.0 110.478 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -57.76 144.96 92.26 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 121.094 1.196 . . . . 0.0 111.284 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.536 ' CD2' ' N ' ' A' ' 45' ' ' LEU . 1.1 pt? -130.42 149.69 51.99 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.527 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -128.03 166.18 18.89 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.639 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.6 141.76 19.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.099 0.476 . . . . 0.0 111.377 -178.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.432 ' O ' ' O ' ' A' ' 51' ' ' ASN . 36.3 p-10 -163.3 -171.53 2.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.653 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -65.08 -46.72 79.97 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.169 -179.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 65.6 mtt -67.92 -42.91 80.36 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -179.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.432 ' O ' ' O ' ' A' ' 48' ' ' ASN . 17.5 m-20 -118.23 145.71 44.8 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 120.784 0.326 . . . . 0.0 111.458 -179.033 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 48' ' ' ASN . 98.2 m-20 -138.47 108.94 6.52 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.088 178.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.8 pt -101.23 134.61 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.472 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.7 t -139.11 155.46 47.87 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.872 0.368 . . . . 0.0 111.176 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.5 m -120.14 129.14 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.158 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.435 ' N ' ' OE2' ' A' ' 56' ' ' GLU . 56.7 mp0 -124.62 179.53 4.92 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.332 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 58.9 tp60 -48.93 147.52 2.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.199 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.48 14.72 80.79 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 111.542 -0.623 . . . . 0.0 111.542 179.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.2 m 61.96 38.33 14.38 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 120.989 0.423 . . . . 0.0 110.266 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 49.3 mt -83.18 129.62 35.03 Favored 'General case' 0 CA--C 1.527 0.064 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.434 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 59.6 m170 -108.68 153.48 23.37 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.0 tp -154.83 116.77 4.17 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.225 -178.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.458 ' CD1' ' N ' ' A' ' 63' ' ' LEU . 7.2 mp -97.43 121.01 38.83 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 23.6 m -108.33 107.11 17.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.396 0.617 . . . . 0.0 109.665 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.423 ' CD2' ' N ' ' A' ' 65' ' ' LEU . 1.5 mm? -92.78 130.53 38.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.873 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.604 ' CG ' ' H ' ' A' ' 67' ' ' LYS . 1.5 t-80 -83.25 -150.9 0.1 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.406 -179.008 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.604 ' H ' ' CG ' ' A' ' 66' ' ' HIS . 13.9 ptpt -60.38 95.92 0.04 OUTLIER 'General case' 0 N--CA 1.461 0.102 0 CA-C-O 121.253 0.549 . . . . 0.0 110.337 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.5 m -96.78 133.98 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 121.302 0.572 . . . . 0.0 110.939 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 27.5 p -88.35 -152.89 0.23 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.202 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.404 ' C ' ' H ' ' A' ' 72' ' ' ASP . 5.4 mp -61.97 -23.56 66.46 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.7 tp10 -66.58 -1.72 3.99 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.098 -0.956 . . . . 0.0 110.142 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.404 ' H ' ' C ' ' A' ' 70' ' ' LEU . 66.4 t0 -54.74 -44.35 73.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.112 -179.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.48 129.83 40.33 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -175.6 143.82 6.84 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 53.1 m -97.01 125.6 41.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.755 0.312 . . . . 0.0 110.873 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.6 t -101.61 126.49 55.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 47.5 t -124.27 140.91 52.51 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.963 0.411 . . . . 0.0 110.485 -179.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -146.9 154.59 41.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.023 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 19.6 p80 -150.69 149.19 29.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.071 0.463 . . . . 0.0 110.55 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.541 ' O ' ' N ' ' A' ' 82' ' ' THR . 4.0 p -146.38 88.16 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.089 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 80' ' ' VAL . . . 30.75 -85.93 0.01 OUTLIER Glycine 0 CA--C 1.53 1.001 0 CA-C-N 115.487 -0.778 . . . . 0.0 112.462 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.541 ' N ' ' O ' ' A' ' 80' ' ' VAL . 25.3 p -39.11 -85.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -179.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.459 ' SG ' ' N ' ' A' ' 84' ' ' SER . 33.1 t -105.65 167.69 9.6 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.043 0.449 . . . . 0.0 111.862 -178.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.459 ' N ' ' SG ' ' A' ' 83' ' ' CYS . 35.3 t -151.11 145.81 25.72 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.265 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.494 ' HG ' ' H ' ' A' ' 86' ' ' GLU . 46.9 t -158.09 172.13 18.98 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.072 0.463 . . . . 0.0 111.151 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.494 ' H ' ' HG ' ' A' ' 85' ' ' SER . 16.3 pt-20 -144.2 162.76 35.51 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.492 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -134.08 156.3 48.51 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.079 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.444 ' O ' ' OD1' ' A' ' 13' ' ' ASP . 98.9 mm-40 -118.59 135.97 54.13 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.823 0.344 . . . . 0.0 111.367 -179.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.415 ' C ' ' CD2' ' A' ' 89' ' ' LEU . 2.2 tt -115.27 109.64 18.24 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -105.66 160.76 14.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.005 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.4 m -117.89 127.35 75.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 120.934 0.397 . . . . 0.0 110.231 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.429 ' O ' ' OG ' ' A' ' 17' ' ' SER . 85.9 m . . . . . 0 N--CA 1.47 0.556 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.101 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 . . . . . 0 CA--C 1.527 0.071 0 CA-C-O 121.048 0.452 . . . . 0.0 110.514 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.7 p -62.04 132.46 27.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.796 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -111.54 122.04 46.77 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 179.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.409 HD12 HG23 ' A' ' 7' ' ' ILE . 76.9 mt -105.1 118.57 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-O 121.755 0.788 . . . . 0.0 111.804 -179.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.9 mt -127.3 75.77 1.61 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.485 -1.234 . . . . 0.0 108.049 178.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.505 ' OE1' ' CE2' ' A' ' 78' ' ' PHE . 35.7 tt0 -114.97 92.83 32.28 Favored Pre-proline 0 N--CA 1.467 0.4 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.984 -177.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.522 ' O ' ' N ' ' A' ' 12' ' ' GLN . 2.6 Cg_endo -75.29 -6.59 18.04 Favored 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 122.042 1.828 . . . . 0.0 111.035 178.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 63.6 mt -60.91 72.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.191 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.522 ' N ' ' O ' ' A' ' 10' ' ' PRO . 70.9 tp60 -74.9 -64.1 1.12 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.124 -179.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.7 p-10 -170.29 133.87 1.13 Allowed 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 120.446 -0.501 . . . . 0.0 111.486 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.5 m -134.65 159.73 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.793 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -135.58 117.14 14.85 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.386 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 81.2 mt -121.2 132.64 54.95 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.439 -179.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.7 m -69.68 158.69 34.87 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.817 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.42 ' OE2' ' O ' ' A' ' 68' ' ' VAL . 52.5 tp10 -58.31 146.37 34.59 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.612 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.7 1.13 80.85 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.497 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -110.23 146.55 35.42 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.893 0.378 . . . . 0.0 110.562 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 52.6 p-10 -82.33 170.53 15.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.053 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -148.12 152.39 37.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.173 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 95.9 p -152.01 123.13 7.63 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.072 0.463 . . . . 0.0 111.048 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -103.82 119.51 39.06 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.453 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -131.52 133.44 45.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.948 0.404 . . . . 0.0 109.958 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 8.4 p -151.59 151.7 31.9 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.107 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 85.2 mtt85 -96.68 132.34 42.44 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.875 179.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.454 ' O ' ' OG1' ' A' ' 59' ' ' THR . 2.9 tt -144.88 106.02 4.19 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.692 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.6 m -62.04 150.83 37.05 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.804 0.335 . . . . 0.0 110.432 179.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -56.33 156.13 6.19 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.528 0.68 . . . . 0.0 112.581 -178.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.78 -174.71 3.53 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.705 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 27.0 m -154.21 -43.93 0.09 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -86.76 -74.16 1.28 Allowed Glycine 0 CA--C 1.521 0.463 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 178.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.454 ' CD ' ' N ' ' A' ' 34' ' ' GLN . 25.4 mp0 -121.98 132.29 54.45 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.924 0.392 . . . . 0.0 110.994 179.048 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -77.28 150.41 35.3 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.835 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.14 147.31 38.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.643 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 45.8 mmm-85 -115.12 137.16 52.33 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.771 0.32 . . . . 0.0 111.225 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 1.8 t-105 -101.79 140.51 35.98 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.013 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -176.38 163.88 2.55 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.119 -179.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -139.66 129.52 24.76 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.246 0.546 . . . . 0.0 110.467 178.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.58 7.03 78.65 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.84 -17.04 58.82 Favored Glycine 0 CA--C 1.529 0.969 0 N-CA-C 111.937 -0.465 . . . . 0.0 111.937 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.1 t -101.55 123.07 45.62 Favored Pre-proline 0 CA--C 1.541 0.633 0 CA-C-N 116.905 0.352 . . . . 0.0 110.37 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -58.69 138.01 83.33 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 CA-C-N 119.875 0.991 . . . . 0.0 111.204 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.0 -174.96 4.18 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.095 0.474 . . . . 0.0 110.551 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.492 ' O ' ' N ' ' A' ' 48' ' ' ASN . 2.6 pm0 -139.06 154.92 48.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.185 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.95 70.33 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.616 -0.433 . . . . 0.0 110.389 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.492 ' N ' ' O ' ' A' ' 46' ' ' GLN . 18.4 t-20 -68.84 157.73 35.9 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.748 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.467 ' N ' ' OD1' ' A' ' 48' ' ' ASN . 86.1 tt0 -55.74 -44.6 77.72 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.246 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 5.4 ptt? -69.31 -35.54 76.08 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 120.907 0.384 . . . . 0.0 110.18 179.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.446 ' O ' ' O ' ' A' ' 48' ' ' ASN . 41.7 m-20 -116.47 104.64 11.64 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.136 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.419 ' OD2' ' O ' ' A' ' 48' ' ' ASN . 96.7 m-20 -107.97 138.1 44.82 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.704 0.288 . . . . 0.0 110.46 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.3 mt -117.98 129.81 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.312 -0.404 . . . . 0.0 109.995 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.1 t -142.38 146.78 35.29 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.02 0.438 . . . . 0.0 111.137 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 51.5 t -122.48 132.17 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.417 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -121.94 177.08 5.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.292 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -42.84 151.45 0.13 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.343 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.12 20.6 80.01 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.454 ' OG1' ' O ' ' A' ' 28' ' ' LEU . 62.8 p 47.62 38.3 8.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.086 0.47 . . . . 0.0 110.444 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 94.6 mt -75.73 138.72 41.45 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.31 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -108.18 148.31 30.09 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.032 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 53.9 tp -160.49 101.19 1.35 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.043 0.449 . . . . 0.0 110.501 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.8 tp -100.24 109.78 22.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.591 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.9 p -86.14 112.08 20.96 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.238 0.542 . . . . 0.0 110.715 -179.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 55.5 tp -111.58 123.71 50.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.183 179.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.519 ' CG ' ' N ' ' A' ' 67' ' ' LYS . 78.3 t60 -145.67 167.94 21.9 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.993 0.425 . . . . 0.0 111.043 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.519 ' N ' ' CG ' ' A' ' 66' ' ' HIS . 72.0 tttt 56.77 57.06 4.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.443 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.42 ' O ' ' OE2' ' A' ' 18' ' ' GLU . 5.7 m -93.7 174.28 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 121.838 0.828 . . . . 0.0 111.544 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.542 ' C ' ' H ' ' A' ' 71' ' ' GLU . 4.4 t -137.89 157.22 46.85 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.121 -1.399 . . . . 0.0 108.216 178.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 67.8 mt -52.55 -5.96 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.521 -0.472 . . . . 0.0 111.202 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.542 ' H ' ' C ' ' A' ' 69' ' ' THR . 80.2 mm-40 -113.82 2.41 15.12 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.437 ' O ' ' O ' ' A' ' 73' ' ' ALA . 24.9 t70 -63.14 -52.71 61.41 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.673 -179.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.437 ' O ' ' O ' ' A' ' 72' ' ' ASP . . . 42.96 -167.81 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 -179.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 157.34 95.01 0.1 Allowed Glycine 0 CA--C 1.524 0.645 0 C-N-CA 120.404 -0.903 . . . . 0.0 112.351 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 40.6 p -90.74 94.54 9.72 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 178.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.0 t -76.87 152.09 5.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.18 0.514 . . . . 0.0 111.128 -179.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 33.9 t -153.64 151.63 29.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.3 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.505 ' CE2' ' OE1' ' A' ' 9' ' ' GLU . 64.6 m-85 -131.62 144.59 51.16 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.029 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -143.47 116.0 8.61 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.582 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.535 ' O ' ' N ' ' A' ' 82' ' ' THR . 5.6 p -129.38 135.0 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.739 178.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -38.01 -21.4 0.01 OUTLIER Glycine 0 CA--C 1.527 0.79 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.674 -178.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.535 ' N ' ' O ' ' A' ' 80' ' ' VAL . 82.7 p -85.19 -74.5 0.4 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.891 0.377 . . . . 0.0 111.14 -179.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.423 ' H ' HG11 ' A' ' 80' ' ' VAL . 60.4 m -128.08 -166.6 1.64 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.416 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 87.8 p -157.1 162.78 39.44 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.761 0.315 . . . . 0.0 110.93 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.9 p -152.9 166.99 30.6 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.904 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -141.97 155.98 45.46 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.147 0.499 . . . . 0.0 111.945 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.99 153.58 33.21 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.413 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -133.93 137.27 44.78 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.585 0.707 . . . . 0.0 112.328 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.7 tp -111.03 116.61 31.46 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.551 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -118.85 164.03 16.02 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.001 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.6 m -123.9 128.25 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 120.997 0.427 . . . . 0.0 110.386 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 23.3 m . . . . . 0 C--N 1.331 -0.203 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.82 -179.51 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 . . . . . 0 CA--C 1.521 -0.135 0 CA-C-O 121.297 0.57 . . . . 0.0 110.967 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.9 p -55.18 131.7 18.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.368 -0.833 . . . . 0.0 108.757 178.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 13.6 m -81.56 123.53 28.73 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 119.482 -0.887 . . . . 0.0 109.442 -179.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.8 mt -108.84 118.26 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 121.582 0.706 . . . . 0.0 112.673 -178.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 85.2 mt -126.31 111.11 14.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.466 -1.243 . . . . 0.0 107.947 177.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.537 ' OE1' ' N ' ' A' ' 9' ' ' GLU . 1.6 pm0 -122.96 88.5 50.76 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.318 -178.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -74.58 -8.51 20.6 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 122.068 1.846 . . . . 0.0 110.677 178.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 67.3 mt -68.83 81.75 0.29 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.692 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -71.89 -58.79 3.15 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.786 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 14' ' ' VAL . 62.4 t0 -175.27 137.63 0.4 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.065 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.529 ' N ' ' OD1' ' A' ' 13' ' ' ASP . 28.4 m -137.54 156.52 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-O 121.11 0.481 . . . . 0.0 111.48 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -123.0 132.22 54.04 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.884 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 59.6 mt -120.54 123.73 43.61 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.476 -178.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.8 t -74.84 145.34 42.9 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 177.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -59.38 137.8 57.87 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.348 -179.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.98 -0.47 72.8 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -114.62 133.14 56.06 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.85 0.357 . . . . 0.0 110.763 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.409 ' C ' ' OD2' ' A' ' 21' ' ' ASP . 54.9 p30 -78.86 172.06 14.29 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.434 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -159.92 173.18 16.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.023 0.44 . . . . 0.0 111.263 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 29.0 p -154.67 162.29 41.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.502 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -127.93 152.55 47.74 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.022 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -130.58 130.06 43.56 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.473 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.466 ' SG ' ' N ' ' A' ' 27' ' ' ARG . 48.5 t -141.89 164.6 29.74 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.412 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.466 ' N ' ' SG ' ' A' ' 26' ' ' CYS . 95.7 mtt180 -140.95 121.19 13.86 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.951 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 86.0 mt -126.39 103.05 7.42 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.842 179.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.654 ' HG ' ' H ' ' A' ' 30' ' ' ARG . 25.1 t -63.52 170.03 3.44 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.654 ' H ' ' HG ' ' A' ' 29' ' ' SER . 39.4 ptt180 -52.62 140.21 23.85 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.378 0.609 . . . . 0.0 111.689 -178.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -91.42 -172.66 3.34 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.21 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 38.0 t -150.58 -60.26 0.19 Allowed 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -72.69 -90.13 0.13 Allowed Glycine 0 CA--C 1.521 0.45 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -123.56 143.33 50.27 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.935 0.397 . . . . 0.0 110.963 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -79.35 151.32 31.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.328 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.74 155.69 39.71 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.427 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -125.45 133.57 52.4 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.19 0.519 . . . . 0.0 111.306 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 1.5 t-105 -76.8 156.86 31.98 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.813 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -169.61 152.64 4.74 Favored 'General case' 0 N--CA 1.461 0.119 0 C-N-CA 119.716 -0.794 . . . . 0.0 111.959 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.43 ' C ' ' CD1' ' A' ' 40' ' ' LEU . 2.4 tm? -125.5 117.32 23.37 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.2 4.1 90.33 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 -179.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 102.62 -9.88 55.8 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.803 -0.519 . . . . 0.0 111.803 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.5 m -107.82 155.3 40.13 Favored Pre-proline 0 N--CA 1.47 0.562 0 CA-C-N 117.08 0.44 . . . . 0.0 110.545 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -68.45 154.77 71.13 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 121.392 1.394 . . . . 0.0 112.258 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.48 -175.87 3.78 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.163 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.561 ' O ' ' N ' ' A' ' 48' ' ' ASN . 50.1 tt0 -141.95 149.74 40.51 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 179.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -50.14 82.64 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.947 0.404 . . . . 0.0 111.204 -179.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.561 ' N ' ' O ' ' A' ' 46' ' ' GLN . 52.3 t30 -81.03 162.17 23.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.372 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -57.77 -45.53 85.82 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.211 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 66.6 mtt -66.13 -38.35 87.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.819 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.452 ' O ' ' O ' ' A' ' 48' ' ' ASN . 79.4 m-20 -108.91 111.27 22.88 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.522 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -105.26 145.42 30.69 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 33.1 mt -125.0 129.85 73.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 90.2 m -124.69 131.74 53.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.601 -179.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 63.8 t -111.99 131.9 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.166 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.436 ' O ' ' O ' ' A' ' 57' ' ' GLN . 75.6 tt0 -137.09 156.77 47.97 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.911 -179.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.436 ' O ' ' O ' ' A' ' 56' ' ' GLU . 6.8 pt20 -41.58 165.87 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.952 0.406 . . . . 0.0 111.201 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.414 ' O ' ' OG1' ' A' ' 59' ' ' THR . . . 69.23 16.75 71.43 Favored Glycine 0 CA--C 1.517 0.16 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.414 ' OG1' ' O ' ' A' ' 58' ' ' GLY . 70.7 p 52.23 31.31 9.0 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.26 -0.47 . . . . 0.0 110.048 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 22.9 mt -72.96 129.69 38.68 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.608 179.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 81.0 m80 -112.85 149.5 33.02 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.819 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 54.1 tp -151.16 106.49 3.34 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 120.809 -0.357 . . . . 0.0 111.126 -179.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -87.44 105.7 17.46 Favored 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.1 m -91.99 107.35 19.15 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.297 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 39.5 tp -97.77 110.42 22.99 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.503 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.426 ' O ' ' O ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -91.85 144.11 25.82 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.817 -179.828 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.426 ' O ' ' O ' ' A' ' 66' ' ' HIS . 99.2 mttt 41.76 96.85 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.09 179.164 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.9 p -75.28 156.12 6.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.073 0.464 . . . . 0.0 110.905 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.7 m -134.61 156.64 48.36 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.095 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 70.6 mt -56.56 -24.65 48.59 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -74.27 -6.32 47.28 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.044 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -60.48 -39.11 86.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.815 0.34 . . . . 0.0 110.754 -179.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -44.27 126.25 5.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.71 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -178.75 -150.52 8.89 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 10.0 m -150.46 106.52 3.45 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 110.336 -0.246 . . . . 0.0 110.336 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.8 t -83.06 133.27 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.1 p -151.62 164.13 37.56 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.16 0.505 . . . . 0.0 111.338 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -141.9 146.53 35.84 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.517 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -119.28 129.29 54.82 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.192 0.52 . . . . 0.0 111.526 -179.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.554 ' C ' ' H ' ' A' ' 82' ' ' THR . 2.0 t -120.68 132.24 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.032 179.185 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -50.32 -6.72 0.11 Allowed Glycine 0 CA--C 1.529 0.925 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.408 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.554 ' H ' ' C ' ' A' ' 80' ' ' VAL . 6.4 p -102.8 -52.0 3.17 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.737 0.303 . . . . 0.0 110.194 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.459 ' H ' ' HG1' ' A' ' 82' ' ' THR . 0.9 OUTLIER -152.8 161.6 42.35 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.946 179.345 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 40.1 t -135.54 143.19 45.58 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.935 0.398 . . . . 0.0 111.001 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 67.1 m -134.13 160.16 38.64 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.46 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.491 ' OE2' ' N ' ' A' ' 86' ' ' GLU . 57.9 mp0 -130.88 156.14 45.55 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.785 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -134.53 142.65 47.07 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.203 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.484 ' N ' ' CD ' ' A' ' 88' ' ' GLN . 14.7 mp0 -106.93 127.29 53.3 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.434 0.635 . . . . 0.0 111.955 -178.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.423 ' CD2' ' C ' ' A' ' 89' ' ' LEU . 4.6 tt -119.69 114.15 21.74 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.164 179.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.409 ' NZ ' ' OD2' ' A' ' 13' ' ' ASP . 23.2 mtmm -109.93 154.03 23.68 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.528 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.8 t -119.42 131.34 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.9 m . . . . . 0 C--N 1.33 -0.267 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.931 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 . . . . . 0 N--CA 1.464 0.259 0 CA-C-O 120.733 0.302 . . . . 0.0 110.72 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.8 t -61.01 133.14 26.8 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.0 m -111.94 131.46 55.37 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.842 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 mt -120.41 124.08 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 120.959 0.409 . . . . 0.0 111.905 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.46 89.93 2.85 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.271 177.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -121.53 83.3 41.02 Favored Pre-proline 0 N--CA 1.469 0.524 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.221 -179.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -73.92 -10.48 23.08 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.215 1.943 . . . . 0.0 111.57 179.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.429 ' CD2' ' H ' ' A' ' 25' ' ' GLN . 0.3 OUTLIER -91.75 55.14 2.63 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.194 0.521 . . . . 0.0 109.908 179.759 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -80.48 -1.19 40.62 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.418 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -151.67 109.39 3.65 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 43.0 t -120.41 133.87 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.017 -178.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -135.07 100.32 4.53 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.961 0.41 . . . . 0.0 110.961 179.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 66.2 mt -115.78 139.98 49.65 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.458 -179.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 85.3 p -74.58 165.68 24.81 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.767 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -69.23 146.41 52.37 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.011 0.434 . . . . 0.0 110.523 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.08 1.33 89.67 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 70.7 tp60 -105.34 148.34 27.17 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.614 0.245 . . . . 0.0 110.48 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 21' ' ' ASP . 54.8 p30 -76.29 153.82 35.61 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.79 147.58 37.52 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.97 -179.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.4 m -163.09 171.23 16.71 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.715 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -128.36 143.7 51.04 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.429 ' H ' ' CD2' ' A' ' 11' ' ' LEU . 88.0 mt-30 -139.19 119.7 13.97 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.723 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 9.7 p -152.04 163.89 38.37 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.418 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -102.05 137.06 40.82 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.459 ' H ' ' HG1' ' A' ' 59' ' ' THR . 0.3 OUTLIER -140.52 95.68 2.91 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.978 -179.774 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 69.1 m -59.25 152.27 21.17 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -54.41 156.02 3.57 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -177.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.29 -178.71 3.06 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 114.606 -1.179 . . . . 0.0 112.123 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 89.6 p -156.71 -52.05 0.08 Allowed 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.223 -0.898 . . . . 0.0 109.713 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -97.29 -65.4 0.9 Allowed Glycine 0 CA--C 1.524 0.648 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 179.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -124.03 152.11 42.99 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -86.18 135.91 33.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.952 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.2 152.71 34.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.513 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -147.05 146.93 30.16 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.163 0.506 . . . . 0.0 111.739 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -81.48 179.64 7.76 Favored 'General case' 0 CA--C 1.521 -0.139 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.607 179.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -165.74 131.6 2.56 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.202 179.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 53.1 tp -133.89 123.35 24.58 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.012 179.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.31 8.83 80.53 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.08 -17.31 58.87 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.4 m -112.16 147.48 37.05 Favored Pre-proline 0 CA--C 1.535 0.381 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -52.39 140.7 52.79 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 121.301 1.334 . . . . 0.0 111.042 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -78.44 168.69 19.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.909 0.385 . . . . 0.0 110.874 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -131.38 142.11 49.99 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.716 -179.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.42 62.89 1.02 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.796 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.459 ' O ' ' O ' ' A' ' 51' ' ' ASN . 97.3 m-20 -74.69 159.53 31.94 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -40.86 -36.49 0.64 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 120.681 -0.407 . . . . 0.0 111.359 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 94.4 mtp -64.55 -43.57 93.54 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.782 0.325 . . . . 0.0 111.117 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.463 ' O ' ' OD2' ' A' ' 52' ' ' ASP . 70.9 m-80 -100.26 149.97 23.04 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.469 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.463 ' OD2' ' O ' ' A' ' 51' ' ' ASN . 84.4 m-20 -140.21 98.51 3.45 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.888 0.375 . . . . 0.0 110.634 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.7 mt -85.72 128.1 39.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.516 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.3 t -140.03 152.22 46.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.987 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.1 t -119.88 130.12 74.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.05 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -126.18 -174.95 3.23 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.405 -179.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -54.3 152.06 6.74 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.858 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.65 26.47 74.42 Favored Glycine 0 CA--C 1.52 0.394 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.459 ' HG1' ' H ' ' A' ' 28' ' ' LEU . 17.8 p 48.33 29.07 1.81 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.762 0.315 . . . . 0.0 110.681 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 23.5 mt -69.32 131.9 45.57 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.278 0.561 . . . . 0.0 111.006 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 64.2 m80 -110.34 149.29 30.43 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.721 178.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.454 ' CD2' ' OG1' ' A' ' 64' ' ' THR . 7.0 tt -156.53 102.72 2.08 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.196 -178.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.35 106.97 19.07 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 177.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.454 ' OG1' ' CD2' ' A' ' 62' ' ' LEU . 15.9 m -88.31 113.11 23.59 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.023 0.439 . . . . 0.0 111.36 -178.384 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.0 tt -101.67 122.1 43.26 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.658 ' NE2' ' NZ ' ' A' ' 67' ' ' LYS . 56.0 t60 -85.28 132.26 34.29 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.263 0.554 . . . . 0.0 112.228 -178.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.658 ' NZ ' ' NE2' ' A' ' 66' ' ' HIS . 52.5 mttp 39.62 83.44 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.039 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.7 p -54.29 162.08 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.014 0.435 . . . . 0.0 110.649 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 28.5 p -137.26 165.27 26.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.447 179.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.439 ' N ' ' CD2' ' A' ' 70' ' ' LEU . 4.1 mm? -60.95 -38.14 84.82 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.354 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -67.54 -36.62 81.34 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.896 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -63.98 -36.81 85.19 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.789 -178.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.28 141.65 55.8 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.559 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -176.39 -165.02 31.41 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 57.7 m -98.93 123.39 43.18 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.627 0.251 . . . . 0.0 110.509 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.1 m -105.37 149.74 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.623 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 51.7 p -159.47 158.23 31.59 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.678 0.275 . . . . 0.0 110.738 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.406 ' CD1' ' C ' ' A' ' 78' ' ' PHE . 45.3 p90 -143.16 157.35 44.59 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 69.8 m80 -142.87 139.66 30.93 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.245 0.545 . . . . 0.0 111.827 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.534 ' O ' ' N ' ' A' ' 82' ' ' THR . 3.2 p -144.12 143.12 23.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.17 178.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -42.21 -14.39 0.01 OUTLIER Glycine 0 CA--C 1.526 0.748 0 CA-C-N 116.471 -0.331 . . . . 0.0 112.854 -178.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.534 ' N ' ' O ' ' A' ' 80' ' ' VAL . 45.6 p -89.3 -72.91 0.53 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 117.081 0.441 . . . . 0.0 110.152 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 6.7 t -139.45 -172.37 3.35 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.633 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 41.6 p -158.56 163.08 37.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.051 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 31.0 m -162.31 173.83 13.65 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.546 -0.462 . . . . 0.0 111.054 179.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.467 ' N ' ' CD ' ' A' ' 86' ' ' GLU . 1.3 pm0 -137.04 152.66 50.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.823 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -143.79 151.68 40.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.269 -0.878 . . . . 0.0 108.922 178.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -110.86 128.6 55.84 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.527 0.679 . . . . 0.0 111.933 -178.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 51.4 tp -101.02 81.69 2.28 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 114.944 -1.025 . . . . 0.0 108.765 178.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -94.55 172.35 8.24 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.3 m -116.02 141.46 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 29.0 m . . . . . 0 C--N 1.327 -0.409 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.68 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.401 ' HG3' ' N ' ' A' ' 5' ' ' VAL . 35.5 tp10 . . . . . 0 C--O 1.231 0.125 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.401 ' N ' ' HG3' ' A' ' 4' ' ' GLU . 1.0 OUTLIER -52.34 137.79 11.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 179.919 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.537 ' N ' ' OG ' ' A' ' 29' ' ' SER . 39.2 m -95.87 123.56 39.51 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 120.04 -0.664 . . . . 0.0 111.074 -178.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.3 mm -109.9 88.9 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.762 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.499 ' O ' ' SG ' ' A' ' 26' ' ' CYS . 55.4 mt -112.81 112.05 23.27 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 177.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -123.95 92.67 48.14 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.57 -178.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -69.25 -11.22 30.99 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 C-N-CA 121.259 1.306 . . . . 0.0 109.334 178.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 63.7 mt -68.09 77.29 0.23 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.502 -1.226 . . . . 0.0 110.575 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 54.1 tp60 -70.66 -41.17 72.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.735 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -176.38 145.54 0.59 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.02 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 70.0 t -121.45 134.72 63.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.314 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -143.16 127.18 17.38 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.229 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.5 pp -162.75 144.3 10.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.861 -179.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.4 m -64.68 146.13 55.18 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -64.48 147.92 51.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.971 0.891 . . . . 0.0 112.218 -178.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.573 ' H ' ' CG1' ' A' ' 68' ' ' VAL . . . 92.75 -8.13 76.75 Favored Glycine 0 CA--C 1.521 0.466 0 CA-C-N 113.906 -1.497 . . . . 0.0 110.427 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -93.05 161.55 14.39 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 179.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -76.41 161.28 28.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.932 0.396 . . . . 0.0 110.588 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -149.39 156.89 42.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.389 -179.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.2 p -160.36 162.53 33.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.951 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -133.41 147.31 51.74 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.146 0.498 . . . . 0.0 111.099 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -139.0 125.48 20.5 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.424 178.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.61 ' SG ' ' N ' ' A' ' 27' ' ' ARG . 8.9 t -146.73 163.31 36.36 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.036 0.446 . . . . 0.0 110.453 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.61 ' N ' ' SG ' ' A' ' 26' ' ' CYS . 78.4 ttt-85 -120.61 119.48 33.01 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.423 ' O ' ' OG1' ' A' ' 59' ' ' THR . 2.6 tt -136.15 105.76 6.14 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.551 -0.459 . . . . 0.0 110.541 -179.026 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.537 ' OG ' ' N ' ' A' ' 6' ' ' THR . 86.6 p -62.4 156.27 23.02 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.342 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 37.7 ptt-85 -50.84 160.68 0.43 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.223 -177.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.02 174.39 6.31 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.196 -178.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.3 t -120.35 1.94 10.77 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 151.65 -24.23 0.94 Allowed Glycine 0 N--CA 1.453 -0.184 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -121.07 119.16 31.67 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 115.416 -0.392 . . . . 0.0 110.449 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -93.71 149.99 20.78 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.123 -179.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -80.63 169.25 17.89 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.298 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.456 ' NH2' ' O ' ' A' ' 38' ' ' TRP . 9.5 ptm180 -144.21 146.06 32.46 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.42 179.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.456 ' O ' ' NH2' ' A' ' 37' ' ' ARG . 81.4 m95 -78.16 176.54 9.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.813 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -164.55 107.21 0.88 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.598 179.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.409 ' CD1' ' C ' ' A' ' 40' ' ' LEU . 0.7 OUTLIER -116.19 114.1 23.98 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.87 17.38 75.26 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.18 -22.19 42.17 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 18.8 m -111.94 148.73 39.62 Favored Pre-proline 0 CA--C 1.539 0.554 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -59.25 144.55 99.35 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 121.253 1.302 . . . . 0.0 111.625 -179.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.69 164.77 14.57 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.436 ' O ' ' N ' ' A' ' 48' ' ' ASN . 78.3 mt-30 -135.91 155.44 50.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.978 0.418 . . . . 0.0 110.298 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.89 74.44 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.576 -179.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' A' ' 46' ' ' GLN . 98.5 m-20 -73.01 160.3 32.31 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.048 179.113 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -54.7 -49.16 71.38 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.326 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 78.4 mtm -69.38 -39.87 77.75 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.74 179.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.435 ' O ' ' O ' ' A' ' 48' ' ' ASN . 64.3 t30 -107.53 112.2 24.83 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.936 0.398 . . . . 0.0 110.975 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 53' ' ' ILE . 66.7 t0 -109.93 143.76 39.41 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.673 179.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.518 ' N ' ' OD1' ' A' ' 52' ' ' ASP . 20.6 tt -127.63 136.24 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.5 p -140.73 158.38 44.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.081 0.467 . . . . 0.0 111.551 -178.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.6 m -120.58 130.14 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.405 178.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -121.29 165.36 15.59 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.163 0.506 . . . . 0.0 111.009 -178.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -42.14 152.69 0.08 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.977 179.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.3 19.07 78.54 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' A' ' 28' ' ' LEU . 51.0 p 50.33 33.35 7.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.931 0.396 . . . . 0.0 110.376 -179.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 76.7 mt -79.32 120.56 23.96 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.714 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -83.69 142.63 30.61 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 56.1 tp -145.66 93.96 2.43 Favored 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 34.4 tp -92.91 106.97 18.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.606 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.537 ' CG2' ' NE2' ' A' ' 66' ' ' HIS . 78.0 m -96.85 98.41 10.1 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.184 -178.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.0 tt -101.27 119.44 38.75 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.537 ' NE2' ' CG2' ' A' ' 64' ' ' THR . 54.1 m170 -112.43 154.22 26.15 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 120.772 0.32 . . . . 0.0 110.513 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 64.3 mttp 53.5 59.16 4.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.262 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.573 ' CG1' ' H ' ' A' ' 19' ' ' GLY . 1.0 OUTLIER -50.7 159.01 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.963 0.411 . . . . 0.0 110.782 -179.682 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 55.0 p -133.97 167.04 21.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.313 179.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 11.0 mp -61.78 -39.32 91.25 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -67.78 -35.55 78.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.158 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -61.74 -43.03 99.65 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.197 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.27 141.15 51.75 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.374 -0.53 . . . . 0.0 109.73 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 168.28 -148.67 12.89 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.596 -0.811 . . . . 0.0 111.15 -179.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 43.6 m -110.1 125.16 52.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.709 -0.246 . . . . 0.0 110.715 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.0 t -111.76 130.58 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.404 ' OG ' ' O ' ' A' ' 85' ' ' SER . 24.9 t -153.4 167.48 29.28 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.127 0.489 . . . . 0.0 110.764 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -146.68 150.33 35.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.066 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -128.62 140.37 51.8 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.092 0.472 . . . . 0.0 111.584 -178.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.527 ' C ' ' H ' ' A' ' 82' ' ' THR . 2.2 t -129.49 133.84 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.974 179.217 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -49.18 -7.48 0.07 OUTLIER Glycine 0 CA--C 1.529 0.928 0 C-N-CA 121.158 -0.544 . . . . 0.0 111.854 -179.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.641 ' HG1' ' N ' ' A' ' 83' ' ' CYS . 31.0 p -107.72 -43.53 4.46 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.978 0.389 . . . . 0.0 110.932 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.641 ' N ' ' HG1' ' A' ' 82' ' ' THR . 14.1 t -154.2 154.62 33.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.336 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.1 m -130.61 157.1 43.66 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.984 0.421 . . . . 0.0 111.569 -179.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.404 ' O ' ' OG ' ' A' ' 77' ' ' SER . 15.8 t -154.68 157.2 37.74 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.848 -179.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -127.4 159.95 32.92 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.368 0.604 . . . . 0.0 111.706 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.49 147.57 27.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.425 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -117.66 139.6 50.78 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.346 0.593 . . . . 0.0 112.522 -178.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.5 tt -119.81 106.78 12.42 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.182 -0.917 . . . . 0.0 108.597 178.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -110.96 160.24 16.99 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.706 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 23.7 m -110.66 131.47 61.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.886 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 98.1 m . . . . . 0 N--CA 1.467 0.387 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.271 -179.429 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 . . . . . 0 N--CA 1.463 0.198 0 CA-C-O 120.966 0.412 . . . . 0.0 110.741 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -58.8 157.71 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 177.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.406 ' H ' ' HB3' ' A' ' 29' ' ' SER . 93.8 m -85.53 86.31 7.38 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 118.262 -1.375 . . . . 0.0 108.407 179.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.428 ' O ' ' CG2' ' A' ' 7' ' ' ILE . 10.6 tt -83.92 90.9 2.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 122.371 1.081 . . . . 0.0 112.52 -177.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 96.8 mt -127.33 83.51 2.17 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 113.457 -1.702 . . . . 0.0 109.056 178.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.486 ' C ' ' H ' ' A' ' 11' ' ' LEU . 4.8 pt-20 -122.93 83.9 50.3 Favored Pre-proline 0 N--CA 1.468 0.464 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.177 -178.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -71.93 17.51 0.32 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.189 1.926 . . . . 0.0 111.577 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.486 ' H ' ' C ' ' A' ' 9' ' ' GLU . 76.6 mt -66.92 77.45 0.12 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.542 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -71.7 -70.47 0.32 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.345 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.417 ' OD2' ' N ' ' A' ' 13' ' ' ASP . 31.7 p-10 -176.72 152.41 0.99 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.336 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.9 m -135.57 161.3 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.068 -179.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -133.45 139.51 46.75 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.383 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -156.64 151.52 26.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.033 0.445 . . . . 0.0 111.417 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.8 p -80.66 168.04 19.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.639 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -64.83 141.68 58.69 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.831 0.348 . . . . 0.0 110.515 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.61 8.2 87.22 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.689 -0.564 . . . . 0.0 111.689 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 93.5 mm-40 -96.48 158.66 15.33 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.846 0.355 . . . . 0.0 110.153 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -86.04 167.54 14.92 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.05 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -161.54 157.08 24.29 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.916 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 73.6 m -163.93 159.47 20.94 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.148 -0.315 . . . . 0.0 110.148 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -128.78 147.91 50.82 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.087 0.47 . . . . 0.0 110.617 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.485 ' OE1' ' CD2' ' A' ' 62' ' ' LEU . 62.6 mm-40 -124.43 125.69 44.69 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.874 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 6.7 t -137.53 146.13 43.78 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.171 0.51 . . . . 0.0 110.701 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -125.99 100.42 6.35 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.244 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.478 ' O ' ' CG2' ' A' ' 59' ' ' THR . 91.0 mt -121.6 110.31 15.84 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.255 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.406 ' HB3' ' H ' ' A' ' 6' ' ' THR . 34.7 t -69.62 172.9 6.7 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 11.6 ptp85 -50.12 151.28 2.05 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 122.038 0.923 . . . . 0.0 113.03 -177.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.6 160.04 20.53 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 113.831 -1.531 . . . . 0.0 112.213 -178.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.9 m -138.77 -82.96 0.29 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.647 179.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -65.58 -85.9 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 178.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -123.56 155.68 37.16 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.303 0.573 . . . . 0.0 110.193 178.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 74.9 tt0 -72.99 153.47 40.92 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.239 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.72 143.6 26.81 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.075 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -108.08 141.74 39.33 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.52 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 8.7 t-105 -111.11 138.87 47.01 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -165.41 155.98 13.6 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 119.45 -0.9 . . . . 0.0 111.762 -178.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.409 ' C ' ' CD2' ' A' ' 40' ' ' LEU . 6.9 tt -131.27 123.57 28.65 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.941 179.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.89 6.31 88.52 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.752 -0.539 . . . . 0.0 111.752 179.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 102.04 -20.34 45.84 Favored Glycine 0 N--CA 1.467 0.704 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.4 m -109.35 151.56 42.17 Favored Pre-proline 0 N--CA 1.467 0.401 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -56.79 141.78 92.34 Favored 'Trans proline' 0 C--N 1.316 -1.171 0 C-N-CA 120.939 1.092 . . . . 0.0 111.048 179.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.474 ' H ' ' CD2' ' A' ' 45' ' ' LEU . 0.8 OUTLIER -93.15 -172.46 2.97 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.14 -179.89 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 61.8 tp60 -144.93 155.7 43.57 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.262 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.14 63.7 1.33 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.44 ' O ' ' O ' ' A' ' 51' ' ' ASN . 13.3 t-20 -65.55 175.87 1.67 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.136 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -66.01 -39.72 90.48 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 78.1 mtm -67.65 -39.35 84.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.164 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.44 ' O ' ' O ' ' A' ' 48' ' ' ASN . 55.6 t30 -126.02 131.95 52.09 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.039 0.447 . . . . 0.0 111.073 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -120.02 140.57 50.77 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.551 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.4 mm -110.69 127.32 67.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.451 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.0 t -145.86 156.55 43.63 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.099 0.476 . . . . 0.0 111.432 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.2 m -115.31 133.65 60.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.029 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -116.91 -177.48 3.21 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.101 0.477 . . . . 0.0 110.669 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.426 ' CD ' ' N ' ' A' ' 58' ' ' GLY . 9.8 tm0? -64.6 147.31 53.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.269 -179.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.426 ' N ' ' CD ' ' A' ' 57' ' ' GLN . . . 80.55 13.04 82.24 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.478 ' CG2' ' O ' ' A' ' 28' ' ' LEU . 1.6 m 70.4 24.53 4.63 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 121.418 0.628 . . . . 0.0 110.385 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.6 mp -79.76 138.85 37.4 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.879 179.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 58.4 m170 -111.18 130.29 55.68 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.485 ' CD2' ' OE1' ' A' ' 25' ' ' GLN . 1.1 tm? -125.13 119.58 28.99 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 111.494 0.183 . . . . 0.0 111.494 -178.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.3 mp -103.36 114.14 28.18 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 177.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 93.1 m -99.61 110.6 23.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.112 0.482 . . . . 0.0 110.746 -179.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.457 ' C ' ' CD2' ' A' ' 65' ' ' LEU . 7.0 tt -110.88 129.28 55.91 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.869 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.484 ' HD1' ' C ' ' A' ' 66' ' ' HIS . 0.8 OUTLIER -153.34 165.11 36.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.414 -179.602 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.5 mttp 42.58 86.78 0.02 OUTLIER 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.313 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.4 m -137.65 163.94 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.588 -178.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.673 ' HG1' ' H ' ' A' ' 71' ' ' GLU . 33.2 p -117.77 -151.86 0.49 Allowed 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.669 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.535 ' C ' ' H ' ' A' ' 72' ' ' ASP . 87.1 mt -63.01 -23.71 67.58 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.675 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.673 ' H ' ' HG1' ' A' ' 69' ' ' THR . 80.0 mm-40 -56.92 -1.07 0.05 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.349 -179.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.535 ' H ' ' C ' ' A' ' 70' ' ' LEU . 18.6 m-20 -62.73 -36.19 82.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.281 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.3 127.92 31.66 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.473 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 172.48 153.18 9.12 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.776 -0.929 . . . . 0.0 110.776 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 85.4 m -111.59 116.69 31.24 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.558 0.218 . . . . 0.0 110.958 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.2 t -91.93 128.2 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.2 p -128.24 145.45 51.04 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.043 0.449 . . . . 0.0 110.835 -179.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -156.87 155.49 31.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.421 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 40.8 p-80 -159.37 151.46 20.88 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.315 0.578 . . . . 0.0 111.911 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.544 ' O ' ' N ' ' A' ' 82' ' ' THR . 12.3 p -124.06 134.22 67.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 115.285 -0.87 . . . . 0.0 108.982 178.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -31.23 -30.01 0.01 OUTLIER Glycine 0 CA--C 1.529 0.958 0 CA-C-N 116.058 -0.519 . . . . 0.0 113.096 -178.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.544 ' N ' ' O ' ' A' ' 80' ' ' VAL . 4.5 m -76.61 -74.3 0.24 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.006 0.431 . . . . 0.0 110.92 -179.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.41 ' O ' ' O ' ' A' ' 80' ' ' VAL . 7.6 t -119.76 -170.04 1.88 Allowed 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 31.4 p -151.74 157.49 42.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.204 0.526 . . . . 0.0 110.718 179.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.4 t -167.06 151.35 6.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.827 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -146.1 156.26 43.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.054 0.454 . . . . 0.0 110.729 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -129.82 152.97 48.72 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.448 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -124.99 137.95 54.24 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.279 0.561 . . . . 0.0 111.459 -179.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.3 tt -110.15 121.97 46.53 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.22 -0.9 . . . . 0.0 108.978 178.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -123.61 157.93 32.63 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.934 0.397 . . . . 0.0 111.367 -179.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 18.6 m -116.06 136.24 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.873 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 46.5 p . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.573 179.917 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.471 ' OE2' ' N ' ' A' ' 5' ' ' VAL . 1.3 tm-20 . . . . . 0 CA--C 1.533 0.325 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.471 ' N ' ' OE2' ' A' ' 4' ' ' GLU . 1.9 p -59.23 130.31 22.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.444 ' CB ' ' HG ' ' A' ' 29' ' ' SER . 12.1 m -66.61 134.31 52.07 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 118.739 -1.184 . . . . 0.0 108.304 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 tp -111.81 31.49 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -177.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.7 mp -81.98 90.1 6.46 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.536 ' C ' ' H ' ' A' ' 11' ' ' LEU . 1.8 pt-20 -121.3 90.5 47.6 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.032 -179.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -68.32 24.93 0.14 Allowed 'Trans proline' 0 C--N 1.314 -1.289 0 C-N-CA 121.861 1.707 . . . . 0.0 112.141 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.536 ' H ' ' C ' ' A' ' 9' ' ' GLU . 71.2 mt -81.01 72.9 8.06 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.104 0.478 . . . . 0.0 110.467 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -74.58 -67.78 0.6 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.446 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -172.26 133.57 0.67 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.357 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.1 m -123.99 142.38 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 120.924 0.392 . . . . 0.0 110.768 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -129.71 112.97 14.17 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.518 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -122.92 151.32 41.89 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.36 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.2 m -72.85 155.09 40.26 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 178.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.2 tm-20 -59.5 139.43 57.13 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.832 0.348 . . . . 0.0 110.728 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.59 -1.41 87.17 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.891 179.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 23.0 mm100 -91.83 168.55 11.36 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.91 0.386 . . . . 0.0 110.725 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -84.3 164.15 19.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.255 179.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -153.27 153.27 32.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.785 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 28.2 p -156.43 159.13 38.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.921 0.391 . . . . 0.0 110.552 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -132.3 147.1 52.39 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.292 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -137.37 121.75 18.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.09 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 37.3 t -129.63 129.82 44.82 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.98 0.419 . . . . 0.0 111.053 -179.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.01 108.38 21.05 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.044 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.459 ' O ' ' OG1' ' A' ' 59' ' ' THR . 74.3 mt -122.38 129.81 52.48 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.537 178.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.444 ' HG ' ' CB ' ' A' ' 6' ' ' THR . 68.6 m -94.32 175.86 6.53 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 -56.67 138.56 52.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.361 0.6 . . . . 0.0 111.208 -179.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -79.27 -176.1 5.01 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.415 -179.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.686 ' HG ' ' N ' ' A' ' 33' ' ' GLY . 82.5 p -146.23 -62.04 0.31 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.711 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.686 ' N ' ' HG ' ' A' ' 32' ' ' SER . . . -93.82 -71.08 1.14 Allowed Glycine 0 CA--C 1.522 0.506 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 179.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 96.5 mm-40 -122.75 135.15 54.47 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.386 0.612 . . . . 0.0 111.78 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -86.75 145.41 26.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.072 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.45 147.63 49.24 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.5 mmt85 -102.52 143.68 31.92 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 20.9 t-105 -102.3 131.43 48.9 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.414 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -172.7 152.81 2.6 Favored 'General case' 0 C--O 1.226 -0.179 0 C-N-CA 119.608 -0.837 . . . . 0.0 112.447 -179.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.7 tt -125.87 121.16 32.42 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.23 -2.99 85.58 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -178.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.28 1.07 58.15 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 112.167 -0.373 . . . . 0.0 112.167 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.7 m -111.59 148.28 38.52 Favored Pre-proline 0 N--CA 1.471 0.603 0 CA-C-N 117.146 0.473 . . . . 0.0 110.709 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -49.85 138.72 33.75 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 121.631 1.554 . . . . 0.0 111.308 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.8 tp -86.62 163.19 17.55 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.899 -178.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -140.41 147.76 40.2 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.62 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.13 62.98 0.67 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.866 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.522 ' OD1' ' N ' ' A' ' 49' ' ' GLU . 60.1 t-20 -66.62 142.62 57.4 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.043 0.449 . . . . 0.0 111.033 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.522 ' N ' ' OD1' ' A' ' 48' ' ' ASN . 74.9 mm-40 -40.07 -42.05 1.35 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.093 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 74.1 mtm -65.99 -39.28 90.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.636 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.514 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 0.6 OUTLIER -112.27 125.88 54.64 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.123 -178.805 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.488 ' OD2' ' N ' ' A' ' 53' ' ' ILE . 56.5 t0 -109.28 154.09 22.95 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.488 ' N ' ' OD2' ' A' ' 52' ' ' ASP . 64.4 mt -137.11 129.22 43.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.9 p -130.86 148.87 52.69 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.035 0.445 . . . . 0.0 110.755 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.0 p -125.34 128.44 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.348 -179.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.454 ' O ' ' O ' ' A' ' 57' ' ' GLN . 96.3 mt-10 -126.82 -173.12 2.8 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.841 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.454 ' O ' ' O ' ' A' ' 56' ' ' GLU . 97.8 mm-40 -28.24 152.12 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.368 -179.123 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.427 ' C ' ' OG1' ' A' ' 59' ' ' THR . . . 58.8 -82.75 0.01 OUTLIER Glycine 0 CA--C 1.521 0.454 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 179.239 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER 175.68 51.29 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.83 0.824 . . . . 0.0 109.134 179.912 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 42.8 mt -80.16 135.93 36.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.95 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -113.76 145.74 40.94 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 tt -153.59 110.94 3.48 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.643 -179.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.8 mp -97.02 128.86 44.4 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 120.969 0.414 . . . . 0.0 110.804 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.9 m -108.71 103.22 12.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.544 179.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.431 ' CD2' ' N ' ' A' ' 65' ' ' LEU . 3.1 mm? -96.06 126.68 41.46 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.132 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.687 ' HD1' ' N ' ' A' ' 67' ' ' LYS . 12.0 t-80 -138.61 160.49 39.47 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.235 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.687 ' N ' ' HD1' ' A' ' 66' ' ' HIS . 70.9 mmtt 57.21 41.54 26.8 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.4 p -94.88 134.95 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.106 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.431 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 44.7 p -122.27 -151.01 0.46 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.102 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.623 ' C ' ' H ' ' A' ' 72' ' ' ASP . 86.0 mt -45.9 -27.4 0.87 Allowed 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.34 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -64.28 13.07 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.725 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.623 ' H ' ' C ' ' A' ' 70' ' ' LEU . 5.1 m-20 -60.34 -35.77 76.42 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.048 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -52.31 138.3 26.97 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.148 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -171.53 173.66 44.95 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 17.1 p -154.43 104.39 2.57 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 110.453 -0.203 . . . . 0.0 110.453 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.2 t -94.89 132.68 38.22 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 CA-C-O 121.147 0.499 . . . . 0.0 110.125 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 11.0 t -132.85 152.47 51.83 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.356 -179.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -127.25 133.67 50.17 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.515 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -114.88 109.86 18.78 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.464 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.408 ' C ' ' H ' ' A' ' 82' ' ' THR . 1.4 t -115.89 129.35 72.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -57.07 -7.08 2.25 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.922 -178.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.408 ' H ' ' C ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -109.15 -43.65 4.12 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 117.064 0.432 . . . . 0.0 110.915 179.993 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 59.7 m -137.38 172.69 12.61 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.9 0.381 . . . . 0.0 111.387 -179.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 87.7 p -133.93 156.42 48.16 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.392 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.8 p -156.73 160.06 38.93 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.989 0.424 . . . . 0.0 111.065 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -143.95 157.7 44.18 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.747 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -142.85 146.82 34.5 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.828 179.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -120.63 130.15 54.03 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.382 0.61 . . . . 0.0 112.255 -178.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 48.0 tp -114.89 119.2 35.76 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 114.992 -1.003 . . . . 0.0 108.822 178.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -133.25 156.64 47.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.216 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 8.6 p -117.16 133.39 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.0 t . . . . . 0 C--N 1.332 -0.166 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.068 -179.364 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.4 ptm . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -174.43 76.1 0.34 Allowed Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.387 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -68.75 146.64 67.14 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.535 2.157 . . . . 0.0 111.842 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.56 ' CD ' ' H ' ' A' ' 4' ' ' GLU . 1.5 pm0 -79.24 -118.46 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.333 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.9 t -84.6 120.12 34.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 80.8 m -84.89 125.58 32.76 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 119.415 -0.914 . . . . 0.0 109.274 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.8 mm -104.54 94.13 2.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.094 0.473 . . . . 0.0 110.802 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 53.4 tp -124.66 79.48 1.77 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.037 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.535 ' C ' ' H ' ' A' ' 11' ' ' LEU . 1.4 pt-20 -122.99 89.06 50.79 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.853 -178.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -69.03 16.7 0.17 Allowed 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 121.988 1.792 . . . . 0.0 111.602 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.535 ' H ' ' C ' ' A' ' 9' ' ' GLU . 64.2 mt -72.46 61.97 0.51 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.433 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -71.08 -40.6 71.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.597 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -172.0 132.38 0.68 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 81.8 t -124.96 132.08 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 120.895 0.378 . . . . 0.0 110.671 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -128.88 138.44 52.02 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.901 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.7 pp -157.03 135.06 11.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.997 0.427 . . . . 0.0 110.889 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 42.4 t -64.49 146.65 54.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.792 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.427 ' CD ' ' N ' ' A' ' 19' ' ' GLY . 14.5 tm-20 -61.02 143.12 55.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.607 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.427 ' N ' ' CD ' ' A' ' 18' ' ' GLU . . . 98.86 -14.26 61.73 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 20.2 mp0 -98.68 147.57 24.72 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.878 0.37 . . . . 0.0 110.736 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -71.93 153.3 41.93 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.741 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -129.87 146.32 51.59 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.857 0.361 . . . . 0.0 110.918 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 36.4 m -146.22 145.03 30.27 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.41 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -119.58 150.24 40.61 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -146.02 131.46 18.67 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.555 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 10.9 p -151.73 140.53 20.92 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.599 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -100.44 118.19 36.15 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.38 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.453 ' O ' ' CG2' ' A' ' 59' ' ' THR . 79.9 mt -129.25 106.16 8.63 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 110.332 -0.248 . . . . 0.0 110.332 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.531 ' HG ' ' H ' ' A' ' 30' ' ' ARG . 22.2 t -62.39 164.4 7.3 Favored 'General case' 0 CA--C 1.515 -0.381 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.026 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.531 ' H ' ' HG ' ' A' ' 29' ' ' SER . 9.5 ptm180 -54.96 162.37 1.31 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.225 -178.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.464 ' O ' ' NH1' ' A' ' 30' ' ' ARG . . . -94.11 -174.11 3.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.411 -179.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.2 m -149.96 -50.59 0.14 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.503 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -89.28 -75.58 1.3 Allowed Glycine 0 CA--C 1.522 0.487 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 178.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -124.83 154.28 41.25 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.824 0.345 . . . . 0.0 110.486 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.9 tp10 -89.97 147.23 23.83 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.976 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.79 147.93 48.42 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.917 0.389 . . . . 0.0 110.364 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -108.15 139.72 42.4 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.644 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 10.1 t-105 -102.45 134.21 46.14 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.448 -0.797 . . . . 0.0 108.901 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -163.19 154.23 16.85 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.083 -0.647 . . . . 0.0 111.587 -178.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.1 tt -128.19 127.72 43.44 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.759 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.32 10.77 84.23 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.29 -16.64 59.32 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 16.8 m -109.21 148.54 38.2 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -56.18 143.9 82.91 Favored 'Trans proline' 0 N--CA 1.488 1.19 0 C-N-CA 121.103 1.202 . . . . 0.0 110.468 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.42 ' H ' ' CD2' ' A' ' 45' ' ' LEU . 0.8 OUTLIER -101.15 -177.46 3.45 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.246 -179.01 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -141.55 124.22 15.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.907 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.84 81.36 0.11 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.932 0.396 . . . . 0.0 110.611 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.442 ' O ' ' O ' ' A' ' 51' ' ' ASN . 85.4 m-20 -66.46 -168.63 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.098 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.44 -52.17 59.43 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.622 -0.431 . . . . 0.0 109.885 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 62.4 ttp -67.01 -39.82 87.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.805 178.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.442 ' O ' ' O ' ' A' ' 48' ' ' ASN . 1.3 t-20 -94.46 102.26 14.21 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.924 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -116.67 140.17 49.71 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 87.8 mt -123.34 132.67 70.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.801 0.334 . . . . 0.0 110.481 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.7 t -130.98 140.77 50.19 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.077 0.465 . . . . 0.0 110.852 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 72.6 t -120.89 131.8 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.534 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -118.84 179.77 4.05 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.759 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -59.87 167.91 2.0 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.997 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.07 15.24 74.23 Favored Glycine 0 CA--C 1.519 0.343 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.453 ' CG2' ' O ' ' A' ' 28' ' ' LEU . 0.6 OUTLIER 54.89 35.44 24.37 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.204 0.526 . . . . 0.0 110.379 -179.771 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 81.1 mt -79.11 139.08 38.16 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.438 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -118.82 147.89 43.44 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.418 ' C ' ' CD2' ' A' ' 62' ' ' LEU . 5.4 tt -155.38 115.2 3.7 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 120.499 -0.481 . . . . 0.0 111.432 -178.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -86.73 106.66 17.81 Favored 'General case' 0 N--CA 1.461 0.11 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 89.9 m -90.21 105.64 17.95 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.898 0.38 . . . . 0.0 110.304 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 80.3 mt -109.82 118.03 35.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.732 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.712 ' HD1' ' N ' ' A' ' 67' ' ' LYS . 24.9 t-80 -77.75 -136.39 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 120.549 -0.461 . . . . 0.0 110.63 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.712 ' N ' ' HD1' ' A' ' 66' ' ' HIS . 15.8 ptmt -53.3 96.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.209 0.528 . . . . 0.0 110.694 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.1 p -69.72 159.29 5.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.874 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 70.6 p -136.95 161.24 36.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.334 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.56 -27.26 66.08 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -71.4 -32.83 68.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.157 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -62.45 -36.52 82.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.026 -178.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -47.43 143.8 3.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.841 0.353 . . . . 0.0 110.438 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 172.86 -175.14 45.91 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 98.1 m -106.81 126.18 51.96 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.654 0.264 . . . . 0.0 111.403 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.3 t -98.51 133.25 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.6 m -122.71 154.01 38.66 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.084 0.469 . . . . 0.0 111.186 -178.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -134.46 144.7 48.26 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.28 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 61.7 m80 -133.44 113.92 13.07 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.74 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.51 ' C ' ' H ' ' A' ' 82' ' ' THR . 2.1 t -122.1 133.76 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.53 -5.07 0.29 Allowed Glycine 0 CA--C 1.528 0.905 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.564 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.51 ' H ' ' C ' ' A' ' 80' ' ' VAL . 5.1 p -109.39 -43.71 4.06 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.854 0.327 . . . . 0.0 111.165 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.591 ' SG ' ' N ' ' A' ' 84' ' ' SER . 44.4 t -152.85 166.05 33.49 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.709 0.29 . . . . 0.0 111.259 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.591 ' N ' ' SG ' ' A' ' 83' ' ' CYS . 60.0 m -129.01 151.35 49.8 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.859 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 37.6 p -158.63 166.61 31.64 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.925 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.43 ' N ' ' CD ' ' A' ' 86' ' ' GLU . 2.4 pm0 -154.24 169.86 22.64 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.943 0.401 . . . . 0.0 110.743 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -154.37 151.62 29.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.976 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -115.29 123.88 49.89 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.025 0.441 . . . . 0.0 111.14 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.8 tt -107.09 115.1 29.59 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -111.85 153.69 26.25 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.54 0.686 . . . . 0.0 111.737 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 43.8 t -120.8 129.89 75.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.396 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 29.5 m -100.68 128.0 46.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.526 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.83 140.83 56.31 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.254 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.777 0 CA-C-O 118.076 -1.402 . . . . 0.0 110.876 -179.727 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.8 mtm . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.571 ' N ' ' CD ' ' A' ' 3' ' ' PRO . . . -179.53 -44.17 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.553 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 2' ' ' ALA . 6.1 Cg_exo -72.0 145.43 44.89 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.447 2.098 . . . . 0.0 111.747 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -92.19 -157.63 0.53 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.509 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.9 p -58.8 128.68 19.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.461 ' OG1' ' CB ' ' A' ' 29' ' ' SER . 53.8 p -86.6 131.17 34.23 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 119.719 -0.792 . . . . 0.0 110.2 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 24.9 mm -99.87 73.0 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.052 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 79.6 mt -112.36 81.36 1.46 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -118.15 88.0 30.89 Favored Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.986 -177.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -73.48 -5.0 16.38 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 121.999 1.799 . . . . 0.0 110.229 178.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.25 90.62 0.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.668 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -97.3 -124.15 0.13 Allowed 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.404 ' O ' ' OD2' ' A' ' 13' ' ' ASP . 47.5 p-10 -109.01 137.5 46.83 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.798 0.333 . . . . 0.0 110.959 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.6 m -130.8 156.71 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -121.38 134.86 55.12 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.866 0.365 . . . . 0.0 110.782 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.9 pp -147.71 135.73 21.24 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.736 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.6 p -75.73 158.21 32.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.497 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -65.64 142.28 58.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.887 0.375 . . . . 0.0 110.022 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.3 -6.67 78.35 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -97.79 156.85 16.39 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 51.1 p30 -78.43 162.32 26.49 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.908 0.385 . . . . 0.0 110.964 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -147.2 150.74 35.49 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.52 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.4 p -160.04 159.07 31.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.346 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -131.8 152.42 50.99 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.951 0.405 . . . . 0.0 110.694 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -142.43 128.33 19.47 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 50.6 m -131.6 155.38 47.63 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.183 0.516 . . . . 0.0 111.577 -179.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -121.85 94.6 4.36 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.68 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 85.5 mt -127.15 112.53 15.26 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.745 -0.207 . . . . 0.0 110.691 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.461 ' CB ' ' OG1' ' A' ' 6' ' ' THR . 46.0 t -62.54 158.02 19.04 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 53.0 ptt85 -55.3 158.46 3.12 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.723 -177.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -86.28 -179.13 6.64 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.84 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 30.9 t -157.77 -49.61 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.141 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -86.15 -75.17 1.26 Allowed Glycine 0 CA--C 1.52 0.366 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -122.84 142.81 50.36 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.103 0.477 . . . . 0.0 111.051 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -75.02 144.02 43.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.768 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -81.54 170.28 16.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.666 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.6 mtm180 -132.46 137.28 47.19 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.355 0.598 . . . . 0.0 111.916 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 76.5 t-105 -117.93 137.49 52.79 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -169.96 165.96 9.44 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 119.474 -0.89 . . . . 0.0 112.484 -177.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.0 tt -136.79 122.5 19.83 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.227 178.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.27 14.6 82.04 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.98 4.17 87.23 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 111.62 -0.592 . . . . 0.0 111.62 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.1 t -113.27 130.26 23.8 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-O 119.491 -0.29 . . . . 0.0 110.467 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -58.34 144.94 95.48 Favored 'Trans proline' 0 N--CA 1.491 1.35 0 C-N-CA 120.919 1.08 . . . . 0.0 110.34 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.2 mt -77.53 150.76 34.78 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.681 -179.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -129.01 153.91 47.12 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.382 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.24 80.88 0.35 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.474 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -77.7 169.08 18.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.716 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -66.79 -37.17 84.04 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.137 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 25.8 ptt? -86.83 -21.23 26.56 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.651 0.262 . . . . 0.0 111.266 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.464 ' OD1' ' N ' ' A' ' 52' ' ' ASP . 58.9 t-20 -103.1 146.33 28.54 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.417 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.464 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 98.3 m-20 -138.84 115.18 10.41 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 48.1 mt -107.95 125.9 64.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.2 t -144.75 153.15 41.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.049 0.452 . . . . 0.0 110.912 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.6 p -104.15 130.89 54.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.501 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -111.77 -179.19 3.63 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.485 -179.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -63.38 152.07 39.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.533 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.14 9.32 86.85 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 -179.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.3 m 67.27 38.75 3.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.866 0.365 . . . . 0.0 110.646 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.9 mp -94.39 130.59 40.66 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.674 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 64.0 m80 -91.38 158.0 16.77 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 48.2 tp -156.77 111.24 2.75 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 120.247 -0.581 . . . . 0.0 111.623 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.44 ' CD1' ' N ' ' A' ' 63' ' ' LEU . 6.5 mp -96.73 115.7 27.88 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.816 178.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 63.7 m -109.94 95.47 5.61 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.4 tt -107.53 121.5 44.76 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 79.3 t60 -80.34 -86.05 0.09 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -178.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? -76.05 106.88 7.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.91 0.386 . . . . 0.0 110.428 -178.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.9 p -88.59 155.11 3.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.906 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 72.8 p -130.95 156.69 44.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.324 -0.398 . . . . 0.0 109.948 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 93.4 mt -59.54 -29.8 68.16 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -67.58 -35.36 78.85 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.959 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -61.72 -32.16 72.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.575 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.27 140.23 39.86 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.625 -0.43 . . . . 0.0 109.893 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 172.55 -171.64 44.44 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 87.8 m -101.53 120.87 40.97 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.735 0.303 . . . . 0.0 111.281 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 10.6 t -86.4 130.91 35.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.2 m -118.2 148.83 41.99 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.109 0.48 . . . . 0.0 110.918 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -136.95 124.96 22.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.453 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 63.4 t-80 -137.62 125.45 22.55 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.831 0.348 . . . . 0.0 111.568 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.411 ' O ' ' C ' ' A' ' 81' ' ' GLY . 5.8 p -141.47 134.3 29.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.579 178.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.411 ' C ' ' O ' ' A' ' 80' ' ' VAL . . . -26.36 -51.94 0.06 OUTLIER Glycine 0 CA--C 1.53 0.977 0 CA-C-N 115.573 -0.739 . . . . 0.0 113.248 -178.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 68.3 p -61.52 -77.27 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 7.3 m -125.56 -166.7 1.59 Allowed 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.06 0.457 . . . . 0.0 111.136 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 28.6 m -149.93 147.06 27.44 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.308 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 50.0 m -126.99 155.42 43.21 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.745 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -129.65 147.2 51.42 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.103 0.478 . . . . 0.0 111.126 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.63 151.92 30.26 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.762 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -130.96 138.51 49.75 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.982 0.42 . . . . 0.0 111.301 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.422 ' CD2' ' C ' ' A' ' 89' ' ' LEU . 2.2 tt -112.49 111.31 22.06 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -117.71 155.1 30.54 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.996 0.427 . . . . 0.0 111.391 -178.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 34.4 m -113.48 133.26 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.461 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 81.2 m -105.27 130.65 53.36 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.525 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.2 169.7 6.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.162 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.729 0 CA-C-O 118.015 -1.436 . . . . 0.0 110.981 179.862 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 82.0 mtp . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.529 ' N ' ' CD ' ' A' ' 3' ' ' PRO . . . -174.41 -44.44 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.703 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.529 ' CD ' ' N ' ' A' ' 2' ' ' ALA . 6.2 Cg_exo -71.04 145.43 49.77 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 122.379 2.053 . . . . 0.0 112.744 -178.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -81.57 153.75 26.57 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.213 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.4 t -67.54 133.2 31.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.545 ' OG1' ' N ' ' A' ' 29' ' ' SER . 71.0 p -90.14 127.16 36.03 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 118.633 -1.227 . . . . 0.0 110.42 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 20.7 mm -104.81 49.46 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.811 -178.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 89.5 mt -88.07 81.02 7.52 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.552 ' C ' ' H ' ' A' ' 11' ' ' LEU . 27.8 mt-10 -111.9 97.07 36.51 Favored Pre-proline 0 CA--C 1.536 0.413 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.695 -179.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -68.9 25.82 0.15 Allowed 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.656 1.571 . . . . 0.0 111.53 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.552 ' H ' ' C ' ' A' ' 9' ' ' GLU . 3.8 mm? -72.82 125.76 28.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.244 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -133.38 -152.65 0.5 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.22 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.443 ' OD2' ' N ' ' A' ' 13' ' ' ASP . 23.0 p-10 -106.32 131.4 53.58 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.796 0.331 . . . . 0.0 110.238 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 26.9 m -133.07 154.74 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-O 121.052 0.453 . . . . 0.0 110.904 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -126.86 112.99 15.98 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 58.3 mt -110.69 132.9 53.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.444 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 55.7 p -73.05 161.86 30.15 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -63.64 142.94 58.21 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.352 -0.539 . . . . 0.0 110.308 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.93 -3.32 77.23 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 111.119 -0.793 . . . . 0.0 111.119 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -103.4 140.8 36.97 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.028 0.442 . . . . 0.0 110.911 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -78.25 173.76 11.93 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.399 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.85 149.9 36.18 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.722 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 41.8 t -162.78 155.36 19.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.027 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -135.83 155.01 51.0 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.075 -0.512 . . . . 0.0 109.643 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -139.37 114.18 9.35 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 179.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -110.91 150.2 29.55 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.181 -178.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 96.3 mtt-85 -114.32 93.37 4.31 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 85.8 mt -119.35 118.65 31.75 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -178.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.545 ' N ' ' OG1' ' A' ' 6' ' ' THR . 88.3 p -76.41 161.11 28.95 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 177.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 12.0 ptp85 -50.64 163.54 0.18 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -176.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -83.32 167.53 17.51 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 113.635 -1.62 . . . . 0.0 110.777 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.2 p -152.22 -59.75 0.15 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -90.99 -70.99 1.21 Allowed Glycine 0 CA--C 1.524 0.621 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 178.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 10.6 tp-100 -122.08 136.27 54.9 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -83.5 148.66 27.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.863 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.49 152.88 39.33 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.91 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 15.4 tpt180 -123.19 123.5 40.94 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.057 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.57 ' CZ2' ' CE1' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -83.59 157.93 22.11 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.151 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -166.78 146.12 5.49 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 119.028 -1.069 . . . . 0.0 112.674 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.7 tt -142.26 128.13 19.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.631 178.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.11 4.27 89.7 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -178.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.56 -24.92 29.9 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 111.941 -0.464 . . . . 0.0 111.941 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 16.7 m -109.41 148.58 38.36 Favored Pre-proline 0 N--CA 1.471 0.607 0 CA-C-N 117.048 0.424 . . . . 0.0 111.37 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -54.97 137.78 76.78 Favored 'Trans proline' 0 N--CA 1.487 1.132 0 C-N-CA 121.449 1.432 . . . . 0.0 110.752 178.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.54 -176.83 3.74 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.03 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -140.52 161.26 38.16 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.648 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.83 81.69 0.89 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.959 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.45 ' O ' ' O ' ' A' ' 51' ' ' ASN . 65.0 t30 -82.0 171.97 13.79 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.984 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -63.82 -35.7 81.49 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.934 0.397 . . . . 0.0 110.108 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 3.2 ppp? -86.96 -3.18 59.06 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.329 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.45 ' O ' ' O ' ' A' ' 48' ' ' ASN . 56.4 t30 -138.51 109.08 6.56 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.554 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -109.67 124.12 50.66 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.121 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.2 mt -110.78 132.15 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.228 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.4 t -144.42 150.5 37.78 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.154 0.502 . . . . 0.0 111.122 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 46.2 t -100.76 116.39 44.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.276 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -88.76 172.73 9.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.309 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -63.15 158.68 19.24 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.784 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.35 17.73 76.31 Favored Glycine 0 CA--C 1.518 0.276 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 66.66 27.9 9.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.95 0.405 . . . . 0.0 110.794 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.7 mp -85.37 131.09 34.45 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.893 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 75.5 m80 -94.49 163.62 13.33 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -155.23 113.17 3.42 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.717 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -94.01 114.61 26.82 Favored 'General case' 0 C--N 1.341 0.215 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 63.9 m -102.2 103.88 14.42 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 38.4 tp -110.58 126.88 54.9 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.724 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -127.94 162.49 26.63 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.596 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt 53.57 72.49 0.43 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.085 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.6 p -91.27 140.92 15.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.067 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.455 ' O ' ' N ' ' A' ' 71' ' ' GLU . 26.9 m -125.39 131.03 53.02 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.4 pp -45.04 -19.22 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.88 0.371 . . . . 0.0 110.757 -178.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.455 ' N ' ' O ' ' A' ' 69' ' ' THR . 98.6 mt-10 -70.66 -32.91 70.36 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.948 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.433 ' O ' ' O ' ' A' ' 73' ' ' ALA . 51.5 t0 -54.16 -70.28 0.1 Allowed 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.373 -178.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.433 ' O ' ' O ' ' A' ' 72' ' ' ASP . . . 33.66 94.19 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.785 0.326 . . . . 0.0 111.019 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -136.73 170.83 23.25 Favored Glycine 0 N--CA 1.463 0.463 0 N-CA-C 111.389 -0.685 . . . . 0.0 111.389 -179.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 28.6 m -117.96 117.49 29.39 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.632 -0.284 . . . . 0.0 110.273 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 11.1 t -93.49 132.99 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 11.3 p -138.17 158.18 44.82 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.012 0.434 . . . . 0.0 111.299 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.57 ' CE1' ' CZ2' ' A' ' 38' ' ' TRP . 4.7 m-85 -130.85 144.95 51.83 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 62.7 t-80 -138.8 115.38 10.59 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.842 0.353 . . . . 0.0 111.601 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.536 ' O ' ' N ' ' A' ' 82' ' ' THR . 2.0 t -123.41 129.88 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -39.2 -20.84 0.01 OUTLIER Glycine 0 CA--C 1.527 0.838 0 CA-C-N 116.339 -0.391 . . . . 0.0 112.214 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.536 ' N ' ' O ' ' A' ' 80' ' ' VAL . 18.4 p -83.5 -74.81 0.35 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.996 0.427 . . . . 0.0 110.162 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 36.6 m -125.53 162.53 24.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.287 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 62.3 m -129.95 155.37 46.19 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.783 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 96.0 p -156.8 162.54 39.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.329 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.51 ' OE2' ' N ' ' A' ' 86' ' ' GLU . 56.7 mp0 -138.14 152.9 49.16 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.111 0.482 . . . . 0.0 111.061 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -139.19 149.58 44.58 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.388 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -119.84 126.57 51.3 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.992 0.425 . . . . 0.0 111.647 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 59.5 tp -113.56 116.13 29.05 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -127.89 147.52 50.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.383 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.7 t -106.52 125.72 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 120.91 0.386 . . . . 0.0 110.029 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.0 t -96.97 164.9 12.34 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.85 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.07 -5.93 58.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.106 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.717 0 CA-C-O 117.912 -1.493 . . . . 0.0 110.99 179.883 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.2 mtt . . . . . 0 N--CA 1.487 1.404 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.441 ' O ' ' OE2' ' A' ' 4' ' ' GLU . . . -159.37 73.26 3.38 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.75 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -63.09 148.78 92.99 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 121.935 1.757 . . . . 0.0 111.902 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.444 ' N ' ' CD ' ' A' ' 4' ' ' GLU . 2.6 pm0 -145.72 -146.92 0.2 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.235 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.3 p -74.65 131.69 34.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.836 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 95.6 m -119.73 128.51 53.84 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.881 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.2 mp -121.62 112.72 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-O 121.121 0.486 . . . . 0.0 111.531 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.6 mt -105.25 93.72 4.84 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 177.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.422 ' OE2' ' CE1' ' A' ' 78' ' ' PHE . 3.4 pt-20 -116.94 89.99 31.31 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.321 -178.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -70.43 -12.59 31.87 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 122.296 1.997 . . . . 0.0 111.792 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.1 68.6 2.7 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.09 0.472 . . . . 0.0 109.737 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -77.99 -2.36 36.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.152 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 39.9 p-10 -172.89 143.36 1.2 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.189 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.8 m -134.93 155.93 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 120.891 0.377 . . . . 0.0 111.338 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -137.25 120.43 16.74 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.189 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 pp -152.14 138.56 18.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.947 0.403 . . . . 0.0 110.828 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.6 m -74.74 150.32 39.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.235 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -56.97 147.49 23.79 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.36 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.92 -9.17 78.55 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.769 -0.533 . . . . 0.0 111.769 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -97.09 156.23 16.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.853 0.358 . . . . 0.0 110.719 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.433 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 19.6 p-10 -75.33 148.91 38.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.495 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -134.54 149.51 50.66 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.814 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 38.2 t -163.17 159.88 23.5 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.567 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -129.47 143.11 50.7 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.383 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -142.39 119.93 11.73 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.905 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 1.2 p -149.6 157.67 43.47 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.078 0.466 . . . . 0.0 111.028 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 96.3 mtt-85 -99.68 143.34 30.03 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.564 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.463 ' O ' ' OG1' ' A' ' 59' ' ' THR . 2.1 tt -145.55 96.41 2.82 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.602 -179.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.7 p -59.97 159.72 8.89 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.805 0.336 . . . . 0.0 110.24 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -57.37 156.3 7.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.868 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -100.05 -173.28 2.4 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.646 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.3 t -141.68 -58.25 0.48 Allowed 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -82.96 -77.07 1.11 Allowed Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -123.91 143.28 50.46 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.797 0.332 . . . . 0.0 110.802 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -92.1 146.21 23.91 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.121 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.86 151.81 43.11 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.373 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 -130.99 151.89 50.9 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.236 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -74.49 178.33 5.37 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.85 125.65 3.66 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.402 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 58.1 tp -129.8 115.91 17.95 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.8 16.67 72.51 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.1 -24.29 25.5 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.5 m -103.4 150.47 38.04 Favored Pre-proline 0 N--CA 1.468 0.448 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -53.93 143.17 61.83 Favored 'Trans proline' 0 C--N 1.315 -1.201 0 C-N-CA 121.455 1.437 . . . . 0.0 110.757 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.08 175.72 7.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.484 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 67.6 tp60 -144.89 153.76 41.91 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.23 72.85 1.26 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.829 0.347 . . . . 0.0 111.539 -178.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' A' ' 51' ' ' ASN . 70.8 m-20 -64.9 -177.16 0.32 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.406 ' OE1' ' N ' ' A' ' 49' ' ' GLU . 56.2 mp0 -68.29 -46.17 71.04 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.469 -0.493 . . . . 0.0 110.685 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 76.6 mtm -67.61 -39.32 84.76 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.943 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' A' ' 48' ' ' ASN . 1.9 m-80 -93.56 143.03 26.68 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.733 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -135.89 136.83 40.84 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.0 mm -107.39 122.5 61.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 95.3 m -129.85 129.49 44.03 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.073 0.463 . . . . 0.0 111.31 -178.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.5 m -121.3 136.88 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.425 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -137.56 -177.26 4.71 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.823 0.344 . . . . 0.0 110.521 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -51.23 157.58 0.92 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.575 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.08 30.29 77.35 Favored Glycine 0 CA--C 1.519 0.322 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.463 ' OG1' ' O ' ' A' ' 28' ' ' LEU . 65.3 p 41.63 39.64 1.19 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.095 0.474 . . . . 0.0 110.263 -179.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 55.5 mt -71.28 131.86 44.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.013 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -107.11 135.71 48.19 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.963 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -146.52 97.32 2.9 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 27.9 tp -96.61 106.97 19.33 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.113 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 26.5 m -89.7 114.59 26.26 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.109 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.402 ' C ' ' CD1' ' A' ' 65' ' ' LEU . 0.3 OUTLIER -105.47 118.37 36.39 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.457 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -110.77 147.02 35.33 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.261 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 65.5 mttm 54.82 58.58 4.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.97 179.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.1 p -56.57 149.02 3.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.343 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.437 ' HG1' ' H ' ' A' ' 72' ' ' ASP . 79.6 p -133.13 155.48 49.19 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.457 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 90.4 mt -60.32 -24.72 65.24 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -68.66 -36.12 78.13 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.145 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.437 ' H ' ' HG1' ' A' ' 69' ' ' THR . 66.2 t0 -62.01 -41.24 97.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.043 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.24 141.54 50.44 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 172.01 -99.28 0.14 Allowed Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.245 -0.979 . . . . 0.0 111.737 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 31.7 m -159.11 117.06 2.82 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.826 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 82.0 t -107.39 129.47 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 57.7 m -138.42 178.77 6.89 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.906 0.384 . . . . 0.0 111.236 -178.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.422 ' CE1' ' OE2' ' A' ' 9' ' ' GLU . 97.4 m-85 -128.53 141.02 51.51 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.101 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -116.99 102.53 9.42 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.451 ' O ' ' O ' ' A' ' 83' ' ' CYS . 2.1 t -118.9 134.38 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.241 -179.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.52 -23.91 61.13 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 121.159 -0.544 . . . . 0.0 111.885 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 43.2 p -98.8 -21.79 16.17 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 117.188 0.494 . . . . 0.0 112.124 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.451 ' O ' ' O ' ' A' ' 80' ' ' VAL . 27.6 p -154.17 -177.83 6.7 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.057 0.456 . . . . 0.0 111.205 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 31.4 t -148.79 150.51 33.2 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 49.2 m -154.13 168.11 27.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.923 0.392 . . . . 0.0 110.871 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -151.14 157.71 43.07 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.645 -179.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.88 146.44 25.66 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.274 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -116.85 131.39 56.96 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.28 0.562 . . . . 0.0 111.605 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.46 ' CD1' ' N ' ' A' ' 89' ' ' LEU . 9.4 mp -101.74 115.81 31.35 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.34 -0.846 . . . . 0.0 108.969 178.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -120.5 152.88 37.45 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.63 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.5 m -113.72 135.62 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 39.9 m -76.98 132.63 39.11 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.037 0.446 . . . . 0.0 111.29 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.4 144.88 51.41 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.105 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.713 0 CA-C-O 118.063 -1.41 . . . . 0.0 110.604 179.713 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.4 mtt . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.401 ' N ' ' CD ' ' A' ' 3' ' ' PRO . . . -175.76 55.08 0.13 Allowed Pre-proline 0 C--N 1.326 -0.422 0 C-N-CA 120.566 -0.454 . . . . 0.0 111.188 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.401 ' CD ' ' N ' ' A' ' 2' ' ' ALA . 5.4 Cg_exo -53.33 134.6 57.68 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 121.788 1.659 . . . . 0.0 111.107 179.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.413 ' OE2' ' OG1' ' A' ' 82' ' ' THR . 79.8 tt0 -176.87 146.32 0.54 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.269 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.453 ' O ' ' CG1' ' A' ' 5' ' ' VAL . 5.6 p -61.88 122.01 11.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.426 ' HB ' ' H ' ' A' ' 29' ' ' SER . 38.2 m -67.82 131.55 45.74 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 119.284 -0.966 . . . . 0.0 109.091 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.404 ' CG2' ' O ' ' A' ' 7' ' ' ILE . 9.7 tp -110.47 101.22 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-O 122.057 0.932 . . . . 0.0 112.072 -178.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.6 mt -129.99 82.06 2.05 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.44 -1.254 . . . . 0.0 109.581 178.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 49.0 tt0 -119.71 86.2 34.79 Favored Pre-proline 0 N--CA 1.468 0.448 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.561 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.445 ' O ' ' N ' ' A' ' 12' ' ' GLN . 3.4 Cg_exo -71.55 -7.68 21.71 Favored 'Trans proline' 0 C--N 1.314 -1.273 0 C-N-CA 122.279 1.986 . . . . 0.0 111.409 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 29.3 mt -64.4 75.2 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.853 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.445 ' N ' ' O ' ' A' ' 10' ' ' PRO . 87.6 mt-30 -76.65 -67.63 0.68 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.119 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.444 ' OD2' ' O ' ' A' ' 12' ' ' GLN . 63.6 m-20 -157.42 127.3 6.18 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.514 -178.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.3 m -129.24 156.9 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 121.362 0.601 . . . . 0.0 111.305 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -120.71 129.33 53.61 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.136 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 74.8 mt -118.88 129.27 55.11 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.053 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.6 m -78.76 148.35 33.02 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 177.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -63.81 134.16 54.73 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.953 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.79 -2.09 64.08 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -112.24 134.5 53.75 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.006 0.431 . . . . 0.0 110.717 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -83.21 167.66 17.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.122 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -159.73 174.87 13.87 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.226 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 29.9 t -156.87 148.62 22.62 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.071 0.463 . . . . 0.0 110.915 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -103.0 141.09 36.39 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -129.39 119.1 23.27 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.118 0.485 . . . . 0.0 110.384 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 2.7 m -126.56 163.95 22.27 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.581 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 77.5 ttt-85 -142.65 115.76 8.87 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.9 mt -127.69 100.91 6.15 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 121.095 -0.242 . . . . 0.0 110.995 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.426 ' H ' ' HB ' ' A' ' 6' ' ' THR . 14.2 t -60.05 177.61 0.23 Allowed 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 119.991 -0.684 . . . . 0.0 109.5 179.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -54.41 136.95 43.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.481 0.658 . . . . 0.0 111.866 -178.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.05 -172.86 3.28 Favored 'General case' 0 CA--C 1.521 -0.136 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.937 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.2 t -147.53 -65.34 0.26 Allowed 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.493 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.84 -88.46 0.22 Allowed Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 178.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -124.13 141.0 52.43 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.234 0.54 . . . . 0.0 111.368 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.4 tp10 -83.63 152.91 24.55 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.246 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.38 139.34 51.88 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.197 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 86.2 mtm-85 -115.97 138.59 51.06 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.763 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 80.8 m95 -76.21 169.16 18.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.008 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -165.1 119.83 1.31 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.809 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.424 ' C ' ' CD2' ' A' ' 40' ' ' LEU . 6.7 tt -118.96 114.75 23.04 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.97 14.7 81.51 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.64 -23.57 35.37 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 16.7 m -104.94 146.52 32.82 Favored Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -54.62 142.12 73.0 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 121.547 1.498 . . . . 0.0 111.892 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.409 ' H ' ' CD2' ' A' ' 45' ' ' LEU . 1.0 OUTLIER -82.4 171.54 14.06 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.279 179.154 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 71.3 tp60 -144.92 142.01 29.51 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.187 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.38 141.57 58.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.82 0.343 . . . . 0.0 110.274 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.456 ' O ' ' O ' ' A' ' 51' ' ' ASN . 45.4 t30 -155.66 -164.89 1.84 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 53.8 mp0 -66.03 -48.49 70.92 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 119.924 -0.71 . . . . 0.0 110.167 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 66.4 ttp -68.35 -43.43 77.47 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.466 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.456 ' O ' ' O ' ' A' ' 48' ' ' ASN . 99.1 m-20 -107.39 137.84 44.7 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.892 0.377 . . . . 0.0 110.84 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 48' ' ' ASN . 96.7 m-20 -139.31 146.74 40.69 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.423 HG21 HD13 ' A' ' 53' ' ' ILE . 98.6 mt -124.06 127.05 73.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 88.5 m -125.43 131.47 52.9 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.886 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.6 t -87.69 128.06 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.209 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -116.1 154.26 30.28 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.545 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -56.36 155.73 6.67 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.583 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.85 12.39 84.48 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 68.77 22.92 7.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.619 -0.291 . . . . 0.0 111.758 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.9 mp -79.28 144.28 34.45 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 178.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 66.1 m170 -110.96 156.18 21.59 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.416 ' CD1' ' C ' ' A' ' 62' ' ' LEU . 0.4 OUTLIER -153.22 108.9 3.28 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.385 -179.208 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.3 mp -95.94 109.58 21.92 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 95.3 m -87.44 113.87 23.54 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.432 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 74.8 mt -99.63 104.13 15.87 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.718 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -97.96 134.79 40.59 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.037 0.446 . . . . 0.0 111.579 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt 52.79 65.68 1.45 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.991 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.1 p -61.84 153.04 6.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.389 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.2 t -135.77 163.34 30.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.735 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 62.8 mt -60.31 -29.01 68.57 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.256 0.551 . . . . 0.0 109.867 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -66.69 -24.11 66.22 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.587 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.4 ' O ' ' C ' ' A' ' 73' ' ' ALA . 55.7 t0 -61.99 -40.76 96.73 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.36 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 72' ' ' ASP . . . -38.9 122.08 1.14 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.518 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -174.97 177.25 47.08 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 52.9 m -103.93 127.61 51.45 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.033 0.444 . . . . 0.0 111.436 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 74.0 t -117.15 129.42 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.242 178.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 36.2 t -144.5 171.68 14.01 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -150.96 150.51 30.89 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.047 0.451 . . . . 0.0 110.996 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -117.26 127.86 54.5 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.62 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.427 ' O ' ' O ' ' A' ' 83' ' ' CYS . 2.5 t -118.36 130.14 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.03 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -48.0 -19.26 0.95 Allowed Glycine 0 CA--C 1.53 1.006 0 CA-C-N 115.962 -0.563 . . . . 0.0 113.061 -178.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.413 ' OG1' ' OE2' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -107.01 -33.63 7.43 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 117.725 0.762 . . . . 0.0 111.549 -179.014 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.427 ' O ' ' O ' ' A' ' 80' ' ' VAL . 33.1 m -144.93 -175.56 4.73 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 96.0 p -159.38 157.95 31.28 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.778 0.323 . . . . 0.0 110.912 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.625 ' HG ' ' H ' ' A' ' 86' ' ' GLU . 48.2 t -167.27 168.33 13.41 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.085 0.469 . . . . 0.0 111.022 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.625 ' H ' ' HG ' ' A' ' 85' ' ' SER . 98.1 mt-10 -133.95 163.27 29.92 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.956 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -149.15 154.04 38.6 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -124.72 132.84 53.35 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.262 0.553 . . . . 0.0 111.512 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 60.7 tp -116.92 103.69 10.55 Favored 'General case' 0 C--N 1.334 -0.094 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.691 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -103.98 147.39 27.41 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 13.2 t -120.01 99.26 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.4 t -139.38 146.26 39.98 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.4 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -92.19 -7.35 48.57 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.155 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.684 0 CA-C-O 118.015 -1.436 . . . . 0.0 111.004 179.867 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.4 mmm . . . . . 0 N--CA 1.488 1.474 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -168.46 77.34 0.81 Allowed Pre-proline 0 C--N 1.329 -0.322 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.652 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -69.04 147.89 68.48 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.602 2.202 . . . . 0.0 112.535 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -65.86 -166.33 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.32 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.6 t -64.32 135.95 27.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.425 ' HB ' ' H ' ' A' ' 29' ' ' SER . 20.4 m -104.14 135.8 44.95 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.767 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.8 mp -121.25 116.25 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 121.379 0.609 . . . . 0.0 111.222 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 96.5 mt -128.35 98.11 4.96 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.073 -0.967 . . . . 0.0 108.581 177.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -122.59 90.14 49.7 Favored Pre-proline 0 N--CA 1.468 0.449 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -178.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -74.23 -5.06 16.41 Favored 'Trans proline' 0 N--CA 1.489 1.231 0 C-N-CA 122.024 1.816 . . . . 0.0 110.068 178.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 65.7 mt -66.45 74.85 0.1 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.353 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -71.6 -49.61 38.67 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.957 0.408 . . . . 0.0 111.775 -179.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -173.7 137.76 0.62 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.989 -178.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 53.0 t -125.11 133.48 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 120.84 0.352 . . . . 0.0 110.578 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -134.24 99.68 4.47 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.126 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 87.4 mt -124.9 139.92 53.39 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.939 0.399 . . . . 0.0 111.309 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.3 t -68.32 141.92 55.66 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.447 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -51.21 149.16 4.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.306 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.95 16.98 78.03 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -115.58 147.48 40.69 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.96 136.59 50.68 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.331 -0.548 . . . . 0.0 109.593 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -132.23 154.92 49.13 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.234 -179.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.9 m -158.63 159.62 35.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.981 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -136.99 148.65 47.02 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.225 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -145.15 122.82 11.82 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.042 0.449 . . . . 0.0 110.935 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 5.9 t -135.56 139.59 44.01 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.248 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 64.6 ttp85 -122.71 127.98 49.96 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.111 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.6 pp -143.69 133.46 23.83 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.22 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.425 ' H ' ' HB ' ' A' ' 6' ' ' THR . 44.7 t -66.22 158.85 27.77 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.008 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 38.4 ptt-85 -51.48 163.93 0.24 Allowed 'General case' 0 C--N 1.32 -0.716 0 O-C-N 123.665 0.603 . . . . 0.0 111.972 -177.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.56 174.8 2.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.322 -178.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.65 ' HG ' ' H ' ' A' ' 33' ' ' GLY . 18.4 p -138.46 -56.82 0.64 Allowed 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.65 ' H ' ' HG ' ' A' ' 32' ' ' SER . . . -104.89 -66.85 0.69 Allowed Glycine 0 CA--C 1.523 0.592 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 178.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.488 HE21 ' H ' ' A' ' 81' ' ' GLY . 14.1 pt20 -122.7 143.08 50.03 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.783 0.325 . . . . 0.0 110.315 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.547 ' CD ' ' H ' ' A' ' 35' ' ' GLU . 1.2 pm0 -70.57 146.46 50.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.528 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.89 157.05 38.21 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -123.97 133.86 53.61 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.337 0.589 . . . . 0.0 111.683 -178.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 22.0 t-105 -99.02 147.87 24.59 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.084 -0.962 . . . . 0.0 108.919 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -172.68 147.6 1.81 Allowed 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 119.883 -0.727 . . . . 0.0 112.419 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.6 tp -124.96 119.03 27.59 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.89 8.52 84.78 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.42 -1.36 58.69 Favored Glycine 0 CA--C 1.531 1.066 0 N-CA-C 111.954 -0.458 . . . . 0.0 111.954 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.9 m -115.87 147.25 38.7 Favored Pre-proline 0 CA--C 1.549 0.93 0 CA-C-N 117.384 0.592 . . . . 0.0 111.618 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -58.45 145.82 92.82 Favored 'Trans proline' 0 N--CA 1.502 2.022 0 C-N-CA 122.008 1.806 . . . . 0.0 112.359 178.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.0 mp -90.29 144.84 25.47 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.084 178.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.437 ' O ' ' N ' ' A' ' 48' ' ' ASN . 1.0 OUTLIER -122.89 153.14 40.05 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.396 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.64 76.57 0.02 OUTLIER 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.489 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.463 ' OD1' ' N ' ' A' ' 49' ' ' GLU . 24.3 t-20 -74.25 165.7 24.72 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.607 179.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.463 ' N ' ' OD1' ' A' ' 48' ' ' ASN . 97.5 mt-10 -62.12 -40.34 95.59 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.616 -0.433 . . . . 0.0 110.885 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 12.4 ptt? -85.6 -15.33 42.9 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 121.032 -0.267 . . . . 0.0 111.173 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.461 ' O ' ' O ' ' A' ' 48' ' ' ASN . 35.1 t-20 -126.11 122.45 35.79 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.594 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -124.5 128.1 48.46 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 75.5 mt -107.1 129.56 60.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.951 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.442 ' HG1' ' N ' ' A' ' 55' ' ' VAL . 1.9 t -143.93 147.98 34.73 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.853 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.442 ' N ' ' HG1' ' A' ' 54' ' ' THR . 6.9 m -110.92 131.32 62.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.371 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.446 ' O ' ' C ' ' A' ' 57' ' ' GLN . 98.8 mt-10 -112.11 -173.51 2.26 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.382 -179.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.446 ' C ' ' O ' ' A' ' 56' ' ' GLU . 45.6 tp60 -25.62 144.07 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 O-C-N 123.834 0.709 . . . . 0.0 111.854 -179.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 58.12 -97.31 0.07 OUTLIER Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 17.9 m -162.5 62.31 0.21 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.991 0.424 . . . . 0.0 110.364 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 8.3 tt -104.31 120.66 41.67 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.915 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -90.8 148.53 22.47 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.202 -0.453 . . . . 0.0 109.833 178.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.3 tt -151.57 114.66 4.73 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.86 0.362 . . . . 0.0 110.409 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.6 mp -97.0 114.94 26.59 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.882 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.6 m -94.11 109.37 21.15 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 62.3 mt -101.06 132.31 46.56 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.545 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 49.7 p-80 -153.25 155.46 36.63 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.76 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt 50.97 55.49 9.48 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 120.889 0.376 . . . . 0.0 110.091 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.5 m -110.49 130.1 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.777 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 64.1 p -86.35 -157.49 0.36 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.052 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 40.5 tp -59.88 -15.96 25.42 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.876 0.369 . . . . 0.0 110.442 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -67.6 -5.45 15.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.966 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 72' ' ' ASP . 25.2 p-10 -53.37 -30.0 37.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.394 -179.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.1 135.02 56.96 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.101 -0.64 . . . . 0.0 109.667 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -174.54 166.83 38.89 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -122.95 108.6 13.14 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.57 0.224 . . . . 0.0 110.707 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 8.6 t -101.15 120.6 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 33.9 t -137.13 152.09 49.57 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.334 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -135.73 147.8 48.58 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.86 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.545 ' ND1' ' OG ' ' A' ' 84' ' ' SER . 93.7 m-70 -125.22 123.83 40.42 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.209 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.508 ' O ' ' N ' ' A' ' 82' ' ' THR . 2.9 p -128.41 130.35 69.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.488 ' H ' HE21 ' A' ' 34' ' ' GLN . . . -31.7 -31.39 0.01 OUTLIER Glycine 0 CA--C 1.529 0.913 0 CA-C-N 115.671 -0.695 . . . . 0.0 113.1 -178.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.703 ' HG1' ' H ' ' A' ' 83' ' ' CYS . 82.5 p -79.04 -75.68 0.23 Allowed 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.659 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.703 ' H ' ' HG1' ' A' ' 82' ' ' THR . 46.2 t -111.56 163.81 13.67 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 120.829 0.347 . . . . 0.0 111.315 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.545 ' OG ' ' ND1' ' A' ' 79' ' ' HIS . 23.3 t -140.74 134.36 30.15 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 13.9 m -160.27 167.91 26.49 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.272 0.558 . . . . 0.0 111.999 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -140.22 164.11 30.96 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.963 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -134.33 148.36 50.72 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -113.61 127.49 56.08 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.267 -179.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.2 tt -112.02 112.34 23.9 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 17.7 ttpt -113.29 170.12 8.46 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.078 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.0 t -111.0 125.58 68.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.476 -179.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.403 HG21 ' H ' ' A' ' 94' ' ' GLY . 97.8 m -79.98 129.77 34.75 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.999 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -88.96 -5.23 58.11 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.39 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.403 ' H ' HG21 ' A' ' 92' ' ' THR . . . . . . . . 0 C--O 1.22 -0.778 0 CA-C-O 117.939 -1.478 . . . . 0.0 110.834 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.5 mtt . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 45.3 70.7 1.85 Allowed Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.078 -179.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -73.92 158.48 46.17 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 122.803 2.335 . . . . 0.0 111.139 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.487 ' HG2' ' H ' ' A' ' 5' ' ' VAL . 39.3 tt0 73.3 176.43 0.26 Allowed 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.487 ' H ' ' HG2' ' A' ' 4' ' ' GLU . 9.8 p -52.65 136.49 13.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 110.431 -0.211 . . . . 0.0 110.431 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.632 ' H ' ' HG ' ' A' ' 29' ' ' SER . 7.1 m -115.96 125.3 52.36 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.42 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.534 ' CD1' ' N ' ' A' ' 7' ' ' ILE . 3.0 mp -108.41 111.43 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 121.144 0.497 . . . . 0.0 111.046 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.8 mp -122.31 84.27 2.23 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.44 ' O ' ' CG ' ' A' ' 9' ' ' GLU . 0.2 OUTLIER -110.74 98.93 39.84 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.806 -178.246 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -73.9 -7.16 19.65 Favored 'Trans proline' 0 N--CA 1.489 1.238 0 C-N-CA 121.454 1.436 . . . . 0.0 110.136 178.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 52.3 mt -61.17 80.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.425 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -79.32 -67.15 0.78 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.422 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -171.78 128.26 0.63 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.651 -0.25 . . . . 0.0 110.37 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.8 m -126.15 162.1 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-O 120.926 0.394 . . . . 0.0 110.978 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -116.95 128.74 55.5 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.127 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 74.6 mt -123.01 129.34 51.39 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.058 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.4 p -76.55 164.18 26.19 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -61.83 128.68 37.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.828 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 77.34 19.53 76.48 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.068 178.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -103.41 138.47 40.1 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.85 0.357 . . . . 0.0 110.963 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 49.5 p30 -82.39 164.89 20.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.044 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -161.89 168.98 22.05 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.914 0.388 . . . . 0.0 110.213 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 73.1 m -147.76 140.85 25.01 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.961 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -111.8 129.85 56.0 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 23.8 tm0? -132.11 127.09 35.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.201 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -149.47 163.94 36.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.333 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -120.28 120.89 37.38 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.09 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.7 tt -132.14 104.78 6.98 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.632 ' HG ' ' H ' ' A' ' 6' ' ' THR . 10.1 p -62.68 153.12 33.45 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.167 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -53.31 153.25 4.0 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.592 -177.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.78 -175.17 3.66 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.848 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 44.9 t -142.44 -49.62 0.36 Allowed 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -91.77 -76.2 1.32 Allowed Glycine 0 CA--C 1.52 0.353 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -124.91 135.49 52.9 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.075 0.464 . . . . 0.0 111.864 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.461 ' O ' ' NH1' ' A' ' 37' ' ' ARG . 22.5 pt-20 -83.6 154.61 23.67 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.978 179.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.59 151.97 42.06 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.783 0.325 . . . . 0.0 110.692 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.461 ' NH1' ' O ' ' A' ' 35' ' ' GLU . 87.4 mmt-85 -106.72 148.24 28.64 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.068 0.461 . . . . 0.0 111.277 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 2.9 t-105 -107.71 148.52 29.31 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 179.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -173.31 155.26 2.85 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 119.864 -0.734 . . . . 0.0 111.73 -178.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 32.9 tp -134.22 124.72 26.42 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.707 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.51 6.14 88.06 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.653 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.73 -16.09 57.87 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 121.278 -0.487 . . . . 0.0 112.068 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.8 m -112.21 141.82 25.74 Favored Pre-proline 0 N--CA 1.472 0.671 0 CA-C-N 117.134 0.467 . . . . 0.0 110.43 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -56.87 143.12 92.43 Favored 'Trans proline' 0 N--CA 1.488 1.202 0 C-N-CA 120.826 1.018 . . . . 0.0 110.873 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.17 -166.69 1.33 Allowed 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.537 ' O ' ' N ' ' A' ' 48' ' ' ASN . 2.3 pm0 -153.28 153.99 33.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.927 0.394 . . . . 0.0 111.02 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -55.4 76.31 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.318 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.537 ' N ' ' O ' ' A' ' 46' ' ' GLN . 10.3 t-20 -75.04 171.37 14.23 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.884 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -62.13 -33.98 75.49 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.883 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 14.8 ptp -94.02 -19.63 20.7 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.772 0.32 . . . . 0.0 110.986 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -120.29 118.98 31.82 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.152 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -121.26 142.42 49.95 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.77 0.319 . . . . 0.0 110.63 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.408 HD13 HG22 ' A' ' 53' ' ' ILE . 15.5 mm -115.6 118.35 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.4 p -138.85 159.61 41.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.934 0.397 . . . . 0.0 111.183 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 55.8 t -117.51 129.04 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.659 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -107.4 167.46 9.91 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.517 ' NE2' ' H ' ' A' ' 58' ' ' GLY . 71.1 tp60 -58.42 152.77 17.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.947 0.403 . . . . 0.0 110.5 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.517 ' H ' ' NE2' ' A' ' 57' ' ' GLN . . . 79.5 11.29 85.0 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 69.15 27.37 5.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.402 -0.399 . . . . 0.0 110.809 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.413 ' N ' ' CD1' ' A' ' 60' ' ' LEU . 10.6 mp -87.09 129.69 34.81 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.32 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -97.51 131.12 44.43 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.425 ' CD1' ' C ' ' A' ' 62' ' ' LEU . 0.5 OUTLIER -123.48 115.57 21.79 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.875 -179.481 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.8 mp -103.01 114.04 28.01 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 25.9 m -88.8 117.01 27.48 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.179 0.514 . . . . 0.0 110.387 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 36.9 tp -107.31 127.13 53.27 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.253 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -85.23 -170.1 2.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.888 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -72.36 71.31 0.9 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.672 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 23.9 m -69.21 -172.54 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.488 0.661 . . . . 0.0 112.069 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.553 ' HG1' ' H ' ' A' ' 71' ' ' GLU . 69.8 p -130.6 -165.31 1.53 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.764 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 53.6 mt -64.23 -15.94 61.02 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.738 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.553 ' H ' ' HG1' ' A' ' 69' ' ' THR . 97.4 mt-10 -65.25 -38.11 89.31 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -66.63 -36.29 82.22 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.744 0.307 . . . . 0.0 111.316 -179.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -40.28 112.79 0.3 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.17 0.51 . . . . 0.0 111.268 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -168.83 -179.65 41.1 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 109.704 -1.359 . . . . 0.0 109.704 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 99.0 m -105.19 120.54 41.79 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.907 0.354 . . . . 0.0 111.413 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 12.0 t -93.59 134.55 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.9 p -140.9 146.62 37.7 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.132 0.491 . . . . 0.0 110.916 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -150.95 147.59 27.36 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.483 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 53.5 p-80 -159.78 163.4 34.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.58 0.705 . . . . 0.0 111.96 -178.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.556 ' O ' ' N ' ' A' ' 82' ' ' THR . 2.5 p -131.59 140.4 48.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.254 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -35.54 -24.5 0.01 OUTLIER Glycine 0 CA--C 1.528 0.897 0 CA-C-N 115.67 -0.695 . . . . 0.0 112.604 -178.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.556 ' N ' ' O ' ' A' ' 80' ' ' VAL . 43.9 p -85.97 -72.73 0.48 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.058 0.456 . . . . 0.0 110.864 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.513 ' N ' ' OG1' ' A' ' 82' ' ' THR . 35.3 m -108.55 -171.56 1.88 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.794 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 83.2 p -156.85 153.95 29.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.896 0.379 . . . . 0.0 111.097 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 47.8 t -152.89 153.79 33.74 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.342 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -134.54 150.96 50.81 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.51 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -139.85 148.37 42.0 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -124.13 125.6 44.75 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.996 0.426 . . . . 0.0 111.793 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.8 tp -113.28 100.84 8.87 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.678 178.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 13.4 ptpt -107.91 172.07 7.04 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 179.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.4 m -128.77 158.6 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 121.328 0.585 . . . . 0.0 111.478 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.8 t -113.73 130.52 56.42 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.745 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.67 140.74 57.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.366 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.217 -0.907 0 CA-C-O 118.066 -1.408 . . . . 0.0 111.14 179.392 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.496 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 50.57 77.74 0.44 Allowed Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.449 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -69.88 -21.75 32.48 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.81 2.34 . . . . 0.0 111.799 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.483 ' O ' ' OG ' ' A' ' 29' ' ' SER . 88.5 tt0 -57.81 150.26 20.43 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.6 m -58.28 122.22 7.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.545 ' OG1' ' N ' ' A' ' 29' ' ' SER . 41.7 p -88.5 138.73 31.17 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 118.81 -1.156 . . . . 0.0 110.189 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 18.8 mm -110.55 62.4 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.643 -179.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -102.09 74.2 1.43 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.346 0.593 . . . . 0.0 109.948 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -122.99 84.32 50.72 Favored Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.921 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -70.9 50.83 1.16 Allowed 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 122.275 1.983 . . . . 0.0 112.25 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.6 mt -79.93 127.39 32.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.169 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 27.3 pt20 -118.81 -145.05 0.37 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.342 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -104.36 130.88 52.19 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.949 0.404 . . . . 0.0 110.426 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.4 m -123.41 138.1 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.2 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -113.32 115.31 27.93 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.264 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 73.3 mt -119.35 135.08 54.89 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.04 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.42 ' HG ' ' N ' ' A' ' 18' ' ' GLU . 31.0 t -63.6 151.39 41.74 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.42 ' N ' ' HG ' ' A' ' 17' ' ' SER . 81.5 tt0 -55.55 144.42 26.35 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.052 0.453 . . . . 0.0 111.504 -179.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.18 19.2 75.09 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -114.68 144.97 42.59 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.281 0.563 . . . . 0.0 111.152 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 51.3 p-10 -75.5 168.24 20.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.305 -0.862 . . . . 0.0 110.028 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -140.79 142.65 34.65 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.69 0.281 . . . . 0.0 110.913 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 60.6 m -136.25 152.54 50.84 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.857 0.361 . . . . 0.0 111.087 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -135.4 152.24 51.23 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.379 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.422 ' C ' ' SG ' ' A' ' 26' ' ' CYS . 58.4 tt0 -134.33 143.49 47.72 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.698 0.285 . . . . 0.0 110.364 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.422 ' SG ' ' C ' ' A' ' 25' ' ' GLN . 30.0 m -150.34 164.34 36.05 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.254 0.55 . . . . 0.0 111.506 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -134.4 99.8 4.48 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 115.427 -0.806 . . . . 0.0 108.859 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.469 ' O ' ' OG1' ' A' ' 59' ' ' THR . 50.1 mt -118.91 128.79 54.76 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.205 -178.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.545 ' N ' ' OG1' ' A' ' 6' ' ' THR . 24.1 p -73.65 158.66 34.32 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 51.7 ptt85 -58.11 169.47 0.81 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 -176.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.8 151.08 45.2 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 113.826 -1.534 . . . . 0.0 111.56 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 73.4 m -139.48 -54.95 0.57 Allowed 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.037 179.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -100.49 -65.81 0.81 Allowed Glycine 0 CA--C 1.52 0.372 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 178.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -123.39 145.27 48.9 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 178.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.608 ' CD ' ' H ' ' A' ' 35' ' ' GLU . 1.7 pm0 -76.17 143.73 40.95 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.092 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.52 152.71 37.78 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.536 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 84.2 mtm180 -128.56 139.74 52.14 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.236 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.532 ' CZ2' ' CE2' ' A' ' 78' ' ' PHE . 10.6 t-105 -101.46 150.96 22.51 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -171.37 157.33 4.89 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 119.498 -0.881 . . . . 0.0 111.914 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.2 tt -123.72 124.94 43.84 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.415 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.27 21.99 76.04 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.98 7.72 88.27 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 71.7 t -113.69 128.77 25.36 Favored Pre-proline 0 N--CA 1.47 0.537 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -57.34 143.56 93.56 Favored 'Trans proline' 0 N--CA 1.488 1.203 0 CA-C-N 120.004 1.037 . . . . 0.0 111.03 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -106.73 179.66 4.2 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.035 0.445 . . . . 0.0 111.245 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -145.86 150.63 36.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.988 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.99 139.26 48.51 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.035 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.431 ' OD1' ' O ' ' A' ' 51' ' ' ASN . 32.8 p-10 -166.54 -175.01 3.02 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.884 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -66.45 -41.79 88.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.576 -0.283 . . . . 0.0 111.66 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 54.4 ttp -67.95 -42.7 80.52 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.431 ' O ' ' OD1' ' A' ' 48' ' ' ASN . 86.7 m-20 -135.31 115.41 13.23 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.392 178.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.481 ' OD1' ' O ' ' A' ' 64' ' ' THR . 12.2 p-10 -111.63 147.41 35.57 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 178.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.1 mm -113.26 126.25 70.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 98.4 m -127.82 134.31 49.44 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.757 0.313 . . . . 0.0 110.9 -178.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.6 p -111.17 133.86 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 57' ' ' GLN . 95.9 mt-10 -116.09 -177.33 3.14 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.035 0.445 . . . . 0.0 111.766 -178.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.449 ' O ' ' N ' ' A' ' 59' ' ' THR . 77.8 mt-30 -24.92 144.11 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.069 -0.969 . . . . 0.0 112.784 -179.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.426 ' O ' ' CG2' ' A' ' 59' ' ' THR . . . 52.91 -89.44 0.01 OUTLIER Glycine 0 CA--C 1.519 0.284 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.469 ' OG1' ' O ' ' A' ' 28' ' ' LEU . 19.7 p -160.33 42.82 0.19 Allowed 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.484 -179.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.6 mp -86.01 112.66 21.43 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 49.1 m170 -86.49 150.93 23.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.874 -179.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.2 tp -149.41 105.91 3.53 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.537 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.469 ' CD2' ' N ' ' A' ' 63' ' ' LEU . 1.3 mm? -83.15 111.41 18.89 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.072 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.481 ' O ' ' OD1' ' A' ' 52' ' ' ASP . 70.9 m -101.79 94.82 6.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.108 0.48 . . . . 0.0 111.206 -178.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.5 mp -95.65 136.37 36.14 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.613 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.626 ' CG ' ' H ' ' A' ' 67' ' ' LYS . 45.7 t60 -70.93 -176.07 1.27 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.587 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.626 ' H ' ' CG ' ' A' ' 66' ' ' HIS . 97.7 mttt -63.47 100.39 0.26 Allowed 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.3 m -100.02 134.36 39.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.258 -178.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 30.9 p -79.28 -148.54 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.247 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.532 ' C ' ' H ' ' A' ' 72' ' ' ASP . 88.4 mt -54.48 -37.31 65.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.598 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -50.25 -8.38 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.661 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.532 ' H ' ' C ' ' A' ' 70' ' ' LEU . 37.1 p-10 -65.64 -35.73 81.66 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.821 0.343 . . . . 0.0 110.839 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -47.45 111.43 0.41 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -173.84 166.55 38.78 Favored Glycine 0 CA--C 1.522 0.496 0 C-N-CA 120.638 -0.792 . . . . 0.0 111.388 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 10.3 m -118.84 126.43 51.82 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.723 -0.239 . . . . 0.0 110.448 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.5 t -103.88 130.76 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 93.9 p -121.92 160.43 24.82 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.171 0.51 . . . . 0.0 110.43 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.532 ' CE2' ' CZ2' ' A' ' 38' ' ' TRP . 12.0 m-85 -135.32 138.31 43.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.172 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 72.6 t60 -127.89 127.52 43.53 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.184 0.516 . . . . 0.0 111.225 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.48 ' O ' ' C ' ' A' ' 81' ' ' GLY . 2.6 p -148.7 116.63 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.337 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.48 ' C ' ' O ' ' A' ' 80' ' ' VAL . . . -5.75 -67.34 0.01 OUTLIER Glycine 0 N--CA 1.473 1.116 0 O-C-N 123.927 0.767 . . . . 0.0 113.877 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.605 ' HG1' ' H ' ' A' ' 83' ' ' CYS . 65.1 p -48.6 -86.59 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -178.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.605 ' H ' ' HG1' ' A' ' 82' ' ' THR . 92.5 m -125.48 -168.71 1.88 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.384 -179.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 51.6 p -153.79 168.71 25.4 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.709 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.676 ' HG ' ' N ' ' A' ' 86' ' ' GLU . 39.1 t -152.11 169.99 21.06 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.723 -179.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.676 ' N ' ' HG ' ' A' ' 85' ' ' SER . 17.6 pt-20 -150.19 164.11 36.51 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 120.973 0.416 . . . . 0.0 111.184 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.0 152.1 38.05 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.114 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -119.5 129.96 54.97 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.215 0.531 . . . . 0.0 111.066 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 8.2 tt -117.53 122.68 44.35 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.399 -0.818 . . . . 0.0 109.684 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -120.23 159.51 24.79 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.015 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.7 p -109.56 126.91 66.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-O 120.889 0.375 . . . . 0.0 110.154 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 31.6 m -66.02 131.27 45.83 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.539 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -100.12 -7.59 24.7 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.469 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.754 0 CA-C-O 117.934 -1.481 . . . . 0.0 110.882 -179.79 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.3 ttp . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -162.22 74.11 2.24 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.275 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -65.5 143.82 77.03 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.646 2.231 . . . . 0.0 111.457 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -92.33 -114.18 0.09 Allowed 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -178.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.6 p -72.09 127.22 33.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.805 ' H ' ' HG ' ' A' ' 29' ' ' SER . 26.2 p -101.0 135.56 42.25 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.721 -179.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.524 ' CD1' ' N ' ' A' ' 7' ' ' ILE . 1.9 mp -107.78 115.16 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 121.492 0.663 . . . . 0.0 111.687 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.455 ' CD2' ' NH1' ' A' ' 27' ' ' ARG . 49.2 tp -126.95 110.77 13.35 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 114.537 -1.211 . . . . 0.0 109.141 178.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.498 ' OE1' ' SG ' ' A' ' 26' ' ' CYS . 24.9 mm-40 -125.15 91.8 48.52 Favored Pre-proline 0 N--CA 1.471 0.598 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -178.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -71.69 -9.32 24.76 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 C-N-CA 121.747 1.632 . . . . 0.0 111.619 177.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.84 87.75 3.43 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.613 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 95.9 mm-40 -69.61 -32.79 71.71 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.097 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 43.6 p-10 -176.96 142.58 0.38 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.904 0.383 . . . . 0.0 110.576 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 51.8 t -119.72 133.1 67.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.557 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.436 HE21 ' CE ' ' A' ' 90' ' ' LYS . 98.1 mt-30 -135.85 108.61 7.53 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -115.13 133.22 56.23 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 120.563 0.221 . . . . 0.0 110.427 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.9 t -68.1 149.52 49.52 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.877 0.37 . . . . 0.0 110.732 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -52.3 132.28 33.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.779 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.94 16.48 56.1 Favored Glycine 0 CA--C 1.534 1.256 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.972 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -125.06 155.87 39.1 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.913 0.387 . . . . 0.0 110.273 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 43.9 p-10 -85.72 169.36 13.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.555 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -134.44 147.36 50.41 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.042 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 44.5 t -134.87 141.21 46.29 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.884 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -119.96 146.38 45.88 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.127 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -128.71 104.89 7.9 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.224 179.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.498 ' SG ' ' OE1' ' A' ' 9' ' ' GLU . 6.6 t -124.45 141.81 51.79 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.455 ' NH1' ' CD2' ' A' ' 8' ' ' LEU . 60.1 ttp180 -124.99 119.52 28.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.922 0.391 . . . . 0.0 110.634 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 84.0 mt -123.4 121.01 34.67 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.383 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.805 ' HG ' ' H ' ' A' ' 6' ' ' THR . 66.3 p -71.6 161.33 31.17 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 18.5 ptp180 -53.9 147.74 11.66 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.377 0.608 . . . . 0.0 112.329 -178.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.29 -173.78 3.33 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.611 -178.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.7 t -163.68 -43.67 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.933 -1.03 . . . . 0.0 109.166 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -98.23 -71.41 1.02 Allowed Glycine 0 CA--C 1.521 0.409 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 179.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 -124.93 135.78 53.15 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.109 0.481 . . . . 0.0 111.926 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -90.12 151.98 21.34 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.211 178.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.2 167.62 15.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.358 -179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -149.65 159.51 44.28 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.195 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.409 ' CZ3' ' CZ ' ' A' ' 78' ' ' PHE . 92.7 m95 -84.63 176.56 8.51 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.922 0.391 . . . . 0.0 110.222 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -166.12 106.32 0.69 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.676 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.1 tt -114.88 118.0 32.26 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.59 21.37 68.87 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.7 -9.29 74.49 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 47.2 t -115.1 134.94 22.45 Favored Pre-proline 0 N--CA 1.471 0.618 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -56.71 142.21 91.55 Favored 'Trans proline' 0 N--CA 1.489 1.227 0 C-N-CA 121.378 1.386 . . . . 0.0 111.589 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.53 159.64 17.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.199 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -139.93 162.22 35.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.011 0.434 . . . . 0.0 110.389 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.99 76.3 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.362 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.505 ' CG ' ' H ' ' A' ' 49' ' ' GLU . 47.9 t30 -71.03 -174.89 1.03 Allowed 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.505 ' H ' ' CG ' ' A' ' 48' ' ' ASN . 86.5 tt0 -62.85 -44.63 95.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.153 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.9 ptt? -90.13 -16.24 29.98 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.02 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -105.32 142.2 35.5 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.092 0.472 . . . . 0.0 111.353 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.487 ' OD2' ' N ' ' A' ' 53' ' ' ILE . 63.3 t0 -148.03 146.47 28.9 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.429 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.487 ' N ' ' OD2' ' A' ' 52' ' ' ASP . 97.9 mt -125.25 130.77 72.93 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 CA-C-O 120.727 0.298 . . . . 0.0 110.616 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.3 p -135.47 157.91 45.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.11 0.481 . . . . 0.0 110.966 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 50.6 t -117.63 131.63 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.221 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.448 ' O ' ' O ' ' A' ' 57' ' ' GLN . 97.1 mt-10 -108.31 177.63 4.74 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.448 ' O ' ' O ' ' A' ' 56' ' ' GLU . 55.5 tt0 -28.15 148.77 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 O-C-N 123.795 0.684 . . . . 0.0 112.137 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 60.6 -98.14 0.14 Allowed Glycine 0 C--N 1.329 0.178 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.2 m -163.27 48.19 0.14 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.327 0.584 . . . . 0.0 110.535 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 8.2 tt -92.19 116.77 29.24 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.264 0.554 . . . . 0.0 110.339 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 -79.07 146.64 33.15 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.264 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.406 ' C ' ' CD2' ' A' ' 62' ' ' LEU . 6.3 tt -143.38 114.57 7.87 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -90.62 106.17 18.32 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 90.9 m -92.45 107.78 19.47 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.695 -178.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 83.2 mt -103.28 124.08 47.98 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.276 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.466 ' O ' ' N ' ' A' ' 68' ' ' VAL . 13.2 t60 -72.72 156.7 38.66 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 66' ' ' HIS . 15.8 ptpt -27.45 89.15 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.599 0.714 . . . . 0.0 112.495 -179.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.466 ' N ' ' O ' ' A' ' 66' ' ' HIS . 28.0 m -82.33 167.45 2.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.031 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.445 ' OG1' ' N ' ' A' ' 70' ' ' LEU . 6.7 t -130.77 -149.68 0.4 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.335 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.515 ' C ' ' H ' ' A' ' 72' ' ' ASP . 3.3 mm? -51.24 -36.35 41.38 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.293 -0.563 . . . . 0.0 109.684 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -60.96 -0.39 0.3 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.481 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.515 ' H ' ' C ' ' A' ' 70' ' ' LEU . 42.8 t0 -63.53 -36.97 85.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.913 -179.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.93 141.25 40.12 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.211 0.529 . . . . 0.0 111.324 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 173.52 153.49 9.71 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.523 -1.031 . . . . 0.0 110.523 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 16.0 p -97.25 111.35 23.63 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.954 0.407 . . . . 0.0 110.91 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 25.2 t -107.59 128.28 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.884 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.695 ' HG ' ' H ' ' A' ' 78' ' ' PHE . 17.5 t -144.29 175.8 9.82 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.28 -179.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.695 ' H ' ' HG ' ' A' ' 77' ' ' SER . 57.9 m-85 -127.07 144.27 51.07 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -131.57 115.3 15.93 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.968 0.413 . . . . 0.0 110.84 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.486 ' O ' ' N ' ' A' ' 82' ' ' THR . 6.0 p -141.23 125.49 17.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.404 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -39.85 -20.38 0.02 OUTLIER Glycine 0 CA--C 1.531 1.068 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.863 -178.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.486 ' N ' ' O ' ' A' ' 80' ' ' VAL . 68.3 p -80.65 -75.19 0.28 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.054 0.454 . . . . 0.0 111.084 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.417 ' N ' ' OG1' ' A' ' 82' ' ' THR . 61.8 m -121.0 179.6 4.33 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.427 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 73.5 m -131.57 151.81 51.3 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 11.4 t -153.07 164.39 38.09 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -148.37 162.07 40.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.065 0.46 . . . . 0.0 111.214 -178.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.2 155.69 34.34 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.933 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -122.45 128.59 51.07 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.424 -179.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.3 tt -121.1 117.55 27.47 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.436 ' CE ' HE21 ' A' ' 15' ' ' GLN . 20.5 pttp -144.57 166.38 25.34 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 120.904 0.383 . . . . 0.0 111.679 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.6 p -104.08 133.22 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.184 0.516 . . . . 0.0 110.137 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.0 t -102.82 141.9 34.85 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.994 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -88.33 -9.12 53.81 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.64 -0.255 . . . . 0.0 111.042 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.724 0 CA-C-O 117.959 -1.467 . . . . 0.0 111.071 -179.94 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ttm . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -159.72 154.83 21.58 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.114 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -55.47 143.63 76.88 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 121.692 1.595 . . . . 0.0 111.648 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -175.92 139.01 0.37 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.519 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.0 p -54.37 130.22 16.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.402 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.599 ' CG2' ' HG ' ' A' ' 29' ' ' SER . 16.6 p -101.23 124.95 47.74 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 22.9 mm -100.8 111.17 29.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.102 0.477 . . . . 0.0 110.948 -178.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.435 ' O ' ' O ' ' A' ' 27' ' ' ARG . 91.6 mt -120.02 106.07 11.65 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.501 178.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.496 ' CD ' ' HG ' ' A' ' 26' ' ' CYS . 34.0 mm-40 -124.81 89.39 52.54 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.957 -179.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -71.79 -3.51 13.29 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 121.622 1.548 . . . . 0.0 110.694 178.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 67.4 mt -69.24 141.5 54.41 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.982 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -124.77 -46.84 1.84 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.174 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 37.3 p30 -176.72 146.43 0.57 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.136 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 65.1 t -125.28 129.31 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.043 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -137.66 135.93 36.97 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.023 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -160.87 160.56 31.15 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.995 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.532 ' HG ' ' NE2' ' A' ' 20' ' ' GLN . 13.0 p -74.69 156.53 36.56 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.978 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -67.91 138.59 56.12 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.21 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.45 -3.38 65.92 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.532 ' NE2' ' HG ' ' A' ' 17' ' ' SER . 86.8 mt-30 -103.33 151.52 22.64 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.871 0.367 . . . . 0.0 110.878 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -76.07 155.23 34.99 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.97 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -135.39 146.29 48.17 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.523 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.5 m -133.43 148.8 51.79 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.31 0.576 . . . . 0.0 111.112 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -128.19 147.35 50.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.608 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -136.38 116.09 13.02 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.452 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.496 ' HG ' ' CD ' ' A' ' 9' ' ' GLU . 3.0 t -131.48 127.99 38.49 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.398 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.435 ' O ' ' O ' ' A' ' 8' ' ' LEU . 99.6 mtt180 -96.76 125.81 41.48 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 178.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 18.8 tp -145.34 112.24 5.96 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.599 ' HG ' ' CG2' ' A' ' 6' ' ' THR . 6.6 p -79.08 155.24 28.86 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 18.1 ptp180 -54.22 157.96 2.46 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -177.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.69 -173.86 2.46 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 114.649 -1.16 . . . . 0.0 111.374 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.8 t -154.85 -44.93 0.09 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.231 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -86.51 -72.12 1.29 Allowed Glycine 0 CA--C 1.522 0.482 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 178.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -122.41 143.39 49.7 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.833 0.349 . . . . 0.0 110.632 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.515 ' OE1' ' N ' ' A' ' 35' ' ' GLU . 56.4 mp0 -91.72 129.64 37.66 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.463 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.48 145.98 48.88 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -129.92 151.86 50.02 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.747 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 62.5 m95 -74.38 176.32 6.85 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -163.24 114.5 1.44 Allowed 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.896 178.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 41.1 tp -124.25 121.27 34.59 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.18 3.21 64.51 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.94 -17.21 58.51 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.9 m -107.08 149.68 38.93 Favored Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -58.76 145.11 97.33 Favored 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 120.885 1.056 . . . . 0.0 111.641 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.13 178.25 6.42 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.687 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -151.22 140.42 21.26 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.007 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.35 142.65 58.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.625 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.456 ' CG ' ' H ' ' A' ' 49' ' ' GLU . 48.4 t30 -169.01 -173.5 1.81 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.798 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.456 ' H ' ' CG ' ' A' ' 48' ' ' ASN . 82.4 tt0 -64.0 -42.25 97.24 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.526 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 97.2 mmm -66.28 -40.18 89.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.513 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.477 ' OD1' ' CD1' ' A' ' 63' ' ' LEU . 46.5 t30 -120.81 119.83 33.83 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.71 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -113.79 136.77 52.49 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 70.9 mt -120.07 129.87 74.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 110.11 -0.329 . . . . 0.0 110.11 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 86.8 m -132.5 142.04 49.04 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.203 0.525 . . . . 0.0 111.182 -178.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 42.1 t -110.58 132.9 57.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.438 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -124.6 -174.66 3.07 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.204 0.526 . . . . 0.0 110.543 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -28.41 137.99 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.466 -179.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.7 -99.63 0.69 Allowed Glycine 0 CA--C 1.52 0.367 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 25.3 p -159.94 51.51 0.32 Allowed 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 52.1 tp -87.22 119.14 27.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.467 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 53.6 m170 -100.97 124.84 47.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.673 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 76.2 mt -119.01 123.81 45.44 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.173 0.511 . . . . 0.0 111.18 -179.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.477 ' CD1' ' OD1' ' A' ' 51' ' ' ASN . 0.3 OUTLIER -97.89 105.69 17.87 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 177.954 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 58.7 m -104.97 105.2 15.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.173 0.511 . . . . 0.0 111.297 -177.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.6 mt -96.42 131.17 43.26 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.019 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -112.84 144.62 42.08 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.986 0.422 . . . . 0.0 111.114 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 74.7 tttt 50.92 57.04 7.08 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.475 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -44.98 152.08 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.087 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 43.7 p -134.5 164.4 27.56 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.9 -33.93 73.88 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -65.06 -22.22 66.94 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.592 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -60.3 -34.6 74.0 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -44.63 118.33 1.55 Allowed 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.594 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -170.74 -179.34 41.98 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 52.6 m -108.63 122.99 48.24 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.833 0.349 . . . . 0.0 110.781 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.14 131.46 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 29.0 t -144.18 175.15 10.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.885 0.374 . . . . 0.0 110.584 -179.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -127.34 138.16 52.97 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.904 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 -120.72 112.0 18.31 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.455 ' C ' ' H ' ' A' ' 82' ' ' THR . 2.4 t -126.67 129.66 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 120.966 0.412 . . . . 0.0 110.336 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -57.18 -7.48 2.66 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.623 ' HG1' ' N ' ' A' ' 83' ' ' CYS . 16.4 p -108.7 -40.53 5.04 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.656 0.265 . . . . 0.0 110.963 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.623 ' N ' ' HG1' ' A' ' 82' ' ' THR . 26.2 m -148.04 -166.37 2.51 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.328 -179.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 91.0 p -160.04 167.02 28.8 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.046 0.45 . . . . 0.0 111.229 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 31.5 t -158.87 166.8 31.04 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.331 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -134.63 153.53 51.93 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.21 0.528 . . . . 0.0 110.969 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.93 151.31 23.41 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.489 -0.778 . . . . 0.0 108.917 178.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -133.66 132.57 40.86 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.846 0.355 . . . . 0.0 111.693 -178.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.406 ' CD2' ' C ' ' A' ' 89' ' ' LEU . 5.3 tt -114.57 118.46 33.8 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -128.17 134.84 49.11 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.912 0.387 . . . . 0.0 110.677 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.2 p -114.94 108.24 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 27.4 m -116.52 118.52 32.89 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.324 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.34 146.36 50.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.823 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.803 0 CA-C-O 118.004 -1.442 . . . . 0.0 110.744 179.79 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.6 ttm . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -165.32 78.38 1.28 Allowed Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.902 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -67.53 146.67 74.87 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 122.545 2.164 . . . . 0.0 111.573 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -87.89 156.95 19.11 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.994 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.2 t -59.99 132.73 25.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.536 ' N ' ' OG ' ' A' ' 29' ' ' SER . 89.6 m -87.15 121.13 29.19 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 119.032 -1.067 . . . . 0.0 110.486 -179.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.423 HG23 HD13 ' A' ' 7' ' ' ILE . 18.2 mm -105.2 100.5 10.69 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.926 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 60.6 mt -128.41 90.26 3.04 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.494 ' OE2' ' CE2' ' A' ' 78' ' ' PHE . 7.6 pt-20 -120.14 84.27 33.38 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.933 -178.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.402 ' O ' ' N ' ' A' ' 12' ' ' GLN . 3.1 Cg_exo -71.23 11.67 0.55 Allowed 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 122.204 1.936 . . . . 0.0 111.491 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.45 ' CD1' ' N ' ' A' ' 11' ' ' LEU . 8.4 mp -70.54 67.07 0.34 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.402 ' N ' ' O ' ' A' ' 10' ' ' PRO . 99.4 mm-40 -69.94 -43.17 72.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.365 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.574 ' CG ' HE21 ' A' ' 15' ' ' GLN . 54.9 t0 -175.04 138.64 0.45 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.916 0.389 . . . . 0.0 110.992 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.424 ' N ' ' OD2' ' A' ' 13' ' ' ASP . 54.7 t -127.0 131.69 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.574 HE21 ' CG ' ' A' ' 13' ' ' ASP . 7.9 mp0 -136.43 102.64 5.02 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.734 0.302 . . . . 0.0 111.035 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -119.68 146.36 45.66 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.239 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.514 ' HG ' ' H ' ' A' ' 18' ' ' GLU . 45.0 t -82.06 162.91 22.4 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.14 179.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.514 ' H ' ' HG ' ' A' ' 17' ' ' SER . 79.2 tt0 -61.61 137.68 58.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.162 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.21 2.29 85.74 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 111.761 -0.535 . . . . 0.0 111.761 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -96.73 166.79 11.48 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.87 0.367 . . . . 0.0 110.72 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 21' ' ' ASP . 39.9 p30 -79.46 151.56 30.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.625 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.07 142.19 29.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.271 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 96.5 p -162.48 161.17 26.96 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.943 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -132.59 150.69 52.12 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.944 0.402 . . . . 0.0 110.644 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -136.45 123.85 22.03 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 8.5 t -134.38 132.9 39.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.277 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 90.6 mtm-85 -104.44 104.72 14.63 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.763 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 85.7 mt -123.81 121.05 34.4 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.0 0.428 . . . . 0.0 111.682 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.536 ' OG ' ' N ' ' A' ' 6' ' ' THR . 85.2 p -75.33 163.68 27.21 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 177.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 35.5 ptt-85 -50.87 149.02 3.68 Favored 'General case' 0 C--N 1.322 -0.618 0 O-C-N 124.181 0.926 . . . . 0.0 113.331 -177.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -75.46 176.43 7.54 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 114.177 -1.374 . . . . 0.0 111.135 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 50.0 m -151.25 -63.51 0.19 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.695 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -88.44 -75.36 1.29 Allowed Glycine 0 CA--C 1.521 0.409 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 178.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -122.43 129.96 52.59 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.711 0.291 . . . . 0.0 110.332 178.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -73.35 145.46 45.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.712 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.34 146.83 48.57 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.587 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 24.2 mmt85 -104.85 132.74 50.72 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.908 179.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -113.0 138.62 49.59 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -176.43 155.53 1.43 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 119.727 -0.789 . . . . 0.0 111.52 -178.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.5 tt -123.06 121.85 37.04 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 86.05 6.04 82.49 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -178.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.33 0.84 79.42 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 112.028 -0.429 . . . . 0.0 112.028 179.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 23.1 m -113.13 143.98 30.26 Favored Pre-proline 0 N--CA 1.47 0.551 0 CA-C-N 116.777 0.289 . . . . 0.0 110.884 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -56.41 144.87 81.88 Favored 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 121.411 1.407 . . . . 0.0 110.449 178.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 14.2 mt -80.87 156.97 25.82 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.034 0.445 . . . . 0.0 111.384 -179.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.465 ' O ' ' N ' ' A' ' 48' ' ' ASN . 89.9 mt-30 -126.6 131.48 51.49 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.21 179.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.01 70.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.943 0.401 . . . . 0.0 111.566 -178.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.465 ' N ' ' O ' ' A' ' 46' ' ' GLN . 87.4 m-20 -76.93 163.21 26.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.645 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -59.26 -46.57 88.15 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 95.2 mtp -66.91 -40.24 87.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.236 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.425 ' O ' ' O ' ' A' ' 48' ' ' ASN . 66.0 m-20 -117.6 107.77 14.65 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.769 179.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -109.82 158.51 18.08 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.7 mt -122.09 130.25 74.71 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-O 120.916 0.389 . . . . 0.0 110.084 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 97.1 m -128.27 129.38 46.27 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.905 -178.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.4 p -111.03 129.25 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.879 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.411 ' O ' ' C ' ' A' ' 57' ' ' GLN . 98.0 mt-10 -112.38 -174.57 2.49 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.144 0.497 . . . . 0.0 111.114 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.411 ' C ' ' O ' ' A' ' 56' ' ' GLU . 63.1 tp60 -24.78 144.56 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 114.791 -1.095 . . . . 0.0 112.462 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 58.52 -94.48 0.05 OUTLIER Glycine 0 CA--C 1.522 0.512 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.672 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 37.5 m -163.7 65.06 0.17 Allowed 'General case' 0 C--O 1.239 0.516 0 CA-C-O 121.324 0.583 . . . . 0.0 110.635 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 91.4 mt -95.8 126.3 40.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.426 178.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 48.7 m170 -107.84 120.61 42.77 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.22 118.39 14.49 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.083 0.468 . . . . 0.0 110.8 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -86.58 118.05 25.75 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 94.9 m -105.64 95.94 6.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.278 -179.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.88 140.84 39.06 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 21.3 p80 -139.19 159.02 43.14 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.575 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 79.2 tttt 47.74 73.17 0.21 Allowed 'General case' 0 C--O 1.231 0.109 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -179.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.7 p -116.47 131.83 67.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.959 -179.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.6 p -79.08 -157.41 0.12 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.523 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.581 ' C ' ' H ' ' A' ' 72' ' ' ASP . 55.4 tp -57.72 -33.74 68.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.421 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -51.28 -2.33 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.235 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.581 ' H ' ' C ' ' A' ' 70' ' ' LEU . 29.1 t0 -53.57 -39.24 64.64 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.697 0.284 . . . . 0.0 110.474 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.65 137.89 57.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.181 0.515 . . . . 0.0 111.068 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 179.99 176.8 47.65 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 110.076 -1.209 . . . . 0.0 110.076 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 94.4 m -126.15 117.26 22.76 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 117.088 0.444 . . . . 0.0 111.003 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.1 t -89.63 131.64 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.1 p -132.04 149.5 52.4 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.149 0.5 . . . . 0.0 110.891 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.494 ' CE2' ' OE2' ' A' ' 9' ' ' GLU . 0.2 OUTLIER -153.52 150.24 28.52 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.826 179.911 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -145.07 141.43 28.84 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.222 0.534 . . . . 0.0 111.112 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.507 ' C ' ' H ' ' A' ' 82' ' ' THR . 2.3 t -130.07 131.53 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.893 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -46.76 -11.89 0.06 OUTLIER Glycine 0 CA--C 1.528 0.896 0 C-N-CA 121.067 -0.587 . . . . 0.0 111.693 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.507 ' H ' ' C ' ' A' ' 80' ' ' VAL . 22.7 p -99.92 -54.01 3.01 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 122.722 -0.281 . . . . 0.0 110.696 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 38.8 t -139.58 162.5 34.93 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.115 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 30.9 p -134.68 155.13 51.06 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.964 0.412 . . . . 0.0 111.254 -179.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.0 t -162.87 166.87 23.53 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.948 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -142.34 165.06 28.44 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.66 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.82 155.69 41.93 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.139 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -125.25 135.89 52.99 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.344 0.592 . . . . 0.0 111.773 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 48.2 tp -109.66 97.68 7.18 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.783 179.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -94.62 166.82 11.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.312 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 53.1 t -119.51 128.37 75.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.61 162.17 24.37 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.63 -179.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.74 139.92 58.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.225 -179.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.794 0 CA-C-O 118.025 -1.431 . . . . 0.0 111.125 -179.879 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.61 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.416 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.443 ' CB ' ' CD ' ' A' ' 3' ' ' PRO . . . -49.72 -66.43 0.62 Allowed Pre-proline 0 CA--C 1.536 0.427 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.495 -179.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.443 ' CD ' ' CB ' ' A' ' 2' ' ' ALA . 3.9 Cg_exo -50.68 140.32 37.31 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 121.672 1.581 . . . . 0.0 111.467 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -97.92 -158.56 0.68 Allowed 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 179.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.7 t -61.28 130.53 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 C-N-CA 120.221 -0.591 . . . . 0.0 109.413 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.543 ' N ' ' OG ' ' A' ' 29' ' ' SER . 72.4 m -91.94 130.21 37.74 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 119.962 -0.695 . . . . 0.0 111.457 -178.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.42 HG22 HD12 ' A' ' 7' ' ' ILE . 33.8 mm -111.86 102.52 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-O 121.275 0.559 . . . . 0.0 111.017 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 39.4 tp -126.3 87.51 2.68 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.08 -0.963 . . . . 0.0 108.768 178.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.513 ' OE2' ' CE2' ' A' ' 78' ' ' PHE . 28.9 mt-10 -120.61 85.03 37.73 Favored Pre-proline 0 N--CA 1.464 0.267 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.354 -179.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -72.2 8.85 1.29 Allowed 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 121.819 1.679 . . . . 0.0 111.557 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.405 ' H ' ' C ' ' A' ' 9' ' ' GLU . 65.2 mt -61.56 84.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.903 179.099 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.408 ' CG ' ' H ' ' A' ' 13' ' ' ASP . 40.5 tp60 -72.86 -133.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.408 ' H ' ' CG ' ' A' ' 12' ' ' GLN . 95.2 m-20 -109.02 138.3 45.58 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.5 m -127.95 156.16 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -136.61 104.51 5.57 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.546 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 78.4 mt -118.45 139.97 50.58 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.249 -178.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 91.5 p -69.26 153.81 43.04 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.996 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -65.94 146.6 54.53 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.085 0.469 . . . . 0.0 111.065 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.43 8.82 65.63 Favored Glycine 0 CA--C 1.53 0.976 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.501 HE21 ' C ' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -112.29 156.78 21.84 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 120.976 0.417 . . . . 0.0 110.366 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.501 ' C ' HE21 ' A' ' 20' ' ' GLN . 87.1 m-20 -78.05 144.81 36.29 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.063 178.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -126.07 146.74 49.79 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.072 0.463 . . . . 0.0 110.594 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 41.5 t -156.77 154.74 30.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.927 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -132.81 152.13 51.87 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.809 0.337 . . . . 0.0 110.641 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.405 ' CD ' ' N ' ' A' ' 25' ' ' GLN . 0.5 OUTLIER -124.9 111.25 15.24 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.125 -0.488 . . . . 0.0 109.755 179.48 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 6.7 t -115.84 137.7 51.84 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 82.1 mtm180 -123.47 125.1 44.3 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.8 pp -147.98 141.17 25.07 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 119.974 -0.691 . . . . 0.0 111.438 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.543 ' OG ' ' N ' ' A' ' 6' ' ' THR . 98.5 p -74.31 162.65 28.68 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 178.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -52.24 162.53 0.49 Allowed 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -177.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.14 157.07 38.28 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 114.018 -1.447 . . . . 0.0 111.401 -179.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.5 t -141.44 -61.34 0.47 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.399 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -101.27 -67.24 0.81 Allowed Glycine 0 N--CA 1.459 0.22 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -123.55 137.72 54.7 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 179.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -79.8 147.58 31.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.589 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.44 152.21 40.85 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.188 179.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 61.3 mtp85 -126.09 147.04 49.68 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.292 -179.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 2.3 t-105 -104.45 151.29 23.72 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.597 -179.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -165.62 148.47 7.72 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.066 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.0 tt -124.99 126.27 45.18 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.65 7.69 88.3 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.87 -12.74 62.5 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.4 m -112.17 150.76 42.96 Favored Pre-proline 0 N--CA 1.468 0.466 0 C-N-CA 121.975 0.11 . . . . 0.0 110.756 -179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -57.71 144.33 93.31 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 121.39 1.393 . . . . 0.0 110.666 178.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.66 171.78 7.43 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.691 0.281 . . . . 0.0 111.069 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -130.58 134.24 46.84 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.952 0.406 . . . . 0.0 110.247 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.01 96.29 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.273 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -75.17 169.67 17.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.997 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -58.43 -45.21 88.96 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 20.6 mmt -67.58 -38.83 84.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.639 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 62.8 t-20 -98.89 106.9 19.21 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.765 -178.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.474 ' O ' ' OG1' ' A' ' 64' ' ' THR . 67.0 m-20 -109.0 108.29 18.97 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 38.4 mt -100.74 133.74 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -179.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.544 ' HG1' ' N ' ' A' ' 55' ' ' VAL . 4.9 t -146.11 159.17 43.65 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -179.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.544 ' N ' ' HG1' ' A' ' 54' ' ' THR . 59.0 t -109.25 137.44 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.268 179.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 57' ' ' GLN . 79.4 mm-40 -116.11 -178.6 3.44 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.438 ' C ' ' O ' ' A' ' 56' ' ' GLU . 56.1 tt0 -26.19 144.98 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 O-C-N 123.889 0.743 . . . . 0.0 112.102 -179.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 59.05 -94.7 0.06 OUTLIER Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.446 ' OG1' ' O ' ' A' ' 59' ' ' THR . 0.0 OUTLIER -166.75 59.49 0.09 Allowed 'General case' 0 C--O 1.24 0.594 0 CA-C-O 121.541 0.686 . . . . 0.0 110.962 -179.797 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.47 ' CD2' ' N ' ' A' ' 60' ' ' LEU . 3.1 mm? -99.55 130.56 45.81 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.099 179.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -107.27 142.96 36.2 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 120.869 0.366 . . . . 0.0 110.261 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.2 mp -137.89 118.92 14.37 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.293 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.33 108.2 19.89 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.474 ' OG1' ' O ' ' A' ' 52' ' ' ASP . 82.1 p -102.75 96.93 7.18 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 121.138 0.494 . . . . 0.0 109.908 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 36.6 tp -103.34 124.65 49.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.513 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.651 ' CG ' ' H ' ' A' ' 67' ' ' LYS . 1.0 OUTLIER -71.13 -152.71 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.41 -179.465 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.651 ' H ' ' CG ' ' A' ' 66' ' ' HIS . 5.4 mtmp? -53.99 97.09 0.02 OUTLIER 'General case' 0 CA--C 1.522 -0.108 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.376 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.0 p -58.19 168.35 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.819 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.451 ' HG1' ' H ' ' A' ' 72' ' ' ASP . 58.2 p -134.41 159.79 39.96 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 47.2 tp -58.54 -40.81 84.02 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -69.9 -33.02 71.64 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.677 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.451 ' H ' ' HG1' ' A' ' 69' ' ' THR . 55.3 m-20 -64.27 -40.27 95.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.86 -178.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.74 140.05 57.68 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.649 -0.421 . . . . 0.0 110.24 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -175.39 -108.02 0.22 Allowed Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 -179.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 97.0 m -156.5 109.69 2.63 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.412 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.5 t -89.07 127.9 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 31.9 t -133.03 146.23 51.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.283 0.563 . . . . 0.0 111.542 -178.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.513 ' CE2' ' OE2' ' A' ' 9' ' ' GLU . 0.1 OUTLIER -140.7 159.2 42.73 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.476 179.585 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.433 ' CD2' ' N ' ' A' ' 79' ' ' HIS . 5.3 p80 -143.41 146.39 33.44 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.973 -179.186 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.48 ' O ' ' N ' ' A' ' 82' ' ' THR . 2.2 t -134.32 134.46 54.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.557 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -43.06 -20.32 0.09 OUTLIER Glycine 0 CA--C 1.533 1.165 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.676 ' HG1' ' N ' ' A' ' 83' ' ' CYS . 33.1 p -82.6 -72.38 0.45 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.839 0.352 . . . . 0.0 110.657 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.676 ' N ' ' HG1' ' A' ' 82' ' ' THR . 7.8 t -128.02 -178.26 4.45 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.699 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.506 ' H ' ' HG ' ' A' ' 83' ' ' CYS . 35.5 m -127.74 149.69 50.12 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.244 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 52.9 p -156.63 162.85 39.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.611 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -160.06 168.14 26.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.983 0.42 . . . . 0.0 111.024 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.78 140.11 28.26 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.865 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 25.1 mp0 -109.7 122.04 46.59 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.098 0.475 . . . . 0.0 111.005 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 53.6 tp -108.54 106.29 16.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.929 179.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -110.02 171.03 7.69 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 24.3 m -113.8 128.7 70.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 120.77 0.319 . . . . 0.0 110.242 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.9 m -66.66 136.5 55.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.247 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -148.4 40.37 0.93 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.152 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.816 0 CA-C-O 118.031 -1.427 . . . . 0.0 111.198 179.909 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.1 mtm . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 55.38 77.42 0.43 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.869 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -67.93 146.75 72.67 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.53 2.153 . . . . 0.0 112.434 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.0 tp10 -78.66 152.52 31.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.411 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.8 t -58.76 132.89 23.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.494 ' OG1' ' N ' ' A' ' 29' ' ' SER . 51.8 p -94.55 133.91 37.66 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 119.177 -1.009 . . . . 0.0 110.936 -179.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.3 mm -112.45 56.93 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.181 -178.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 48.0 tp -90.1 78.03 6.71 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.537 ' OE1' ' CZ ' ' A' ' 78' ' ' PHE . 16.3 tt0 -121.7 83.82 42.66 Favored Pre-proline 0 N--CA 1.466 0.369 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.286 -179.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -71.46 47.14 0.83 Allowed 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.447 2.098 . . . . 0.0 112.067 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -81.69 82.47 7.4 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.418 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -74.12 -86.08 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.811 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.431 ' O ' ' OD2' ' A' ' 13' ' ' ASP . 44.0 p-10 -172.7 133.83 0.6 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.328 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.0 m -131.03 156.5 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-O 120.975 0.417 . . . . 0.0 110.697 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.87 121.66 30.6 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.33 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 53.4 mt -124.66 141.02 52.4 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.319 -179.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.2 t -83.92 155.55 22.8 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 -52.27 143.33 14.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.015 0.436 . . . . 0.0 111.426 -179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.42 2.1 85.42 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.844 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -101.08 146.76 27.04 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.003 0.43 . . . . 0.0 111.219 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -73.79 153.87 39.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.588 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.462 ' C ' ' HG ' ' A' ' 23' ' ' SER . . . -134.8 138.92 44.7 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.986 0.422 . . . . 0.0 110.049 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.462 ' HG ' ' C ' ' A' ' 22' ' ' ALA . 71.0 m -161.51 158.05 25.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.235 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -135.41 151.08 50.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.158 179.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -124.09 135.31 53.46 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.532 ' SG ' ' N ' ' A' ' 27' ' ' ARG . 53.8 t -149.8 163.62 37.5 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.043 0.449 . . . . 0.0 111.441 -179.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.532 ' N ' ' SG ' ' A' ' 26' ' ' CYS . 80.2 mtp85 -129.91 96.52 4.23 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.085 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.426 ' O ' ' CG2' ' A' ' 59' ' ' THR . 76.2 mt -113.32 113.66 25.57 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.728 -0.214 . . . . 0.0 111.384 -179.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.541 ' HG ' ' N ' ' A' ' 30' ' ' ARG . 44.2 t -68.04 156.2 37.87 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 178.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.541 ' N ' ' HG ' ' A' ' 29' ' ' SER . 16.2 ptm180 -53.33 167.03 0.22 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -177.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.24 159.88 16.87 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 113.691 -1.595 . . . . 0.0 111.799 -179.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.7 t -140.87 -58.19 0.51 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.49 -69.71 0.7 Allowed Glycine 0 CA--C 1.521 0.437 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 177.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -121.75 144.48 48.77 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.05 0.452 . . . . 0.0 110.652 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -83.85 142.12 30.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.57 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.29 152.68 41.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.443 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -124.15 126.72 46.64 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.199 0.523 . . . . 0.0 110.683 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 40.8 t-105 -93.73 148.05 22.47 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.951 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -167.37 154.99 8.96 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 119.632 -0.827 . . . . 0.0 112.123 -179.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 67.2 tp -118.17 117.03 28.05 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.74 8.7 82.38 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.9 3.93 79.39 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.5 t -113.48 134.8 21.9 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-O 119.224 -0.417 . . . . 0.0 110.357 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -50.83 138.49 41.88 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 121.022 1.148 . . . . 0.0 110.57 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -114.25 174.16 6.09 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.923 0.392 . . . . 0.0 111.792 -178.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -136.98 150.25 48.03 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.294 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.19 78.43 0.05 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.624 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.427 ' O ' ' O ' ' A' ' 51' ' ' ASN . 7.9 m120 -71.41 178.89 3.19 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.021 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.407 ' OE2' ' N ' ' A' ' 49' ' ' GLU . 56.8 mp0 -61.31 -44.88 96.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.228 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 25.9 ptm -83.69 -17.15 42.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.074 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.427 ' O ' ' O ' ' A' ' 48' ' ' ASN . 77.1 m-20 -114.16 105.07 12.75 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.29 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -115.12 130.41 56.92 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 42.7 mt -123.78 133.99 67.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.2 t -137.61 153.23 49.92 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.024 0.44 . . . . 0.0 110.781 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 53.4 t -111.85 131.87 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.254 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -108.12 162.0 14.45 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.932 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -49.87 150.76 2.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.787 -179.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.31 13.09 82.35 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.426 ' CG2' ' O ' ' A' ' 28' ' ' LEU . 1.0 OUTLIER 67.38 26.68 8.35 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.835 0.35 . . . . 0.0 110.629 -179.76 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.6 mp -77.47 136.36 38.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.14 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 5.6 t-160 -104.97 153.39 21.49 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.213 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.1 tp -152.77 110.68 3.63 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 121.01 0.434 . . . . 0.0 109.969 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.416 ' C ' ' CD1' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -86.14 107.54 17.91 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.517 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 60.3 m -99.93 99.93 10.76 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.262 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 41.0 tp -110.94 120.66 43.14 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.452 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.519 ' CG ' ' H ' ' A' ' 67' ' ' LYS . 26.8 t60 -138.55 175.46 9.55 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.215 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.519 ' H ' ' CG ' ' A' ' 66' ' ' HIS . 64.1 mttp 55.18 57.09 5.8 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -179.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 28.2 m -108.28 156.3 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-O 121.448 0.642 . . . . 0.0 111.5 -179.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 36.5 p -135.69 -149.6 0.34 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.69 178.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 16.7 mt -56.52 -23.68 41.44 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -71.45 -1.15 12.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.693 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -56.89 -39.74 74.94 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.711 -0.395 . . . . 0.0 109.945 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.61 147.45 18.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.653 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 171.38 -161.14 33.51 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 87.5 m -153.5 109.28 3.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.719 0.295 . . . . 0.0 110.31 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.0 m -80.3 136.29 23.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.577 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.9 t -144.8 145.82 31.82 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.029 0.442 . . . . 0.0 110.904 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.537 ' CZ ' ' OE1' ' A' ' 9' ' ' GLU . 38.9 p90 -150.07 151.7 33.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.07 179.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.543 ' ND1' ' OG ' ' A' ' 84' ' ' SER . 64.9 t60 -134.86 131.22 37.12 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.906 -179.161 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.529 ' O ' ' N ' ' A' ' 82' ' ' THR . 2.4 t -127.87 130.89 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.22 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -39.91 -21.33 0.03 OUTLIER Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.775 -0.53 . . . . 0.0 111.775 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.529 ' N ' ' O ' ' A' ' 80' ' ' VAL . 19.0 p -88.54 -71.93 0.56 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.87 0.367 . . . . 0.0 110.233 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 4.1 t -132.04 160.1 36.88 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.939 179.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.543 ' OG ' ' ND1' ' A' ' 79' ' ' HIS . 20.4 m -133.91 154.88 50.77 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.157 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.5 m -160.28 161.65 33.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.116 0.484 . . . . 0.0 111.26 -179.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -143.05 150.13 39.15 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.424 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -135.01 153.24 52.16 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.303 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -108.43 135.74 49.22 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 121.365 0.603 . . . . 0.0 111.412 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 50.0 tp -115.59 96.42 5.62 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.103 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.5 ttmt -94.28 169.74 10.01 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.536 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.8 t -118.38 131.37 71.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -108.92 134.61 51.36 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.719 0.295 . . . . 0.0 110.798 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.22 137.77 57.84 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.422 -0.511 . . . . 0.0 109.838 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.701 0 CA-C-O 117.915 -1.492 . . . . 0.0 111.34 -179.115 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 ptm . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.31 149.84 30.16 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.158 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -56.69 -25.11 58.4 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 121.711 1.607 . . . . 0.0 111.383 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -38.0 142.5 0.16 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.479 0.657 . . . . 0.0 111.71 -179.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.7 p -65.1 133.85 30.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.401 179.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.87 ' HG1' ' H ' ' A' ' 29' ' ' SER . 59.7 p -92.77 136.48 33.21 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.337 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.497 ' O ' ' CG2' ' A' ' 7' ' ' ILE . 2.4 tp -118.21 107.0 20.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-O 122.487 1.137 . . . . 0.0 111.455 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.7 mp -126.14 79.94 1.88 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 113.996 -1.456 . . . . 0.0 108.418 178.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -120.62 87.8 42.27 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.652 -178.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.45 ' O ' ' N ' ' A' ' 12' ' ' GLN . 2.5 Cg_endo -73.75 -7.0 19.54 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 C-N-CA 122.109 1.873 . . . . 0.0 110.727 178.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 98.2 mt -56.23 83.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.233 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.45 ' N ' ' O ' ' A' ' 10' ' ' PRO . 59.5 tt0 -85.64 -64.76 1.1 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.594 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 14' ' ' VAL . 60.1 t0 -170.64 142.88 2.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.721 -178.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.545 ' N ' ' OD1' ' A' ' 13' ' ' ASP . 29.3 m -132.82 161.68 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.984 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.422 ' CD ' ' N ' ' A' ' 15' ' ' GLN . 0.6 OUTLIER -128.47 115.71 18.59 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.883 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 60.4 mt -122.16 143.78 49.35 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.949 0.404 . . . . 0.0 111.465 -179.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 92' ' ' THR . 17.7 m -80.74 157.86 25.7 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.003 178.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -65.9 148.53 51.65 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.585 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.8 10.16 84.53 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 111.071 -0.811 . . . . 0.0 111.071 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -121.16 145.14 48.13 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -74.29 162.25 29.09 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.403 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -131.22 162.24 30.42 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 28.1 p -159.39 158.51 32.32 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.196 -0.602 . . . . 0.0 111.476 -179.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -139.75 148.22 41.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.294 179.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -136.33 126.99 27.14 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.595 ' SG ' ' N ' ' A' ' 27' ' ' ARG . 8.2 t -130.13 162.47 28.76 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.472 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.595 ' N ' ' SG ' ' A' ' 26' ' ' CYS . 79.4 ttt180 -143.41 116.01 8.65 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.4 pp -146.06 123.47 11.67 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 119.846 -0.742 . . . . 0.0 111.71 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.87 ' H ' ' HG1' ' A' ' 6' ' ' THR . 92.4 p -62.25 160.23 13.49 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -53.52 155.84 2.81 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 122.015 0.912 . . . . 0.0 113.388 -177.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -53.47 179.57 0.02 OUTLIER 'General case' 0 C--O 1.232 0.163 0 CA-C-N 113.875 -1.511 . . . . 0.0 112.044 -179.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.4 p -156.56 -50.39 0.08 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.406 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -101.69 -66.87 0.79 Allowed Glycine 0 CA--C 1.522 0.507 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 178.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -122.69 157.46 32.21 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.726 0.298 . . . . 0.0 110.34 179.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -79.85 141.64 35.98 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.798 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.42 145.84 36.93 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.332 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -128.95 144.27 51.13 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.268 0.556 . . . . 0.0 111.062 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 18.8 t-105 -100.67 155.7 17.74 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.797 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -164.56 151.3 11.07 Favored 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 119.774 -0.77 . . . . 0.0 111.913 -179.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.403 ' CD1' ' C ' ' A' ' 40' ' ' LEU . 0.5 OUTLIER -129.32 116.63 19.37 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.057 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.85 19.07 69.23 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -178.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.13 4.11 84.43 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.966 -0.853 . . . . 0.0 110.966 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.2 t -111.02 128.38 25.41 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-O 119.491 -0.29 . . . . 0.0 110.478 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -57.76 144.96 92.26 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 121.094 1.196 . . . . 0.0 111.284 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.536 ' CD2' ' N ' ' A' ' 45' ' ' LEU . 1.1 pt? -130.42 149.69 51.99 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.527 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -128.03 166.18 18.89 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.639 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.6 141.76 19.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.099 0.476 . . . . 0.0 111.377 -178.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.432 ' O ' ' O ' ' A' ' 51' ' ' ASN . 36.3 p-10 -163.3 -171.53 2.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.653 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -65.08 -46.72 79.97 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.169 -179.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 65.6 mtt -67.92 -42.91 80.36 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -179.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.432 ' O ' ' O ' ' A' ' 48' ' ' ASN . 17.5 m-20 -118.23 145.71 44.8 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 120.784 0.326 . . . . 0.0 111.458 -179.033 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 48' ' ' ASN . 98.2 m-20 -138.47 108.94 6.52 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.088 178.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.8 pt -101.23 134.61 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.472 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.7 t -139.11 155.46 47.87 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.872 0.368 . . . . 0.0 111.176 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.5 m -120.14 129.14 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.158 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.435 ' N ' ' OE2' ' A' ' 56' ' ' GLU . 56.7 mp0 -124.62 179.53 4.92 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.332 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 58.9 tp60 -48.93 147.52 2.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.199 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.48 14.72 80.79 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 111.542 -0.623 . . . . 0.0 111.542 179.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.2 m 61.96 38.33 14.38 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 120.989 0.423 . . . . 0.0 110.266 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 49.3 mt -83.18 129.62 35.03 Favored 'General case' 0 CA--C 1.527 0.064 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.434 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 59.6 m170 -108.68 153.48 23.37 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.0 tp -154.83 116.77 4.17 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.225 -178.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.458 ' CD1' ' N ' ' A' ' 63' ' ' LEU . 7.2 mp -97.43 121.01 38.83 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 23.6 m -108.33 107.11 17.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.396 0.617 . . . . 0.0 109.665 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.423 ' CD2' ' N ' ' A' ' 65' ' ' LEU . 1.5 mm? -92.78 130.53 38.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.873 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.604 ' CG ' ' H ' ' A' ' 67' ' ' LYS . 1.5 t-80 -83.25 -150.9 0.1 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.406 -179.008 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.604 ' H ' ' CG ' ' A' ' 66' ' ' HIS . 13.9 ptpt -60.38 95.92 0.04 OUTLIER 'General case' 0 N--CA 1.461 0.102 0 CA-C-O 121.253 0.549 . . . . 0.0 110.337 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.5 m -96.78 133.98 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 121.302 0.572 . . . . 0.0 110.939 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 27.5 p -88.35 -152.89 0.23 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.202 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.404 ' C ' ' H ' ' A' ' 72' ' ' ASP . 5.4 mp -61.97 -23.56 66.46 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.7 tp10 -66.58 -1.72 3.99 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.098 -0.956 . . . . 0.0 110.142 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.404 ' H ' ' C ' ' A' ' 70' ' ' LEU . 66.4 t0 -54.74 -44.35 73.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.112 -179.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.48 129.83 40.33 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -175.6 143.82 6.84 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 53.1 m -97.01 125.6 41.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.755 0.312 . . . . 0.0 110.873 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.6 t -101.61 126.49 55.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 47.5 t -124.27 140.91 52.51 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.963 0.411 . . . . 0.0 110.485 -179.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -146.9 154.59 41.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.023 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 19.6 p80 -150.69 149.19 29.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.071 0.463 . . . . 0.0 110.55 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.541 ' O ' ' N ' ' A' ' 82' ' ' THR . 4.0 p -146.38 88.16 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.089 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 80' ' ' VAL . . . 30.75 -85.93 0.01 OUTLIER Glycine 0 CA--C 1.53 1.001 0 CA-C-N 115.487 -0.778 . . . . 0.0 112.462 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.541 ' N ' ' O ' ' A' ' 80' ' ' VAL . 25.3 p -39.11 -85.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -179.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.459 ' SG ' ' N ' ' A' ' 84' ' ' SER . 33.1 t -105.65 167.69 9.6 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.043 0.449 . . . . 0.0 111.862 -178.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.459 ' N ' ' SG ' ' A' ' 83' ' ' CYS . 35.3 t -151.11 145.81 25.72 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.265 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.494 ' HG ' ' H ' ' A' ' 86' ' ' GLU . 46.9 t -158.09 172.13 18.98 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.072 0.463 . . . . 0.0 111.151 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.494 ' H ' ' HG ' ' A' ' 85' ' ' SER . 16.3 pt-20 -144.2 162.76 35.51 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.492 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -134.08 156.3 48.51 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.079 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.444 ' O ' ' OD1' ' A' ' 13' ' ' ASP . 98.9 mm-40 -118.59 135.97 54.13 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.823 0.344 . . . . 0.0 111.367 -179.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.415 ' C ' ' CD2' ' A' ' 89' ' ' LEU . 2.2 tt -115.27 109.64 18.24 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -105.66 160.76 14.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.005 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.4 m -117.89 127.35 75.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 120.934 0.397 . . . . 0.0 110.231 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.429 ' O ' ' OG ' ' A' ' 17' ' ' SER . 85.9 m -123.3 127.68 48.88 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.101 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -89.64 -6.04 56.56 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.006 0.431 . . . . 0.0 109.964 179.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.75 0 CA-C-O 117.936 -1.48 . . . . 0.0 111.202 -179.989 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.0 mtm . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -169.42 79.74 0.68 Allowed Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.97 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -69.54 -22.05 33.63 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.368 2.045 . . . . 0.0 111.945 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -74.23 154.94 38.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.048 0.452 . . . . 0.0 110.514 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.7 p -62.04 132.46 27.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.796 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -111.54 122.04 46.77 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 179.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.409 HD12 HG23 ' A' ' 7' ' ' ILE . 76.9 mt -105.1 118.57 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-O 121.755 0.788 . . . . 0.0 111.804 -179.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.9 mt -127.3 75.77 1.61 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.485 -1.234 . . . . 0.0 108.049 178.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.505 ' OE1' ' CE2' ' A' ' 78' ' ' PHE . 35.7 tt0 -114.97 92.83 32.28 Favored Pre-proline 0 N--CA 1.467 0.4 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.984 -177.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.522 ' O ' ' N ' ' A' ' 12' ' ' GLN . 2.6 Cg_endo -75.29 -6.59 18.04 Favored 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 122.042 1.828 . . . . 0.0 111.035 178.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 63.6 mt -60.91 72.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.191 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.522 ' N ' ' O ' ' A' ' 10' ' ' PRO . 70.9 tp60 -74.9 -64.1 1.12 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.124 -179.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.7 p-10 -170.29 133.87 1.13 Allowed 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 120.446 -0.501 . . . . 0.0 111.486 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.5 m -134.65 159.73 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.793 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -135.58 117.14 14.85 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.386 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 81.2 mt -121.2 132.64 54.95 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.439 -179.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.7 m -69.68 158.69 34.87 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.817 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.42 ' OE2' ' O ' ' A' ' 68' ' ' VAL . 52.5 tp10 -58.31 146.37 34.59 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.612 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.7 1.13 80.85 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.497 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -110.23 146.55 35.42 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.893 0.378 . . . . 0.0 110.562 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 52.6 p-10 -82.33 170.53 15.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.053 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -148.12 152.39 37.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.173 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 95.9 p -152.01 123.13 7.63 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.072 0.463 . . . . 0.0 111.048 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -103.82 119.51 39.06 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.453 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -131.52 133.44 45.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.948 0.404 . . . . 0.0 109.958 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 8.4 p -151.59 151.7 31.9 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.107 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 85.2 mtt85 -96.68 132.34 42.44 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.875 179.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.454 ' O ' ' OG1' ' A' ' 59' ' ' THR . 2.9 tt -144.88 106.02 4.19 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.692 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.6 m -62.04 150.83 37.05 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.804 0.335 . . . . 0.0 110.432 179.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -56.33 156.13 6.19 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.528 0.68 . . . . 0.0 112.581 -178.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.78 -174.71 3.53 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.705 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 27.0 m -154.21 -43.93 0.09 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -86.76 -74.16 1.28 Allowed Glycine 0 CA--C 1.521 0.463 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 178.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.454 ' CD ' ' N ' ' A' ' 34' ' ' GLN . 25.4 mp0 -121.98 132.29 54.45 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.924 0.392 . . . . 0.0 110.994 179.048 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -77.28 150.41 35.3 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.835 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.14 147.31 38.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.643 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 45.8 mmm-85 -115.12 137.16 52.33 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.771 0.32 . . . . 0.0 111.225 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 1.8 t-105 -101.79 140.51 35.98 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.013 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -176.38 163.88 2.55 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.119 -179.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -139.66 129.52 24.76 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.246 0.546 . . . . 0.0 110.467 178.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.58 7.03 78.65 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.84 -17.04 58.82 Favored Glycine 0 CA--C 1.529 0.969 0 N-CA-C 111.937 -0.465 . . . . 0.0 111.937 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.1 t -101.55 123.07 45.62 Favored Pre-proline 0 CA--C 1.541 0.633 0 CA-C-N 116.905 0.352 . . . . 0.0 110.37 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -58.69 138.01 83.33 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 CA-C-N 119.875 0.991 . . . . 0.0 111.204 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.0 -174.96 4.18 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.095 0.474 . . . . 0.0 110.551 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.492 ' O ' ' N ' ' A' ' 48' ' ' ASN . 2.6 pm0 -139.06 154.92 48.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.185 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.95 70.33 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.616 -0.433 . . . . 0.0 110.389 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.492 ' N ' ' O ' ' A' ' 46' ' ' GLN . 18.4 t-20 -68.84 157.73 35.9 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.748 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.467 ' N ' ' OD1' ' A' ' 48' ' ' ASN . 86.1 tt0 -55.74 -44.6 77.72 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.246 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 5.4 ptt? -69.31 -35.54 76.08 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 120.907 0.384 . . . . 0.0 110.18 179.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.446 ' O ' ' O ' ' A' ' 48' ' ' ASN . 41.7 m-20 -116.47 104.64 11.64 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.136 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.419 ' OD2' ' O ' ' A' ' 48' ' ' ASN . 96.7 m-20 -107.97 138.1 44.82 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.704 0.288 . . . . 0.0 110.46 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.3 mt -117.98 129.81 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.312 -0.404 . . . . 0.0 109.995 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.1 t -142.38 146.78 35.29 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.02 0.438 . . . . 0.0 111.137 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 51.5 t -122.48 132.17 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.417 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -121.94 177.08 5.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.292 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -42.84 151.45 0.13 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.343 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.12 20.6 80.01 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.454 ' OG1' ' O ' ' A' ' 28' ' ' LEU . 62.8 p 47.62 38.3 8.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.086 0.47 . . . . 0.0 110.444 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 94.6 mt -75.73 138.72 41.45 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.31 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -108.18 148.31 30.09 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.032 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 53.9 tp -160.49 101.19 1.35 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.043 0.449 . . . . 0.0 110.501 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.8 tp -100.24 109.78 22.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.591 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.9 p -86.14 112.08 20.96 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.238 0.542 . . . . 0.0 110.715 -179.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 55.5 tp -111.58 123.71 50.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.183 179.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.519 ' CG ' ' N ' ' A' ' 67' ' ' LYS . 78.3 t60 -145.67 167.94 21.9 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.993 0.425 . . . . 0.0 111.043 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.519 ' N ' ' CG ' ' A' ' 66' ' ' HIS . 72.0 tttt 56.77 57.06 4.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.443 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.42 ' O ' ' OE2' ' A' ' 18' ' ' GLU . 5.7 m -93.7 174.28 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 121.838 0.828 . . . . 0.0 111.544 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.542 ' C ' ' H ' ' A' ' 71' ' ' GLU . 4.4 t -137.89 157.22 46.85 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.121 -1.399 . . . . 0.0 108.216 178.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 67.8 mt -52.55 -5.96 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.521 -0.472 . . . . 0.0 111.202 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.542 ' H ' ' C ' ' A' ' 69' ' ' THR . 80.2 mm-40 -113.82 2.41 15.12 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.437 ' O ' ' O ' ' A' ' 73' ' ' ALA . 24.9 t70 -63.14 -52.71 61.41 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.673 -179.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.437 ' O ' ' O ' ' A' ' 72' ' ' ASP . . . 42.96 -167.81 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 -179.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 157.34 95.01 0.1 Allowed Glycine 0 CA--C 1.524 0.645 0 C-N-CA 120.404 -0.903 . . . . 0.0 112.351 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 40.6 p -90.74 94.54 9.72 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 178.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.0 t -76.87 152.09 5.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.18 0.514 . . . . 0.0 111.128 -179.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 33.9 t -153.64 151.63 29.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.3 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.505 ' CE2' ' OE1' ' A' ' 9' ' ' GLU . 64.6 m-85 -131.62 144.59 51.16 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.029 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -143.47 116.0 8.61 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.582 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.535 ' O ' ' N ' ' A' ' 82' ' ' THR . 5.6 p -129.38 135.0 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.739 178.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -38.01 -21.4 0.01 OUTLIER Glycine 0 CA--C 1.527 0.79 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.674 -178.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.535 ' N ' ' O ' ' A' ' 80' ' ' VAL . 82.7 p -85.19 -74.5 0.4 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.891 0.377 . . . . 0.0 111.14 -179.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.423 ' H ' HG11 ' A' ' 80' ' ' VAL . 60.4 m -128.08 -166.6 1.64 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.416 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 87.8 p -157.1 162.78 39.44 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.761 0.315 . . . . 0.0 110.93 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.9 p -152.9 166.99 30.6 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.904 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -141.97 155.98 45.46 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.147 0.499 . . . . 0.0 111.945 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.99 153.58 33.21 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.413 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -133.93 137.27 44.78 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.585 0.707 . . . . 0.0 112.328 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.7 tp -111.03 116.61 31.46 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.551 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -118.85 164.03 16.02 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.001 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.6 m -123.9 128.25 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 120.997 0.427 . . . . 0.0 110.386 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 23.3 m -73.3 134.19 44.11 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.82 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.74 148.95 51.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.444 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.666 0 CA-C-O 117.994 -1.448 . . . . 0.0 111.066 -179.875 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.7 mtt . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.584 ' N ' ' CD ' ' A' ' 3' ' ' PRO . . . -67.43 -39.47 20.35 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.783 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 2' ' ' ALA . 3.2 Cg_exo -75.43 -172.23 1.24 Allowed 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 122.298 1.999 . . . . 0.0 111.866 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -52.79 -171.74 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.297 0.57 . . . . 0.0 110.967 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.9 p -55.18 131.7 18.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.368 -0.833 . . . . 0.0 108.757 178.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 13.6 m -81.56 123.53 28.73 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 119.482 -0.887 . . . . 0.0 109.442 -179.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.8 mt -108.84 118.26 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 121.582 0.706 . . . . 0.0 112.673 -178.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 85.2 mt -126.31 111.11 14.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.466 -1.243 . . . . 0.0 107.947 177.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.537 ' N ' ' OE1' ' A' ' 9' ' ' GLU . 1.6 pm0 -122.96 88.5 50.76 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.318 -178.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -74.58 -8.51 20.6 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 122.068 1.846 . . . . 0.0 110.677 178.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 67.3 mt -68.83 81.75 0.29 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.692 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -71.89 -58.79 3.15 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.786 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 14' ' ' VAL . 62.4 t0 -175.27 137.63 0.4 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.065 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.529 ' N ' ' OD1' ' A' ' 13' ' ' ASP . 28.4 m -137.54 156.52 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-O 121.11 0.481 . . . . 0.0 111.48 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -123.0 132.22 54.04 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.884 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 59.6 mt -120.54 123.73 43.61 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.476 -178.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.8 t -74.84 145.34 42.9 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 177.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -59.38 137.8 57.87 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.348 -179.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.98 -0.47 72.8 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -114.62 133.14 56.06 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.85 0.357 . . . . 0.0 110.763 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.409 ' C ' ' OD2' ' A' ' 21' ' ' ASP . 54.9 p30 -78.86 172.06 14.29 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.434 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -159.92 173.18 16.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.023 0.44 . . . . 0.0 111.263 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 29.0 p -154.67 162.29 41.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.502 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -127.93 152.55 47.74 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.022 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -130.58 130.06 43.56 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.473 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.466 ' SG ' ' N ' ' A' ' 27' ' ' ARG . 48.5 t -141.89 164.6 29.74 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.412 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.466 ' N ' ' SG ' ' A' ' 26' ' ' CYS . 95.7 mtt180 -140.95 121.19 13.86 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.951 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 86.0 mt -126.39 103.05 7.42 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.842 179.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.654 ' HG ' ' H ' ' A' ' 30' ' ' ARG . 25.1 t -63.52 170.03 3.44 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.654 ' H ' ' HG ' ' A' ' 29' ' ' SER . 39.4 ptt180 -52.62 140.21 23.85 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.378 0.609 . . . . 0.0 111.689 -178.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -91.42 -172.66 3.34 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.21 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 38.0 t -150.58 -60.26 0.19 Allowed 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -72.69 -90.13 0.13 Allowed Glycine 0 CA--C 1.521 0.45 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -123.56 143.33 50.27 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.935 0.397 . . . . 0.0 110.963 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -79.35 151.32 31.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.328 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.74 155.69 39.71 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.427 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -125.45 133.57 52.4 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.19 0.519 . . . . 0.0 111.306 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 1.5 t-105 -76.8 156.86 31.98 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.813 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -169.61 152.64 4.74 Favored 'General case' 0 N--CA 1.461 0.119 0 C-N-CA 119.716 -0.794 . . . . 0.0 111.959 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.43 ' CD1' ' C ' ' A' ' 40' ' ' LEU . 2.4 tm? -125.5 117.32 23.37 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.2 4.1 90.33 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 -179.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 102.62 -9.88 55.8 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.803 -0.519 . . . . 0.0 111.803 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.5 m -107.82 155.3 40.13 Favored Pre-proline 0 N--CA 1.47 0.562 0 CA-C-N 117.08 0.44 . . . . 0.0 110.545 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -68.45 154.77 71.13 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 121.392 1.394 . . . . 0.0 112.258 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.48 -175.87 3.78 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.163 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.561 ' O ' ' N ' ' A' ' 48' ' ' ASN . 50.1 tt0 -141.95 149.74 40.51 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 179.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -50.14 82.64 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.947 0.404 . . . . 0.0 111.204 -179.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.561 ' N ' ' O ' ' A' ' 46' ' ' GLN . 52.3 t30 -81.03 162.17 23.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.372 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -57.77 -45.53 85.82 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.211 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 66.6 mtt -66.13 -38.35 87.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.819 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.452 ' O ' ' O ' ' A' ' 48' ' ' ASN . 79.4 m-20 -108.91 111.27 22.88 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.522 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -105.26 145.42 30.69 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 33.1 mt -125.0 129.85 73.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 90.2 m -124.69 131.74 53.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.601 -179.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 63.8 t -111.99 131.9 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.166 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.436 ' O ' ' O ' ' A' ' 57' ' ' GLN . 75.6 tt0 -137.09 156.77 47.97 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.911 -179.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.436 ' O ' ' O ' ' A' ' 56' ' ' GLU . 6.8 pt20 -41.58 165.87 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.952 0.406 . . . . 0.0 111.201 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.414 ' O ' ' OG1' ' A' ' 59' ' ' THR . . . 69.23 16.75 71.43 Favored Glycine 0 CA--C 1.517 0.16 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.414 ' OG1' ' O ' ' A' ' 58' ' ' GLY . 70.7 p 52.23 31.31 9.0 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.26 -0.47 . . . . 0.0 110.048 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 22.9 mt -72.96 129.69 38.68 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.608 179.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 81.0 m80 -112.85 149.5 33.02 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.819 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 54.1 tp -151.16 106.49 3.34 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 120.809 -0.357 . . . . 0.0 111.126 -179.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -87.44 105.7 17.46 Favored 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.1 m -91.99 107.35 19.15 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.297 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 39.5 tp -97.77 110.42 22.99 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.503 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.426 ' O ' ' O ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -91.85 144.11 25.82 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.817 -179.828 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.426 ' O ' ' O ' ' A' ' 66' ' ' HIS . 99.2 mttt 41.76 96.85 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.09 179.164 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.9 p -75.28 156.12 6.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.073 0.464 . . . . 0.0 110.905 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.7 m -134.61 156.64 48.36 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.095 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 70.6 mt -56.56 -24.65 48.59 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -74.27 -6.32 47.28 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.044 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -60.48 -39.11 86.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.815 0.34 . . . . 0.0 110.754 -179.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -44.27 126.25 5.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.71 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -178.75 -150.52 8.89 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 10.0 m -150.46 106.52 3.45 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 110.336 -0.246 . . . . 0.0 110.336 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.8 t -83.06 133.27 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.1 p -151.62 164.13 37.56 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.16 0.505 . . . . 0.0 111.338 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -141.9 146.53 35.84 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.517 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -119.28 129.29 54.82 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.192 0.52 . . . . 0.0 111.526 -179.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.554 ' C ' ' H ' ' A' ' 82' ' ' THR . 2.0 t -120.68 132.24 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.032 179.185 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -50.32 -6.72 0.11 Allowed Glycine 0 CA--C 1.529 0.925 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.408 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.554 ' H ' ' C ' ' A' ' 80' ' ' VAL . 6.4 p -102.8 -52.0 3.17 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.737 0.303 . . . . 0.0 110.194 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.459 ' H ' ' HG1' ' A' ' 82' ' ' THR . 0.9 OUTLIER -152.8 161.6 42.35 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.946 179.345 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 40.1 t -135.54 143.19 45.58 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.935 0.398 . . . . 0.0 111.001 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 67.1 m -134.13 160.16 38.64 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.46 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.491 ' N ' ' OE2' ' A' ' 86' ' ' GLU . 57.9 mp0 -130.88 156.14 45.55 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.785 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -134.53 142.65 47.07 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.203 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.484 ' CD ' ' N ' ' A' ' 88' ' ' GLN . 14.7 mp0 -106.93 127.29 53.3 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.434 0.635 . . . . 0.0 111.955 -178.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.423 ' C ' ' CD2' ' A' ' 89' ' ' LEU . 4.6 tt -119.69 114.15 21.74 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.164 179.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.409 ' NZ ' ' OD2' ' A' ' 13' ' ' ASP . 23.2 mtmm -109.93 154.03 23.68 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.528 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.8 t -119.42 131.34 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.9 m -84.8 131.57 34.52 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.64 3.13 3.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.009 -179.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.693 0 CA-C-O 118.052 -1.416 . . . . 0.0 110.926 179.895 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.3 mmm . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -172.26 71.57 0.44 Allowed Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.54 -179.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -70.67 -18.77 32.47 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.474 2.116 . . . . 0.0 111.781 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -81.77 155.99 25.17 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.72 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.8 t -61.01 133.14 26.8 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.0 m -111.94 131.46 55.37 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.842 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 mt -120.41 124.08 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 120.959 0.409 . . . . 0.0 111.905 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.46 89.93 2.85 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.271 177.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -121.53 83.3 41.02 Favored Pre-proline 0 N--CA 1.469 0.524 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.221 -179.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -73.92 -10.48 23.08 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.215 1.943 . . . . 0.0 111.57 179.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.429 ' CD2' ' H ' ' A' ' 25' ' ' GLN . 0.3 OUTLIER -91.75 55.14 2.63 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.194 0.521 . . . . 0.0 109.908 179.759 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -80.48 -1.19 40.62 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.418 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -151.67 109.39 3.65 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 43.0 t -120.41 133.87 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.017 -178.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -135.07 100.32 4.53 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.961 0.41 . . . . 0.0 110.961 179.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 66.2 mt -115.78 139.98 49.65 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.458 -179.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 85.3 p -74.58 165.68 24.81 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.767 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -69.23 146.41 52.37 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.011 0.434 . . . . 0.0 110.523 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.08 1.33 89.67 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 70.7 tp60 -105.34 148.34 27.17 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.614 0.245 . . . . 0.0 110.48 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 21' ' ' ASP . 54.8 p30 -76.29 153.82 35.61 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.79 147.58 37.52 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.97 -179.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.4 m -163.09 171.23 16.71 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.715 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -128.36 143.7 51.04 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.429 ' H ' ' CD2' ' A' ' 11' ' ' LEU . 88.0 mt-30 -139.19 119.7 13.97 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.723 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 9.7 p -152.04 163.89 38.37 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.418 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -102.05 137.06 40.82 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.459 ' H ' ' HG1' ' A' ' 59' ' ' THR . 0.3 OUTLIER -140.52 95.68 2.91 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.978 -179.774 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 69.1 m -59.25 152.27 21.17 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -54.41 156.02 3.57 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -177.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.29 -178.71 3.06 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 114.606 -1.179 . . . . 0.0 112.123 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 89.6 p -156.71 -52.05 0.08 Allowed 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.223 -0.898 . . . . 0.0 109.713 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -97.29 -65.4 0.9 Allowed Glycine 0 CA--C 1.524 0.648 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 179.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -124.03 152.11 42.99 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -86.18 135.91 33.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.952 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.2 152.71 34.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.513 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -147.05 146.93 30.16 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.163 0.506 . . . . 0.0 111.739 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -81.48 179.64 7.76 Favored 'General case' 0 CA--C 1.521 -0.139 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.607 179.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -165.74 131.6 2.56 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.202 179.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 53.1 tp -133.89 123.35 24.58 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.012 179.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.31 8.83 80.53 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.08 -17.31 58.87 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.4 m -112.16 147.48 37.05 Favored Pre-proline 0 CA--C 1.535 0.381 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -52.39 140.7 52.79 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 121.301 1.334 . . . . 0.0 111.042 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -78.44 168.69 19.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.909 0.385 . . . . 0.0 110.874 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -131.38 142.11 49.99 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.716 -179.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.42 62.89 1.02 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.796 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.459 ' O ' ' O ' ' A' ' 51' ' ' ASN . 97.3 m-20 -74.69 159.53 31.94 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -40.86 -36.49 0.64 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 120.681 -0.407 . . . . 0.0 111.359 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 94.4 mtp -64.55 -43.57 93.54 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.782 0.325 . . . . 0.0 111.117 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.463 ' O ' ' OD2' ' A' ' 52' ' ' ASP . 70.9 m-80 -100.26 149.97 23.04 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.469 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.463 ' OD2' ' O ' ' A' ' 51' ' ' ASN . 84.4 m-20 -140.21 98.51 3.45 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.888 0.375 . . . . 0.0 110.634 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.7 mt -85.72 128.1 39.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.516 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.3 t -140.03 152.22 46.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.987 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.1 t -119.88 130.12 74.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.05 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -126.18 -174.95 3.23 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.405 -179.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -54.3 152.06 6.74 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.858 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.65 26.47 74.42 Favored Glycine 0 CA--C 1.52 0.394 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.459 ' HG1' ' H ' ' A' ' 28' ' ' LEU . 17.8 p 48.33 29.07 1.81 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.762 0.315 . . . . 0.0 110.681 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 23.5 mt -69.32 131.9 45.57 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.278 0.561 . . . . 0.0 111.006 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 64.2 m80 -110.34 149.29 30.43 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.721 178.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.454 ' CD2' ' OG1' ' A' ' 64' ' ' THR . 7.0 tt -156.53 102.72 2.08 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.196 -178.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.35 106.97 19.07 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 177.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.454 ' OG1' ' CD2' ' A' ' 62' ' ' LEU . 15.9 m -88.31 113.11 23.59 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.023 0.439 . . . . 0.0 111.36 -178.384 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.0 tt -101.67 122.1 43.26 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.658 ' NE2' ' NZ ' ' A' ' 67' ' ' LYS . 56.0 t60 -85.28 132.26 34.29 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.263 0.554 . . . . 0.0 112.228 -178.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.658 ' NZ ' ' NE2' ' A' ' 66' ' ' HIS . 52.5 mttp 39.62 83.44 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.039 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.7 p -54.29 162.08 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.014 0.435 . . . . 0.0 110.649 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 28.5 p -137.26 165.27 26.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.447 179.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.439 ' N ' ' CD2' ' A' ' 70' ' ' LEU . 4.1 mm? -60.95 -38.14 84.82 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.354 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -67.54 -36.62 81.34 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.896 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -63.98 -36.81 85.19 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.789 -178.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.28 141.65 55.8 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.559 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -176.39 -165.02 31.41 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 57.7 m -98.93 123.39 43.18 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.627 0.251 . . . . 0.0 110.509 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.1 m -105.37 149.74 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.623 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 51.7 p -159.47 158.23 31.59 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.678 0.275 . . . . 0.0 110.738 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.406 ' CD1' ' C ' ' A' ' 78' ' ' PHE . 45.3 p90 -143.16 157.35 44.59 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 69.8 m80 -142.87 139.66 30.93 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.245 0.545 . . . . 0.0 111.827 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.534 ' O ' ' N ' ' A' ' 82' ' ' THR . 3.2 p -144.12 143.12 23.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.17 178.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -42.21 -14.39 0.01 OUTLIER Glycine 0 CA--C 1.526 0.748 0 CA-C-N 116.471 -0.331 . . . . 0.0 112.854 -178.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.534 ' N ' ' O ' ' A' ' 80' ' ' VAL . 45.6 p -89.3 -72.91 0.53 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 117.081 0.441 . . . . 0.0 110.152 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 6.7 t -139.45 -172.37 3.35 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.633 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 41.6 p -158.56 163.08 37.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.051 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 31.0 m -162.31 173.83 13.65 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.546 -0.462 . . . . 0.0 111.054 179.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.467 ' N ' ' CD ' ' A' ' 86' ' ' GLU . 1.3 pm0 -137.04 152.66 50.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.823 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -143.79 151.68 40.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.269 -0.878 . . . . 0.0 108.922 178.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -110.86 128.6 55.84 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.527 0.679 . . . . 0.0 111.933 -178.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 51.4 tp -101.02 81.69 2.28 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 114.944 -1.025 . . . . 0.0 108.765 178.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -94.55 172.35 8.24 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.3 m -116.02 141.46 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 29.0 m -64.14 135.37 56.28 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.0 140.55 58.88 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.894 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.764 0 CA-C-O 117.754 -1.581 . . . . 0.0 111.588 179.958 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.9 ptm . . . . . 0 N--CA 1.492 1.65 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.48 150.79 82.64 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -53.68 144.51 53.11 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 121.257 1.304 . . . . 0.0 111.723 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.401 ' HG3' ' N ' ' A' ' 5' ' ' VAL . 35.5 tp10 -72.52 162.54 29.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.735 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.401 ' N ' ' HG3' ' A' ' 4' ' ' GLU . 1.0 OUTLIER -52.34 137.79 11.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 179.919 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.537 ' N ' ' OG ' ' A' ' 29' ' ' SER . 39.2 m -95.87 123.56 39.51 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 120.04 -0.664 . . . . 0.0 111.074 -178.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.3 mm -109.9 88.9 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.762 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.499 ' O ' ' SG ' ' A' ' 26' ' ' CYS . 55.4 mt -112.81 112.05 23.27 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 177.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -123.95 92.67 48.14 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.57 -178.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -69.25 -11.22 30.99 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 C-N-CA 121.259 1.306 . . . . 0.0 109.334 178.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 63.7 mt -68.09 77.29 0.23 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.502 -1.226 . . . . 0.0 110.575 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 54.1 tp60 -70.66 -41.17 72.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.735 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -176.38 145.54 0.59 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.02 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 70.0 t -121.45 134.72 63.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.314 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -143.16 127.18 17.38 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.229 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.5 pp -162.75 144.3 10.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.861 -179.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.4 m -64.68 146.13 55.18 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -64.48 147.92 51.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.971 0.891 . . . . 0.0 112.218 -178.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.573 ' H ' ' CG1' ' A' ' 68' ' ' VAL . . . 92.75 -8.13 76.75 Favored Glycine 0 CA--C 1.521 0.466 0 CA-C-N 113.906 -1.497 . . . . 0.0 110.427 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -93.05 161.55 14.39 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 179.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -76.41 161.28 28.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.932 0.396 . . . . 0.0 110.588 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -149.39 156.89 42.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.389 -179.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.2 p -160.36 162.53 33.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.951 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -133.41 147.31 51.74 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.146 0.498 . . . . 0.0 111.099 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -139.0 125.48 20.5 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.424 178.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.61 ' SG ' ' N ' ' A' ' 27' ' ' ARG . 8.9 t -146.73 163.31 36.36 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.036 0.446 . . . . 0.0 110.453 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.61 ' N ' ' SG ' ' A' ' 26' ' ' CYS . 78.4 ttt-85 -120.61 119.48 33.01 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.423 ' O ' ' OG1' ' A' ' 59' ' ' THR . 2.6 tt -136.15 105.76 6.14 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.551 -0.459 . . . . 0.0 110.541 -179.026 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.537 ' OG ' ' N ' ' A' ' 6' ' ' THR . 86.6 p -62.4 156.27 23.02 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.342 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 37.7 ptt-85 -50.84 160.68 0.43 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.223 -177.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.02 174.39 6.31 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.196 -178.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.3 t -120.35 1.94 10.77 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 151.65 -24.23 0.94 Allowed Glycine 0 N--CA 1.453 -0.184 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -121.07 119.16 31.67 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 115.416 -0.392 . . . . 0.0 110.449 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -93.71 149.99 20.78 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.123 -179.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -80.63 169.25 17.89 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.298 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.456 ' NH2' ' O ' ' A' ' 38' ' ' TRP . 9.5 ptm180 -144.21 146.06 32.46 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.42 179.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.456 ' O ' ' NH2' ' A' ' 37' ' ' ARG . 81.4 m95 -78.16 176.54 9.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.813 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -164.55 107.21 0.88 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.598 179.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.409 ' CD1' ' C ' ' A' ' 40' ' ' LEU . 0.7 OUTLIER -116.19 114.1 23.98 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.87 17.38 75.26 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.18 -22.19 42.17 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 18.8 m -111.94 148.73 39.62 Favored Pre-proline 0 CA--C 1.539 0.554 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -59.25 144.55 99.35 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 121.253 1.302 . . . . 0.0 111.625 -179.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.69 164.77 14.57 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.436 ' O ' ' N ' ' A' ' 48' ' ' ASN . 78.3 mt-30 -135.91 155.44 50.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.978 0.418 . . . . 0.0 110.298 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.89 74.44 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.576 -179.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' A' ' 46' ' ' GLN . 98.5 m-20 -73.01 160.3 32.31 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.048 179.113 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -54.7 -49.16 71.38 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.326 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 78.4 mtm -69.38 -39.87 77.75 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.74 179.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.435 ' O ' ' O ' ' A' ' 48' ' ' ASN . 64.3 t30 -107.53 112.2 24.83 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.936 0.398 . . . . 0.0 110.975 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 53' ' ' ILE . 66.7 t0 -109.93 143.76 39.41 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.673 179.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.518 ' N ' ' OD1' ' A' ' 52' ' ' ASP . 20.6 tt -127.63 136.24 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.5 p -140.73 158.38 44.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.081 0.467 . . . . 0.0 111.551 -178.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.6 m -120.58 130.14 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.405 178.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -121.29 165.36 15.59 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.163 0.506 . . . . 0.0 111.009 -178.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -42.14 152.69 0.08 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.977 179.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.3 19.07 78.54 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' A' ' 28' ' ' LEU . 51.0 p 50.33 33.35 7.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.931 0.396 . . . . 0.0 110.376 -179.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 76.7 mt -79.32 120.56 23.96 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.714 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -83.69 142.63 30.61 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 56.1 tp -145.66 93.96 2.43 Favored 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 34.4 tp -92.91 106.97 18.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.606 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.537 ' CG2' ' NE2' ' A' ' 66' ' ' HIS . 78.0 m -96.85 98.41 10.1 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.184 -178.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.0 tt -101.27 119.44 38.75 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.537 ' NE2' ' CG2' ' A' ' 64' ' ' THR . 54.1 m170 -112.43 154.22 26.15 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 120.772 0.32 . . . . 0.0 110.513 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 64.3 mttp 53.5 59.16 4.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.262 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.573 ' CG1' ' H ' ' A' ' 19' ' ' GLY . 1.0 OUTLIER -50.7 159.01 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.963 0.411 . . . . 0.0 110.782 -179.682 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 55.0 p -133.97 167.04 21.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.313 179.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 11.0 mp -61.78 -39.32 91.25 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -67.78 -35.55 78.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.158 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -61.74 -43.03 99.65 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.197 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.27 141.15 51.75 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.374 -0.53 . . . . 0.0 109.73 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 168.28 -148.67 12.89 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.596 -0.811 . . . . 0.0 111.15 -179.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 43.6 m -110.1 125.16 52.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.709 -0.246 . . . . 0.0 110.715 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.0 t -111.76 130.58 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.404 ' OG ' ' O ' ' A' ' 85' ' ' SER . 24.9 t -153.4 167.48 29.28 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.127 0.489 . . . . 0.0 110.764 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -146.68 150.33 35.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.066 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -128.62 140.37 51.8 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.092 0.472 . . . . 0.0 111.584 -178.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.527 ' C ' ' H ' ' A' ' 82' ' ' THR . 2.2 t -129.49 133.84 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.974 179.217 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -49.18 -7.48 0.07 OUTLIER Glycine 0 CA--C 1.529 0.928 0 C-N-CA 121.158 -0.544 . . . . 0.0 111.854 -179.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.641 ' HG1' ' N ' ' A' ' 83' ' ' CYS . 31.0 p -107.72 -43.53 4.46 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.978 0.389 . . . . 0.0 110.932 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.641 ' N ' ' HG1' ' A' ' 82' ' ' THR . 14.1 t -154.2 154.62 33.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.336 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.1 m -130.61 157.1 43.66 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.984 0.421 . . . . 0.0 111.569 -179.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.404 ' O ' ' OG ' ' A' ' 77' ' ' SER . 15.8 t -154.68 157.2 37.74 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.848 -179.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -127.4 159.95 32.92 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.368 0.604 . . . . 0.0 111.706 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.49 147.57 27.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.425 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -117.66 139.6 50.78 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.346 0.593 . . . . 0.0 112.522 -178.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.5 tt -119.81 106.78 12.42 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.182 -0.917 . . . . 0.0 108.597 178.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -110.96 160.24 16.99 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.706 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 23.7 m -110.66 131.47 61.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.886 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 98.1 m -112.65 127.32 56.08 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.271 -179.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -82.96 -78.63 0.21 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.087 -179.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.827 0 CA-C-O 117.838 -1.534 . . . . 0.0 111.332 -179.724 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 80.8 mtp . . . . . 0 N--CA 1.493 1.689 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.33 151.63 75.91 Favored Pre-proline 0 CA--C 1.532 0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.83 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.459 ' O ' ' O ' ' A' ' 4' ' ' GLU . 2.1 Cg_endo -46.85 -76.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.316 -1.163 0 C-N-CA 121.426 1.418 . . . . 0.0 110.485 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.459 ' O ' ' O ' ' A' ' 3' ' ' PRO . 80.9 mm-40 41.19 -165.64 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.741 179.195 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -58.8 157.71 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 177.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.406 ' H ' ' HB3' ' A' ' 29' ' ' SER . 93.8 m -85.53 86.31 7.38 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 118.262 -1.375 . . . . 0.0 108.407 179.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.428 ' O ' ' CG2' ' A' ' 7' ' ' ILE . 10.6 tt -83.92 90.9 2.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 122.371 1.081 . . . . 0.0 112.52 -177.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 96.8 mt -127.33 83.51 2.17 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 113.457 -1.702 . . . . 0.0 109.056 178.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.486 ' C ' ' H ' ' A' ' 11' ' ' LEU . 4.8 pt-20 -122.93 83.9 50.3 Favored Pre-proline 0 N--CA 1.468 0.464 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.177 -178.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -71.93 17.51 0.32 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.189 1.926 . . . . 0.0 111.577 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.486 ' H ' ' C ' ' A' ' 9' ' ' GLU . 76.6 mt -66.92 77.45 0.12 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.542 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -71.7 -70.47 0.32 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.345 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.417 ' OD2' ' N ' ' A' ' 13' ' ' ASP . 31.7 p-10 -176.72 152.41 0.99 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.336 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.9 m -135.57 161.3 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.068 -179.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -133.45 139.51 46.75 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.383 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -156.64 151.52 26.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.033 0.445 . . . . 0.0 111.417 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.8 p -80.66 168.04 19.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.639 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -64.83 141.68 58.69 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.831 0.348 . . . . 0.0 110.515 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.61 8.2 87.22 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.689 -0.564 . . . . 0.0 111.689 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 93.5 mm-40 -96.48 158.66 15.33 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.846 0.355 . . . . 0.0 110.153 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -86.04 167.54 14.92 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.05 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -161.54 157.08 24.29 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.916 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 73.6 m -163.93 159.47 20.94 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.148 -0.315 . . . . 0.0 110.148 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -128.78 147.91 50.82 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.087 0.47 . . . . 0.0 110.617 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.485 ' OE1' ' CD2' ' A' ' 62' ' ' LEU . 62.6 mm-40 -124.43 125.69 44.69 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.874 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 6.7 t -137.53 146.13 43.78 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.171 0.51 . . . . 0.0 110.701 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -125.99 100.42 6.35 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.244 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.478 ' O ' ' CG2' ' A' ' 59' ' ' THR . 91.0 mt -121.6 110.31 15.84 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.255 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.406 ' HB3' ' H ' ' A' ' 6' ' ' THR . 34.7 t -69.62 172.9 6.7 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 11.6 ptp85 -50.12 151.28 2.05 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 122.038 0.923 . . . . 0.0 113.03 -177.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.6 160.04 20.53 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 113.831 -1.531 . . . . 0.0 112.213 -178.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.9 m -138.77 -82.96 0.29 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.647 179.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -65.58 -85.9 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 178.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -123.56 155.68 37.16 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.303 0.573 . . . . 0.0 110.193 178.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 74.9 tt0 -72.99 153.47 40.92 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.239 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.72 143.6 26.81 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.075 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -108.08 141.74 39.33 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.52 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 8.7 t-105 -111.11 138.87 47.01 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -165.41 155.98 13.6 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 119.45 -0.9 . . . . 0.0 111.762 -178.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.409 ' C ' ' CD2' ' A' ' 40' ' ' LEU . 6.9 tt -131.27 123.57 28.65 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.941 179.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.89 6.31 88.52 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.752 -0.539 . . . . 0.0 111.752 179.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 102.04 -20.34 45.84 Favored Glycine 0 N--CA 1.467 0.704 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.4 m -109.35 151.56 42.17 Favored Pre-proline 0 N--CA 1.467 0.401 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -56.79 141.78 92.34 Favored 'Trans proline' 0 C--N 1.316 -1.171 0 C-N-CA 120.939 1.092 . . . . 0.0 111.048 179.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.474 ' H ' ' CD2' ' A' ' 45' ' ' LEU . 0.8 OUTLIER -93.15 -172.46 2.97 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.14 -179.89 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 61.8 tp60 -144.93 155.7 43.57 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.262 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.14 63.7 1.33 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.44 ' O ' ' O ' ' A' ' 51' ' ' ASN . 13.3 t-20 -65.55 175.87 1.67 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.136 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -66.01 -39.72 90.48 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 78.1 mtm -67.65 -39.35 84.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.164 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.44 ' O ' ' O ' ' A' ' 48' ' ' ASN . 55.6 t30 -126.02 131.95 52.09 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.039 0.447 . . . . 0.0 111.073 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -120.02 140.57 50.77 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.551 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.4 mm -110.69 127.32 67.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.451 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.0 t -145.86 156.55 43.63 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.099 0.476 . . . . 0.0 111.432 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.2 m -115.31 133.65 60.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.029 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -116.91 -177.48 3.21 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.101 0.477 . . . . 0.0 110.669 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.426 ' CD ' ' N ' ' A' ' 58' ' ' GLY . 9.8 tm0? -64.6 147.31 53.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.269 -179.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.426 ' N ' ' CD ' ' A' ' 57' ' ' GLN . . . 80.55 13.04 82.24 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.478 ' CG2' ' O ' ' A' ' 28' ' ' LEU . 1.6 m 70.4 24.53 4.63 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 121.418 0.628 . . . . 0.0 110.385 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.6 mp -79.76 138.85 37.4 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.879 179.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 58.4 m170 -111.18 130.29 55.68 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.485 ' CD2' ' OE1' ' A' ' 25' ' ' GLN . 1.1 tm? -125.13 119.58 28.99 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 111.494 0.183 . . . . 0.0 111.494 -178.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.3 mp -103.36 114.14 28.18 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 177.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 93.1 m -99.61 110.6 23.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.112 0.482 . . . . 0.0 110.746 -179.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.457 ' C ' ' CD2' ' A' ' 65' ' ' LEU . 7.0 tt -110.88 129.28 55.91 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.869 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.484 ' HD1' ' C ' ' A' ' 66' ' ' HIS . 0.8 OUTLIER -153.34 165.11 36.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.414 -179.602 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.5 mttp 42.58 86.78 0.02 OUTLIER 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.313 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.4 m -137.65 163.94 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.588 -178.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.673 ' HG1' ' H ' ' A' ' 71' ' ' GLU . 33.2 p -117.77 -151.86 0.49 Allowed 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.669 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.535 ' C ' ' H ' ' A' ' 72' ' ' ASP . 87.1 mt -63.01 -23.71 67.58 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.675 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.673 ' H ' ' HG1' ' A' ' 69' ' ' THR . 80.0 mm-40 -56.92 -1.07 0.05 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.349 -179.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.535 ' H ' ' C ' ' A' ' 70' ' ' LEU . 18.6 m-20 -62.73 -36.19 82.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.281 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.3 127.92 31.66 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.473 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 172.48 153.18 9.12 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.776 -0.929 . . . . 0.0 110.776 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 85.4 m -111.59 116.69 31.24 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.558 0.218 . . . . 0.0 110.958 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.2 t -91.93 128.2 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.2 p -128.24 145.45 51.04 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.043 0.449 . . . . 0.0 110.835 -179.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -156.87 155.49 31.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.421 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 40.8 p-80 -159.37 151.46 20.88 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.315 0.578 . . . . 0.0 111.911 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.544 ' O ' ' N ' ' A' ' 82' ' ' THR . 12.3 p -124.06 134.22 67.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 115.285 -0.87 . . . . 0.0 108.982 178.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -31.23 -30.01 0.01 OUTLIER Glycine 0 CA--C 1.529 0.958 0 CA-C-N 116.058 -0.519 . . . . 0.0 113.096 -178.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.544 ' N ' ' O ' ' A' ' 80' ' ' VAL . 4.5 m -76.61 -74.3 0.24 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.006 0.431 . . . . 0.0 110.92 -179.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.41 ' O ' ' O ' ' A' ' 80' ' ' VAL . 7.6 t -119.76 -170.04 1.88 Allowed 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 31.4 p -151.74 157.49 42.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.204 0.526 . . . . 0.0 110.718 179.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.4 t -167.06 151.35 6.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.827 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -146.1 156.26 43.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.054 0.454 . . . . 0.0 110.729 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -129.82 152.97 48.72 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.448 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -124.99 137.95 54.24 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.279 0.561 . . . . 0.0 111.459 -179.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.3 tt -110.15 121.97 46.53 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.22 -0.9 . . . . 0.0 108.978 178.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -123.61 157.93 32.63 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.934 0.397 . . . . 0.0 111.367 -179.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 18.6 m -116.06 136.24 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.873 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 46.5 p -99.06 134.73 41.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.573 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -164.96 -19.25 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.263 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.768 0 CA-C-O 118.143 -1.365 . . . . 0.0 111.647 -179.16 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.9 mpp? . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.569 ' N ' ' CD ' ' A' ' 3' ' ' PRO . . . -176.16 44.79 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.427 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.569 ' CD ' ' N ' ' A' ' 2' ' ' ALA . 2.3 Cg_endo -42.66 -55.55 2.61 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.733 2.288 . . . . 0.0 112.112 -179.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.471 ' OE2' ' N ' ' A' ' 5' ' ' VAL . 1.3 tm-20 -70.96 161.03 31.81 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.471 ' N ' ' OE2' ' A' ' 4' ' ' GLU . 1.9 p -59.23 130.31 22.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.444 ' CB ' ' HG ' ' A' ' 29' ' ' SER . 12.1 m -66.61 134.31 52.07 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 118.739 -1.184 . . . . 0.0 108.304 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 tp -111.81 31.49 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -177.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.7 mp -81.98 90.1 6.46 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.536 ' C ' ' H ' ' A' ' 11' ' ' LEU . 1.8 pt-20 -121.3 90.5 47.6 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.032 -179.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -68.32 24.93 0.14 Allowed 'Trans proline' 0 C--N 1.314 -1.289 0 C-N-CA 121.861 1.707 . . . . 0.0 112.141 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.536 ' H ' ' C ' ' A' ' 9' ' ' GLU . 71.2 mt -81.01 72.9 8.06 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.104 0.478 . . . . 0.0 110.467 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -74.58 -67.78 0.6 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.446 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -172.26 133.57 0.67 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.357 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.1 m -123.99 142.38 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 120.924 0.392 . . . . 0.0 110.768 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -129.71 112.97 14.17 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.518 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -122.92 151.32 41.89 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.36 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.2 m -72.85 155.09 40.26 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 178.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.2 tm-20 -59.5 139.43 57.13 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.832 0.348 . . . . 0.0 110.728 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.59 -1.41 87.17 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.891 179.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 23.0 mm100 -91.83 168.55 11.36 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.91 0.386 . . . . 0.0 110.725 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -84.3 164.15 19.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.255 179.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -153.27 153.27 32.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.785 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 28.2 p -156.43 159.13 38.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.921 0.391 . . . . 0.0 110.552 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -132.3 147.1 52.39 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.292 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -137.37 121.75 18.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.09 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 37.3 t -129.63 129.82 44.82 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.98 0.419 . . . . 0.0 111.053 -179.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.01 108.38 21.05 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.044 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.459 ' O ' ' OG1' ' A' ' 59' ' ' THR . 74.3 mt -122.38 129.81 52.48 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.537 178.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.444 ' HG ' ' CB ' ' A' ' 6' ' ' THR . 68.6 m -94.32 175.86 6.53 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 -56.67 138.56 52.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.361 0.6 . . . . 0.0 111.208 -179.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -79.27 -176.1 5.01 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.415 -179.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.686 ' HG ' ' N ' ' A' ' 33' ' ' GLY . 82.5 p -146.23 -62.04 0.31 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.711 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.686 ' N ' ' HG ' ' A' ' 32' ' ' SER . . . -93.82 -71.08 1.14 Allowed Glycine 0 CA--C 1.522 0.506 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 179.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 96.5 mm-40 -122.75 135.15 54.47 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.386 0.612 . . . . 0.0 111.78 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -86.75 145.41 26.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.072 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.45 147.63 49.24 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.5 mmt85 -102.52 143.68 31.92 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 20.9 t-105 -102.3 131.43 48.9 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.414 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -172.7 152.81 2.6 Favored 'General case' 0 C--O 1.226 -0.179 0 C-N-CA 119.608 -0.837 . . . . 0.0 112.447 -179.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.7 tt -125.87 121.16 32.42 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.23 -2.99 85.58 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -178.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.28 1.07 58.15 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 112.167 -0.373 . . . . 0.0 112.167 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.7 m -111.59 148.28 38.52 Favored Pre-proline 0 N--CA 1.471 0.603 0 CA-C-N 117.146 0.473 . . . . 0.0 110.709 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -49.85 138.72 33.75 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 121.631 1.554 . . . . 0.0 111.308 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.8 tp -86.62 163.19 17.55 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.899 -178.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -140.41 147.76 40.2 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.62 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.13 62.98 0.67 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.866 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.522 ' OD1' ' N ' ' A' ' 49' ' ' GLU . 60.1 t-20 -66.62 142.62 57.4 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.043 0.449 . . . . 0.0 111.033 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.522 ' N ' ' OD1' ' A' ' 48' ' ' ASN . 74.9 mm-40 -40.07 -42.05 1.35 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.093 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 74.1 mtm -65.99 -39.28 90.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.636 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.514 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 0.6 OUTLIER -112.27 125.88 54.64 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.123 -178.805 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.488 ' OD2' ' N ' ' A' ' 53' ' ' ILE . 56.5 t0 -109.28 154.09 22.95 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.488 ' N ' ' OD2' ' A' ' 52' ' ' ASP . 64.4 mt -137.11 129.22 43.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.9 p -130.86 148.87 52.69 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.035 0.445 . . . . 0.0 110.755 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.0 p -125.34 128.44 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.348 -179.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.454 ' O ' ' O ' ' A' ' 57' ' ' GLN . 96.3 mt-10 -126.82 -173.12 2.8 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.841 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.454 ' O ' ' O ' ' A' ' 56' ' ' GLU . 97.8 mm-40 -28.24 152.12 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.368 -179.123 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.427 ' C ' ' OG1' ' A' ' 59' ' ' THR . . . 58.8 -82.75 0.01 OUTLIER Glycine 0 CA--C 1.521 0.454 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 179.239 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER 175.68 51.29 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.83 0.824 . . . . 0.0 109.134 179.912 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 42.8 mt -80.16 135.93 36.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.95 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -113.76 145.74 40.94 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 tt -153.59 110.94 3.48 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.643 -179.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.8 mp -97.02 128.86 44.4 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 120.969 0.414 . . . . 0.0 110.804 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.9 m -108.71 103.22 12.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.544 179.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.431 ' CD2' ' N ' ' A' ' 65' ' ' LEU . 3.1 mm? -96.06 126.68 41.46 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.132 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.687 ' HD1' ' N ' ' A' ' 67' ' ' LYS . 12.0 t-80 -138.61 160.49 39.47 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.235 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.687 ' N ' ' HD1' ' A' ' 66' ' ' HIS . 70.9 mmtt 57.21 41.54 26.8 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.4 p -94.88 134.95 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.106 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.431 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 44.7 p -122.27 -151.01 0.46 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.102 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.623 ' C ' ' H ' ' A' ' 72' ' ' ASP . 86.0 mt -45.9 -27.4 0.87 Allowed 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.34 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -64.28 13.07 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.725 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.623 ' H ' ' C ' ' A' ' 70' ' ' LEU . 5.1 m-20 -60.34 -35.77 76.42 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.048 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -52.31 138.3 26.97 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.148 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -171.53 173.66 44.95 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 17.1 p -154.43 104.39 2.57 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 110.453 -0.203 . . . . 0.0 110.453 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.2 t -94.89 132.68 38.22 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 CA-C-O 121.147 0.499 . . . . 0.0 110.125 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 11.0 t -132.85 152.47 51.83 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.356 -179.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -127.25 133.67 50.17 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.515 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -114.88 109.86 18.78 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.464 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.408 ' C ' ' H ' ' A' ' 82' ' ' THR . 1.4 t -115.89 129.35 72.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -57.07 -7.08 2.25 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.922 -178.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.408 ' H ' ' C ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -109.15 -43.65 4.12 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 117.064 0.432 . . . . 0.0 110.915 179.993 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 59.7 m -137.38 172.69 12.61 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.9 0.381 . . . . 0.0 111.387 -179.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 87.7 p -133.93 156.42 48.16 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.392 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.8 p -156.73 160.06 38.93 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.989 0.424 . . . . 0.0 111.065 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -143.95 157.7 44.18 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.747 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -142.85 146.82 34.5 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.828 179.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -120.63 130.15 54.03 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.382 0.61 . . . . 0.0 112.255 -178.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 48.0 tp -114.89 119.2 35.76 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 114.992 -1.003 . . . . 0.0 108.822 178.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -133.25 156.64 47.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.216 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 8.6 p -117.16 133.39 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.598 ' HG1' ' H ' ' A' ' 93' ' ' ALA . 3.0 t -85.71 166.0 16.49 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.068 -179.364 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.598 ' H ' ' HG1' ' A' ' 92' ' ' THR . . . 73.15 20.13 3.44 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.173 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.72 0 CA-C-O 117.951 -1.472 . . . . 0.0 110.476 179.641 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 . . . . . 0 CA--C 1.529 0.136 0 CA-C-O 120.637 0.256 . . . . 0.0 110.333 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.511 HG22 ' HA ' ' A' ' 31' ' ' ALA . 3.9 t -84.6 120.12 34.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.439 ' HB ' ' H ' ' A' ' 29' ' ' SER . 80.8 m -84.89 125.58 32.76 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 119.415 -0.914 . . . . 0.0 109.274 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.8 mm -104.54 94.13 2.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.094 0.473 . . . . 0.0 110.802 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 53.4 tp -124.66 79.48 1.77 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.037 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.504 ' C ' ' H ' ' A' ' 11' ' ' LEU . 1.4 pt-20 -122.99 89.06 50.79 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.853 -178.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -69.03 16.7 0.17 Allowed 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 121.988 1.792 . . . . 0.0 111.602 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.504 ' H ' ' C ' ' A' ' 9' ' ' GLU . 64.2 mt -72.46 61.97 0.51 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.433 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -71.08 -40.6 71.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.597 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -172.0 132.38 0.68 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 81.8 t -124.96 132.08 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 120.895 0.378 . . . . 0.0 110.671 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -128.88 138.44 52.02 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.901 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.425 HD22 ' HB2' ' A' ' 22' ' ' ALA . 2.7 pp -157.03 135.06 11.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.997 0.427 . . . . 0.0 110.889 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 42.4 t -64.49 146.65 54.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.792 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.427 ' CD ' ' N ' ' A' ' 19' ' ' GLY . 14.5 tm-20 -61.02 143.12 55.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.607 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.427 ' N ' ' CD ' ' A' ' 18' ' ' GLU . . . 98.86 -14.26 61.73 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.519 ' NE2' ' N ' ' A' ' 20' ' ' GLN . 2.9 mp0 -98.68 147.57 24.72 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.878 0.37 . . . . 0.0 110.736 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -71.93 153.3 41.93 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.741 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.425 ' HB2' HD22 ' A' ' 16' ' ' LEU . . . -129.87 146.32 51.59 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.857 0.361 . . . . 0.0 110.918 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 36.4 m -146.22 145.03 30.27 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.41 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.464 ' CE2' HD12 ' A' ' 89' ' ' LEU . 2.7 m-85 -119.58 150.24 40.61 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -146.02 131.46 18.67 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.555 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 10.9 p -151.73 140.53 20.92 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.599 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -100.44 118.19 36.15 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.38 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.453 ' O ' ' CG2' ' A' ' 59' ' ' THR . 79.9 mt -129.25 106.16 8.63 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 110.332 -0.248 . . . . 0.0 110.332 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.439 ' H ' ' HB ' ' A' ' 6' ' ' THR . 22.2 t -62.39 164.4 7.3 Favored 'General case' 0 CA--C 1.515 -0.381 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.026 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.464 ' NH1' ' O ' ' A' ' 31' ' ' ALA . 9.5 ptm180 -54.96 162.37 1.31 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.225 -178.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.511 ' HA ' HG22 ' A' ' 5' ' ' VAL . . . -94.11 -174.11 3.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.411 -179.209 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.2 m -149.96 -50.59 0.14 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.503 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -89.28 -75.58 1.3 Allowed Glycine 0 CA--C 1.522 0.487 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 178.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -124.83 154.28 41.25 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.824 0.345 . . . . 0.0 110.486 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.9 tp10 -89.97 147.23 23.83 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.976 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.439 ' CB ' HG22 ' A' ' 80' ' ' VAL . . . -70.79 147.93 48.42 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.917 0.389 . . . . 0.0 110.364 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -108.15 139.72 42.4 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.644 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 10.1 t-105 -102.45 134.21 46.14 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.448 -0.797 . . . . 0.0 108.901 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -163.19 154.23 16.85 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.083 -0.647 . . . . 0.0 111.587 -178.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.1 tt -128.19 127.72 43.44 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.759 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.32 10.77 84.23 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.29 -16.64 59.32 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 16.8 m -109.21 148.54 38.2 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -56.18 143.9 82.91 Favored 'Trans proline' 0 N--CA 1.488 1.19 0 C-N-CA 121.103 1.202 . . . . 0.0 110.468 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.515 ' H ' ' CD2' ' A' ' 45' ' ' LEU . 0.8 OUTLIER -101.15 -177.46 3.45 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.246 -179.01 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -141.55 124.22 15.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.907 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.84 81.36 0.11 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.932 0.396 . . . . 0.0 110.611 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.442 ' O ' ' O ' ' A' ' 51' ' ' ASN . 85.4 m-20 -66.46 -168.63 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.098 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.44 -52.17 59.43 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.622 -0.431 . . . . 0.0 109.885 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 62.4 ttp -67.01 -39.82 87.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.805 178.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.442 ' O ' ' O ' ' A' ' 48' ' ' ASN . 26.2 t30 -94.46 102.26 14.21 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.924 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -116.67 140.17 49.71 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 87.8 mt -123.34 132.67 70.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.801 0.334 . . . . 0.0 110.481 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.7 t -130.98 140.77 50.19 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.077 0.465 . . . . 0.0 110.852 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 72.6 t -120.89 131.8 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.534 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -118.84 179.77 4.05 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.759 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -59.87 167.91 2.0 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.997 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.07 15.24 74.23 Favored Glycine 0 CA--C 1.519 0.343 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.453 ' CG2' ' O ' ' A' ' 28' ' ' LEU . 0.6 OUTLIER 54.89 35.44 24.37 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.204 0.526 . . . . 0.0 110.379 -179.771 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 81.1 mt -79.11 139.08 38.16 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.438 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -118.82 147.89 43.44 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.6 ' C ' HD23 ' A' ' 62' ' ' LEU . 5.4 tt -155.38 115.2 3.7 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 120.499 -0.481 . . . . 0.0 111.432 -178.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.522 ' N ' HD23 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -86.73 106.66 17.81 Favored 'General case' 0 N--CA 1.461 0.11 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.363 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 89.9 m -90.21 105.64 17.95 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.898 0.38 . . . . 0.0 110.304 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 80.3 mt -109.82 118.03 35.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.732 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.544 ' ND1' ' N ' ' A' ' 67' ' ' LYS . 24.9 t-80 -77.75 -136.39 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 120.549 -0.461 . . . . 0.0 110.63 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.544 ' N ' ' ND1' ' A' ' 66' ' ' HIS . 15.8 ptmt -53.3 96.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.209 0.528 . . . . 0.0 110.694 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.1 p -69.72 159.29 5.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.874 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 70.6 p -136.95 161.24 36.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.334 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.479 ' H ' HD23 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -59.56 -27.26 66.08 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.193 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -71.4 -32.83 68.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.157 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -62.45 -36.52 82.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.026 -178.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -47.43 143.8 3.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.841 0.353 . . . . 0.0 110.438 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 172.86 -175.14 45.91 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 98.1 m -106.81 126.18 51.96 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.654 0.264 . . . . 0.0 111.403 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.3 t -98.51 133.25 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.6 m -122.71 154.01 38.66 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.084 0.469 . . . . 0.0 111.186 -178.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -134.46 144.7 48.26 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.28 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 61.7 m80 -133.44 113.92 13.07 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.74 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.479 ' C ' ' H ' ' A' ' 82' ' ' THR . 2.1 t -122.1 133.76 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.53 -5.07 0.29 Allowed Glycine 0 CA--C 1.528 0.905 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.564 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.479 ' H ' ' C ' ' A' ' 80' ' ' VAL . 5.1 p -109.39 -43.71 4.06 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.854 0.327 . . . . 0.0 111.165 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.591 ' SG ' ' N ' ' A' ' 84' ' ' SER . 44.4 t -152.85 166.05 33.49 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.709 0.29 . . . . 0.0 111.259 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.591 ' N ' ' SG ' ' A' ' 83' ' ' CYS . 60.0 m -129.01 151.35 49.8 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.859 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 37.6 p -158.63 166.61 31.64 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.925 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.43 ' N ' ' CD ' ' A' ' 86' ' ' GLU . 2.4 pm0 -154.24 169.86 22.64 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.943 0.401 . . . . 0.0 110.743 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -154.37 151.62 29.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.976 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -115.29 123.88 49.89 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.025 0.441 . . . . 0.0 111.14 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.58 HD23 ' C ' ' A' ' 89' ' ' LEU . 5.8 tt -107.09 115.1 29.59 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.462 ' N ' HD23 ' A' ' 89' ' ' LEU . 68.6 mttm -111.85 153.69 26.25 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.54 0.686 . . . . 0.0 111.737 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 43.8 t -120.8 129.89 75.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.396 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 29.5 m . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.526 -179.827 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 . . . . . 0 N--CA 1.464 0.236 0 CA-C-O 120.798 0.332 . . . . 0.0 110.509 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 29' ' ' SER . 9.9 p -58.8 128.68 19.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.461 ' OG1' ' CB ' ' A' ' 29' ' ' SER . 53.8 p -86.6 131.17 34.23 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 119.719 -0.792 . . . . 0.0 110.2 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 24.9 mm -99.87 73.0 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.052 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 79.6 mt -112.36 81.36 1.46 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -118.15 88.0 30.89 Favored Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.986 -177.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -73.48 -5.0 16.38 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 121.999 1.799 . . . . 0.0 110.229 178.206 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.413 HD22 ' HA ' ' A' ' 11' ' ' LEU . 0.2 OUTLIER -64.25 90.62 0.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.668 -179.694 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -97.3 -124.15 0.13 Allowed 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.404 ' O ' ' OD2' ' A' ' 13' ' ' ASP . 47.5 p-10 -109.01 137.5 46.83 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.798 0.333 . . . . 0.0 110.959 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.6 m -130.8 156.71 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -121.38 134.86 55.12 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.866 0.365 . . . . 0.0 110.782 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.9 pp -147.71 135.73 21.24 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.736 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.6 p -75.73 158.21 32.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.497 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -65.64 142.28 58.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.887 0.375 . . . . 0.0 110.022 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.3 -6.67 78.35 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -97.79 156.85 16.39 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 51.1 p30 -78.43 162.32 26.49 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.908 0.385 . . . . 0.0 110.964 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -147.2 150.74 35.49 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.52 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.4 p -160.04 159.07 31.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.346 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.411 ' O ' HD12 ' A' ' 62' ' ' LEU . 57.8 m-85 -131.8 152.42 50.99 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.951 0.405 . . . . 0.0 110.694 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -142.43 128.33 19.47 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 50.6 m -131.6 155.38 47.63 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.183 0.516 . . . . 0.0 111.577 -179.262 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -121.85 94.6 4.36 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.68 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 85.5 mt -127.15 112.53 15.26 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.745 -0.207 . . . . 0.0 110.691 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.467 ' O ' HG23 ' A' ' 5' ' ' VAL . 46.0 t -62.54 158.02 19.04 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.128 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 53.0 ptt85 -55.3 158.46 3.12 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.723 -177.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -86.28 -179.13 6.64 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.84 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 30.9 t -157.77 -49.61 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.141 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -86.15 -75.17 1.26 Allowed Glycine 0 CA--C 1.52 0.366 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -122.84 142.81 50.36 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.103 0.477 . . . . 0.0 111.051 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -75.02 144.02 43.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.768 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -81.54 170.28 16.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.666 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.6 mtm180 -132.46 137.28 47.19 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.355 0.598 . . . . 0.0 111.916 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 76.5 t-105 -117.93 137.49 52.79 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -169.96 165.96 9.44 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 119.474 -0.89 . . . . 0.0 112.484 -177.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.626 ' C ' HD23 ' A' ' 40' ' ' LEU . 7.0 tt -136.79 122.5 19.83 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.227 178.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.546 ' N ' HD23 ' A' ' 40' ' ' LEU . . . 78.27 14.6 82.04 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.98 4.17 87.23 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 111.62 -0.592 . . . . 0.0 111.62 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.1 t -113.27 130.26 23.8 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-O 119.491 -0.29 . . . . 0.0 110.467 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -58.34 144.94 95.48 Favored 'Trans proline' 0 N--CA 1.491 1.35 0 C-N-CA 120.919 1.08 . . . . 0.0 110.34 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.2 mt -77.53 150.76 34.78 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.681 -179.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -129.01 153.91 47.12 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.382 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.24 80.88 0.35 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.474 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -77.7 169.08 18.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.716 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -66.79 -37.17 84.04 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.137 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 25.8 ptt? -86.83 -21.23 26.56 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.651 0.262 . . . . 0.0 111.266 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.464 ' OD1' ' N ' ' A' ' 52' ' ' ASP . 58.9 t-20 -103.1 146.33 28.54 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.417 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.464 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 98.3 m-20 -138.84 115.18 10.41 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.414 HG21 HD13 ' A' ' 53' ' ' ILE . 48.1 mt -107.95 125.9 64.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.2 t -144.75 153.15 41.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.049 0.452 . . . . 0.0 110.912 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.423 ' O ' HG13 ' A' ' 55' ' ' VAL . 14.6 p -104.15 130.89 54.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.501 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -111.77 -179.19 3.63 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.485 -179.093 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -63.38 152.07 39.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.533 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.14 9.32 86.85 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 -179.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.3 m 67.27 38.75 3.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.866 0.365 . . . . 0.0 110.646 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.9 mp -94.39 130.59 40.66 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.674 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 64.0 m80 -91.38 158.0 16.77 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.035 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.411 HD12 ' O ' ' A' ' 24' ' ' PHE . 48.2 tp -156.77 111.24 2.75 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 120.247 -0.581 . . . . 0.0 111.623 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.44 ' CD1' ' N ' ' A' ' 63' ' ' LEU . 6.5 mp -96.73 115.7 27.88 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.816 178.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 63.7 m -109.94 95.47 5.61 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.551 HD23 ' N ' ' A' ' 66' ' ' HIS . 5.4 tt -107.53 121.5 44.76 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.551 ' N ' HD23 ' A' ' 65' ' ' LEU . 79.3 t60 -80.34 -86.05 0.09 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -178.596 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? -76.05 106.88 7.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.91 0.386 . . . . 0.0 110.428 -178.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.9 p -88.59 155.11 3.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.906 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 72.8 p -130.95 156.69 44.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.324 -0.398 . . . . 0.0 109.948 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 93.4 mt -59.54 -29.8 68.16 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -67.58 -35.36 78.85 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.959 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -61.72 -32.16 72.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.575 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.27 140.23 39.86 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.625 -0.43 . . . . 0.0 109.893 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 172.55 -171.64 44.44 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 87.8 m -101.53 120.87 40.97 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.735 0.303 . . . . 0.0 111.281 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 10.6 t -86.4 130.91 35.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.2 m -118.2 148.83 41.99 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.109 0.48 . . . . 0.0 110.918 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -136.95 124.96 22.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.453 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 63.4 t-80 -137.62 125.45 22.55 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.831 0.348 . . . . 0.0 111.568 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.411 ' O ' ' C ' ' A' ' 81' ' ' GLY . 5.8 p -141.47 134.3 29.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.579 178.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.411 ' C ' ' O ' ' A' ' 80' ' ' VAL . . . -26.36 -51.94 0.06 OUTLIER Glycine 0 CA--C 1.53 0.977 0 CA-C-N 115.573 -0.739 . . . . 0.0 113.248 -178.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 68.3 p -61.52 -77.27 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 7.3 m -125.56 -166.7 1.59 Allowed 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.06 0.457 . . . . 0.0 111.136 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 28.6 m -149.93 147.06 27.44 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.308 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 50.0 m -126.99 155.42 43.21 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.745 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -129.65 147.2 51.42 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.103 0.478 . . . . 0.0 111.126 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.63 151.92 30.26 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.762 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -130.96 138.51 49.75 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.982 0.42 . . . . 0.0 111.301 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.51 HD23 ' N ' ' A' ' 90' ' ' LYS . 2.2 tt -112.49 111.31 22.06 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.51 ' N ' HD23 ' A' ' 89' ' ' LEU . 57.3 mtpt -117.71 155.1 30.54 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.996 0.427 . . . . 0.0 111.391 -178.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 34.4 m -113.48 133.26 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.461 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 81.2 m . . . . . 0 N--CA 1.468 0.436 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.525 -179.919 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 . . . . . 0 CA--C 1.529 0.165 0 N-CA-C 110.213 -0.292 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.522 HG22 ' HA ' ' A' ' 31' ' ' ALA . 2.4 t -67.54 133.2 31.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.584 HG23 ' OG ' ' A' ' 29' ' ' SER . 71.0 p -90.14 127.16 36.03 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 118.633 -1.227 . . . . 0.0 110.42 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 20.7 mm -104.81 49.46 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.811 -178.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 89.5 mt -88.07 81.02 7.52 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.532 ' C ' ' H ' ' A' ' 11' ' ' LEU . 27.8 mt-10 -111.9 97.07 36.51 Favored Pre-proline 0 CA--C 1.536 0.413 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.695 -179.225 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -68.9 25.82 0.15 Allowed 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.656 1.571 . . . . 0.0 111.53 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.532 ' H ' ' C ' ' A' ' 9' ' ' GLU . 3.8 mm? -72.82 125.76 28.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.244 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -133.38 -152.65 0.5 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.22 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.417 ' OD2' ' N ' ' A' ' 13' ' ' ASP . 23.0 p-10 -106.32 131.4 53.58 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.796 0.331 . . . . 0.0 110.238 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 26.9 m -133.07 154.74 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-O 121.052 0.453 . . . . 0.0 110.904 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -126.86 112.99 15.98 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 58.3 mt -110.69 132.9 53.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.444 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 55.7 p -73.05 161.86 30.15 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -63.64 142.94 58.21 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.352 -0.539 . . . . 0.0 110.308 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.93 -3.32 77.23 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 111.119 -0.793 . . . . 0.0 111.119 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -103.4 140.8 36.97 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.028 0.442 . . . . 0.0 110.911 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -78.25 173.76 11.93 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.399 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.85 149.9 36.18 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.722 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 41.8 t -162.78 155.36 19.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.027 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.416 ' HB3' HD11 ' A' ' 11' ' ' LEU . 70.6 m-85 -135.83 155.01 51.0 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.075 -0.512 . . . . 0.0 109.643 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -139.37 114.18 9.35 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 179.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.455 ' HG ' ' HZ2' ' A' ' 38' ' ' TRP . 1.0 OUTLIER -110.91 150.2 29.55 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.181 -178.762 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 96.3 mtt-85 -114.32 93.37 4.31 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.406 HD21 ' CG ' ' A' ' 9' ' ' GLU . 85.8 mt -119.35 118.65 31.75 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -178.347 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.584 ' OG ' HG23 ' A' ' 6' ' ' THR . 88.3 p -76.41 161.11 28.95 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 177.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 12.0 ptp85 -50.64 163.54 0.18 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -176.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.522 ' HA ' HG22 ' A' ' 5' ' ' VAL . . . -83.32 167.53 17.51 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 113.635 -1.62 . . . . 0.0 110.777 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.2 p -152.22 -59.75 0.15 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -90.99 -70.99 1.21 Allowed Glycine 0 CA--C 1.524 0.621 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 178.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 10.6 tp-100 -122.08 136.27 54.9 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -83.5 148.66 27.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.863 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.49 152.88 39.33 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.91 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 15.4 tpt180 -123.19 123.5 40.94 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.057 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.57 ' CZ2' ' CE1' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -83.59 157.93 22.11 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.151 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -166.78 146.12 5.49 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 119.028 -1.069 . . . . 0.0 112.674 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.521 ' C ' HD23 ' A' ' 40' ' ' LEU . 8.7 tt -142.26 128.13 19.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.631 178.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.456 ' N ' HD23 ' A' ' 40' ' ' LEU . . . 80.11 4.27 89.7 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -178.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.56 -24.92 29.9 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 111.941 -0.464 . . . . 0.0 111.941 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 16.7 m -109.41 148.58 38.36 Favored Pre-proline 0 N--CA 1.471 0.607 0 CA-C-N 117.048 0.424 . . . . 0.0 111.37 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -54.97 137.78 76.78 Favored 'Trans proline' 0 N--CA 1.487 1.132 0 C-N-CA 121.449 1.432 . . . . 0.0 110.752 178.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.54 -176.83 3.74 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.03 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -140.52 161.26 38.16 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.648 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.83 81.69 0.89 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.959 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.45 ' O ' ' O ' ' A' ' 51' ' ' ASN . 65.0 t30 -82.0 171.97 13.79 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.984 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -63.82 -35.7 81.49 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.934 0.397 . . . . 0.0 110.108 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 3.2 ppp? -86.96 -3.18 59.06 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.329 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.45 ' O ' ' O ' ' A' ' 48' ' ' ASN . 56.4 t30 -138.51 109.08 6.56 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.554 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -109.67 124.12 50.66 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.121 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.2 mt -110.78 132.15 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.228 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.4 t -144.42 150.5 37.78 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.154 0.502 . . . . 0.0 111.122 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 46.2 t -100.76 116.39 44.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.276 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -88.76 172.73 9.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.309 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -63.15 158.68 19.24 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.784 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.35 17.73 76.31 Favored Glycine 0 CA--C 1.518 0.276 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 66.66 27.9 9.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.95 0.405 . . . . 0.0 110.794 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.7 mp -85.37 131.09 34.45 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.893 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 75.5 m80 -94.49 163.62 13.33 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.468 HD13 ' N ' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -155.23 113.17 3.42 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.717 -179.425 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.468 ' N ' HD13 ' A' ' 62' ' ' LEU . 4.3 mm? -94.01 114.61 26.82 Favored 'General case' 0 C--N 1.341 0.215 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.579 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 63.9 m -102.2 103.88 14.42 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 38.4 tp -110.58 126.88 54.9 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.724 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -127.94 162.49 26.63 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.596 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt 53.57 72.49 0.43 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.085 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.6 p -91.27 140.92 15.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.067 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.455 ' O ' ' N ' ' A' ' 71' ' ' GLU . 26.9 m -125.39 131.03 53.02 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.4 pp -45.04 -19.22 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.88 0.371 . . . . 0.0 110.757 -178.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.455 ' N ' ' O ' ' A' ' 69' ' ' THR . 98.6 mt-10 -70.66 -32.91 70.36 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.948 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.433 ' O ' ' O ' ' A' ' 73' ' ' ALA . 51.5 t0 -54.16 -70.28 0.1 Allowed 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.373 -178.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.433 ' O ' ' O ' ' A' ' 72' ' ' ASP . . . 33.66 94.19 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.785 0.326 . . . . 0.0 111.019 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -136.73 170.83 23.25 Favored Glycine 0 N--CA 1.463 0.463 0 N-CA-C 111.389 -0.685 . . . . 0.0 111.389 -179.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 28.6 m -117.96 117.49 29.39 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.632 -0.284 . . . . 0.0 110.273 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 11.1 t -93.49 132.99 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 11.3 p -138.17 158.18 44.82 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.012 0.434 . . . . 0.0 111.299 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.57 ' CE1' ' CZ2' ' A' ' 38' ' ' TRP . 4.7 m-85 -130.85 144.95 51.83 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 62.7 t-80 -138.8 115.38 10.59 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.842 0.353 . . . . 0.0 111.601 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.536 ' O ' ' N ' ' A' ' 82' ' ' THR . 2.0 t -123.41 129.88 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.103 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -39.2 -20.84 0.01 OUTLIER Glycine 0 CA--C 1.527 0.838 0 CA-C-N 116.339 -0.391 . . . . 0.0 112.214 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.536 ' N ' ' O ' ' A' ' 80' ' ' VAL . 18.4 p -83.5 -74.81 0.35 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.996 0.427 . . . . 0.0 110.162 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 36.6 m -125.53 162.53 24.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.287 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 62.3 m -129.95 155.37 46.19 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.783 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 96.0 p -156.8 162.54 39.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.329 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.51 ' N ' ' OE2' ' A' ' 86' ' ' GLU . 56.7 mp0 -138.14 152.9 49.16 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.111 0.482 . . . . 0.0 111.061 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -139.19 149.58 44.58 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.388 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -119.84 126.57 51.3 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.992 0.425 . . . . 0.0 111.647 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 59.5 tp -113.56 116.13 29.05 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -127.89 147.52 50.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.383 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.7 t -106.52 125.72 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 120.91 0.386 . . . . 0.0 110.029 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 C--N 1.331 -0.215 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.85 -179.621 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.444 ' N ' ' CD ' ' A' ' 4' ' ' GLU . 2.6 pm0 . . . . . 0 N--CA 1.465 0.298 0 CA-C-O 120.769 0.319 . . . . 0.0 110.235 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.47 ' O ' HG13 ' A' ' 5' ' ' VAL . 9.3 p -74.65 131.69 34.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.836 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 95.6 m -119.73 128.51 53.84 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.881 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.2 mp -121.62 112.72 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-O 121.121 0.486 . . . . 0.0 111.531 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.6 mt -105.25 93.72 4.84 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 177.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.422 ' OE2' ' CE1' ' A' ' 78' ' ' PHE . 3.4 pt-20 -116.94 89.99 31.31 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.321 -178.144 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -70.43 -12.59 31.87 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 122.296 1.997 . . . . 0.0 111.792 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.1 68.6 2.7 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.09 0.472 . . . . 0.0 109.737 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -77.99 -2.36 36.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.152 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 39.9 p-10 -172.89 143.36 1.2 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.189 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.8 m -134.93 155.93 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 120.891 0.377 . . . . 0.0 111.338 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -137.25 120.43 16.74 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.189 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 pp -152.14 138.56 18.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.947 0.403 . . . . 0.0 110.828 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.6 m -74.74 150.32 39.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.235 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -56.97 147.49 23.79 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.36 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.92 -9.17 78.55 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.769 -0.533 . . . . 0.0 111.769 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -97.09 156.23 16.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.853 0.358 . . . . 0.0 110.719 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.433 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 19.6 p-10 -75.33 148.91 38.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.495 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -134.54 149.51 50.66 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.814 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 38.2 t -163.17 159.88 23.5 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.567 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -129.47 143.11 50.7 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.383 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -142.39 119.93 11.73 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.905 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 1.2 p -149.6 157.67 43.47 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.078 0.466 . . . . 0.0 111.028 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 96.3 mtt-85 -99.68 143.34 30.03 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.564 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.463 ' O ' ' OG1' ' A' ' 59' ' ' THR . 2.1 tt -145.55 96.41 2.82 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.602 -179.002 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.7 p -59.97 159.72 8.89 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.805 0.336 . . . . 0.0 110.24 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -57.37 156.3 7.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.868 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -100.05 -173.28 2.4 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.646 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.3 t -141.68 -58.25 0.48 Allowed 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -82.96 -77.07 1.11 Allowed Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -123.91 143.28 50.46 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.797 0.332 . . . . 0.0 110.802 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -92.1 146.21 23.91 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.121 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.479 ' CB ' HG22 ' A' ' 80' ' ' VAL . . . -71.86 151.81 43.11 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.373 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 -130.99 151.89 50.9 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.236 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -74.49 178.33 5.37 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.85 125.65 3.66 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.402 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 58.1 tp -129.8 115.91 17.95 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.8 16.67 72.51 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.1 -24.29 25.5 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.5 m -103.4 150.47 38.04 Favored Pre-proline 0 N--CA 1.468 0.448 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -53.93 143.17 61.83 Favored 'Trans proline' 0 C--N 1.315 -1.201 0 C-N-CA 121.455 1.437 . . . . 0.0 110.757 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.476 ' H ' ' CD2' ' A' ' 45' ' ' LEU . 0.8 OUTLIER -89.08 175.72 7.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.484 179.867 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 11.6 tp-100 -144.89 153.76 41.91 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.23 72.85 1.26 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.829 0.347 . . . . 0.0 111.539 -178.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' A' ' 51' ' ' ASN . 70.8 m-20 -64.9 -177.16 0.32 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 56.2 mp0 -68.29 -46.17 71.04 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.469 -0.493 . . . . 0.0 110.685 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 76.6 mtm -67.61 -39.32 84.76 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.943 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' A' ' 48' ' ' ASN . 1.9 m-80 -93.56 143.03 26.68 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.733 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.462 ' O ' HD12 ' A' ' 63' ' ' LEU . 97.8 m-20 -135.89 136.83 40.84 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.0 mm -107.39 122.5 61.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 95.3 m -129.85 129.49 44.03 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.073 0.463 . . . . 0.0 111.31 -178.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.5 m -121.3 136.88 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.425 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -137.56 -177.26 4.71 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.823 0.344 . . . . 0.0 110.521 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -51.23 157.58 0.92 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.575 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.08 30.29 77.35 Favored Glycine 0 CA--C 1.519 0.322 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.463 ' OG1' ' O ' ' A' ' 28' ' ' LEU . 65.3 p 41.63 39.64 1.19 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.095 0.474 . . . . 0.0 110.263 -179.454 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 55.5 mt -71.28 131.86 44.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.013 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -107.11 135.71 48.19 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.963 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.443 HD13 ' C ' ' A' ' 62' ' ' LEU . 0.3 OUTLIER -146.52 97.32 2.9 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.462 HD12 ' O ' ' A' ' 52' ' ' ASP . 27.9 tp -96.61 106.97 19.33 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.113 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 26.5 m -89.7 114.59 26.26 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.109 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.586 HD13 ' N ' ' A' ' 66' ' ' HIS . 0.3 OUTLIER -105.47 118.37 36.39 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.457 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.586 ' N ' HD13 ' A' ' 65' ' ' LEU . 85.5 m-70 -110.77 147.02 35.33 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.261 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 65.5 mttm 54.82 58.58 4.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.97 179.05 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.1 p -56.57 149.02 3.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.343 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 79.6 p -133.13 155.48 49.19 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.457 179.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 90.4 mt -60.32 -24.72 65.24 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -68.66 -36.12 78.13 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.145 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -62.01 -41.24 97.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.043 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.24 141.54 50.44 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 172.01 -99.28 0.14 Allowed Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.245 -0.979 . . . . 0.0 111.737 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 31.7 m -159.11 117.06 2.82 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.826 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 82.0 t -107.39 129.47 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 57.7 m -138.42 178.77 6.89 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.906 0.384 . . . . 0.0 111.236 -178.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.422 ' CE1' ' OE2' ' A' ' 9' ' ' GLU . 97.4 m-85 -128.53 141.02 51.51 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.101 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -116.99 102.53 9.42 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.479 HG22 ' CB ' ' A' ' 36' ' ' ALA . 2.1 t -118.9 134.38 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.241 -179.044 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.52 -23.91 61.13 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 121.159 -0.544 . . . . 0.0 111.885 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 43.2 p -98.8 -21.79 16.17 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 117.188 0.494 . . . . 0.0 112.124 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.451 ' O ' ' O ' ' A' ' 80' ' ' VAL . 27.6 p -154.17 -177.83 6.7 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.057 0.456 . . . . 0.0 111.205 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 31.4 t -148.79 150.51 33.2 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 49.2 m -154.13 168.11 27.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.923 0.392 . . . . 0.0 110.871 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -151.14 157.71 43.07 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.645 -179.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.88 146.44 25.66 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.274 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.482 ' C ' HD12 ' A' ' 89' ' ' LEU . 87.6 mt-30 -116.85 131.39 56.96 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.28 0.562 . . . . 0.0 111.605 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.54 ' N ' HD12 ' A' ' 89' ' ' LEU . 9.4 mp -101.74 115.81 31.35 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.34 -0.846 . . . . 0.0 108.969 178.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -120.5 152.88 37.45 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.63 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.5 m -113.72 135.62 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 39.9 m . . . . . 0 C--N 1.323 -0.572 0 CA-C-O 121.037 0.446 . . . . 0.0 111.29 -179.134 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 . . . . . 0 C--O 1.233 0.187 0 CA-C-O 120.716 0.293 . . . . 0.0 110.269 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.528 ' O ' HG13 ' A' ' 5' ' ' VAL . 5.6 p -61.88 122.01 11.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.512 ' HB ' ' H ' ' A' ' 29' ' ' SER . 38.2 m -67.82 131.55 45.74 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 119.284 -0.966 . . . . 0.0 109.091 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.645 HG23 ' O ' ' A' ' 7' ' ' ILE . 9.7 tp -110.47 101.22 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-O 122.057 0.932 . . . . 0.0 112.072 -178.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.6 mt -129.99 82.06 2.05 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.44 -1.254 . . . . 0.0 109.581 178.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 49.0 tt0 -119.71 86.2 34.79 Favored Pre-proline 0 N--CA 1.468 0.448 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.561 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.454 ' O ' ' N ' ' A' ' 12' ' ' GLN . 3.4 Cg_exo -71.55 -7.68 21.71 Favored 'Trans proline' 0 C--N 1.314 -1.273 0 C-N-CA 122.279 1.986 . . . . 0.0 111.409 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 29.3 mt -64.4 75.2 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.853 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.454 ' N ' ' O ' ' A' ' 10' ' ' PRO . 87.6 mt-30 -76.65 -67.63 0.68 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.119 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.444 ' OD2' ' O ' ' A' ' 12' ' ' GLN . 63.6 m-20 -157.42 127.3 6.18 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.514 -178.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.3 m -129.24 156.9 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 121.362 0.601 . . . . 0.0 111.305 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -120.71 129.33 53.61 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.136 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 74.8 mt -118.88 129.27 55.11 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.053 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.6 m -78.76 148.35 33.02 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 177.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -63.81 134.16 54.73 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.953 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.79 -2.09 64.08 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -112.24 134.5 53.75 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.006 0.431 . . . . 0.0 110.717 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -83.21 167.66 17.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.122 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -159.73 174.87 13.87 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.226 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.434 ' OG ' HD11 ' A' ' 62' ' ' LEU . 29.9 t -156.87 148.62 22.62 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.071 0.463 . . . . 0.0 110.915 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -103.0 141.09 36.39 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -129.39 119.1 23.27 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.118 0.485 . . . . 0.0 110.384 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 2.7 m -126.56 163.95 22.27 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.581 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 77.5 ttt-85 -142.65 115.76 8.87 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.9 mt -127.69 100.91 6.15 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 121.095 -0.242 . . . . 0.0 110.995 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.512 ' H ' ' HB ' ' A' ' 6' ' ' THR . 14.2 t -60.05 177.61 0.23 Allowed 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 119.991 -0.684 . . . . 0.0 109.5 179.162 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -54.41 136.95 43.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.481 0.658 . . . . 0.0 111.866 -178.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.05 -172.86 3.28 Favored 'General case' 0 CA--C 1.521 -0.136 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.937 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.2 t -147.53 -65.34 0.26 Allowed 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.493 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.84 -88.46 0.22 Allowed Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 178.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -124.13 141.0 52.43 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.234 0.54 . . . . 0.0 111.368 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.4 tp10 -83.63 152.91 24.55 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.246 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.41 ' CB ' HG22 ' A' ' 80' ' ' VAL . . . -70.38 139.34 51.88 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.197 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 86.2 mtm-85 -115.97 138.59 51.06 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.763 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 80.8 m95 -76.21 169.16 18.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.008 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -165.1 119.83 1.31 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.809 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.638 ' C ' HD23 ' A' ' 40' ' ' LEU . 6.7 tt -118.96 114.75 23.04 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.432 ' N ' HD23 ' A' ' 40' ' ' LEU . . . 74.97 14.7 81.51 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.64 -23.57 35.37 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 16.7 m -104.94 146.52 32.82 Favored Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -54.62 142.12 73.0 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 121.547 1.498 . . . . 0.0 111.892 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.489 ' H ' ' CD2' ' A' ' 45' ' ' LEU . 1.0 OUTLIER -82.4 171.54 14.06 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.279 179.154 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 71.3 tp60 -144.92 142.01 29.51 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.187 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.38 141.57 58.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.82 0.343 . . . . 0.0 110.274 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.456 ' O ' ' O ' ' A' ' 51' ' ' ASN . 45.4 t30 -155.66 -164.89 1.84 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 53.8 mp0 -66.03 -48.49 70.92 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 119.924 -0.71 . . . . 0.0 110.167 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 66.4 ttp -68.35 -43.43 77.47 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.466 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.456 ' O ' ' O ' ' A' ' 48' ' ' ASN . 99.1 m-20 -107.39 137.84 44.7 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.892 0.377 . . . . 0.0 110.84 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 48' ' ' ASN . 96.7 m-20 -139.31 146.74 40.69 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 98.6 mt -124.06 127.05 73.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 88.5 m -125.43 131.47 52.9 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.886 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.6 t -87.69 128.06 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.209 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -116.1 154.26 30.28 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.545 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -56.36 155.73 6.67 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.583 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.85 12.39 84.48 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 68.77 22.92 7.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.619 -0.291 . . . . 0.0 111.758 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.9 mp -79.28 144.28 34.45 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 178.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 66.1 m170 -110.96 156.18 21.59 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.461 HD13 ' C ' ' A' ' 62' ' ' LEU . 0.4 OUTLIER -153.22 108.9 3.28 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.385 -179.208 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.427 ' N ' HD13 ' A' ' 62' ' ' LEU . 7.3 mp -95.94 109.58 21.92 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.273 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 95.3 m -87.44 113.87 23.54 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.432 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 74.8 mt -99.63 104.13 15.87 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.718 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -97.96 134.79 40.59 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.037 0.446 . . . . 0.0 111.579 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt 52.79 65.68 1.45 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.991 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.1 p -61.84 153.04 6.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.389 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.2 t -135.77 163.34 30.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.735 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 62.8 mt -60.31 -29.01 68.57 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.256 0.551 . . . . 0.0 109.867 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -66.69 -24.11 66.22 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.587 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.4 ' O ' ' C ' ' A' ' 73' ' ' ALA . 55.7 t0 -61.99 -40.76 96.73 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.36 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 72' ' ' ASP . . . -38.9 122.08 1.14 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.518 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -174.97 177.25 47.08 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 52.9 m -103.93 127.61 51.45 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.033 0.444 . . . . 0.0 111.436 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 74.0 t -117.15 129.42 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.242 178.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 36.2 t -144.5 171.68 14.01 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -150.96 150.51 30.89 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.047 0.451 . . . . 0.0 110.996 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -117.26 127.86 54.5 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.62 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.427 ' O ' ' O ' ' A' ' 83' ' ' CYS . 2.5 t -118.36 130.14 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.03 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -48.0 -19.26 0.95 Allowed Glycine 0 CA--C 1.53 1.006 0 CA-C-N 115.962 -0.563 . . . . 0.0 113.061 -178.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.01 -33.63 7.43 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 117.725 0.762 . . . . 0.0 111.549 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.427 ' O ' ' O ' ' A' ' 80' ' ' VAL . 33.1 m -144.93 -175.56 4.73 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 96.0 p -159.38 157.95 31.28 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.778 0.323 . . . . 0.0 110.912 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 48.2 t -167.27 168.33 13.41 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.085 0.469 . . . . 0.0 111.022 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -133.95 163.27 29.92 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.956 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -149.15 154.04 38.6 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -124.72 132.84 53.35 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.262 0.553 . . . . 0.0 111.512 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 60.7 tp -116.92 103.69 10.55 Favored 'General case' 0 C--N 1.334 -0.094 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.691 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -103.98 147.39 27.41 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.141 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 13.2 t -120.01 99.26 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.4 t . . . . . 0 N--CA 1.468 0.471 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.4 -179.931 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 . . . . . 0 N--CA 1.456 -0.158 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.6 t -64.32 135.95 27.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.742 ' C ' HD12 ' A' ' 7' ' ' ILE . 20.4 m -104.14 135.8 44.95 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.767 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.742 HD12 ' C ' ' A' ' 6' ' ' THR . 1.8 mp -121.25 116.25 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 121.379 0.609 . . . . 0.0 111.222 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 96.5 mt -128.35 98.11 4.96 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.073 -0.967 . . . . 0.0 108.581 177.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -122.59 90.14 49.7 Favored Pre-proline 0 N--CA 1.468 0.449 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -178.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -74.23 -5.06 16.41 Favored 'Trans proline' 0 N--CA 1.489 1.231 0 C-N-CA 122.024 1.816 . . . . 0.0 110.068 178.087 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 65.7 mt -66.45 74.85 0.1 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.353 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -71.6 -49.61 38.67 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.957 0.408 . . . . 0.0 111.775 -179.185 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -173.7 137.76 0.62 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.989 -178.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 53.0 t -125.11 133.48 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 120.84 0.352 . . . . 0.0 110.578 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -134.24 99.68 4.47 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.126 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 87.4 mt -124.9 139.92 53.39 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.939 0.399 . . . . 0.0 111.309 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.3 t -68.32 141.92 55.66 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.447 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -51.21 149.16 4.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.306 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.95 16.98 78.03 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -115.58 147.48 40.69 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.96 136.59 50.68 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.331 -0.548 . . . . 0.0 109.593 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -132.23 154.92 49.13 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.234 -179.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.9 m -158.63 159.62 35.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.981 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -136.99 148.65 47.02 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.225 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -145.15 122.82 11.82 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.042 0.449 . . . . 0.0 110.935 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 5.9 t -135.56 139.59 44.01 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.248 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 64.6 ttp85 -122.71 127.98 49.96 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.111 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.6 pp -143.69 133.46 23.83 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.22 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.514 ' H ' ' HB ' ' A' ' 6' ' ' THR . 44.7 t -66.22 158.85 27.77 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.008 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 38.4 ptt-85 -51.48 163.93 0.24 Allowed 'General case' 0 C--N 1.32 -0.716 0 O-C-N 123.665 0.603 . . . . 0.0 111.972 -177.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.56 174.8 2.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.322 -178.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.462 ' OG ' ' N ' ' A' ' 33' ' ' GLY . 18.4 p -138.46 -56.82 0.64 Allowed 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.194 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.462 ' N ' ' OG ' ' A' ' 32' ' ' SER . . . -104.89 -66.85 0.69 Allowed Glycine 0 CA--C 1.523 0.592 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 178.432 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -122.7 143.08 50.03 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.783 0.325 . . . . 0.0 110.315 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.632 ' CD ' ' H ' ' A' ' 35' ' ' GLU . 1.2 pm0 -70.57 146.46 50.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.528 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.89 157.05 38.21 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.064 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -123.97 133.86 53.61 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.337 0.589 . . . . 0.0 111.683 -178.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 22.0 t-105 -99.02 147.87 24.59 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.084 -0.962 . . . . 0.0 108.919 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -172.68 147.6 1.81 Allowed 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 119.883 -0.727 . . . . 0.0 112.419 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.59 ' N ' HD11 ' A' ' 45' ' ' LEU . 15.6 tp -124.96 119.03 27.59 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.396 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.89 8.52 84.78 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.42 -1.36 58.69 Favored Glycine 0 CA--C 1.531 1.066 0 N-CA-C 111.954 -0.458 . . . . 0.0 111.954 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.9 m -115.87 147.25 38.7 Favored Pre-proline 0 CA--C 1.549 0.93 0 CA-C-N 117.384 0.592 . . . . 0.0 111.618 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -58.45 145.82 92.82 Favored 'Trans proline' 0 N--CA 1.502 2.022 0 C-N-CA 122.008 1.806 . . . . 0.0 112.359 178.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.59 HD11 ' N ' ' A' ' 40' ' ' LEU . 9.0 mp -90.29 144.84 25.47 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.084 178.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.437 ' O ' ' N ' ' A' ' 48' ' ' ASN . 1.0 OUTLIER -122.89 153.14 40.05 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.396 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.64 76.57 0.02 OUTLIER 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.489 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.463 ' OD1' ' N ' ' A' ' 49' ' ' GLU . 24.3 t-20 -74.25 165.7 24.72 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.607 179.121 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.463 ' N ' ' OD1' ' A' ' 48' ' ' ASN . 97.5 mt-10 -62.12 -40.34 95.59 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.616 -0.433 . . . . 0.0 110.885 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 12.4 ptt? -85.6 -15.33 42.9 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 121.032 -0.267 . . . . 0.0 111.173 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.461 ' O ' ' O ' ' A' ' 48' ' ' ASN . 35.1 t-20 -126.11 122.45 35.79 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.594 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -124.5 128.1 48.46 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 75.5 mt -107.1 129.56 60.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.951 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.9 t -143.93 147.98 34.73 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.853 -179.282 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.9 m -110.92 131.32 62.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.371 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.446 ' O ' ' C ' ' A' ' 57' ' ' GLN . 98.8 mt-10 -112.11 -173.51 2.26 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.382 -179.478 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.446 ' C ' ' O ' ' A' ' 56' ' ' GLU . 45.6 tp60 -25.62 144.07 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 O-C-N 123.834 0.709 . . . . 0.0 111.854 -179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 58.12 -97.31 0.07 OUTLIER Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 17.9 m -162.5 62.31 0.21 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.991 0.424 . . . . 0.0 110.364 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 8.3 tt -104.31 120.66 41.67 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.915 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -90.8 148.53 22.47 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.202 -0.453 . . . . 0.0 109.833 178.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.468 ' C ' HD23 ' A' ' 62' ' ' LEU . 8.3 tt -151.57 114.66 4.73 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.86 0.362 . . . . 0.0 110.409 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.6 mp -97.0 114.94 26.59 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.882 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.6 m -94.11 109.37 21.15 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 62.3 mt -101.06 132.31 46.56 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.545 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 49.7 p-80 -153.25 155.46 36.63 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.76 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt 50.97 55.49 9.48 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 120.889 0.376 . . . . 0.0 110.091 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.5 m -110.49 130.1 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.777 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 64.1 p -86.35 -157.49 0.36 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.052 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 40.5 tp -59.88 -15.96 25.42 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.876 0.369 . . . . 0.0 110.442 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -67.6 -5.45 15.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.966 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.427 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 25.2 p-10 -53.37 -30.0 37.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.394 -179.21 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.1 135.02 56.96 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.101 -0.64 . . . . 0.0 109.667 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -174.54 166.83 38.89 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.427 ' O ' HD12 ' A' ' 40' ' ' LEU . 1.0 OUTLIER -122.95 108.6 13.14 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.57 0.224 . . . . 0.0 110.707 -179.954 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 8.6 t -101.15 120.6 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 33.9 t -137.13 152.09 49.57 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.334 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -135.73 147.8 48.58 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.86 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.52 ' ND1' ' OG ' ' A' ' 84' ' ' SER . 93.7 m-70 -125.22 123.83 40.42 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.209 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.508 ' O ' ' N ' ' A' ' 82' ' ' THR . 2.9 p -128.41 130.35 69.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -31.7 -31.39 0.01 OUTLIER Glycine 0 CA--C 1.529 0.913 0 CA-C-N 115.671 -0.695 . . . . 0.0 113.1 -178.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.508 ' N ' ' O ' ' A' ' 80' ' ' VAL . 82.5 p -79.04 -75.68 0.23 Allowed 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.659 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.449 ' SG ' ' N ' ' A' ' 84' ' ' SER . 46.2 t -111.56 163.81 13.67 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 120.829 0.347 . . . . 0.0 111.315 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.52 ' OG ' ' ND1' ' A' ' 79' ' ' HIS . 23.3 t -140.74 134.36 30.15 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 13.9 m -160.27 167.91 26.49 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.272 0.558 . . . . 0.0 111.999 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -140.22 164.11 30.96 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.963 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -134.33 148.36 50.72 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -113.61 127.49 56.08 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.267 -179.094 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.56 HD23 ' C ' ' A' ' 89' ' ' LEU . 4.2 tt -112.02 112.34 23.9 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.52 ' N ' HD23 ' A' ' 89' ' ' LEU . 17.7 ttpt -113.29 170.12 8.46 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.078 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.0 t -111.0 125.58 68.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.476 -179.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 97.8 m . . . . . 0 C--N 1.333 -0.135 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.999 -179.608 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.514 ' HG2' ' H ' ' A' ' 5' ' ' VAL . 39.3 tt0 . . . . . 0 N--CA 1.464 0.241 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.514 ' H ' ' HG2' ' A' ' 4' ' ' GLU . 9.8 p -52.65 136.49 13.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 110.431 -0.211 . . . . 0.0 110.431 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.559 HG22 ' CD1' ' A' ' 8' ' ' LEU . 7.1 m -115.96 125.3 52.36 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.42 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.791 ' N ' HD12 ' A' ' 7' ' ' ILE . 3.0 mp -108.41 111.43 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 121.144 0.497 . . . . 0.0 111.046 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.559 ' CD1' HG22 ' A' ' 6' ' ' THR . 8.8 mp -122.31 84.27 2.23 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.44 ' CG ' ' O ' ' A' ' 9' ' ' GLU . 0.2 OUTLIER -110.74 98.93 39.84 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.806 -178.246 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -73.9 -7.16 19.65 Favored 'Trans proline' 0 N--CA 1.489 1.238 0 C-N-CA 121.454 1.436 . . . . 0.0 110.136 178.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 52.3 mt -61.17 80.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.425 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -79.32 -67.15 0.78 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.422 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -171.78 128.26 0.63 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.651 -0.25 . . . . 0.0 110.37 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.8 m -126.15 162.1 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-O 120.926 0.394 . . . . 0.0 110.978 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -116.95 128.74 55.5 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.127 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 74.6 mt -123.01 129.34 51.39 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.058 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.4 p -76.55 164.18 26.19 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.081 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -61.83 128.68 37.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.828 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 77.34 19.53 76.48 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.068 178.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -103.41 138.47 40.1 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.85 0.357 . . . . 0.0 110.963 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 49.5 p30 -82.39 164.89 20.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.044 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -161.89 168.98 22.05 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.914 0.388 . . . . 0.0 110.213 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 73.1 m -147.76 140.85 25.01 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.961 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -111.8 129.85 56.0 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 23.8 tm0? -132.11 127.09 35.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.201 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -149.47 163.94 36.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.333 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -120.28 120.89 37.38 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.09 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.475 ' C ' HD23 ' A' ' 28' ' ' LEU . 3.7 tt -132.14 104.78 6.98 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.445 ' O ' HD23 ' A' ' 28' ' ' LEU . 10.1 p -62.68 153.12 33.45 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.167 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -53.31 153.25 4.0 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.592 -177.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.78 -175.17 3.66 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.848 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 44.9 t -142.44 -49.62 0.36 Allowed 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -91.77 -76.2 1.32 Allowed Glycine 0 CA--C 1.52 0.353 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -124.91 135.49 52.9 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.075 0.464 . . . . 0.0 111.864 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.461 ' O ' ' NH1' ' A' ' 37' ' ' ARG . 22.5 pt-20 -83.6 154.61 23.67 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.978 179.023 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.59 151.97 42.06 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.783 0.325 . . . . 0.0 110.692 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.461 ' NH1' ' O ' ' A' ' 35' ' ' GLU . 87.4 mmt-85 -106.72 148.24 28.64 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.068 0.461 . . . . 0.0 111.277 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 2.9 t-105 -107.71 148.52 29.31 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 179.185 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -173.31 155.26 2.85 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 119.864 -0.734 . . . . 0.0 111.73 -178.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 32.9 tp -134.22 124.72 26.42 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.707 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.51 6.14 88.06 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.653 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.73 -16.09 57.87 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 121.278 -0.487 . . . . 0.0 112.068 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.8 m -112.21 141.82 25.74 Favored Pre-proline 0 N--CA 1.472 0.671 0 CA-C-N 117.134 0.467 . . . . 0.0 110.43 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -56.87 143.12 92.43 Favored 'Trans proline' 0 N--CA 1.488 1.202 0 C-N-CA 120.826 1.018 . . . . 0.0 110.873 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.17 -166.69 1.33 Allowed 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.537 ' O ' ' N ' ' A' ' 48' ' ' ASN . 2.3 pm0 -153.28 153.99 33.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.927 0.394 . . . . 0.0 111.02 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -55.4 76.31 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.318 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.537 ' N ' ' O ' ' A' ' 46' ' ' GLN . 10.3 t-20 -75.04 171.37 14.23 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.884 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -62.13 -33.98 75.49 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.883 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 14.8 ptp -94.02 -19.63 20.7 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.772 0.32 . . . . 0.0 110.986 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -120.29 118.98 31.82 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.152 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -121.26 142.42 49.95 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.77 0.319 . . . . 0.0 110.63 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 15.5 mm -115.6 118.35 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.4 p -138.85 159.61 41.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.934 0.397 . . . . 0.0 111.183 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 55.8 t -117.51 129.04 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.659 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -107.4 167.46 9.91 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 12.5 tp-100 -58.42 152.77 17.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.947 0.403 . . . . 0.0 110.5 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.5 11.29 85.0 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 69.15 27.37 5.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.402 -0.399 . . . . 0.0 110.809 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.521 ' N ' HD12 ' A' ' 60' ' ' LEU . 10.6 mp -87.09 129.69 34.81 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.32 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -97.51 131.12 44.43 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.556 HD13 ' N ' ' A' ' 63' ' ' LEU . 0.5 OUTLIER -123.48 115.57 21.79 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.875 -179.481 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.556 ' N ' HD13 ' A' ' 62' ' ' LEU . 6.8 mp -103.01 114.04 28.01 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.065 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 25.9 m -88.8 117.01 27.48 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.179 0.514 . . . . 0.0 110.387 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.563 HD11 HG11 ' A' ' 68' ' ' VAL . 36.9 tp -107.31 127.13 53.27 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.253 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -85.23 -170.1 2.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.888 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -72.36 71.31 0.9 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.672 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.563 HG11 HD11 ' A' ' 65' ' ' LEU . 23.9 m -69.21 -172.54 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.488 0.661 . . . . 0.0 112.069 -179.361 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 69.8 p -130.6 -165.31 1.53 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.764 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 53.6 mt -64.23 -15.94 61.02 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.738 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.25 -38.11 89.31 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -66.63 -36.29 82.22 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.744 0.307 . . . . 0.0 111.316 -179.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -40.28 112.79 0.3 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.17 0.51 . . . . 0.0 111.268 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -168.83 -179.65 41.1 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 109.704 -1.359 . . . . 0.0 109.704 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 99.0 m -105.19 120.54 41.79 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.907 0.354 . . . . 0.0 111.413 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 12.0 t -93.59 134.55 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.9 p -140.9 146.62 37.7 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.132 0.491 . . . . 0.0 110.916 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -150.95 147.59 27.36 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.483 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 53.5 p-80 -159.78 163.4 34.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.58 0.705 . . . . 0.0 111.96 -178.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.561 HG22 ' H ' ' A' ' 82' ' ' THR . 2.5 p -131.59 140.4 48.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.254 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -35.54 -24.5 0.01 OUTLIER Glycine 0 CA--C 1.528 0.897 0 CA-C-N 115.67 -0.695 . . . . 0.0 112.604 -178.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.561 ' H ' HG22 ' A' ' 80' ' ' VAL . 43.9 p -85.97 -72.73 0.48 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.058 0.456 . . . . 0.0 110.864 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.513 ' N ' ' OG1' ' A' ' 82' ' ' THR . 35.3 m -108.55 -171.56 1.88 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.794 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 83.2 p -156.85 153.95 29.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.896 0.379 . . . . 0.0 111.097 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 47.8 t -152.89 153.79 33.74 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.342 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -134.54 150.96 50.81 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.51 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -139.85 148.37 42.0 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -124.13 125.6 44.75 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.996 0.426 . . . . 0.0 111.793 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.8 tp -113.28 100.84 8.87 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.678 178.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 13.4 ptpt -107.91 172.07 7.04 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 179.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.4 m -128.77 158.6 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 121.328 0.585 . . . . 0.0 111.478 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 N--CA 1.466 0.344 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.745 -179.828 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.468 ' O ' ' OG ' ' A' ' 29' ' ' SER . 88.5 tt0 . . . . . 0 N--CA 1.454 -0.252 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.444 ' O ' HG23 ' A' ' 5' ' ' VAL . 18.6 m -58.28 122.22 7.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.545 ' OG1' ' N ' ' A' ' 29' ' ' SER . 41.7 p -88.5 138.73 31.17 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 118.81 -1.156 . . . . 0.0 110.189 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 18.8 mm -110.55 62.4 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.643 -179.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.404 HD22 ' HA ' ' A' ' 8' ' ' LEU . 0.3 OUTLIER -102.09 74.2 1.43 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.346 0.593 . . . . 0.0 109.948 -179.798 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -122.99 84.32 50.72 Favored Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.921 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -70.9 50.83 1.16 Allowed 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 122.275 1.983 . . . . 0.0 112.25 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.455 HD11 ' SG ' ' A' ' 26' ' ' CYS . 96.6 mt -79.93 127.39 32.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.169 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 27.3 pt20 -118.81 -145.05 0.37 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.342 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -104.36 130.88 52.19 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.949 0.404 . . . . 0.0 110.426 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.4 m -123.41 138.1 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.2 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -113.32 115.31 27.93 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.264 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 73.3 mt -119.35 135.08 54.89 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.04 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.0 t -63.6 151.39 41.74 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -55.55 144.42 26.35 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.052 0.453 . . . . 0.0 111.504 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.18 19.2 75.09 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -114.68 144.97 42.59 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.281 0.563 . . . . 0.0 111.152 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 51.3 p-10 -75.5 168.24 20.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.305 -0.862 . . . . 0.0 110.028 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -140.79 142.65 34.65 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.69 0.281 . . . . 0.0 110.913 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 60.6 m -136.25 152.54 50.84 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.857 0.361 . . . . 0.0 111.087 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -135.4 152.24 51.23 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.379 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.422 ' C ' ' SG ' ' A' ' 26' ' ' CYS . 58.4 tt0 -134.33 143.49 47.72 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.698 0.285 . . . . 0.0 110.364 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.455 ' SG ' HD11 ' A' ' 11' ' ' LEU . 30.0 m -150.34 164.34 36.05 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.254 0.55 . . . . 0.0 111.506 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -134.4 99.8 4.48 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 115.427 -0.806 . . . . 0.0 108.859 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.417 ' O ' ' OG1' ' A' ' 59' ' ' THR . 50.1 mt -118.91 128.79 54.76 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.205 -178.546 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.545 ' N ' ' OG1' ' A' ' 6' ' ' THR . 24.1 p -73.65 158.66 34.32 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 51.7 ptt85 -58.11 169.47 0.81 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 -176.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.8 151.08 45.2 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 113.826 -1.534 . . . . 0.0 111.56 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 73.4 m -139.48 -54.95 0.57 Allowed 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.037 179.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -100.49 -65.81 0.81 Allowed Glycine 0 CA--C 1.52 0.372 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 178.46 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -123.39 145.27 48.9 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 178.44 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.696 ' CD ' ' H ' ' A' ' 35' ' ' GLU . 1.7 pm0 -76.17 143.73 40.95 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.092 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.52 152.71 37.78 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.536 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 84.2 mtm180 -128.56 139.74 52.14 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.236 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.532 ' CZ2' ' CE2' ' A' ' 78' ' ' PHE . 10.6 t-105 -101.46 150.96 22.51 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -171.37 157.33 4.89 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 119.498 -0.881 . . . . 0.0 111.914 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.564 ' C ' HD23 ' A' ' 40' ' ' LEU . 7.2 tt -123.72 124.94 43.84 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.415 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.477 ' N ' HD23 ' A' ' 40' ' ' LEU . . . 69.27 21.99 76.04 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.98 7.72 88.27 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 71.7 t -113.69 128.77 25.36 Favored Pre-proline 0 N--CA 1.47 0.537 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -57.34 143.56 93.56 Favored 'Trans proline' 0 N--CA 1.488 1.203 0 CA-C-N 120.004 1.037 . . . . 0.0 111.03 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -106.73 179.66 4.2 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.035 0.445 . . . . 0.0 111.245 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -145.86 150.63 36.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.988 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.99 139.26 48.51 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.035 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.431 ' OD1' ' O ' ' A' ' 51' ' ' ASN . 32.8 p-10 -166.54 -175.01 3.02 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.884 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -66.45 -41.79 88.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.576 -0.283 . . . . 0.0 111.66 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 54.4 ttp -67.95 -42.7 80.52 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.431 ' O ' ' OD1' ' A' ' 48' ' ' ASN . 86.7 m-20 -135.31 115.41 13.23 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.392 178.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.481 ' OD1' ' O ' ' A' ' 64' ' ' THR . 12.2 p-10 -111.63 147.41 35.57 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 178.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.1 mm -113.26 126.25 70.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 98.4 m -127.82 134.31 49.44 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.757 0.313 . . . . 0.0 110.9 -178.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.6 p -111.17 133.86 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 57' ' ' GLN . 95.9 mt-10 -116.09 -177.33 3.14 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.035 0.445 . . . . 0.0 111.766 -178.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.449 ' O ' ' N ' ' A' ' 59' ' ' THR . 77.8 mt-30 -24.92 144.11 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.069 -0.969 . . . . 0.0 112.784 -179.469 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.576 ' O ' HG23 ' A' ' 59' ' ' THR . . . 52.91 -89.44 0.01 OUTLIER Glycine 0 CA--C 1.519 0.284 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.576 HG23 ' O ' ' A' ' 58' ' ' GLY . 19.7 p -160.33 42.82 0.19 Allowed 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.484 -179.22 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.447 ' N ' HD12 ' A' ' 60' ' ' LEU . 10.6 mp -86.01 112.66 21.43 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 179.316 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 49.1 m170 -86.49 150.93 23.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.874 -179.113 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.2 tp -149.41 105.91 3.53 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.537 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.469 ' CD2' ' N ' ' A' ' 63' ' ' LEU . 1.3 mm? -83.15 111.41 18.89 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.072 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.481 ' O ' ' OD1' ' A' ' 52' ' ' ASP . 70.9 m -101.79 94.82 6.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.108 0.48 . . . . 0.0 111.206 -178.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.511 ' N ' HD12 ' A' ' 65' ' ' LEU . 10.5 mp -95.65 136.37 36.14 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.613 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.59 ' CG ' ' H ' ' A' ' 67' ' ' LYS . 45.7 t60 -70.93 -176.07 1.27 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.587 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.59 ' H ' ' CG ' ' A' ' 66' ' ' HIS . 97.7 mttt -63.47 100.39 0.26 Allowed 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.3 m -100.02 134.36 39.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.258 -178.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 30.9 p -79.28 -148.54 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.247 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.494 ' C ' ' H ' ' A' ' 72' ' ' ASP . 88.4 mt -54.48 -37.31 65.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.598 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -50.25 -8.38 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.661 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.494 ' H ' ' C ' ' A' ' 70' ' ' LEU . 37.1 p-10 -65.64 -35.73 81.66 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.821 0.343 . . . . 0.0 110.839 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -47.45 111.43 0.41 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -173.84 166.55 38.78 Favored Glycine 0 CA--C 1.522 0.496 0 C-N-CA 120.638 -0.792 . . . . 0.0 111.388 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 10.3 m -118.84 126.43 51.82 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.723 -0.239 . . . . 0.0 110.448 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.5 t -103.88 130.76 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 93.9 p -121.92 160.43 24.82 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.171 0.51 . . . . 0.0 110.43 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.532 ' CE2' ' CZ2' ' A' ' 38' ' ' TRP . 12.0 m-85 -135.32 138.31 43.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.172 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 72.6 t60 -127.89 127.52 43.53 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.184 0.516 . . . . 0.0 111.225 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.48 ' O ' ' C ' ' A' ' 81' ' ' GLY . 2.6 p -148.7 116.63 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.337 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.48 ' C ' ' O ' ' A' ' 80' ' ' VAL . . . -5.75 -67.34 0.01 OUTLIER Glycine 0 N--CA 1.473 1.116 0 O-C-N 123.927 0.767 . . . . 0.0 113.877 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.446 ' OG1' ' N ' ' A' ' 83' ' ' CYS . 65.1 p -48.6 -86.59 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -178.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.446 ' N ' ' OG1' ' A' ' 82' ' ' THR . 92.5 m -125.48 -168.71 1.88 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.384 -179.459 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 51.6 p -153.79 168.71 25.4 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.709 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 39.1 t -152.11 169.99 21.06 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.723 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -150.19 164.11 36.51 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 120.973 0.416 . . . . 0.0 111.184 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.0 152.1 38.05 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.114 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -119.5 129.96 54.97 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.215 0.531 . . . . 0.0 111.066 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 8.2 tt -117.53 122.68 44.35 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.399 -0.818 . . . . 0.0 109.684 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -120.23 159.51 24.79 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.015 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.466 ' O ' HG13 ' A' ' 91' ' ' VAL . 7.7 p -109.56 126.91 66.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-O 120.889 0.375 . . . . 0.0 110.154 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 31.6 m . . . . . 0 C--N 1.325 -0.461 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.539 -179.579 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 . . . . . 0 N--CA 1.466 0.359 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.479 ' O ' HG13 ' A' ' 5' ' ' VAL . 9.6 p -72.09 127.22 33.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.599 HG23 ' OG ' ' A' ' 29' ' ' SER . 26.2 p -101.0 135.56 42.25 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.721 -179.3 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.74 ' N ' HD12 ' A' ' 7' ' ' ILE . 1.9 mp -107.78 115.16 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 121.492 0.663 . . . . 0.0 111.687 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.455 ' CD2' ' NH1' ' A' ' 27' ' ' ARG . 49.2 tp -126.95 110.77 13.35 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 114.537 -1.211 . . . . 0.0 109.141 178.326 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.498 ' OE1' ' SG ' ' A' ' 26' ' ' CYS . 24.9 mm-40 -125.15 91.8 48.52 Favored Pre-proline 0 N--CA 1.471 0.598 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -178.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -71.69 -9.32 24.76 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 C-N-CA 121.747 1.632 . . . . 0.0 111.619 177.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.84 87.75 3.43 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.613 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 95.9 mm-40 -69.61 -32.79 71.71 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.097 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 43.6 p-10 -176.96 142.58 0.38 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.904 0.383 . . . . 0.0 110.576 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 51.8 t -119.72 133.1 67.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.557 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.483 ' C ' HD22 ' A' ' 16' ' ' LEU . 24.1 mt-30 -135.85 108.61 7.53 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.483 HD22 ' C ' ' A' ' 15' ' ' GLN . 3.9 mm? -115.13 133.22 56.23 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 120.563 0.221 . . . . 0.0 110.427 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.9 t -68.1 149.52 49.52 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.877 0.37 . . . . 0.0 110.732 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -52.3 132.28 33.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.779 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.94 16.48 56.1 Favored Glycine 0 CA--C 1.534 1.256 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.972 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -125.06 155.87 39.1 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.913 0.387 . . . . 0.0 110.273 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 43.9 p-10 -85.72 169.36 13.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.555 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -134.44 147.36 50.41 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.042 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 44.5 t -134.87 141.21 46.29 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.884 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -119.96 146.38 45.88 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.127 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 30.4 mm100 -128.71 104.89 7.9 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.224 179.052 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.498 ' SG ' ' OE1' ' A' ' 9' ' ' GLU . 6.6 t -124.45 141.81 51.79 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.02 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.455 ' NH1' ' CD2' ' A' ' 8' ' ' LEU . 60.1 ttp180 -124.99 119.52 28.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.922 0.391 . . . . 0.0 110.634 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 84.0 mt -123.4 121.01 34.67 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.383 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.599 ' OG ' HG23 ' A' ' 6' ' ' THR . 66.3 p -71.6 161.33 31.17 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.399 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 18.5 ptp180 -53.9 147.74 11.66 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.377 0.608 . . . . 0.0 112.329 -178.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.29 -173.78 3.33 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.611 -178.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.7 t -163.68 -43.67 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.933 -1.03 . . . . 0.0 109.166 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -98.23 -71.41 1.02 Allowed Glycine 0 CA--C 1.521 0.409 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 179.106 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 -124.93 135.78 53.15 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.109 0.481 . . . . 0.0 111.926 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -90.12 151.98 21.34 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.211 178.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.2 167.62 15.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.358 -179.562 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -149.65 159.51 44.28 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.195 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.5 ' CB ' HD11 ' A' ' 45' ' ' LEU . 92.7 m95 -84.63 176.56 8.51 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.922 0.391 . . . . 0.0 110.222 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -166.12 106.32 0.69 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.676 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.449 ' C ' HD23 ' A' ' 40' ' ' LEU . 7.1 tt -114.88 118.0 32.26 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.59 21.37 68.87 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.7 -9.29 74.49 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 47.2 t -115.1 134.94 22.45 Favored Pre-proline 0 N--CA 1.471 0.618 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -56.71 142.21 91.55 Favored 'Trans proline' 0 N--CA 1.489 1.227 0 C-N-CA 121.378 1.386 . . . . 0.0 111.589 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.58 ' O ' HD12 ' A' ' 45' ' ' LEU . 0.4 OUTLIER -88.53 159.64 17.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.199 179.809 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -139.93 162.22 35.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.011 0.434 . . . . 0.0 110.389 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.99 76.3 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.362 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.468 ' CG ' ' H ' ' A' ' 49' ' ' GLU . 47.9 t30 -71.03 -174.89 1.03 Allowed 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.468 ' H ' ' CG ' ' A' ' 48' ' ' ASN . 86.5 tt0 -62.85 -44.63 95.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.153 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.9 ptt? -90.13 -16.24 29.98 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.02 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -105.32 142.2 35.5 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.092 0.472 . . . . 0.0 111.353 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.487 ' OD2' ' N ' ' A' ' 53' ' ' ILE . 63.3 t0 -148.03 146.47 28.9 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.429 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.487 ' N ' ' OD2' ' A' ' 52' ' ' ASP . 97.9 mt -125.25 130.77 72.93 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 CA-C-O 120.727 0.298 . . . . 0.0 110.616 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.3 p -135.47 157.91 45.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.11 0.481 . . . . 0.0 110.966 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 50.6 t -117.63 131.63 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.221 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.448 ' O ' ' O ' ' A' ' 57' ' ' GLN . 97.1 mt-10 -108.31 177.63 4.74 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.448 ' O ' ' O ' ' A' ' 56' ' ' GLU . 55.5 tt0 -28.15 148.77 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 O-C-N 123.795 0.684 . . . . 0.0 112.137 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 60.6 -98.14 0.14 Allowed Glycine 0 C--N 1.329 0.178 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.2 m -163.27 48.19 0.14 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.327 0.584 . . . . 0.0 110.535 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 8.2 tt -92.19 116.77 29.24 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.264 0.554 . . . . 0.0 110.339 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 -79.07 146.64 33.15 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.264 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.624 ' C ' HD23 ' A' ' 62' ' ' LEU . 6.3 tt -143.38 114.57 7.87 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.442 ' N ' HD23 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -90.62 106.17 18.32 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.511 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 90.9 m -92.45 107.78 19.47 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.695 -178.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 83.2 mt -103.28 124.08 47.98 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.276 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.522 ' O ' HG13 ' A' ' 68' ' ' VAL . 13.2 t60 -72.72 156.7 38.66 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 66' ' ' HIS . 15.8 ptpt -27.45 89.15 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.599 0.714 . . . . 0.0 112.495 -179.089 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.522 HG13 ' O ' ' A' ' 66' ' ' HIS . 28.0 m -82.33 167.45 2.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.031 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.521 HG23 ' H ' ' A' ' 71' ' ' GLU . 6.7 t -130.77 -149.68 0.4 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.335 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.501 ' C ' ' H ' ' A' ' 72' ' ' ASP . 3.3 mm? -51.24 -36.35 41.38 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.293 -0.563 . . . . 0.0 109.684 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.521 ' H ' HG23 ' A' ' 69' ' ' THR . 98.3 mt-10 -60.96 -0.39 0.3 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.481 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.501 ' H ' ' C ' ' A' ' 70' ' ' LEU . 42.8 t0 -63.53 -36.97 85.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.913 -179.113 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.93 141.25 40.12 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.211 0.529 . . . . 0.0 111.324 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 173.52 153.49 9.71 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.523 -1.031 . . . . 0.0 110.523 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 16.0 p -97.25 111.35 23.63 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.954 0.407 . . . . 0.0 110.91 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 25.2 t -107.59 128.28 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.884 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.5 t -144.29 175.8 9.82 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.28 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.409 ' CZ ' ' CZ3' ' A' ' 38' ' ' TRP . 57.9 m-85 -127.07 144.27 51.07 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -131.57 115.3 15.93 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.968 0.413 . . . . 0.0 110.84 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.486 ' O ' ' N ' ' A' ' 82' ' ' THR . 6.0 p -141.23 125.49 17.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.404 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -39.85 -20.38 0.02 OUTLIER Glycine 0 CA--C 1.531 1.068 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.863 -178.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.486 ' N ' ' O ' ' A' ' 80' ' ' VAL . 68.3 p -80.65 -75.19 0.28 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.054 0.454 . . . . 0.0 111.084 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.417 ' N ' ' OG1' ' A' ' 82' ' ' THR . 61.8 m -121.0 179.6 4.33 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.427 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 73.5 m -131.57 151.81 51.3 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 11.4 t -153.07 164.39 38.09 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -148.37 162.07 40.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.065 0.46 . . . . 0.0 111.214 -178.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.2 155.69 34.34 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.933 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -122.45 128.59 51.07 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.424 -179.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.548 HD23 ' N ' ' A' ' 90' ' ' LYS . 2.3 tt -121.1 117.55 27.47 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.548 ' N ' HD23 ' A' ' 89' ' ' LEU . 20.5 pttp -144.57 166.38 25.34 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 120.904 0.383 . . . . 0.0 111.679 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.6 p -104.08 133.22 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.184 0.516 . . . . 0.0 110.137 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.0 t . . . . . 0 C--N 1.332 -0.195 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.994 -179.3 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 . . . . . 0 N--CA 1.458 -0.071 0 CA-C-O 120.931 0.396 . . . . 0.0 110.519 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.477 ' O ' HG13 ' A' ' 5' ' ' VAL . 10.0 p -54.37 130.22 16.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.402 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.504 ' HG1' ' CB ' ' A' ' 29' ' ' SER . 16.6 p -101.23 124.95 47.74 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 22.9 mm -100.8 111.17 29.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.102 0.477 . . . . 0.0 110.948 -178.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.435 ' O ' ' O ' ' A' ' 27' ' ' ARG . 91.6 mt -120.02 106.07 11.65 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.501 178.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.47 ' OE1' ' SG ' ' A' ' 26' ' ' CYS . 34.0 mm-40 -124.81 89.39 52.54 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.957 -179.363 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -71.79 -3.51 13.29 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 121.622 1.548 . . . . 0.0 110.694 178.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 67.4 mt -69.24 141.5 54.41 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.982 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -124.77 -46.84 1.84 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.174 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 37.3 p30 -176.72 146.43 0.57 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.136 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 65.1 t -125.28 129.31 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.043 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -137.66 135.93 36.97 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.023 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -160.87 160.56 31.15 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.995 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.0 p -74.69 156.53 36.56 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.978 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -67.91 138.59 56.12 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.21 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.45 -3.38 65.92 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -103.33 151.52 22.64 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.871 0.367 . . . . 0.0 110.878 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -76.07 155.23 34.99 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.97 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -135.39 146.29 48.17 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.523 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.5 m -133.43 148.8 51.79 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.31 0.576 . . . . 0.0 111.112 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -128.19 147.35 50.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.608 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -136.38 116.09 13.02 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.452 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.47 ' SG ' ' OE1' ' A' ' 9' ' ' GLU . 3.0 t -131.48 127.99 38.49 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.398 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.435 ' O ' ' O ' ' A' ' 8' ' ' LEU . 99.6 mtt180 -96.76 125.81 41.48 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 178.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.442 HD12 ' O ' ' A' ' 6' ' ' THR . 18.8 tp -145.34 112.24 5.96 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -178.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.504 ' CB ' ' HG1' ' A' ' 6' ' ' THR . 6.6 p -79.08 155.24 28.86 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.265 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 18.1 ptp180 -54.22 157.96 2.46 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -177.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.69 -173.86 2.46 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 114.649 -1.16 . . . . 0.0 111.374 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.8 t -154.85 -44.93 0.09 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.231 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -86.51 -72.12 1.29 Allowed Glycine 0 CA--C 1.522 0.482 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 178.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -122.41 143.39 49.7 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.833 0.349 . . . . 0.0 110.632 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.515 ' N ' ' OE1' ' A' ' 35' ' ' GLU . 56.4 mp0 -91.72 129.64 37.66 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.463 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.412 ' CB ' HG22 ' A' ' 80' ' ' VAL . . . -71.48 145.98 48.88 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.372 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -129.92 151.86 50.02 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.747 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.445 ' CZ2' HD23 ' A' ' 63' ' ' LEU . 62.5 m95 -74.38 176.32 6.85 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.077 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -163.24 114.5 1.44 Allowed 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.896 178.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 41.1 tp -124.25 121.27 34.59 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.207 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.18 3.21 64.51 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.94 -17.21 58.51 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.9 m -107.08 149.68 38.93 Favored Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -58.76 145.11 97.33 Favored 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 120.885 1.056 . . . . 0.0 111.641 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.475 ' H ' ' CD2' ' A' ' 45' ' ' LEU . 0.9 OUTLIER -89.13 178.25 6.42 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.687 179.967 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -151.22 140.42 21.26 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.007 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.35 142.65 58.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.625 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.429 ' CG ' ' H ' ' A' ' 49' ' ' GLU . 48.4 t30 -169.01 -173.5 1.81 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.798 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.429 ' H ' ' CG ' ' A' ' 48' ' ' ASN . 82.4 tt0 -64.0 -42.25 97.24 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.526 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 97.2 mmm -66.28 -40.18 89.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.513 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.477 ' OD1' ' CD1' ' A' ' 63' ' ' LEU . 46.5 t30 -120.81 119.83 33.83 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.71 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -113.79 136.77 52.49 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 70.9 mt -120.07 129.87 74.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 110.11 -0.329 . . . . 0.0 110.11 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 86.8 m -132.5 142.04 49.04 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.203 0.525 . . . . 0.0 111.182 -178.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 42.1 t -110.58 132.9 57.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.438 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -124.6 -174.66 3.07 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.204 0.526 . . . . 0.0 110.543 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -28.41 137.99 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.466 -179.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.536 ' O ' HG23 ' A' ' 59' ' ' THR . . . 69.7 -99.63 0.69 Allowed Glycine 0 CA--C 1.52 0.367 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.536 HG23 ' O ' ' A' ' 58' ' ' GLY . 25.3 p -159.94 51.51 0.32 Allowed 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 52.1 tp -87.22 119.14 27.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.467 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 53.6 m170 -100.97 124.84 47.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.673 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 76.2 mt -119.01 123.81 45.44 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.173 0.511 . . . . 0.0 111.18 -179.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.477 ' CD1' ' OD1' ' A' ' 51' ' ' ASN . 0.3 OUTLIER -97.89 105.69 17.87 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 177.954 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 58.7 m -104.97 105.2 15.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.173 0.511 . . . . 0.0 111.297 -177.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.6 mt -96.42 131.17 43.26 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.019 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -112.84 144.62 42.08 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.986 0.422 . . . . 0.0 111.114 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 74.7 tttt 50.92 57.04 7.08 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.475 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -44.98 152.08 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.087 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 43.7 p -134.5 164.4 27.56 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.628 HD13 ' O ' ' A' ' 70' ' ' LEU . 0.3 OUTLIER -60.9 -33.93 73.88 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.301 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -65.06 -22.22 66.94 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.592 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -60.3 -34.6 74.0 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -44.63 118.33 1.55 Allowed 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.594 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -170.74 -179.34 41.98 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 52.6 m -108.63 122.99 48.24 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.833 0.349 . . . . 0.0 110.781 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.14 131.46 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 29.0 t -144.18 175.15 10.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.885 0.374 . . . . 0.0 110.584 -179.079 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -127.34 138.16 52.97 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.904 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 -120.72 112.0 18.31 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.504 ' HB ' ' H ' ' A' ' 83' ' ' CYS . 2.4 t -126.67 129.66 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 120.966 0.412 . . . . 0.0 110.336 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -57.18 -7.48 2.66 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.421 ' H ' ' C ' ' A' ' 80' ' ' VAL . 16.4 p -108.7 -40.53 5.04 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.656 0.265 . . . . 0.0 110.963 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.504 ' H ' ' HB ' ' A' ' 80' ' ' VAL . 26.2 m -148.04 -166.37 2.51 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.328 -179.131 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 91.0 p -160.04 167.02 28.8 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.046 0.45 . . . . 0.0 111.229 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 31.5 t -158.87 166.8 31.04 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.331 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -134.63 153.53 51.93 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.21 0.528 . . . . 0.0 110.969 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.93 151.31 23.41 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.489 -0.778 . . . . 0.0 108.917 178.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -133.66 132.57 40.86 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.846 0.355 . . . . 0.0 111.693 -178.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.595 HD23 ' N ' ' A' ' 90' ' ' LYS . 5.3 tt -114.57 118.46 33.8 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.595 ' N ' HD23 ' A' ' 89' ' ' LEU . 32.3 ttmt -128.17 134.84 49.11 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.912 0.387 . . . . 0.0 110.677 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.2 p -114.94 108.24 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 27.4 m . . . . . 0 N--CA 1.464 0.246 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.324 -179.7 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 . . . . . 0 N--CA 1.464 0.252 0 CA-C-O 120.91 0.386 . . . . 0.0 110.994 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.643 HG22 ' HA ' ' A' ' 31' ' ' ALA . 3.2 t -59.99 132.73 25.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.338 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.596 ' HB ' ' H ' ' A' ' 29' ' ' SER . 89.6 m -87.15 121.13 29.19 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 119.032 -1.067 . . . . 0.0 110.486 -179.471 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 18.2 mm -105.2 100.5 10.69 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.926 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 60.6 mt -128.41 90.26 3.04 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.494 ' OE2' ' CE2' ' A' ' 78' ' ' PHE . 7.6 pt-20 -120.14 84.27 33.38 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.933 -178.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.402 ' O ' ' N ' ' A' ' 12' ' ' GLN . 3.1 Cg_exo -71.23 11.67 0.55 Allowed 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 122.204 1.936 . . . . 0.0 111.491 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.615 HD12 ' N ' ' A' ' 11' ' ' LEU . 8.4 mp -70.54 67.07 0.34 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.402 ' N ' ' O ' ' A' ' 10' ' ' PRO . 99.4 mm-40 -69.94 -43.17 72.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.365 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.424 ' OD2' ' N ' ' A' ' 14' ' ' VAL . 54.9 t0 -175.04 138.64 0.45 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.916 0.389 . . . . 0.0 110.992 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.424 ' N ' ' OD2' ' A' ' 13' ' ' ASP . 54.7 t -127.0 131.69 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.626 ' C ' HD22 ' A' ' 16' ' ' LEU . 0.4 OUTLIER -136.43 102.64 5.02 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.734 0.302 . . . . 0.0 111.035 179.905 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.626 HD22 ' C ' ' A' ' 15' ' ' GLN . 4.4 mm? -119.68 146.36 45.66 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.239 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 45.0 t -82.06 162.91 22.4 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.14 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -61.61 137.68 58.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.162 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.21 2.29 85.74 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 111.761 -0.535 . . . . 0.0 111.761 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -96.73 166.79 11.48 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.87 0.367 . . . . 0.0 110.72 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 21' ' ' ASP . 39.9 p30 -79.46 151.56 30.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.625 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.07 142.19 29.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.271 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 96.5 p -162.48 161.17 26.96 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.943 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -132.59 150.69 52.12 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.944 0.402 . . . . 0.0 110.644 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -136.45 123.85 22.03 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 8.5 t -134.38 132.9 39.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.277 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 90.6 mtm-85 -104.44 104.72 14.63 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.763 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 85.7 mt -123.81 121.05 34.4 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.0 0.428 . . . . 0.0 111.682 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.596 ' H ' ' HB ' ' A' ' 6' ' ' THR . 85.2 p -75.33 163.68 27.21 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 177.77 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 35.5 ptt-85 -50.87 149.02 3.68 Favored 'General case' 0 C--N 1.322 -0.618 0 O-C-N 124.181 0.926 . . . . 0.0 113.331 -177.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.643 ' HA ' HG22 ' A' ' 5' ' ' VAL . . . -75.46 176.43 7.54 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 114.177 -1.374 . . . . 0.0 111.135 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 50.0 m -151.25 -63.51 0.19 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.695 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -88.44 -75.36 1.29 Allowed Glycine 0 CA--C 1.521 0.409 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 178.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -122.43 129.96 52.59 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.711 0.291 . . . . 0.0 110.332 178.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -73.35 145.46 45.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.712 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.47 ' CB ' HG22 ' A' ' 80' ' ' VAL . . . -71.34 146.83 48.57 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.587 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 24.2 mmt85 -104.85 132.74 50.72 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.908 179.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -113.0 138.62 49.59 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.46 ' HB1' ' O ' ' A' ' 43' ' ' VAL . . . -176.43 155.53 1.43 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 119.727 -0.789 . . . . 0.0 111.52 -178.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.623 HD23 ' N ' ' A' ' 41' ' ' GLY . 6.5 tt -123.06 121.85 37.04 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.209 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.623 ' N ' HD23 ' A' ' 40' ' ' LEU . . . 86.05 6.04 82.49 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -178.434 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.33 0.84 79.42 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 112.028 -0.429 . . . . 0.0 112.028 179.109 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.46 ' O ' ' HB1' ' A' ' 39' ' ' ALA . 23.1 m -113.13 143.98 30.26 Favored Pre-proline 0 N--CA 1.47 0.551 0 CA-C-N 116.777 0.289 . . . . 0.0 110.884 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -56.41 144.87 81.88 Favored 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 121.411 1.407 . . . . 0.0 110.449 178.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.557 HD21 ' N ' ' A' ' 40' ' ' LEU . 14.2 mt -80.87 156.97 25.82 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.034 0.445 . . . . 0.0 111.384 -179.238 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.465 ' O ' ' N ' ' A' ' 48' ' ' ASN . 89.9 mt-30 -126.6 131.48 51.49 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.21 179.016 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.01 70.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.943 0.401 . . . . 0.0 111.566 -178.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.465 ' N ' ' O ' ' A' ' 46' ' ' GLN . 87.4 m-20 -76.93 163.21 26.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.645 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -59.26 -46.57 88.15 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 95.2 mtp -66.91 -40.24 87.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.236 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.425 ' O ' ' O ' ' A' ' 48' ' ' ASN . 66.0 m-20 -117.6 107.77 14.65 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.769 179.669 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -109.82 158.51 18.08 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.7 mt -122.09 130.25 74.71 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-O 120.916 0.389 . . . . 0.0 110.084 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 97.1 m -128.27 129.38 46.27 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.905 -178.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.425 ' O ' HG13 ' A' ' 55' ' ' VAL . 7.4 p -111.03 129.25 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.879 179.519 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.411 ' O ' ' C ' ' A' ' 57' ' ' GLN . 98.0 mt-10 -112.38 -174.57 2.49 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.144 0.497 . . . . 0.0 111.114 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.411 ' C ' ' O ' ' A' ' 56' ' ' GLU . 63.1 tp60 -24.78 144.56 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 114.791 -1.095 . . . . 0.0 112.462 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 58.52 -94.48 0.05 OUTLIER Glycine 0 CA--C 1.522 0.512 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.672 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 37.5 m -163.7 65.06 0.17 Allowed 'General case' 0 C--O 1.239 0.516 0 CA-C-O 121.324 0.583 . . . . 0.0 110.635 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 91.4 mt -95.8 126.3 40.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.426 178.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 48.7 m170 -107.84 120.61 42.77 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.22 118.39 14.49 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.083 0.468 . . . . 0.0 110.8 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -86.58 118.05 25.75 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 94.9 m -105.64 95.94 6.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.278 -179.093 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.481 ' N ' HD23 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -106.88 140.84 39.06 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.593 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 21.3 p80 -139.19 159.02 43.14 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.575 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 79.2 tttt 47.74 73.17 0.21 Allowed 'General case' 0 C--O 1.231 0.109 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -179.13 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.425 HG13 ' O ' ' A' ' 68' ' ' VAL . 11.7 p -116.47 131.83 67.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.959 -179.269 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.6 p -79.08 -157.41 0.12 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.523 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.577 ' C ' ' H ' ' A' ' 72' ' ' ASP . 55.4 tp -57.72 -33.74 68.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.421 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -51.28 -2.33 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.235 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.577 ' H ' ' C ' ' A' ' 70' ' ' LEU . 29.1 t0 -53.57 -39.24 64.64 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.697 0.284 . . . . 0.0 110.474 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.65 137.89 57.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.181 0.515 . . . . 0.0 111.068 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 179.99 176.8 47.65 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 110.076 -1.209 . . . . 0.0 110.076 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 94.4 m -126.15 117.26 22.76 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 117.088 0.444 . . . . 0.0 111.003 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.1 t -89.63 131.64 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.201 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.1 p -132.04 149.5 52.4 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.149 0.5 . . . . 0.0 110.891 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.494 ' CE2' ' OE2' ' A' ' 9' ' ' GLU . 0.2 OUTLIER -153.52 150.24 28.52 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.826 179.911 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -145.07 141.43 28.84 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.222 0.534 . . . . 0.0 111.112 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.498 ' O ' ' N ' ' A' ' 82' ' ' THR . 2.3 t -130.07 131.53 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.893 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -46.76 -11.89 0.06 OUTLIER Glycine 0 CA--C 1.528 0.896 0 C-N-CA 121.067 -0.587 . . . . 0.0 111.693 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.498 ' N ' ' O ' ' A' ' 80' ' ' VAL . 22.7 p -99.92 -54.01 3.01 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 122.722 -0.281 . . . . 0.0 110.696 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 38.8 t -139.58 162.5 34.93 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.115 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 30.9 p -134.68 155.13 51.06 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.964 0.412 . . . . 0.0 111.254 -179.493 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.0 t -162.87 166.87 23.53 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.948 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -142.34 165.06 28.44 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.66 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.82 155.69 41.93 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.139 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -125.25 135.89 52.99 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.344 0.592 . . . . 0.0 111.773 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 48.2 tp -109.66 97.68 7.18 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.783 179.077 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -94.62 166.82 11.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.312 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 53.1 t -119.51 128.37 75.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.256 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.63 -179.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 . . . . . 0 N--CA 1.47 0.556 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.521 HG22 ' HA ' ' A' ' 31' ' ' ALA . 2.7 t -61.28 130.53 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 C-N-CA 120.221 -0.591 . . . . 0.0 109.413 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.607 ' HB ' ' H ' ' A' ' 29' ' ' SER . 72.4 m -91.94 130.21 37.74 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 119.962 -0.695 . . . . 0.0 111.457 -178.415 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 33.8 mm -111.86 102.52 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-O 121.275 0.559 . . . . 0.0 111.017 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 39.4 tp -126.3 87.51 2.68 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.08 -0.963 . . . . 0.0 108.768 178.408 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.513 ' OE2' ' CE2' ' A' ' 78' ' ' PHE . 28.9 mt-10 -120.61 85.03 37.73 Favored Pre-proline 0 N--CA 1.464 0.267 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.354 -179.178 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -72.2 8.85 1.29 Allowed 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 121.819 1.679 . . . . 0.0 111.557 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 65.2 mt -61.56 84.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.903 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 40.5 tp60 -72.86 -133.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.45 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -109.02 138.3 45.58 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.5 m -127.95 156.16 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -136.61 104.51 5.57 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.546 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 78.4 mt -118.45 139.97 50.58 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.249 -178.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.519 ' O ' ' NE2' ' A' ' 20' ' ' GLN . 91.5 p -69.26 153.81 43.04 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.996 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -65.94 146.6 54.53 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.085 0.469 . . . . 0.0 111.065 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.43 8.82 65.63 Favored Glycine 0 CA--C 1.53 0.976 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.519 ' NE2' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -112.29 156.78 21.84 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 120.976 0.417 . . . . 0.0 110.366 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -78.05 144.81 36.29 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.063 178.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -126.07 146.74 49.79 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.072 0.463 . . . . 0.0 110.594 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 41.5 t -156.77 154.74 30.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.927 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -132.81 152.13 51.87 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.809 0.337 . . . . 0.0 110.641 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.405 ' CD ' ' N ' ' A' ' 25' ' ' GLN . 0.5 OUTLIER -124.9 111.25 15.24 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.125 -0.488 . . . . 0.0 109.755 179.48 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 6.7 t -115.84 137.7 51.84 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 82.1 mtm180 -123.47 125.1 44.3 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.8 pp -147.98 141.17 25.07 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 119.974 -0.691 . . . . 0.0 111.438 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.607 ' H ' ' HB ' ' A' ' 6' ' ' THR . 98.5 p -74.31 162.65 28.68 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 178.622 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -52.24 162.53 0.49 Allowed 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -177.098 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.521 ' HA ' HG22 ' A' ' 5' ' ' VAL . . . -70.14 157.07 38.28 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 114.018 -1.447 . . . . 0.0 111.401 -179.029 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.5 t -141.44 -61.34 0.47 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.399 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -101.27 -67.24 0.81 Allowed Glycine 0 N--CA 1.459 0.22 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -123.55 137.72 54.7 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 179.118 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -79.8 147.58 31.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.589 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.44 152.21 40.85 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.188 179.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 61.3 mtp85 -126.09 147.04 49.68 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.292 -179.005 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 2.3 t-105 -104.45 151.29 23.72 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.597 -179.341 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -165.62 148.47 7.72 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.066 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.548 ' C ' HD23 ' A' ' 40' ' ' LEU . 8.0 tt -124.99 126.27 45.18 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.474 ' N ' HD23 ' A' ' 40' ' ' LEU . . . 80.65 7.69 88.3 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.87 -12.74 62.5 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.4 m -112.17 150.76 42.96 Favored Pre-proline 0 N--CA 1.468 0.466 0 C-N-CA 121.975 0.11 . . . . 0.0 110.756 -179.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -57.71 144.33 93.31 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 121.39 1.393 . . . . 0.0 110.666 178.256 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.476 ' H ' HD23 ' A' ' 45' ' ' LEU . 0.9 OUTLIER -114.66 171.78 7.43 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.691 0.281 . . . . 0.0 111.069 179.756 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -130.58 134.24 46.84 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.952 0.406 . . . . 0.0 110.247 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.01 96.29 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.273 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -75.17 169.67 17.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.997 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -58.43 -45.21 88.96 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 20.6 mmt -67.58 -38.83 84.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.639 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 62.8 t-20 -98.89 106.9 19.21 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.765 -178.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.431 ' O ' ' OG1' ' A' ' 64' ' ' THR . 67.0 m-20 -109.0 108.29 18.97 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.4 HG21 HD13 ' A' ' 53' ' ' ILE . 38.4 mt -100.74 133.74 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -179.353 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.9 t -146.11 159.17 43.65 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -179.117 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.0 t -109.25 137.44 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.268 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 57' ' ' GLN . 79.4 mm-40 -116.11 -178.6 3.44 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.438 ' C ' ' O ' ' A' ' 56' ' ' GLU . 56.1 tt0 -26.19 144.98 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 O-C-N 123.889 0.743 . . . . 0.0 112.102 -179.465 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 59.05 -94.7 0.06 OUTLIER Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.446 ' O ' ' OG1' ' A' ' 59' ' ' THR . 0.0 OUTLIER -166.75 59.49 0.09 Allowed 'General case' 0 C--O 1.24 0.594 0 CA-C-O 121.541 0.686 . . . . 0.0 110.962 -179.797 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.47 ' CD2' ' N ' ' A' ' 60' ' ' LEU . 3.1 mm? -99.55 130.56 45.81 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.099 179.128 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -107.27 142.96 36.2 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 120.869 0.366 . . . . 0.0 110.261 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.2 mp -137.89 118.92 14.37 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.293 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.33 108.2 19.89 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 52' ' ' ASP . 82.1 p -102.75 96.93 7.18 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 121.138 0.494 . . . . 0.0 109.908 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 36.6 tp -103.34 124.65 49.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.513 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.613 ' CG ' ' H ' ' A' ' 67' ' ' LYS . 1.0 OUTLIER -71.13 -152.71 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.41 -179.465 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.613 ' H ' ' CG ' ' A' ' 66' ' ' HIS . 5.4 mtmp? -53.99 97.09 0.02 OUTLIER 'General case' 0 CA--C 1.522 -0.108 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.376 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.498 HG22 ' H ' ' A' ' 69' ' ' THR . 3.0 p -58.19 168.35 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.819 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.498 ' H ' HG22 ' A' ' 68' ' ' VAL . 58.2 p -134.41 159.79 39.96 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 47.2 tp -58.54 -40.81 84.02 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -69.9 -33.02 71.64 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.677 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.45 ' HB2' ' H ' ' A' ' 69' ' ' THR . 55.3 m-20 -64.27 -40.27 95.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.86 -178.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.74 140.05 57.68 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.649 -0.421 . . . . 0.0 110.24 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -175.39 -108.02 0.22 Allowed Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 -179.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 97.0 m -156.5 109.69 2.63 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.412 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.5 t -89.07 127.9 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.051 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 31.9 t -133.03 146.23 51.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.283 0.563 . . . . 0.0 111.542 -178.088 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.513 ' CE2' ' OE2' ' A' ' 9' ' ' GLU . 0.1 OUTLIER -140.7 159.2 42.73 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.476 179.585 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 15.5 p-80 -143.41 146.39 33.44 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.973 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.48 ' O ' ' N ' ' A' ' 82' ' ' THR . 2.2 t -134.32 134.46 54.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.557 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -43.06 -20.32 0.09 OUTLIER Glycine 0 CA--C 1.533 1.165 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.517 ' OG1' ' N ' ' A' ' 83' ' ' CYS . 33.1 p -82.6 -72.38 0.45 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.839 0.352 . . . . 0.0 110.657 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.517 ' N ' ' OG1' ' A' ' 82' ' ' THR . 7.8 t -128.02 -178.26 4.45 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.699 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.413 ' N ' ' SG ' ' A' ' 83' ' ' CYS . 35.5 m -127.74 149.69 50.12 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.244 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 52.9 p -156.63 162.85 39.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.611 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -160.06 168.14 26.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.983 0.42 . . . . 0.0 111.024 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.78 140.11 28.26 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.865 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 25.1 mp0 -109.7 122.04 46.59 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.098 0.475 . . . . 0.0 111.005 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 53.6 tp -108.54 106.29 16.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.929 179.331 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -110.02 171.03 7.69 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.458 ' O ' HG23 ' A' ' 91' ' ' VAL . 24.3 m -113.8 128.7 70.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 120.77 0.319 . . . . 0.0 110.242 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.9 m . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.247 -179.894 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.0 tp10 . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.973 0.416 . . . . 0.0 110.411 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.47 HG22 ' HA ' ' A' ' 31' ' ' ALA . 4.8 t -58.76 132.89 23.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.293 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.487 ' OG1' ' N ' ' A' ' 29' ' ' SER . 51.8 p -94.55 133.91 37.66 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 119.177 -1.009 . . . . 0.0 110.936 -179.678 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.3 mm -112.45 56.93 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.181 -178.508 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 48.0 tp -90.1 78.03 6.71 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.537 ' OE1' ' CZ ' ' A' ' 78' ' ' PHE . 16.3 tt0 -121.7 83.82 42.66 Favored Pre-proline 0 N--CA 1.466 0.369 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.286 -179.082 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -71.46 47.14 0.83 Allowed 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.447 2.098 . . . . 0.0 112.067 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.444 HD11 ' CD2' ' A' ' 24' ' ' PHE . 2.3 mm? -81.69 82.47 7.4 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.418 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -74.12 -86.08 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.811 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.431 ' O ' ' OD2' ' A' ' 13' ' ' ASP . 44.0 p-10 -172.7 133.83 0.6 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.328 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.0 m -131.03 156.5 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-O 120.975 0.417 . . . . 0.0 110.697 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.87 121.66 30.6 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.33 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 53.4 mt -124.66 141.02 52.4 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.319 -179.299 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.2 t -83.92 155.55 22.8 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.227 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 -52.27 143.33 14.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.015 0.436 . . . . 0.0 111.426 -179.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.42 2.1 85.42 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.844 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -101.08 146.76 27.04 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.003 0.43 . . . . 0.0 111.219 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -73.79 153.87 39.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.588 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -134.8 138.92 44.7 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.986 0.422 . . . . 0.0 110.049 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 71.0 m -161.51 158.05 25.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.235 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.444 ' CD2' HD11 ' A' ' 11' ' ' LEU . 67.9 m-85 -135.41 151.08 50.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.158 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -124.09 135.31 53.46 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.532 ' SG ' ' N ' ' A' ' 27' ' ' ARG . 53.8 t -149.8 163.62 37.5 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.043 0.449 . . . . 0.0 111.441 -179.157 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.532 ' N ' ' SG ' ' A' ' 26' ' ' CYS . 80.2 mtp85 -129.91 96.52 4.23 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.085 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.426 ' O ' ' CG2' ' A' ' 59' ' ' THR . 76.2 mt -113.32 113.66 25.57 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.728 -0.214 . . . . 0.0 111.384 -179.246 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.487 ' N ' ' OG1' ' A' ' 6' ' ' THR . 44.2 t -68.04 156.2 37.87 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 178.226 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -53.33 167.03 0.22 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -177.296 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.47 ' HA ' HG22 ' A' ' 5' ' ' VAL . . . -63.24 159.88 16.87 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 113.691 -1.595 . . . . 0.0 111.799 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.7 t -140.87 -58.19 0.51 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.49 -69.71 0.7 Allowed Glycine 0 CA--C 1.521 0.437 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 177.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -121.75 144.48 48.77 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.05 0.452 . . . . 0.0 110.652 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -83.85 142.12 30.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.57 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.29 152.68 41.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.443 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -124.15 126.72 46.64 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.199 0.523 . . . . 0.0 110.683 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 40.8 t-105 -93.73 148.05 22.47 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.951 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -167.37 154.99 8.96 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 119.632 -0.827 . . . . 0.0 112.123 -179.163 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 67.2 tp -118.17 117.03 28.05 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.74 8.7 82.38 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.9 3.93 79.39 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.5 t -113.48 134.8 21.9 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-O 119.224 -0.417 . . . . 0.0 110.357 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -50.83 138.49 41.88 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 121.022 1.148 . . . . 0.0 110.57 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -114.25 174.16 6.09 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.923 0.392 . . . . 0.0 111.792 -178.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -136.98 150.25 48.03 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.294 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.19 78.43 0.05 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.624 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.427 ' O ' ' O ' ' A' ' 51' ' ' ASN . 7.9 m120 -71.41 178.89 3.19 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.021 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 56.8 mp0 -61.31 -44.88 96.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.228 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 25.9 ptm -83.69 -17.15 42.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.074 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.427 ' O ' ' O ' ' A' ' 48' ' ' ASN . 77.1 m-20 -114.16 105.07 12.75 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.29 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -115.12 130.41 56.92 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 42.7 mt -123.78 133.99 67.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.2 t -137.61 153.23 49.92 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.024 0.44 . . . . 0.0 110.781 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 53.4 t -111.85 131.87 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.254 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -108.12 162.0 14.45 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.932 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -49.87 150.76 2.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.787 -179.264 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.31 13.09 82.35 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.426 ' CG2' ' O ' ' A' ' 28' ' ' LEU . 1.0 OUTLIER 67.38 26.68 8.35 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.835 0.35 . . . . 0.0 110.629 -179.76 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.6 mp -77.47 136.36 38.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.14 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 5.6 t-160 -104.97 153.39 21.49 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.213 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.1 tp -152.77 110.68 3.63 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 121.01 0.434 . . . . 0.0 109.969 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.416 ' C ' ' CD1' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -86.14 107.54 17.91 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.517 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 60.3 m -99.93 99.93 10.76 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.262 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 41.0 tp -110.94 120.66 43.14 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.452 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.484 ' CG ' ' H ' ' A' ' 67' ' ' LYS . 26.8 t60 -138.55 175.46 9.55 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.215 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.484 ' H ' ' CG ' ' A' ' 66' ' ' HIS . 64.1 mttp 55.18 57.09 5.8 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -179.157 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 28.2 m -108.28 156.3 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-O 121.448 0.642 . . . . 0.0 111.5 -179.119 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 36.5 p -135.69 -149.6 0.34 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.69 178.575 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 16.7 mt -56.52 -23.68 41.44 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -71.45 -1.15 12.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.693 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -56.89 -39.74 74.94 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.711 -0.395 . . . . 0.0 109.945 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.61 147.45 18.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.653 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 171.38 -161.14 33.51 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 87.5 m -153.5 109.28 3.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.719 0.295 . . . . 0.0 110.31 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.0 m -80.3 136.29 23.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.577 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.9 t -144.8 145.82 31.82 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.029 0.442 . . . . 0.0 110.904 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.537 ' CZ ' ' OE1' ' A' ' 9' ' ' GLU . 38.9 p90 -150.07 151.7 33.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.07 179.064 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.513 ' CE1' ' HG ' ' A' ' 84' ' ' SER . 64.9 t60 -134.86 131.22 37.12 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.906 -179.161 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.529 ' O ' ' N ' ' A' ' 82' ' ' THR . 2.4 t -127.87 130.89 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.22 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -39.91 -21.33 0.03 OUTLIER Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.775 -0.53 . . . . 0.0 111.775 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.529 ' N ' ' O ' ' A' ' 80' ' ' VAL . 19.0 p -88.54 -71.93 0.56 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.87 0.367 . . . . 0.0 110.233 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 4.1 t -132.04 160.1 36.88 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.939 179.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.513 ' HG ' ' CE1' ' A' ' 79' ' ' HIS . 20.4 m -133.91 154.88 50.77 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.157 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.5 m -160.28 161.65 33.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.116 0.484 . . . . 0.0 111.26 -179.49 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -143.05 150.13 39.15 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.424 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -135.01 153.24 52.16 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.303 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -108.43 135.74 49.22 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 121.365 0.603 . . . . 0.0 111.412 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 50.0 tp -115.59 96.42 5.62 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.103 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.5 ttmt -94.28 169.74 10.01 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.536 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.8 t -118.38 131.37 71.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.471 0.6 0 CA-C-O 120.719 0.295 . . . . 0.0 110.798 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 . . . . . 0 N--CA 1.461 0.099 0 CA-C-O 121.479 0.657 . . . . 0.0 111.71 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.41 HG13 ' O ' ' A' ' 5' ' ' VAL . 8.7 p -65.1 133.85 30.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.401 179.184 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.476 ' N ' ' OG ' ' A' ' 29' ' ' SER . 59.7 p -92.77 136.48 33.21 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.337 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.547 HG23 ' O ' ' A' ' 7' ' ' ILE . 2.4 tp -118.21 107.0 20.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-O 122.487 1.137 . . . . 0.0 111.455 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.544 HD12 ' C ' ' A' ' 7' ' ' ILE . 9.7 mp -126.14 79.94 1.88 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 113.996 -1.456 . . . . 0.0 108.418 178.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -120.62 87.8 42.27 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.652 -178.449 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.45 ' O ' ' N ' ' A' ' 12' ' ' GLN . 2.5 Cg_endo -73.75 -7.0 19.54 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 C-N-CA 122.109 1.873 . . . . 0.0 110.727 178.736 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 98.2 mt -56.23 83.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.233 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.45 ' N ' ' O ' ' A' ' 10' ' ' PRO . 59.5 tt0 -85.64 -64.76 1.1 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.594 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 14' ' ' VAL . 60.1 t0 -170.64 142.88 2.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.721 -178.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.545 ' N ' ' OD1' ' A' ' 13' ' ' ASP . 29.3 m -132.82 161.68 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.984 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.422 ' CD ' ' N ' ' A' ' 15' ' ' GLN . 0.2 OUTLIER -128.47 115.71 18.59 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.883 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 60.4 mt -122.16 143.78 49.35 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.949 0.404 . . . . 0.0 111.465 -179.249 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.7 m -80.74 157.86 25.7 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.003 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -65.9 148.53 51.65 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.585 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.8 10.16 84.53 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 111.071 -0.811 . . . . 0.0 111.071 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -121.16 145.14 48.13 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -74.29 162.25 29.09 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.403 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -131.22 162.24 30.42 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 28.1 p -159.39 158.51 32.32 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.196 -0.602 . . . . 0.0 111.476 -179.457 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -139.75 148.22 41.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.294 179.092 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -136.33 126.99 27.14 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.595 ' SG ' ' N ' ' A' ' 27' ' ' ARG . 8.2 t -130.13 162.47 28.76 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.472 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.595 ' N ' ' SG ' ' A' ' 26' ' ' CYS . 79.4 ttt180 -143.41 116.01 8.65 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.471 ' O ' HG21 ' A' ' 59' ' ' THR . 2.4 pp -146.06 123.47 11.67 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 119.846 -0.742 . . . . 0.0 111.71 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.476 ' OG ' ' N ' ' A' ' 6' ' ' THR . 92.4 p -62.25 160.23 13.49 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.678 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -53.52 155.84 2.81 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 122.015 0.912 . . . . 0.0 113.388 -177.019 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -53.47 179.57 0.02 OUTLIER 'General case' 0 C--O 1.232 0.163 0 CA-C-N 113.875 -1.511 . . . . 0.0 112.044 -179.291 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.4 p -156.56 -50.39 0.08 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.406 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -101.69 -66.87 0.79 Allowed Glycine 0 CA--C 1.522 0.507 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 178.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -122.69 157.46 32.21 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.726 0.298 . . . . 0.0 110.34 179.257 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -79.85 141.64 35.98 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.798 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.42 145.84 36.93 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.332 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -128.95 144.27 51.13 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.268 0.556 . . . . 0.0 111.062 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 18.8 t-105 -100.67 155.7 17.74 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.797 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -164.56 151.3 11.07 Favored 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 119.774 -0.77 . . . . 0.0 111.913 -179.381 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.559 HD13 ' N ' ' A' ' 41' ' ' GLY . 0.5 OUTLIER -129.32 116.63 19.37 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.057 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.559 ' N ' HD13 ' A' ' 40' ' ' LEU . . . 66.85 19.07 69.23 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -178.757 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.13 4.11 84.43 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.966 -0.853 . . . . 0.0 110.966 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.2 t -111.02 128.38 25.41 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-O 119.491 -0.29 . . . . 0.0 110.478 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -57.76 144.96 92.26 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 121.094 1.196 . . . . 0.0 111.284 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.821 ' H ' HD23 ' A' ' 45' ' ' LEU . 1.1 pt? -130.42 149.69 51.99 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.527 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -128.03 166.18 18.89 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.639 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.6 141.76 19.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.099 0.476 . . . . 0.0 111.377 -178.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.432 ' O ' ' O ' ' A' ' 51' ' ' ASN . 36.3 p-10 -163.3 -171.53 2.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.653 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -65.08 -46.72 79.97 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.169 -179.594 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 65.6 mtt -67.92 -42.91 80.36 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -179.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.432 ' O ' ' O ' ' A' ' 48' ' ' ASN . 17.5 m-20 -118.23 145.71 44.8 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 120.784 0.326 . . . . 0.0 111.458 -179.033 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 48' ' ' ASN . 98.2 m-20 -138.47 108.94 6.52 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.088 178.59 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.8 pt -101.23 134.61 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.472 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.7 t -139.11 155.46 47.87 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.872 0.368 . . . . 0.0 111.176 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.417 ' O ' HG23 ' A' ' 55' ' ' VAL . 35.5 m -120.14 129.14 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.158 -179.614 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.435 ' N ' ' OE2' ' A' ' 56' ' ' GLU . 56.7 mp0 -124.62 179.53 4.92 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.332 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 58.9 tp60 -48.93 147.52 2.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.199 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.48 14.72 80.79 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 111.542 -0.623 . . . . 0.0 111.542 179.169 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.471 HG21 ' O ' ' A' ' 28' ' ' LEU . 2.2 m 61.96 38.33 14.38 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 120.989 0.423 . . . . 0.0 110.266 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 49.3 mt -83.18 129.62 35.03 Favored 'General case' 0 CA--C 1.527 0.064 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.434 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 59.6 m170 -108.68 153.48 23.37 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.0 tp -154.83 116.77 4.17 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.225 -178.402 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.458 ' CD1' ' N ' ' A' ' 63' ' ' LEU . 7.2 mp -97.43 121.01 38.83 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.666 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 23.6 m -108.33 107.11 17.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.396 0.617 . . . . 0.0 109.665 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.423 ' CD2' ' N ' ' A' ' 65' ' ' LEU . 1.5 mm? -92.78 130.53 38.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.873 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.569 ' CG ' ' H ' ' A' ' 67' ' ' LYS . 1.5 t-80 -83.25 -150.9 0.1 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.406 -179.008 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.569 ' H ' ' CG ' ' A' ' 66' ' ' HIS . 13.9 ptpt -60.38 95.92 0.04 OUTLIER 'General case' 0 N--CA 1.461 0.102 0 CA-C-O 121.253 0.549 . . . . 0.0 110.337 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.5 m -96.78 133.98 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 121.302 0.572 . . . . 0.0 110.939 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 27.5 p -88.35 -152.89 0.23 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.202 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.4 mp -61.97 -23.56 66.46 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.7 tp10 -66.58 -1.72 3.99 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.098 -0.956 . . . . 0.0 110.142 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -54.74 -44.35 73.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.112 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.48 129.83 40.33 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -175.6 143.82 6.84 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 53.1 m -97.01 125.6 41.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.755 0.312 . . . . 0.0 110.873 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.6 t -101.61 126.49 55.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.553 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 47.5 t -124.27 140.91 52.51 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.963 0.411 . . . . 0.0 110.485 -179.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -146.9 154.59 41.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.023 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 19.6 p80 -150.69 149.19 29.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.071 0.463 . . . . 0.0 110.55 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.541 ' O ' ' N ' ' A' ' 82' ' ' THR . 4.0 p -146.38 88.16 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.089 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 80' ' ' VAL . . . 30.75 -85.93 0.01 OUTLIER Glycine 0 CA--C 1.53 1.001 0 CA-C-N 115.487 -0.778 . . . . 0.0 112.462 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.541 ' N ' ' O ' ' A' ' 80' ' ' VAL . 25.3 p -39.11 -85.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -179.105 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.459 ' SG ' ' N ' ' A' ' 84' ' ' SER . 33.1 t -105.65 167.69 9.6 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.043 0.449 . . . . 0.0 111.862 -178.424 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.459 ' N ' ' SG ' ' A' ' 83' ' ' CYS . 35.3 t -151.11 145.81 25.72 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.265 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 46.9 t -158.09 172.13 18.98 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.072 0.463 . . . . 0.0 111.151 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -144.2 162.76 35.51 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.492 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -134.08 156.3 48.51 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.079 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.444 ' O ' ' OD1' ' A' ' 13' ' ' ASP . 29.3 mm100 -118.59 135.97 54.13 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.823 0.344 . . . . 0.0 111.367 -179.237 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.497 HD23 ' C ' ' A' ' 89' ' ' LEU . 2.2 tt -115.27 109.64 18.24 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.495 ' N ' HD23 ' A' ' 89' ' ' LEU . 32.5 mmtp -105.66 160.76 14.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.005 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.4 m -117.89 127.35 75.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 120.934 0.397 . . . . 0.0 110.231 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 85.9 m . . . . . 0 N--CA 1.47 0.556 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.101 -179.322 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 . . . . . 0 CA--C 1.527 0.071 0 CA-C-O 121.048 0.452 . . . . 0.0 110.514 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.465 ' O ' HG13 ' A' ' 5' ' ' VAL . 8.7 p -62.04 132.46 27.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.796 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -111.54 122.04 46.77 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 179.299 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 76.9 mt -105.1 118.57 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-O 121.755 0.788 . . . . 0.0 111.804 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.9 mt -127.3 75.77 1.61 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.485 -1.234 . . . . 0.0 108.049 178.412 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.505 ' OE1' ' CE2' ' A' ' 78' ' ' PHE . 35.7 tt0 -114.97 92.83 32.28 Favored Pre-proline 0 N--CA 1.467 0.4 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.984 -177.588 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.53 ' O ' ' N ' ' A' ' 12' ' ' GLN . 2.6 Cg_endo -75.29 -6.59 18.04 Favored 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 122.042 1.828 . . . . 0.0 111.035 178.613 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 63.6 mt -60.91 72.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.191 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.53 ' N ' ' O ' ' A' ' 10' ' ' PRO . 70.9 tp60 -74.9 -64.1 1.12 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.124 -179.422 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.7 p-10 -170.29 133.87 1.13 Allowed 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 120.446 -0.501 . . . . 0.0 111.486 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.5 m -134.65 159.73 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.793 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -135.58 117.14 14.85 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.386 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 81.2 mt -121.2 132.64 54.95 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.439 -179.143 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.7 m -69.68 158.69 34.87 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.817 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.42 ' OE2' ' O ' ' A' ' 68' ' ' VAL . 52.5 tp10 -58.31 146.37 34.59 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.612 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.7 1.13 80.85 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.497 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -110.23 146.55 35.42 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.893 0.378 . . . . 0.0 110.562 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 52.6 p-10 -82.33 170.53 15.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.053 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -148.12 152.39 37.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.173 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 95.9 p -152.01 123.13 7.63 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.072 0.463 . . . . 0.0 111.048 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -103.82 119.51 39.06 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.453 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -131.52 133.44 45.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.948 0.404 . . . . 0.0 109.958 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 8.4 p -151.59 151.7 31.9 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.107 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 85.2 mtt85 -96.68 132.34 42.44 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.875 179.376 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.516 ' C ' HD23 ' A' ' 28' ' ' LEU . 2.9 tt -144.88 106.02 4.19 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.692 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.6 m -62.04 150.83 37.05 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.804 0.335 . . . . 0.0 110.432 179.434 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -56.33 156.13 6.19 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.528 0.68 . . . . 0.0 112.581 -178.227 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.78 -174.71 3.53 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.705 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 27.0 m -154.21 -43.93 0.09 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -86.76 -74.16 1.28 Allowed Glycine 0 CA--C 1.521 0.463 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 178.416 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.454 ' CD ' ' N ' ' A' ' 34' ' ' GLN . 25.4 mp0 -121.98 132.29 54.45 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.924 0.392 . . . . 0.0 110.994 179.048 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -77.28 150.41 35.3 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.835 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.14 147.31 38.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.643 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 45.8 mmm-85 -115.12 137.16 52.33 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.771 0.32 . . . . 0.0 111.225 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 1.8 t-105 -101.79 140.51 35.98 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.013 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -176.38 163.88 2.55 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.119 -179.293 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.62 HD23 ' H ' ' A' ' 40' ' ' LEU . 1.6 pt? -139.66 129.52 24.76 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.246 0.546 . . . . 0.0 110.467 178.524 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.58 7.03 78.65 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.84 -17.04 58.82 Favored Glycine 0 CA--C 1.529 0.969 0 N-CA-C 111.937 -0.465 . . . . 0.0 111.937 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.1 t -101.55 123.07 45.62 Favored Pre-proline 0 CA--C 1.541 0.633 0 CA-C-N 116.905 0.352 . . . . 0.0 110.37 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -58.69 138.01 83.33 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 CA-C-N 119.875 0.991 . . . . 0.0 111.204 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.0 -174.96 4.18 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.095 0.474 . . . . 0.0 110.551 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.492 ' O ' ' N ' ' A' ' 48' ' ' ASN . 2.6 pm0 -139.06 154.92 48.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.185 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.95 70.33 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.616 -0.433 . . . . 0.0 110.389 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.492 ' N ' ' O ' ' A' ' 46' ' ' GLN . 18.4 t-20 -68.84 157.73 35.9 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.748 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.467 ' N ' ' OD1' ' A' ' 48' ' ' ASN . 86.1 tt0 -55.74 -44.6 77.72 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.246 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 5.4 ptt? -69.31 -35.54 76.08 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 120.907 0.384 . . . . 0.0 110.18 179.238 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.446 ' O ' ' O ' ' A' ' 48' ' ' ASN . 41.7 m-20 -116.47 104.64 11.64 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.136 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.419 ' OD2' ' O ' ' A' ' 48' ' ' ASN . 96.7 m-20 -107.97 138.1 44.82 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.704 0.288 . . . . 0.0 110.46 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.3 mt -117.98 129.81 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.312 -0.404 . . . . 0.0 109.995 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.1 t -142.38 146.78 35.29 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.02 0.438 . . . . 0.0 111.137 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 51.5 t -122.48 132.17 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.417 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -121.94 177.08 5.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.292 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -42.84 151.45 0.13 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.343 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.12 20.6 80.01 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.454 ' OG1' ' O ' ' A' ' 28' ' ' LEU . 62.8 p 47.62 38.3 8.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.086 0.47 . . . . 0.0 110.444 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 94.6 mt -75.73 138.72 41.45 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.31 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -108.18 148.31 30.09 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.032 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 53.9 tp -160.49 101.19 1.35 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.043 0.449 . . . . 0.0 110.501 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.439 HD12 ' N ' ' A' ' 64' ' ' THR . 4.8 tp -100.24 109.78 22.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.591 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.439 ' N ' HD12 ' A' ' 63' ' ' LEU . 2.9 p -86.14 112.08 20.96 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.238 0.542 . . . . 0.0 110.715 -179.465 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 55.5 tp -111.58 123.71 50.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.183 179.167 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.519 ' CG ' ' N ' ' A' ' 67' ' ' LYS . 78.3 t60 -145.67 167.94 21.9 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.993 0.425 . . . . 0.0 111.043 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.519 ' N ' ' CG ' ' A' ' 66' ' ' HIS . 72.0 tttt 56.77 57.06 4.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.443 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.42 ' O ' ' OE2' ' A' ' 18' ' ' GLU . 5.7 m -93.7 174.28 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 121.838 0.828 . . . . 0.0 111.544 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.491 ' C ' ' H ' ' A' ' 71' ' ' GLU . 4.4 t -137.89 157.22 46.85 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.121 -1.399 . . . . 0.0 108.216 178.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 67.8 mt -52.55 -5.96 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.521 -0.472 . . . . 0.0 111.202 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.491 ' H ' ' C ' ' A' ' 69' ' ' THR . 80.2 mm-40 -113.82 2.41 15.12 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.415 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.437 ' O ' ' O ' ' A' ' 73' ' ' ALA . 24.9 t70 -63.14 -52.71 61.41 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.673 -179.306 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.437 ' O ' ' O ' ' A' ' 72' ' ' ASP . . . 42.96 -167.81 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 -179.304 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 157.34 95.01 0.1 Allowed Glycine 0 CA--C 1.524 0.645 0 C-N-CA 120.404 -0.903 . . . . 0.0 112.351 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 40.6 p -90.74 94.54 9.72 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 178.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.0 t -76.87 152.09 5.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.18 0.514 . . . . 0.0 111.128 -179.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 33.9 t -153.64 151.63 29.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.3 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.505 ' CE2' ' OE1' ' A' ' 9' ' ' GLU . 64.6 m-85 -131.62 144.59 51.16 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.029 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -143.47 116.0 8.61 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.582 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.535 ' O ' ' N ' ' A' ' 82' ' ' THR . 5.6 p -129.38 135.0 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.739 178.729 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -38.01 -21.4 0.01 OUTLIER Glycine 0 CA--C 1.527 0.79 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.674 -178.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.535 ' N ' ' O ' ' A' ' 80' ' ' VAL . 82.7 p -85.19 -74.5 0.4 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.891 0.377 . . . . 0.0 111.14 -179.341 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.505 ' H ' HG13 ' A' ' 80' ' ' VAL . 60.4 m -128.08 -166.6 1.64 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.416 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 87.8 p -157.1 162.78 39.44 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.761 0.315 . . . . 0.0 110.93 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.9 p -152.9 166.99 30.6 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.904 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -141.97 155.98 45.46 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.147 0.499 . . . . 0.0 111.945 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.99 153.58 33.21 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.413 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -133.93 137.27 44.78 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.585 0.707 . . . . 0.0 112.328 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.7 tp -111.03 116.61 31.46 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.551 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -118.85 164.03 16.02 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.001 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.6 m -123.9 128.25 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 120.997 0.427 . . . . 0.0 110.386 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 23.3 m . . . . . 0 C--N 1.331 -0.203 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.82 -179.51 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 . . . . . 0 CA--C 1.521 -0.135 0 CA-C-O 121.297 0.57 . . . . 0.0 110.967 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.738 HG23 ' O ' ' A' ' 29' ' ' SER . 8.9 p -55.18 131.7 18.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.368 -0.833 . . . . 0.0 108.757 178.71 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 13.6 m -81.56 123.53 28.73 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 119.482 -0.887 . . . . 0.0 109.442 -179.289 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.8 mt -108.84 118.26 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 121.582 0.706 . . . . 0.0 112.673 -178.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 85.2 mt -126.31 111.11 14.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.466 -1.243 . . . . 0.0 107.947 177.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.537 ' N ' ' OE1' ' A' ' 9' ' ' GLU . 1.6 pm0 -122.96 88.5 50.76 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.318 -178.103 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -74.58 -8.51 20.6 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 122.068 1.846 . . . . 0.0 110.677 178.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.406 HD21 ' H ' ' A' ' 25' ' ' GLN . 67.3 mt -68.83 81.75 0.29 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.692 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -71.89 -58.79 3.15 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.786 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 14' ' ' VAL . 62.4 t0 -175.27 137.63 0.4 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.065 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.529 ' N ' ' OD1' ' A' ' 13' ' ' ASP . 28.4 m -137.54 156.52 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-O 121.11 0.481 . . . . 0.0 111.48 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -123.0 132.22 54.04 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.884 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.422 HD22 ' HB2' ' A' ' 22' ' ' ALA . 59.6 mt -120.54 123.73 43.61 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.476 -178.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.8 t -74.84 145.34 42.9 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 177.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -59.38 137.8 57.87 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.348 -179.576 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.98 -0.47 72.8 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -114.62 133.14 56.06 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.85 0.357 . . . . 0.0 110.763 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.409 ' C ' ' OD2' ' A' ' 21' ' ' ASP . 54.9 p30 -78.86 172.06 14.29 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.434 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.422 ' HB2' HD22 ' A' ' 16' ' ' LEU . . . -159.92 173.18 16.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.023 0.44 . . . . 0.0 111.263 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 29.0 p -154.67 162.29 41.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.502 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -127.93 152.55 47.74 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.022 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.406 ' H ' HD21 ' A' ' 11' ' ' LEU . 61.8 tt0 -130.58 130.06 43.56 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.473 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.466 ' SG ' ' N ' ' A' ' 27' ' ' ARG . 48.5 t -141.89 164.6 29.74 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.412 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.466 ' N ' ' SG ' ' A' ' 26' ' ' CYS . 95.7 mtt180 -140.95 121.19 13.86 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.951 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 86.0 mt -126.39 103.05 7.42 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.842 179.396 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.738 ' O ' HG23 ' A' ' 5' ' ' VAL . 25.1 t -63.52 170.03 3.44 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.231 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -52.62 140.21 23.85 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.378 0.609 . . . . 0.0 111.689 -178.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -91.42 -172.66 3.34 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.21 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 38.0 t -150.58 -60.26 0.19 Allowed 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -72.69 -90.13 0.13 Allowed Glycine 0 CA--C 1.521 0.45 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -123.56 143.33 50.27 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.935 0.397 . . . . 0.0 110.963 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -79.35 151.32 31.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.328 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.416 ' CB ' HG22 ' A' ' 80' ' ' VAL . . . -72.74 155.69 39.71 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.427 179.303 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -125.45 133.57 52.4 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.19 0.519 . . . . 0.0 111.306 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 1.5 t-105 -76.8 156.86 31.98 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.813 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -169.61 152.64 4.74 Favored 'General case' 0 N--CA 1.461 0.119 0 C-N-CA 119.716 -0.794 . . . . 0.0 111.959 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.61 HD13 ' C ' ' A' ' 40' ' ' LEU . 2.4 tm? -125.5 117.32 23.37 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.681 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.572 ' N ' HD13 ' A' ' 40' ' ' LEU . . . 82.2 4.1 90.33 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 -179.259 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 102.62 -9.88 55.8 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.803 -0.519 . . . . 0.0 111.803 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.5 m -107.82 155.3 40.13 Favored Pre-proline 0 N--CA 1.47 0.562 0 CA-C-N 117.08 0.44 . . . . 0.0 110.545 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -68.45 154.77 71.13 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 121.392 1.394 . . . . 0.0 112.258 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.475 HD12 ' C ' ' A' ' 45' ' ' LEU . 0.4 OUTLIER -130.48 -175.87 3.78 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.163 179.419 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.561 ' O ' ' N ' ' A' ' 48' ' ' ASN . 50.1 tt0 -141.95 149.74 40.51 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 179.289 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -50.14 82.64 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.947 0.404 . . . . 0.0 111.204 -179.371 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.561 ' N ' ' O ' ' A' ' 46' ' ' GLN . 52.3 t30 -81.03 162.17 23.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.372 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -57.77 -45.53 85.82 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.211 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 66.6 mtt -66.13 -38.35 87.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.819 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.452 ' O ' ' O ' ' A' ' 48' ' ' ASN . 79.4 m-20 -108.91 111.27 22.88 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.522 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -105.26 145.42 30.69 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.515 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 33.1 mt -125.0 129.85 73.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.574 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 90.2 m -124.69 131.74 53.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.601 -179.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 63.8 t -111.99 131.9 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.166 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.436 ' O ' ' O ' ' A' ' 57' ' ' GLN . 75.6 tt0 -137.09 156.77 47.97 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.911 -179.626 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.436 ' O ' ' O ' ' A' ' 56' ' ' GLU . 6.8 pt20 -41.58 165.87 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.952 0.406 . . . . 0.0 111.201 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.23 16.75 71.43 Favored Glycine 0 CA--C 1.517 0.16 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 70.7 p 52.23 31.31 9.0 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.26 -0.47 . . . . 0.0 110.048 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 22.9 mt -72.96 129.69 38.68 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.608 179.488 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 81.0 m80 -112.85 149.5 33.02 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.819 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 54.1 tp -151.16 106.49 3.34 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 120.809 -0.357 . . . . 0.0 111.126 -179.365 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -87.44 105.7 17.46 Favored 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.365 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.1 m -91.99 107.35 19.15 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.297 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 39.5 tp -97.77 110.42 22.99 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.503 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.426 ' O ' ' O ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -91.85 144.11 25.82 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.817 -179.828 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.426 ' O ' ' O ' ' A' ' 66' ' ' HIS . 99.2 mttt 41.76 96.85 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.09 179.164 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.9 p -75.28 156.12 6.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.073 0.464 . . . . 0.0 110.905 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.7 m -134.61 156.64 48.36 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.095 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 70.6 mt -56.56 -24.65 48.59 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -74.27 -6.32 47.28 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.044 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -60.48 -39.11 86.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.815 0.34 . . . . 0.0 110.754 -179.45 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -44.27 126.25 5.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.71 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -178.75 -150.52 8.89 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.459 HG23 ' O ' ' A' ' 87' ' ' ALA . 10.0 m -150.46 106.52 3.45 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 110.336 -0.246 . . . . 0.0 110.336 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.8 t -83.06 133.27 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.1 p -151.62 164.13 37.56 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.16 0.505 . . . . 0.0 111.338 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -141.9 146.53 35.84 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.517 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -119.28 129.29 54.82 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.192 0.52 . . . . 0.0 111.526 -179.016 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.531 ' C ' ' H ' ' A' ' 82' ' ' THR . 2.0 t -120.68 132.24 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.032 179.185 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -50.32 -6.72 0.11 Allowed Glycine 0 CA--C 1.529 0.925 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.408 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.531 ' H ' ' C ' ' A' ' 80' ' ' VAL . 6.4 p -102.8 -52.0 3.17 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.737 0.303 . . . . 0.0 110.194 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -152.8 161.6 42.35 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.946 179.345 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 40.1 t -135.54 143.19 45.58 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.935 0.398 . . . . 0.0 111.001 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 67.1 m -134.13 160.16 38.64 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.46 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.491 ' N ' ' OE2' ' A' ' 86' ' ' GLU . 57.9 mp0 -130.88 156.14 45.55 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.785 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.459 ' O ' HG23 ' A' ' 75' ' ' THR . . . -134.53 142.65 47.07 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.203 179.411 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.484 ' CD ' ' N ' ' A' ' 88' ' ' GLN . 14.7 mp0 -106.93 127.29 53.3 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.434 0.635 . . . . 0.0 111.955 -178.473 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.582 HD23 ' C ' ' A' ' 89' ' ' LEU . 4.6 tt -119.69 114.15 21.74 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.164 179.197 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.54 ' N ' HD23 ' A' ' 89' ' ' LEU . 23.2 mtmm -109.93 154.03 23.68 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.528 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.8 t -119.42 131.34 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.9 m . . . . . 0 C--N 1.33 -0.267 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.931 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 . . . . . 0 N--CA 1.464 0.259 0 CA-C-O 120.733 0.302 . . . . 0.0 110.72 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.61 HG22 ' HA ' ' A' ' 31' ' ' ALA . 2.8 t -61.01 133.14 26.8 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.455 ' H ' ' HB2' ' A' ' 29' ' ' SER . 9.0 m -111.94 131.46 55.37 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.842 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.407 HD11 HG11 ' A' ' 80' ' ' VAL . 2.4 mt -120.41 124.08 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 120.959 0.409 . . . . 0.0 111.905 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.431 ' HA ' HD22 ' A' ' 8' ' ' LEU . 0.2 OUTLIER -130.46 89.93 2.85 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.271 177.845 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -121.53 83.3 41.02 Favored Pre-proline 0 N--CA 1.469 0.524 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.221 -179.058 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -73.92 -10.48 23.08 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.215 1.943 . . . . 0.0 111.57 179.164 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.472 ' CD2' ' H ' ' A' ' 25' ' ' GLN . 0.3 OUTLIER -91.75 55.14 2.63 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.194 0.521 . . . . 0.0 109.908 179.759 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -80.48 -1.19 40.62 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.418 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -151.67 109.39 3.65 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 43.0 t -120.41 133.87 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.017 -178.622 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -135.07 100.32 4.53 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.961 0.41 . . . . 0.0 110.961 179.489 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 66.2 mt -115.78 139.98 49.65 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.458 -179.263 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 85.3 p -74.58 165.68 24.81 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.767 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -69.23 146.41 52.37 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.011 0.434 . . . . 0.0 110.523 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.08 1.33 89.67 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 70.7 tp60 -105.34 148.34 27.17 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.614 0.245 . . . . 0.0 110.48 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 21' ' ' ASP . 54.8 p30 -76.29 153.82 35.61 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.464 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.79 147.58 37.52 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.97 -179.134 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.4 m -163.09 171.23 16.71 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.715 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -128.36 143.7 51.04 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.472 ' H ' ' CD2' ' A' ' 11' ' ' LEU . 88.0 mt-30 -139.19 119.7 13.97 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.723 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 9.7 p -152.04 163.89 38.37 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.418 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -102.05 137.06 40.82 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.524 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.419 ' C ' HD13 ' A' ' 28' ' ' LEU . 0.3 OUTLIER -140.52 95.68 2.91 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.978 -179.774 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.455 ' HB2' ' H ' ' A' ' 6' ' ' THR . 69.1 m -59.25 152.27 21.17 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.006 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -54.41 156.02 3.57 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -177.135 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.61 ' HA ' HG22 ' A' ' 5' ' ' VAL . . . -73.29 -178.71 3.06 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 114.606 -1.179 . . . . 0.0 112.123 -179.233 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 89.6 p -156.71 -52.05 0.08 Allowed 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.223 -0.898 . . . . 0.0 109.713 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -97.29 -65.4 0.9 Allowed Glycine 0 CA--C 1.524 0.648 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 179.134 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.446 ' HB2' ' H ' ' A' ' 81' ' ' GLY . 87.1 mt-30 -124.03 152.11 42.99 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.74 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -86.18 135.91 33.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.952 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.2 152.71 34.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.513 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -147.05 146.93 30.16 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.163 0.506 . . . . 0.0 111.739 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -81.48 179.64 7.76 Favored 'General case' 0 CA--C 1.521 -0.139 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.607 179.32 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.649 ' HB3' ' O ' ' A' ' 77' ' ' SER . . . -165.74 131.6 2.56 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.202 179.09 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 53.1 tp -133.89 123.35 24.58 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.012 179.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.31 8.83 80.53 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.08 -17.31 58.87 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.4 m -112.16 147.48 37.05 Favored Pre-proline 0 CA--C 1.535 0.381 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -52.39 140.7 52.79 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 121.301 1.334 . . . . 0.0 111.042 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.432 ' H ' ' CD2' ' A' ' 45' ' ' LEU . 0.9 OUTLIER -78.44 168.69 19.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.909 0.385 . . . . 0.0 110.874 -179.546 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -131.38 142.11 49.99 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.716 -179.407 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.42 62.89 1.02 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.796 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.459 ' O ' ' O ' ' A' ' 51' ' ' ASN . 97.3 m-20 -74.69 159.53 31.94 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -40.86 -36.49 0.64 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 120.681 -0.407 . . . . 0.0 111.359 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 94.4 mtp -64.55 -43.57 93.54 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.782 0.325 . . . . 0.0 111.117 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.463 ' O ' ' OD2' ' A' ' 52' ' ' ASP . 70.9 m-80 -100.26 149.97 23.04 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.469 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.463 ' OD2' ' O ' ' A' ' 51' ' ' ASN . 84.4 m-20 -140.21 98.51 3.45 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.888 0.375 . . . . 0.0 110.634 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.7 mt -85.72 128.1 39.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.516 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.3 t -140.03 152.22 46.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.987 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.1 t -119.88 130.12 74.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.05 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -126.18 -174.95 3.23 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.405 -179.188 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -54.3 152.06 6.74 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.858 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.65 26.47 74.42 Favored Glycine 0 CA--C 1.52 0.394 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.414 ' OG1' ' O ' ' A' ' 28' ' ' LEU . 17.8 p 48.33 29.07 1.81 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.762 0.315 . . . . 0.0 110.681 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 23.5 mt -69.32 131.9 45.57 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.278 0.561 . . . . 0.0 111.006 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 64.2 m80 -110.34 149.29 30.43 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.721 178.489 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.552 ' C ' HD23 ' A' ' 62' ' ' LEU . 7.0 tt -156.53 102.72 2.08 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.196 -178.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.35 106.97 19.07 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 177.702 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.454 ' OG1' ' CD2' ' A' ' 62' ' ' LEU . 15.9 m -88.31 113.11 23.59 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.023 0.439 . . . . 0.0 111.36 -178.384 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.0 tt -101.67 122.1 43.26 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.112 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.658 ' NE2' ' NZ ' ' A' ' 67' ' ' LYS . 56.0 t60 -85.28 132.26 34.29 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.263 0.554 . . . . 0.0 112.228 -178.113 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.658 ' NZ ' ' NE2' ' A' ' 66' ' ' HIS . 52.5 mttp 39.62 83.44 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.039 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.7 p -54.29 162.08 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.014 0.435 . . . . 0.0 110.649 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.45 ' H ' ' HB2' ' A' ' 72' ' ' ASP . 28.5 p -137.26 165.27 26.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.447 179.146 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.468 HD22 ' N ' ' A' ' 70' ' ' LEU . 4.1 mm? -60.95 -38.14 84.82 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.354 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -67.54 -36.62 81.34 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.896 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.45 ' HB2' ' H ' ' A' ' 69' ' ' THR . 44.3 m-20 -63.98 -36.81 85.19 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.789 -178.573 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.28 141.65 55.8 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.559 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -176.39 -165.02 31.41 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 57.7 m -98.93 123.39 43.18 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.627 0.251 . . . . 0.0 110.509 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.1 m -105.37 149.74 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.623 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.649 ' O ' ' HB3' ' A' ' 39' ' ' ALA . 51.7 p -159.47 158.23 31.59 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.678 0.275 . . . . 0.0 110.738 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.406 ' CD1' ' C ' ' A' ' 78' ' ' PHE . 45.3 p90 -143.16 157.35 44.59 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.361 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 69.8 m80 -142.87 139.66 30.93 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.245 0.545 . . . . 0.0 111.827 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.534 ' O ' ' N ' ' A' ' 82' ' ' THR . 3.2 p -144.12 143.12 23.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.17 178.751 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.446 ' H ' ' HB2' ' A' ' 34' ' ' GLN . . . -42.21 -14.39 0.01 OUTLIER Glycine 0 CA--C 1.526 0.748 0 CA-C-N 116.471 -0.331 . . . . 0.0 112.854 -178.602 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.534 ' N ' ' O ' ' A' ' 80' ' ' VAL . 45.6 p -89.3 -72.91 0.53 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 117.081 0.441 . . . . 0.0 110.152 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.443 ' H ' HG13 ' A' ' 80' ' ' VAL . 6.7 t -139.45 -172.37 3.35 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.633 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 41.6 p -158.56 163.08 37.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.051 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 31.0 m -162.31 173.83 13.65 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.546 -0.462 . . . . 0.0 111.054 179.394 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.467 ' N ' ' CD ' ' A' ' 86' ' ' GLU . 1.3 pm0 -137.04 152.66 50.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.823 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -143.79 151.68 40.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.269 -0.878 . . . . 0.0 108.922 178.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -110.86 128.6 55.84 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.527 0.679 . . . . 0.0 111.933 -178.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 51.4 tp -101.02 81.69 2.28 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 114.944 -1.025 . . . . 0.0 108.765 178.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -94.55 172.35 8.24 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.3 m -116.02 141.46 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 29.0 m . . . . . 0 C--N 1.327 -0.409 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.68 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.408 ' HG3' ' N ' ' A' ' 5' ' ' VAL . 35.5 tp10 . . . . . 0 C--O 1.231 0.125 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.491 ' H ' HG13 ' A' ' 5' ' ' VAL . 1.0 OUTLIER -52.34 137.79 11.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 179.919 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.537 ' N ' ' OG ' ' A' ' 29' ' ' SER . 39.2 m -95.87 123.56 39.51 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 120.04 -0.664 . . . . 0.0 111.074 -178.727 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.3 mm -109.9 88.9 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.762 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.474 ' O ' ' SG ' ' A' ' 26' ' ' CYS . 55.4 mt -112.81 112.05 23.27 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 177.77 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -123.95 92.67 48.14 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.57 -178.378 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -69.25 -11.22 30.99 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 C-N-CA 121.259 1.306 . . . . 0.0 109.334 178.105 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.432 HD21 ' H ' ' A' ' 25' ' ' GLN . 63.7 mt -68.09 77.29 0.23 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.502 -1.226 . . . . 0.0 110.575 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 54.1 tp60 -70.66 -41.17 72.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.735 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -176.38 145.54 0.59 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.02 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.476 HG21 ' CE2' ' A' ' 24' ' ' PHE . 70.0 t -121.45 134.72 63.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.314 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -143.16 127.18 17.38 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.229 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.5 pp -162.75 144.3 10.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.861 -179.187 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.4 m -64.68 146.13 55.18 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -64.48 147.92 51.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.971 0.891 . . . . 0.0 112.218 -178.743 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.626 ' H ' ' CG1' ' A' ' 68' ' ' VAL . . . 92.75 -8.13 76.75 Favored Glycine 0 CA--C 1.521 0.466 0 CA-C-N 113.906 -1.497 . . . . 0.0 110.427 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -93.05 161.55 14.39 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 179.22 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -76.41 161.28 28.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.932 0.396 . . . . 0.0 110.588 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -149.39 156.89 42.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.389 -179.532 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.2 p -160.36 162.53 33.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.951 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.476 ' CE2' HG21 ' A' ' 14' ' ' VAL . 96.1 m-85 -133.41 147.31 51.74 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.146 0.498 . . . . 0.0 111.099 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.432 ' H ' HD21 ' A' ' 11' ' ' LEU . 89.0 mt-30 -139.0 125.48 20.5 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.424 178.718 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.61 ' SG ' ' N ' ' A' ' 27' ' ' ARG . 8.9 t -146.73 163.31 36.36 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.036 0.446 . . . . 0.0 110.453 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.61 ' N ' ' SG ' ' A' ' 26' ' ' CYS . 78.4 ttt-85 -120.61 119.48 33.01 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.365 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.449 ' C ' HD23 ' A' ' 28' ' ' LEU . 2.6 tt -136.15 105.76 6.14 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.551 -0.459 . . . . 0.0 110.541 -179.026 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.537 ' OG ' ' N ' ' A' ' 6' ' ' THR . 86.6 p -62.4 156.27 23.02 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.342 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 37.7 ptt-85 -50.84 160.68 0.43 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.223 -177.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.429 ' HA ' HG12 ' A' ' 5' ' ' VAL . . . -71.02 174.39 6.31 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.196 -178.676 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.3 t -120.35 1.94 10.77 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.36 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 151.65 -24.23 0.94 Allowed Glycine 0 N--CA 1.453 -0.184 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -121.07 119.16 31.67 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 115.416 -0.392 . . . . 0.0 110.449 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -93.71 149.99 20.78 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.123 -179.383 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.494 ' CB ' HG22 ' A' ' 80' ' ' VAL . . . -80.63 169.25 17.89 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.298 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.456 ' NH2' ' O ' ' A' ' 38' ' ' TRP . 9.5 ptm180 -144.21 146.06 32.46 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.42 179.383 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.458 ' CB ' HD11 ' A' ' 45' ' ' LEU . 81.4 m95 -78.16 176.54 9.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.813 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 77' ' ' SER . . . -164.55 107.21 0.88 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.598 179.242 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.532 HD13 ' N ' ' A' ' 41' ' ' GLY . 0.7 OUTLIER -116.19 114.1 23.98 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.532 ' N ' HD13 ' A' ' 40' ' ' LEU . . . 70.87 17.38 75.26 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.18 -22.19 42.17 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 18.8 m -111.94 148.73 39.62 Favored Pre-proline 0 CA--C 1.539 0.554 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -59.25 144.55 99.35 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 121.253 1.302 . . . . 0.0 111.625 -179.559 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.486 ' O ' HD12 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -89.69 164.77 14.57 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.085 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.436 ' O ' ' N ' ' A' ' 48' ' ' ASN . 78.3 mt-30 -135.91 155.44 50.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.978 0.418 . . . . 0.0 110.298 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.89 74.44 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.576 -179.04 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' A' ' 46' ' ' GLN . 98.5 m-20 -73.01 160.3 32.31 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.048 179.113 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -54.7 -49.16 71.38 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.326 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 78.4 mtm -69.38 -39.87 77.75 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.74 179.509 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.435 ' O ' ' O ' ' A' ' 48' ' ' ASN . 64.3 t30 -107.53 112.2 24.83 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.936 0.398 . . . . 0.0 110.975 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 53' ' ' ILE . 66.7 t0 -109.93 143.76 39.41 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.673 179.426 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.518 ' N ' ' OD1' ' A' ' 52' ' ' ASP . 20.6 tt -127.63 136.24 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.5 p -140.73 158.38 44.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.081 0.467 . . . . 0.0 111.551 -178.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.6 m -120.58 130.14 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.405 178.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -121.29 165.36 15.59 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.163 0.506 . . . . 0.0 111.009 -178.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -42.14 152.69 0.08 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.977 179.324 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.3 19.07 78.54 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' A' ' 28' ' ' LEU . 51.0 p 50.33 33.35 7.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.931 0.396 . . . . 0.0 110.376 -179.264 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 76.7 mt -79.32 120.56 23.96 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.714 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -83.69 142.63 30.61 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 56.1 tp -145.66 93.96 2.43 Favored 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 34.4 tp -92.91 106.97 18.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.606 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.537 ' CG2' ' NE2' ' A' ' 66' ' ' HIS . 78.0 m -96.85 98.41 10.1 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.184 -178.78 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.557 HD23 ' N ' ' A' ' 66' ' ' HIS . 4.0 tt -101.27 119.44 38.75 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.104 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.557 ' N ' HD23 ' A' ' 65' ' ' LEU . 54.1 m170 -112.43 154.22 26.15 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 120.772 0.32 . . . . 0.0 110.513 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 64.3 mttp 53.5 59.16 4.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.262 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.626 ' CG1' ' H ' ' A' ' 19' ' ' GLY . 1.0 OUTLIER -50.7 159.01 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.963 0.411 . . . . 0.0 110.782 -179.682 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.42 ' H ' ' HB2' ' A' ' 72' ' ' ASP . 55.0 p -133.97 167.04 21.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.313 179.315 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.445 HD12 ' N ' ' A' ' 70' ' ' LEU . 11.0 mp -61.78 -39.32 91.25 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.577 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -67.78 -35.55 78.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.158 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.42 ' HB2' ' H ' ' A' ' 69' ' ' THR . 98.9 m-20 -61.74 -43.03 99.65 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.197 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.27 141.15 51.75 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.374 -0.53 . . . . 0.0 109.73 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 168.28 -148.67 12.89 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.596 -0.811 . . . . 0.0 111.15 -179.205 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 43.6 m -110.1 125.16 52.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.709 -0.246 . . . . 0.0 110.715 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.0 t -111.76 130.58 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.178 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.52 ' O ' ' HB3' ' A' ' 39' ' ' ALA . 24.9 t -153.4 167.48 29.28 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.127 0.489 . . . . 0.0 110.764 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -146.68 150.33 35.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.066 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -128.62 140.37 51.8 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.092 0.472 . . . . 0.0 111.584 -178.608 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.509 ' C ' ' H ' ' A' ' 82' ' ' THR . 2.2 t -129.49 133.84 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.974 179.217 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -49.18 -7.48 0.07 OUTLIER Glycine 0 CA--C 1.529 0.928 0 C-N-CA 121.158 -0.544 . . . . 0.0 111.854 -179.241 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.509 ' H ' ' C ' ' A' ' 80' ' ' VAL . 31.0 p -107.72 -43.53 4.46 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.978 0.389 . . . . 0.0 110.932 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 14.1 t -154.2 154.62 33.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.336 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.1 m -130.61 157.1 43.66 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.984 0.421 . . . . 0.0 111.569 -179.141 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.404 ' O ' ' OG ' ' A' ' 77' ' ' SER . 15.8 t -154.68 157.2 37.74 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.848 -179.578 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -127.4 159.95 32.92 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.368 0.604 . . . . 0.0 111.706 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.49 147.57 27.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.425 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -117.66 139.6 50.78 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.346 0.593 . . . . 0.0 112.522 -178.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.512 HD23 ' C ' ' A' ' 89' ' ' LEU . 3.5 tt -119.81 106.78 12.42 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.182 -0.917 . . . . 0.0 108.597 178.249 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.414 ' N ' HD23 ' A' ' 89' ' ' LEU . 61.5 pttt -110.96 160.24 16.99 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.706 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.421 ' O ' HG23 ' A' ' 91' ' ' VAL . 23.7 m -110.66 131.47 61.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.886 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 98.1 m . . . . . 0 N--CA 1.467 0.387 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.271 -179.429 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 . . . . . 0 N--CA 1.463 0.198 0 CA-C-O 120.966 0.412 . . . . 0.0 110.741 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 29' ' ' SER . 0.2 OUTLIER -58.8 157.71 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 177.351 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.5 ' HB ' ' H ' ' A' ' 29' ' ' SER . 93.8 m -85.53 86.31 7.38 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 118.262 -1.375 . . . . 0.0 108.407 179.381 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.67 HG23 ' O ' ' A' ' 7' ' ' ILE . 10.6 tt -83.92 90.9 2.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 122.371 1.081 . . . . 0.0 112.52 -177.721 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 96.8 mt -127.33 83.51 2.17 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 113.457 -1.702 . . . . 0.0 109.056 178.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.446 ' C ' ' H ' ' A' ' 11' ' ' LEU . 4.8 pt-20 -122.93 83.9 50.3 Favored Pre-proline 0 N--CA 1.468 0.464 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.177 -178.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -71.93 17.51 0.32 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.189 1.926 . . . . 0.0 111.577 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.478 HD21 ' O ' ' A' ' 25' ' ' GLN . 76.6 mt -66.92 77.45 0.12 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.542 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -71.7 -70.47 0.32 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.345 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.417 ' OD2' ' N ' ' A' ' 13' ' ' ASP . 31.7 p-10 -176.72 152.41 0.99 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.336 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.9 m -135.57 161.3 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.068 -179.331 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -133.45 139.51 46.75 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.383 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -156.64 151.52 26.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.033 0.445 . . . . 0.0 111.417 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.8 p -80.66 168.04 19.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.639 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -64.83 141.68 58.69 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.831 0.348 . . . . 0.0 110.515 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.61 8.2 87.22 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.689 -0.564 . . . . 0.0 111.689 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 93.5 mm-40 -96.48 158.66 15.33 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.846 0.355 . . . . 0.0 110.153 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -86.04 167.54 14.92 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.05 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.493 ' HB3' HD22 ' A' ' 65' ' ' LEU . . . -161.54 157.08 24.29 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.916 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 73.6 m -163.93 159.47 20.94 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.148 -0.315 . . . . 0.0 110.148 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -128.78 147.91 50.82 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.087 0.47 . . . . 0.0 110.617 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.485 ' OE1' ' CD2' ' A' ' 62' ' ' LEU . 62.6 mm-40 -124.43 125.69 44.69 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.874 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 6.7 t -137.53 146.13 43.78 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.171 0.51 . . . . 0.0 110.701 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -125.99 100.42 6.35 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.244 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.478 ' O ' ' CG2' ' A' ' 59' ' ' THR . 91.0 mt -121.6 110.31 15.84 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.255 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.5 ' H ' ' HB ' ' A' ' 6' ' ' THR . 34.7 t -69.62 172.9 6.7 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.45 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 11.6 ptp85 -50.12 151.28 2.05 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 122.038 0.923 . . . . 0.0 113.03 -177.161 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.6 160.04 20.53 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 113.831 -1.531 . . . . 0.0 112.213 -178.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.9 m -138.77 -82.96 0.29 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.647 179.105 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -65.58 -85.9 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 178.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -123.56 155.68 37.16 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.303 0.573 . . . . 0.0 110.193 178.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 74.9 tt0 -72.99 153.47 40.92 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.239 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.72 143.6 26.81 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.075 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -108.08 141.74 39.33 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.52 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 8.7 t-105 -111.11 138.87 47.01 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.215 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -165.41 155.98 13.6 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 119.45 -0.9 . . . . 0.0 111.762 -178.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.633 ' C ' HD23 ' A' ' 40' ' ' LEU . 6.9 tt -131.27 123.57 28.65 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.941 179.603 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.564 ' N ' HD23 ' A' ' 40' ' ' LEU . . . 82.89 6.31 88.52 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.752 -0.539 . . . . 0.0 111.752 179.159 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 102.04 -20.34 45.84 Favored Glycine 0 N--CA 1.467 0.704 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.4 m -109.35 151.56 42.17 Favored Pre-proline 0 N--CA 1.467 0.401 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -56.79 141.78 92.34 Favored 'Trans proline' 0 C--N 1.316 -1.171 0 C-N-CA 120.939 1.092 . . . . 0.0 111.048 179.119 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.563 ' H ' ' CD2' ' A' ' 45' ' ' LEU . 0.8 OUTLIER -93.15 -172.46 2.97 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.14 -179.89 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 61.8 tp60 -144.93 155.7 43.57 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.262 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.14 63.7 1.33 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.44 ' O ' ' O ' ' A' ' 51' ' ' ASN . 13.3 t-20 -65.55 175.87 1.67 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.136 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -66.01 -39.72 90.48 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 78.1 mtm -67.65 -39.35 84.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.164 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.44 ' O ' ' O ' ' A' ' 48' ' ' ASN . 55.6 t30 -126.02 131.95 52.09 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.039 0.447 . . . . 0.0 111.073 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -120.02 140.57 50.77 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.551 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.4 mm -110.69 127.32 67.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.451 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.441 HG22 ' O ' ' A' ' 62' ' ' LEU . 5.0 t -145.86 156.55 43.63 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.099 0.476 . . . . 0.0 111.432 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.2 m -115.31 133.65 60.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.029 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -116.91 -177.48 3.21 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.101 0.477 . . . . 0.0 110.669 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.426 ' CD ' ' N ' ' A' ' 58' ' ' GLY . 9.8 tm0? -64.6 147.31 53.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.269 -179.243 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.426 ' N ' ' CD ' ' A' ' 57' ' ' GLN . . . 80.55 13.04 82.24 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.478 ' CG2' ' O ' ' A' ' 28' ' ' LEU . 1.6 m 70.4 24.53 4.63 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 121.418 0.628 . . . . 0.0 110.385 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.6 mp -79.76 138.85 37.4 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.879 179.097 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 58.4 m170 -111.18 130.29 55.68 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.628 HD13 ' N ' ' A' ' 63' ' ' LEU . 1.1 tm? -125.13 119.58 28.99 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 111.494 0.183 . . . . 0.0 111.494 -178.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.628 ' N ' HD13 ' A' ' 62' ' ' LEU . 6.3 mp -103.36 114.14 28.18 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 177.579 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 93.1 m -99.61 110.6 23.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.112 0.482 . . . . 0.0 110.746 -179.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.709 ' C ' HD23 ' A' ' 65' ' ' LEU . 7.0 tt -110.88 129.28 55.91 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.869 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.505 ' N ' HD23 ' A' ' 65' ' ' LEU . 0.8 OUTLIER -153.34 165.11 36.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.414 -179.602 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.5 mttp 42.58 86.78 0.02 OUTLIER 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.313 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.482 HG11 HD21 ' A' ' 65' ' ' LEU . 21.4 m -137.65 163.94 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.588 -178.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 33.2 p -117.77 -151.86 0.49 Allowed 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.669 179.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.506 ' C ' ' H ' ' A' ' 72' ' ' ASP . 87.1 mt -63.01 -23.71 67.58 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.675 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -56.92 -1.07 0.05 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.349 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.506 ' H ' ' C ' ' A' ' 70' ' ' LEU . 18.6 m-20 -62.73 -36.19 82.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.281 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.3 127.92 31.66 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.473 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 172.48 153.18 9.12 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.776 -0.929 . . . . 0.0 110.776 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 85.4 m -111.59 116.69 31.24 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.558 0.218 . . . . 0.0 110.958 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.2 t -91.93 128.2 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.2 p -128.24 145.45 51.04 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.043 0.449 . . . . 0.0 110.835 -179.457 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -156.87 155.49 31.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.421 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 40.8 p-80 -159.37 151.46 20.88 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.315 0.578 . . . . 0.0 111.911 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.544 ' O ' ' N ' ' A' ' 82' ' ' THR . 12.3 p -124.06 134.22 67.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 115.285 -0.87 . . . . 0.0 108.982 178.51 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -31.23 -30.01 0.01 OUTLIER Glycine 0 CA--C 1.529 0.958 0 CA-C-N 116.058 -0.519 . . . . 0.0 113.096 -178.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.544 ' N ' ' O ' ' A' ' 80' ' ' VAL . 4.5 m -76.61 -74.3 0.24 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.006 0.431 . . . . 0.0 110.92 -179.394 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.41 ' O ' ' O ' ' A' ' 80' ' ' VAL . 7.6 t -119.76 -170.04 1.88 Allowed 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 31.4 p -151.74 157.49 42.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.204 0.526 . . . . 0.0 110.718 179.231 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.4 t -167.06 151.35 6.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.827 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -146.1 156.26 43.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.054 0.454 . . . . 0.0 110.729 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -129.82 152.97 48.72 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.448 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -124.99 137.95 54.24 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.279 0.561 . . . . 0.0 111.459 -179.418 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.598 HD23 ' C ' ' A' ' 89' ' ' LEU . 6.3 tt -110.15 121.97 46.53 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.22 -0.9 . . . . 0.0 108.978 178.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.58 ' N ' HD23 ' A' ' 89' ' ' LEU . 17.7 ptpt -123.61 157.93 32.63 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.934 0.397 . . . . 0.0 111.367 -179.232 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 18.6 m -116.06 136.24 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.873 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 46.5 p . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.573 179.917 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.471 ' OE2' ' N ' ' A' ' 5' ' ' VAL . 1.3 tm-20 . . . . . 0 CA--C 1.533 0.325 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 29' ' ' SER . 1.9 p -59.23 130.31 22.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.545 HG22 ' H ' ' A' ' 8' ' ' LEU . 12.1 m -66.61 134.31 52.07 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 118.739 -1.184 . . . . 0.0 108.304 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.58 HG23 ' O ' ' A' ' 7' ' ' ILE . 2.4 tp -111.81 31.49 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -177.188 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.545 ' H ' HG22 ' A' ' 6' ' ' THR . 7.7 mp -81.98 90.1 6.46 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.505 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.502 ' C ' ' H ' ' A' ' 11' ' ' LEU . 1.8 pt-20 -121.3 90.5 47.6 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.032 -179.538 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -68.32 24.93 0.14 Allowed 'Trans proline' 0 C--N 1.314 -1.289 0 C-N-CA 121.861 1.707 . . . . 0.0 112.141 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.502 ' H ' ' C ' ' A' ' 9' ' ' GLU . 71.2 mt -81.01 72.9 8.06 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.104 0.478 . . . . 0.0 110.467 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -74.58 -67.78 0.6 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.446 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -172.26 133.57 0.67 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.357 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.1 m -123.99 142.38 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 120.924 0.392 . . . . 0.0 110.768 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.533 ' C ' HD22 ' A' ' 16' ' ' LEU . 89.5 mt-30 -129.71 112.97 14.17 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.518 -179.319 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.56 ' O ' HG23 ' A' ' 91' ' ' VAL . 4.5 mm? -122.92 151.32 41.89 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.36 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.2 m -72.85 155.09 40.26 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 178.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.2 tm-20 -59.5 139.43 57.13 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.832 0.348 . . . . 0.0 110.728 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.59 -1.41 87.17 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.891 179.293 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 23.0 mm100 -91.83 168.55 11.36 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.91 0.386 . . . . 0.0 110.725 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -84.3 164.15 19.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.255 179.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -153.27 153.27 32.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.785 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 28.2 p -156.43 159.13 38.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.921 0.391 . . . . 0.0 110.552 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -132.3 147.1 52.39 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.292 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.404 ' O ' HD21 ' A' ' 11' ' ' LEU . 52.5 tt0 -137.37 121.75 18.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.09 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 37.3 t -129.63 129.82 44.82 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.98 0.419 . . . . 0.0 111.053 -179.443 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.01 108.38 21.05 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.044 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.447 ' O ' ' OG1' ' A' ' 59' ' ' THR . 74.3 mt -122.38 129.81 52.48 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.537 178.471 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.568 ' O ' HG23 ' A' ' 5' ' ' VAL . 68.6 m -94.32 175.86 6.53 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 -56.67 138.56 52.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.361 0.6 . . . . 0.0 111.208 -179.158 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -79.27 -176.1 5.01 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.415 -179.184 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.42 ' OG ' ' N ' ' A' ' 33' ' ' GLY . 82.5 p -146.23 -62.04 0.31 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.711 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.42 ' N ' ' OG ' ' A' ' 32' ' ' SER . . . -93.82 -71.08 1.14 Allowed Glycine 0 CA--C 1.522 0.506 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 179.257 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 96.5 mm-40 -122.75 135.15 54.47 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.386 0.612 . . . . 0.0 111.78 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -86.75 145.41 26.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.072 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.477 ' CB ' HG22 ' A' ' 80' ' ' VAL . . . -70.45 147.63 49.24 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.5 mmt85 -102.52 143.68 31.92 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 20.9 t-105 -102.3 131.43 48.9 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.414 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -172.7 152.81 2.6 Favored 'General case' 0 C--O 1.226 -0.179 0 C-N-CA 119.608 -0.837 . . . . 0.0 112.447 -179.069 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.62 ' C ' HD23 ' A' ' 40' ' ' LEU . 6.7 tt -125.87 121.16 32.42 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.046 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.525 ' N ' HD23 ' A' ' 40' ' ' LEU . . . 88.23 -2.99 85.58 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -178.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.28 1.07 58.15 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 112.167 -0.373 . . . . 0.0 112.167 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.7 m -111.59 148.28 38.52 Favored Pre-proline 0 N--CA 1.471 0.603 0 CA-C-N 117.146 0.473 . . . . 0.0 110.709 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -49.85 138.72 33.75 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 121.631 1.554 . . . . 0.0 111.308 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.8 tp -86.62 163.19 17.55 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.899 -178.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -140.41 147.76 40.2 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.62 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.13 62.98 0.67 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.866 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.522 ' OD1' ' N ' ' A' ' 49' ' ' GLU . 60.1 t-20 -66.62 142.62 57.4 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.043 0.449 . . . . 0.0 111.033 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.522 ' N ' ' OD1' ' A' ' 48' ' ' ASN . 74.9 mm-40 -40.07 -42.05 1.35 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.093 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 74.1 mtm -65.99 -39.28 90.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.636 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.514 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 0.6 OUTLIER -112.27 125.88 54.64 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.123 -178.805 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.49 ' OD2' ' N ' ' A' ' 53' ' ' ILE . 56.5 t0 -109.28 154.09 22.95 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.13 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.49 ' N ' ' OD2' ' A' ' 52' ' ' ASP . 64.4 mt -137.11 129.22 43.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.9 p -130.86 148.87 52.69 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.035 0.445 . . . . 0.0 110.755 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.0 p -125.34 128.44 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.348 -179.734 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.454 ' O ' ' O ' ' A' ' 57' ' ' GLN . 96.3 mt-10 -126.82 -173.12 2.8 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.841 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.454 ' O ' ' O ' ' A' ' 56' ' ' GLU . 97.8 mm-40 -28.24 152.12 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.368 -179.123 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.427 ' C ' ' OG1' ' A' ' 59' ' ' THR . . . 58.8 -82.75 0.01 OUTLIER Glycine 0 CA--C 1.521 0.454 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 179.239 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER 175.68 51.29 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.83 0.824 . . . . 0.0 109.134 179.912 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 42.8 mt -80.16 135.93 36.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.95 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -113.76 145.74 40.94 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.522 ' C ' HD23 ' A' ' 62' ' ' LEU . 3.2 tt -153.59 110.94 3.48 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.643 -179.404 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.486 ' N ' HD23 ' A' ' 62' ' ' LEU . 7.8 mp -97.02 128.86 44.4 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 120.969 0.414 . . . . 0.0 110.804 179.314 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.9 m -108.71 103.22 12.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.544 179.087 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.431 ' CD2' ' N ' ' A' ' 65' ' ' LEU . 3.1 mm? -96.06 126.68 41.46 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.132 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.478 ' ND1' ' N ' ' A' ' 67' ' ' LYS . 12.0 t-80 -138.61 160.49 39.47 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.235 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.478 ' N ' ' ND1' ' A' ' 66' ' ' HIS . 70.9 mmtt 57.21 41.54 26.8 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.4 p -94.88 134.95 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.106 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.431 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 44.7 p -122.27 -151.01 0.46 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.102 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.589 ' C ' ' H ' ' A' ' 72' ' ' ASP . 86.0 mt -45.9 -27.4 0.87 Allowed 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.34 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -64.28 13.07 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.725 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.589 ' H ' ' C ' ' A' ' 70' ' ' LEU . 5.1 m-20 -60.34 -35.77 76.42 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.048 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -52.31 138.3 26.97 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.148 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -171.53 173.66 44.95 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 17.1 p -154.43 104.39 2.57 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 110.453 -0.203 . . . . 0.0 110.453 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.2 t -94.89 132.68 38.22 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 CA-C-O 121.147 0.499 . . . . 0.0 110.125 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 11.0 t -132.85 152.47 51.83 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.356 -179.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -127.25 133.67 50.17 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.515 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -114.88 109.86 18.78 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.464 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.477 HG22 ' CB ' ' A' ' 36' ' ' ALA . 1.4 t -115.89 129.35 72.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.464 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -57.07 -7.08 2.25 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.922 -178.278 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.15 -43.65 4.12 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 117.064 0.432 . . . . 0.0 110.915 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 59.7 m -137.38 172.69 12.61 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.9 0.381 . . . . 0.0 111.387 -179.545 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 87.7 p -133.93 156.42 48.16 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.392 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.8 p -156.73 160.06 38.93 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.989 0.424 . . . . 0.0 111.065 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -143.95 157.7 44.18 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.747 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -142.85 146.82 34.5 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.828 179.367 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -120.63 130.15 54.03 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.382 0.61 . . . . 0.0 112.255 -178.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 48.0 tp -114.89 119.2 35.76 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 114.992 -1.003 . . . . 0.0 108.822 178.181 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -133.25 156.64 47.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.216 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 16' ' ' LEU . 8.6 p -117.16 133.39 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.0 t . . . . . 0 C--N 1.332 -0.166 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.068 -179.364 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.4 ptm . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -174.43 76.1 0.34 Allowed Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.387 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -68.75 146.64 67.14 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.535 2.157 . . . . 0.0 111.842 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.649 ' CD ' ' H ' ' A' ' 4' ' ' GLU . 1.5 pm0 -79.24 -118.46 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.333 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.511 HG22 ' HA ' ' A' ' 31' ' ' ALA . 3.9 t -84.6 120.12 34.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.439 ' HB ' ' H ' ' A' ' 29' ' ' SER . 80.8 m -84.89 125.58 32.76 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 119.415 -0.914 . . . . 0.0 109.274 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.8 mm -104.54 94.13 2.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.094 0.473 . . . . 0.0 110.802 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 53.4 tp -124.66 79.48 1.77 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.037 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.504 ' C ' ' H ' ' A' ' 11' ' ' LEU . 1.4 pt-20 -122.99 89.06 50.79 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.853 -178.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -69.03 16.7 0.17 Allowed 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 121.988 1.792 . . . . 0.0 111.602 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.504 ' H ' ' C ' ' A' ' 9' ' ' GLU . 64.2 mt -72.46 61.97 0.51 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.433 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -71.08 -40.6 71.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.597 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -172.0 132.38 0.68 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 81.8 t -124.96 132.08 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 120.895 0.378 . . . . 0.0 110.671 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -128.88 138.44 52.02 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.901 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.425 HD22 ' HB2' ' A' ' 22' ' ' ALA . 2.7 pp -157.03 135.06 11.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.997 0.427 . . . . 0.0 110.889 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 42.4 t -64.49 146.65 54.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.792 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.427 ' CD ' ' N ' ' A' ' 19' ' ' GLY . 14.5 tm-20 -61.02 143.12 55.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.607 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.427 ' N ' ' CD ' ' A' ' 18' ' ' GLU . . . 98.86 -14.26 61.73 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.519 ' NE2' ' N ' ' A' ' 20' ' ' GLN . 2.9 mp0 -98.68 147.57 24.72 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.878 0.37 . . . . 0.0 110.736 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -71.93 153.3 41.93 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.741 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.425 ' HB2' HD22 ' A' ' 16' ' ' LEU . . . -129.87 146.32 51.59 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.857 0.361 . . . . 0.0 110.918 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 36.4 m -146.22 145.03 30.27 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.41 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.464 ' CE2' HD12 ' A' ' 89' ' ' LEU . 2.7 m-85 -119.58 150.24 40.61 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -146.02 131.46 18.67 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.555 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 10.9 p -151.73 140.53 20.92 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.599 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -100.44 118.19 36.15 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.38 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.453 ' O ' ' CG2' ' A' ' 59' ' ' THR . 79.9 mt -129.25 106.16 8.63 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 110.332 -0.248 . . . . 0.0 110.332 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.439 ' H ' ' HB ' ' A' ' 6' ' ' THR . 22.2 t -62.39 164.4 7.3 Favored 'General case' 0 CA--C 1.515 -0.381 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.026 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.464 ' NH1' ' O ' ' A' ' 31' ' ' ALA . 9.5 ptm180 -54.96 162.37 1.31 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.225 -178.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.511 ' HA ' HG22 ' A' ' 5' ' ' VAL . . . -94.11 -174.11 3.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.411 -179.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.2 m -149.96 -50.59 0.14 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.503 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -89.28 -75.58 1.3 Allowed Glycine 0 CA--C 1.522 0.487 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 178.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -124.83 154.28 41.25 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.824 0.345 . . . . 0.0 110.486 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.9 tp10 -89.97 147.23 23.83 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.976 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.439 ' CB ' HG22 ' A' ' 80' ' ' VAL . . . -70.79 147.93 48.42 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.917 0.389 . . . . 0.0 110.364 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -108.15 139.72 42.4 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.644 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 10.1 t-105 -102.45 134.21 46.14 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.448 -0.797 . . . . 0.0 108.901 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -163.19 154.23 16.85 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.083 -0.647 . . . . 0.0 111.587 -178.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.1 tt -128.19 127.72 43.44 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.759 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.32 10.77 84.23 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.29 -16.64 59.32 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 16.8 m -109.21 148.54 38.2 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -56.18 143.9 82.91 Favored 'Trans proline' 0 N--CA 1.488 1.19 0 C-N-CA 121.103 1.202 . . . . 0.0 110.468 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.515 ' H ' ' CD2' ' A' ' 45' ' ' LEU . 0.8 OUTLIER -101.15 -177.46 3.45 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.246 -179.01 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -141.55 124.22 15.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.907 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.84 81.36 0.11 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.932 0.396 . . . . 0.0 110.611 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.442 ' O ' ' O ' ' A' ' 51' ' ' ASN . 85.4 m-20 -66.46 -168.63 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.098 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.44 -52.17 59.43 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.622 -0.431 . . . . 0.0 109.885 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 62.4 ttp -67.01 -39.82 87.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.805 178.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.442 ' O ' ' O ' ' A' ' 48' ' ' ASN . 26.2 t30 -94.46 102.26 14.21 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.924 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -116.67 140.17 49.71 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 87.8 mt -123.34 132.67 70.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.801 0.334 . . . . 0.0 110.481 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.7 t -130.98 140.77 50.19 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.077 0.465 . . . . 0.0 110.852 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 72.6 t -120.89 131.8 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.534 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -118.84 179.77 4.05 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.759 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -59.87 167.91 2.0 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.997 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.07 15.24 74.23 Favored Glycine 0 CA--C 1.519 0.343 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.453 ' CG2' ' O ' ' A' ' 28' ' ' LEU . 0.6 OUTLIER 54.89 35.44 24.37 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.204 0.526 . . . . 0.0 110.379 -179.771 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 81.1 mt -79.11 139.08 38.16 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.438 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -118.82 147.89 43.44 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.6 ' C ' HD23 ' A' ' 62' ' ' LEU . 5.4 tt -155.38 115.2 3.7 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 120.499 -0.481 . . . . 0.0 111.432 -178.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.522 ' N ' HD23 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -86.73 106.66 17.81 Favored 'General case' 0 N--CA 1.461 0.11 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.363 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 89.9 m -90.21 105.64 17.95 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.898 0.38 . . . . 0.0 110.304 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 80.3 mt -109.82 118.03 35.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.732 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.544 ' ND1' ' N ' ' A' ' 67' ' ' LYS . 24.9 t-80 -77.75 -136.39 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 120.549 -0.461 . . . . 0.0 110.63 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.544 ' N ' ' ND1' ' A' ' 66' ' ' HIS . 15.8 ptmt -53.3 96.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.209 0.528 . . . . 0.0 110.694 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.1 p -69.72 159.29 5.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.874 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 70.6 p -136.95 161.24 36.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.334 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.479 ' H ' HD23 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -59.56 -27.26 66.08 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.193 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -71.4 -32.83 68.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.157 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -62.45 -36.52 82.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.026 -178.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -47.43 143.8 3.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.841 0.353 . . . . 0.0 110.438 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 172.86 -175.14 45.91 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 98.1 m -106.81 126.18 51.96 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.654 0.264 . . . . 0.0 111.403 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.3 t -98.51 133.25 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.6 m -122.71 154.01 38.66 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.084 0.469 . . . . 0.0 111.186 -178.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -134.46 144.7 48.26 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.28 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 61.7 m80 -133.44 113.92 13.07 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.74 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.479 ' C ' ' H ' ' A' ' 82' ' ' THR . 2.1 t -122.1 133.76 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.53 -5.07 0.29 Allowed Glycine 0 CA--C 1.528 0.905 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.564 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.479 ' H ' ' C ' ' A' ' 80' ' ' VAL . 5.1 p -109.39 -43.71 4.06 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.854 0.327 . . . . 0.0 111.165 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.591 ' SG ' ' N ' ' A' ' 84' ' ' SER . 44.4 t -152.85 166.05 33.49 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.709 0.29 . . . . 0.0 111.259 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.591 ' N ' ' SG ' ' A' ' 83' ' ' CYS . 60.0 m -129.01 151.35 49.8 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.859 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 37.6 p -158.63 166.61 31.64 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.925 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.43 ' N ' ' CD ' ' A' ' 86' ' ' GLU . 2.4 pm0 -154.24 169.86 22.64 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.943 0.401 . . . . 0.0 110.743 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -154.37 151.62 29.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.976 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -115.29 123.88 49.89 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.025 0.441 . . . . 0.0 111.14 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.58 HD23 ' C ' ' A' ' 89' ' ' LEU . 5.8 tt -107.09 115.1 29.59 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.462 ' N ' HD23 ' A' ' 89' ' ' LEU . 68.6 mttm -111.85 153.69 26.25 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.54 0.686 . . . . 0.0 111.737 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 43.8 t -120.8 129.89 75.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.396 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 29.5 m -100.68 128.0 46.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.526 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.83 140.83 56.31 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.254 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.777 0 CA-C-O 118.076 -1.402 . . . . 0.0 110.876 -179.727 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.8 mtm . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.571 ' N ' ' CD ' ' A' ' 3' ' ' PRO . . . -179.53 -44.17 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.553 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 2' ' ' ALA . 6.1 Cg_exo -72.0 145.43 44.89 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.447 2.098 . . . . 0.0 111.747 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -92.19 -157.63 0.53 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.509 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 29' ' ' SER . 9.9 p -58.8 128.68 19.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.461 ' OG1' ' CB ' ' A' ' 29' ' ' SER . 53.8 p -86.6 131.17 34.23 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 119.719 -0.792 . . . . 0.0 110.2 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 24.9 mm -99.87 73.0 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.052 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 79.6 mt -112.36 81.36 1.46 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -118.15 88.0 30.89 Favored Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.986 -177.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -73.48 -5.0 16.38 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 121.999 1.799 . . . . 0.0 110.229 178.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.413 HD22 ' HA ' ' A' ' 11' ' ' LEU . 0.2 OUTLIER -64.25 90.62 0.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.668 -179.694 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -97.3 -124.15 0.13 Allowed 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.404 ' O ' ' OD2' ' A' ' 13' ' ' ASP . 47.5 p-10 -109.01 137.5 46.83 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.798 0.333 . . . . 0.0 110.959 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.6 m -130.8 156.71 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -121.38 134.86 55.12 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.866 0.365 . . . . 0.0 110.782 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.9 pp -147.71 135.73 21.24 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.736 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.6 p -75.73 158.21 32.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.497 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -65.64 142.28 58.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.887 0.375 . . . . 0.0 110.022 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.3 -6.67 78.35 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -97.79 156.85 16.39 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 51.1 p30 -78.43 162.32 26.49 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.908 0.385 . . . . 0.0 110.964 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -147.2 150.74 35.49 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.52 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.4 p -160.04 159.07 31.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.346 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.411 ' O ' HD12 ' A' ' 62' ' ' LEU . 57.8 m-85 -131.8 152.42 50.99 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.951 0.405 . . . . 0.0 110.694 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -142.43 128.33 19.47 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 50.6 m -131.6 155.38 47.63 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.183 0.516 . . . . 0.0 111.577 -179.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -121.85 94.6 4.36 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.68 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 85.5 mt -127.15 112.53 15.26 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.745 -0.207 . . . . 0.0 110.691 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.467 ' O ' HG23 ' A' ' 5' ' ' VAL . 46.0 t -62.54 158.02 19.04 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.128 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 53.0 ptt85 -55.3 158.46 3.12 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.723 -177.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -86.28 -179.13 6.64 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.84 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 30.9 t -157.77 -49.61 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.141 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -86.15 -75.17 1.26 Allowed Glycine 0 CA--C 1.52 0.366 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -122.84 142.81 50.36 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.103 0.477 . . . . 0.0 111.051 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -75.02 144.02 43.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.768 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -81.54 170.28 16.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.666 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.6 mtm180 -132.46 137.28 47.19 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.355 0.598 . . . . 0.0 111.916 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 76.5 t-105 -117.93 137.49 52.79 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -169.96 165.96 9.44 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 119.474 -0.89 . . . . 0.0 112.484 -177.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.626 ' C ' HD23 ' A' ' 40' ' ' LEU . 7.0 tt -136.79 122.5 19.83 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.227 178.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.546 ' N ' HD23 ' A' ' 40' ' ' LEU . . . 78.27 14.6 82.04 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.98 4.17 87.23 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 111.62 -0.592 . . . . 0.0 111.62 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.1 t -113.27 130.26 23.8 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-O 119.491 -0.29 . . . . 0.0 110.467 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -58.34 144.94 95.48 Favored 'Trans proline' 0 N--CA 1.491 1.35 0 C-N-CA 120.919 1.08 . . . . 0.0 110.34 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.2 mt -77.53 150.76 34.78 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.681 -179.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -129.01 153.91 47.12 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.382 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.24 80.88 0.35 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.474 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -77.7 169.08 18.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.716 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -66.79 -37.17 84.04 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.137 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 25.8 ptt? -86.83 -21.23 26.56 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.651 0.262 . . . . 0.0 111.266 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.464 ' OD1' ' N ' ' A' ' 52' ' ' ASP . 58.9 t-20 -103.1 146.33 28.54 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.417 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.464 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 98.3 m-20 -138.84 115.18 10.41 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.414 HG21 HD13 ' A' ' 53' ' ' ILE . 48.1 mt -107.95 125.9 64.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.2 t -144.75 153.15 41.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.049 0.452 . . . . 0.0 110.912 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.423 ' O ' HG13 ' A' ' 55' ' ' VAL . 14.6 p -104.15 130.89 54.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.501 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -111.77 -179.19 3.63 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.485 -179.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -63.38 152.07 39.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.533 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.14 9.32 86.85 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 -179.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.3 m 67.27 38.75 3.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.866 0.365 . . . . 0.0 110.646 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.9 mp -94.39 130.59 40.66 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.674 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 64.0 m80 -91.38 158.0 16.77 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.411 HD12 ' O ' ' A' ' 24' ' ' PHE . 48.2 tp -156.77 111.24 2.75 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 120.247 -0.581 . . . . 0.0 111.623 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.44 ' CD1' ' N ' ' A' ' 63' ' ' LEU . 6.5 mp -96.73 115.7 27.88 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.816 178.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 63.7 m -109.94 95.47 5.61 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.551 HD23 ' N ' ' A' ' 66' ' ' HIS . 5.4 tt -107.53 121.5 44.76 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.551 ' N ' HD23 ' A' ' 65' ' ' LEU . 79.3 t60 -80.34 -86.05 0.09 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -178.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? -76.05 106.88 7.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.91 0.386 . . . . 0.0 110.428 -178.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.9 p -88.59 155.11 3.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.906 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 72.8 p -130.95 156.69 44.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.324 -0.398 . . . . 0.0 109.948 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 93.4 mt -59.54 -29.8 68.16 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -67.58 -35.36 78.85 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.959 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -61.72 -32.16 72.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.575 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.27 140.23 39.86 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.625 -0.43 . . . . 0.0 109.893 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 172.55 -171.64 44.44 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 87.8 m -101.53 120.87 40.97 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.735 0.303 . . . . 0.0 111.281 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 10.6 t -86.4 130.91 35.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.2 m -118.2 148.83 41.99 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.109 0.48 . . . . 0.0 110.918 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -136.95 124.96 22.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.453 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 63.4 t-80 -137.62 125.45 22.55 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.831 0.348 . . . . 0.0 111.568 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.411 ' O ' ' C ' ' A' ' 81' ' ' GLY . 5.8 p -141.47 134.3 29.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.579 178.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.411 ' C ' ' O ' ' A' ' 80' ' ' VAL . . . -26.36 -51.94 0.06 OUTLIER Glycine 0 CA--C 1.53 0.977 0 CA-C-N 115.573 -0.739 . . . . 0.0 113.248 -178.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 68.3 p -61.52 -77.27 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 7.3 m -125.56 -166.7 1.59 Allowed 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.06 0.457 . . . . 0.0 111.136 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 28.6 m -149.93 147.06 27.44 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.308 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 50.0 m -126.99 155.42 43.21 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.745 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -129.65 147.2 51.42 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.103 0.478 . . . . 0.0 111.126 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.63 151.92 30.26 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.762 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -130.96 138.51 49.75 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.982 0.42 . . . . 0.0 111.301 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.51 HD23 ' N ' ' A' ' 90' ' ' LYS . 2.2 tt -112.49 111.31 22.06 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.51 ' N ' HD23 ' A' ' 89' ' ' LEU . 57.3 mtpt -117.71 155.1 30.54 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.996 0.427 . . . . 0.0 111.391 -178.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 34.4 m -113.48 133.26 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.461 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 81.2 m -105.27 130.65 53.36 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.525 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.2 169.7 6.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.162 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.729 0 CA-C-O 118.015 -1.436 . . . . 0.0 110.981 179.862 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 82.0 mtp . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.558 ' H ' ' CD ' ' A' ' 3' ' ' PRO . . . -174.41 -44.44 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.703 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.558 ' CD ' ' H ' ' A' ' 2' ' ' ALA . 6.2 Cg_exo -71.04 145.43 49.77 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 122.379 2.053 . . . . 0.0 112.744 -178.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -81.57 153.75 26.57 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.213 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.522 HG22 ' HA ' ' A' ' 31' ' ' ALA . 2.4 t -67.54 133.2 31.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.584 HG23 ' OG ' ' A' ' 29' ' ' SER . 71.0 p -90.14 127.16 36.03 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 118.633 -1.227 . . . . 0.0 110.42 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 20.7 mm -104.81 49.46 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.811 -178.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 89.5 mt -88.07 81.02 7.52 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.532 ' C ' ' H ' ' A' ' 11' ' ' LEU . 27.8 mt-10 -111.9 97.07 36.51 Favored Pre-proline 0 CA--C 1.536 0.413 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.695 -179.225 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -68.9 25.82 0.15 Allowed 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.656 1.571 . . . . 0.0 111.53 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.532 ' H ' ' C ' ' A' ' 9' ' ' GLU . 3.8 mm? -72.82 125.76 28.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.244 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -133.38 -152.65 0.5 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.22 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.417 ' OD2' ' N ' ' A' ' 13' ' ' ASP . 23.0 p-10 -106.32 131.4 53.58 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.796 0.331 . . . . 0.0 110.238 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 26.9 m -133.07 154.74 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-O 121.052 0.453 . . . . 0.0 110.904 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -126.86 112.99 15.98 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 58.3 mt -110.69 132.9 53.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.444 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 55.7 p -73.05 161.86 30.15 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -63.64 142.94 58.21 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.352 -0.539 . . . . 0.0 110.308 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.93 -3.32 77.23 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 111.119 -0.793 . . . . 0.0 111.119 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -103.4 140.8 36.97 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.028 0.442 . . . . 0.0 110.911 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -78.25 173.76 11.93 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.399 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.85 149.9 36.18 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.722 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 41.8 t -162.78 155.36 19.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.027 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.416 ' HB3' HD11 ' A' ' 11' ' ' LEU . 70.6 m-85 -135.83 155.01 51.0 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.075 -0.512 . . . . 0.0 109.643 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -139.37 114.18 9.35 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 179.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.455 ' HG ' ' HZ2' ' A' ' 38' ' ' TRP . 1.0 OUTLIER -110.91 150.2 29.55 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.181 -178.762 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 96.3 mtt-85 -114.32 93.37 4.31 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.406 HD21 ' CG ' ' A' ' 9' ' ' GLU . 85.8 mt -119.35 118.65 31.75 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -178.347 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.584 ' OG ' HG23 ' A' ' 6' ' ' THR . 88.3 p -76.41 161.11 28.95 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 177.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 12.0 ptp85 -50.64 163.54 0.18 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -176.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.522 ' HA ' HG22 ' A' ' 5' ' ' VAL . . . -83.32 167.53 17.51 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 113.635 -1.62 . . . . 0.0 110.777 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.2 p -152.22 -59.75 0.15 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -90.99 -70.99 1.21 Allowed Glycine 0 CA--C 1.524 0.621 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 178.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 10.6 tp-100 -122.08 136.27 54.9 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -83.5 148.66 27.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.863 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.49 152.88 39.33 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.91 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 15.4 tpt180 -123.19 123.5 40.94 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.057 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.57 ' CZ2' ' CE1' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -83.59 157.93 22.11 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.151 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -166.78 146.12 5.49 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 119.028 -1.069 . . . . 0.0 112.674 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.521 ' C ' HD23 ' A' ' 40' ' ' LEU . 8.7 tt -142.26 128.13 19.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.631 178.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.456 ' N ' HD23 ' A' ' 40' ' ' LEU . . . 80.11 4.27 89.7 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -178.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.56 -24.92 29.9 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 111.941 -0.464 . . . . 0.0 111.941 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 16.7 m -109.41 148.58 38.36 Favored Pre-proline 0 N--CA 1.471 0.607 0 CA-C-N 117.048 0.424 . . . . 0.0 111.37 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -54.97 137.78 76.78 Favored 'Trans proline' 0 N--CA 1.487 1.132 0 C-N-CA 121.449 1.432 . . . . 0.0 110.752 178.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.54 -176.83 3.74 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.03 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -140.52 161.26 38.16 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.648 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.83 81.69 0.89 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.959 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.45 ' O ' ' O ' ' A' ' 51' ' ' ASN . 65.0 t30 -82.0 171.97 13.79 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.984 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -63.82 -35.7 81.49 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.934 0.397 . . . . 0.0 110.108 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 3.2 ppp? -86.96 -3.18 59.06 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.329 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.45 ' O ' ' O ' ' A' ' 48' ' ' ASN . 56.4 t30 -138.51 109.08 6.56 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.554 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -109.67 124.12 50.66 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.121 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.2 mt -110.78 132.15 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.228 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.4 t -144.42 150.5 37.78 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.154 0.502 . . . . 0.0 111.122 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 46.2 t -100.76 116.39 44.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.276 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -88.76 172.73 9.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.309 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -63.15 158.68 19.24 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.784 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.35 17.73 76.31 Favored Glycine 0 CA--C 1.518 0.276 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 66.66 27.9 9.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.95 0.405 . . . . 0.0 110.794 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.7 mp -85.37 131.09 34.45 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.893 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 75.5 m80 -94.49 163.62 13.33 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.468 HD13 ' N ' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -155.23 113.17 3.42 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.717 -179.425 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.468 ' N ' HD13 ' A' ' 62' ' ' LEU . 4.3 mm? -94.01 114.61 26.82 Favored 'General case' 0 C--N 1.341 0.215 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 63.9 m -102.2 103.88 14.42 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 38.4 tp -110.58 126.88 54.9 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.724 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -127.94 162.49 26.63 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.596 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt 53.57 72.49 0.43 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.085 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.6 p -91.27 140.92 15.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.067 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.455 ' O ' ' N ' ' A' ' 71' ' ' GLU . 26.9 m -125.39 131.03 53.02 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.4 pp -45.04 -19.22 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.88 0.371 . . . . 0.0 110.757 -178.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.455 ' N ' ' O ' ' A' ' 69' ' ' THR . 98.6 mt-10 -70.66 -32.91 70.36 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.948 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.433 ' O ' ' O ' ' A' ' 73' ' ' ALA . 51.5 t0 -54.16 -70.28 0.1 Allowed 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.373 -178.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.433 ' O ' ' O ' ' A' ' 72' ' ' ASP . . . 33.66 94.19 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.785 0.326 . . . . 0.0 111.019 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -136.73 170.83 23.25 Favored Glycine 0 N--CA 1.463 0.463 0 N-CA-C 111.389 -0.685 . . . . 0.0 111.389 -179.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 28.6 m -117.96 117.49 29.39 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.632 -0.284 . . . . 0.0 110.273 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 11.1 t -93.49 132.99 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 11.3 p -138.17 158.18 44.82 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.012 0.434 . . . . 0.0 111.299 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.57 ' CE1' ' CZ2' ' A' ' 38' ' ' TRP . 4.7 m-85 -130.85 144.95 51.83 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 62.7 t-80 -138.8 115.38 10.59 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.842 0.353 . . . . 0.0 111.601 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.536 ' O ' ' N ' ' A' ' 82' ' ' THR . 2.0 t -123.41 129.88 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.103 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -39.2 -20.84 0.01 OUTLIER Glycine 0 CA--C 1.527 0.838 0 CA-C-N 116.339 -0.391 . . . . 0.0 112.214 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.536 ' N ' ' O ' ' A' ' 80' ' ' VAL . 18.4 p -83.5 -74.81 0.35 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.996 0.427 . . . . 0.0 110.162 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 36.6 m -125.53 162.53 24.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.287 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 62.3 m -129.95 155.37 46.19 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.783 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 96.0 p -156.8 162.54 39.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.329 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.51 ' N ' ' OE2' ' A' ' 86' ' ' GLU . 56.7 mp0 -138.14 152.9 49.16 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.111 0.482 . . . . 0.0 111.061 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -139.19 149.58 44.58 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.388 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -119.84 126.57 51.3 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.992 0.425 . . . . 0.0 111.647 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 59.5 tp -113.56 116.13 29.05 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -127.89 147.52 50.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.383 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.7 t -106.52 125.72 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 120.91 0.386 . . . . 0.0 110.029 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.0 t -96.97 164.9 12.34 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.85 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.07 -5.93 58.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.106 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.717 0 CA-C-O 117.912 -1.493 . . . . 0.0 110.99 179.883 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.2 mtt . . . . . 0 N--CA 1.487 1.404 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.441 ' O ' ' OE2' ' A' ' 4' ' ' GLU . . . -159.37 73.26 3.38 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.75 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -63.09 148.78 92.99 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 121.935 1.757 . . . . 0.0 111.902 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.444 ' N ' ' CD ' ' A' ' 4' ' ' GLU . 2.6 pm0 -145.72 -146.92 0.2 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.235 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.47 ' O ' HG13 ' A' ' 5' ' ' VAL . 9.3 p -74.65 131.69 34.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.836 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 95.6 m -119.73 128.51 53.84 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.881 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.2 mp -121.62 112.72 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-O 121.121 0.486 . . . . 0.0 111.531 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.6 mt -105.25 93.72 4.84 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 177.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.422 ' OE2' ' CE1' ' A' ' 78' ' ' PHE . 3.4 pt-20 -116.94 89.99 31.31 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.321 -178.144 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -70.43 -12.59 31.87 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 122.296 1.997 . . . . 0.0 111.792 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.1 68.6 2.7 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.09 0.472 . . . . 0.0 109.737 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -77.99 -2.36 36.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.152 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 39.9 p-10 -172.89 143.36 1.2 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.189 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.8 m -134.93 155.93 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 120.891 0.377 . . . . 0.0 111.338 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -137.25 120.43 16.74 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.189 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 pp -152.14 138.56 18.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.947 0.403 . . . . 0.0 110.828 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.6 m -74.74 150.32 39.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.235 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -56.97 147.49 23.79 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.36 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.92 -9.17 78.55 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.769 -0.533 . . . . 0.0 111.769 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -97.09 156.23 16.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.853 0.358 . . . . 0.0 110.719 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.433 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 19.6 p-10 -75.33 148.91 38.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.495 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -134.54 149.51 50.66 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.814 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 38.2 t -163.17 159.88 23.5 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.567 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -129.47 143.11 50.7 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.383 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -142.39 119.93 11.73 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.905 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 1.2 p -149.6 157.67 43.47 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.078 0.466 . . . . 0.0 111.028 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 96.3 mtt-85 -99.68 143.34 30.03 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.564 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.463 ' O ' ' OG1' ' A' ' 59' ' ' THR . 2.1 tt -145.55 96.41 2.82 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.602 -179.002 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.7 p -59.97 159.72 8.89 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.805 0.336 . . . . 0.0 110.24 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -57.37 156.3 7.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.868 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -100.05 -173.28 2.4 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.646 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.3 t -141.68 -58.25 0.48 Allowed 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -82.96 -77.07 1.11 Allowed Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -123.91 143.28 50.46 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.797 0.332 . . . . 0.0 110.802 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -92.1 146.21 23.91 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.121 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.479 ' CB ' HG22 ' A' ' 80' ' ' VAL . . . -71.86 151.81 43.11 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.373 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 -130.99 151.89 50.9 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.236 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -74.49 178.33 5.37 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.85 125.65 3.66 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.402 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 58.1 tp -129.8 115.91 17.95 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.8 16.67 72.51 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.1 -24.29 25.5 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.5 m -103.4 150.47 38.04 Favored Pre-proline 0 N--CA 1.468 0.448 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -53.93 143.17 61.83 Favored 'Trans proline' 0 C--N 1.315 -1.201 0 C-N-CA 121.455 1.437 . . . . 0.0 110.757 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.476 ' H ' ' CD2' ' A' ' 45' ' ' LEU . 0.8 OUTLIER -89.08 175.72 7.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.484 179.867 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 11.6 tp-100 -144.89 153.76 41.91 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.23 72.85 1.26 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.829 0.347 . . . . 0.0 111.539 -178.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' A' ' 51' ' ' ASN . 70.8 m-20 -64.9 -177.16 0.32 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 56.2 mp0 -68.29 -46.17 71.04 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.469 -0.493 . . . . 0.0 110.685 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 76.6 mtm -67.61 -39.32 84.76 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.943 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' A' ' 48' ' ' ASN . 1.9 m-80 -93.56 143.03 26.68 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.733 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.462 ' O ' HD12 ' A' ' 63' ' ' LEU . 97.8 m-20 -135.89 136.83 40.84 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.0 mm -107.39 122.5 61.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 95.3 m -129.85 129.49 44.03 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.073 0.463 . . . . 0.0 111.31 -178.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.5 m -121.3 136.88 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.425 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -137.56 -177.26 4.71 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.823 0.344 . . . . 0.0 110.521 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -51.23 157.58 0.92 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.575 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.08 30.29 77.35 Favored Glycine 0 CA--C 1.519 0.322 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.463 ' OG1' ' O ' ' A' ' 28' ' ' LEU . 65.3 p 41.63 39.64 1.19 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.095 0.474 . . . . 0.0 110.263 -179.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 55.5 mt -71.28 131.86 44.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.013 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -107.11 135.71 48.19 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.963 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.443 HD13 ' C ' ' A' ' 62' ' ' LEU . 0.3 OUTLIER -146.52 97.32 2.9 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.462 HD12 ' O ' ' A' ' 52' ' ' ASP . 27.9 tp -96.61 106.97 19.33 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.113 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 26.5 m -89.7 114.59 26.26 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.109 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.586 HD13 ' N ' ' A' ' 66' ' ' HIS . 0.3 OUTLIER -105.47 118.37 36.39 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.457 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.586 ' N ' HD13 ' A' ' 65' ' ' LEU . 85.5 m-70 -110.77 147.02 35.33 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.261 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 65.5 mttm 54.82 58.58 4.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.97 179.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.1 p -56.57 149.02 3.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.343 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 79.6 p -133.13 155.48 49.19 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.457 179.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 90.4 mt -60.32 -24.72 65.24 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -68.66 -36.12 78.13 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.145 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -62.01 -41.24 97.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.043 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.24 141.54 50.44 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 172.01 -99.28 0.14 Allowed Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.245 -0.979 . . . . 0.0 111.737 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 31.7 m -159.11 117.06 2.82 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.826 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 82.0 t -107.39 129.47 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 57.7 m -138.42 178.77 6.89 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.906 0.384 . . . . 0.0 111.236 -178.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.422 ' CE1' ' OE2' ' A' ' 9' ' ' GLU . 97.4 m-85 -128.53 141.02 51.51 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.101 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -116.99 102.53 9.42 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.479 HG22 ' CB ' ' A' ' 36' ' ' ALA . 2.1 t -118.9 134.38 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.241 -179.044 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.52 -23.91 61.13 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 121.159 -0.544 . . . . 0.0 111.885 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 43.2 p -98.8 -21.79 16.17 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 117.188 0.494 . . . . 0.0 112.124 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.451 ' O ' ' O ' ' A' ' 80' ' ' VAL . 27.6 p -154.17 -177.83 6.7 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.057 0.456 . . . . 0.0 111.205 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 31.4 t -148.79 150.51 33.2 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 49.2 m -154.13 168.11 27.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.923 0.392 . . . . 0.0 110.871 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -151.14 157.71 43.07 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.645 -179.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.88 146.44 25.66 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.274 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.482 ' C ' HD12 ' A' ' 89' ' ' LEU . 87.6 mt-30 -116.85 131.39 56.96 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.28 0.562 . . . . 0.0 111.605 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.54 HD12 ' N ' ' A' ' 89' ' ' LEU . 9.4 mp -101.74 115.81 31.35 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.34 -0.846 . . . . 0.0 108.969 178.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -120.5 152.88 37.45 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.63 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.5 m -113.72 135.62 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 39.9 m -76.98 132.63 39.11 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.037 0.446 . . . . 0.0 111.29 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.4 144.88 51.41 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.105 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.713 0 CA-C-O 118.063 -1.41 . . . . 0.0 110.604 179.713 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.4 mtt . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.401 ' N ' ' CD ' ' A' ' 3' ' ' PRO . . . -175.76 55.08 0.13 Allowed Pre-proline 0 C--N 1.326 -0.422 0 C-N-CA 120.566 -0.454 . . . . 0.0 111.188 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.401 ' CD ' ' N ' ' A' ' 2' ' ' ALA . 5.4 Cg_exo -53.33 134.6 57.68 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 121.788 1.659 . . . . 0.0 111.107 179.545 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -176.87 146.32 0.54 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.269 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.528 ' O ' HG13 ' A' ' 5' ' ' VAL . 5.6 p -61.88 122.01 11.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.512 ' HB ' ' H ' ' A' ' 29' ' ' SER . 38.2 m -67.82 131.55 45.74 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 119.284 -0.966 . . . . 0.0 109.091 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.645 HG23 ' O ' ' A' ' 7' ' ' ILE . 9.7 tp -110.47 101.22 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-O 122.057 0.932 . . . . 0.0 112.072 -178.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.6 mt -129.99 82.06 2.05 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.44 -1.254 . . . . 0.0 109.581 178.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 49.0 tt0 -119.71 86.2 34.79 Favored Pre-proline 0 N--CA 1.468 0.448 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.561 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.454 ' O ' ' N ' ' A' ' 12' ' ' GLN . 3.4 Cg_exo -71.55 -7.68 21.71 Favored 'Trans proline' 0 C--N 1.314 -1.273 0 C-N-CA 122.279 1.986 . . . . 0.0 111.409 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 29.3 mt -64.4 75.2 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.853 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.454 ' N ' ' O ' ' A' ' 10' ' ' PRO . 87.6 mt-30 -76.65 -67.63 0.68 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.119 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.444 ' OD2' ' O ' ' A' ' 12' ' ' GLN . 63.6 m-20 -157.42 127.3 6.18 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.514 -178.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.3 m -129.24 156.9 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 121.362 0.601 . . . . 0.0 111.305 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -120.71 129.33 53.61 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.136 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 74.8 mt -118.88 129.27 55.11 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.053 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.6 m -78.76 148.35 33.02 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 177.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -63.81 134.16 54.73 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.953 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.79 -2.09 64.08 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -112.24 134.5 53.75 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.006 0.431 . . . . 0.0 110.717 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -83.21 167.66 17.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.122 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -159.73 174.87 13.87 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.226 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.434 ' OG ' HD11 ' A' ' 62' ' ' LEU . 29.9 t -156.87 148.62 22.62 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.071 0.463 . . . . 0.0 110.915 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -103.0 141.09 36.39 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -129.39 119.1 23.27 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.118 0.485 . . . . 0.0 110.384 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 2.7 m -126.56 163.95 22.27 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.581 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 77.5 ttt-85 -142.65 115.76 8.87 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.9 mt -127.69 100.91 6.15 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 121.095 -0.242 . . . . 0.0 110.995 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.512 ' H ' ' HB ' ' A' ' 6' ' ' THR . 14.2 t -60.05 177.61 0.23 Allowed 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 119.991 -0.684 . . . . 0.0 109.5 179.162 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -54.41 136.95 43.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.481 0.658 . . . . 0.0 111.866 -178.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.05 -172.86 3.28 Favored 'General case' 0 CA--C 1.521 -0.136 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.937 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.2 t -147.53 -65.34 0.26 Allowed 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.493 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.84 -88.46 0.22 Allowed Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 178.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -124.13 141.0 52.43 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.234 0.54 . . . . 0.0 111.368 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.4 tp10 -83.63 152.91 24.55 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.246 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.41 ' CB ' HG22 ' A' ' 80' ' ' VAL . . . -70.38 139.34 51.88 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.197 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 86.2 mtm-85 -115.97 138.59 51.06 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.763 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 80.8 m95 -76.21 169.16 18.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.008 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -165.1 119.83 1.31 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.809 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.638 ' C ' HD23 ' A' ' 40' ' ' LEU . 6.7 tt -118.96 114.75 23.04 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.432 ' N ' HD23 ' A' ' 40' ' ' LEU . . . 74.97 14.7 81.51 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.64 -23.57 35.37 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 16.7 m -104.94 146.52 32.82 Favored Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -54.62 142.12 73.0 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 121.547 1.498 . . . . 0.0 111.892 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.489 ' H ' ' CD2' ' A' ' 45' ' ' LEU . 1.0 OUTLIER -82.4 171.54 14.06 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.279 179.154 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 71.3 tp60 -144.92 142.01 29.51 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.187 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.38 141.57 58.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.82 0.343 . . . . 0.0 110.274 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.456 ' O ' ' O ' ' A' ' 51' ' ' ASN . 45.4 t30 -155.66 -164.89 1.84 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 53.8 mp0 -66.03 -48.49 70.92 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 119.924 -0.71 . . . . 0.0 110.167 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 66.4 ttp -68.35 -43.43 77.47 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.466 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.456 ' O ' ' O ' ' A' ' 48' ' ' ASN . 99.1 m-20 -107.39 137.84 44.7 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.892 0.377 . . . . 0.0 110.84 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 48' ' ' ASN . 96.7 m-20 -139.31 146.74 40.69 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 98.6 mt -124.06 127.05 73.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 88.5 m -125.43 131.47 52.9 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.886 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.6 t -87.69 128.06 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.209 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -116.1 154.26 30.28 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.545 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -56.36 155.73 6.67 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.583 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.85 12.39 84.48 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 68.77 22.92 7.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.619 -0.291 . . . . 0.0 111.758 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.9 mp -79.28 144.28 34.45 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 178.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 66.1 m170 -110.96 156.18 21.59 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.461 HD13 ' C ' ' A' ' 62' ' ' LEU . 0.4 OUTLIER -153.22 108.9 3.28 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.385 -179.208 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.427 ' N ' HD13 ' A' ' 62' ' ' LEU . 7.3 mp -95.94 109.58 21.92 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.273 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 95.3 m -87.44 113.87 23.54 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.432 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 74.8 mt -99.63 104.13 15.87 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.718 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -97.96 134.79 40.59 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.037 0.446 . . . . 0.0 111.579 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt 52.79 65.68 1.45 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.991 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.1 p -61.84 153.04 6.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.389 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.2 t -135.77 163.34 30.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.735 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 62.8 mt -60.31 -29.01 68.57 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.256 0.551 . . . . 0.0 109.867 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -66.69 -24.11 66.22 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.587 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.4 ' O ' ' C ' ' A' ' 73' ' ' ALA . 55.7 t0 -61.99 -40.76 96.73 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.36 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 72' ' ' ASP . . . -38.9 122.08 1.14 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.518 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -174.97 177.25 47.08 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 52.9 m -103.93 127.61 51.45 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.033 0.444 . . . . 0.0 111.436 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 74.0 t -117.15 129.42 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.242 178.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 36.2 t -144.5 171.68 14.01 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -150.96 150.51 30.89 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.047 0.451 . . . . 0.0 110.996 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -117.26 127.86 54.5 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.62 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.427 ' O ' ' O ' ' A' ' 83' ' ' CYS . 2.5 t -118.36 130.14 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.03 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -48.0 -19.26 0.95 Allowed Glycine 0 CA--C 1.53 1.006 0 CA-C-N 115.962 -0.563 . . . . 0.0 113.061 -178.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.01 -33.63 7.43 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 117.725 0.762 . . . . 0.0 111.549 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.427 ' O ' ' O ' ' A' ' 80' ' ' VAL . 33.1 m -144.93 -175.56 4.73 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 96.0 p -159.38 157.95 31.28 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.778 0.323 . . . . 0.0 110.912 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 48.2 t -167.27 168.33 13.41 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.085 0.469 . . . . 0.0 111.022 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -133.95 163.27 29.92 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.956 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -149.15 154.04 38.6 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -124.72 132.84 53.35 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.262 0.553 . . . . 0.0 111.512 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 60.7 tp -116.92 103.69 10.55 Favored 'General case' 0 C--N 1.334 -0.094 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.691 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -103.98 147.39 27.41 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 13.2 t -120.01 99.26 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.4 t -139.38 146.26 39.98 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.4 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -92.19 -7.35 48.57 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.155 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.684 0 CA-C-O 118.015 -1.436 . . . . 0.0 111.004 179.867 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.4 mmm . . . . . 0 N--CA 1.488 1.474 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -168.46 77.34 0.81 Allowed Pre-proline 0 C--N 1.329 -0.322 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.652 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -69.04 147.89 68.48 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.602 2.202 . . . . 0.0 112.535 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -65.86 -166.33 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.32 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.6 t -64.32 135.95 27.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.742 ' C ' HD12 ' A' ' 7' ' ' ILE . 20.4 m -104.14 135.8 44.95 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.767 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.742 HD12 ' C ' ' A' ' 6' ' ' THR . 1.8 mp -121.25 116.25 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 121.379 0.609 . . . . 0.0 111.222 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 96.5 mt -128.35 98.11 4.96 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.073 -0.967 . . . . 0.0 108.581 177.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -122.59 90.14 49.7 Favored Pre-proline 0 N--CA 1.468 0.449 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -178.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -74.23 -5.06 16.41 Favored 'Trans proline' 0 N--CA 1.489 1.231 0 C-N-CA 122.024 1.816 . . . . 0.0 110.068 178.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 65.7 mt -66.45 74.85 0.1 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.353 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -71.6 -49.61 38.67 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.957 0.408 . . . . 0.0 111.775 -179.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -173.7 137.76 0.62 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.989 -178.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 53.0 t -125.11 133.48 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 120.84 0.352 . . . . 0.0 110.578 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -134.24 99.68 4.47 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.126 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 87.4 mt -124.9 139.92 53.39 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.939 0.399 . . . . 0.0 111.309 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.3 t -68.32 141.92 55.66 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.447 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -51.21 149.16 4.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.306 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.95 16.98 78.03 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -115.58 147.48 40.69 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.96 136.59 50.68 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.331 -0.548 . . . . 0.0 109.593 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -132.23 154.92 49.13 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.234 -179.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.9 m -158.63 159.62 35.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.981 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -136.99 148.65 47.02 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.225 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -145.15 122.82 11.82 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.042 0.449 . . . . 0.0 110.935 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 5.9 t -135.56 139.59 44.01 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.248 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 64.6 ttp85 -122.71 127.98 49.96 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.111 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.6 pp -143.69 133.46 23.83 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.22 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.514 ' H ' ' HB ' ' A' ' 6' ' ' THR . 44.7 t -66.22 158.85 27.77 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.008 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 38.4 ptt-85 -51.48 163.93 0.24 Allowed 'General case' 0 C--N 1.32 -0.716 0 O-C-N 123.665 0.603 . . . . 0.0 111.972 -177.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.56 174.8 2.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.322 -178.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.462 ' OG ' ' N ' ' A' ' 33' ' ' GLY . 18.4 p -138.46 -56.82 0.64 Allowed 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.194 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.462 ' N ' ' OG ' ' A' ' 32' ' ' SER . . . -104.89 -66.85 0.69 Allowed Glycine 0 CA--C 1.523 0.592 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 178.432 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -122.7 143.08 50.03 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.783 0.325 . . . . 0.0 110.315 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.632 ' CD ' ' H ' ' A' ' 35' ' ' GLU . 1.2 pm0 -70.57 146.46 50.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.528 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.89 157.05 38.21 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -123.97 133.86 53.61 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.337 0.589 . . . . 0.0 111.683 -178.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 22.0 t-105 -99.02 147.87 24.59 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.084 -0.962 . . . . 0.0 108.919 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -172.68 147.6 1.81 Allowed 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 119.883 -0.727 . . . . 0.0 112.419 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.59 ' N ' HD11 ' A' ' 45' ' ' LEU . 15.6 tp -124.96 119.03 27.59 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.89 8.52 84.78 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.42 -1.36 58.69 Favored Glycine 0 CA--C 1.531 1.066 0 N-CA-C 111.954 -0.458 . . . . 0.0 111.954 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.9 m -115.87 147.25 38.7 Favored Pre-proline 0 CA--C 1.549 0.93 0 CA-C-N 117.384 0.592 . . . . 0.0 111.618 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -58.45 145.82 92.82 Favored 'Trans proline' 0 N--CA 1.502 2.022 0 C-N-CA 122.008 1.806 . . . . 0.0 112.359 178.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.59 HD11 ' N ' ' A' ' 40' ' ' LEU . 9.0 mp -90.29 144.84 25.47 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.084 178.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.437 ' O ' ' N ' ' A' ' 48' ' ' ASN . 1.0 OUTLIER -122.89 153.14 40.05 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.396 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.64 76.57 0.02 OUTLIER 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.489 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.463 ' OD1' ' N ' ' A' ' 49' ' ' GLU . 24.3 t-20 -74.25 165.7 24.72 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.607 179.121 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.463 ' N ' ' OD1' ' A' ' 48' ' ' ASN . 97.5 mt-10 -62.12 -40.34 95.59 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.616 -0.433 . . . . 0.0 110.885 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 12.4 ptt? -85.6 -15.33 42.9 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 121.032 -0.267 . . . . 0.0 111.173 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.461 ' O ' ' O ' ' A' ' 48' ' ' ASN . 35.1 t-20 -126.11 122.45 35.79 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.594 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -124.5 128.1 48.46 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 75.5 mt -107.1 129.56 60.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.951 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.9 t -143.93 147.98 34.73 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.853 -179.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.9 m -110.92 131.32 62.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.371 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.446 ' O ' ' C ' ' A' ' 57' ' ' GLN . 98.8 mt-10 -112.11 -173.51 2.26 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.382 -179.478 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.446 ' C ' ' O ' ' A' ' 56' ' ' GLU . 45.6 tp60 -25.62 144.07 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 O-C-N 123.834 0.709 . . . . 0.0 111.854 -179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 58.12 -97.31 0.07 OUTLIER Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 17.9 m -162.5 62.31 0.21 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.991 0.424 . . . . 0.0 110.364 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 8.3 tt -104.31 120.66 41.67 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.915 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -90.8 148.53 22.47 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.202 -0.453 . . . . 0.0 109.833 178.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.468 ' C ' HD23 ' A' ' 62' ' ' LEU . 8.3 tt -151.57 114.66 4.73 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.86 0.362 . . . . 0.0 110.409 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.6 mp -97.0 114.94 26.59 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.882 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.6 m -94.11 109.37 21.15 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 62.3 mt -101.06 132.31 46.56 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.545 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 49.7 p-80 -153.25 155.46 36.63 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.76 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt 50.97 55.49 9.48 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 120.889 0.376 . . . . 0.0 110.091 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.5 m -110.49 130.1 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.777 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 64.1 p -86.35 -157.49 0.36 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.052 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 40.5 tp -59.88 -15.96 25.42 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.876 0.369 . . . . 0.0 110.442 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -67.6 -5.45 15.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.966 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.427 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 25.2 p-10 -53.37 -30.0 37.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.394 -179.21 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.1 135.02 56.96 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.101 -0.64 . . . . 0.0 109.667 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -174.54 166.83 38.89 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.427 ' O ' HD12 ' A' ' 40' ' ' LEU . 1.0 OUTLIER -122.95 108.6 13.14 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.57 0.224 . . . . 0.0 110.707 -179.954 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 8.6 t -101.15 120.6 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 33.9 t -137.13 152.09 49.57 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.334 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -135.73 147.8 48.58 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.86 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.52 ' ND1' ' OG ' ' A' ' 84' ' ' SER . 93.7 m-70 -125.22 123.83 40.42 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.209 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.508 ' O ' ' N ' ' A' ' 82' ' ' THR . 2.9 p -128.41 130.35 69.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -31.7 -31.39 0.01 OUTLIER Glycine 0 CA--C 1.529 0.913 0 CA-C-N 115.671 -0.695 . . . . 0.0 113.1 -178.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.508 ' N ' ' O ' ' A' ' 80' ' ' VAL . 82.5 p -79.04 -75.68 0.23 Allowed 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.659 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.449 ' SG ' ' N ' ' A' ' 84' ' ' SER . 46.2 t -111.56 163.81 13.67 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 120.829 0.347 . . . . 0.0 111.315 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.52 ' OG ' ' ND1' ' A' ' 79' ' ' HIS . 23.3 t -140.74 134.36 30.15 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 13.9 m -160.27 167.91 26.49 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.272 0.558 . . . . 0.0 111.999 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -140.22 164.11 30.96 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.963 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -134.33 148.36 50.72 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -113.61 127.49 56.08 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.267 -179.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.56 HD23 ' C ' ' A' ' 89' ' ' LEU . 4.2 tt -112.02 112.34 23.9 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.52 ' N ' HD23 ' A' ' 89' ' ' LEU . 17.7 ttpt -113.29 170.12 8.46 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.078 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.0 t -111.0 125.58 68.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.476 -179.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.705 HG22 ' H ' ' A' ' 94' ' ' GLY . 97.8 m -79.98 129.77 34.75 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.999 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -88.96 -5.23 58.11 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.39 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.705 ' H ' HG22 ' A' ' 92' ' ' THR . . . . . . . . 0 C--O 1.22 -0.778 0 CA-C-O 117.939 -1.478 . . . . 0.0 110.834 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.5 mtt . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 45.3 70.7 1.85 Allowed Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.078 -179.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -73.92 158.48 46.17 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 122.803 2.335 . . . . 0.0 111.139 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.514 ' HG2' ' H ' ' A' ' 5' ' ' VAL . 39.3 tt0 73.3 176.43 0.26 Allowed 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.514 ' H ' ' HG2' ' A' ' 4' ' ' GLU . 9.8 p -52.65 136.49 13.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 110.431 -0.211 . . . . 0.0 110.431 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.559 HG22 ' CD1' ' A' ' 8' ' ' LEU . 7.1 m -115.96 125.3 52.36 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.42 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.791 ' N ' HD12 ' A' ' 7' ' ' ILE . 3.0 mp -108.41 111.43 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 121.144 0.497 . . . . 0.0 111.046 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.559 ' CD1' HG22 ' A' ' 6' ' ' THR . 8.8 mp -122.31 84.27 2.23 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.44 ' CG ' ' O ' ' A' ' 9' ' ' GLU . 0.2 OUTLIER -110.74 98.93 39.84 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.806 -178.246 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -73.9 -7.16 19.65 Favored 'Trans proline' 0 N--CA 1.489 1.238 0 C-N-CA 121.454 1.436 . . . . 0.0 110.136 178.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 52.3 mt -61.17 80.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.425 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -79.32 -67.15 0.78 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.422 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -171.78 128.26 0.63 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.651 -0.25 . . . . 0.0 110.37 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.8 m -126.15 162.1 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-O 120.926 0.394 . . . . 0.0 110.978 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -116.95 128.74 55.5 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.127 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 74.6 mt -123.01 129.34 51.39 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.058 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.4 p -76.55 164.18 26.19 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -61.83 128.68 37.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.828 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 77.34 19.53 76.48 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.068 178.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -103.41 138.47 40.1 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.85 0.357 . . . . 0.0 110.963 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 49.5 p30 -82.39 164.89 20.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.044 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -161.89 168.98 22.05 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.914 0.388 . . . . 0.0 110.213 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 73.1 m -147.76 140.85 25.01 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.961 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -111.8 129.85 56.0 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 23.8 tm0? -132.11 127.09 35.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.201 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -149.47 163.94 36.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.333 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -120.28 120.89 37.38 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.09 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.475 ' C ' HD23 ' A' ' 28' ' ' LEU . 3.7 tt -132.14 104.78 6.98 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.445 ' O ' HD23 ' A' ' 28' ' ' LEU . 10.1 p -62.68 153.12 33.45 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.167 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -53.31 153.25 4.0 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.592 -177.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.78 -175.17 3.66 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.848 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 44.9 t -142.44 -49.62 0.36 Allowed 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -91.77 -76.2 1.32 Allowed Glycine 0 CA--C 1.52 0.353 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -124.91 135.49 52.9 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.075 0.464 . . . . 0.0 111.864 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.461 ' O ' ' NH1' ' A' ' 37' ' ' ARG . 22.5 pt-20 -83.6 154.61 23.67 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.978 179.023 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.59 151.97 42.06 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.783 0.325 . . . . 0.0 110.692 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.461 ' NH1' ' O ' ' A' ' 35' ' ' GLU . 87.4 mmt-85 -106.72 148.24 28.64 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.068 0.461 . . . . 0.0 111.277 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 2.9 t-105 -107.71 148.52 29.31 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 179.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -173.31 155.26 2.85 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 119.864 -0.734 . . . . 0.0 111.73 -178.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 32.9 tp -134.22 124.72 26.42 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.707 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.51 6.14 88.06 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.653 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.73 -16.09 57.87 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 121.278 -0.487 . . . . 0.0 112.068 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.8 m -112.21 141.82 25.74 Favored Pre-proline 0 N--CA 1.472 0.671 0 CA-C-N 117.134 0.467 . . . . 0.0 110.43 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -56.87 143.12 92.43 Favored 'Trans proline' 0 N--CA 1.488 1.202 0 C-N-CA 120.826 1.018 . . . . 0.0 110.873 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.17 -166.69 1.33 Allowed 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.537 ' O ' ' N ' ' A' ' 48' ' ' ASN . 2.3 pm0 -153.28 153.99 33.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.927 0.394 . . . . 0.0 111.02 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -55.4 76.31 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.318 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.537 ' N ' ' O ' ' A' ' 46' ' ' GLN . 10.3 t-20 -75.04 171.37 14.23 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.884 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -62.13 -33.98 75.49 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.883 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 14.8 ptp -94.02 -19.63 20.7 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.772 0.32 . . . . 0.0 110.986 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -120.29 118.98 31.82 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.152 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -121.26 142.42 49.95 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.77 0.319 . . . . 0.0 110.63 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 15.5 mm -115.6 118.35 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.4 p -138.85 159.61 41.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.934 0.397 . . . . 0.0 111.183 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 55.8 t -117.51 129.04 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.659 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -107.4 167.46 9.91 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 12.5 tp-100 -58.42 152.77 17.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.947 0.403 . . . . 0.0 110.5 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.5 11.29 85.0 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 69.15 27.37 5.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.402 -0.399 . . . . 0.0 110.809 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.521 ' N ' HD12 ' A' ' 60' ' ' LEU . 10.6 mp -87.09 129.69 34.81 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.32 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -97.51 131.12 44.43 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.556 HD13 ' N ' ' A' ' 63' ' ' LEU . 0.5 OUTLIER -123.48 115.57 21.79 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.875 -179.481 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.556 ' N ' HD13 ' A' ' 62' ' ' LEU . 6.8 mp -103.01 114.04 28.01 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.065 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 25.9 m -88.8 117.01 27.48 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.179 0.514 . . . . 0.0 110.387 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.563 HD11 HG11 ' A' ' 68' ' ' VAL . 36.9 tp -107.31 127.13 53.27 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.253 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -85.23 -170.1 2.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.888 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -72.36 71.31 0.9 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.672 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.563 HG11 HD11 ' A' ' 65' ' ' LEU . 23.9 m -69.21 -172.54 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.488 0.661 . . . . 0.0 112.069 -179.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 69.8 p -130.6 -165.31 1.53 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.764 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 53.6 mt -64.23 -15.94 61.02 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.738 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.25 -38.11 89.31 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -66.63 -36.29 82.22 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.744 0.307 . . . . 0.0 111.316 -179.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -40.28 112.79 0.3 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.17 0.51 . . . . 0.0 111.268 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -168.83 -179.65 41.1 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 109.704 -1.359 . . . . 0.0 109.704 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 99.0 m -105.19 120.54 41.79 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.907 0.354 . . . . 0.0 111.413 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 12.0 t -93.59 134.55 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.9 p -140.9 146.62 37.7 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.132 0.491 . . . . 0.0 110.916 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -150.95 147.59 27.36 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.483 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 53.5 p-80 -159.78 163.4 34.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.58 0.705 . . . . 0.0 111.96 -178.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.561 HG22 ' H ' ' A' ' 82' ' ' THR . 2.5 p -131.59 140.4 48.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.254 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -35.54 -24.5 0.01 OUTLIER Glycine 0 CA--C 1.528 0.897 0 CA-C-N 115.67 -0.695 . . . . 0.0 112.604 -178.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.561 ' H ' HG22 ' A' ' 80' ' ' VAL . 43.9 p -85.97 -72.73 0.48 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.058 0.456 . . . . 0.0 110.864 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.513 ' N ' ' OG1' ' A' ' 82' ' ' THR . 35.3 m -108.55 -171.56 1.88 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.794 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 83.2 p -156.85 153.95 29.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.896 0.379 . . . . 0.0 111.097 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 47.8 t -152.89 153.79 33.74 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.342 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -134.54 150.96 50.81 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.51 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -139.85 148.37 42.0 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -124.13 125.6 44.75 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.996 0.426 . . . . 0.0 111.793 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.8 tp -113.28 100.84 8.87 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.678 178.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 13.4 ptpt -107.91 172.07 7.04 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 179.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.4 m -128.77 158.6 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 121.328 0.585 . . . . 0.0 111.478 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.8 t -113.73 130.52 56.42 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.745 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.67 140.74 57.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.366 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.217 -0.907 0 CA-C-O 118.066 -1.408 . . . . 0.0 111.14 179.392 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.496 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 50.57 77.74 0.44 Allowed Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.449 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -69.88 -21.75 32.48 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.81 2.34 . . . . 0.0 111.799 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.468 ' O ' ' OG ' ' A' ' 29' ' ' SER . 88.5 tt0 -57.81 150.26 20.43 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.444 ' O ' HG23 ' A' ' 5' ' ' VAL . 18.6 m -58.28 122.22 7.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.545 ' OG1' ' N ' ' A' ' 29' ' ' SER . 41.7 p -88.5 138.73 31.17 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 118.81 -1.156 . . . . 0.0 110.189 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 18.8 mm -110.55 62.4 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.643 -179.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.404 HD22 ' HA ' ' A' ' 8' ' ' LEU . 0.3 OUTLIER -102.09 74.2 1.43 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.346 0.593 . . . . 0.0 109.948 -179.798 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -122.99 84.32 50.72 Favored Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.921 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -70.9 50.83 1.16 Allowed 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 122.275 1.983 . . . . 0.0 112.25 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.455 HD11 ' SG ' ' A' ' 26' ' ' CYS . 96.6 mt -79.93 127.39 32.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.169 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 27.3 pt20 -118.81 -145.05 0.37 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.342 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -104.36 130.88 52.19 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.949 0.404 . . . . 0.0 110.426 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.4 m -123.41 138.1 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.2 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -113.32 115.31 27.93 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.264 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 73.3 mt -119.35 135.08 54.89 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.04 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.0 t -63.6 151.39 41.74 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -55.55 144.42 26.35 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.052 0.453 . . . . 0.0 111.504 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.18 19.2 75.09 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -114.68 144.97 42.59 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.281 0.563 . . . . 0.0 111.152 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 51.3 p-10 -75.5 168.24 20.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.305 -0.862 . . . . 0.0 110.028 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -140.79 142.65 34.65 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.69 0.281 . . . . 0.0 110.913 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 60.6 m -136.25 152.54 50.84 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.857 0.361 . . . . 0.0 111.087 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -135.4 152.24 51.23 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.379 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.422 ' C ' ' SG ' ' A' ' 26' ' ' CYS . 58.4 tt0 -134.33 143.49 47.72 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.698 0.285 . . . . 0.0 110.364 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.455 ' SG ' HD11 ' A' ' 11' ' ' LEU . 30.0 m -150.34 164.34 36.05 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.254 0.55 . . . . 0.0 111.506 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -134.4 99.8 4.48 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 115.427 -0.806 . . . . 0.0 108.859 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.417 ' O ' ' OG1' ' A' ' 59' ' ' THR . 50.1 mt -118.91 128.79 54.76 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.205 -178.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.545 ' N ' ' OG1' ' A' ' 6' ' ' THR . 24.1 p -73.65 158.66 34.32 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 51.7 ptt85 -58.11 169.47 0.81 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 -176.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.8 151.08 45.2 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 113.826 -1.534 . . . . 0.0 111.56 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 73.4 m -139.48 -54.95 0.57 Allowed 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.037 179.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -100.49 -65.81 0.81 Allowed Glycine 0 CA--C 1.52 0.372 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 178.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -123.39 145.27 48.9 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 178.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.696 ' CD ' ' H ' ' A' ' 35' ' ' GLU . 1.7 pm0 -76.17 143.73 40.95 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.092 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.52 152.71 37.78 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.536 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 84.2 mtm180 -128.56 139.74 52.14 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.236 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.532 ' CZ2' ' CE2' ' A' ' 78' ' ' PHE . 10.6 t-105 -101.46 150.96 22.51 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -171.37 157.33 4.89 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 119.498 -0.881 . . . . 0.0 111.914 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.564 ' C ' HD23 ' A' ' 40' ' ' LEU . 7.2 tt -123.72 124.94 43.84 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.415 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.477 ' N ' HD23 ' A' ' 40' ' ' LEU . . . 69.27 21.99 76.04 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.98 7.72 88.27 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 71.7 t -113.69 128.77 25.36 Favored Pre-proline 0 N--CA 1.47 0.537 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -57.34 143.56 93.56 Favored 'Trans proline' 0 N--CA 1.488 1.203 0 CA-C-N 120.004 1.037 . . . . 0.0 111.03 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -106.73 179.66 4.2 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.035 0.445 . . . . 0.0 111.245 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -145.86 150.63 36.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.988 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.99 139.26 48.51 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.035 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.431 ' OD1' ' O ' ' A' ' 51' ' ' ASN . 32.8 p-10 -166.54 -175.01 3.02 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.884 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -66.45 -41.79 88.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.576 -0.283 . . . . 0.0 111.66 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 54.4 ttp -67.95 -42.7 80.52 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.431 ' O ' ' OD1' ' A' ' 48' ' ' ASN . 86.7 m-20 -135.31 115.41 13.23 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.392 178.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.481 ' OD1' ' O ' ' A' ' 64' ' ' THR . 12.2 p-10 -111.63 147.41 35.57 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 178.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.1 mm -113.26 126.25 70.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 98.4 m -127.82 134.31 49.44 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.757 0.313 . . . . 0.0 110.9 -178.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.6 p -111.17 133.86 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 57' ' ' GLN . 95.9 mt-10 -116.09 -177.33 3.14 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.035 0.445 . . . . 0.0 111.766 -178.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.449 ' O ' ' N ' ' A' ' 59' ' ' THR . 77.8 mt-30 -24.92 144.11 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.069 -0.969 . . . . 0.0 112.784 -179.469 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.576 ' O ' HG23 ' A' ' 59' ' ' THR . . . 52.91 -89.44 0.01 OUTLIER Glycine 0 CA--C 1.519 0.284 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.576 HG23 ' O ' ' A' ' 58' ' ' GLY . 19.7 p -160.33 42.82 0.19 Allowed 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.484 -179.22 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.447 ' N ' HD12 ' A' ' 60' ' ' LEU . 10.6 mp -86.01 112.66 21.43 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 179.316 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 49.1 m170 -86.49 150.93 23.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.874 -179.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.2 tp -149.41 105.91 3.53 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.537 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.469 ' CD2' ' N ' ' A' ' 63' ' ' LEU . 1.3 mm? -83.15 111.41 18.89 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.072 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.481 ' O ' ' OD1' ' A' ' 52' ' ' ASP . 70.9 m -101.79 94.82 6.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.108 0.48 . . . . 0.0 111.206 -178.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.511 ' N ' HD12 ' A' ' 65' ' ' LEU . 10.5 mp -95.65 136.37 36.14 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.613 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.59 ' CG ' ' H ' ' A' ' 67' ' ' LYS . 45.7 t60 -70.93 -176.07 1.27 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.587 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.59 ' H ' ' CG ' ' A' ' 66' ' ' HIS . 97.7 mttt -63.47 100.39 0.26 Allowed 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.3 m -100.02 134.36 39.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.258 -178.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 30.9 p -79.28 -148.54 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.247 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.494 ' C ' ' H ' ' A' ' 72' ' ' ASP . 88.4 mt -54.48 -37.31 65.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.598 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -50.25 -8.38 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.661 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.494 ' H ' ' C ' ' A' ' 70' ' ' LEU . 37.1 p-10 -65.64 -35.73 81.66 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.821 0.343 . . . . 0.0 110.839 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -47.45 111.43 0.41 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -173.84 166.55 38.78 Favored Glycine 0 CA--C 1.522 0.496 0 C-N-CA 120.638 -0.792 . . . . 0.0 111.388 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 10.3 m -118.84 126.43 51.82 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.723 -0.239 . . . . 0.0 110.448 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.5 t -103.88 130.76 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 93.9 p -121.92 160.43 24.82 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.171 0.51 . . . . 0.0 110.43 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.532 ' CE2' ' CZ2' ' A' ' 38' ' ' TRP . 12.0 m-85 -135.32 138.31 43.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.172 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 72.6 t60 -127.89 127.52 43.53 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.184 0.516 . . . . 0.0 111.225 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.48 ' O ' ' C ' ' A' ' 81' ' ' GLY . 2.6 p -148.7 116.63 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.337 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.48 ' C ' ' O ' ' A' ' 80' ' ' VAL . . . -5.75 -67.34 0.01 OUTLIER Glycine 0 N--CA 1.473 1.116 0 O-C-N 123.927 0.767 . . . . 0.0 113.877 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.446 ' OG1' ' N ' ' A' ' 83' ' ' CYS . 65.1 p -48.6 -86.59 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -178.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.446 ' N ' ' OG1' ' A' ' 82' ' ' THR . 92.5 m -125.48 -168.71 1.88 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.384 -179.459 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 51.6 p -153.79 168.71 25.4 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.709 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 39.1 t -152.11 169.99 21.06 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.723 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -150.19 164.11 36.51 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 120.973 0.416 . . . . 0.0 111.184 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.0 152.1 38.05 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.114 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -119.5 129.96 54.97 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.215 0.531 . . . . 0.0 111.066 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 8.2 tt -117.53 122.68 44.35 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.399 -0.818 . . . . 0.0 109.684 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -120.23 159.51 24.79 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.015 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.466 ' O ' HG13 ' A' ' 91' ' ' VAL . 7.7 p -109.56 126.91 66.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-O 120.889 0.375 . . . . 0.0 110.154 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 31.6 m -66.02 131.27 45.83 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.539 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -100.12 -7.59 24.7 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.469 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.754 0 CA-C-O 117.934 -1.481 . . . . 0.0 110.882 -179.79 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.3 ttp . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -162.22 74.11 2.24 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.275 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -65.5 143.82 77.03 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.646 2.231 . . . . 0.0 111.457 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.406 ' HG2' ' H ' ' A' ' 4' ' ' GLU . 7.4 pt-20 -92.33 -114.18 0.09 Allowed 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -178.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.479 ' O ' HG13 ' A' ' 5' ' ' VAL . 9.6 p -72.09 127.22 33.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.599 HG23 ' OG ' ' A' ' 29' ' ' SER . 26.2 p -101.0 135.56 42.25 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.721 -179.3 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.74 ' N ' HD12 ' A' ' 7' ' ' ILE . 1.9 mp -107.78 115.16 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 121.492 0.663 . . . . 0.0 111.687 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.455 ' CD2' ' NH1' ' A' ' 27' ' ' ARG . 49.2 tp -126.95 110.77 13.35 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 114.537 -1.211 . . . . 0.0 109.141 178.326 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.498 ' OE1' ' SG ' ' A' ' 26' ' ' CYS . 24.9 mm-40 -125.15 91.8 48.52 Favored Pre-proline 0 N--CA 1.471 0.598 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -178.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -71.69 -9.32 24.76 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 C-N-CA 121.747 1.632 . . . . 0.0 111.619 177.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.84 87.75 3.43 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.613 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 95.9 mm-40 -69.61 -32.79 71.71 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.097 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 43.6 p-10 -176.96 142.58 0.38 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.904 0.383 . . . . 0.0 110.576 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 51.8 t -119.72 133.1 67.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.557 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.483 ' C ' HD22 ' A' ' 16' ' ' LEU . 24.1 mt-30 -135.85 108.61 7.53 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.483 HD22 ' C ' ' A' ' 15' ' ' GLN . 3.9 mm? -115.13 133.22 56.23 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 120.563 0.221 . . . . 0.0 110.427 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.9 t -68.1 149.52 49.52 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.877 0.37 . . . . 0.0 110.732 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -52.3 132.28 33.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.779 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.94 16.48 56.1 Favored Glycine 0 CA--C 1.534 1.256 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.972 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -125.06 155.87 39.1 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.913 0.387 . . . . 0.0 110.273 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 43.9 p-10 -85.72 169.36 13.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.555 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -134.44 147.36 50.41 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.042 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 44.5 t -134.87 141.21 46.29 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.884 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -119.96 146.38 45.88 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.127 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 30.4 mm100 -128.71 104.89 7.9 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.224 179.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.498 ' SG ' ' OE1' ' A' ' 9' ' ' GLU . 6.6 t -124.45 141.81 51.79 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.02 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.455 ' NH1' ' CD2' ' A' ' 8' ' ' LEU . 60.1 ttp180 -124.99 119.52 28.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.922 0.391 . . . . 0.0 110.634 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 84.0 mt -123.4 121.01 34.67 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.383 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.599 ' OG ' HG23 ' A' ' 6' ' ' THR . 66.3 p -71.6 161.33 31.17 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.399 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 18.5 ptp180 -53.9 147.74 11.66 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.377 0.608 . . . . 0.0 112.329 -178.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.29 -173.78 3.33 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.611 -178.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.7 t -163.68 -43.67 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.933 -1.03 . . . . 0.0 109.166 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -98.23 -71.41 1.02 Allowed Glycine 0 CA--C 1.521 0.409 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 179.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 -124.93 135.78 53.15 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.109 0.481 . . . . 0.0 111.926 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -90.12 151.98 21.34 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.211 178.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.2 167.62 15.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.358 -179.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -149.65 159.51 44.28 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.195 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.5 ' CB ' HD11 ' A' ' 45' ' ' LEU . 92.7 m95 -84.63 176.56 8.51 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.922 0.391 . . . . 0.0 110.222 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -166.12 106.32 0.69 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.676 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.449 ' C ' HD23 ' A' ' 40' ' ' LEU . 7.1 tt -114.88 118.0 32.26 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.59 21.37 68.87 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.7 -9.29 74.49 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 47.2 t -115.1 134.94 22.45 Favored Pre-proline 0 N--CA 1.471 0.618 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -56.71 142.21 91.55 Favored 'Trans proline' 0 N--CA 1.489 1.227 0 C-N-CA 121.378 1.386 . . . . 0.0 111.589 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.58 ' O ' HD12 ' A' ' 45' ' ' LEU . 0.4 OUTLIER -88.53 159.64 17.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.199 179.809 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -139.93 162.22 35.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.011 0.434 . . . . 0.0 110.389 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.99 76.3 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.362 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.468 ' CG ' ' H ' ' A' ' 49' ' ' GLU . 47.9 t30 -71.03 -174.89 1.03 Allowed 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.468 ' H ' ' CG ' ' A' ' 48' ' ' ASN . 86.5 tt0 -62.85 -44.63 95.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.153 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.9 ptt? -90.13 -16.24 29.98 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.02 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -105.32 142.2 35.5 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.092 0.472 . . . . 0.0 111.353 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.487 ' OD2' ' N ' ' A' ' 53' ' ' ILE . 63.3 t0 -148.03 146.47 28.9 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.429 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.487 ' N ' ' OD2' ' A' ' 52' ' ' ASP . 97.9 mt -125.25 130.77 72.93 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 CA-C-O 120.727 0.298 . . . . 0.0 110.616 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.3 p -135.47 157.91 45.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.11 0.481 . . . . 0.0 110.966 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 50.6 t -117.63 131.63 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.221 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.448 ' O ' ' O ' ' A' ' 57' ' ' GLN . 97.1 mt-10 -108.31 177.63 4.74 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.448 ' O ' ' O ' ' A' ' 56' ' ' GLU . 55.5 tt0 -28.15 148.77 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 O-C-N 123.795 0.684 . . . . 0.0 112.137 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 60.6 -98.14 0.14 Allowed Glycine 0 C--N 1.329 0.178 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.2 m -163.27 48.19 0.14 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.327 0.584 . . . . 0.0 110.535 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 8.2 tt -92.19 116.77 29.24 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.264 0.554 . . . . 0.0 110.339 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 -79.07 146.64 33.15 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.264 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.624 ' C ' HD23 ' A' ' 62' ' ' LEU . 6.3 tt -143.38 114.57 7.87 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.442 ' N ' HD23 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -90.62 106.17 18.32 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.511 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 90.9 m -92.45 107.78 19.47 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.695 -178.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 83.2 mt -103.28 124.08 47.98 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.276 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.522 ' O ' HG13 ' A' ' 68' ' ' VAL . 13.2 t60 -72.72 156.7 38.66 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 66' ' ' HIS . 15.8 ptpt -27.45 89.15 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.599 0.714 . . . . 0.0 112.495 -179.089 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.522 HG13 ' O ' ' A' ' 66' ' ' HIS . 28.0 m -82.33 167.45 2.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.031 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.521 HG23 ' H ' ' A' ' 71' ' ' GLU . 6.7 t -130.77 -149.68 0.4 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.335 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.501 ' C ' ' H ' ' A' ' 72' ' ' ASP . 3.3 mm? -51.24 -36.35 41.38 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.293 -0.563 . . . . 0.0 109.684 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.521 ' H ' HG23 ' A' ' 69' ' ' THR . 98.3 mt-10 -60.96 -0.39 0.3 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.481 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.501 ' H ' ' C ' ' A' ' 70' ' ' LEU . 42.8 t0 -63.53 -36.97 85.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.913 -179.113 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.93 141.25 40.12 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.211 0.529 . . . . 0.0 111.324 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 173.52 153.49 9.71 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.523 -1.031 . . . . 0.0 110.523 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 16.0 p -97.25 111.35 23.63 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.954 0.407 . . . . 0.0 110.91 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 25.2 t -107.59 128.28 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.884 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.5 t -144.29 175.8 9.82 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.28 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.409 ' CZ ' ' CZ3' ' A' ' 38' ' ' TRP . 57.9 m-85 -127.07 144.27 51.07 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -131.57 115.3 15.93 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.968 0.413 . . . . 0.0 110.84 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.486 ' O ' ' N ' ' A' ' 82' ' ' THR . 6.0 p -141.23 125.49 17.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.404 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -39.85 -20.38 0.02 OUTLIER Glycine 0 CA--C 1.531 1.068 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.863 -178.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.486 ' N ' ' O ' ' A' ' 80' ' ' VAL . 68.3 p -80.65 -75.19 0.28 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.054 0.454 . . . . 0.0 111.084 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.417 ' N ' ' OG1' ' A' ' 82' ' ' THR . 61.8 m -121.0 179.6 4.33 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.427 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 73.5 m -131.57 151.81 51.3 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 11.4 t -153.07 164.39 38.09 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -148.37 162.07 40.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.065 0.46 . . . . 0.0 111.214 -178.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.2 155.69 34.34 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.933 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -122.45 128.59 51.07 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.424 -179.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.548 HD23 ' N ' ' A' ' 90' ' ' LYS . 2.3 tt -121.1 117.55 27.47 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.548 ' N ' HD23 ' A' ' 89' ' ' LEU . 20.5 pttp -144.57 166.38 25.34 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 120.904 0.383 . . . . 0.0 111.679 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.6 p -104.08 133.22 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.184 0.516 . . . . 0.0 110.137 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.0 t -102.82 141.9 34.85 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.994 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -88.33 -9.12 53.81 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.64 -0.255 . . . . 0.0 111.042 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.724 0 CA-C-O 117.959 -1.467 . . . . 0.0 111.071 -179.94 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ttm . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -159.72 154.83 21.58 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.114 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -55.47 143.63 76.88 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 121.692 1.595 . . . . 0.0 111.648 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -175.92 139.01 0.37 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.519 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.477 ' O ' HG13 ' A' ' 5' ' ' VAL . 10.0 p -54.37 130.22 16.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.402 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.504 ' HG1' ' CB ' ' A' ' 29' ' ' SER . 16.6 p -101.23 124.95 47.74 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 22.9 mm -100.8 111.17 29.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.102 0.477 . . . . 0.0 110.948 -178.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.435 ' O ' ' O ' ' A' ' 27' ' ' ARG . 91.6 mt -120.02 106.07 11.65 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.501 178.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.47 ' OE1' ' SG ' ' A' ' 26' ' ' CYS . 34.0 mm-40 -124.81 89.39 52.54 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.957 -179.363 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -71.79 -3.51 13.29 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 121.622 1.548 . . . . 0.0 110.694 178.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 67.4 mt -69.24 141.5 54.41 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.982 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -124.77 -46.84 1.84 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.174 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 37.3 p30 -176.72 146.43 0.57 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.136 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 65.1 t -125.28 129.31 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.043 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -137.66 135.93 36.97 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.023 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -160.87 160.56 31.15 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.995 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.0 p -74.69 156.53 36.56 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.978 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -67.91 138.59 56.12 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.21 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.45 -3.38 65.92 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -103.33 151.52 22.64 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.871 0.367 . . . . 0.0 110.878 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -76.07 155.23 34.99 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.97 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -135.39 146.29 48.17 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.523 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.5 m -133.43 148.8 51.79 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.31 0.576 . . . . 0.0 111.112 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -128.19 147.35 50.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.608 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -136.38 116.09 13.02 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.452 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.47 ' SG ' ' OE1' ' A' ' 9' ' ' GLU . 3.0 t -131.48 127.99 38.49 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.398 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.435 ' O ' ' O ' ' A' ' 8' ' ' LEU . 99.6 mtt180 -96.76 125.81 41.48 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 178.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.442 HD12 ' O ' ' A' ' 6' ' ' THR . 18.8 tp -145.34 112.24 5.96 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -178.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.504 ' CB ' ' HG1' ' A' ' 6' ' ' THR . 6.6 p -79.08 155.24 28.86 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.265 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 18.1 ptp180 -54.22 157.96 2.46 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -177.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.69 -173.86 2.46 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 114.649 -1.16 . . . . 0.0 111.374 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.8 t -154.85 -44.93 0.09 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.231 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -86.51 -72.12 1.29 Allowed Glycine 0 CA--C 1.522 0.482 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 178.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -122.41 143.39 49.7 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.833 0.349 . . . . 0.0 110.632 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.515 ' N ' ' OE1' ' A' ' 35' ' ' GLU . 56.4 mp0 -91.72 129.64 37.66 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.463 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.412 ' CB ' HG22 ' A' ' 80' ' ' VAL . . . -71.48 145.98 48.88 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.372 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -129.92 151.86 50.02 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.747 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.445 ' CZ2' HD23 ' A' ' 63' ' ' LEU . 62.5 m95 -74.38 176.32 6.85 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.077 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -163.24 114.5 1.44 Allowed 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.896 178.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 41.1 tp -124.25 121.27 34.59 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.18 3.21 64.51 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.94 -17.21 58.51 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.9 m -107.08 149.68 38.93 Favored Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -58.76 145.11 97.33 Favored 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 120.885 1.056 . . . . 0.0 111.641 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.475 ' H ' ' CD2' ' A' ' 45' ' ' LEU . 0.9 OUTLIER -89.13 178.25 6.42 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.687 179.967 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -151.22 140.42 21.26 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.007 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.35 142.65 58.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.625 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.429 ' CG ' ' H ' ' A' ' 49' ' ' GLU . 48.4 t30 -169.01 -173.5 1.81 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.798 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.429 ' H ' ' CG ' ' A' ' 48' ' ' ASN . 82.4 tt0 -64.0 -42.25 97.24 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.526 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 97.2 mmm -66.28 -40.18 89.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.513 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.477 ' OD1' ' CD1' ' A' ' 63' ' ' LEU . 46.5 t30 -120.81 119.83 33.83 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.71 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -113.79 136.77 52.49 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 70.9 mt -120.07 129.87 74.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 110.11 -0.329 . . . . 0.0 110.11 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 86.8 m -132.5 142.04 49.04 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.203 0.525 . . . . 0.0 111.182 -178.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 42.1 t -110.58 132.9 57.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.438 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -124.6 -174.66 3.07 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.204 0.526 . . . . 0.0 110.543 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -28.41 137.99 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.466 -179.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.536 ' O ' HG23 ' A' ' 59' ' ' THR . . . 69.7 -99.63 0.69 Allowed Glycine 0 CA--C 1.52 0.367 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.536 HG23 ' O ' ' A' ' 58' ' ' GLY . 25.3 p -159.94 51.51 0.32 Allowed 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 52.1 tp -87.22 119.14 27.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.467 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 53.6 m170 -100.97 124.84 47.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.673 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 76.2 mt -119.01 123.81 45.44 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.173 0.511 . . . . 0.0 111.18 -179.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.477 ' CD1' ' OD1' ' A' ' 51' ' ' ASN . 0.3 OUTLIER -97.89 105.69 17.87 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 177.954 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 58.7 m -104.97 105.2 15.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.173 0.511 . . . . 0.0 111.297 -177.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.6 mt -96.42 131.17 43.26 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.019 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -112.84 144.62 42.08 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.986 0.422 . . . . 0.0 111.114 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 74.7 tttt 50.92 57.04 7.08 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.475 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -44.98 152.08 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.087 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 43.7 p -134.5 164.4 27.56 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.628 HD13 ' O ' ' A' ' 70' ' ' LEU . 0.3 OUTLIER -60.9 -33.93 73.88 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.301 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -65.06 -22.22 66.94 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.592 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -60.3 -34.6 74.0 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -44.63 118.33 1.55 Allowed 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.594 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -170.74 -179.34 41.98 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 52.6 m -108.63 122.99 48.24 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.833 0.349 . . . . 0.0 110.781 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.14 131.46 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 29.0 t -144.18 175.15 10.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.885 0.374 . . . . 0.0 110.584 -179.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -127.34 138.16 52.97 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.904 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 -120.72 112.0 18.31 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.504 ' HB ' ' H ' ' A' ' 83' ' ' CYS . 2.4 t -126.67 129.66 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 120.966 0.412 . . . . 0.0 110.336 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -57.18 -7.48 2.66 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.421 ' H ' ' C ' ' A' ' 80' ' ' VAL . 16.4 p -108.7 -40.53 5.04 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.656 0.265 . . . . 0.0 110.963 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.504 ' H ' ' HB ' ' A' ' 80' ' ' VAL . 26.2 m -148.04 -166.37 2.51 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.328 -179.131 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 91.0 p -160.04 167.02 28.8 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.046 0.45 . . . . 0.0 111.229 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 31.5 t -158.87 166.8 31.04 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.331 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -134.63 153.53 51.93 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.21 0.528 . . . . 0.0 110.969 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.93 151.31 23.41 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.489 -0.778 . . . . 0.0 108.917 178.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -133.66 132.57 40.86 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.846 0.355 . . . . 0.0 111.693 -178.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.595 HD23 ' N ' ' A' ' 90' ' ' LYS . 5.3 tt -114.57 118.46 33.8 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.595 ' N ' HD23 ' A' ' 89' ' ' LEU . 32.3 ttmt -128.17 134.84 49.11 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.912 0.387 . . . . 0.0 110.677 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.2 p -114.94 108.24 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 27.4 m -116.52 118.52 32.89 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.324 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.34 146.36 50.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.823 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.803 0 CA-C-O 118.004 -1.442 . . . . 0.0 110.744 179.79 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.6 ttm . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -165.32 78.38 1.28 Allowed Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.902 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -67.53 146.67 74.87 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 122.545 2.164 . . . . 0.0 111.573 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -87.89 156.95 19.11 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.994 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.643 HG22 ' HA ' ' A' ' 31' ' ' ALA . 3.2 t -59.99 132.73 25.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.338 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.596 ' HB ' ' H ' ' A' ' 29' ' ' SER . 89.6 m -87.15 121.13 29.19 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 119.032 -1.067 . . . . 0.0 110.486 -179.471 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 18.2 mm -105.2 100.5 10.69 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.926 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 60.6 mt -128.41 90.26 3.04 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.494 ' OE2' ' CE2' ' A' ' 78' ' ' PHE . 7.6 pt-20 -120.14 84.27 33.38 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.933 -178.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.402 ' O ' ' N ' ' A' ' 12' ' ' GLN . 3.1 Cg_exo -71.23 11.67 0.55 Allowed 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 122.204 1.936 . . . . 0.0 111.491 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.615 HD12 ' N ' ' A' ' 11' ' ' LEU . 8.4 mp -70.54 67.07 0.34 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.402 ' N ' ' O ' ' A' ' 10' ' ' PRO . 99.4 mm-40 -69.94 -43.17 72.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.365 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.424 ' OD2' ' N ' ' A' ' 14' ' ' VAL . 54.9 t0 -175.04 138.64 0.45 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.916 0.389 . . . . 0.0 110.992 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.424 ' N ' ' OD2' ' A' ' 13' ' ' ASP . 54.7 t -127.0 131.69 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.626 ' C ' HD22 ' A' ' 16' ' ' LEU . 0.4 OUTLIER -136.43 102.64 5.02 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.734 0.302 . . . . 0.0 111.035 179.905 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.626 HD22 ' C ' ' A' ' 15' ' ' GLN . 4.4 mm? -119.68 146.36 45.66 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.239 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 45.0 t -82.06 162.91 22.4 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.14 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -61.61 137.68 58.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.162 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.21 2.29 85.74 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 111.761 -0.535 . . . . 0.0 111.761 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -96.73 166.79 11.48 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.87 0.367 . . . . 0.0 110.72 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 21' ' ' ASP . 39.9 p30 -79.46 151.56 30.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.625 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.07 142.19 29.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.271 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 96.5 p -162.48 161.17 26.96 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.943 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -132.59 150.69 52.12 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.944 0.402 . . . . 0.0 110.644 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -136.45 123.85 22.03 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 8.5 t -134.38 132.9 39.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.277 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 90.6 mtm-85 -104.44 104.72 14.63 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.763 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 85.7 mt -123.81 121.05 34.4 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.0 0.428 . . . . 0.0 111.682 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.596 ' H ' ' HB ' ' A' ' 6' ' ' THR . 85.2 p -75.33 163.68 27.21 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 177.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 35.5 ptt-85 -50.87 149.02 3.68 Favored 'General case' 0 C--N 1.322 -0.618 0 O-C-N 124.181 0.926 . . . . 0.0 113.331 -177.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.643 ' HA ' HG22 ' A' ' 5' ' ' VAL . . . -75.46 176.43 7.54 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 114.177 -1.374 . . . . 0.0 111.135 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 50.0 m -151.25 -63.51 0.19 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.695 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -88.44 -75.36 1.29 Allowed Glycine 0 CA--C 1.521 0.409 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 178.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -122.43 129.96 52.59 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.711 0.291 . . . . 0.0 110.332 178.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -73.35 145.46 45.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.712 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.47 ' CB ' HG22 ' A' ' 80' ' ' VAL . . . -71.34 146.83 48.57 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.587 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 24.2 mmt85 -104.85 132.74 50.72 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.908 179.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -113.0 138.62 49.59 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.46 ' HB1' ' O ' ' A' ' 43' ' ' VAL . . . -176.43 155.53 1.43 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 119.727 -0.789 . . . . 0.0 111.52 -178.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.623 HD23 ' N ' ' A' ' 41' ' ' GLY . 6.5 tt -123.06 121.85 37.04 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.209 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.623 ' N ' HD23 ' A' ' 40' ' ' LEU . . . 86.05 6.04 82.49 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -178.434 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.33 0.84 79.42 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 112.028 -0.429 . . . . 0.0 112.028 179.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.46 ' O ' ' HB1' ' A' ' 39' ' ' ALA . 23.1 m -113.13 143.98 30.26 Favored Pre-proline 0 N--CA 1.47 0.551 0 CA-C-N 116.777 0.289 . . . . 0.0 110.884 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -56.41 144.87 81.88 Favored 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 121.411 1.407 . . . . 0.0 110.449 178.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.557 HD21 ' N ' ' A' ' 40' ' ' LEU . 14.2 mt -80.87 156.97 25.82 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.034 0.445 . . . . 0.0 111.384 -179.238 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.465 ' O ' ' N ' ' A' ' 48' ' ' ASN . 89.9 mt-30 -126.6 131.48 51.49 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.21 179.016 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.01 70.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.943 0.401 . . . . 0.0 111.566 -178.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.465 ' N ' ' O ' ' A' ' 46' ' ' GLN . 87.4 m-20 -76.93 163.21 26.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.645 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -59.26 -46.57 88.15 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 95.2 mtp -66.91 -40.24 87.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.236 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.425 ' O ' ' O ' ' A' ' 48' ' ' ASN . 66.0 m-20 -117.6 107.77 14.65 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.769 179.669 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -109.82 158.51 18.08 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.7 mt -122.09 130.25 74.71 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-O 120.916 0.389 . . . . 0.0 110.084 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 97.1 m -128.27 129.38 46.27 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.905 -178.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.425 ' O ' HG13 ' A' ' 55' ' ' VAL . 7.4 p -111.03 129.25 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.879 179.519 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.411 ' O ' ' C ' ' A' ' 57' ' ' GLN . 98.0 mt-10 -112.38 -174.57 2.49 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.144 0.497 . . . . 0.0 111.114 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.411 ' C ' ' O ' ' A' ' 56' ' ' GLU . 63.1 tp60 -24.78 144.56 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 114.791 -1.095 . . . . 0.0 112.462 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 58.52 -94.48 0.05 OUTLIER Glycine 0 CA--C 1.522 0.512 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.672 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 37.5 m -163.7 65.06 0.17 Allowed 'General case' 0 C--O 1.239 0.516 0 CA-C-O 121.324 0.583 . . . . 0.0 110.635 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 91.4 mt -95.8 126.3 40.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.426 178.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 48.7 m170 -107.84 120.61 42.77 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.22 118.39 14.49 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.083 0.468 . . . . 0.0 110.8 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -86.58 118.05 25.75 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 94.9 m -105.64 95.94 6.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.278 -179.093 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.481 ' N ' HD23 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -106.88 140.84 39.06 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.593 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 21.3 p80 -139.19 159.02 43.14 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.575 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 79.2 tttt 47.74 73.17 0.21 Allowed 'General case' 0 C--O 1.231 0.109 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -179.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.425 HG13 ' O ' ' A' ' 68' ' ' VAL . 11.7 p -116.47 131.83 67.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.959 -179.269 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.6 p -79.08 -157.41 0.12 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.523 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.577 ' C ' ' H ' ' A' ' 72' ' ' ASP . 55.4 tp -57.72 -33.74 68.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.421 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -51.28 -2.33 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.235 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.577 ' H ' ' C ' ' A' ' 70' ' ' LEU . 29.1 t0 -53.57 -39.24 64.64 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.697 0.284 . . . . 0.0 110.474 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.65 137.89 57.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.181 0.515 . . . . 0.0 111.068 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 179.99 176.8 47.65 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 110.076 -1.209 . . . . 0.0 110.076 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 94.4 m -126.15 117.26 22.76 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 117.088 0.444 . . . . 0.0 111.003 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.1 t -89.63 131.64 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.1 p -132.04 149.5 52.4 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.149 0.5 . . . . 0.0 110.891 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.494 ' CE2' ' OE2' ' A' ' 9' ' ' GLU . 0.2 OUTLIER -153.52 150.24 28.52 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.826 179.911 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -145.07 141.43 28.84 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.222 0.534 . . . . 0.0 111.112 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.498 ' O ' ' N ' ' A' ' 82' ' ' THR . 2.3 t -130.07 131.53 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.893 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -46.76 -11.89 0.06 OUTLIER Glycine 0 CA--C 1.528 0.896 0 C-N-CA 121.067 -0.587 . . . . 0.0 111.693 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.498 ' N ' ' O ' ' A' ' 80' ' ' VAL . 22.7 p -99.92 -54.01 3.01 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 122.722 -0.281 . . . . 0.0 110.696 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 38.8 t -139.58 162.5 34.93 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.115 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 30.9 p -134.68 155.13 51.06 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.964 0.412 . . . . 0.0 111.254 -179.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.0 t -162.87 166.87 23.53 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.948 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -142.34 165.06 28.44 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.66 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.82 155.69 41.93 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.139 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -125.25 135.89 52.99 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.344 0.592 . . . . 0.0 111.773 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 48.2 tp -109.66 97.68 7.18 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.783 179.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -94.62 166.82 11.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.312 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 53.1 t -119.51 128.37 75.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.61 162.17 24.37 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.63 -179.386 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.74 139.92 58.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.225 -179.329 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.794 0 CA-C-O 118.025 -1.431 . . . . 0.0 111.125 -179.879 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.61 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.416 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.65 ' HB3' ' HD3' ' A' ' 3' ' ' PRO . . . -49.72 -66.43 0.62 Allowed Pre-proline 0 CA--C 1.536 0.427 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.495 -179.598 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.65 ' HD3' ' HB3' ' A' ' 2' ' ' ALA . 3.9 Cg_exo -50.68 140.32 37.31 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 121.672 1.581 . . . . 0.0 111.467 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -97.92 -158.56 0.68 Allowed 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 179.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.521 HG22 ' HA ' ' A' ' 31' ' ' ALA . 2.7 t -61.28 130.53 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 C-N-CA 120.221 -0.591 . . . . 0.0 109.413 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.607 ' HB ' ' H ' ' A' ' 29' ' ' SER . 72.4 m -91.94 130.21 37.74 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 119.962 -0.695 . . . . 0.0 111.457 -178.415 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 33.8 mm -111.86 102.52 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-O 121.275 0.559 . . . . 0.0 111.017 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 39.4 tp -126.3 87.51 2.68 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.08 -0.963 . . . . 0.0 108.768 178.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.513 ' OE2' ' CE2' ' A' ' 78' ' ' PHE . 28.9 mt-10 -120.61 85.03 37.73 Favored Pre-proline 0 N--CA 1.464 0.267 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.354 -179.178 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -72.2 8.85 1.29 Allowed 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 121.819 1.679 . . . . 0.0 111.557 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 65.2 mt -61.56 84.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.903 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 40.5 tp60 -72.86 -133.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -109.02 138.3 45.58 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.5 m -127.95 156.16 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -136.61 104.51 5.57 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.546 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 78.4 mt -118.45 139.97 50.58 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.249 -178.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.519 ' O ' ' NE2' ' A' ' 20' ' ' GLN . 91.5 p -69.26 153.81 43.04 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.996 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -65.94 146.6 54.53 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.085 0.469 . . . . 0.0 111.065 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.43 8.82 65.63 Favored Glycine 0 CA--C 1.53 0.976 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.519 ' NE2' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -112.29 156.78 21.84 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 120.976 0.417 . . . . 0.0 110.366 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -78.05 144.81 36.29 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.063 178.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -126.07 146.74 49.79 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.072 0.463 . . . . 0.0 110.594 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 41.5 t -156.77 154.74 30.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.927 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -132.81 152.13 51.87 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.809 0.337 . . . . 0.0 110.641 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.405 ' CD ' ' N ' ' A' ' 25' ' ' GLN . 0.5 OUTLIER -124.9 111.25 15.24 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.125 -0.488 . . . . 0.0 109.755 179.48 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 6.7 t -115.84 137.7 51.84 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 82.1 mtm180 -123.47 125.1 44.3 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.8 pp -147.98 141.17 25.07 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 119.974 -0.691 . . . . 0.0 111.438 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.607 ' H ' ' HB ' ' A' ' 6' ' ' THR . 98.5 p -74.31 162.65 28.68 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 178.622 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -52.24 162.53 0.49 Allowed 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -177.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.521 ' HA ' HG22 ' A' ' 5' ' ' VAL . . . -70.14 157.07 38.28 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 114.018 -1.447 . . . . 0.0 111.401 -179.029 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.5 t -141.44 -61.34 0.47 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.399 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -101.27 -67.24 0.81 Allowed Glycine 0 N--CA 1.459 0.22 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -123.55 137.72 54.7 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 179.118 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -79.8 147.58 31.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.589 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.44 152.21 40.85 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.188 179.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 61.3 mtp85 -126.09 147.04 49.68 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.292 -179.005 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 2.3 t-105 -104.45 151.29 23.72 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.597 -179.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -165.62 148.47 7.72 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.066 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.548 ' C ' HD23 ' A' ' 40' ' ' LEU . 8.0 tt -124.99 126.27 45.18 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.474 ' N ' HD23 ' A' ' 40' ' ' LEU . . . 80.65 7.69 88.3 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.87 -12.74 62.5 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.4 m -112.17 150.76 42.96 Favored Pre-proline 0 N--CA 1.468 0.466 0 C-N-CA 121.975 0.11 . . . . 0.0 110.756 -179.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -57.71 144.33 93.31 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 121.39 1.393 . . . . 0.0 110.666 178.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.476 ' H ' HD23 ' A' ' 45' ' ' LEU . 0.9 OUTLIER -114.66 171.78 7.43 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.691 0.281 . . . . 0.0 111.069 179.756 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -130.58 134.24 46.84 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.952 0.406 . . . . 0.0 110.247 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.01 96.29 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.273 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -75.17 169.67 17.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.997 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -58.43 -45.21 88.96 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 20.6 mmt -67.58 -38.83 84.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.639 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 62.8 t-20 -98.89 106.9 19.21 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.765 -178.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.431 ' O ' ' OG1' ' A' ' 64' ' ' THR . 67.0 m-20 -109.0 108.29 18.97 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.4 HG21 HD13 ' A' ' 53' ' ' ILE . 38.4 mt -100.74 133.74 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -179.353 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.9 t -146.11 159.17 43.65 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -179.117 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.0 t -109.25 137.44 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.268 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 57' ' ' GLN . 79.4 mm-40 -116.11 -178.6 3.44 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.438 ' C ' ' O ' ' A' ' 56' ' ' GLU . 56.1 tt0 -26.19 144.98 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 O-C-N 123.889 0.743 . . . . 0.0 112.102 -179.465 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 59.05 -94.7 0.06 OUTLIER Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.446 ' O ' ' OG1' ' A' ' 59' ' ' THR . 0.0 OUTLIER -166.75 59.49 0.09 Allowed 'General case' 0 C--O 1.24 0.594 0 CA-C-O 121.541 0.686 . . . . 0.0 110.962 -179.797 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.47 ' CD2' ' N ' ' A' ' 60' ' ' LEU . 3.1 mm? -99.55 130.56 45.81 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.099 179.128 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -107.27 142.96 36.2 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 120.869 0.366 . . . . 0.0 110.261 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.2 mp -137.89 118.92 14.37 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.293 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.33 108.2 19.89 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 52' ' ' ASP . 82.1 p -102.75 96.93 7.18 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 121.138 0.494 . . . . 0.0 109.908 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 36.6 tp -103.34 124.65 49.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.513 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.613 ' CG ' ' H ' ' A' ' 67' ' ' LYS . 1.0 OUTLIER -71.13 -152.71 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.41 -179.465 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.613 ' H ' ' CG ' ' A' ' 66' ' ' HIS . 5.4 mtmp? -53.99 97.09 0.02 OUTLIER 'General case' 0 CA--C 1.522 -0.108 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.376 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.498 HG22 ' H ' ' A' ' 69' ' ' THR . 3.0 p -58.19 168.35 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.819 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.498 ' H ' HG22 ' A' ' 68' ' ' VAL . 58.2 p -134.41 159.79 39.96 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 47.2 tp -58.54 -40.81 84.02 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -69.9 -33.02 71.64 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.677 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.45 ' HB2' ' H ' ' A' ' 69' ' ' THR . 55.3 m-20 -64.27 -40.27 95.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.86 -178.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.74 140.05 57.68 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.649 -0.421 . . . . 0.0 110.24 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -175.39 -108.02 0.22 Allowed Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 -179.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 97.0 m -156.5 109.69 2.63 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.412 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.5 t -89.07 127.9 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.051 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 31.9 t -133.03 146.23 51.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.283 0.563 . . . . 0.0 111.542 -178.088 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.513 ' CE2' ' OE2' ' A' ' 9' ' ' GLU . 0.1 OUTLIER -140.7 159.2 42.73 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.476 179.585 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 15.5 p-80 -143.41 146.39 33.44 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.973 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.48 ' O ' ' N ' ' A' ' 82' ' ' THR . 2.2 t -134.32 134.46 54.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.557 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -43.06 -20.32 0.09 OUTLIER Glycine 0 CA--C 1.533 1.165 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.517 ' OG1' ' N ' ' A' ' 83' ' ' CYS . 33.1 p -82.6 -72.38 0.45 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.839 0.352 . . . . 0.0 110.657 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.517 ' N ' ' OG1' ' A' ' 82' ' ' THR . 7.8 t -128.02 -178.26 4.45 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.699 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.413 ' N ' ' SG ' ' A' ' 83' ' ' CYS . 35.5 m -127.74 149.69 50.12 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.244 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 52.9 p -156.63 162.85 39.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.611 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -160.06 168.14 26.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.983 0.42 . . . . 0.0 111.024 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.78 140.11 28.26 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.865 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 25.1 mp0 -109.7 122.04 46.59 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.098 0.475 . . . . 0.0 111.005 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 53.6 tp -108.54 106.29 16.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.929 179.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -110.02 171.03 7.69 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.458 ' O ' HG23 ' A' ' 91' ' ' VAL . 24.3 m -113.8 128.7 70.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 120.77 0.319 . . . . 0.0 110.242 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.9 m -66.66 136.5 55.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.247 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -148.4 40.37 0.93 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.152 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.816 0 CA-C-O 118.031 -1.427 . . . . 0.0 111.198 179.909 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.1 mtm . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 55.38 77.42 0.43 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.869 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -67.93 146.75 72.67 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.53 2.153 . . . . 0.0 112.434 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.0 tp10 -78.66 152.52 31.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.411 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.47 HG22 ' HA ' ' A' ' 31' ' ' ALA . 4.8 t -58.76 132.89 23.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.293 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.487 ' OG1' ' N ' ' A' ' 29' ' ' SER . 51.8 p -94.55 133.91 37.66 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 119.177 -1.009 . . . . 0.0 110.936 -179.678 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.3 mm -112.45 56.93 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.181 -178.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 48.0 tp -90.1 78.03 6.71 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.537 ' OE1' ' CZ ' ' A' ' 78' ' ' PHE . 16.3 tt0 -121.7 83.82 42.66 Favored Pre-proline 0 N--CA 1.466 0.369 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.286 -179.082 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -71.46 47.14 0.83 Allowed 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.447 2.098 . . . . 0.0 112.067 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.444 HD11 ' CD2' ' A' ' 24' ' ' PHE . 2.3 mm? -81.69 82.47 7.4 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.418 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -74.12 -86.08 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.811 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.431 ' O ' ' OD2' ' A' ' 13' ' ' ASP . 44.0 p-10 -172.7 133.83 0.6 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.328 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.0 m -131.03 156.5 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-O 120.975 0.417 . . . . 0.0 110.697 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.87 121.66 30.6 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.33 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 53.4 mt -124.66 141.02 52.4 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.319 -179.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.2 t -83.92 155.55 22.8 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 -52.27 143.33 14.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.015 0.436 . . . . 0.0 111.426 -179.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.42 2.1 85.42 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.844 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -101.08 146.76 27.04 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.003 0.43 . . . . 0.0 111.219 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -73.79 153.87 39.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.588 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -134.8 138.92 44.7 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.986 0.422 . . . . 0.0 110.049 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 71.0 m -161.51 158.05 25.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.235 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.444 ' CD2' HD11 ' A' ' 11' ' ' LEU . 67.9 m-85 -135.41 151.08 50.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.158 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -124.09 135.31 53.46 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.532 ' SG ' ' N ' ' A' ' 27' ' ' ARG . 53.8 t -149.8 163.62 37.5 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.043 0.449 . . . . 0.0 111.441 -179.157 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.532 ' N ' ' SG ' ' A' ' 26' ' ' CYS . 80.2 mtp85 -129.91 96.52 4.23 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.085 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.426 ' O ' ' CG2' ' A' ' 59' ' ' THR . 76.2 mt -113.32 113.66 25.57 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.728 -0.214 . . . . 0.0 111.384 -179.246 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.487 ' N ' ' OG1' ' A' ' 6' ' ' THR . 44.2 t -68.04 156.2 37.87 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 178.226 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -53.33 167.03 0.22 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -177.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.47 ' HA ' HG22 ' A' ' 5' ' ' VAL . . . -63.24 159.88 16.87 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 113.691 -1.595 . . . . 0.0 111.799 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.7 t -140.87 -58.19 0.51 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.49 -69.71 0.7 Allowed Glycine 0 CA--C 1.521 0.437 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 177.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -121.75 144.48 48.77 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.05 0.452 . . . . 0.0 110.652 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -83.85 142.12 30.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.57 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.29 152.68 41.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.443 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -124.15 126.72 46.64 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.199 0.523 . . . . 0.0 110.683 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 40.8 t-105 -93.73 148.05 22.47 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.951 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -167.37 154.99 8.96 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 119.632 -0.827 . . . . 0.0 112.123 -179.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 67.2 tp -118.17 117.03 28.05 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.74 8.7 82.38 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.9 3.93 79.39 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.5 t -113.48 134.8 21.9 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-O 119.224 -0.417 . . . . 0.0 110.357 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -50.83 138.49 41.88 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 121.022 1.148 . . . . 0.0 110.57 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -114.25 174.16 6.09 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.923 0.392 . . . . 0.0 111.792 -178.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -136.98 150.25 48.03 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.294 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.19 78.43 0.05 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.624 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.427 ' O ' ' O ' ' A' ' 51' ' ' ASN . 7.9 m120 -71.41 178.89 3.19 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.021 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 56.8 mp0 -61.31 -44.88 96.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.228 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 25.9 ptm -83.69 -17.15 42.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.074 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.427 ' O ' ' O ' ' A' ' 48' ' ' ASN . 77.1 m-20 -114.16 105.07 12.75 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.29 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -115.12 130.41 56.92 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 42.7 mt -123.78 133.99 67.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.2 t -137.61 153.23 49.92 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.024 0.44 . . . . 0.0 110.781 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 53.4 t -111.85 131.87 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.254 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -108.12 162.0 14.45 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.932 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -49.87 150.76 2.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.787 -179.264 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.31 13.09 82.35 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.426 ' CG2' ' O ' ' A' ' 28' ' ' LEU . 1.0 OUTLIER 67.38 26.68 8.35 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.835 0.35 . . . . 0.0 110.629 -179.76 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.6 mp -77.47 136.36 38.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.14 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 5.6 t-160 -104.97 153.39 21.49 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.213 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.1 tp -152.77 110.68 3.63 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 121.01 0.434 . . . . 0.0 109.969 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.416 ' C ' ' CD1' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -86.14 107.54 17.91 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.517 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 60.3 m -99.93 99.93 10.76 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.262 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 41.0 tp -110.94 120.66 43.14 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.452 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.484 ' CG ' ' H ' ' A' ' 67' ' ' LYS . 26.8 t60 -138.55 175.46 9.55 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.215 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.484 ' H ' ' CG ' ' A' ' 66' ' ' HIS . 64.1 mttp 55.18 57.09 5.8 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -179.157 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 28.2 m -108.28 156.3 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-O 121.448 0.642 . . . . 0.0 111.5 -179.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 36.5 p -135.69 -149.6 0.34 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.69 178.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 16.7 mt -56.52 -23.68 41.44 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -71.45 -1.15 12.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.693 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -56.89 -39.74 74.94 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.711 -0.395 . . . . 0.0 109.945 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.61 147.45 18.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.653 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 171.38 -161.14 33.51 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 87.5 m -153.5 109.28 3.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.719 0.295 . . . . 0.0 110.31 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.0 m -80.3 136.29 23.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.577 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.9 t -144.8 145.82 31.82 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.029 0.442 . . . . 0.0 110.904 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.537 ' CZ ' ' OE1' ' A' ' 9' ' ' GLU . 38.9 p90 -150.07 151.7 33.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.07 179.064 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.513 ' CE1' ' HG ' ' A' ' 84' ' ' SER . 64.9 t60 -134.86 131.22 37.12 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.906 -179.161 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.529 ' O ' ' N ' ' A' ' 82' ' ' THR . 2.4 t -127.87 130.89 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.22 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -39.91 -21.33 0.03 OUTLIER Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.775 -0.53 . . . . 0.0 111.775 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.529 ' N ' ' O ' ' A' ' 80' ' ' VAL . 19.0 p -88.54 -71.93 0.56 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.87 0.367 . . . . 0.0 110.233 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 4.1 t -132.04 160.1 36.88 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.939 179.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.513 ' HG ' ' CE1' ' A' ' 79' ' ' HIS . 20.4 m -133.91 154.88 50.77 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.157 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.5 m -160.28 161.65 33.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.116 0.484 . . . . 0.0 111.26 -179.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -143.05 150.13 39.15 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.424 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -135.01 153.24 52.16 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.303 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -108.43 135.74 49.22 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 121.365 0.603 . . . . 0.0 111.412 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 50.0 tp -115.59 96.42 5.62 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.103 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.5 ttmt -94.28 169.74 10.01 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.536 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.8 t -118.38 131.37 71.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -108.92 134.61 51.36 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.719 0.295 . . . . 0.0 110.798 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.22 137.77 57.84 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.422 -0.511 . . . . 0.0 109.838 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.701 0 CA-C-O 117.915 -1.492 . . . . 0.0 111.34 -179.115 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 ptm . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.31 149.84 30.16 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.158 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -56.69 -25.11 58.4 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 121.711 1.607 . . . . 0.0 111.383 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -38.0 142.5 0.16 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.479 0.657 . . . . 0.0 111.71 -179.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.41 HG13 ' O ' ' A' ' 5' ' ' VAL . 8.7 p -65.1 133.85 30.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.401 179.184 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.476 ' N ' ' OG ' ' A' ' 29' ' ' SER . 59.7 p -92.77 136.48 33.21 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.337 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.547 HG23 ' O ' ' A' ' 7' ' ' ILE . 2.4 tp -118.21 107.0 20.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-O 122.487 1.137 . . . . 0.0 111.455 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.544 HD12 ' C ' ' A' ' 7' ' ' ILE . 9.7 mp -126.14 79.94 1.88 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 113.996 -1.456 . . . . 0.0 108.418 178.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -120.62 87.8 42.27 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.652 -178.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.45 ' O ' ' N ' ' A' ' 12' ' ' GLN . 2.5 Cg_endo -73.75 -7.0 19.54 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 C-N-CA 122.109 1.873 . . . . 0.0 110.727 178.736 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 98.2 mt -56.23 83.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.233 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.45 ' N ' ' O ' ' A' ' 10' ' ' PRO . 59.5 tt0 -85.64 -64.76 1.1 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.594 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 14' ' ' VAL . 60.1 t0 -170.64 142.88 2.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.721 -178.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.545 ' N ' ' OD1' ' A' ' 13' ' ' ASP . 29.3 m -132.82 161.68 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.984 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.422 ' CD ' ' N ' ' A' ' 15' ' ' GLN . 0.2 OUTLIER -128.47 115.71 18.59 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.883 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 60.4 mt -122.16 143.78 49.35 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.949 0.404 . . . . 0.0 111.465 -179.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.7 m -80.74 157.86 25.7 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.003 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -65.9 148.53 51.65 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.585 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.8 10.16 84.53 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 111.071 -0.811 . . . . 0.0 111.071 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -121.16 145.14 48.13 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -74.29 162.25 29.09 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.403 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -131.22 162.24 30.42 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 28.1 p -159.39 158.51 32.32 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.196 -0.602 . . . . 0.0 111.476 -179.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -139.75 148.22 41.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.294 179.092 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -136.33 126.99 27.14 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.595 ' SG ' ' N ' ' A' ' 27' ' ' ARG . 8.2 t -130.13 162.47 28.76 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.472 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.595 ' N ' ' SG ' ' A' ' 26' ' ' CYS . 79.4 ttt180 -143.41 116.01 8.65 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.471 ' O ' HG21 ' A' ' 59' ' ' THR . 2.4 pp -146.06 123.47 11.67 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 119.846 -0.742 . . . . 0.0 111.71 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.476 ' OG ' ' N ' ' A' ' 6' ' ' THR . 92.4 p -62.25 160.23 13.49 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -53.52 155.84 2.81 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 122.015 0.912 . . . . 0.0 113.388 -177.019 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -53.47 179.57 0.02 OUTLIER 'General case' 0 C--O 1.232 0.163 0 CA-C-N 113.875 -1.511 . . . . 0.0 112.044 -179.291 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.4 p -156.56 -50.39 0.08 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.406 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -101.69 -66.87 0.79 Allowed Glycine 0 CA--C 1.522 0.507 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 178.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -122.69 157.46 32.21 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.726 0.298 . . . . 0.0 110.34 179.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -79.85 141.64 35.98 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.798 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.42 145.84 36.93 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.332 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -128.95 144.27 51.13 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.268 0.556 . . . . 0.0 111.062 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 18.8 t-105 -100.67 155.7 17.74 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.797 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -164.56 151.3 11.07 Favored 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 119.774 -0.77 . . . . 0.0 111.913 -179.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.559 HD13 ' N ' ' A' ' 41' ' ' GLY . 0.5 OUTLIER -129.32 116.63 19.37 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.057 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.559 ' N ' HD13 ' A' ' 40' ' ' LEU . . . 66.85 19.07 69.23 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -178.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.13 4.11 84.43 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.966 -0.853 . . . . 0.0 110.966 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.2 t -111.02 128.38 25.41 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-O 119.491 -0.29 . . . . 0.0 110.478 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -57.76 144.96 92.26 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 121.094 1.196 . . . . 0.0 111.284 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.821 ' H ' HD23 ' A' ' 45' ' ' LEU . 1.1 pt? -130.42 149.69 51.99 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.527 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -128.03 166.18 18.89 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.639 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.6 141.76 19.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.099 0.476 . . . . 0.0 111.377 -178.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.432 ' O ' ' O ' ' A' ' 51' ' ' ASN . 36.3 p-10 -163.3 -171.53 2.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.653 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -65.08 -46.72 79.97 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.169 -179.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 65.6 mtt -67.92 -42.91 80.36 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -179.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.432 ' O ' ' O ' ' A' ' 48' ' ' ASN . 17.5 m-20 -118.23 145.71 44.8 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 120.784 0.326 . . . . 0.0 111.458 -179.033 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 48' ' ' ASN . 98.2 m-20 -138.47 108.94 6.52 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.088 178.59 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.8 pt -101.23 134.61 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.472 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.7 t -139.11 155.46 47.87 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.872 0.368 . . . . 0.0 111.176 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.417 ' O ' HG23 ' A' ' 55' ' ' VAL . 35.5 m -120.14 129.14 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.158 -179.614 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.435 ' N ' ' OE2' ' A' ' 56' ' ' GLU . 56.7 mp0 -124.62 179.53 4.92 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.332 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 58.9 tp60 -48.93 147.52 2.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.199 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.48 14.72 80.79 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 111.542 -0.623 . . . . 0.0 111.542 179.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.471 HG21 ' O ' ' A' ' 28' ' ' LEU . 2.2 m 61.96 38.33 14.38 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 120.989 0.423 . . . . 0.0 110.266 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 49.3 mt -83.18 129.62 35.03 Favored 'General case' 0 CA--C 1.527 0.064 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.434 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 59.6 m170 -108.68 153.48 23.37 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.0 tp -154.83 116.77 4.17 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.225 -178.402 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.458 ' CD1' ' N ' ' A' ' 63' ' ' LEU . 7.2 mp -97.43 121.01 38.83 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 23.6 m -108.33 107.11 17.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.396 0.617 . . . . 0.0 109.665 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.423 ' CD2' ' N ' ' A' ' 65' ' ' LEU . 1.5 mm? -92.78 130.53 38.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.873 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.569 ' CG ' ' H ' ' A' ' 67' ' ' LYS . 1.5 t-80 -83.25 -150.9 0.1 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.406 -179.008 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.569 ' H ' ' CG ' ' A' ' 66' ' ' HIS . 13.9 ptpt -60.38 95.92 0.04 OUTLIER 'General case' 0 N--CA 1.461 0.102 0 CA-C-O 121.253 0.549 . . . . 0.0 110.337 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.5 m -96.78 133.98 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 121.302 0.572 . . . . 0.0 110.939 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 27.5 p -88.35 -152.89 0.23 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.202 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.4 mp -61.97 -23.56 66.46 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.7 tp10 -66.58 -1.72 3.99 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.098 -0.956 . . . . 0.0 110.142 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -54.74 -44.35 73.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.112 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.48 129.83 40.33 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -175.6 143.82 6.84 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 53.1 m -97.01 125.6 41.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.755 0.312 . . . . 0.0 110.873 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.6 t -101.61 126.49 55.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 47.5 t -124.27 140.91 52.51 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.963 0.411 . . . . 0.0 110.485 -179.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -146.9 154.59 41.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.023 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 19.6 p80 -150.69 149.19 29.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.071 0.463 . . . . 0.0 110.55 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.541 ' O ' ' N ' ' A' ' 82' ' ' THR . 4.0 p -146.38 88.16 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.089 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 80' ' ' VAL . . . 30.75 -85.93 0.01 OUTLIER Glycine 0 CA--C 1.53 1.001 0 CA-C-N 115.487 -0.778 . . . . 0.0 112.462 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.541 ' N ' ' O ' ' A' ' 80' ' ' VAL . 25.3 p -39.11 -85.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -179.105 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.459 ' SG ' ' N ' ' A' ' 84' ' ' SER . 33.1 t -105.65 167.69 9.6 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.043 0.449 . . . . 0.0 111.862 -178.424 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.459 ' N ' ' SG ' ' A' ' 83' ' ' CYS . 35.3 t -151.11 145.81 25.72 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.265 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 46.9 t -158.09 172.13 18.98 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.072 0.463 . . . . 0.0 111.151 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -144.2 162.76 35.51 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.492 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -134.08 156.3 48.51 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.079 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.444 ' O ' ' OD1' ' A' ' 13' ' ' ASP . 29.3 mm100 -118.59 135.97 54.13 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.823 0.344 . . . . 0.0 111.367 -179.237 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.497 HD23 ' C ' ' A' ' 89' ' ' LEU . 2.2 tt -115.27 109.64 18.24 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.495 ' N ' HD23 ' A' ' 89' ' ' LEU . 32.5 mmtp -105.66 160.76 14.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.005 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.4 m -117.89 127.35 75.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 120.934 0.397 . . . . 0.0 110.231 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.656 HG22 ' H ' ' A' ' 94' ' ' GLY . 85.9 m -123.3 127.68 48.88 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.101 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -89.64 -6.04 56.56 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.006 0.431 . . . . 0.0 109.964 179.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.656 ' H ' HG22 ' A' ' 92' ' ' THR . . . . . . . . 0 C--O 1.22 -0.75 0 CA-C-O 117.936 -1.48 . . . . 0.0 111.202 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.0 mtm . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -169.42 79.74 0.68 Allowed Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.97 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -69.54 -22.05 33.63 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.368 2.045 . . . . 0.0 111.945 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -74.23 154.94 38.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.048 0.452 . . . . 0.0 110.514 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.465 ' O ' HG13 ' A' ' 5' ' ' VAL . 8.7 p -62.04 132.46 27.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.796 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -111.54 122.04 46.77 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 179.299 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 76.9 mt -105.1 118.57 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-O 121.755 0.788 . . . . 0.0 111.804 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.9 mt -127.3 75.77 1.61 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.485 -1.234 . . . . 0.0 108.049 178.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.505 ' OE1' ' CE2' ' A' ' 78' ' ' PHE . 35.7 tt0 -114.97 92.83 32.28 Favored Pre-proline 0 N--CA 1.467 0.4 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.984 -177.588 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.53 ' O ' ' N ' ' A' ' 12' ' ' GLN . 2.6 Cg_endo -75.29 -6.59 18.04 Favored 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 122.042 1.828 . . . . 0.0 111.035 178.613 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 63.6 mt -60.91 72.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.191 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.53 ' N ' ' O ' ' A' ' 10' ' ' PRO . 70.9 tp60 -74.9 -64.1 1.12 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.124 -179.422 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.7 p-10 -170.29 133.87 1.13 Allowed 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 120.446 -0.501 . . . . 0.0 111.486 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.5 m -134.65 159.73 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.793 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -135.58 117.14 14.85 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.386 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 81.2 mt -121.2 132.64 54.95 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.439 -179.143 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.7 m -69.68 158.69 34.87 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.817 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.42 ' OE2' ' O ' ' A' ' 68' ' ' VAL . 52.5 tp10 -58.31 146.37 34.59 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.612 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.7 1.13 80.85 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.497 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -110.23 146.55 35.42 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.893 0.378 . . . . 0.0 110.562 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 52.6 p-10 -82.33 170.53 15.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.053 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -148.12 152.39 37.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.173 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 95.9 p -152.01 123.13 7.63 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.072 0.463 . . . . 0.0 111.048 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -103.82 119.51 39.06 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.453 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -131.52 133.44 45.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.948 0.404 . . . . 0.0 109.958 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 8.4 p -151.59 151.7 31.9 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.107 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 85.2 mtt85 -96.68 132.34 42.44 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.875 179.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.516 ' C ' HD23 ' A' ' 28' ' ' LEU . 2.9 tt -144.88 106.02 4.19 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.692 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.6 m -62.04 150.83 37.05 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.804 0.335 . . . . 0.0 110.432 179.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -56.33 156.13 6.19 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.528 0.68 . . . . 0.0 112.581 -178.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.78 -174.71 3.53 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.705 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 27.0 m -154.21 -43.93 0.09 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -86.76 -74.16 1.28 Allowed Glycine 0 CA--C 1.521 0.463 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 178.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.454 ' CD ' ' N ' ' A' ' 34' ' ' GLN . 25.4 mp0 -121.98 132.29 54.45 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.924 0.392 . . . . 0.0 110.994 179.048 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -77.28 150.41 35.3 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.835 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.14 147.31 38.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.643 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 45.8 mmm-85 -115.12 137.16 52.33 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.771 0.32 . . . . 0.0 111.225 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 1.8 t-105 -101.79 140.51 35.98 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.013 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -176.38 163.88 2.55 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.119 -179.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.62 HD23 ' H ' ' A' ' 40' ' ' LEU . 1.6 pt? -139.66 129.52 24.76 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.246 0.546 . . . . 0.0 110.467 178.524 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.58 7.03 78.65 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.84 -17.04 58.82 Favored Glycine 0 CA--C 1.529 0.969 0 N-CA-C 111.937 -0.465 . . . . 0.0 111.937 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.1 t -101.55 123.07 45.62 Favored Pre-proline 0 CA--C 1.541 0.633 0 CA-C-N 116.905 0.352 . . . . 0.0 110.37 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -58.69 138.01 83.33 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 CA-C-N 119.875 0.991 . . . . 0.0 111.204 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.0 -174.96 4.18 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.095 0.474 . . . . 0.0 110.551 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.492 ' O ' ' N ' ' A' ' 48' ' ' ASN . 2.6 pm0 -139.06 154.92 48.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.185 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.95 70.33 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.616 -0.433 . . . . 0.0 110.389 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.492 ' N ' ' O ' ' A' ' 46' ' ' GLN . 18.4 t-20 -68.84 157.73 35.9 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.748 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.467 ' N ' ' OD1' ' A' ' 48' ' ' ASN . 86.1 tt0 -55.74 -44.6 77.72 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.246 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 5.4 ptt? -69.31 -35.54 76.08 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 120.907 0.384 . . . . 0.0 110.18 179.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.446 ' O ' ' O ' ' A' ' 48' ' ' ASN . 41.7 m-20 -116.47 104.64 11.64 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.136 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.419 ' OD2' ' O ' ' A' ' 48' ' ' ASN . 96.7 m-20 -107.97 138.1 44.82 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.704 0.288 . . . . 0.0 110.46 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.3 mt -117.98 129.81 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.312 -0.404 . . . . 0.0 109.995 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.1 t -142.38 146.78 35.29 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.02 0.438 . . . . 0.0 111.137 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 51.5 t -122.48 132.17 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.417 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -121.94 177.08 5.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.292 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -42.84 151.45 0.13 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.343 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.12 20.6 80.01 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.454 ' OG1' ' O ' ' A' ' 28' ' ' LEU . 62.8 p 47.62 38.3 8.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.086 0.47 . . . . 0.0 110.444 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 94.6 mt -75.73 138.72 41.45 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.31 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -108.18 148.31 30.09 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.032 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 53.9 tp -160.49 101.19 1.35 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.043 0.449 . . . . 0.0 110.501 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.439 HD12 ' N ' ' A' ' 64' ' ' THR . 4.8 tp -100.24 109.78 22.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.591 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.439 ' N ' HD12 ' A' ' 63' ' ' LEU . 2.9 p -86.14 112.08 20.96 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.238 0.542 . . . . 0.0 110.715 -179.465 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 55.5 tp -111.58 123.71 50.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.183 179.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.519 ' CG ' ' N ' ' A' ' 67' ' ' LYS . 78.3 t60 -145.67 167.94 21.9 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.993 0.425 . . . . 0.0 111.043 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.519 ' N ' ' CG ' ' A' ' 66' ' ' HIS . 72.0 tttt 56.77 57.06 4.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.443 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.42 ' O ' ' OE2' ' A' ' 18' ' ' GLU . 5.7 m -93.7 174.28 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 121.838 0.828 . . . . 0.0 111.544 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.491 ' C ' ' H ' ' A' ' 71' ' ' GLU . 4.4 t -137.89 157.22 46.85 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.121 -1.399 . . . . 0.0 108.216 178.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 67.8 mt -52.55 -5.96 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.521 -0.472 . . . . 0.0 111.202 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.491 ' H ' ' C ' ' A' ' 69' ' ' THR . 80.2 mm-40 -113.82 2.41 15.12 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.415 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.437 ' O ' ' O ' ' A' ' 73' ' ' ALA . 24.9 t70 -63.14 -52.71 61.41 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.673 -179.306 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.437 ' O ' ' O ' ' A' ' 72' ' ' ASP . . . 42.96 -167.81 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 -179.304 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 157.34 95.01 0.1 Allowed Glycine 0 CA--C 1.524 0.645 0 C-N-CA 120.404 -0.903 . . . . 0.0 112.351 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 40.6 p -90.74 94.54 9.72 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 178.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.0 t -76.87 152.09 5.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.18 0.514 . . . . 0.0 111.128 -179.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 33.9 t -153.64 151.63 29.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.3 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.505 ' CE2' ' OE1' ' A' ' 9' ' ' GLU . 64.6 m-85 -131.62 144.59 51.16 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.029 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -143.47 116.0 8.61 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.582 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.535 ' O ' ' N ' ' A' ' 82' ' ' THR . 5.6 p -129.38 135.0 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.739 178.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -38.01 -21.4 0.01 OUTLIER Glycine 0 CA--C 1.527 0.79 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.674 -178.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.535 ' N ' ' O ' ' A' ' 80' ' ' VAL . 82.7 p -85.19 -74.5 0.4 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.891 0.377 . . . . 0.0 111.14 -179.341 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.505 ' H ' HG13 ' A' ' 80' ' ' VAL . 60.4 m -128.08 -166.6 1.64 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.416 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 87.8 p -157.1 162.78 39.44 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.761 0.315 . . . . 0.0 110.93 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.9 p -152.9 166.99 30.6 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.904 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -141.97 155.98 45.46 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.147 0.499 . . . . 0.0 111.945 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.99 153.58 33.21 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.413 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -133.93 137.27 44.78 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.585 0.707 . . . . 0.0 112.328 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.7 tp -111.03 116.61 31.46 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.551 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -118.85 164.03 16.02 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.001 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.6 m -123.9 128.25 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 120.997 0.427 . . . . 0.0 110.386 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 23.3 m -73.3 134.19 44.11 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.82 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.74 148.95 51.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.444 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.666 0 CA-C-O 117.994 -1.448 . . . . 0.0 111.066 -179.875 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.7 mtt . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.584 ' N ' ' CD ' ' A' ' 3' ' ' PRO . . . -67.43 -39.47 20.35 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.783 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 2' ' ' ALA . 3.2 Cg_exo -75.43 -172.23 1.24 Allowed 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 122.298 1.999 . . . . 0.0 111.866 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -52.79 -171.74 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.297 0.57 . . . . 0.0 110.967 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.738 HG23 ' O ' ' A' ' 29' ' ' SER . 8.9 p -55.18 131.7 18.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.368 -0.833 . . . . 0.0 108.757 178.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 13.6 m -81.56 123.53 28.73 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 119.482 -0.887 . . . . 0.0 109.442 -179.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.8 mt -108.84 118.26 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 121.582 0.706 . . . . 0.0 112.673 -178.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 85.2 mt -126.31 111.11 14.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.466 -1.243 . . . . 0.0 107.947 177.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.537 ' N ' ' OE1' ' A' ' 9' ' ' GLU . 1.6 pm0 -122.96 88.5 50.76 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.318 -178.103 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -74.58 -8.51 20.6 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 122.068 1.846 . . . . 0.0 110.677 178.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.406 HD21 ' H ' ' A' ' 25' ' ' GLN . 67.3 mt -68.83 81.75 0.29 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.692 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -71.89 -58.79 3.15 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.786 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 14' ' ' VAL . 62.4 t0 -175.27 137.63 0.4 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.065 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.529 ' N ' ' OD1' ' A' ' 13' ' ' ASP . 28.4 m -137.54 156.52 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-O 121.11 0.481 . . . . 0.0 111.48 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -123.0 132.22 54.04 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.884 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.422 HD22 ' HB2' ' A' ' 22' ' ' ALA . 59.6 mt -120.54 123.73 43.61 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.476 -178.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.8 t -74.84 145.34 42.9 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 177.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -59.38 137.8 57.87 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.348 -179.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.98 -0.47 72.8 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -114.62 133.14 56.06 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.85 0.357 . . . . 0.0 110.763 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.409 ' C ' ' OD2' ' A' ' 21' ' ' ASP . 54.9 p30 -78.86 172.06 14.29 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.434 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.422 ' HB2' HD22 ' A' ' 16' ' ' LEU . . . -159.92 173.18 16.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.023 0.44 . . . . 0.0 111.263 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 29.0 p -154.67 162.29 41.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.502 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -127.93 152.55 47.74 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.022 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.406 ' H ' HD21 ' A' ' 11' ' ' LEU . 61.8 tt0 -130.58 130.06 43.56 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.473 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.466 ' SG ' ' N ' ' A' ' 27' ' ' ARG . 48.5 t -141.89 164.6 29.74 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.412 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.466 ' N ' ' SG ' ' A' ' 26' ' ' CYS . 95.7 mtt180 -140.95 121.19 13.86 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.951 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 86.0 mt -126.39 103.05 7.42 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.842 179.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.738 ' O ' HG23 ' A' ' 5' ' ' VAL . 25.1 t -63.52 170.03 3.44 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.231 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -52.62 140.21 23.85 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.378 0.609 . . . . 0.0 111.689 -178.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -91.42 -172.66 3.34 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.21 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 38.0 t -150.58 -60.26 0.19 Allowed 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -72.69 -90.13 0.13 Allowed Glycine 0 CA--C 1.521 0.45 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -123.56 143.33 50.27 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.935 0.397 . . . . 0.0 110.963 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -79.35 151.32 31.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.328 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.416 ' CB ' HG22 ' A' ' 80' ' ' VAL . . . -72.74 155.69 39.71 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.427 179.303 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -125.45 133.57 52.4 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.19 0.519 . . . . 0.0 111.306 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 1.5 t-105 -76.8 156.86 31.98 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.813 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -169.61 152.64 4.74 Favored 'General case' 0 N--CA 1.461 0.119 0 C-N-CA 119.716 -0.794 . . . . 0.0 111.959 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.61 HD13 ' C ' ' A' ' 40' ' ' LEU . 2.4 tm? -125.5 117.32 23.37 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.681 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.572 ' N ' HD13 ' A' ' 40' ' ' LEU . . . 82.2 4.1 90.33 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 -179.259 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 102.62 -9.88 55.8 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.803 -0.519 . . . . 0.0 111.803 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.5 m -107.82 155.3 40.13 Favored Pre-proline 0 N--CA 1.47 0.562 0 CA-C-N 117.08 0.44 . . . . 0.0 110.545 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -68.45 154.77 71.13 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 121.392 1.394 . . . . 0.0 112.258 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.475 HD12 ' C ' ' A' ' 45' ' ' LEU . 0.4 OUTLIER -130.48 -175.87 3.78 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.163 179.419 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.561 ' O ' ' N ' ' A' ' 48' ' ' ASN . 50.1 tt0 -141.95 149.74 40.51 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 179.289 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -50.14 82.64 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.947 0.404 . . . . 0.0 111.204 -179.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.561 ' N ' ' O ' ' A' ' 46' ' ' GLN . 52.3 t30 -81.03 162.17 23.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.372 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -57.77 -45.53 85.82 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.211 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 66.6 mtt -66.13 -38.35 87.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.819 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.452 ' O ' ' O ' ' A' ' 48' ' ' ASN . 79.4 m-20 -108.91 111.27 22.88 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.522 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -105.26 145.42 30.69 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 33.1 mt -125.0 129.85 73.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 90.2 m -124.69 131.74 53.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.601 -179.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 63.8 t -111.99 131.9 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.166 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.436 ' O ' ' O ' ' A' ' 57' ' ' GLN . 75.6 tt0 -137.09 156.77 47.97 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.911 -179.626 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.436 ' O ' ' O ' ' A' ' 56' ' ' GLU . 6.8 pt20 -41.58 165.87 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.952 0.406 . . . . 0.0 111.201 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.23 16.75 71.43 Favored Glycine 0 CA--C 1.517 0.16 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 70.7 p 52.23 31.31 9.0 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.26 -0.47 . . . . 0.0 110.048 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 22.9 mt -72.96 129.69 38.68 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.608 179.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 81.0 m80 -112.85 149.5 33.02 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.819 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 54.1 tp -151.16 106.49 3.34 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 120.809 -0.357 . . . . 0.0 111.126 -179.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -87.44 105.7 17.46 Favored 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.365 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.1 m -91.99 107.35 19.15 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.297 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 39.5 tp -97.77 110.42 22.99 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.503 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.426 ' O ' ' O ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -91.85 144.11 25.82 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.817 -179.828 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.426 ' O ' ' O ' ' A' ' 66' ' ' HIS . 99.2 mttt 41.76 96.85 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.09 179.164 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.9 p -75.28 156.12 6.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.073 0.464 . . . . 0.0 110.905 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.7 m -134.61 156.64 48.36 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.095 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 70.6 mt -56.56 -24.65 48.59 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -74.27 -6.32 47.28 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.044 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -60.48 -39.11 86.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.815 0.34 . . . . 0.0 110.754 -179.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -44.27 126.25 5.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.71 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -178.75 -150.52 8.89 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.459 HG23 ' O ' ' A' ' 87' ' ' ALA . 10.0 m -150.46 106.52 3.45 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 110.336 -0.246 . . . . 0.0 110.336 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.8 t -83.06 133.27 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.1 p -151.62 164.13 37.56 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.16 0.505 . . . . 0.0 111.338 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -141.9 146.53 35.84 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.517 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -119.28 129.29 54.82 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.192 0.52 . . . . 0.0 111.526 -179.016 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.531 ' C ' ' H ' ' A' ' 82' ' ' THR . 2.0 t -120.68 132.24 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.032 179.185 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -50.32 -6.72 0.11 Allowed Glycine 0 CA--C 1.529 0.925 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.408 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.531 ' H ' ' C ' ' A' ' 80' ' ' VAL . 6.4 p -102.8 -52.0 3.17 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.737 0.303 . . . . 0.0 110.194 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -152.8 161.6 42.35 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.946 179.345 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 40.1 t -135.54 143.19 45.58 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.935 0.398 . . . . 0.0 111.001 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 67.1 m -134.13 160.16 38.64 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.46 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.491 ' N ' ' OE2' ' A' ' 86' ' ' GLU . 57.9 mp0 -130.88 156.14 45.55 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.785 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.459 ' O ' HG23 ' A' ' 75' ' ' THR . . . -134.53 142.65 47.07 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.203 179.411 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.484 ' CD ' ' N ' ' A' ' 88' ' ' GLN . 14.7 mp0 -106.93 127.29 53.3 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.434 0.635 . . . . 0.0 111.955 -178.473 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.582 HD23 ' C ' ' A' ' 89' ' ' LEU . 4.6 tt -119.69 114.15 21.74 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.164 179.197 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.54 ' N ' HD23 ' A' ' 89' ' ' LEU . 23.2 mtmm -109.93 154.03 23.68 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.528 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.8 t -119.42 131.34 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.9 m -84.8 131.57 34.52 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.64 3.13 3.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.009 -179.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.693 0 CA-C-O 118.052 -1.416 . . . . 0.0 110.926 179.895 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.3 mmm . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -172.26 71.57 0.44 Allowed Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.54 -179.261 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -70.67 -18.77 32.47 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.474 2.116 . . . . 0.0 111.781 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -81.77 155.99 25.17 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.72 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.61 HG22 ' HA ' ' A' ' 31' ' ' ALA . 2.8 t -61.01 133.14 26.8 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.455 ' H ' ' HB2' ' A' ' 29' ' ' SER . 9.0 m -111.94 131.46 55.37 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.842 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.407 HD11 HG11 ' A' ' 80' ' ' VAL . 2.4 mt -120.41 124.08 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 120.959 0.409 . . . . 0.0 111.905 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.431 ' HA ' HD22 ' A' ' 8' ' ' LEU . 0.2 OUTLIER -130.46 89.93 2.85 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.271 177.845 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -121.53 83.3 41.02 Favored Pre-proline 0 N--CA 1.469 0.524 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.221 -179.058 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -73.92 -10.48 23.08 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.215 1.943 . . . . 0.0 111.57 179.164 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.472 ' CD2' ' H ' ' A' ' 25' ' ' GLN . 0.3 OUTLIER -91.75 55.14 2.63 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.194 0.521 . . . . 0.0 109.908 179.759 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -80.48 -1.19 40.62 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.418 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -151.67 109.39 3.65 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 43.0 t -120.41 133.87 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.017 -178.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -135.07 100.32 4.53 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.961 0.41 . . . . 0.0 110.961 179.489 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 66.2 mt -115.78 139.98 49.65 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.458 -179.263 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 85.3 p -74.58 165.68 24.81 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.767 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -69.23 146.41 52.37 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.011 0.434 . . . . 0.0 110.523 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.08 1.33 89.67 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 70.7 tp60 -105.34 148.34 27.17 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.614 0.245 . . . . 0.0 110.48 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 21' ' ' ASP . 54.8 p30 -76.29 153.82 35.61 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.464 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.79 147.58 37.52 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.97 -179.134 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.4 m -163.09 171.23 16.71 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.715 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -128.36 143.7 51.04 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.472 ' H ' ' CD2' ' A' ' 11' ' ' LEU . 88.0 mt-30 -139.19 119.7 13.97 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.723 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 9.7 p -152.04 163.89 38.37 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.418 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -102.05 137.06 40.82 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.419 ' C ' HD13 ' A' ' 28' ' ' LEU . 0.3 OUTLIER -140.52 95.68 2.91 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.978 -179.774 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.455 ' HB2' ' H ' ' A' ' 6' ' ' THR . 69.1 m -59.25 152.27 21.17 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.006 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -54.41 156.02 3.57 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -177.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.61 ' HA ' HG22 ' A' ' 5' ' ' VAL . . . -73.29 -178.71 3.06 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 114.606 -1.179 . . . . 0.0 112.123 -179.233 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 89.6 p -156.71 -52.05 0.08 Allowed 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.223 -0.898 . . . . 0.0 109.713 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -97.29 -65.4 0.9 Allowed Glycine 0 CA--C 1.524 0.648 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 179.134 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.446 ' HB2' ' H ' ' A' ' 81' ' ' GLY . 87.1 mt-30 -124.03 152.11 42.99 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -86.18 135.91 33.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.952 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.2 152.71 34.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.513 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -147.05 146.93 30.16 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.163 0.506 . . . . 0.0 111.739 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -81.48 179.64 7.76 Favored 'General case' 0 CA--C 1.521 -0.139 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.607 179.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.649 ' HB3' ' O ' ' A' ' 77' ' ' SER . . . -165.74 131.6 2.56 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.202 179.09 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 53.1 tp -133.89 123.35 24.58 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.012 179.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.31 8.83 80.53 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.08 -17.31 58.87 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.4 m -112.16 147.48 37.05 Favored Pre-proline 0 CA--C 1.535 0.381 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -52.39 140.7 52.79 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 121.301 1.334 . . . . 0.0 111.042 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.432 ' H ' ' CD2' ' A' ' 45' ' ' LEU . 0.9 OUTLIER -78.44 168.69 19.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.909 0.385 . . . . 0.0 110.874 -179.546 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -131.38 142.11 49.99 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.716 -179.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.42 62.89 1.02 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.796 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.459 ' O ' ' O ' ' A' ' 51' ' ' ASN . 97.3 m-20 -74.69 159.53 31.94 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -40.86 -36.49 0.64 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 120.681 -0.407 . . . . 0.0 111.359 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 94.4 mtp -64.55 -43.57 93.54 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.782 0.325 . . . . 0.0 111.117 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.463 ' O ' ' OD2' ' A' ' 52' ' ' ASP . 70.9 m-80 -100.26 149.97 23.04 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.469 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.463 ' OD2' ' O ' ' A' ' 51' ' ' ASN . 84.4 m-20 -140.21 98.51 3.45 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.888 0.375 . . . . 0.0 110.634 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.7 mt -85.72 128.1 39.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.516 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.3 t -140.03 152.22 46.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.987 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.1 t -119.88 130.12 74.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.05 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -126.18 -174.95 3.23 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.405 -179.188 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -54.3 152.06 6.74 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.858 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.65 26.47 74.42 Favored Glycine 0 CA--C 1.52 0.394 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.414 ' OG1' ' O ' ' A' ' 28' ' ' LEU . 17.8 p 48.33 29.07 1.81 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.762 0.315 . . . . 0.0 110.681 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 23.5 mt -69.32 131.9 45.57 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.278 0.561 . . . . 0.0 111.006 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 64.2 m80 -110.34 149.29 30.43 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.721 178.489 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.552 ' C ' HD23 ' A' ' 62' ' ' LEU . 7.0 tt -156.53 102.72 2.08 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.196 -178.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.35 106.97 19.07 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 177.702 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.454 ' OG1' ' CD2' ' A' ' 62' ' ' LEU . 15.9 m -88.31 113.11 23.59 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.023 0.439 . . . . 0.0 111.36 -178.384 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.0 tt -101.67 122.1 43.26 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.112 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.658 ' NE2' ' NZ ' ' A' ' 67' ' ' LYS . 56.0 t60 -85.28 132.26 34.29 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.263 0.554 . . . . 0.0 112.228 -178.113 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.658 ' NZ ' ' NE2' ' A' ' 66' ' ' HIS . 52.5 mttp 39.62 83.44 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.039 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.7 p -54.29 162.08 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.014 0.435 . . . . 0.0 110.649 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.45 ' H ' ' HB2' ' A' ' 72' ' ' ASP . 28.5 p -137.26 165.27 26.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.447 179.146 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.468 HD22 ' N ' ' A' ' 70' ' ' LEU . 4.1 mm? -60.95 -38.14 84.82 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.354 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -67.54 -36.62 81.34 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.896 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.45 ' HB2' ' H ' ' A' ' 69' ' ' THR . 44.3 m-20 -63.98 -36.81 85.19 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.789 -178.573 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.28 141.65 55.8 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.559 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -176.39 -165.02 31.41 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 57.7 m -98.93 123.39 43.18 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.627 0.251 . . . . 0.0 110.509 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.1 m -105.37 149.74 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.623 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.649 ' O ' ' HB3' ' A' ' 39' ' ' ALA . 51.7 p -159.47 158.23 31.59 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.678 0.275 . . . . 0.0 110.738 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.406 ' CD1' ' C ' ' A' ' 78' ' ' PHE . 45.3 p90 -143.16 157.35 44.59 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.361 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 69.8 m80 -142.87 139.66 30.93 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.245 0.545 . . . . 0.0 111.827 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.534 ' O ' ' N ' ' A' ' 82' ' ' THR . 3.2 p -144.12 143.12 23.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.17 178.751 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.446 ' H ' ' HB2' ' A' ' 34' ' ' GLN . . . -42.21 -14.39 0.01 OUTLIER Glycine 0 CA--C 1.526 0.748 0 CA-C-N 116.471 -0.331 . . . . 0.0 112.854 -178.602 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.534 ' N ' ' O ' ' A' ' 80' ' ' VAL . 45.6 p -89.3 -72.91 0.53 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 117.081 0.441 . . . . 0.0 110.152 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.443 ' H ' HG13 ' A' ' 80' ' ' VAL . 6.7 t -139.45 -172.37 3.35 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.633 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 41.6 p -158.56 163.08 37.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.051 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 31.0 m -162.31 173.83 13.65 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.546 -0.462 . . . . 0.0 111.054 179.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.467 ' N ' ' CD ' ' A' ' 86' ' ' GLU . 1.3 pm0 -137.04 152.66 50.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.823 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -143.79 151.68 40.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.269 -0.878 . . . . 0.0 108.922 178.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -110.86 128.6 55.84 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.527 0.679 . . . . 0.0 111.933 -178.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 51.4 tp -101.02 81.69 2.28 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 114.944 -1.025 . . . . 0.0 108.765 178.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -94.55 172.35 8.24 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.3 m -116.02 141.46 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 29.0 m -64.14 135.37 56.28 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.0 140.55 58.88 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.894 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.764 0 CA-C-O 117.754 -1.581 . . . . 0.0 111.588 179.958 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.9 ptm . . . . . 0 N--CA 1.492 1.65 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.48 150.79 82.64 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -53.68 144.51 53.11 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 121.257 1.304 . . . . 0.0 111.723 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.408 ' HG3' ' N ' ' A' ' 5' ' ' VAL . 35.5 tp10 -72.52 162.54 29.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.735 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.491 ' H ' HG13 ' A' ' 5' ' ' VAL . 1.0 OUTLIER -52.34 137.79 11.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 179.919 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.537 ' N ' ' OG ' ' A' ' 29' ' ' SER . 39.2 m -95.87 123.56 39.51 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 120.04 -0.664 . . . . 0.0 111.074 -178.727 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.3 mm -109.9 88.9 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.762 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.474 ' O ' ' SG ' ' A' ' 26' ' ' CYS . 55.4 mt -112.81 112.05 23.27 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 177.77 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -123.95 92.67 48.14 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.57 -178.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -69.25 -11.22 30.99 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 C-N-CA 121.259 1.306 . . . . 0.0 109.334 178.105 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.432 HD21 ' H ' ' A' ' 25' ' ' GLN . 63.7 mt -68.09 77.29 0.23 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.502 -1.226 . . . . 0.0 110.575 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 54.1 tp60 -70.66 -41.17 72.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.735 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -176.38 145.54 0.59 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.02 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.476 HG21 ' CE2' ' A' ' 24' ' ' PHE . 70.0 t -121.45 134.72 63.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.314 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -143.16 127.18 17.38 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.229 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.5 pp -162.75 144.3 10.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.861 -179.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.4 m -64.68 146.13 55.18 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -64.48 147.92 51.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.971 0.891 . . . . 0.0 112.218 -178.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.626 ' H ' ' CG1' ' A' ' 68' ' ' VAL . . . 92.75 -8.13 76.75 Favored Glycine 0 CA--C 1.521 0.466 0 CA-C-N 113.906 -1.497 . . . . 0.0 110.427 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -93.05 161.55 14.39 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 179.22 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -76.41 161.28 28.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.932 0.396 . . . . 0.0 110.588 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -149.39 156.89 42.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.389 -179.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.2 p -160.36 162.53 33.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.951 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.476 ' CE2' HG21 ' A' ' 14' ' ' VAL . 96.1 m-85 -133.41 147.31 51.74 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.146 0.498 . . . . 0.0 111.099 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.432 ' H ' HD21 ' A' ' 11' ' ' LEU . 89.0 mt-30 -139.0 125.48 20.5 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.424 178.718 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.61 ' SG ' ' N ' ' A' ' 27' ' ' ARG . 8.9 t -146.73 163.31 36.36 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.036 0.446 . . . . 0.0 110.453 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.61 ' N ' ' SG ' ' A' ' 26' ' ' CYS . 78.4 ttt-85 -120.61 119.48 33.01 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.365 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.449 ' C ' HD23 ' A' ' 28' ' ' LEU . 2.6 tt -136.15 105.76 6.14 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.551 -0.459 . . . . 0.0 110.541 -179.026 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.537 ' OG ' ' N ' ' A' ' 6' ' ' THR . 86.6 p -62.4 156.27 23.02 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.342 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 37.7 ptt-85 -50.84 160.68 0.43 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.223 -177.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.429 ' HA ' HG12 ' A' ' 5' ' ' VAL . . . -71.02 174.39 6.31 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.196 -178.676 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.3 t -120.35 1.94 10.77 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 151.65 -24.23 0.94 Allowed Glycine 0 N--CA 1.453 -0.184 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -121.07 119.16 31.67 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 115.416 -0.392 . . . . 0.0 110.449 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -93.71 149.99 20.78 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.123 -179.383 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.494 ' CB ' HG22 ' A' ' 80' ' ' VAL . . . -80.63 169.25 17.89 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.298 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.456 ' NH2' ' O ' ' A' ' 38' ' ' TRP . 9.5 ptm180 -144.21 146.06 32.46 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.42 179.383 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.458 ' CB ' HD11 ' A' ' 45' ' ' LEU . 81.4 m95 -78.16 176.54 9.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.813 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 77' ' ' SER . . . -164.55 107.21 0.88 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.598 179.242 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.532 HD13 ' N ' ' A' ' 41' ' ' GLY . 0.7 OUTLIER -116.19 114.1 23.98 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.532 ' N ' HD13 ' A' ' 40' ' ' LEU . . . 70.87 17.38 75.26 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.18 -22.19 42.17 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 18.8 m -111.94 148.73 39.62 Favored Pre-proline 0 CA--C 1.539 0.554 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -59.25 144.55 99.35 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 121.253 1.302 . . . . 0.0 111.625 -179.559 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.486 ' O ' HD12 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -89.69 164.77 14.57 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.085 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.436 ' O ' ' N ' ' A' ' 48' ' ' ASN . 78.3 mt-30 -135.91 155.44 50.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.978 0.418 . . . . 0.0 110.298 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.89 74.44 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.576 -179.04 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' A' ' 46' ' ' GLN . 98.5 m-20 -73.01 160.3 32.31 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.048 179.113 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -54.7 -49.16 71.38 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.326 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 78.4 mtm -69.38 -39.87 77.75 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.74 179.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.435 ' O ' ' O ' ' A' ' 48' ' ' ASN . 64.3 t30 -107.53 112.2 24.83 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.936 0.398 . . . . 0.0 110.975 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 53' ' ' ILE . 66.7 t0 -109.93 143.76 39.41 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.673 179.426 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.518 ' N ' ' OD1' ' A' ' 52' ' ' ASP . 20.6 tt -127.63 136.24 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.5 p -140.73 158.38 44.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.081 0.467 . . . . 0.0 111.551 -178.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.6 m -120.58 130.14 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.405 178.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -121.29 165.36 15.59 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.163 0.506 . . . . 0.0 111.009 -178.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -42.14 152.69 0.08 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.977 179.324 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.3 19.07 78.54 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' A' ' 28' ' ' LEU . 51.0 p 50.33 33.35 7.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.931 0.396 . . . . 0.0 110.376 -179.264 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 76.7 mt -79.32 120.56 23.96 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.714 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -83.69 142.63 30.61 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 56.1 tp -145.66 93.96 2.43 Favored 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 34.4 tp -92.91 106.97 18.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.606 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.537 ' CG2' ' NE2' ' A' ' 66' ' ' HIS . 78.0 m -96.85 98.41 10.1 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.184 -178.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.557 HD23 ' N ' ' A' ' 66' ' ' HIS . 4.0 tt -101.27 119.44 38.75 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.104 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.557 ' N ' HD23 ' A' ' 65' ' ' LEU . 54.1 m170 -112.43 154.22 26.15 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 120.772 0.32 . . . . 0.0 110.513 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 64.3 mttp 53.5 59.16 4.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.262 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.626 ' CG1' ' H ' ' A' ' 19' ' ' GLY . 1.0 OUTLIER -50.7 159.01 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.963 0.411 . . . . 0.0 110.782 -179.682 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.42 ' H ' ' HB2' ' A' ' 72' ' ' ASP . 55.0 p -133.97 167.04 21.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.313 179.315 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.445 HD12 ' N ' ' A' ' 70' ' ' LEU . 11.0 mp -61.78 -39.32 91.25 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.577 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -67.78 -35.55 78.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.158 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.42 ' HB2' ' H ' ' A' ' 69' ' ' THR . 98.9 m-20 -61.74 -43.03 99.65 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.197 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.27 141.15 51.75 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.374 -0.53 . . . . 0.0 109.73 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 168.28 -148.67 12.89 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.596 -0.811 . . . . 0.0 111.15 -179.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 43.6 m -110.1 125.16 52.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.709 -0.246 . . . . 0.0 110.715 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.0 t -111.76 130.58 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.52 ' O ' ' HB3' ' A' ' 39' ' ' ALA . 24.9 t -153.4 167.48 29.28 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.127 0.489 . . . . 0.0 110.764 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -146.68 150.33 35.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.066 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -128.62 140.37 51.8 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.092 0.472 . . . . 0.0 111.584 -178.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.509 ' C ' ' H ' ' A' ' 82' ' ' THR . 2.2 t -129.49 133.84 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.974 179.217 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -49.18 -7.48 0.07 OUTLIER Glycine 0 CA--C 1.529 0.928 0 C-N-CA 121.158 -0.544 . . . . 0.0 111.854 -179.241 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.509 ' H ' ' C ' ' A' ' 80' ' ' VAL . 31.0 p -107.72 -43.53 4.46 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.978 0.389 . . . . 0.0 110.932 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 14.1 t -154.2 154.62 33.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.336 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.1 m -130.61 157.1 43.66 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.984 0.421 . . . . 0.0 111.569 -179.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.404 ' O ' ' OG ' ' A' ' 77' ' ' SER . 15.8 t -154.68 157.2 37.74 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.848 -179.578 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -127.4 159.95 32.92 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.368 0.604 . . . . 0.0 111.706 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.49 147.57 27.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.425 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -117.66 139.6 50.78 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.346 0.593 . . . . 0.0 112.522 -178.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.512 HD23 ' C ' ' A' ' 89' ' ' LEU . 3.5 tt -119.81 106.78 12.42 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.182 -0.917 . . . . 0.0 108.597 178.249 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.414 ' N ' HD23 ' A' ' 89' ' ' LEU . 61.5 pttt -110.96 160.24 16.99 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.706 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.421 ' O ' HG23 ' A' ' 91' ' ' VAL . 23.7 m -110.66 131.47 61.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.886 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 98.1 m -112.65 127.32 56.08 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.271 -179.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -82.96 -78.63 0.21 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.087 -179.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.827 0 CA-C-O 117.838 -1.534 . . . . 0.0 111.332 -179.724 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 80.8 mtp . . . . . 0 N--CA 1.493 1.689 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.33 151.63 75.91 Favored Pre-proline 0 CA--C 1.532 0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.83 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.459 ' O ' ' O ' ' A' ' 4' ' ' GLU . 2.1 Cg_endo -46.85 -76.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.316 -1.163 0 C-N-CA 121.426 1.418 . . . . 0.0 110.485 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.459 ' O ' ' O ' ' A' ' 3' ' ' PRO . 80.9 mm-40 41.19 -165.64 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.741 179.195 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 29' ' ' SER . 0.2 OUTLIER -58.8 157.71 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 177.351 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.5 ' HB ' ' H ' ' A' ' 29' ' ' SER . 93.8 m -85.53 86.31 7.38 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 118.262 -1.375 . . . . 0.0 108.407 179.381 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.67 HG23 ' O ' ' A' ' 7' ' ' ILE . 10.6 tt -83.92 90.9 2.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 122.371 1.081 . . . . 0.0 112.52 -177.721 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 96.8 mt -127.33 83.51 2.17 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 113.457 -1.702 . . . . 0.0 109.056 178.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.446 ' C ' ' H ' ' A' ' 11' ' ' LEU . 4.8 pt-20 -122.93 83.9 50.3 Favored Pre-proline 0 N--CA 1.468 0.464 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.177 -178.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -71.93 17.51 0.32 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.189 1.926 . . . . 0.0 111.577 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.478 HD21 ' O ' ' A' ' 25' ' ' GLN . 76.6 mt -66.92 77.45 0.12 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.542 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -71.7 -70.47 0.32 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.345 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.417 ' OD2' ' N ' ' A' ' 13' ' ' ASP . 31.7 p-10 -176.72 152.41 0.99 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.336 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.9 m -135.57 161.3 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.068 -179.331 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -133.45 139.51 46.75 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.383 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -156.64 151.52 26.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.033 0.445 . . . . 0.0 111.417 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.8 p -80.66 168.04 19.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.639 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -64.83 141.68 58.69 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.831 0.348 . . . . 0.0 110.515 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.61 8.2 87.22 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.689 -0.564 . . . . 0.0 111.689 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 93.5 mm-40 -96.48 158.66 15.33 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.846 0.355 . . . . 0.0 110.153 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -86.04 167.54 14.92 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.05 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.493 ' HB3' HD22 ' A' ' 65' ' ' LEU . . . -161.54 157.08 24.29 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.916 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 73.6 m -163.93 159.47 20.94 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.148 -0.315 . . . . 0.0 110.148 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -128.78 147.91 50.82 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.087 0.47 . . . . 0.0 110.617 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.485 ' OE1' ' CD2' ' A' ' 62' ' ' LEU . 62.6 mm-40 -124.43 125.69 44.69 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.874 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 6.7 t -137.53 146.13 43.78 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.171 0.51 . . . . 0.0 110.701 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -125.99 100.42 6.35 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.244 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.478 ' O ' ' CG2' ' A' ' 59' ' ' THR . 91.0 mt -121.6 110.31 15.84 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.255 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.5 ' H ' ' HB ' ' A' ' 6' ' ' THR . 34.7 t -69.62 172.9 6.7 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.45 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 11.6 ptp85 -50.12 151.28 2.05 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 122.038 0.923 . . . . 0.0 113.03 -177.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.6 160.04 20.53 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 113.831 -1.531 . . . . 0.0 112.213 -178.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.9 m -138.77 -82.96 0.29 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.647 179.105 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -65.58 -85.9 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 178.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -123.56 155.68 37.16 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.303 0.573 . . . . 0.0 110.193 178.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 74.9 tt0 -72.99 153.47 40.92 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.239 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.72 143.6 26.81 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.075 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -108.08 141.74 39.33 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.52 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 8.7 t-105 -111.11 138.87 47.01 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -165.41 155.98 13.6 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 119.45 -0.9 . . . . 0.0 111.762 -178.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.633 ' C ' HD23 ' A' ' 40' ' ' LEU . 6.9 tt -131.27 123.57 28.65 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.941 179.603 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.564 ' N ' HD23 ' A' ' 40' ' ' LEU . . . 82.89 6.31 88.52 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.752 -0.539 . . . . 0.0 111.752 179.159 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 102.04 -20.34 45.84 Favored Glycine 0 N--CA 1.467 0.704 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.4 m -109.35 151.56 42.17 Favored Pre-proline 0 N--CA 1.467 0.401 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -56.79 141.78 92.34 Favored 'Trans proline' 0 C--N 1.316 -1.171 0 C-N-CA 120.939 1.092 . . . . 0.0 111.048 179.119 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.563 ' H ' ' CD2' ' A' ' 45' ' ' LEU . 0.8 OUTLIER -93.15 -172.46 2.97 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.14 -179.89 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 61.8 tp60 -144.93 155.7 43.57 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.262 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.14 63.7 1.33 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.44 ' O ' ' O ' ' A' ' 51' ' ' ASN . 13.3 t-20 -65.55 175.87 1.67 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.136 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -66.01 -39.72 90.48 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 78.1 mtm -67.65 -39.35 84.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.164 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.44 ' O ' ' O ' ' A' ' 48' ' ' ASN . 55.6 t30 -126.02 131.95 52.09 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.039 0.447 . . . . 0.0 111.073 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -120.02 140.57 50.77 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.551 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.4 mm -110.69 127.32 67.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.451 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.441 HG22 ' O ' ' A' ' 62' ' ' LEU . 5.0 t -145.86 156.55 43.63 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.099 0.476 . . . . 0.0 111.432 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.2 m -115.31 133.65 60.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.029 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -116.91 -177.48 3.21 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.101 0.477 . . . . 0.0 110.669 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.426 ' CD ' ' N ' ' A' ' 58' ' ' GLY . 9.8 tm0? -64.6 147.31 53.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.269 -179.243 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.426 ' N ' ' CD ' ' A' ' 57' ' ' GLN . . . 80.55 13.04 82.24 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.478 ' CG2' ' O ' ' A' ' 28' ' ' LEU . 1.6 m 70.4 24.53 4.63 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 121.418 0.628 . . . . 0.0 110.385 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.6 mp -79.76 138.85 37.4 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.879 179.097 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 58.4 m170 -111.18 130.29 55.68 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.628 HD13 ' N ' ' A' ' 63' ' ' LEU . 1.1 tm? -125.13 119.58 28.99 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 111.494 0.183 . . . . 0.0 111.494 -178.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.628 ' N ' HD13 ' A' ' 62' ' ' LEU . 6.3 mp -103.36 114.14 28.18 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 177.579 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 93.1 m -99.61 110.6 23.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.112 0.482 . . . . 0.0 110.746 -179.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.709 ' C ' HD23 ' A' ' 65' ' ' LEU . 7.0 tt -110.88 129.28 55.91 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.869 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.505 ' N ' HD23 ' A' ' 65' ' ' LEU . 0.8 OUTLIER -153.34 165.11 36.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.414 -179.602 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.5 mttp 42.58 86.78 0.02 OUTLIER 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.313 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.482 HG11 HD21 ' A' ' 65' ' ' LEU . 21.4 m -137.65 163.94 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.588 -178.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 33.2 p -117.77 -151.86 0.49 Allowed 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.669 179.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.506 ' C ' ' H ' ' A' ' 72' ' ' ASP . 87.1 mt -63.01 -23.71 67.58 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.675 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -56.92 -1.07 0.05 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.349 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.506 ' H ' ' C ' ' A' ' 70' ' ' LEU . 18.6 m-20 -62.73 -36.19 82.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.281 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.3 127.92 31.66 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.473 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 172.48 153.18 9.12 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.776 -0.929 . . . . 0.0 110.776 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 85.4 m -111.59 116.69 31.24 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.558 0.218 . . . . 0.0 110.958 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.2 t -91.93 128.2 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.2 p -128.24 145.45 51.04 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.043 0.449 . . . . 0.0 110.835 -179.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -156.87 155.49 31.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.421 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 40.8 p-80 -159.37 151.46 20.88 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.315 0.578 . . . . 0.0 111.911 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.544 ' O ' ' N ' ' A' ' 82' ' ' THR . 12.3 p -124.06 134.22 67.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 115.285 -0.87 . . . . 0.0 108.982 178.51 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -31.23 -30.01 0.01 OUTLIER Glycine 0 CA--C 1.529 0.958 0 CA-C-N 116.058 -0.519 . . . . 0.0 113.096 -178.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.544 ' N ' ' O ' ' A' ' 80' ' ' VAL . 4.5 m -76.61 -74.3 0.24 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.006 0.431 . . . . 0.0 110.92 -179.394 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.41 ' O ' ' O ' ' A' ' 80' ' ' VAL . 7.6 t -119.76 -170.04 1.88 Allowed 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 31.4 p -151.74 157.49 42.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.204 0.526 . . . . 0.0 110.718 179.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.4 t -167.06 151.35 6.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.827 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -146.1 156.26 43.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.054 0.454 . . . . 0.0 110.729 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -129.82 152.97 48.72 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.448 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -124.99 137.95 54.24 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.279 0.561 . . . . 0.0 111.459 -179.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.598 HD23 ' C ' ' A' ' 89' ' ' LEU . 6.3 tt -110.15 121.97 46.53 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.22 -0.9 . . . . 0.0 108.978 178.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.58 ' N ' HD23 ' A' ' 89' ' ' LEU . 17.7 ptpt -123.61 157.93 32.63 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.934 0.397 . . . . 0.0 111.367 -179.232 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 18.6 m -116.06 136.24 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.873 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 46.5 p -99.06 134.73 41.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.573 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -164.96 -19.25 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.263 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.768 0 CA-C-O 118.143 -1.365 . . . . 0.0 111.647 -179.16 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.9 mpp? . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.569 ' N ' ' CD ' ' A' ' 3' ' ' PRO . . . -176.16 44.79 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.427 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.569 ' CD ' ' N ' ' A' ' 2' ' ' ALA . 2.3 Cg_endo -42.66 -55.55 2.61 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.733 2.288 . . . . 0.0 112.112 -179.244 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.471 ' OE2' ' N ' ' A' ' 5' ' ' VAL . 1.3 tm-20 -70.96 161.03 31.81 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 29' ' ' SER . 1.9 p -59.23 130.31 22.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.545 HG22 ' H ' ' A' ' 8' ' ' LEU . 12.1 m -66.61 134.31 52.07 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 118.739 -1.184 . . . . 0.0 108.304 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.58 HG23 ' O ' ' A' ' 7' ' ' ILE . 2.4 tp -111.81 31.49 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -177.188 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.545 ' H ' HG22 ' A' ' 6' ' ' THR . 7.7 mp -81.98 90.1 6.46 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.505 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.502 ' C ' ' H ' ' A' ' 11' ' ' LEU . 1.8 pt-20 -121.3 90.5 47.6 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.032 -179.538 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -68.32 24.93 0.14 Allowed 'Trans proline' 0 C--N 1.314 -1.289 0 C-N-CA 121.861 1.707 . . . . 0.0 112.141 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.502 ' H ' ' C ' ' A' ' 9' ' ' GLU . 71.2 mt -81.01 72.9 8.06 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.104 0.478 . . . . 0.0 110.467 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -74.58 -67.78 0.6 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.446 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -172.26 133.57 0.67 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.357 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.1 m -123.99 142.38 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 120.924 0.392 . . . . 0.0 110.768 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.533 ' C ' HD22 ' A' ' 16' ' ' LEU . 89.5 mt-30 -129.71 112.97 14.17 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.518 -179.319 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.56 ' O ' HG23 ' A' ' 91' ' ' VAL . 4.5 mm? -122.92 151.32 41.89 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.36 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.2 m -72.85 155.09 40.26 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 178.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.2 tm-20 -59.5 139.43 57.13 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.832 0.348 . . . . 0.0 110.728 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.59 -1.41 87.17 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.891 179.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 23.0 mm100 -91.83 168.55 11.36 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.91 0.386 . . . . 0.0 110.725 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -84.3 164.15 19.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.255 179.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -153.27 153.27 32.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.785 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 28.2 p -156.43 159.13 38.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.921 0.391 . . . . 0.0 110.552 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -132.3 147.1 52.39 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.292 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.404 ' O ' HD21 ' A' ' 11' ' ' LEU . 52.5 tt0 -137.37 121.75 18.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.09 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 37.3 t -129.63 129.82 44.82 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.98 0.419 . . . . 0.0 111.053 -179.443 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.01 108.38 21.05 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.044 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.447 ' O ' ' OG1' ' A' ' 59' ' ' THR . 74.3 mt -122.38 129.81 52.48 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.537 178.471 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.568 ' O ' HG23 ' A' ' 5' ' ' VAL . 68.6 m -94.32 175.86 6.53 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 -56.67 138.56 52.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.361 0.6 . . . . 0.0 111.208 -179.158 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -79.27 -176.1 5.01 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.415 -179.184 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.42 ' OG ' ' N ' ' A' ' 33' ' ' GLY . 82.5 p -146.23 -62.04 0.31 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.711 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.42 ' N ' ' OG ' ' A' ' 32' ' ' SER . . . -93.82 -71.08 1.14 Allowed Glycine 0 CA--C 1.522 0.506 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 179.257 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 96.5 mm-40 -122.75 135.15 54.47 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.386 0.612 . . . . 0.0 111.78 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -86.75 145.41 26.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.072 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.477 ' CB ' HG22 ' A' ' 80' ' ' VAL . . . -70.45 147.63 49.24 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.5 mmt85 -102.52 143.68 31.92 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 20.9 t-105 -102.3 131.43 48.9 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.414 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -172.7 152.81 2.6 Favored 'General case' 0 C--O 1.226 -0.179 0 C-N-CA 119.608 -0.837 . . . . 0.0 112.447 -179.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.62 ' C ' HD23 ' A' ' 40' ' ' LEU . 6.7 tt -125.87 121.16 32.42 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.046 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.525 ' N ' HD23 ' A' ' 40' ' ' LEU . . . 88.23 -2.99 85.58 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -178.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.28 1.07 58.15 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 112.167 -0.373 . . . . 0.0 112.167 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.7 m -111.59 148.28 38.52 Favored Pre-proline 0 N--CA 1.471 0.603 0 CA-C-N 117.146 0.473 . . . . 0.0 110.709 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -49.85 138.72 33.75 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 121.631 1.554 . . . . 0.0 111.308 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.8 tp -86.62 163.19 17.55 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.899 -178.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -140.41 147.76 40.2 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.62 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.13 62.98 0.67 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.866 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.522 ' OD1' ' N ' ' A' ' 49' ' ' GLU . 60.1 t-20 -66.62 142.62 57.4 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.043 0.449 . . . . 0.0 111.033 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.522 ' N ' ' OD1' ' A' ' 48' ' ' ASN . 74.9 mm-40 -40.07 -42.05 1.35 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.093 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 74.1 mtm -65.99 -39.28 90.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.636 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.514 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 0.6 OUTLIER -112.27 125.88 54.64 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.123 -178.805 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.49 ' OD2' ' N ' ' A' ' 53' ' ' ILE . 56.5 t0 -109.28 154.09 22.95 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.13 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.49 ' N ' ' OD2' ' A' ' 52' ' ' ASP . 64.4 mt -137.11 129.22 43.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.9 p -130.86 148.87 52.69 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.035 0.445 . . . . 0.0 110.755 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.0 p -125.34 128.44 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.348 -179.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.454 ' O ' ' O ' ' A' ' 57' ' ' GLN . 96.3 mt-10 -126.82 -173.12 2.8 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.841 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.454 ' O ' ' O ' ' A' ' 56' ' ' GLU . 97.8 mm-40 -28.24 152.12 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.368 -179.123 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.427 ' C ' ' OG1' ' A' ' 59' ' ' THR . . . 58.8 -82.75 0.01 OUTLIER Glycine 0 CA--C 1.521 0.454 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 179.239 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER 175.68 51.29 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.83 0.824 . . . . 0.0 109.134 179.912 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 42.8 mt -80.16 135.93 36.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.95 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -113.76 145.74 40.94 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.522 ' C ' HD23 ' A' ' 62' ' ' LEU . 3.2 tt -153.59 110.94 3.48 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.643 -179.404 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.486 ' N ' HD23 ' A' ' 62' ' ' LEU . 7.8 mp -97.02 128.86 44.4 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 120.969 0.414 . . . . 0.0 110.804 179.314 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.9 m -108.71 103.22 12.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.544 179.087 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.431 ' CD2' ' N ' ' A' ' 65' ' ' LEU . 3.1 mm? -96.06 126.68 41.46 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.132 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.478 ' ND1' ' N ' ' A' ' 67' ' ' LYS . 12.0 t-80 -138.61 160.49 39.47 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.235 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.478 ' N ' ' ND1' ' A' ' 66' ' ' HIS . 70.9 mmtt 57.21 41.54 26.8 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.4 p -94.88 134.95 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.106 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.431 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 44.7 p -122.27 -151.01 0.46 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.102 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.589 ' C ' ' H ' ' A' ' 72' ' ' ASP . 86.0 mt -45.9 -27.4 0.87 Allowed 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.34 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -64.28 13.07 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.725 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.589 ' H ' ' C ' ' A' ' 70' ' ' LEU . 5.1 m-20 -60.34 -35.77 76.42 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.048 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -52.31 138.3 26.97 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.148 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -171.53 173.66 44.95 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 17.1 p -154.43 104.39 2.57 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 110.453 -0.203 . . . . 0.0 110.453 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.2 t -94.89 132.68 38.22 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 CA-C-O 121.147 0.499 . . . . 0.0 110.125 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 11.0 t -132.85 152.47 51.83 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.356 -179.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -127.25 133.67 50.17 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.515 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -114.88 109.86 18.78 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.464 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.477 HG22 ' CB ' ' A' ' 36' ' ' ALA . 1.4 t -115.89 129.35 72.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.464 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -57.07 -7.08 2.25 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.922 -178.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.15 -43.65 4.12 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 117.064 0.432 . . . . 0.0 110.915 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 59.7 m -137.38 172.69 12.61 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.9 0.381 . . . . 0.0 111.387 -179.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 87.7 p -133.93 156.42 48.16 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.392 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.8 p -156.73 160.06 38.93 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.989 0.424 . . . . 0.0 111.065 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -143.95 157.7 44.18 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.747 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -142.85 146.82 34.5 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.828 179.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -120.63 130.15 54.03 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.382 0.61 . . . . 0.0 112.255 -178.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 48.0 tp -114.89 119.2 35.76 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 114.992 -1.003 . . . . 0.0 108.822 178.181 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -133.25 156.64 47.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.216 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 16' ' ' LEU . 8.6 p -117.16 133.39 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.499 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 3.0 t -85.71 166.0 16.49 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.068 -179.364 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' A' ' 92' ' ' THR . . . 73.15 20.13 3.44 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.173 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.72 0 CA-C-O 117.951 -1.472 . . . . 0.0 110.476 179.641 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 . . . . . 0 CA--C 1.529 0.136 0 CA-C-O 120.637 0.256 . . . . 0.0 110.333 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.511 HG22 ' HA ' ' A' ' 31' ' ' ALA . 3.9 t -84.6 120.12 34.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.439 ' HB ' ' H ' ' A' ' 29' ' ' SER . 80.8 m -84.89 125.58 32.76 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 119.415 -0.914 . . . . 0.0 109.274 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.8 mm -104.54 94.13 2.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.094 0.473 . . . . 0.0 110.802 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 53.4 tp -124.66 79.48 1.77 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.037 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.504 ' C ' ' H ' ' A' ' 11' ' ' LEU . 1.4 pt-20 -122.99 89.06 50.79 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.853 -178.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -69.03 16.7 0.17 Allowed 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 121.988 1.792 . . . . 0.0 111.602 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.504 ' H ' ' C ' ' A' ' 9' ' ' GLU . 64.2 mt -72.46 61.97 0.51 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.433 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -71.08 -40.6 71.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.597 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -172.0 132.38 0.68 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 81.8 t -124.96 132.08 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 120.895 0.378 . . . . 0.0 110.671 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -128.88 138.44 52.02 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.901 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.425 HD22 ' HB2' ' A' ' 22' ' ' ALA . 2.7 pp -157.03 135.06 11.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.997 0.427 . . . . 0.0 110.889 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 42.4 t -64.49 146.65 54.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.792 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.427 ' CD ' ' N ' ' A' ' 19' ' ' GLY . 14.5 tm-20 -61.02 143.12 55.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.607 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.427 ' N ' ' CD ' ' A' ' 18' ' ' GLU . . . 98.86 -14.26 61.73 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 20.2 mp0 -98.68 147.57 24.72 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.878 0.37 . . . . 0.0 110.736 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -71.93 153.3 41.93 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.741 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.425 ' HB2' HD22 ' A' ' 16' ' ' LEU . . . -129.87 146.32 51.59 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.857 0.361 . . . . 0.0 110.918 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 36.4 m -146.22 145.03 30.27 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.41 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.464 ' CE2' HD12 ' A' ' 89' ' ' LEU . 2.7 m-85 -119.58 150.24 40.61 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -146.02 131.46 18.67 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.555 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 10.9 p -151.73 140.53 20.92 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.599 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -100.44 118.19 36.15 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.38 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.453 ' O ' ' CG2' ' A' ' 59' ' ' THR . 79.9 mt -129.25 106.16 8.63 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 110.332 -0.248 . . . . 0.0 110.332 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.439 ' H ' ' HB ' ' A' ' 6' ' ' THR . 22.2 t -62.39 164.4 7.3 Favored 'General case' 0 CA--C 1.515 -0.381 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.026 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.464 ' NH1' ' O ' ' A' ' 31' ' ' ALA . 9.5 ptm180 -54.96 162.37 1.31 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.225 -178.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.511 ' HA ' HG22 ' A' ' 5' ' ' VAL . . . -94.11 -174.11 3.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.411 -179.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.2 m -149.96 -50.59 0.14 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.503 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -89.28 -75.58 1.3 Allowed Glycine 0 CA--C 1.522 0.487 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 178.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -124.83 154.28 41.25 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.824 0.345 . . . . 0.0 110.486 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.9 tp10 -89.97 147.23 23.83 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.976 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.439 ' CB ' HG22 ' A' ' 80' ' ' VAL . . . -70.79 147.93 48.42 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.917 0.389 . . . . 0.0 110.364 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -108.15 139.72 42.4 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.644 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 10.1 t-105 -102.45 134.21 46.14 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.448 -0.797 . . . . 0.0 108.901 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -163.19 154.23 16.85 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.083 -0.647 . . . . 0.0 111.587 -178.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.1 tt -128.19 127.72 43.44 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.759 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.32 10.77 84.23 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.29 -16.64 59.32 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 16.8 m -109.21 148.54 38.2 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -56.18 143.9 82.91 Favored 'Trans proline' 0 N--CA 1.488 1.19 0 C-N-CA 121.103 1.202 . . . . 0.0 110.468 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.515 ' H ' ' CD2' ' A' ' 45' ' ' LEU . 0.8 OUTLIER -101.15 -177.46 3.45 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.246 -179.01 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -141.55 124.22 15.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.907 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.84 81.36 0.11 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.932 0.396 . . . . 0.0 110.611 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.442 ' O ' ' O ' ' A' ' 51' ' ' ASN . 85.4 m-20 -66.46 -168.63 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.098 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.44 -52.17 59.43 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.622 -0.431 . . . . 0.0 109.885 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 62.4 ttp -67.01 -39.82 87.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.805 178.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.525 HD21 HD11 ' A' ' 63' ' ' LEU . 1.3 t-20 -94.46 102.26 14.21 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.924 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -116.67 140.17 49.71 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 87.8 mt -123.34 132.67 70.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.801 0.334 . . . . 0.0 110.481 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.7 t -130.98 140.77 50.19 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.077 0.465 . . . . 0.0 110.852 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 72.6 t -120.89 131.8 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.534 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -118.84 179.77 4.05 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.759 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -59.87 167.91 2.0 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.997 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.07 15.24 74.23 Favored Glycine 0 CA--C 1.519 0.343 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.453 ' CG2' ' O ' ' A' ' 28' ' ' LEU . 0.6 OUTLIER 54.89 35.44 24.37 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.204 0.526 . . . . 0.0 110.379 -179.771 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 81.1 mt -79.11 139.08 38.16 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.438 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -118.82 147.89 43.44 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.6 ' C ' HD23 ' A' ' 62' ' ' LEU . 5.4 tt -155.38 115.2 3.7 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 120.499 -0.481 . . . . 0.0 111.432 -178.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.525 HD11 HD21 ' A' ' 51' ' ' ASN . 0.0 OUTLIER -86.73 106.66 17.81 Favored 'General case' 0 N--CA 1.461 0.11 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.363 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 89.9 m -90.21 105.64 17.95 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.898 0.38 . . . . 0.0 110.304 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 80.3 mt -109.82 118.03 35.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.732 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.544 ' ND1' ' N ' ' A' ' 67' ' ' LYS . 24.9 t-80 -77.75 -136.39 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 120.549 -0.461 . . . . 0.0 110.63 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.544 ' N ' ' ND1' ' A' ' 66' ' ' HIS . 15.8 ptmt -53.3 96.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.209 0.528 . . . . 0.0 110.694 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.1 p -69.72 159.29 5.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.874 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 70.6 p -136.95 161.24 36.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.334 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.479 ' H ' HD23 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -59.56 -27.26 66.08 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.193 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -71.4 -32.83 68.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.157 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -62.45 -36.52 82.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.026 -178.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -47.43 143.8 3.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.841 0.353 . . . . 0.0 110.438 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 172.86 -175.14 45.91 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 98.1 m -106.81 126.18 51.96 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.654 0.264 . . . . 0.0 111.403 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.3 t -98.51 133.25 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.6 m -122.71 154.01 38.66 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.084 0.469 . . . . 0.0 111.186 -178.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -134.46 144.7 48.26 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.28 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 61.7 m80 -133.44 113.92 13.07 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.74 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.479 ' C ' ' H ' ' A' ' 82' ' ' THR . 2.1 t -122.1 133.76 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.53 -5.07 0.29 Allowed Glycine 0 CA--C 1.528 0.905 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.564 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.479 ' H ' ' C ' ' A' ' 80' ' ' VAL . 5.1 p -109.39 -43.71 4.06 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.854 0.327 . . . . 0.0 111.165 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.591 ' SG ' ' N ' ' A' ' 84' ' ' SER . 44.4 t -152.85 166.05 33.49 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.709 0.29 . . . . 0.0 111.259 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.591 ' N ' ' SG ' ' A' ' 83' ' ' CYS . 60.0 m -129.01 151.35 49.8 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.859 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 37.6 p -158.63 166.61 31.64 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.925 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.43 ' N ' ' CD ' ' A' ' 86' ' ' GLU . 2.4 pm0 -154.24 169.86 22.64 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.943 0.401 . . . . 0.0 110.743 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -154.37 151.62 29.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.976 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -115.29 123.88 49.89 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.025 0.441 . . . . 0.0 111.14 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.58 HD23 ' C ' ' A' ' 89' ' ' LEU . 5.8 tt -107.09 115.1 29.59 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.462 ' N ' HD23 ' A' ' 89' ' ' LEU . 68.6 mttm -111.85 153.69 26.25 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.54 0.686 . . . . 0.0 111.737 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 43.8 t -120.8 129.89 75.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.396 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 29.5 m . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.526 -179.827 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 . . . . . 0 N--CA 1.464 0.236 0 CA-C-O 120.798 0.332 . . . . 0.0 110.509 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 29' ' ' SER . 9.9 p -58.8 128.68 19.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.461 ' OG1' ' CB ' ' A' ' 29' ' ' SER . 53.8 p -86.6 131.17 34.23 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 119.719 -0.792 . . . . 0.0 110.2 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 24.9 mm -99.87 73.0 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.052 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 79.6 mt -112.36 81.36 1.46 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -118.15 88.0 30.89 Favored Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.986 -177.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -73.48 -5.0 16.38 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 121.999 1.799 . . . . 0.0 110.229 178.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.413 HD22 ' HA ' ' A' ' 11' ' ' LEU . 0.2 OUTLIER -64.25 90.62 0.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.668 -179.694 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -97.3 -124.15 0.13 Allowed 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.404 ' O ' ' OD2' ' A' ' 13' ' ' ASP . 47.5 p-10 -109.01 137.5 46.83 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.798 0.333 . . . . 0.0 110.959 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.6 m -130.8 156.71 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -121.38 134.86 55.12 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.866 0.365 . . . . 0.0 110.782 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.9 pp -147.71 135.73 21.24 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.736 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.6 p -75.73 158.21 32.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.497 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -65.64 142.28 58.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.887 0.375 . . . . 0.0 110.022 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.3 -6.67 78.35 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -97.79 156.85 16.39 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 51.1 p30 -78.43 162.32 26.49 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.908 0.385 . . . . 0.0 110.964 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -147.2 150.74 35.49 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.52 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.4 p -160.04 159.07 31.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.346 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.411 ' O ' HD12 ' A' ' 62' ' ' LEU . 57.8 m-85 -131.8 152.42 50.99 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.951 0.405 . . . . 0.0 110.694 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -142.43 128.33 19.47 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 50.6 m -131.6 155.38 47.63 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.183 0.516 . . . . 0.0 111.577 -179.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -121.85 94.6 4.36 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.68 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 85.5 mt -127.15 112.53 15.26 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.745 -0.207 . . . . 0.0 110.691 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.467 ' O ' HG23 ' A' ' 5' ' ' VAL . 46.0 t -62.54 158.02 19.04 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 53.0 ptt85 -55.3 158.46 3.12 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.723 -177.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -86.28 -179.13 6.64 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.84 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 30.9 t -157.77 -49.61 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.141 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -86.15 -75.17 1.26 Allowed Glycine 0 CA--C 1.52 0.366 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -122.84 142.81 50.36 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.103 0.477 . . . . 0.0 111.051 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -75.02 144.02 43.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.768 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -81.54 170.28 16.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.666 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.6 mtm180 -132.46 137.28 47.19 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.355 0.598 . . . . 0.0 111.916 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 76.5 t-105 -117.93 137.49 52.79 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -169.96 165.96 9.44 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 119.474 -0.89 . . . . 0.0 112.484 -177.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.626 ' C ' HD23 ' A' ' 40' ' ' LEU . 7.0 tt -136.79 122.5 19.83 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.227 178.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.546 ' N ' HD23 ' A' ' 40' ' ' LEU . . . 78.27 14.6 82.04 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.98 4.17 87.23 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 111.62 -0.592 . . . . 0.0 111.62 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.1 t -113.27 130.26 23.8 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-O 119.491 -0.29 . . . . 0.0 110.467 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -58.34 144.94 95.48 Favored 'Trans proline' 0 N--CA 1.491 1.35 0 C-N-CA 120.919 1.08 . . . . 0.0 110.34 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.2 mt -77.53 150.76 34.78 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.681 -179.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -129.01 153.91 47.12 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.382 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.24 80.88 0.35 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.474 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -77.7 169.08 18.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.716 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -66.79 -37.17 84.04 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.137 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 25.8 ptt? -86.83 -21.23 26.56 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.651 0.262 . . . . 0.0 111.266 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.464 ' OD1' ' N ' ' A' ' 52' ' ' ASP . 58.9 t-20 -103.1 146.33 28.54 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.417 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.464 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 98.3 m-20 -138.84 115.18 10.41 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.414 HG21 HD13 ' A' ' 53' ' ' ILE . 48.1 mt -107.95 125.9 64.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.2 t -144.75 153.15 41.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.049 0.452 . . . . 0.0 110.912 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.423 ' O ' HG13 ' A' ' 55' ' ' VAL . 14.6 p -104.15 130.89 54.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.501 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -111.77 -179.19 3.63 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.485 -179.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -63.38 152.07 39.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.533 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.14 9.32 86.85 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 -179.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.3 m 67.27 38.75 3.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.866 0.365 . . . . 0.0 110.646 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.9 mp -94.39 130.59 40.66 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.674 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 64.0 m80 -91.38 158.0 16.77 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.411 HD12 ' O ' ' A' ' 24' ' ' PHE . 48.2 tp -156.77 111.24 2.75 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 120.247 -0.581 . . . . 0.0 111.623 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.44 ' CD1' ' N ' ' A' ' 63' ' ' LEU . 6.5 mp -96.73 115.7 27.88 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.816 178.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 63.7 m -109.94 95.47 5.61 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.551 HD23 ' N ' ' A' ' 66' ' ' HIS . 5.4 tt -107.53 121.5 44.76 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.551 ' N ' HD23 ' A' ' 65' ' ' LEU . 79.3 t60 -80.34 -86.05 0.09 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -178.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? -76.05 106.88 7.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.91 0.386 . . . . 0.0 110.428 -178.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.9 p -88.59 155.11 3.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.906 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 72.8 p -130.95 156.69 44.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.324 -0.398 . . . . 0.0 109.948 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 93.4 mt -59.54 -29.8 68.16 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -67.58 -35.36 78.85 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.959 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -61.72 -32.16 72.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.575 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.27 140.23 39.86 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.625 -0.43 . . . . 0.0 109.893 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 172.55 -171.64 44.44 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 87.8 m -101.53 120.87 40.97 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.735 0.303 . . . . 0.0 111.281 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 10.6 t -86.4 130.91 35.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.2 m -118.2 148.83 41.99 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.109 0.48 . . . . 0.0 110.918 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -136.95 124.96 22.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.453 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 63.4 t-80 -137.62 125.45 22.55 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.831 0.348 . . . . 0.0 111.568 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.411 ' O ' ' C ' ' A' ' 81' ' ' GLY . 5.8 p -141.47 134.3 29.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.579 178.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.411 ' C ' ' O ' ' A' ' 80' ' ' VAL . . . -26.36 -51.94 0.06 OUTLIER Glycine 0 CA--C 1.53 0.977 0 CA-C-N 115.573 -0.739 . . . . 0.0 113.248 -178.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 68.3 p -61.52 -77.27 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 7.3 m -125.56 -166.7 1.59 Allowed 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.06 0.457 . . . . 0.0 111.136 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 28.6 m -149.93 147.06 27.44 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.308 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 50.0 m -126.99 155.42 43.21 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.745 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -129.65 147.2 51.42 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.103 0.478 . . . . 0.0 111.126 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.63 151.92 30.26 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.762 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -130.96 138.51 49.75 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.982 0.42 . . . . 0.0 111.301 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.51 HD23 ' N ' ' A' ' 90' ' ' LYS . 2.2 tt -112.49 111.31 22.06 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.51 ' N ' HD23 ' A' ' 89' ' ' LEU . 57.3 mtpt -117.71 155.1 30.54 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.996 0.427 . . . . 0.0 111.391 -178.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 34.4 m -113.48 133.26 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.461 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 81.2 m . . . . . 0 N--CA 1.468 0.436 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.525 -179.919 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 . . . . . 0 CA--C 1.529 0.165 0 N-CA-C 110.213 -0.292 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.522 HG22 ' HA ' ' A' ' 31' ' ' ALA . 2.4 t -67.54 133.2 31.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.584 HG23 ' OG ' ' A' ' 29' ' ' SER . 71.0 p -90.14 127.16 36.03 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 118.633 -1.227 . . . . 0.0 110.42 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 20.7 mm -104.81 49.46 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.811 -178.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 89.5 mt -88.07 81.02 7.52 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.532 ' C ' ' H ' ' A' ' 11' ' ' LEU . 27.8 mt-10 -111.9 97.07 36.51 Favored Pre-proline 0 CA--C 1.536 0.413 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.695 -179.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -68.9 25.82 0.15 Allowed 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.656 1.571 . . . . 0.0 111.53 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.532 ' H ' ' C ' ' A' ' 9' ' ' GLU . 3.8 mm? -72.82 125.76 28.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.244 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -133.38 -152.65 0.5 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.22 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.417 ' OD2' ' N ' ' A' ' 13' ' ' ASP . 23.0 p-10 -106.32 131.4 53.58 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.796 0.331 . . . . 0.0 110.238 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 26.9 m -133.07 154.74 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-O 121.052 0.453 . . . . 0.0 110.904 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -126.86 112.99 15.98 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 58.3 mt -110.69 132.9 53.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.444 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 55.7 p -73.05 161.86 30.15 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -63.64 142.94 58.21 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.352 -0.539 . . . . 0.0 110.308 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.93 -3.32 77.23 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 111.119 -0.793 . . . . 0.0 111.119 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -103.4 140.8 36.97 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.028 0.442 . . . . 0.0 110.911 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -78.25 173.76 11.93 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.399 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.85 149.9 36.18 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.722 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 41.8 t -162.78 155.36 19.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.027 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.416 ' HB3' HD11 ' A' ' 11' ' ' LEU . 70.6 m-85 -135.83 155.01 51.0 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.075 -0.512 . . . . 0.0 109.643 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -139.37 114.18 9.35 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 179.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.455 ' HG ' ' HZ2' ' A' ' 38' ' ' TRP . 1.0 OUTLIER -110.91 150.2 29.55 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.181 -178.762 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 96.3 mtt-85 -114.32 93.37 4.31 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.406 HD21 ' CG ' ' A' ' 9' ' ' GLU . 85.8 mt -119.35 118.65 31.75 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -178.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.584 ' OG ' HG23 ' A' ' 6' ' ' THR . 88.3 p -76.41 161.11 28.95 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 177.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 12.0 ptp85 -50.64 163.54 0.18 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -176.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.522 ' HA ' HG22 ' A' ' 5' ' ' VAL . . . -83.32 167.53 17.51 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 113.635 -1.62 . . . . 0.0 110.777 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.2 p -152.22 -59.75 0.15 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -90.99 -70.99 1.21 Allowed Glycine 0 CA--C 1.524 0.621 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 178.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 10.6 tp-100 -122.08 136.27 54.9 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -83.5 148.66 27.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.863 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.49 152.88 39.33 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.91 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 15.4 tpt180 -123.19 123.5 40.94 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.057 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.57 ' CZ2' ' CE1' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -83.59 157.93 22.11 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.151 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -166.78 146.12 5.49 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 119.028 -1.069 . . . . 0.0 112.674 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.521 ' C ' HD23 ' A' ' 40' ' ' LEU . 8.7 tt -142.26 128.13 19.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.631 178.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.456 ' N ' HD23 ' A' ' 40' ' ' LEU . . . 80.11 4.27 89.7 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -178.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.56 -24.92 29.9 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 111.941 -0.464 . . . . 0.0 111.941 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 16.7 m -109.41 148.58 38.36 Favored Pre-proline 0 N--CA 1.471 0.607 0 CA-C-N 117.048 0.424 . . . . 0.0 111.37 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -54.97 137.78 76.78 Favored 'Trans proline' 0 N--CA 1.487 1.132 0 C-N-CA 121.449 1.432 . . . . 0.0 110.752 178.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.54 -176.83 3.74 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.03 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -140.52 161.26 38.16 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.648 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.83 81.69 0.89 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.959 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.45 ' O ' ' O ' ' A' ' 51' ' ' ASN . 65.0 t30 -82.0 171.97 13.79 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.984 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -63.82 -35.7 81.49 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.934 0.397 . . . . 0.0 110.108 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 3.2 ppp? -86.96 -3.18 59.06 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.329 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.45 ' O ' ' O ' ' A' ' 48' ' ' ASN . 56.4 t30 -138.51 109.08 6.56 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.554 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -109.67 124.12 50.66 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.121 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.2 mt -110.78 132.15 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.228 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.4 t -144.42 150.5 37.78 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.154 0.502 . . . . 0.0 111.122 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 46.2 t -100.76 116.39 44.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.276 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -88.76 172.73 9.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.309 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -63.15 158.68 19.24 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.784 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.35 17.73 76.31 Favored Glycine 0 CA--C 1.518 0.276 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 66.66 27.9 9.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.95 0.405 . . . . 0.0 110.794 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.7 mp -85.37 131.09 34.45 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.893 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 75.5 m80 -94.49 163.62 13.33 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.468 HD13 ' N ' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -155.23 113.17 3.42 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.717 -179.425 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.468 ' N ' HD13 ' A' ' 62' ' ' LEU . 4.3 mm? -94.01 114.61 26.82 Favored 'General case' 0 C--N 1.341 0.215 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 63.9 m -102.2 103.88 14.42 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 38.4 tp -110.58 126.88 54.9 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.724 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -127.94 162.49 26.63 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.596 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt 53.57 72.49 0.43 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.085 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.6 p -91.27 140.92 15.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.067 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.455 ' O ' ' N ' ' A' ' 71' ' ' GLU . 26.9 m -125.39 131.03 53.02 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.4 pp -45.04 -19.22 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.88 0.371 . . . . 0.0 110.757 -178.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.455 ' N ' ' O ' ' A' ' 69' ' ' THR . 98.6 mt-10 -70.66 -32.91 70.36 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.948 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.433 ' O ' ' O ' ' A' ' 73' ' ' ALA . 51.5 t0 -54.16 -70.28 0.1 Allowed 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.373 -178.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.433 ' O ' ' O ' ' A' ' 72' ' ' ASP . . . 33.66 94.19 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.785 0.326 . . . . 0.0 111.019 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -136.73 170.83 23.25 Favored Glycine 0 N--CA 1.463 0.463 0 N-CA-C 111.389 -0.685 . . . . 0.0 111.389 -179.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 28.6 m -117.96 117.49 29.39 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.632 -0.284 . . . . 0.0 110.273 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 11.1 t -93.49 132.99 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 11.3 p -138.17 158.18 44.82 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.012 0.434 . . . . 0.0 111.299 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.57 ' CE1' ' CZ2' ' A' ' 38' ' ' TRP . 4.7 m-85 -130.85 144.95 51.83 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 62.7 t-80 -138.8 115.38 10.59 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.842 0.353 . . . . 0.0 111.601 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.536 ' O ' ' N ' ' A' ' 82' ' ' THR . 2.0 t -123.41 129.88 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -39.2 -20.84 0.01 OUTLIER Glycine 0 CA--C 1.527 0.838 0 CA-C-N 116.339 -0.391 . . . . 0.0 112.214 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.536 ' N ' ' O ' ' A' ' 80' ' ' VAL . 18.4 p -83.5 -74.81 0.35 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.996 0.427 . . . . 0.0 110.162 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 36.6 m -125.53 162.53 24.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.287 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 62.3 m -129.95 155.37 46.19 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.783 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 96.0 p -156.8 162.54 39.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.329 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.51 ' N ' ' OE2' ' A' ' 86' ' ' GLU . 56.7 mp0 -138.14 152.9 49.16 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.111 0.482 . . . . 0.0 111.061 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -139.19 149.58 44.58 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.388 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -119.84 126.57 51.3 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.992 0.425 . . . . 0.0 111.647 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 59.5 tp -113.56 116.13 29.05 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -127.89 147.52 50.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.383 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.7 t -106.52 125.72 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 120.91 0.386 . . . . 0.0 110.029 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 C--N 1.331 -0.215 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.85 -179.621 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.444 ' N ' ' CD ' ' A' ' 4' ' ' GLU . 2.6 pm0 . . . . . 0 N--CA 1.465 0.298 0 CA-C-O 120.769 0.319 . . . . 0.0 110.235 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.47 ' O ' HG13 ' A' ' 5' ' ' VAL . 9.3 p -74.65 131.69 34.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.836 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 95.6 m -119.73 128.51 53.84 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.881 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.2 mp -121.62 112.72 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-O 121.121 0.486 . . . . 0.0 111.531 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.6 mt -105.25 93.72 4.84 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 177.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.422 ' OE2' ' CE1' ' A' ' 78' ' ' PHE . 3.4 pt-20 -116.94 89.99 31.31 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.321 -178.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -70.43 -12.59 31.87 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 122.296 1.997 . . . . 0.0 111.792 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.1 68.6 2.7 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.09 0.472 . . . . 0.0 109.737 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -77.99 -2.36 36.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.152 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 39.9 p-10 -172.89 143.36 1.2 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.189 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.8 m -134.93 155.93 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 120.891 0.377 . . . . 0.0 111.338 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -137.25 120.43 16.74 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.189 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 pp -152.14 138.56 18.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.947 0.403 . . . . 0.0 110.828 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.6 m -74.74 150.32 39.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.235 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -56.97 147.49 23.79 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.36 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.92 -9.17 78.55 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.769 -0.533 . . . . 0.0 111.769 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -97.09 156.23 16.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.853 0.358 . . . . 0.0 110.719 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.433 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 19.6 p-10 -75.33 148.91 38.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.495 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -134.54 149.51 50.66 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.814 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 38.2 t -163.17 159.88 23.5 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.567 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -129.47 143.11 50.7 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.383 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -142.39 119.93 11.73 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.905 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 1.2 p -149.6 157.67 43.47 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.078 0.466 . . . . 0.0 111.028 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 96.3 mtt-85 -99.68 143.34 30.03 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.564 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.463 ' O ' ' OG1' ' A' ' 59' ' ' THR . 2.1 tt -145.55 96.41 2.82 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.602 -179.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.7 p -59.97 159.72 8.89 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.805 0.336 . . . . 0.0 110.24 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -57.37 156.3 7.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.868 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -100.05 -173.28 2.4 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.646 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.3 t -141.68 -58.25 0.48 Allowed 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -82.96 -77.07 1.11 Allowed Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -123.91 143.28 50.46 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.797 0.332 . . . . 0.0 110.802 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -92.1 146.21 23.91 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.121 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.479 ' CB ' HG22 ' A' ' 80' ' ' VAL . . . -71.86 151.81 43.11 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.373 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 -130.99 151.89 50.9 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.236 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -74.49 178.33 5.37 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.85 125.65 3.66 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.402 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 58.1 tp -129.8 115.91 17.95 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.8 16.67 72.51 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.1 -24.29 25.5 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.5 m -103.4 150.47 38.04 Favored Pre-proline 0 N--CA 1.468 0.448 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -53.93 143.17 61.83 Favored 'Trans proline' 0 C--N 1.315 -1.201 0 C-N-CA 121.455 1.437 . . . . 0.0 110.757 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.476 ' H ' ' CD2' ' A' ' 45' ' ' LEU . 0.8 OUTLIER -89.08 175.72 7.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.484 179.867 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.442 HE21 ' H ' ' A' ' 47' ' ' ALA . 67.6 tp60 -144.89 153.76 41.91 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.442 ' H ' HE21 ' A' ' 46' ' ' GLN . . . -73.23 72.85 1.26 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.829 0.347 . . . . 0.0 111.539 -178.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' A' ' 51' ' ' ASN . 70.8 m-20 -64.9 -177.16 0.32 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 56.2 mp0 -68.29 -46.17 71.04 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.469 -0.493 . . . . 0.0 110.685 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 76.6 mtm -67.61 -39.32 84.76 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.943 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' A' ' 48' ' ' ASN . 1.9 m-80 -93.56 143.03 26.68 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.733 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.462 ' O ' HD12 ' A' ' 63' ' ' LEU . 97.8 m-20 -135.89 136.83 40.84 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.0 mm -107.39 122.5 61.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 95.3 m -129.85 129.49 44.03 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.073 0.463 . . . . 0.0 111.31 -178.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.5 m -121.3 136.88 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.425 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -137.56 -177.26 4.71 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.823 0.344 . . . . 0.0 110.521 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -51.23 157.58 0.92 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.575 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.08 30.29 77.35 Favored Glycine 0 CA--C 1.519 0.322 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.463 ' OG1' ' O ' ' A' ' 28' ' ' LEU . 65.3 p 41.63 39.64 1.19 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.095 0.474 . . . . 0.0 110.263 -179.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 55.5 mt -71.28 131.86 44.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.013 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -107.11 135.71 48.19 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.963 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.443 HD13 ' C ' ' A' ' 62' ' ' LEU . 0.3 OUTLIER -146.52 97.32 2.9 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.462 HD12 ' O ' ' A' ' 52' ' ' ASP . 27.9 tp -96.61 106.97 19.33 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.113 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 26.5 m -89.7 114.59 26.26 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.109 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.586 HD13 ' N ' ' A' ' 66' ' ' HIS . 0.3 OUTLIER -105.47 118.37 36.39 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.457 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.586 ' N ' HD13 ' A' ' 65' ' ' LEU . 85.5 m-70 -110.77 147.02 35.33 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.261 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 65.5 mttm 54.82 58.58 4.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.97 179.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.1 p -56.57 149.02 3.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.343 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 79.6 p -133.13 155.48 49.19 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.457 179.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 90.4 mt -60.32 -24.72 65.24 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -68.66 -36.12 78.13 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.145 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -62.01 -41.24 97.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.043 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.24 141.54 50.44 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 172.01 -99.28 0.14 Allowed Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.245 -0.979 . . . . 0.0 111.737 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 31.7 m -159.11 117.06 2.82 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.826 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 82.0 t -107.39 129.47 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 57.7 m -138.42 178.77 6.89 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.906 0.384 . . . . 0.0 111.236 -178.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.422 ' CE1' ' OE2' ' A' ' 9' ' ' GLU . 97.4 m-85 -128.53 141.02 51.51 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.101 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -116.99 102.53 9.42 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.479 HG22 ' CB ' ' A' ' 36' ' ' ALA . 2.1 t -118.9 134.38 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.241 -179.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.52 -23.91 61.13 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 121.159 -0.544 . . . . 0.0 111.885 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 43.2 p -98.8 -21.79 16.17 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 117.188 0.494 . . . . 0.0 112.124 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.451 ' O ' ' O ' ' A' ' 80' ' ' VAL . 27.6 p -154.17 -177.83 6.7 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.057 0.456 . . . . 0.0 111.205 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 31.4 t -148.79 150.51 33.2 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 49.2 m -154.13 168.11 27.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.923 0.392 . . . . 0.0 110.871 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -151.14 157.71 43.07 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.645 -179.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.88 146.44 25.66 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.274 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.482 ' C ' HD12 ' A' ' 89' ' ' LEU . 87.6 mt-30 -116.85 131.39 56.96 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.28 0.562 . . . . 0.0 111.605 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.54 HD12 ' N ' ' A' ' 89' ' ' LEU . 9.4 mp -101.74 115.81 31.35 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.34 -0.846 . . . . 0.0 108.969 178.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -120.5 152.88 37.45 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.63 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.5 m -113.72 135.62 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 39.9 m . . . . . 0 C--N 1.323 -0.572 0 CA-C-O 121.037 0.446 . . . . 0.0 111.29 -179.134 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 . . . . . 0 C--O 1.233 0.187 0 CA-C-O 120.716 0.293 . . . . 0.0 110.269 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.528 ' O ' HG13 ' A' ' 5' ' ' VAL . 5.6 p -61.88 122.01 11.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.512 ' HB ' ' H ' ' A' ' 29' ' ' SER . 38.2 m -67.82 131.55 45.74 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 119.284 -0.966 . . . . 0.0 109.091 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.645 HG23 ' O ' ' A' ' 7' ' ' ILE . 9.7 tp -110.47 101.22 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-O 122.057 0.932 . . . . 0.0 112.072 -178.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.6 mt -129.99 82.06 2.05 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.44 -1.254 . . . . 0.0 109.581 178.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 49.0 tt0 -119.71 86.2 34.79 Favored Pre-proline 0 N--CA 1.468 0.448 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.561 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.454 ' O ' ' N ' ' A' ' 12' ' ' GLN . 3.4 Cg_exo -71.55 -7.68 21.71 Favored 'Trans proline' 0 C--N 1.314 -1.273 0 C-N-CA 122.279 1.986 . . . . 0.0 111.409 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 29.3 mt -64.4 75.2 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.853 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.454 ' N ' ' O ' ' A' ' 10' ' ' PRO . 87.6 mt-30 -76.65 -67.63 0.68 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.119 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.444 ' OD2' ' O ' ' A' ' 12' ' ' GLN . 63.6 m-20 -157.42 127.3 6.18 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.514 -178.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.3 m -129.24 156.9 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 121.362 0.601 . . . . 0.0 111.305 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -120.71 129.33 53.61 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.136 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 74.8 mt -118.88 129.27 55.11 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.053 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.6 m -78.76 148.35 33.02 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 177.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -63.81 134.16 54.73 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.953 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.79 -2.09 64.08 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -112.24 134.5 53.75 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.006 0.431 . . . . 0.0 110.717 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -83.21 167.66 17.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.122 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -159.73 174.87 13.87 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.226 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.434 ' OG ' HD11 ' A' ' 62' ' ' LEU . 29.9 t -156.87 148.62 22.62 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.071 0.463 . . . . 0.0 110.915 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -103.0 141.09 36.39 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -129.39 119.1 23.27 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.118 0.485 . . . . 0.0 110.384 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 2.7 m -126.56 163.95 22.27 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.581 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 77.5 ttt-85 -142.65 115.76 8.87 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.9 mt -127.69 100.91 6.15 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 121.095 -0.242 . . . . 0.0 110.995 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.512 ' H ' ' HB ' ' A' ' 6' ' ' THR . 14.2 t -60.05 177.61 0.23 Allowed 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 119.991 -0.684 . . . . 0.0 109.5 179.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -54.41 136.95 43.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.481 0.658 . . . . 0.0 111.866 -178.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.05 -172.86 3.28 Favored 'General case' 0 CA--C 1.521 -0.136 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.937 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.2 t -147.53 -65.34 0.26 Allowed 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.493 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.84 -88.46 0.22 Allowed Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 178.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -124.13 141.0 52.43 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.234 0.54 . . . . 0.0 111.368 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.4 tp10 -83.63 152.91 24.55 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.246 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.41 ' CB ' HG22 ' A' ' 80' ' ' VAL . . . -70.38 139.34 51.88 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.197 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 86.2 mtm-85 -115.97 138.59 51.06 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.763 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 80.8 m95 -76.21 169.16 18.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.008 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -165.1 119.83 1.31 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.809 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.638 ' C ' HD23 ' A' ' 40' ' ' LEU . 6.7 tt -118.96 114.75 23.04 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.432 ' N ' HD23 ' A' ' 40' ' ' LEU . . . 74.97 14.7 81.51 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.64 -23.57 35.37 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 16.7 m -104.94 146.52 32.82 Favored Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -54.62 142.12 73.0 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 121.547 1.498 . . . . 0.0 111.892 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.489 ' H ' ' CD2' ' A' ' 45' ' ' LEU . 1.0 OUTLIER -82.4 171.54 14.06 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.279 179.154 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 71.3 tp60 -144.92 142.01 29.51 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.187 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.38 141.57 58.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.82 0.343 . . . . 0.0 110.274 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.456 ' O ' ' O ' ' A' ' 51' ' ' ASN . 45.4 t30 -155.66 -164.89 1.84 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 53.8 mp0 -66.03 -48.49 70.92 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 119.924 -0.71 . . . . 0.0 110.167 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 66.4 ttp -68.35 -43.43 77.47 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.466 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.456 ' O ' ' O ' ' A' ' 48' ' ' ASN . 99.1 m-20 -107.39 137.84 44.7 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.892 0.377 . . . . 0.0 110.84 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 48' ' ' ASN . 96.7 m-20 -139.31 146.74 40.69 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 98.6 mt -124.06 127.05 73.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 88.5 m -125.43 131.47 52.9 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.886 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.6 t -87.69 128.06 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.209 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -116.1 154.26 30.28 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.545 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -56.36 155.73 6.67 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.583 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.85 12.39 84.48 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 68.77 22.92 7.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.619 -0.291 . . . . 0.0 111.758 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.9 mp -79.28 144.28 34.45 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 178.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 66.1 m170 -110.96 156.18 21.59 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.461 HD13 ' C ' ' A' ' 62' ' ' LEU . 0.4 OUTLIER -153.22 108.9 3.28 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.385 -179.208 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.427 ' N ' HD13 ' A' ' 62' ' ' LEU . 7.3 mp -95.94 109.58 21.92 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 95.3 m -87.44 113.87 23.54 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.432 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 74.8 mt -99.63 104.13 15.87 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.718 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -97.96 134.79 40.59 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.037 0.446 . . . . 0.0 111.579 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt 52.79 65.68 1.45 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.991 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.1 p -61.84 153.04 6.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.389 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.2 t -135.77 163.34 30.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.735 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 62.8 mt -60.31 -29.01 68.57 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.256 0.551 . . . . 0.0 109.867 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -66.69 -24.11 66.22 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.587 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.4 ' O ' ' C ' ' A' ' 73' ' ' ALA . 55.7 t0 -61.99 -40.76 96.73 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.36 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 72' ' ' ASP . . . -38.9 122.08 1.14 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.518 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -174.97 177.25 47.08 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 52.9 m -103.93 127.61 51.45 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.033 0.444 . . . . 0.0 111.436 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 74.0 t -117.15 129.42 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.242 178.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 36.2 t -144.5 171.68 14.01 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -150.96 150.51 30.89 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.047 0.451 . . . . 0.0 110.996 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -117.26 127.86 54.5 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.62 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.427 ' O ' ' O ' ' A' ' 83' ' ' CYS . 2.5 t -118.36 130.14 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.03 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -48.0 -19.26 0.95 Allowed Glycine 0 CA--C 1.53 1.006 0 CA-C-N 115.962 -0.563 . . . . 0.0 113.061 -178.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.01 -33.63 7.43 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 117.725 0.762 . . . . 0.0 111.549 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.427 ' O ' ' O ' ' A' ' 80' ' ' VAL . 33.1 m -144.93 -175.56 4.73 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 96.0 p -159.38 157.95 31.28 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.778 0.323 . . . . 0.0 110.912 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 48.2 t -167.27 168.33 13.41 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.085 0.469 . . . . 0.0 111.022 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -133.95 163.27 29.92 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.956 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -149.15 154.04 38.6 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -124.72 132.84 53.35 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.262 0.553 . . . . 0.0 111.512 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 60.7 tp -116.92 103.69 10.55 Favored 'General case' 0 C--N 1.334 -0.094 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.691 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -103.98 147.39 27.41 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 13.2 t -120.01 99.26 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.4 t . . . . . 0 N--CA 1.468 0.471 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.4 -179.931 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 . . . . . 0 N--CA 1.456 -0.158 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.6 t -64.32 135.95 27.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.742 ' C ' HD12 ' A' ' 7' ' ' ILE . 20.4 m -104.14 135.8 44.95 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.767 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.742 HD12 ' C ' ' A' ' 6' ' ' THR . 1.8 mp -121.25 116.25 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 121.379 0.609 . . . . 0.0 111.222 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 96.5 mt -128.35 98.11 4.96 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.073 -0.967 . . . . 0.0 108.581 177.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -122.59 90.14 49.7 Favored Pre-proline 0 N--CA 1.468 0.449 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -178.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -74.23 -5.06 16.41 Favored 'Trans proline' 0 N--CA 1.489 1.231 0 C-N-CA 122.024 1.816 . . . . 0.0 110.068 178.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 65.7 mt -66.45 74.85 0.1 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.353 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -71.6 -49.61 38.67 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.957 0.408 . . . . 0.0 111.775 -179.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -173.7 137.76 0.62 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.989 -178.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 53.0 t -125.11 133.48 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 120.84 0.352 . . . . 0.0 110.578 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -134.24 99.68 4.47 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.126 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 87.4 mt -124.9 139.92 53.39 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.939 0.399 . . . . 0.0 111.309 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.3 t -68.32 141.92 55.66 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.447 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -51.21 149.16 4.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.306 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.95 16.98 78.03 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -115.58 147.48 40.69 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.96 136.59 50.68 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.331 -0.548 . . . . 0.0 109.593 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -132.23 154.92 49.13 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.234 -179.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.9 m -158.63 159.62 35.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.981 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -136.99 148.65 47.02 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.225 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -145.15 122.82 11.82 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.042 0.449 . . . . 0.0 110.935 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 5.9 t -135.56 139.59 44.01 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.248 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 64.6 ttp85 -122.71 127.98 49.96 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.111 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.6 pp -143.69 133.46 23.83 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.22 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.514 ' H ' ' HB ' ' A' ' 6' ' ' THR . 44.7 t -66.22 158.85 27.77 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 38.4 ptt-85 -51.48 163.93 0.24 Allowed 'General case' 0 C--N 1.32 -0.716 0 O-C-N 123.665 0.603 . . . . 0.0 111.972 -177.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.56 174.8 2.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.322 -178.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.462 ' OG ' ' N ' ' A' ' 33' ' ' GLY . 18.4 p -138.46 -56.82 0.64 Allowed 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.462 ' N ' ' OG ' ' A' ' 32' ' ' SER . . . -104.89 -66.85 0.69 Allowed Glycine 0 CA--C 1.523 0.592 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 178.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.549 HE21 ' H ' ' A' ' 81' ' ' GLY . 14.1 pt20 -122.7 143.08 50.03 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.783 0.325 . . . . 0.0 110.315 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.632 ' CD ' ' H ' ' A' ' 35' ' ' GLU . 1.2 pm0 -70.57 146.46 50.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.528 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.89 157.05 38.21 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -123.97 133.86 53.61 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.337 0.589 . . . . 0.0 111.683 -178.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 22.0 t-105 -99.02 147.87 24.59 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.084 -0.962 . . . . 0.0 108.919 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -172.68 147.6 1.81 Allowed 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 119.883 -0.727 . . . . 0.0 112.419 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.59 ' N ' HD11 ' A' ' 45' ' ' LEU . 15.6 tp -124.96 119.03 27.59 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.89 8.52 84.78 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.42 -1.36 58.69 Favored Glycine 0 CA--C 1.531 1.066 0 N-CA-C 111.954 -0.458 . . . . 0.0 111.954 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.9 m -115.87 147.25 38.7 Favored Pre-proline 0 CA--C 1.549 0.93 0 CA-C-N 117.384 0.592 . . . . 0.0 111.618 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -58.45 145.82 92.82 Favored 'Trans proline' 0 N--CA 1.502 2.022 0 C-N-CA 122.008 1.806 . . . . 0.0 112.359 178.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.59 HD11 ' N ' ' A' ' 40' ' ' LEU . 9.0 mp -90.29 144.84 25.47 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.084 178.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.437 ' O ' ' N ' ' A' ' 48' ' ' ASN . 1.0 OUTLIER -122.89 153.14 40.05 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.396 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.64 76.57 0.02 OUTLIER 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.489 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.463 ' OD1' ' N ' ' A' ' 49' ' ' GLU . 24.3 t-20 -74.25 165.7 24.72 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.607 179.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.463 ' N ' ' OD1' ' A' ' 48' ' ' ASN . 97.5 mt-10 -62.12 -40.34 95.59 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.616 -0.433 . . . . 0.0 110.885 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 12.4 ptt? -85.6 -15.33 42.9 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 121.032 -0.267 . . . . 0.0 111.173 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.461 ' O ' ' O ' ' A' ' 48' ' ' ASN . 35.1 t-20 -126.11 122.45 35.79 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.594 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -124.5 128.1 48.46 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 75.5 mt -107.1 129.56 60.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.951 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.9 t -143.93 147.98 34.73 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.853 -179.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.9 m -110.92 131.32 62.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.371 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.446 ' O ' ' C ' ' A' ' 57' ' ' GLN . 98.8 mt-10 -112.11 -173.51 2.26 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.382 -179.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.446 ' C ' ' O ' ' A' ' 56' ' ' GLU . 45.6 tp60 -25.62 144.07 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 O-C-N 123.834 0.709 . . . . 0.0 111.854 -179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 58.12 -97.31 0.07 OUTLIER Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 17.9 m -162.5 62.31 0.21 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.991 0.424 . . . . 0.0 110.364 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 8.3 tt -104.31 120.66 41.67 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.915 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -90.8 148.53 22.47 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.202 -0.453 . . . . 0.0 109.833 178.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.468 ' C ' HD23 ' A' ' 62' ' ' LEU . 8.3 tt -151.57 114.66 4.73 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.86 0.362 . . . . 0.0 110.409 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.6 mp -97.0 114.94 26.59 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.882 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.6 m -94.11 109.37 21.15 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 62.3 mt -101.06 132.31 46.56 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.545 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 49.7 p-80 -153.25 155.46 36.63 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.76 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt 50.97 55.49 9.48 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 120.889 0.376 . . . . 0.0 110.091 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.5 m -110.49 130.1 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.777 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 64.1 p -86.35 -157.49 0.36 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.052 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 40.5 tp -59.88 -15.96 25.42 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.876 0.369 . . . . 0.0 110.442 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -67.6 -5.45 15.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.966 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.427 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 25.2 p-10 -53.37 -30.0 37.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.394 -179.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.1 135.02 56.96 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.101 -0.64 . . . . 0.0 109.667 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -174.54 166.83 38.89 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.427 ' O ' HD12 ' A' ' 40' ' ' LEU . 1.0 OUTLIER -122.95 108.6 13.14 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.57 0.224 . . . . 0.0 110.707 -179.954 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 8.6 t -101.15 120.6 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 33.9 t -137.13 152.09 49.57 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.334 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -135.73 147.8 48.58 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.86 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.52 ' ND1' ' OG ' ' A' ' 84' ' ' SER . 93.7 m-70 -125.22 123.83 40.42 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.209 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.508 ' O ' ' N ' ' A' ' 82' ' ' THR . 2.9 p -128.41 130.35 69.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.549 ' H ' HE21 ' A' ' 34' ' ' GLN . . . -31.7 -31.39 0.01 OUTLIER Glycine 0 CA--C 1.529 0.913 0 CA-C-N 115.671 -0.695 . . . . 0.0 113.1 -178.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.508 ' N ' ' O ' ' A' ' 80' ' ' VAL . 82.5 p -79.04 -75.68 0.23 Allowed 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.659 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.449 ' SG ' ' N ' ' A' ' 84' ' ' SER . 46.2 t -111.56 163.81 13.67 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 120.829 0.347 . . . . 0.0 111.315 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.52 ' OG ' ' ND1' ' A' ' 79' ' ' HIS . 23.3 t -140.74 134.36 30.15 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 13.9 m -160.27 167.91 26.49 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.272 0.558 . . . . 0.0 111.999 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -140.22 164.11 30.96 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.963 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -134.33 148.36 50.72 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -113.61 127.49 56.08 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.267 -179.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.56 HD23 ' C ' ' A' ' 89' ' ' LEU . 4.2 tt -112.02 112.34 23.9 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.52 ' N ' HD23 ' A' ' 89' ' ' LEU . 17.7 ttpt -113.29 170.12 8.46 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.078 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.0 t -111.0 125.58 68.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.476 -179.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 97.8 m . . . . . 0 C--N 1.333 -0.135 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.999 -179.608 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.514 ' HG2' ' H ' ' A' ' 5' ' ' VAL . 39.3 tt0 . . . . . 0 N--CA 1.464 0.241 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.514 ' H ' ' HG2' ' A' ' 4' ' ' GLU . 9.8 p -52.65 136.49 13.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 110.431 -0.211 . . . . 0.0 110.431 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.559 HG22 ' CD1' ' A' ' 8' ' ' LEU . 7.1 m -115.96 125.3 52.36 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.42 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.791 ' N ' HD12 ' A' ' 7' ' ' ILE . 3.0 mp -108.41 111.43 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 121.144 0.497 . . . . 0.0 111.046 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.559 ' CD1' HG22 ' A' ' 6' ' ' THR . 8.8 mp -122.31 84.27 2.23 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.44 ' CG ' ' O ' ' A' ' 9' ' ' GLU . 0.2 OUTLIER -110.74 98.93 39.84 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.806 -178.246 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -73.9 -7.16 19.65 Favored 'Trans proline' 0 N--CA 1.489 1.238 0 C-N-CA 121.454 1.436 . . . . 0.0 110.136 178.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 52.3 mt -61.17 80.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.425 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -79.32 -67.15 0.78 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.422 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -171.78 128.26 0.63 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.651 -0.25 . . . . 0.0 110.37 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.8 m -126.15 162.1 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-O 120.926 0.394 . . . . 0.0 110.978 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -116.95 128.74 55.5 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.127 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 74.6 mt -123.01 129.34 51.39 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.058 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.4 p -76.55 164.18 26.19 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -61.83 128.68 37.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.828 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 77.34 19.53 76.48 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.068 178.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -103.41 138.47 40.1 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.85 0.357 . . . . 0.0 110.963 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 49.5 p30 -82.39 164.89 20.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.044 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -161.89 168.98 22.05 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.914 0.388 . . . . 0.0 110.213 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 73.1 m -147.76 140.85 25.01 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.961 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -111.8 129.85 56.0 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 23.8 tm0? -132.11 127.09 35.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.201 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -149.47 163.94 36.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.333 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -120.28 120.89 37.38 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.09 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.475 ' C ' HD23 ' A' ' 28' ' ' LEU . 3.7 tt -132.14 104.78 6.98 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.445 ' O ' HD23 ' A' ' 28' ' ' LEU . 10.1 p -62.68 153.12 33.45 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.167 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -53.31 153.25 4.0 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.592 -177.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.78 -175.17 3.66 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.848 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 44.9 t -142.44 -49.62 0.36 Allowed 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -91.77 -76.2 1.32 Allowed Glycine 0 CA--C 1.52 0.353 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -124.91 135.49 52.9 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.075 0.464 . . . . 0.0 111.864 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.461 ' O ' ' NH1' ' A' ' 37' ' ' ARG . 22.5 pt-20 -83.6 154.61 23.67 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.978 179.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.59 151.97 42.06 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.783 0.325 . . . . 0.0 110.692 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.461 ' NH1' ' O ' ' A' ' 35' ' ' GLU . 87.4 mmt-85 -106.72 148.24 28.64 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.068 0.461 . . . . 0.0 111.277 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 2.9 t-105 -107.71 148.52 29.31 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 179.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -173.31 155.26 2.85 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 119.864 -0.734 . . . . 0.0 111.73 -178.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 32.9 tp -134.22 124.72 26.42 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.707 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.51 6.14 88.06 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.653 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.73 -16.09 57.87 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 121.278 -0.487 . . . . 0.0 112.068 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.8 m -112.21 141.82 25.74 Favored Pre-proline 0 N--CA 1.472 0.671 0 CA-C-N 117.134 0.467 . . . . 0.0 110.43 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -56.87 143.12 92.43 Favored 'Trans proline' 0 N--CA 1.488 1.202 0 C-N-CA 120.826 1.018 . . . . 0.0 110.873 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.17 -166.69 1.33 Allowed 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.537 ' O ' ' N ' ' A' ' 48' ' ' ASN . 2.3 pm0 -153.28 153.99 33.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.927 0.394 . . . . 0.0 111.02 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -55.4 76.31 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.318 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.537 ' N ' ' O ' ' A' ' 46' ' ' GLN . 10.3 t-20 -75.04 171.37 14.23 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.884 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -62.13 -33.98 75.49 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.883 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 14.8 ptp -94.02 -19.63 20.7 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.772 0.32 . . . . 0.0 110.986 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -120.29 118.98 31.82 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.152 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -121.26 142.42 49.95 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.77 0.319 . . . . 0.0 110.63 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 15.5 mm -115.6 118.35 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.4 p -138.85 159.61 41.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.934 0.397 . . . . 0.0 111.183 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 55.8 t -117.51 129.04 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.659 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -107.4 167.46 9.91 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.547 ' NE2' ' H ' ' A' ' 58' ' ' GLY . 71.1 tp60 -58.42 152.77 17.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.947 0.403 . . . . 0.0 110.5 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.547 ' H ' ' NE2' ' A' ' 57' ' ' GLN . . . 79.5 11.29 85.0 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 69.15 27.37 5.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.402 -0.399 . . . . 0.0 110.809 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.521 ' N ' HD12 ' A' ' 60' ' ' LEU . 10.6 mp -87.09 129.69 34.81 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.32 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -97.51 131.12 44.43 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.556 HD13 ' N ' ' A' ' 63' ' ' LEU . 0.5 OUTLIER -123.48 115.57 21.79 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.875 -179.481 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.556 ' N ' HD13 ' A' ' 62' ' ' LEU . 6.8 mp -103.01 114.04 28.01 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 25.9 m -88.8 117.01 27.48 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.179 0.514 . . . . 0.0 110.387 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.563 HD11 HG11 ' A' ' 68' ' ' VAL . 36.9 tp -107.31 127.13 53.27 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.253 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -85.23 -170.1 2.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.888 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -72.36 71.31 0.9 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.672 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.563 HG11 HD11 ' A' ' 65' ' ' LEU . 23.9 m -69.21 -172.54 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.488 0.661 . . . . 0.0 112.069 -179.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 69.8 p -130.6 -165.31 1.53 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.764 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 53.6 mt -64.23 -15.94 61.02 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.738 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.25 -38.11 89.31 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -66.63 -36.29 82.22 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.744 0.307 . . . . 0.0 111.316 -179.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -40.28 112.79 0.3 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.17 0.51 . . . . 0.0 111.268 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -168.83 -179.65 41.1 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 109.704 -1.359 . . . . 0.0 109.704 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 99.0 m -105.19 120.54 41.79 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.907 0.354 . . . . 0.0 111.413 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 12.0 t -93.59 134.55 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.9 p -140.9 146.62 37.7 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.132 0.491 . . . . 0.0 110.916 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -150.95 147.59 27.36 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.483 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 53.5 p-80 -159.78 163.4 34.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.58 0.705 . . . . 0.0 111.96 -178.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.561 HG22 ' H ' ' A' ' 82' ' ' THR . 2.5 p -131.59 140.4 48.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.254 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -35.54 -24.5 0.01 OUTLIER Glycine 0 CA--C 1.528 0.897 0 CA-C-N 115.67 -0.695 . . . . 0.0 112.604 -178.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.561 ' H ' HG22 ' A' ' 80' ' ' VAL . 43.9 p -85.97 -72.73 0.48 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.058 0.456 . . . . 0.0 110.864 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.513 ' N ' ' OG1' ' A' ' 82' ' ' THR . 35.3 m -108.55 -171.56 1.88 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.794 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 83.2 p -156.85 153.95 29.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.896 0.379 . . . . 0.0 111.097 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 47.8 t -152.89 153.79 33.74 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.342 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -134.54 150.96 50.81 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.51 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -139.85 148.37 42.0 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -124.13 125.6 44.75 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.996 0.426 . . . . 0.0 111.793 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.8 tp -113.28 100.84 8.87 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.678 178.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 13.4 ptpt -107.91 172.07 7.04 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 179.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.4 m -128.77 158.6 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 121.328 0.585 . . . . 0.0 111.478 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 N--CA 1.466 0.344 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.745 -179.828 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.468 ' O ' ' OG ' ' A' ' 29' ' ' SER . 88.5 tt0 . . . . . 0 N--CA 1.454 -0.252 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.444 ' O ' HG23 ' A' ' 5' ' ' VAL . 18.6 m -58.28 122.22 7.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.545 ' OG1' ' N ' ' A' ' 29' ' ' SER . 41.7 p -88.5 138.73 31.17 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 118.81 -1.156 . . . . 0.0 110.189 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 18.8 mm -110.55 62.4 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.643 -179.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.404 HD22 ' HA ' ' A' ' 8' ' ' LEU . 0.3 OUTLIER -102.09 74.2 1.43 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.346 0.593 . . . . 0.0 109.948 -179.798 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -122.99 84.32 50.72 Favored Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.921 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -70.9 50.83 1.16 Allowed 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 122.275 1.983 . . . . 0.0 112.25 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.455 HD11 ' SG ' ' A' ' 26' ' ' CYS . 96.6 mt -79.93 127.39 32.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.169 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 27.3 pt20 -118.81 -145.05 0.37 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.342 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -104.36 130.88 52.19 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.949 0.404 . . . . 0.0 110.426 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.4 m -123.41 138.1 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.2 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -113.32 115.31 27.93 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.264 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 73.3 mt -119.35 135.08 54.89 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.04 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.0 t -63.6 151.39 41.74 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -55.55 144.42 26.35 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.052 0.453 . . . . 0.0 111.504 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.18 19.2 75.09 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -114.68 144.97 42.59 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.281 0.563 . . . . 0.0 111.152 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 51.3 p-10 -75.5 168.24 20.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.305 -0.862 . . . . 0.0 110.028 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -140.79 142.65 34.65 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.69 0.281 . . . . 0.0 110.913 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 60.6 m -136.25 152.54 50.84 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.857 0.361 . . . . 0.0 111.087 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -135.4 152.24 51.23 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.379 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.422 ' C ' ' SG ' ' A' ' 26' ' ' CYS . 58.4 tt0 -134.33 143.49 47.72 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.698 0.285 . . . . 0.0 110.364 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.455 ' SG ' HD11 ' A' ' 11' ' ' LEU . 30.0 m -150.34 164.34 36.05 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.254 0.55 . . . . 0.0 111.506 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -134.4 99.8 4.48 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 115.427 -0.806 . . . . 0.0 108.859 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.417 ' O ' ' OG1' ' A' ' 59' ' ' THR . 50.1 mt -118.91 128.79 54.76 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.205 -178.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.545 ' N ' ' OG1' ' A' ' 6' ' ' THR . 24.1 p -73.65 158.66 34.32 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 51.7 ptt85 -58.11 169.47 0.81 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 -176.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.8 151.08 45.2 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 113.826 -1.534 . . . . 0.0 111.56 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 73.4 m -139.48 -54.95 0.57 Allowed 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.037 179.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -100.49 -65.81 0.81 Allowed Glycine 0 CA--C 1.52 0.372 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 178.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -123.39 145.27 48.9 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 178.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.696 ' CD ' ' H ' ' A' ' 35' ' ' GLU . 1.7 pm0 -76.17 143.73 40.95 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.092 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.52 152.71 37.78 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.536 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 84.2 mtm180 -128.56 139.74 52.14 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.236 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.532 ' CZ2' ' CE2' ' A' ' 78' ' ' PHE . 10.6 t-105 -101.46 150.96 22.51 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -171.37 157.33 4.89 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 119.498 -0.881 . . . . 0.0 111.914 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.564 ' C ' HD23 ' A' ' 40' ' ' LEU . 7.2 tt -123.72 124.94 43.84 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.415 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.477 ' N ' HD23 ' A' ' 40' ' ' LEU . . . 69.27 21.99 76.04 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.98 7.72 88.27 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 71.7 t -113.69 128.77 25.36 Favored Pre-proline 0 N--CA 1.47 0.537 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -57.34 143.56 93.56 Favored 'Trans proline' 0 N--CA 1.488 1.203 0 CA-C-N 120.004 1.037 . . . . 0.0 111.03 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -106.73 179.66 4.2 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.035 0.445 . . . . 0.0 111.245 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -145.86 150.63 36.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.988 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.99 139.26 48.51 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.035 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.431 ' OD1' ' O ' ' A' ' 51' ' ' ASN . 32.8 p-10 -166.54 -175.01 3.02 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.884 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -66.45 -41.79 88.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.576 -0.283 . . . . 0.0 111.66 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 54.4 ttp -67.95 -42.7 80.52 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.431 ' O ' ' OD1' ' A' ' 48' ' ' ASN . 86.7 m-20 -135.31 115.41 13.23 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.392 178.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.481 ' OD1' ' O ' ' A' ' 64' ' ' THR . 12.2 p-10 -111.63 147.41 35.57 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 178.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.1 mm -113.26 126.25 70.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 98.4 m -127.82 134.31 49.44 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.757 0.313 . . . . 0.0 110.9 -178.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.6 p -111.17 133.86 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 57' ' ' GLN . 95.9 mt-10 -116.09 -177.33 3.14 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.035 0.445 . . . . 0.0 111.766 -178.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.449 ' O ' ' N ' ' A' ' 59' ' ' THR . 77.8 mt-30 -24.92 144.11 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.069 -0.969 . . . . 0.0 112.784 -179.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.576 ' O ' HG23 ' A' ' 59' ' ' THR . . . 52.91 -89.44 0.01 OUTLIER Glycine 0 CA--C 1.519 0.284 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.576 HG23 ' O ' ' A' ' 58' ' ' GLY . 19.7 p -160.33 42.82 0.19 Allowed 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.484 -179.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.447 ' N ' HD12 ' A' ' 60' ' ' LEU . 10.6 mp -86.01 112.66 21.43 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 179.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 49.1 m170 -86.49 150.93 23.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.874 -179.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.2 tp -149.41 105.91 3.53 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.537 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.469 ' CD2' ' N ' ' A' ' 63' ' ' LEU . 1.3 mm? -83.15 111.41 18.89 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.481 ' O ' ' OD1' ' A' ' 52' ' ' ASP . 70.9 m -101.79 94.82 6.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.108 0.48 . . . . 0.0 111.206 -178.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.511 ' N ' HD12 ' A' ' 65' ' ' LEU . 10.5 mp -95.65 136.37 36.14 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.613 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.59 ' CG ' ' H ' ' A' ' 67' ' ' LYS . 45.7 t60 -70.93 -176.07 1.27 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.587 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.59 ' H ' ' CG ' ' A' ' 66' ' ' HIS . 97.7 mttt -63.47 100.39 0.26 Allowed 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.3 m -100.02 134.36 39.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.258 -178.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 30.9 p -79.28 -148.54 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.247 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.494 ' C ' ' H ' ' A' ' 72' ' ' ASP . 88.4 mt -54.48 -37.31 65.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.598 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -50.25 -8.38 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.661 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.494 ' H ' ' C ' ' A' ' 70' ' ' LEU . 37.1 p-10 -65.64 -35.73 81.66 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.821 0.343 . . . . 0.0 110.839 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -47.45 111.43 0.41 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -173.84 166.55 38.78 Favored Glycine 0 CA--C 1.522 0.496 0 C-N-CA 120.638 -0.792 . . . . 0.0 111.388 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 10.3 m -118.84 126.43 51.82 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.723 -0.239 . . . . 0.0 110.448 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.5 t -103.88 130.76 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 93.9 p -121.92 160.43 24.82 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.171 0.51 . . . . 0.0 110.43 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.532 ' CE2' ' CZ2' ' A' ' 38' ' ' TRP . 12.0 m-85 -135.32 138.31 43.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.172 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 72.6 t60 -127.89 127.52 43.53 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.184 0.516 . . . . 0.0 111.225 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.48 ' O ' ' C ' ' A' ' 81' ' ' GLY . 2.6 p -148.7 116.63 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.337 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.48 ' C ' ' O ' ' A' ' 80' ' ' VAL . . . -5.75 -67.34 0.01 OUTLIER Glycine 0 N--CA 1.473 1.116 0 O-C-N 123.927 0.767 . . . . 0.0 113.877 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.446 ' OG1' ' N ' ' A' ' 83' ' ' CYS . 65.1 p -48.6 -86.59 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -178.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.446 ' N ' ' OG1' ' A' ' 82' ' ' THR . 92.5 m -125.48 -168.71 1.88 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.384 -179.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 51.6 p -153.79 168.71 25.4 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.709 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 39.1 t -152.11 169.99 21.06 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.723 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -150.19 164.11 36.51 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 120.973 0.416 . . . . 0.0 111.184 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.0 152.1 38.05 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.114 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -119.5 129.96 54.97 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.215 0.531 . . . . 0.0 111.066 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 8.2 tt -117.53 122.68 44.35 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.399 -0.818 . . . . 0.0 109.684 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -120.23 159.51 24.79 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.015 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.466 ' O ' HG13 ' A' ' 91' ' ' VAL . 7.7 p -109.56 126.91 66.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-O 120.889 0.375 . . . . 0.0 110.154 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 31.6 m . . . . . 0 C--N 1.325 -0.461 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.539 -179.579 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 . . . . . 0 N--CA 1.466 0.359 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.479 ' O ' HG13 ' A' ' 5' ' ' VAL . 9.6 p -72.09 127.22 33.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.599 HG23 ' OG ' ' A' ' 29' ' ' SER . 26.2 p -101.0 135.56 42.25 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.721 -179.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.74 ' N ' HD12 ' A' ' 7' ' ' ILE . 1.9 mp -107.78 115.16 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 121.492 0.663 . . . . 0.0 111.687 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.455 ' CD2' ' NH1' ' A' ' 27' ' ' ARG . 49.2 tp -126.95 110.77 13.35 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 114.537 -1.211 . . . . 0.0 109.141 178.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.498 ' OE1' ' SG ' ' A' ' 26' ' ' CYS . 24.9 mm-40 -125.15 91.8 48.52 Favored Pre-proline 0 N--CA 1.471 0.598 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -178.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -71.69 -9.32 24.76 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 C-N-CA 121.747 1.632 . . . . 0.0 111.619 177.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.84 87.75 3.43 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.613 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 95.9 mm-40 -69.61 -32.79 71.71 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.097 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 43.6 p-10 -176.96 142.58 0.38 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.904 0.383 . . . . 0.0 110.576 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 51.8 t -119.72 133.1 67.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.557 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.483 ' C ' HD22 ' A' ' 16' ' ' LEU . 98.1 mt-30 -135.85 108.61 7.53 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.483 HD22 ' C ' ' A' ' 15' ' ' GLN . 3.9 mm? -115.13 133.22 56.23 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 120.563 0.221 . . . . 0.0 110.427 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.9 t -68.1 149.52 49.52 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.877 0.37 . . . . 0.0 110.732 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -52.3 132.28 33.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.779 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.94 16.48 56.1 Favored Glycine 0 CA--C 1.534 1.256 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.972 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -125.06 155.87 39.1 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.913 0.387 . . . . 0.0 110.273 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 43.9 p-10 -85.72 169.36 13.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.555 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -134.44 147.36 50.41 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.042 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 44.5 t -134.87 141.21 46.29 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.884 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -119.96 146.38 45.88 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.127 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -128.71 104.89 7.9 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.224 179.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.498 ' SG ' ' OE1' ' A' ' 9' ' ' GLU . 6.6 t -124.45 141.81 51.79 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.455 ' NH1' ' CD2' ' A' ' 8' ' ' LEU . 60.1 ttp180 -124.99 119.52 28.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.922 0.391 . . . . 0.0 110.634 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 84.0 mt -123.4 121.01 34.67 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.383 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.599 ' OG ' HG23 ' A' ' 6' ' ' THR . 66.3 p -71.6 161.33 31.17 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 18.5 ptp180 -53.9 147.74 11.66 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.377 0.608 . . . . 0.0 112.329 -178.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.29 -173.78 3.33 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.611 -178.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.7 t -163.68 -43.67 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.933 -1.03 . . . . 0.0 109.166 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -98.23 -71.41 1.02 Allowed Glycine 0 CA--C 1.521 0.409 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 179.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 -124.93 135.78 53.15 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.109 0.481 . . . . 0.0 111.926 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -90.12 151.98 21.34 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.211 178.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.2 167.62 15.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.358 -179.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -149.65 159.51 44.28 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.195 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.5 ' CB ' HD11 ' A' ' 45' ' ' LEU . 92.7 m95 -84.63 176.56 8.51 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.922 0.391 . . . . 0.0 110.222 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -166.12 106.32 0.69 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.676 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.449 ' C ' HD23 ' A' ' 40' ' ' LEU . 7.1 tt -114.88 118.0 32.26 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.59 21.37 68.87 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.7 -9.29 74.49 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 47.2 t -115.1 134.94 22.45 Favored Pre-proline 0 N--CA 1.471 0.618 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -56.71 142.21 91.55 Favored 'Trans proline' 0 N--CA 1.489 1.227 0 C-N-CA 121.378 1.386 . . . . 0.0 111.589 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.58 ' O ' HD12 ' A' ' 45' ' ' LEU . 0.4 OUTLIER -88.53 159.64 17.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.199 179.809 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -139.93 162.22 35.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.011 0.434 . . . . 0.0 110.389 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.99 76.3 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.362 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.468 ' CG ' ' H ' ' A' ' 49' ' ' GLU . 47.9 t30 -71.03 -174.89 1.03 Allowed 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.468 ' H ' ' CG ' ' A' ' 48' ' ' ASN . 86.5 tt0 -62.85 -44.63 95.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.153 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.9 ptt? -90.13 -16.24 29.98 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.02 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -105.32 142.2 35.5 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.092 0.472 . . . . 0.0 111.353 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.487 ' OD2' ' N ' ' A' ' 53' ' ' ILE . 63.3 t0 -148.03 146.47 28.9 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.429 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.487 ' N ' ' OD2' ' A' ' 52' ' ' ASP . 97.9 mt -125.25 130.77 72.93 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 CA-C-O 120.727 0.298 . . . . 0.0 110.616 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.3 p -135.47 157.91 45.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.11 0.481 . . . . 0.0 110.966 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 50.6 t -117.63 131.63 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.221 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.448 ' O ' ' O ' ' A' ' 57' ' ' GLN . 97.1 mt-10 -108.31 177.63 4.74 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.448 ' O ' ' O ' ' A' ' 56' ' ' GLU . 55.5 tt0 -28.15 148.77 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 O-C-N 123.795 0.684 . . . . 0.0 112.137 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 60.6 -98.14 0.14 Allowed Glycine 0 C--N 1.329 0.178 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.2 m -163.27 48.19 0.14 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.327 0.584 . . . . 0.0 110.535 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 8.2 tt -92.19 116.77 29.24 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.264 0.554 . . . . 0.0 110.339 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 -79.07 146.64 33.15 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.264 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.624 ' C ' HD23 ' A' ' 62' ' ' LEU . 6.3 tt -143.38 114.57 7.87 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.442 ' N ' HD23 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -90.62 106.17 18.32 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.511 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 90.9 m -92.45 107.78 19.47 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.695 -178.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 83.2 mt -103.28 124.08 47.98 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.276 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.522 ' O ' HG13 ' A' ' 68' ' ' VAL . 13.2 t60 -72.72 156.7 38.66 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 66' ' ' HIS . 15.8 ptpt -27.45 89.15 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.599 0.714 . . . . 0.0 112.495 -179.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.522 HG13 ' O ' ' A' ' 66' ' ' HIS . 28.0 m -82.33 167.45 2.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.031 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.521 HG23 ' H ' ' A' ' 71' ' ' GLU . 6.7 t -130.77 -149.68 0.4 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.335 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.501 ' C ' ' H ' ' A' ' 72' ' ' ASP . 3.3 mm? -51.24 -36.35 41.38 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.293 -0.563 . . . . 0.0 109.684 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.521 ' H ' HG23 ' A' ' 69' ' ' THR . 98.3 mt-10 -60.96 -0.39 0.3 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.481 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.501 ' H ' ' C ' ' A' ' 70' ' ' LEU . 42.8 t0 -63.53 -36.97 85.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.913 -179.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.93 141.25 40.12 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.211 0.529 . . . . 0.0 111.324 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 173.52 153.49 9.71 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.523 -1.031 . . . . 0.0 110.523 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 16.0 p -97.25 111.35 23.63 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.954 0.407 . . . . 0.0 110.91 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 25.2 t -107.59 128.28 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.884 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.5 t -144.29 175.8 9.82 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.28 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.409 ' CZ ' ' CZ3' ' A' ' 38' ' ' TRP . 57.9 m-85 -127.07 144.27 51.07 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -131.57 115.3 15.93 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.968 0.413 . . . . 0.0 110.84 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.486 ' O ' ' N ' ' A' ' 82' ' ' THR . 6.0 p -141.23 125.49 17.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.404 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -39.85 -20.38 0.02 OUTLIER Glycine 0 CA--C 1.531 1.068 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.863 -178.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.486 ' N ' ' O ' ' A' ' 80' ' ' VAL . 68.3 p -80.65 -75.19 0.28 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.054 0.454 . . . . 0.0 111.084 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.417 ' N ' ' OG1' ' A' ' 82' ' ' THR . 61.8 m -121.0 179.6 4.33 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.427 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 73.5 m -131.57 151.81 51.3 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 11.4 t -153.07 164.39 38.09 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -148.37 162.07 40.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.065 0.46 . . . . 0.0 111.214 -178.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.2 155.69 34.34 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.933 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -122.45 128.59 51.07 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.424 -179.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.548 HD23 ' N ' ' A' ' 90' ' ' LYS . 2.3 tt -121.1 117.55 27.47 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.548 ' N ' HD23 ' A' ' 89' ' ' LEU . 20.5 pttp -144.57 166.38 25.34 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 120.904 0.383 . . . . 0.0 111.679 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.6 p -104.08 133.22 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.184 0.516 . . . . 0.0 110.137 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.0 t . . . . . 0 C--N 1.332 -0.195 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.994 -179.3 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 . . . . . 0 N--CA 1.458 -0.071 0 CA-C-O 120.931 0.396 . . . . 0.0 110.519 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.477 ' O ' HG13 ' A' ' 5' ' ' VAL . 10.0 p -54.37 130.22 16.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.402 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.504 ' HG1' ' CB ' ' A' ' 29' ' ' SER . 16.6 p -101.23 124.95 47.74 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 22.9 mm -100.8 111.17 29.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.102 0.477 . . . . 0.0 110.948 -178.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.435 ' O ' ' O ' ' A' ' 27' ' ' ARG . 91.6 mt -120.02 106.07 11.65 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.501 178.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.47 ' OE1' ' SG ' ' A' ' 26' ' ' CYS . 34.0 mm-40 -124.81 89.39 52.54 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.957 -179.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -71.79 -3.51 13.29 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 121.622 1.548 . . . . 0.0 110.694 178.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 67.4 mt -69.24 141.5 54.41 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.982 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -124.77 -46.84 1.84 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.174 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 37.3 p30 -176.72 146.43 0.57 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.136 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 65.1 t -125.28 129.31 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.043 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -137.66 135.93 36.97 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.023 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -160.87 160.56 31.15 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.995 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.0 p -74.69 156.53 36.56 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.978 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -67.91 138.59 56.12 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.21 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.45 -3.38 65.92 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -103.33 151.52 22.64 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.871 0.367 . . . . 0.0 110.878 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -76.07 155.23 34.99 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.97 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -135.39 146.29 48.17 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.523 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.5 m -133.43 148.8 51.79 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.31 0.576 . . . . 0.0 111.112 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -128.19 147.35 50.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.608 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -136.38 116.09 13.02 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.452 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.47 ' SG ' ' OE1' ' A' ' 9' ' ' GLU . 3.0 t -131.48 127.99 38.49 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.398 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.435 ' O ' ' O ' ' A' ' 8' ' ' LEU . 99.6 mtt180 -96.76 125.81 41.48 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 178.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.442 HD12 ' O ' ' A' ' 6' ' ' THR . 18.8 tp -145.34 112.24 5.96 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -178.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.504 ' CB ' ' HG1' ' A' ' 6' ' ' THR . 6.6 p -79.08 155.24 28.86 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 18.1 ptp180 -54.22 157.96 2.46 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -177.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.69 -173.86 2.46 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 114.649 -1.16 . . . . 0.0 111.374 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.8 t -154.85 -44.93 0.09 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.231 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -86.51 -72.12 1.29 Allowed Glycine 0 CA--C 1.522 0.482 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 178.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -122.41 143.39 49.7 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.833 0.349 . . . . 0.0 110.632 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.515 ' N ' ' OE1' ' A' ' 35' ' ' GLU . 56.4 mp0 -91.72 129.64 37.66 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.463 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.412 ' CB ' HG22 ' A' ' 80' ' ' VAL . . . -71.48 145.98 48.88 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -129.92 151.86 50.02 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.747 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.445 ' CZ2' HD23 ' A' ' 63' ' ' LEU . 62.5 m95 -74.38 176.32 6.85 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -163.24 114.5 1.44 Allowed 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.896 178.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 41.1 tp -124.25 121.27 34.59 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.18 3.21 64.51 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.94 -17.21 58.51 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.9 m -107.08 149.68 38.93 Favored Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -58.76 145.11 97.33 Favored 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 120.885 1.056 . . . . 0.0 111.641 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.475 ' H ' ' CD2' ' A' ' 45' ' ' LEU . 0.9 OUTLIER -89.13 178.25 6.42 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.687 179.967 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -151.22 140.42 21.26 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.007 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.35 142.65 58.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.625 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.429 ' CG ' ' H ' ' A' ' 49' ' ' GLU . 48.4 t30 -169.01 -173.5 1.81 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.798 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.429 ' H ' ' CG ' ' A' ' 48' ' ' ASN . 82.4 tt0 -64.0 -42.25 97.24 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.526 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 97.2 mmm -66.28 -40.18 89.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.513 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.477 ' OD1' ' CD1' ' A' ' 63' ' ' LEU . 46.5 t30 -120.81 119.83 33.83 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.71 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -113.79 136.77 52.49 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 70.9 mt -120.07 129.87 74.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 110.11 -0.329 . . . . 0.0 110.11 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 86.8 m -132.5 142.04 49.04 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.203 0.525 . . . . 0.0 111.182 -178.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 42.1 t -110.58 132.9 57.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.438 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -124.6 -174.66 3.07 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.204 0.526 . . . . 0.0 110.543 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -28.41 137.99 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.466 -179.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.536 ' O ' HG23 ' A' ' 59' ' ' THR . . . 69.7 -99.63 0.69 Allowed Glycine 0 CA--C 1.52 0.367 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.536 HG23 ' O ' ' A' ' 58' ' ' GLY . 25.3 p -159.94 51.51 0.32 Allowed 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 52.1 tp -87.22 119.14 27.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.467 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 53.6 m170 -100.97 124.84 47.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.673 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 76.2 mt -119.01 123.81 45.44 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.173 0.511 . . . . 0.0 111.18 -179.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.477 ' CD1' ' OD1' ' A' ' 51' ' ' ASN . 0.3 OUTLIER -97.89 105.69 17.87 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 177.954 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 58.7 m -104.97 105.2 15.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.173 0.511 . . . . 0.0 111.297 -177.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.6 mt -96.42 131.17 43.26 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.019 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -112.84 144.62 42.08 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.986 0.422 . . . . 0.0 111.114 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 74.7 tttt 50.92 57.04 7.08 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.475 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -44.98 152.08 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.087 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 43.7 p -134.5 164.4 27.56 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.628 HD13 ' O ' ' A' ' 70' ' ' LEU . 0.3 OUTLIER -60.9 -33.93 73.88 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.301 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -65.06 -22.22 66.94 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.592 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -60.3 -34.6 74.0 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -44.63 118.33 1.55 Allowed 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.594 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -170.74 -179.34 41.98 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 52.6 m -108.63 122.99 48.24 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.833 0.349 . . . . 0.0 110.781 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.14 131.46 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 29.0 t -144.18 175.15 10.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.885 0.374 . . . . 0.0 110.584 -179.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -127.34 138.16 52.97 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.904 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 -120.72 112.0 18.31 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.504 ' HB ' ' H ' ' A' ' 83' ' ' CYS . 2.4 t -126.67 129.66 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 120.966 0.412 . . . . 0.0 110.336 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -57.18 -7.48 2.66 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.421 ' H ' ' C ' ' A' ' 80' ' ' VAL . 16.4 p -108.7 -40.53 5.04 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.656 0.265 . . . . 0.0 110.963 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.504 ' H ' ' HB ' ' A' ' 80' ' ' VAL . 26.2 m -148.04 -166.37 2.51 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.328 -179.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 91.0 p -160.04 167.02 28.8 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.046 0.45 . . . . 0.0 111.229 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 31.5 t -158.87 166.8 31.04 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.331 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -134.63 153.53 51.93 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.21 0.528 . . . . 0.0 110.969 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.93 151.31 23.41 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.489 -0.778 . . . . 0.0 108.917 178.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -133.66 132.57 40.86 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.846 0.355 . . . . 0.0 111.693 -178.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.595 HD23 ' N ' ' A' ' 90' ' ' LYS . 5.3 tt -114.57 118.46 33.8 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.595 ' N ' HD23 ' A' ' 89' ' ' LEU . 32.3 ttmt -128.17 134.84 49.11 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.912 0.387 . . . . 0.0 110.677 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.2 p -114.94 108.24 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 27.4 m . . . . . 0 N--CA 1.464 0.246 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.324 -179.7 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 . . . . . 0 N--CA 1.464 0.252 0 CA-C-O 120.91 0.386 . . . . 0.0 110.994 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.643 HG22 ' HA ' ' A' ' 31' ' ' ALA . 3.2 t -59.99 132.73 25.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.338 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.596 ' HB ' ' H ' ' A' ' 29' ' ' SER . 89.6 m -87.15 121.13 29.19 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 119.032 -1.067 . . . . 0.0 110.486 -179.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 18.2 mm -105.2 100.5 10.69 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.926 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 60.6 mt -128.41 90.26 3.04 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.494 ' OE2' ' CE2' ' A' ' 78' ' ' PHE . 7.6 pt-20 -120.14 84.27 33.38 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.933 -178.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.402 ' O ' ' N ' ' A' ' 12' ' ' GLN . 3.1 Cg_exo -71.23 11.67 0.55 Allowed 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 122.204 1.936 . . . . 0.0 111.491 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.615 HD12 ' N ' ' A' ' 11' ' ' LEU . 8.4 mp -70.54 67.07 0.34 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.402 ' N ' ' O ' ' A' ' 10' ' ' PRO . 99.4 mm-40 -69.94 -43.17 72.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.365 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.593 ' CG ' HE21 ' A' ' 15' ' ' GLN . 54.9 t0 -175.04 138.64 0.45 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.916 0.389 . . . . 0.0 110.992 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.424 ' N ' ' OD2' ' A' ' 13' ' ' ASP . 54.7 t -127.0 131.69 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.626 ' C ' HD22 ' A' ' 16' ' ' LEU . 7.9 mp0 -136.43 102.64 5.02 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.734 0.302 . . . . 0.0 111.035 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.626 HD22 ' C ' ' A' ' 15' ' ' GLN . 4.4 mm? -119.68 146.36 45.66 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.239 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 45.0 t -82.06 162.91 22.4 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.14 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -61.61 137.68 58.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.162 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.21 2.29 85.74 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 111.761 -0.535 . . . . 0.0 111.761 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -96.73 166.79 11.48 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.87 0.367 . . . . 0.0 110.72 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 21' ' ' ASP . 39.9 p30 -79.46 151.56 30.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.625 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.07 142.19 29.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.271 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 96.5 p -162.48 161.17 26.96 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.943 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -132.59 150.69 52.12 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.944 0.402 . . . . 0.0 110.644 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -136.45 123.85 22.03 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 8.5 t -134.38 132.9 39.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.277 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 90.6 mtm-85 -104.44 104.72 14.63 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.763 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 85.7 mt -123.81 121.05 34.4 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.0 0.428 . . . . 0.0 111.682 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.596 ' H ' ' HB ' ' A' ' 6' ' ' THR . 85.2 p -75.33 163.68 27.21 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 177.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 35.5 ptt-85 -50.87 149.02 3.68 Favored 'General case' 0 C--N 1.322 -0.618 0 O-C-N 124.181 0.926 . . . . 0.0 113.331 -177.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.643 ' HA ' HG22 ' A' ' 5' ' ' VAL . . . -75.46 176.43 7.54 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 114.177 -1.374 . . . . 0.0 111.135 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 50.0 m -151.25 -63.51 0.19 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.695 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -88.44 -75.36 1.29 Allowed Glycine 0 CA--C 1.521 0.409 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 178.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -122.43 129.96 52.59 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.711 0.291 . . . . 0.0 110.332 178.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -73.35 145.46 45.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.712 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.47 ' CB ' HG22 ' A' ' 80' ' ' VAL . . . -71.34 146.83 48.57 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.587 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 24.2 mmt85 -104.85 132.74 50.72 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.908 179.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -113.0 138.62 49.59 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.46 ' HB1' ' O ' ' A' ' 43' ' ' VAL . . . -176.43 155.53 1.43 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 119.727 -0.789 . . . . 0.0 111.52 -178.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.623 HD23 ' N ' ' A' ' 41' ' ' GLY . 6.5 tt -123.06 121.85 37.04 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.623 ' N ' HD23 ' A' ' 40' ' ' LEU . . . 86.05 6.04 82.49 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -178.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.33 0.84 79.42 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 112.028 -0.429 . . . . 0.0 112.028 179.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.46 ' O ' ' HB1' ' A' ' 39' ' ' ALA . 23.1 m -113.13 143.98 30.26 Favored Pre-proline 0 N--CA 1.47 0.551 0 CA-C-N 116.777 0.289 . . . . 0.0 110.884 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -56.41 144.87 81.88 Favored 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 121.411 1.407 . . . . 0.0 110.449 178.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.557 HD21 ' N ' ' A' ' 40' ' ' LEU . 14.2 mt -80.87 156.97 25.82 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.034 0.445 . . . . 0.0 111.384 -179.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.465 ' O ' ' N ' ' A' ' 48' ' ' ASN . 89.9 mt-30 -126.6 131.48 51.49 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.21 179.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.01 70.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.943 0.401 . . . . 0.0 111.566 -178.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.465 ' N ' ' O ' ' A' ' 46' ' ' GLN . 87.4 m-20 -76.93 163.21 26.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.645 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -59.26 -46.57 88.15 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 95.2 mtp -66.91 -40.24 87.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.236 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.425 ' O ' ' O ' ' A' ' 48' ' ' ASN . 66.0 m-20 -117.6 107.77 14.65 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.769 179.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -109.82 158.51 18.08 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.7 mt -122.09 130.25 74.71 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-O 120.916 0.389 . . . . 0.0 110.084 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 97.1 m -128.27 129.38 46.27 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.905 -178.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.425 ' O ' HG13 ' A' ' 55' ' ' VAL . 7.4 p -111.03 129.25 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.879 179.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.411 ' O ' ' C ' ' A' ' 57' ' ' GLN . 98.0 mt-10 -112.38 -174.57 2.49 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.144 0.497 . . . . 0.0 111.114 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.411 ' C ' ' O ' ' A' ' 56' ' ' GLU . 63.1 tp60 -24.78 144.56 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 114.791 -1.095 . . . . 0.0 112.462 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 58.52 -94.48 0.05 OUTLIER Glycine 0 CA--C 1.522 0.512 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.672 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 37.5 m -163.7 65.06 0.17 Allowed 'General case' 0 C--O 1.239 0.516 0 CA-C-O 121.324 0.583 . . . . 0.0 110.635 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 91.4 mt -95.8 126.3 40.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.426 178.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 48.7 m170 -107.84 120.61 42.77 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.22 118.39 14.49 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.083 0.468 . . . . 0.0 110.8 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -86.58 118.05 25.75 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 94.9 m -105.64 95.94 6.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.278 -179.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.481 ' N ' HD23 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -106.88 140.84 39.06 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.593 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 21.3 p80 -139.19 159.02 43.14 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.575 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 79.2 tttt 47.74 73.17 0.21 Allowed 'General case' 0 C--O 1.231 0.109 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -179.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.425 HG13 ' O ' ' A' ' 68' ' ' VAL . 11.7 p -116.47 131.83 67.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.959 -179.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.6 p -79.08 -157.41 0.12 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.523 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.577 ' C ' ' H ' ' A' ' 72' ' ' ASP . 55.4 tp -57.72 -33.74 68.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.421 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -51.28 -2.33 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.235 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.577 ' H ' ' C ' ' A' ' 70' ' ' LEU . 29.1 t0 -53.57 -39.24 64.64 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.697 0.284 . . . . 0.0 110.474 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.65 137.89 57.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.181 0.515 . . . . 0.0 111.068 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 179.99 176.8 47.65 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 110.076 -1.209 . . . . 0.0 110.076 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 94.4 m -126.15 117.26 22.76 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 117.088 0.444 . . . . 0.0 111.003 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.1 t -89.63 131.64 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.1 p -132.04 149.5 52.4 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.149 0.5 . . . . 0.0 110.891 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.494 ' CE2' ' OE2' ' A' ' 9' ' ' GLU . 0.2 OUTLIER -153.52 150.24 28.52 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.826 179.911 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -145.07 141.43 28.84 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.222 0.534 . . . . 0.0 111.112 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.498 ' O ' ' N ' ' A' ' 82' ' ' THR . 2.3 t -130.07 131.53 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.893 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -46.76 -11.89 0.06 OUTLIER Glycine 0 CA--C 1.528 0.896 0 C-N-CA 121.067 -0.587 . . . . 0.0 111.693 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.498 ' N ' ' O ' ' A' ' 80' ' ' VAL . 22.7 p -99.92 -54.01 3.01 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 122.722 -0.281 . . . . 0.0 110.696 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 38.8 t -139.58 162.5 34.93 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.115 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 30.9 p -134.68 155.13 51.06 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.964 0.412 . . . . 0.0 111.254 -179.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.0 t -162.87 166.87 23.53 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.948 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -142.34 165.06 28.44 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.66 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.82 155.69 41.93 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.139 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -125.25 135.89 52.99 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.344 0.592 . . . . 0.0 111.773 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 48.2 tp -109.66 97.68 7.18 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.783 179.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -94.62 166.82 11.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.312 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 53.1 t -119.51 128.37 75.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.256 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.63 -179.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 . . . . . 0 N--CA 1.47 0.556 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.521 HG22 ' HA ' ' A' ' 31' ' ' ALA . 2.7 t -61.28 130.53 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 C-N-CA 120.221 -0.591 . . . . 0.0 109.413 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.607 ' HB ' ' H ' ' A' ' 29' ' ' SER . 72.4 m -91.94 130.21 37.74 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 119.962 -0.695 . . . . 0.0 111.457 -178.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 33.8 mm -111.86 102.52 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-O 121.275 0.559 . . . . 0.0 111.017 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 39.4 tp -126.3 87.51 2.68 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.08 -0.963 . . . . 0.0 108.768 178.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.513 ' OE2' ' CE2' ' A' ' 78' ' ' PHE . 28.9 mt-10 -120.61 85.03 37.73 Favored Pre-proline 0 N--CA 1.464 0.267 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.354 -179.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -72.2 8.85 1.29 Allowed 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 121.819 1.679 . . . . 0.0 111.557 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 65.2 mt -61.56 84.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.903 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 40.5 tp60 -72.86 -133.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -109.02 138.3 45.58 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.5 m -127.95 156.16 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -136.61 104.51 5.57 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.546 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 78.4 mt -118.45 139.97 50.58 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.249 -178.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 91.5 p -69.26 153.81 43.04 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.996 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -65.94 146.6 54.53 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.085 0.469 . . . . 0.0 111.065 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.43 8.82 65.63 Favored Glycine 0 CA--C 1.53 0.976 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.526 HE21 ' C ' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -112.29 156.78 21.84 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 120.976 0.417 . . . . 0.0 110.366 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.526 ' C ' HE21 ' A' ' 20' ' ' GLN . 87.1 m-20 -78.05 144.81 36.29 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.063 178.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -126.07 146.74 49.79 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.072 0.463 . . . . 0.0 110.594 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 41.5 t -156.77 154.74 30.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.927 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -132.81 152.13 51.87 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.809 0.337 . . . . 0.0 110.641 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.405 ' CD ' ' N ' ' A' ' 25' ' ' GLN . 0.5 OUTLIER -124.9 111.25 15.24 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.125 -0.488 . . . . 0.0 109.755 179.48 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 6.7 t -115.84 137.7 51.84 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 82.1 mtm180 -123.47 125.1 44.3 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.8 pp -147.98 141.17 25.07 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 119.974 -0.691 . . . . 0.0 111.438 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.607 ' H ' ' HB ' ' A' ' 6' ' ' THR . 98.5 p -74.31 162.65 28.68 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 178.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -52.24 162.53 0.49 Allowed 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -177.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.521 ' HA ' HG22 ' A' ' 5' ' ' VAL . . . -70.14 157.07 38.28 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 114.018 -1.447 . . . . 0.0 111.401 -179.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.5 t -141.44 -61.34 0.47 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.399 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -101.27 -67.24 0.81 Allowed Glycine 0 N--CA 1.459 0.22 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -123.55 137.72 54.7 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 179.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -79.8 147.58 31.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.589 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.44 152.21 40.85 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.188 179.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 61.3 mtp85 -126.09 147.04 49.68 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.292 -179.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 2.3 t-105 -104.45 151.29 23.72 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.597 -179.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -165.62 148.47 7.72 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.066 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.548 ' C ' HD23 ' A' ' 40' ' ' LEU . 8.0 tt -124.99 126.27 45.18 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.474 ' N ' HD23 ' A' ' 40' ' ' LEU . . . 80.65 7.69 88.3 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.87 -12.74 62.5 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.4 m -112.17 150.76 42.96 Favored Pre-proline 0 N--CA 1.468 0.466 0 C-N-CA 121.975 0.11 . . . . 0.0 110.756 -179.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -57.71 144.33 93.31 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 121.39 1.393 . . . . 0.0 110.666 178.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.476 ' H ' HD23 ' A' ' 45' ' ' LEU . 0.9 OUTLIER -114.66 171.78 7.43 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.691 0.281 . . . . 0.0 111.069 179.756 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -130.58 134.24 46.84 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.952 0.406 . . . . 0.0 110.247 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.01 96.29 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.273 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -75.17 169.67 17.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.997 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -58.43 -45.21 88.96 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 20.6 mmt -67.58 -38.83 84.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.639 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 62.8 t-20 -98.89 106.9 19.21 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.765 -178.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.431 ' O ' ' OG1' ' A' ' 64' ' ' THR . 67.0 m-20 -109.0 108.29 18.97 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.4 HG21 HD13 ' A' ' 53' ' ' ILE . 38.4 mt -100.74 133.74 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -179.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.9 t -146.11 159.17 43.65 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -179.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.0 t -109.25 137.44 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.268 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 57' ' ' GLN . 79.4 mm-40 -116.11 -178.6 3.44 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.438 ' C ' ' O ' ' A' ' 56' ' ' GLU . 56.1 tt0 -26.19 144.98 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 O-C-N 123.889 0.743 . . . . 0.0 112.102 -179.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 59.05 -94.7 0.06 OUTLIER Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.446 ' O ' ' OG1' ' A' ' 59' ' ' THR . 0.0 OUTLIER -166.75 59.49 0.09 Allowed 'General case' 0 C--O 1.24 0.594 0 CA-C-O 121.541 0.686 . . . . 0.0 110.962 -179.797 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.47 ' CD2' ' N ' ' A' ' 60' ' ' LEU . 3.1 mm? -99.55 130.56 45.81 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.099 179.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -107.27 142.96 36.2 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 120.869 0.366 . . . . 0.0 110.261 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.2 mp -137.89 118.92 14.37 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.293 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.33 108.2 19.89 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 52' ' ' ASP . 82.1 p -102.75 96.93 7.18 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 121.138 0.494 . . . . 0.0 109.908 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 36.6 tp -103.34 124.65 49.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.513 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.613 ' CG ' ' H ' ' A' ' 67' ' ' LYS . 1.0 OUTLIER -71.13 -152.71 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.41 -179.465 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.613 ' H ' ' CG ' ' A' ' 66' ' ' HIS . 5.4 mtmp? -53.99 97.09 0.02 OUTLIER 'General case' 0 CA--C 1.522 -0.108 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.376 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.498 HG22 ' H ' ' A' ' 69' ' ' THR . 3.0 p -58.19 168.35 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.819 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.498 ' H ' HG22 ' A' ' 68' ' ' VAL . 58.2 p -134.41 159.79 39.96 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 47.2 tp -58.54 -40.81 84.02 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -69.9 -33.02 71.64 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.677 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.45 ' HB2' ' H ' ' A' ' 69' ' ' THR . 55.3 m-20 -64.27 -40.27 95.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.86 -178.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.74 140.05 57.68 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.649 -0.421 . . . . 0.0 110.24 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -175.39 -108.02 0.22 Allowed Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 -179.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 97.0 m -156.5 109.69 2.63 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.412 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.5 t -89.07 127.9 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 31.9 t -133.03 146.23 51.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.283 0.563 . . . . 0.0 111.542 -178.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.513 ' CE2' ' OE2' ' A' ' 9' ' ' GLU . 0.1 OUTLIER -140.7 159.2 42.73 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.476 179.585 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.433 ' CD2' ' N ' ' A' ' 79' ' ' HIS . 5.3 p80 -143.41 146.39 33.44 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.973 -179.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.48 ' O ' ' N ' ' A' ' 82' ' ' THR . 2.2 t -134.32 134.46 54.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.557 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -43.06 -20.32 0.09 OUTLIER Glycine 0 CA--C 1.533 1.165 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.517 ' OG1' ' N ' ' A' ' 83' ' ' CYS . 33.1 p -82.6 -72.38 0.45 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.839 0.352 . . . . 0.0 110.657 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.517 ' N ' ' OG1' ' A' ' 82' ' ' THR . 7.8 t -128.02 -178.26 4.45 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.699 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.413 ' N ' ' SG ' ' A' ' 83' ' ' CYS . 35.5 m -127.74 149.69 50.12 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.244 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 52.9 p -156.63 162.85 39.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.611 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -160.06 168.14 26.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.983 0.42 . . . . 0.0 111.024 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.78 140.11 28.26 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.865 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 25.1 mp0 -109.7 122.04 46.59 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.098 0.475 . . . . 0.0 111.005 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 53.6 tp -108.54 106.29 16.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.929 179.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -110.02 171.03 7.69 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.458 ' O ' HG23 ' A' ' 91' ' ' VAL . 24.3 m -113.8 128.7 70.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 120.77 0.319 . . . . 0.0 110.242 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.9 m . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.247 -179.894 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.0 tp10 . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.973 0.416 . . . . 0.0 110.411 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.47 HG22 ' HA ' ' A' ' 31' ' ' ALA . 4.8 t -58.76 132.89 23.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.487 ' OG1' ' N ' ' A' ' 29' ' ' SER . 51.8 p -94.55 133.91 37.66 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 119.177 -1.009 . . . . 0.0 110.936 -179.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.3 mm -112.45 56.93 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.181 -178.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 48.0 tp -90.1 78.03 6.71 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.537 ' OE1' ' CZ ' ' A' ' 78' ' ' PHE . 16.3 tt0 -121.7 83.82 42.66 Favored Pre-proline 0 N--CA 1.466 0.369 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.286 -179.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -71.46 47.14 0.83 Allowed 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.447 2.098 . . . . 0.0 112.067 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.444 HD11 ' CD2' ' A' ' 24' ' ' PHE . 2.3 mm? -81.69 82.47 7.4 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.418 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -74.12 -86.08 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.811 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.431 ' O ' ' OD2' ' A' ' 13' ' ' ASP . 44.0 p-10 -172.7 133.83 0.6 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.328 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.0 m -131.03 156.5 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-O 120.975 0.417 . . . . 0.0 110.697 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.87 121.66 30.6 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.33 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 53.4 mt -124.66 141.02 52.4 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.319 -179.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.2 t -83.92 155.55 22.8 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 -52.27 143.33 14.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.015 0.436 . . . . 0.0 111.426 -179.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.42 2.1 85.42 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.844 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -101.08 146.76 27.04 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.003 0.43 . . . . 0.0 111.219 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -73.79 153.87 39.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.588 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -134.8 138.92 44.7 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.986 0.422 . . . . 0.0 110.049 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 71.0 m -161.51 158.05 25.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.235 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.444 ' CD2' HD11 ' A' ' 11' ' ' LEU . 67.9 m-85 -135.41 151.08 50.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.158 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -124.09 135.31 53.46 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.532 ' SG ' ' N ' ' A' ' 27' ' ' ARG . 53.8 t -149.8 163.62 37.5 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.043 0.449 . . . . 0.0 111.441 -179.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.532 ' N ' ' SG ' ' A' ' 26' ' ' CYS . 80.2 mtp85 -129.91 96.52 4.23 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.085 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.426 ' O ' ' CG2' ' A' ' 59' ' ' THR . 76.2 mt -113.32 113.66 25.57 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.728 -0.214 . . . . 0.0 111.384 -179.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.487 ' N ' ' OG1' ' A' ' 6' ' ' THR . 44.2 t -68.04 156.2 37.87 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 178.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -53.33 167.03 0.22 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -177.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.47 ' HA ' HG22 ' A' ' 5' ' ' VAL . . . -63.24 159.88 16.87 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 113.691 -1.595 . . . . 0.0 111.799 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.7 t -140.87 -58.19 0.51 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.49 -69.71 0.7 Allowed Glycine 0 CA--C 1.521 0.437 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 177.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -121.75 144.48 48.77 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.05 0.452 . . . . 0.0 110.652 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -83.85 142.12 30.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.57 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.29 152.68 41.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.443 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -124.15 126.72 46.64 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.199 0.523 . . . . 0.0 110.683 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 40.8 t-105 -93.73 148.05 22.47 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.951 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -167.37 154.99 8.96 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 119.632 -0.827 . . . . 0.0 112.123 -179.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 67.2 tp -118.17 117.03 28.05 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.74 8.7 82.38 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.9 3.93 79.39 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.5 t -113.48 134.8 21.9 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-O 119.224 -0.417 . . . . 0.0 110.357 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -50.83 138.49 41.88 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 121.022 1.148 . . . . 0.0 110.57 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -114.25 174.16 6.09 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.923 0.392 . . . . 0.0 111.792 -178.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -136.98 150.25 48.03 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.294 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.19 78.43 0.05 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.624 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.427 ' O ' ' O ' ' A' ' 51' ' ' ASN . 7.9 m120 -71.41 178.89 3.19 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.021 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 56.8 mp0 -61.31 -44.88 96.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.228 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 25.9 ptm -83.69 -17.15 42.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.074 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.427 ' O ' ' O ' ' A' ' 48' ' ' ASN . 77.1 m-20 -114.16 105.07 12.75 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.29 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -115.12 130.41 56.92 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 42.7 mt -123.78 133.99 67.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.2 t -137.61 153.23 49.92 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.024 0.44 . . . . 0.0 110.781 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 53.4 t -111.85 131.87 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.254 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -108.12 162.0 14.45 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.932 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -49.87 150.76 2.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.787 -179.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.31 13.09 82.35 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.426 ' CG2' ' O ' ' A' ' 28' ' ' LEU . 1.0 OUTLIER 67.38 26.68 8.35 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.835 0.35 . . . . 0.0 110.629 -179.76 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.6 mp -77.47 136.36 38.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.14 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 5.6 t-160 -104.97 153.39 21.49 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.213 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.1 tp -152.77 110.68 3.63 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 121.01 0.434 . . . . 0.0 109.969 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.416 ' C ' ' CD1' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -86.14 107.54 17.91 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.517 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 60.3 m -99.93 99.93 10.76 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.262 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 41.0 tp -110.94 120.66 43.14 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.452 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.484 ' CG ' ' H ' ' A' ' 67' ' ' LYS . 26.8 t60 -138.55 175.46 9.55 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.215 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.484 ' H ' ' CG ' ' A' ' 66' ' ' HIS . 64.1 mttp 55.18 57.09 5.8 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -179.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 28.2 m -108.28 156.3 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-O 121.448 0.642 . . . . 0.0 111.5 -179.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 36.5 p -135.69 -149.6 0.34 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.69 178.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 16.7 mt -56.52 -23.68 41.44 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -71.45 -1.15 12.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.693 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -56.89 -39.74 74.94 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.711 -0.395 . . . . 0.0 109.945 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.61 147.45 18.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.653 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 171.38 -161.14 33.51 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 87.5 m -153.5 109.28 3.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.719 0.295 . . . . 0.0 110.31 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.0 m -80.3 136.29 23.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.577 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.9 t -144.8 145.82 31.82 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.029 0.442 . . . . 0.0 110.904 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.537 ' CZ ' ' OE1' ' A' ' 9' ' ' GLU . 38.9 p90 -150.07 151.7 33.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.07 179.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.513 ' CE1' ' HG ' ' A' ' 84' ' ' SER . 64.9 t60 -134.86 131.22 37.12 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.906 -179.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.529 ' O ' ' N ' ' A' ' 82' ' ' THR . 2.4 t -127.87 130.89 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.22 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -39.91 -21.33 0.03 OUTLIER Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.775 -0.53 . . . . 0.0 111.775 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.529 ' N ' ' O ' ' A' ' 80' ' ' VAL . 19.0 p -88.54 -71.93 0.56 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.87 0.367 . . . . 0.0 110.233 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 4.1 t -132.04 160.1 36.88 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.939 179.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.513 ' HG ' ' CE1' ' A' ' 79' ' ' HIS . 20.4 m -133.91 154.88 50.77 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.157 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.5 m -160.28 161.65 33.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.116 0.484 . . . . 0.0 111.26 -179.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -143.05 150.13 39.15 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.424 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -135.01 153.24 52.16 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.303 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -108.43 135.74 49.22 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 121.365 0.603 . . . . 0.0 111.412 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 50.0 tp -115.59 96.42 5.62 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.103 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.5 ttmt -94.28 169.74 10.01 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.536 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.8 t -118.38 131.37 71.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.471 0.6 0 CA-C-O 120.719 0.295 . . . . 0.0 110.798 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 . . . . . 0 N--CA 1.461 0.099 0 CA-C-O 121.479 0.657 . . . . 0.0 111.71 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.41 HG13 ' O ' ' A' ' 5' ' ' VAL . 8.7 p -65.1 133.85 30.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.401 179.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.476 ' N ' ' OG ' ' A' ' 29' ' ' SER . 59.7 p -92.77 136.48 33.21 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.337 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.547 HG23 ' O ' ' A' ' 7' ' ' ILE . 2.4 tp -118.21 107.0 20.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-O 122.487 1.137 . . . . 0.0 111.455 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.544 HD12 ' C ' ' A' ' 7' ' ' ILE . 9.7 mp -126.14 79.94 1.88 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 113.996 -1.456 . . . . 0.0 108.418 178.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -120.62 87.8 42.27 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.652 -178.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.45 ' O ' ' N ' ' A' ' 12' ' ' GLN . 2.5 Cg_endo -73.75 -7.0 19.54 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 C-N-CA 122.109 1.873 . . . . 0.0 110.727 178.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 98.2 mt -56.23 83.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.233 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.45 ' N ' ' O ' ' A' ' 10' ' ' PRO . 59.5 tt0 -85.64 -64.76 1.1 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.594 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 14' ' ' VAL . 60.1 t0 -170.64 142.88 2.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.721 -178.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.545 ' N ' ' OD1' ' A' ' 13' ' ' ASP . 29.3 m -132.82 161.68 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.984 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.422 ' CD ' ' N ' ' A' ' 15' ' ' GLN . 0.6 OUTLIER -128.47 115.71 18.59 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.883 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 60.4 mt -122.16 143.78 49.35 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.949 0.404 . . . . 0.0 111.465 -179.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.7 m -80.74 157.86 25.7 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.003 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -65.9 148.53 51.65 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.585 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.8 10.16 84.53 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 111.071 -0.811 . . . . 0.0 111.071 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -121.16 145.14 48.13 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -74.29 162.25 29.09 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.403 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -131.22 162.24 30.42 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 28.1 p -159.39 158.51 32.32 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.196 -0.602 . . . . 0.0 111.476 -179.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -139.75 148.22 41.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.294 179.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -136.33 126.99 27.14 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.595 ' SG ' ' N ' ' A' ' 27' ' ' ARG . 8.2 t -130.13 162.47 28.76 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.472 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.595 ' N ' ' SG ' ' A' ' 26' ' ' CYS . 79.4 ttt180 -143.41 116.01 8.65 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.471 ' O ' HG21 ' A' ' 59' ' ' THR . 2.4 pp -146.06 123.47 11.67 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 119.846 -0.742 . . . . 0.0 111.71 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.476 ' OG ' ' N ' ' A' ' 6' ' ' THR . 92.4 p -62.25 160.23 13.49 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -53.52 155.84 2.81 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 122.015 0.912 . . . . 0.0 113.388 -177.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -53.47 179.57 0.02 OUTLIER 'General case' 0 C--O 1.232 0.163 0 CA-C-N 113.875 -1.511 . . . . 0.0 112.044 -179.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.4 p -156.56 -50.39 0.08 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.406 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -101.69 -66.87 0.79 Allowed Glycine 0 CA--C 1.522 0.507 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 178.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -122.69 157.46 32.21 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.726 0.298 . . . . 0.0 110.34 179.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -79.85 141.64 35.98 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.798 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.42 145.84 36.93 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.332 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -128.95 144.27 51.13 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.268 0.556 . . . . 0.0 111.062 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 18.8 t-105 -100.67 155.7 17.74 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.797 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -164.56 151.3 11.07 Favored 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 119.774 -0.77 . . . . 0.0 111.913 -179.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.559 HD13 ' N ' ' A' ' 41' ' ' GLY . 0.5 OUTLIER -129.32 116.63 19.37 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.057 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.559 ' N ' HD13 ' A' ' 40' ' ' LEU . . . 66.85 19.07 69.23 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -178.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.13 4.11 84.43 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.966 -0.853 . . . . 0.0 110.966 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.2 t -111.02 128.38 25.41 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-O 119.491 -0.29 . . . . 0.0 110.478 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -57.76 144.96 92.26 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 121.094 1.196 . . . . 0.0 111.284 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.821 ' H ' HD23 ' A' ' 45' ' ' LEU . 1.1 pt? -130.42 149.69 51.99 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.527 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -128.03 166.18 18.89 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.639 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.6 141.76 19.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.099 0.476 . . . . 0.0 111.377 -178.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.432 ' O ' ' O ' ' A' ' 51' ' ' ASN . 36.3 p-10 -163.3 -171.53 2.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.653 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -65.08 -46.72 79.97 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.169 -179.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 65.6 mtt -67.92 -42.91 80.36 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -179.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.432 ' O ' ' O ' ' A' ' 48' ' ' ASN . 17.5 m-20 -118.23 145.71 44.8 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 120.784 0.326 . . . . 0.0 111.458 -179.033 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 48' ' ' ASN . 98.2 m-20 -138.47 108.94 6.52 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.088 178.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.8 pt -101.23 134.61 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.472 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.7 t -139.11 155.46 47.87 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.872 0.368 . . . . 0.0 111.176 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.417 ' O ' HG23 ' A' ' 55' ' ' VAL . 35.5 m -120.14 129.14 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.158 -179.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.435 ' N ' ' OE2' ' A' ' 56' ' ' GLU . 56.7 mp0 -124.62 179.53 4.92 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.332 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 58.9 tp60 -48.93 147.52 2.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.199 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.48 14.72 80.79 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 111.542 -0.623 . . . . 0.0 111.542 179.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.471 HG21 ' O ' ' A' ' 28' ' ' LEU . 2.2 m 61.96 38.33 14.38 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 120.989 0.423 . . . . 0.0 110.266 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 49.3 mt -83.18 129.62 35.03 Favored 'General case' 0 CA--C 1.527 0.064 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.434 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 59.6 m170 -108.68 153.48 23.37 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.0 tp -154.83 116.77 4.17 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.225 -178.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.458 ' CD1' ' N ' ' A' ' 63' ' ' LEU . 7.2 mp -97.43 121.01 38.83 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 23.6 m -108.33 107.11 17.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.396 0.617 . . . . 0.0 109.665 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.423 ' CD2' ' N ' ' A' ' 65' ' ' LEU . 1.5 mm? -92.78 130.53 38.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.873 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.569 ' CG ' ' H ' ' A' ' 67' ' ' LYS . 1.5 t-80 -83.25 -150.9 0.1 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.406 -179.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.569 ' H ' ' CG ' ' A' ' 66' ' ' HIS . 13.9 ptpt -60.38 95.92 0.04 OUTLIER 'General case' 0 N--CA 1.461 0.102 0 CA-C-O 121.253 0.549 . . . . 0.0 110.337 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.5 m -96.78 133.98 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 121.302 0.572 . . . . 0.0 110.939 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 27.5 p -88.35 -152.89 0.23 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.202 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.4 mp -61.97 -23.56 66.46 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.7 tp10 -66.58 -1.72 3.99 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.098 -0.956 . . . . 0.0 110.142 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -54.74 -44.35 73.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.112 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.48 129.83 40.33 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -175.6 143.82 6.84 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.402 HG23 ' NE2' ' A' ' 88' ' ' GLN . 53.1 m -97.01 125.6 41.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.755 0.312 . . . . 0.0 110.873 -179.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.6 t -101.61 126.49 55.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 47.5 t -124.27 140.91 52.51 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.963 0.411 . . . . 0.0 110.485 -179.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -146.9 154.59 41.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.023 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 19.6 p80 -150.69 149.19 29.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.071 0.463 . . . . 0.0 110.55 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.541 ' O ' ' N ' ' A' ' 82' ' ' THR . 4.0 p -146.38 88.16 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.089 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 80' ' ' VAL . . . 30.75 -85.93 0.01 OUTLIER Glycine 0 CA--C 1.53 1.001 0 CA-C-N 115.487 -0.778 . . . . 0.0 112.462 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.541 ' N ' ' O ' ' A' ' 80' ' ' VAL . 25.3 p -39.11 -85.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -179.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.459 ' SG ' ' N ' ' A' ' 84' ' ' SER . 33.1 t -105.65 167.69 9.6 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.043 0.449 . . . . 0.0 111.862 -178.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.459 ' N ' ' SG ' ' A' ' 83' ' ' CYS . 35.3 t -151.11 145.81 25.72 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.265 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 46.9 t -158.09 172.13 18.98 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.072 0.463 . . . . 0.0 111.151 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -144.2 162.76 35.51 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.492 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -134.08 156.3 48.51 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.079 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.444 ' O ' ' OD1' ' A' ' 13' ' ' ASP . 98.9 mm-40 -118.59 135.97 54.13 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.823 0.344 . . . . 0.0 111.367 -179.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.497 HD23 ' C ' ' A' ' 89' ' ' LEU . 2.2 tt -115.27 109.64 18.24 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.495 ' N ' HD23 ' A' ' 89' ' ' LEU . 32.5 mmtp -105.66 160.76 14.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.005 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.4 m -117.89 127.35 75.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 120.934 0.397 . . . . 0.0 110.231 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 85.9 m . . . . . 0 N--CA 1.47 0.556 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.101 -179.322 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 . . . . . 0 CA--C 1.527 0.071 0 CA-C-O 121.048 0.452 . . . . 0.0 110.514 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.465 ' O ' HG13 ' A' ' 5' ' ' VAL . 8.7 p -62.04 132.46 27.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.796 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -111.54 122.04 46.77 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 179.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 76.9 mt -105.1 118.57 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-O 121.755 0.788 . . . . 0.0 111.804 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.9 mt -127.3 75.77 1.61 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.485 -1.234 . . . . 0.0 108.049 178.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.505 ' OE1' ' CE2' ' A' ' 78' ' ' PHE . 35.7 tt0 -114.97 92.83 32.28 Favored Pre-proline 0 N--CA 1.467 0.4 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.984 -177.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.53 ' O ' ' N ' ' A' ' 12' ' ' GLN . 2.6 Cg_endo -75.29 -6.59 18.04 Favored 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 122.042 1.828 . . . . 0.0 111.035 178.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 63.6 mt -60.91 72.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.191 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.53 ' N ' ' O ' ' A' ' 10' ' ' PRO . 70.9 tp60 -74.9 -64.1 1.12 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.124 -179.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.7 p-10 -170.29 133.87 1.13 Allowed 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 120.446 -0.501 . . . . 0.0 111.486 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.5 m -134.65 159.73 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.793 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -135.58 117.14 14.85 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.386 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 81.2 mt -121.2 132.64 54.95 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.439 -179.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.7 m -69.68 158.69 34.87 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.817 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.42 ' OE2' ' O ' ' A' ' 68' ' ' VAL . 52.5 tp10 -58.31 146.37 34.59 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.612 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.7 1.13 80.85 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.497 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -110.23 146.55 35.42 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.893 0.378 . . . . 0.0 110.562 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 52.6 p-10 -82.33 170.53 15.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.053 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -148.12 152.39 37.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.173 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 95.9 p -152.01 123.13 7.63 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.072 0.463 . . . . 0.0 111.048 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -103.82 119.51 39.06 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.453 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -131.52 133.44 45.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.948 0.404 . . . . 0.0 109.958 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 8.4 p -151.59 151.7 31.9 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.107 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 85.2 mtt85 -96.68 132.34 42.44 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.875 179.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.516 ' C ' HD23 ' A' ' 28' ' ' LEU . 2.9 tt -144.88 106.02 4.19 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.692 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.6 m -62.04 150.83 37.05 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.804 0.335 . . . . 0.0 110.432 179.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -56.33 156.13 6.19 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.528 0.68 . . . . 0.0 112.581 -178.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.78 -174.71 3.53 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.705 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 27.0 m -154.21 -43.93 0.09 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -86.76 -74.16 1.28 Allowed Glycine 0 CA--C 1.521 0.463 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 178.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.454 ' CD ' ' N ' ' A' ' 34' ' ' GLN . 25.4 mp0 -121.98 132.29 54.45 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.924 0.392 . . . . 0.0 110.994 179.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -77.28 150.41 35.3 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.835 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.14 147.31 38.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.643 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 45.8 mmm-85 -115.12 137.16 52.33 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.771 0.32 . . . . 0.0 111.225 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 1.8 t-105 -101.79 140.51 35.98 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.013 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -176.38 163.88 2.55 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.119 -179.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.62 HD23 ' H ' ' A' ' 40' ' ' LEU . 1.6 pt? -139.66 129.52 24.76 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.246 0.546 . . . . 0.0 110.467 178.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.58 7.03 78.65 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.84 -17.04 58.82 Favored Glycine 0 CA--C 1.529 0.969 0 N-CA-C 111.937 -0.465 . . . . 0.0 111.937 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.1 t -101.55 123.07 45.62 Favored Pre-proline 0 CA--C 1.541 0.633 0 CA-C-N 116.905 0.352 . . . . 0.0 110.37 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -58.69 138.01 83.33 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 CA-C-N 119.875 0.991 . . . . 0.0 111.204 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.0 -174.96 4.18 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.095 0.474 . . . . 0.0 110.551 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.492 ' O ' ' N ' ' A' ' 48' ' ' ASN . 2.6 pm0 -139.06 154.92 48.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.185 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.95 70.33 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.616 -0.433 . . . . 0.0 110.389 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.492 ' N ' ' O ' ' A' ' 46' ' ' GLN . 18.4 t-20 -68.84 157.73 35.9 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.748 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.467 ' N ' ' OD1' ' A' ' 48' ' ' ASN . 86.1 tt0 -55.74 -44.6 77.72 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.246 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 5.4 ptt? -69.31 -35.54 76.08 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 120.907 0.384 . . . . 0.0 110.18 179.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.446 ' O ' ' O ' ' A' ' 48' ' ' ASN . 41.7 m-20 -116.47 104.64 11.64 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.136 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.419 ' OD2' ' O ' ' A' ' 48' ' ' ASN . 96.7 m-20 -107.97 138.1 44.82 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.704 0.288 . . . . 0.0 110.46 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.3 mt -117.98 129.81 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.312 -0.404 . . . . 0.0 109.995 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.1 t -142.38 146.78 35.29 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.02 0.438 . . . . 0.0 111.137 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 51.5 t -122.48 132.17 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.417 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -121.94 177.08 5.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.292 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -42.84 151.45 0.13 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.343 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.12 20.6 80.01 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.454 ' OG1' ' O ' ' A' ' 28' ' ' LEU . 62.8 p 47.62 38.3 8.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.086 0.47 . . . . 0.0 110.444 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 94.6 mt -75.73 138.72 41.45 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.31 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -108.18 148.31 30.09 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.032 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 53.9 tp -160.49 101.19 1.35 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.043 0.449 . . . . 0.0 110.501 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.439 HD12 ' N ' ' A' ' 64' ' ' THR . 4.8 tp -100.24 109.78 22.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.591 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.439 ' N ' HD12 ' A' ' 63' ' ' LEU . 2.9 p -86.14 112.08 20.96 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.238 0.542 . . . . 0.0 110.715 -179.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 55.5 tp -111.58 123.71 50.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.183 179.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.519 ' CG ' ' N ' ' A' ' 67' ' ' LYS . 78.3 t60 -145.67 167.94 21.9 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.993 0.425 . . . . 0.0 111.043 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.519 ' N ' ' CG ' ' A' ' 66' ' ' HIS . 72.0 tttt 56.77 57.06 4.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.443 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.42 ' O ' ' OE2' ' A' ' 18' ' ' GLU . 5.7 m -93.7 174.28 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 121.838 0.828 . . . . 0.0 111.544 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.491 ' C ' ' H ' ' A' ' 71' ' ' GLU . 4.4 t -137.89 157.22 46.85 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.121 -1.399 . . . . 0.0 108.216 178.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 67.8 mt -52.55 -5.96 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.521 -0.472 . . . . 0.0 111.202 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.491 ' H ' ' C ' ' A' ' 69' ' ' THR . 80.2 mm-40 -113.82 2.41 15.12 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.437 ' O ' ' O ' ' A' ' 73' ' ' ALA . 24.9 t70 -63.14 -52.71 61.41 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.673 -179.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.437 ' O ' ' O ' ' A' ' 72' ' ' ASP . . . 42.96 -167.81 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 -179.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 157.34 95.01 0.1 Allowed Glycine 0 CA--C 1.524 0.645 0 C-N-CA 120.404 -0.903 . . . . 0.0 112.351 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 40.6 p -90.74 94.54 9.72 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 178.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.0 t -76.87 152.09 5.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.18 0.514 . . . . 0.0 111.128 -179.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 33.9 t -153.64 151.63 29.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.3 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.505 ' CE2' ' OE1' ' A' ' 9' ' ' GLU . 64.6 m-85 -131.62 144.59 51.16 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.029 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -143.47 116.0 8.61 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.582 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.535 ' O ' ' N ' ' A' ' 82' ' ' THR . 5.6 p -129.38 135.0 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.739 178.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -38.01 -21.4 0.01 OUTLIER Glycine 0 CA--C 1.527 0.79 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.674 -178.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.535 ' N ' ' O ' ' A' ' 80' ' ' VAL . 82.7 p -85.19 -74.5 0.4 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.891 0.377 . . . . 0.0 111.14 -179.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.505 ' H ' HG13 ' A' ' 80' ' ' VAL . 60.4 m -128.08 -166.6 1.64 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.416 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 87.8 p -157.1 162.78 39.44 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.761 0.315 . . . . 0.0 110.93 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.9 p -152.9 166.99 30.6 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.904 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -141.97 155.98 45.46 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.147 0.499 . . . . 0.0 111.945 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.99 153.58 33.21 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.413 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -133.93 137.27 44.78 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.585 0.707 . . . . 0.0 112.328 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.7 tp -111.03 116.61 31.46 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.551 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -118.85 164.03 16.02 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.001 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.6 m -123.9 128.25 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 120.997 0.427 . . . . 0.0 110.386 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 23.3 m . . . . . 0 C--N 1.331 -0.203 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.82 -179.51 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 . . . . . 0 CA--C 1.521 -0.135 0 CA-C-O 121.297 0.57 . . . . 0.0 110.967 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.738 HG23 ' O ' ' A' ' 29' ' ' SER . 8.9 p -55.18 131.7 18.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.368 -0.833 . . . . 0.0 108.757 178.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 13.6 m -81.56 123.53 28.73 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 119.482 -0.887 . . . . 0.0 109.442 -179.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.8 mt -108.84 118.26 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 121.582 0.706 . . . . 0.0 112.673 -178.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 85.2 mt -126.31 111.11 14.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.466 -1.243 . . . . 0.0 107.947 177.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.537 ' N ' ' OE1' ' A' ' 9' ' ' GLU . 1.6 pm0 -122.96 88.5 50.76 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.318 -178.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -74.58 -8.51 20.6 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 122.068 1.846 . . . . 0.0 110.677 178.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.406 HD21 ' H ' ' A' ' 25' ' ' GLN . 67.3 mt -68.83 81.75 0.29 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.692 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -71.89 -58.79 3.15 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.786 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 14' ' ' VAL . 62.4 t0 -175.27 137.63 0.4 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.065 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.529 ' N ' ' OD1' ' A' ' 13' ' ' ASP . 28.4 m -137.54 156.52 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-O 121.11 0.481 . . . . 0.0 111.48 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -123.0 132.22 54.04 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.884 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.422 HD22 ' HB2' ' A' ' 22' ' ' ALA . 59.6 mt -120.54 123.73 43.61 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.476 -178.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.8 t -74.84 145.34 42.9 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 177.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -59.38 137.8 57.87 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.348 -179.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.98 -0.47 72.8 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -114.62 133.14 56.06 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.85 0.357 . . . . 0.0 110.763 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.409 ' C ' ' OD2' ' A' ' 21' ' ' ASP . 54.9 p30 -78.86 172.06 14.29 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.434 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.422 ' HB2' HD22 ' A' ' 16' ' ' LEU . . . -159.92 173.18 16.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.023 0.44 . . . . 0.0 111.263 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 29.0 p -154.67 162.29 41.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.502 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -127.93 152.55 47.74 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.022 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.406 ' H ' HD21 ' A' ' 11' ' ' LEU . 61.8 tt0 -130.58 130.06 43.56 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.473 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.466 ' SG ' ' N ' ' A' ' 27' ' ' ARG . 48.5 t -141.89 164.6 29.74 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.412 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.466 ' N ' ' SG ' ' A' ' 26' ' ' CYS . 95.7 mtt180 -140.95 121.19 13.86 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.951 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 86.0 mt -126.39 103.05 7.42 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.842 179.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.738 ' O ' HG23 ' A' ' 5' ' ' VAL . 25.1 t -63.52 170.03 3.44 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -52.62 140.21 23.85 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.378 0.609 . . . . 0.0 111.689 -178.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -91.42 -172.66 3.34 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.21 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 38.0 t -150.58 -60.26 0.19 Allowed 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -72.69 -90.13 0.13 Allowed Glycine 0 CA--C 1.521 0.45 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -123.56 143.33 50.27 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.935 0.397 . . . . 0.0 110.963 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -79.35 151.32 31.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.328 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.416 ' CB ' HG22 ' A' ' 80' ' ' VAL . . . -72.74 155.69 39.71 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.427 179.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -125.45 133.57 52.4 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.19 0.519 . . . . 0.0 111.306 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 1.5 t-105 -76.8 156.86 31.98 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.813 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -169.61 152.64 4.74 Favored 'General case' 0 N--CA 1.461 0.119 0 C-N-CA 119.716 -0.794 . . . . 0.0 111.959 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.61 HD13 ' C ' ' A' ' 40' ' ' LEU . 2.4 tm? -125.5 117.32 23.37 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.572 ' N ' HD13 ' A' ' 40' ' ' LEU . . . 82.2 4.1 90.33 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 -179.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 102.62 -9.88 55.8 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.803 -0.519 . . . . 0.0 111.803 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.5 m -107.82 155.3 40.13 Favored Pre-proline 0 N--CA 1.47 0.562 0 CA-C-N 117.08 0.44 . . . . 0.0 110.545 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -68.45 154.77 71.13 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 121.392 1.394 . . . . 0.0 112.258 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.475 HD12 ' C ' ' A' ' 45' ' ' LEU . 0.4 OUTLIER -130.48 -175.87 3.78 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.163 179.419 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.561 ' O ' ' N ' ' A' ' 48' ' ' ASN . 50.1 tt0 -141.95 149.74 40.51 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 179.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -50.14 82.64 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.947 0.404 . . . . 0.0 111.204 -179.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.561 ' N ' ' O ' ' A' ' 46' ' ' GLN . 52.3 t30 -81.03 162.17 23.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.372 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -57.77 -45.53 85.82 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.211 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 66.6 mtt -66.13 -38.35 87.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.819 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.452 ' O ' ' O ' ' A' ' 48' ' ' ASN . 79.4 m-20 -108.91 111.27 22.88 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.522 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -105.26 145.42 30.69 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 33.1 mt -125.0 129.85 73.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 90.2 m -124.69 131.74 53.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.601 -179.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 63.8 t -111.99 131.9 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.166 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.436 ' O ' ' O ' ' A' ' 57' ' ' GLN . 75.6 tt0 -137.09 156.77 47.97 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.911 -179.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.436 ' O ' ' O ' ' A' ' 56' ' ' GLU . 6.8 pt20 -41.58 165.87 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.952 0.406 . . . . 0.0 111.201 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.23 16.75 71.43 Favored Glycine 0 CA--C 1.517 0.16 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 70.7 p 52.23 31.31 9.0 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.26 -0.47 . . . . 0.0 110.048 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 22.9 mt -72.96 129.69 38.68 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.608 179.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 81.0 m80 -112.85 149.5 33.02 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.819 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 54.1 tp -151.16 106.49 3.34 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 120.809 -0.357 . . . . 0.0 111.126 -179.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -87.44 105.7 17.46 Favored 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.1 m -91.99 107.35 19.15 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.297 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 39.5 tp -97.77 110.42 22.99 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.503 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.426 ' O ' ' O ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -91.85 144.11 25.82 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.817 -179.828 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.426 ' O ' ' O ' ' A' ' 66' ' ' HIS . 99.2 mttt 41.76 96.85 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.09 179.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.9 p -75.28 156.12 6.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.073 0.464 . . . . 0.0 110.905 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.7 m -134.61 156.64 48.36 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.095 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 70.6 mt -56.56 -24.65 48.59 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -74.27 -6.32 47.28 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.044 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -60.48 -39.11 86.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.815 0.34 . . . . 0.0 110.754 -179.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -44.27 126.25 5.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.71 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -178.75 -150.52 8.89 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.459 HG23 ' O ' ' A' ' 87' ' ' ALA . 10.0 m -150.46 106.52 3.45 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 110.336 -0.246 . . . . 0.0 110.336 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.8 t -83.06 133.27 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.1 p -151.62 164.13 37.56 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.16 0.505 . . . . 0.0 111.338 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -141.9 146.53 35.84 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.517 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -119.28 129.29 54.82 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.192 0.52 . . . . 0.0 111.526 -179.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.531 ' C ' ' H ' ' A' ' 82' ' ' THR . 2.0 t -120.68 132.24 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.032 179.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -50.32 -6.72 0.11 Allowed Glycine 0 CA--C 1.529 0.925 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.408 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.531 ' H ' ' C ' ' A' ' 80' ' ' VAL . 6.4 p -102.8 -52.0 3.17 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.737 0.303 . . . . 0.0 110.194 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -152.8 161.6 42.35 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.946 179.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 40.1 t -135.54 143.19 45.58 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.935 0.398 . . . . 0.0 111.001 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 67.1 m -134.13 160.16 38.64 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.46 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.491 ' N ' ' OE2' ' A' ' 86' ' ' GLU . 57.9 mp0 -130.88 156.14 45.55 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.785 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.459 ' O ' HG23 ' A' ' 75' ' ' THR . . . -134.53 142.65 47.07 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.203 179.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.484 ' CD ' ' N ' ' A' ' 88' ' ' GLN . 14.7 mp0 -106.93 127.29 53.3 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.434 0.635 . . . . 0.0 111.955 -178.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.582 HD23 ' C ' ' A' ' 89' ' ' LEU . 4.6 tt -119.69 114.15 21.74 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.164 179.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.54 ' N ' HD23 ' A' ' 89' ' ' LEU . 23.2 mtmm -109.93 154.03 23.68 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.528 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.8 t -119.42 131.34 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.9 m . . . . . 0 C--N 1.33 -0.267 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.931 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 . . . . . 0 N--CA 1.464 0.259 0 CA-C-O 120.733 0.302 . . . . 0.0 110.72 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.61 HG22 ' HA ' ' A' ' 31' ' ' ALA . 2.8 t -61.01 133.14 26.8 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.455 ' H ' ' HB2' ' A' ' 29' ' ' SER . 9.0 m -111.94 131.46 55.37 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.842 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.407 HD11 HG11 ' A' ' 80' ' ' VAL . 2.4 mt -120.41 124.08 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 120.959 0.409 . . . . 0.0 111.905 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.431 ' HA ' HD22 ' A' ' 8' ' ' LEU . 0.2 OUTLIER -130.46 89.93 2.85 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.271 177.845 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -121.53 83.3 41.02 Favored Pre-proline 0 N--CA 1.469 0.524 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.221 -179.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -73.92 -10.48 23.08 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.215 1.943 . . . . 0.0 111.57 179.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.472 ' CD2' ' H ' ' A' ' 25' ' ' GLN . 0.3 OUTLIER -91.75 55.14 2.63 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.194 0.521 . . . . 0.0 109.908 179.759 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -80.48 -1.19 40.62 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.418 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -151.67 109.39 3.65 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 43.0 t -120.41 133.87 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.017 -178.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -135.07 100.32 4.53 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.961 0.41 . . . . 0.0 110.961 179.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 66.2 mt -115.78 139.98 49.65 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.458 -179.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 85.3 p -74.58 165.68 24.81 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.767 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -69.23 146.41 52.37 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.011 0.434 . . . . 0.0 110.523 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.08 1.33 89.67 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 70.7 tp60 -105.34 148.34 27.17 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.614 0.245 . . . . 0.0 110.48 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 21' ' ' ASP . 54.8 p30 -76.29 153.82 35.61 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.79 147.58 37.52 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.97 -179.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.4 m -163.09 171.23 16.71 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.715 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -128.36 143.7 51.04 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.472 ' H ' ' CD2' ' A' ' 11' ' ' LEU . 88.0 mt-30 -139.19 119.7 13.97 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.723 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 9.7 p -152.04 163.89 38.37 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.418 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -102.05 137.06 40.82 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.419 ' C ' HD13 ' A' ' 28' ' ' LEU . 0.3 OUTLIER -140.52 95.68 2.91 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.978 -179.774 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.455 ' HB2' ' H ' ' A' ' 6' ' ' THR . 69.1 m -59.25 152.27 21.17 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.006 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -54.41 156.02 3.57 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -177.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.61 ' HA ' HG22 ' A' ' 5' ' ' VAL . . . -73.29 -178.71 3.06 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 114.606 -1.179 . . . . 0.0 112.123 -179.233 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 89.6 p -156.71 -52.05 0.08 Allowed 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.223 -0.898 . . . . 0.0 109.713 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -97.29 -65.4 0.9 Allowed Glycine 0 CA--C 1.524 0.648 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 179.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.446 ' HB2' ' H ' ' A' ' 81' ' ' GLY . 87.1 mt-30 -124.03 152.11 42.99 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -86.18 135.91 33.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.952 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.2 152.71 34.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.513 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -147.05 146.93 30.16 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.163 0.506 . . . . 0.0 111.739 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -81.48 179.64 7.76 Favored 'General case' 0 CA--C 1.521 -0.139 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.607 179.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.649 ' HB3' ' O ' ' A' ' 77' ' ' SER . . . -165.74 131.6 2.56 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.202 179.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 53.1 tp -133.89 123.35 24.58 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.012 179.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.31 8.83 80.53 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.08 -17.31 58.87 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.4 m -112.16 147.48 37.05 Favored Pre-proline 0 CA--C 1.535 0.381 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -52.39 140.7 52.79 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 121.301 1.334 . . . . 0.0 111.042 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.432 ' H ' ' CD2' ' A' ' 45' ' ' LEU . 0.9 OUTLIER -78.44 168.69 19.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.909 0.385 . . . . 0.0 110.874 -179.546 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -131.38 142.11 49.99 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.716 -179.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.42 62.89 1.02 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.796 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.459 ' O ' ' O ' ' A' ' 51' ' ' ASN . 97.3 m-20 -74.69 159.53 31.94 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -40.86 -36.49 0.64 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 120.681 -0.407 . . . . 0.0 111.359 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 94.4 mtp -64.55 -43.57 93.54 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.782 0.325 . . . . 0.0 111.117 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.463 ' O ' ' OD2' ' A' ' 52' ' ' ASP . 70.9 m-80 -100.26 149.97 23.04 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.469 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.463 ' OD2' ' O ' ' A' ' 51' ' ' ASN . 84.4 m-20 -140.21 98.51 3.45 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.888 0.375 . . . . 0.0 110.634 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.7 mt -85.72 128.1 39.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.516 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.3 t -140.03 152.22 46.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.987 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.1 t -119.88 130.12 74.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.05 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -126.18 -174.95 3.23 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.405 -179.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -54.3 152.06 6.74 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.858 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.65 26.47 74.42 Favored Glycine 0 CA--C 1.52 0.394 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.414 ' OG1' ' O ' ' A' ' 28' ' ' LEU . 17.8 p 48.33 29.07 1.81 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.762 0.315 . . . . 0.0 110.681 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 23.5 mt -69.32 131.9 45.57 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.278 0.561 . . . . 0.0 111.006 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 64.2 m80 -110.34 149.29 30.43 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.721 178.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.552 ' C ' HD23 ' A' ' 62' ' ' LEU . 7.0 tt -156.53 102.72 2.08 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.196 -178.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.35 106.97 19.07 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 177.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.454 ' OG1' ' CD2' ' A' ' 62' ' ' LEU . 15.9 m -88.31 113.11 23.59 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.023 0.439 . . . . 0.0 111.36 -178.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.0 tt -101.67 122.1 43.26 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.658 ' NE2' ' NZ ' ' A' ' 67' ' ' LYS . 56.0 t60 -85.28 132.26 34.29 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.263 0.554 . . . . 0.0 112.228 -178.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.658 ' NZ ' ' NE2' ' A' ' 66' ' ' HIS . 52.5 mttp 39.62 83.44 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.039 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.7 p -54.29 162.08 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.014 0.435 . . . . 0.0 110.649 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.45 ' H ' ' HB2' ' A' ' 72' ' ' ASP . 28.5 p -137.26 165.27 26.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.447 179.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.468 HD22 ' N ' ' A' ' 70' ' ' LEU . 4.1 mm? -60.95 -38.14 84.82 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -67.54 -36.62 81.34 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.896 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.45 ' HB2' ' H ' ' A' ' 69' ' ' THR . 44.3 m-20 -63.98 -36.81 85.19 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.789 -178.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.28 141.65 55.8 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.559 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -176.39 -165.02 31.41 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 57.7 m -98.93 123.39 43.18 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.627 0.251 . . . . 0.0 110.509 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.1 m -105.37 149.74 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.623 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.649 ' O ' ' HB3' ' A' ' 39' ' ' ALA . 51.7 p -159.47 158.23 31.59 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.678 0.275 . . . . 0.0 110.738 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.406 ' CD1' ' C ' ' A' ' 78' ' ' PHE . 45.3 p90 -143.16 157.35 44.59 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 69.8 m80 -142.87 139.66 30.93 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.245 0.545 . . . . 0.0 111.827 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.534 ' O ' ' N ' ' A' ' 82' ' ' THR . 3.2 p -144.12 143.12 23.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.17 178.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.446 ' H ' ' HB2' ' A' ' 34' ' ' GLN . . . -42.21 -14.39 0.01 OUTLIER Glycine 0 CA--C 1.526 0.748 0 CA-C-N 116.471 -0.331 . . . . 0.0 112.854 -178.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.534 ' N ' ' O ' ' A' ' 80' ' ' VAL . 45.6 p -89.3 -72.91 0.53 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 117.081 0.441 . . . . 0.0 110.152 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.443 ' H ' HG13 ' A' ' 80' ' ' VAL . 6.7 t -139.45 -172.37 3.35 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.633 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 41.6 p -158.56 163.08 37.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.051 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 31.0 m -162.31 173.83 13.65 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.546 -0.462 . . . . 0.0 111.054 179.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.467 ' N ' ' CD ' ' A' ' 86' ' ' GLU . 1.3 pm0 -137.04 152.66 50.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.823 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -143.79 151.68 40.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.269 -0.878 . . . . 0.0 108.922 178.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -110.86 128.6 55.84 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.527 0.679 . . . . 0.0 111.933 -178.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 51.4 tp -101.02 81.69 2.28 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 114.944 -1.025 . . . . 0.0 108.765 178.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -94.55 172.35 8.24 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.3 m -116.02 141.46 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 29.0 m . . . . . 0 C--N 1.327 -0.409 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.68 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.408 ' HG3' ' N ' ' A' ' 5' ' ' VAL . 35.5 tp10 . . . . . 0 C--O 1.231 0.125 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.491 ' H ' HG13 ' A' ' 5' ' ' VAL . 1.0 OUTLIER -52.34 137.79 11.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 179.919 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.537 ' N ' ' OG ' ' A' ' 29' ' ' SER . 39.2 m -95.87 123.56 39.51 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 120.04 -0.664 . . . . 0.0 111.074 -178.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.3 mm -109.9 88.9 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.762 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.474 ' O ' ' SG ' ' A' ' 26' ' ' CYS . 55.4 mt -112.81 112.05 23.27 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 177.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -123.95 92.67 48.14 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.57 -178.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -69.25 -11.22 30.99 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 C-N-CA 121.259 1.306 . . . . 0.0 109.334 178.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.432 HD21 ' H ' ' A' ' 25' ' ' GLN . 63.7 mt -68.09 77.29 0.23 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.502 -1.226 . . . . 0.0 110.575 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 54.1 tp60 -70.66 -41.17 72.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.735 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -176.38 145.54 0.59 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.02 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.476 HG21 ' CE2' ' A' ' 24' ' ' PHE . 70.0 t -121.45 134.72 63.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.314 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -143.16 127.18 17.38 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.229 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.5 pp -162.75 144.3 10.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.861 -179.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.4 m -64.68 146.13 55.18 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -64.48 147.92 51.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.971 0.891 . . . . 0.0 112.218 -178.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.626 ' H ' ' CG1' ' A' ' 68' ' ' VAL . . . 92.75 -8.13 76.75 Favored Glycine 0 CA--C 1.521 0.466 0 CA-C-N 113.906 -1.497 . . . . 0.0 110.427 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -93.05 161.55 14.39 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 179.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -76.41 161.28 28.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.932 0.396 . . . . 0.0 110.588 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -149.39 156.89 42.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.389 -179.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.2 p -160.36 162.53 33.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.951 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.476 ' CE2' HG21 ' A' ' 14' ' ' VAL . 96.1 m-85 -133.41 147.31 51.74 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.146 0.498 . . . . 0.0 111.099 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.432 ' H ' HD21 ' A' ' 11' ' ' LEU . 89.0 mt-30 -139.0 125.48 20.5 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.424 178.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.61 ' SG ' ' N ' ' A' ' 27' ' ' ARG . 8.9 t -146.73 163.31 36.36 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.036 0.446 . . . . 0.0 110.453 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.61 ' N ' ' SG ' ' A' ' 26' ' ' CYS . 78.4 ttt-85 -120.61 119.48 33.01 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.449 ' C ' HD23 ' A' ' 28' ' ' LEU . 2.6 tt -136.15 105.76 6.14 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.551 -0.459 . . . . 0.0 110.541 -179.026 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.537 ' OG ' ' N ' ' A' ' 6' ' ' THR . 86.6 p -62.4 156.27 23.02 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 37.7 ptt-85 -50.84 160.68 0.43 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.223 -177.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.429 ' HA ' HG12 ' A' ' 5' ' ' VAL . . . -71.02 174.39 6.31 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.196 -178.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.3 t -120.35 1.94 10.77 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 151.65 -24.23 0.94 Allowed Glycine 0 N--CA 1.453 -0.184 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -121.07 119.16 31.67 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 115.416 -0.392 . . . . 0.0 110.449 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -93.71 149.99 20.78 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.123 -179.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.494 ' CB ' HG22 ' A' ' 80' ' ' VAL . . . -80.63 169.25 17.89 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.298 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.456 ' NH2' ' O ' ' A' ' 38' ' ' TRP . 9.5 ptm180 -144.21 146.06 32.46 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.42 179.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.458 ' CB ' HD11 ' A' ' 45' ' ' LEU . 81.4 m95 -78.16 176.54 9.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.813 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 77' ' ' SER . . . -164.55 107.21 0.88 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.598 179.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.532 HD13 ' N ' ' A' ' 41' ' ' GLY . 0.7 OUTLIER -116.19 114.1 23.98 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.532 ' N ' HD13 ' A' ' 40' ' ' LEU . . . 70.87 17.38 75.26 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.18 -22.19 42.17 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 18.8 m -111.94 148.73 39.62 Favored Pre-proline 0 CA--C 1.539 0.554 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -59.25 144.55 99.35 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 121.253 1.302 . . . . 0.0 111.625 -179.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.486 ' O ' HD12 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -89.69 164.77 14.57 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.085 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.436 ' O ' ' N ' ' A' ' 48' ' ' ASN . 78.3 mt-30 -135.91 155.44 50.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.978 0.418 . . . . 0.0 110.298 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.89 74.44 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.576 -179.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' A' ' 46' ' ' GLN . 98.5 m-20 -73.01 160.3 32.31 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.048 179.113 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -54.7 -49.16 71.38 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.326 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 78.4 mtm -69.38 -39.87 77.75 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.74 179.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.435 ' O ' ' O ' ' A' ' 48' ' ' ASN . 64.3 t30 -107.53 112.2 24.83 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.936 0.398 . . . . 0.0 110.975 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 53' ' ' ILE . 66.7 t0 -109.93 143.76 39.41 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.673 179.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.518 ' N ' ' OD1' ' A' ' 52' ' ' ASP . 20.6 tt -127.63 136.24 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.5 p -140.73 158.38 44.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.081 0.467 . . . . 0.0 111.551 -178.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.6 m -120.58 130.14 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.405 178.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -121.29 165.36 15.59 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.163 0.506 . . . . 0.0 111.009 -178.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -42.14 152.69 0.08 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.977 179.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.3 19.07 78.54 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' A' ' 28' ' ' LEU . 51.0 p 50.33 33.35 7.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.931 0.396 . . . . 0.0 110.376 -179.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 76.7 mt -79.32 120.56 23.96 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.714 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -83.69 142.63 30.61 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 56.1 tp -145.66 93.96 2.43 Favored 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 34.4 tp -92.91 106.97 18.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.606 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.537 ' CG2' ' NE2' ' A' ' 66' ' ' HIS . 78.0 m -96.85 98.41 10.1 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.184 -178.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.557 HD23 ' N ' ' A' ' 66' ' ' HIS . 4.0 tt -101.27 119.44 38.75 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.104 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.557 ' N ' HD23 ' A' ' 65' ' ' LEU . 54.1 m170 -112.43 154.22 26.15 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 120.772 0.32 . . . . 0.0 110.513 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 64.3 mttp 53.5 59.16 4.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.262 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.626 ' CG1' ' H ' ' A' ' 19' ' ' GLY . 1.0 OUTLIER -50.7 159.01 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.963 0.411 . . . . 0.0 110.782 -179.682 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.42 ' H ' ' HB2' ' A' ' 72' ' ' ASP . 55.0 p -133.97 167.04 21.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.313 179.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.445 HD12 ' N ' ' A' ' 70' ' ' LEU . 11.0 mp -61.78 -39.32 91.25 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -67.78 -35.55 78.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.158 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.42 ' HB2' ' H ' ' A' ' 69' ' ' THR . 98.9 m-20 -61.74 -43.03 99.65 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.197 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.27 141.15 51.75 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.374 -0.53 . . . . 0.0 109.73 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 168.28 -148.67 12.89 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.596 -0.811 . . . . 0.0 111.15 -179.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 43.6 m -110.1 125.16 52.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.709 -0.246 . . . . 0.0 110.715 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.0 t -111.76 130.58 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.52 ' O ' ' HB3' ' A' ' 39' ' ' ALA . 24.9 t -153.4 167.48 29.28 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.127 0.489 . . . . 0.0 110.764 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -146.68 150.33 35.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.066 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -128.62 140.37 51.8 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.092 0.472 . . . . 0.0 111.584 -178.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.509 ' C ' ' H ' ' A' ' 82' ' ' THR . 2.2 t -129.49 133.84 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.974 179.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -49.18 -7.48 0.07 OUTLIER Glycine 0 CA--C 1.529 0.928 0 C-N-CA 121.158 -0.544 . . . . 0.0 111.854 -179.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.509 ' H ' ' C ' ' A' ' 80' ' ' VAL . 31.0 p -107.72 -43.53 4.46 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.978 0.389 . . . . 0.0 110.932 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 14.1 t -154.2 154.62 33.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.336 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.1 m -130.61 157.1 43.66 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.984 0.421 . . . . 0.0 111.569 -179.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.404 ' O ' ' OG ' ' A' ' 77' ' ' SER . 15.8 t -154.68 157.2 37.74 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.848 -179.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -127.4 159.95 32.92 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.368 0.604 . . . . 0.0 111.706 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.49 147.57 27.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.425 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -117.66 139.6 50.78 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.346 0.593 . . . . 0.0 112.522 -178.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.512 HD23 ' C ' ' A' ' 89' ' ' LEU . 3.5 tt -119.81 106.78 12.42 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.182 -0.917 . . . . 0.0 108.597 178.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.414 ' N ' HD23 ' A' ' 89' ' ' LEU . 61.5 pttt -110.96 160.24 16.99 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.706 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.421 ' O ' HG23 ' A' ' 91' ' ' VAL . 23.7 m -110.66 131.47 61.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.886 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 98.1 m . . . . . 0 N--CA 1.467 0.387 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.271 -179.429 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 . . . . . 0 N--CA 1.463 0.198 0 CA-C-O 120.966 0.412 . . . . 0.0 110.741 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 29' ' ' SER . 0.2 OUTLIER -58.8 157.71 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 177.351 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.5 ' HB ' ' H ' ' A' ' 29' ' ' SER . 93.8 m -85.53 86.31 7.38 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 118.262 -1.375 . . . . 0.0 108.407 179.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.67 HG23 ' O ' ' A' ' 7' ' ' ILE . 10.6 tt -83.92 90.9 2.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 122.371 1.081 . . . . 0.0 112.52 -177.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 96.8 mt -127.33 83.51 2.17 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 113.457 -1.702 . . . . 0.0 109.056 178.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.446 ' C ' ' H ' ' A' ' 11' ' ' LEU . 4.8 pt-20 -122.93 83.9 50.3 Favored Pre-proline 0 N--CA 1.468 0.464 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.177 -178.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -71.93 17.51 0.32 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.189 1.926 . . . . 0.0 111.577 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.478 HD21 ' O ' ' A' ' 25' ' ' GLN . 76.6 mt -66.92 77.45 0.12 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.542 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -71.7 -70.47 0.32 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.345 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.417 ' OD2' ' N ' ' A' ' 13' ' ' ASP . 31.7 p-10 -176.72 152.41 0.99 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.336 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.9 m -135.57 161.3 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.068 -179.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -133.45 139.51 46.75 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.383 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -156.64 151.52 26.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.033 0.445 . . . . 0.0 111.417 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.8 p -80.66 168.04 19.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.639 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -64.83 141.68 58.69 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.831 0.348 . . . . 0.0 110.515 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.61 8.2 87.22 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.689 -0.564 . . . . 0.0 111.689 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 93.5 mm-40 -96.48 158.66 15.33 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.846 0.355 . . . . 0.0 110.153 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -86.04 167.54 14.92 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.05 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.493 ' HB3' HD22 ' A' ' 65' ' ' LEU . . . -161.54 157.08 24.29 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.916 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 73.6 m -163.93 159.47 20.94 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.148 -0.315 . . . . 0.0 110.148 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -128.78 147.91 50.82 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.087 0.47 . . . . 0.0 110.617 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.485 ' OE1' ' CD2' ' A' ' 62' ' ' LEU . 62.6 mm-40 -124.43 125.69 44.69 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.874 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 6.7 t -137.53 146.13 43.78 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.171 0.51 . . . . 0.0 110.701 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -125.99 100.42 6.35 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.244 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.478 ' O ' ' CG2' ' A' ' 59' ' ' THR . 91.0 mt -121.6 110.31 15.84 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.255 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.5 ' H ' ' HB ' ' A' ' 6' ' ' THR . 34.7 t -69.62 172.9 6.7 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.45 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 11.6 ptp85 -50.12 151.28 2.05 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 122.038 0.923 . . . . 0.0 113.03 -177.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.6 160.04 20.53 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 113.831 -1.531 . . . . 0.0 112.213 -178.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.9 m -138.77 -82.96 0.29 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.647 179.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -65.58 -85.9 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 178.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -123.56 155.68 37.16 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.303 0.573 . . . . 0.0 110.193 178.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 74.9 tt0 -72.99 153.47 40.92 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.239 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.72 143.6 26.81 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.075 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -108.08 141.74 39.33 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.52 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 8.7 t-105 -111.11 138.87 47.01 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -165.41 155.98 13.6 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 119.45 -0.9 . . . . 0.0 111.762 -178.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.633 ' C ' HD23 ' A' ' 40' ' ' LEU . 6.9 tt -131.27 123.57 28.65 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.941 179.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.564 ' N ' HD23 ' A' ' 40' ' ' LEU . . . 82.89 6.31 88.52 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.752 -0.539 . . . . 0.0 111.752 179.159 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 102.04 -20.34 45.84 Favored Glycine 0 N--CA 1.467 0.704 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.4 m -109.35 151.56 42.17 Favored Pre-proline 0 N--CA 1.467 0.401 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -56.79 141.78 92.34 Favored 'Trans proline' 0 C--N 1.316 -1.171 0 C-N-CA 120.939 1.092 . . . . 0.0 111.048 179.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.563 ' H ' ' CD2' ' A' ' 45' ' ' LEU . 0.8 OUTLIER -93.15 -172.46 2.97 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.14 -179.89 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 61.8 tp60 -144.93 155.7 43.57 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.262 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.14 63.7 1.33 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.44 ' O ' ' O ' ' A' ' 51' ' ' ASN . 13.3 t-20 -65.55 175.87 1.67 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.136 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -66.01 -39.72 90.48 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 78.1 mtm -67.65 -39.35 84.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.164 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.44 ' O ' ' O ' ' A' ' 48' ' ' ASN . 55.6 t30 -126.02 131.95 52.09 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.039 0.447 . . . . 0.0 111.073 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -120.02 140.57 50.77 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.551 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.4 mm -110.69 127.32 67.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.451 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.441 HG22 ' O ' ' A' ' 62' ' ' LEU . 5.0 t -145.86 156.55 43.63 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.099 0.476 . . . . 0.0 111.432 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.2 m -115.31 133.65 60.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.029 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -116.91 -177.48 3.21 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.101 0.477 . . . . 0.0 110.669 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.426 ' CD ' ' N ' ' A' ' 58' ' ' GLY . 9.8 tm0? -64.6 147.31 53.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.269 -179.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.426 ' N ' ' CD ' ' A' ' 57' ' ' GLN . . . 80.55 13.04 82.24 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.478 ' CG2' ' O ' ' A' ' 28' ' ' LEU . 1.6 m 70.4 24.53 4.63 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 121.418 0.628 . . . . 0.0 110.385 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.6 mp -79.76 138.85 37.4 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.879 179.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 58.4 m170 -111.18 130.29 55.68 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.628 HD13 ' N ' ' A' ' 63' ' ' LEU . 1.1 tm? -125.13 119.58 28.99 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 111.494 0.183 . . . . 0.0 111.494 -178.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.628 ' N ' HD13 ' A' ' 62' ' ' LEU . 6.3 mp -103.36 114.14 28.18 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 177.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 93.1 m -99.61 110.6 23.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.112 0.482 . . . . 0.0 110.746 -179.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.709 ' C ' HD23 ' A' ' 65' ' ' LEU . 7.0 tt -110.88 129.28 55.91 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.869 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.505 ' N ' HD23 ' A' ' 65' ' ' LEU . 0.8 OUTLIER -153.34 165.11 36.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.414 -179.602 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.5 mttp 42.58 86.78 0.02 OUTLIER 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.313 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.482 HG11 HD21 ' A' ' 65' ' ' LEU . 21.4 m -137.65 163.94 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.588 -178.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 33.2 p -117.77 -151.86 0.49 Allowed 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.669 179.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.506 ' C ' ' H ' ' A' ' 72' ' ' ASP . 87.1 mt -63.01 -23.71 67.58 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.675 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -56.92 -1.07 0.05 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.349 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.506 ' H ' ' C ' ' A' ' 70' ' ' LEU . 18.6 m-20 -62.73 -36.19 82.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.281 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.3 127.92 31.66 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.473 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 172.48 153.18 9.12 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.776 -0.929 . . . . 0.0 110.776 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 85.4 m -111.59 116.69 31.24 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.558 0.218 . . . . 0.0 110.958 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.2 t -91.93 128.2 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.2 p -128.24 145.45 51.04 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.043 0.449 . . . . 0.0 110.835 -179.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -156.87 155.49 31.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.421 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 40.8 p-80 -159.37 151.46 20.88 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.315 0.578 . . . . 0.0 111.911 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.544 ' O ' ' N ' ' A' ' 82' ' ' THR . 12.3 p -124.06 134.22 67.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 115.285 -0.87 . . . . 0.0 108.982 178.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -31.23 -30.01 0.01 OUTLIER Glycine 0 CA--C 1.529 0.958 0 CA-C-N 116.058 -0.519 . . . . 0.0 113.096 -178.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.544 ' N ' ' O ' ' A' ' 80' ' ' VAL . 4.5 m -76.61 -74.3 0.24 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.006 0.431 . . . . 0.0 110.92 -179.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.41 ' O ' ' O ' ' A' ' 80' ' ' VAL . 7.6 t -119.76 -170.04 1.88 Allowed 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 31.4 p -151.74 157.49 42.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.204 0.526 . . . . 0.0 110.718 179.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.4 t -167.06 151.35 6.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.827 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -146.1 156.26 43.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.054 0.454 . . . . 0.0 110.729 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -129.82 152.97 48.72 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.448 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -124.99 137.95 54.24 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.279 0.561 . . . . 0.0 111.459 -179.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.598 HD23 ' C ' ' A' ' 89' ' ' LEU . 6.3 tt -110.15 121.97 46.53 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.22 -0.9 . . . . 0.0 108.978 178.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.58 ' N ' HD23 ' A' ' 89' ' ' LEU . 17.7 ptpt -123.61 157.93 32.63 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.934 0.397 . . . . 0.0 111.367 -179.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 18.6 m -116.06 136.24 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.873 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 46.5 p . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.573 179.917 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.471 ' OE2' ' N ' ' A' ' 5' ' ' VAL . 1.3 tm-20 . . . . . 0 CA--C 1.533 0.325 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 29' ' ' SER . 1.9 p -59.23 130.31 22.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.545 HG22 ' H ' ' A' ' 8' ' ' LEU . 12.1 m -66.61 134.31 52.07 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 118.739 -1.184 . . . . 0.0 108.304 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.58 HG23 ' O ' ' A' ' 7' ' ' ILE . 2.4 tp -111.81 31.49 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -177.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.545 ' H ' HG22 ' A' ' 6' ' ' THR . 7.7 mp -81.98 90.1 6.46 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.502 ' C ' ' H ' ' A' ' 11' ' ' LEU . 1.8 pt-20 -121.3 90.5 47.6 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.032 -179.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -68.32 24.93 0.14 Allowed 'Trans proline' 0 C--N 1.314 -1.289 0 C-N-CA 121.861 1.707 . . . . 0.0 112.141 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.502 ' H ' ' C ' ' A' ' 9' ' ' GLU . 71.2 mt -81.01 72.9 8.06 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.104 0.478 . . . . 0.0 110.467 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -74.58 -67.78 0.6 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.446 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -172.26 133.57 0.67 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.357 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.1 m -123.99 142.38 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 120.924 0.392 . . . . 0.0 110.768 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.533 ' C ' HD22 ' A' ' 16' ' ' LEU . 89.5 mt-30 -129.71 112.97 14.17 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.518 -179.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.56 ' O ' HG23 ' A' ' 91' ' ' VAL . 4.5 mm? -122.92 151.32 41.89 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.36 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.2 m -72.85 155.09 40.26 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 178.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.2 tm-20 -59.5 139.43 57.13 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.832 0.348 . . . . 0.0 110.728 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.59 -1.41 87.17 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.891 179.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 23.0 mm100 -91.83 168.55 11.36 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.91 0.386 . . . . 0.0 110.725 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -84.3 164.15 19.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.255 179.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -153.27 153.27 32.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.785 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 28.2 p -156.43 159.13 38.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.921 0.391 . . . . 0.0 110.552 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -132.3 147.1 52.39 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.292 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.404 ' O ' HD21 ' A' ' 11' ' ' LEU . 52.5 tt0 -137.37 121.75 18.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.09 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 37.3 t -129.63 129.82 44.82 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.98 0.419 . . . . 0.0 111.053 -179.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.01 108.38 21.05 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.044 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.447 ' O ' ' OG1' ' A' ' 59' ' ' THR . 74.3 mt -122.38 129.81 52.48 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.537 178.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.568 ' O ' HG23 ' A' ' 5' ' ' VAL . 68.6 m -94.32 175.86 6.53 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 -56.67 138.56 52.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.361 0.6 . . . . 0.0 111.208 -179.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -79.27 -176.1 5.01 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.415 -179.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.42 ' OG ' ' N ' ' A' ' 33' ' ' GLY . 82.5 p -146.23 -62.04 0.31 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.711 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.42 ' N ' ' OG ' ' A' ' 32' ' ' SER . . . -93.82 -71.08 1.14 Allowed Glycine 0 CA--C 1.522 0.506 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 179.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 96.5 mm-40 -122.75 135.15 54.47 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.386 0.612 . . . . 0.0 111.78 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -86.75 145.41 26.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.072 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.477 ' CB ' HG22 ' A' ' 80' ' ' VAL . . . -70.45 147.63 49.24 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.5 mmt85 -102.52 143.68 31.92 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 20.9 t-105 -102.3 131.43 48.9 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.414 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -172.7 152.81 2.6 Favored 'General case' 0 C--O 1.226 -0.179 0 C-N-CA 119.608 -0.837 . . . . 0.0 112.447 -179.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.62 ' C ' HD23 ' A' ' 40' ' ' LEU . 6.7 tt -125.87 121.16 32.42 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.046 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.525 ' N ' HD23 ' A' ' 40' ' ' LEU . . . 88.23 -2.99 85.58 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -178.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.28 1.07 58.15 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 112.167 -0.373 . . . . 0.0 112.167 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.7 m -111.59 148.28 38.52 Favored Pre-proline 0 N--CA 1.471 0.603 0 CA-C-N 117.146 0.473 . . . . 0.0 110.709 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -49.85 138.72 33.75 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 121.631 1.554 . . . . 0.0 111.308 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.8 tp -86.62 163.19 17.55 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.899 -178.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -140.41 147.76 40.2 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.62 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.13 62.98 0.67 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.866 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.522 ' OD1' ' N ' ' A' ' 49' ' ' GLU . 60.1 t-20 -66.62 142.62 57.4 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.043 0.449 . . . . 0.0 111.033 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.522 ' N ' ' OD1' ' A' ' 48' ' ' ASN . 74.9 mm-40 -40.07 -42.05 1.35 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.093 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 74.1 mtm -65.99 -39.28 90.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.636 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.514 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 0.6 OUTLIER -112.27 125.88 54.64 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.123 -178.805 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.49 ' OD2' ' N ' ' A' ' 53' ' ' ILE . 56.5 t0 -109.28 154.09 22.95 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.49 ' N ' ' OD2' ' A' ' 52' ' ' ASP . 64.4 mt -137.11 129.22 43.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.9 p -130.86 148.87 52.69 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.035 0.445 . . . . 0.0 110.755 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.0 p -125.34 128.44 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.348 -179.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.454 ' O ' ' O ' ' A' ' 57' ' ' GLN . 96.3 mt-10 -126.82 -173.12 2.8 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.841 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.454 ' O ' ' O ' ' A' ' 56' ' ' GLU . 97.8 mm-40 -28.24 152.12 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.368 -179.123 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.427 ' C ' ' OG1' ' A' ' 59' ' ' THR . . . 58.8 -82.75 0.01 OUTLIER Glycine 0 CA--C 1.521 0.454 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 179.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER 175.68 51.29 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.83 0.824 . . . . 0.0 109.134 179.912 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 42.8 mt -80.16 135.93 36.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.95 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -113.76 145.74 40.94 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.522 ' C ' HD23 ' A' ' 62' ' ' LEU . 3.2 tt -153.59 110.94 3.48 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.643 -179.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.486 ' N ' HD23 ' A' ' 62' ' ' LEU . 7.8 mp -97.02 128.86 44.4 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 120.969 0.414 . . . . 0.0 110.804 179.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.9 m -108.71 103.22 12.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.544 179.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.431 ' CD2' ' N ' ' A' ' 65' ' ' LEU . 3.1 mm? -96.06 126.68 41.46 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.132 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.478 ' ND1' ' N ' ' A' ' 67' ' ' LYS . 12.0 t-80 -138.61 160.49 39.47 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.235 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.478 ' N ' ' ND1' ' A' ' 66' ' ' HIS . 70.9 mmtt 57.21 41.54 26.8 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.4 p -94.88 134.95 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.106 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.431 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 44.7 p -122.27 -151.01 0.46 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.102 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.589 ' C ' ' H ' ' A' ' 72' ' ' ASP . 86.0 mt -45.9 -27.4 0.87 Allowed 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.34 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -64.28 13.07 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.725 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.589 ' H ' ' C ' ' A' ' 70' ' ' LEU . 5.1 m-20 -60.34 -35.77 76.42 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.048 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -52.31 138.3 26.97 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.148 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -171.53 173.66 44.95 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 17.1 p -154.43 104.39 2.57 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 110.453 -0.203 . . . . 0.0 110.453 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.2 t -94.89 132.68 38.22 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 CA-C-O 121.147 0.499 . . . . 0.0 110.125 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 11.0 t -132.85 152.47 51.83 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.356 -179.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -127.25 133.67 50.17 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.515 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -114.88 109.86 18.78 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.464 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.477 HG22 ' CB ' ' A' ' 36' ' ' ALA . 1.4 t -115.89 129.35 72.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -57.07 -7.08 2.25 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.922 -178.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.15 -43.65 4.12 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 117.064 0.432 . . . . 0.0 110.915 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 59.7 m -137.38 172.69 12.61 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.9 0.381 . . . . 0.0 111.387 -179.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 87.7 p -133.93 156.42 48.16 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.392 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.8 p -156.73 160.06 38.93 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.989 0.424 . . . . 0.0 111.065 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -143.95 157.7 44.18 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.747 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -142.85 146.82 34.5 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.828 179.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -120.63 130.15 54.03 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.382 0.61 . . . . 0.0 112.255 -178.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 48.0 tp -114.89 119.2 35.76 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 114.992 -1.003 . . . . 0.0 108.822 178.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -133.25 156.64 47.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.216 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 16' ' ' LEU . 8.6 p -117.16 133.39 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.0 t . . . . . 0 C--N 1.332 -0.166 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.068 -179.364 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.4 ptm . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -174.43 76.1 0.34 Allowed Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.387 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -68.75 146.64 67.14 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.535 2.157 . . . . 0.0 111.842 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.649 ' CD ' ' H ' ' A' ' 4' ' ' GLU . 1.5 pm0 -79.24 -118.46 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.333 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.511 HG22 ' HA ' ' A' ' 31' ' ' ALA . 3.9 t -84.6 120.12 34.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.439 ' HB ' ' H ' ' A' ' 29' ' ' SER . 80.8 m -84.89 125.58 32.76 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 119.415 -0.914 . . . . 0.0 109.274 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.8 mm -104.54 94.13 2.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.094 0.473 . . . . 0.0 110.802 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 53.4 tp -124.66 79.48 1.77 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.037 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.504 ' C ' ' H ' ' A' ' 11' ' ' LEU . 1.4 pt-20 -122.99 89.06 50.79 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.853 -178.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -69.03 16.7 0.17 Allowed 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 121.988 1.792 . . . . 0.0 111.602 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.504 ' H ' ' C ' ' A' ' 9' ' ' GLU . 64.2 mt -72.46 61.97 0.51 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.433 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -71.08 -40.6 71.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.597 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -172.0 132.38 0.68 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 81.8 t -124.96 132.08 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 120.895 0.378 . . . . 0.0 110.671 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -128.88 138.44 52.02 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.901 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.425 HD22 ' HB2' ' A' ' 22' ' ' ALA . 2.7 pp -157.03 135.06 11.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.997 0.427 . . . . 0.0 110.889 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 42.4 t -64.49 146.65 54.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.792 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.427 ' CD ' ' N ' ' A' ' 19' ' ' GLY . 14.5 tm-20 -61.02 143.12 55.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.607 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.427 ' N ' ' CD ' ' A' ' 18' ' ' GLU . . . 98.86 -14.26 61.73 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 20.2 mp0 -98.68 147.57 24.72 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.878 0.37 . . . . 0.0 110.736 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -71.93 153.3 41.93 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.741 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.425 ' HB2' HD22 ' A' ' 16' ' ' LEU . . . -129.87 146.32 51.59 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.857 0.361 . . . . 0.0 110.918 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 36.4 m -146.22 145.03 30.27 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.41 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.464 ' CE2' HD12 ' A' ' 89' ' ' LEU . 2.7 m-85 -119.58 150.24 40.61 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -146.02 131.46 18.67 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.555 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 10.9 p -151.73 140.53 20.92 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.599 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -100.44 118.19 36.15 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.38 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.453 ' O ' ' CG2' ' A' ' 59' ' ' THR . 79.9 mt -129.25 106.16 8.63 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 110.332 -0.248 . . . . 0.0 110.332 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.439 ' H ' ' HB ' ' A' ' 6' ' ' THR . 22.2 t -62.39 164.4 7.3 Favored 'General case' 0 CA--C 1.515 -0.381 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.026 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.464 ' NH1' ' O ' ' A' ' 31' ' ' ALA . 9.5 ptm180 -54.96 162.37 1.31 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.225 -178.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.511 ' HA ' HG22 ' A' ' 5' ' ' VAL . . . -94.11 -174.11 3.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.411 -179.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.2 m -149.96 -50.59 0.14 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.503 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -89.28 -75.58 1.3 Allowed Glycine 0 CA--C 1.522 0.487 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 178.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -124.83 154.28 41.25 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.824 0.345 . . . . 0.0 110.486 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.9 tp10 -89.97 147.23 23.83 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.976 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.439 ' CB ' HG22 ' A' ' 80' ' ' VAL . . . -70.79 147.93 48.42 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.917 0.389 . . . . 0.0 110.364 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -108.15 139.72 42.4 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.644 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 10.1 t-105 -102.45 134.21 46.14 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.448 -0.797 . . . . 0.0 108.901 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -163.19 154.23 16.85 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.083 -0.647 . . . . 0.0 111.587 -178.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.1 tt -128.19 127.72 43.44 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.759 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.32 10.77 84.23 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.29 -16.64 59.32 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 16.8 m -109.21 148.54 38.2 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -56.18 143.9 82.91 Favored 'Trans proline' 0 N--CA 1.488 1.19 0 C-N-CA 121.103 1.202 . . . . 0.0 110.468 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.515 ' H ' ' CD2' ' A' ' 45' ' ' LEU . 0.8 OUTLIER -101.15 -177.46 3.45 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.246 -179.01 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -141.55 124.22 15.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.907 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.84 81.36 0.11 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.932 0.396 . . . . 0.0 110.611 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.442 ' O ' ' O ' ' A' ' 51' ' ' ASN . 85.4 m-20 -66.46 -168.63 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.098 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.44 -52.17 59.43 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.622 -0.431 . . . . 0.0 109.885 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 62.4 ttp -67.01 -39.82 87.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.805 178.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.525 HD21 HD11 ' A' ' 63' ' ' LEU . 1.3 t-20 -94.46 102.26 14.21 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.924 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -116.67 140.17 49.71 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 87.8 mt -123.34 132.67 70.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.801 0.334 . . . . 0.0 110.481 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.7 t -130.98 140.77 50.19 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.077 0.465 . . . . 0.0 110.852 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 72.6 t -120.89 131.8 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.534 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -118.84 179.77 4.05 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.759 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -59.87 167.91 2.0 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.997 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.07 15.24 74.23 Favored Glycine 0 CA--C 1.519 0.343 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.453 ' CG2' ' O ' ' A' ' 28' ' ' LEU . 0.6 OUTLIER 54.89 35.44 24.37 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.204 0.526 . . . . 0.0 110.379 -179.771 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 81.1 mt -79.11 139.08 38.16 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.438 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -118.82 147.89 43.44 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.6 ' C ' HD23 ' A' ' 62' ' ' LEU . 5.4 tt -155.38 115.2 3.7 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 120.499 -0.481 . . . . 0.0 111.432 -178.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.525 HD11 HD21 ' A' ' 51' ' ' ASN . 0.0 OUTLIER -86.73 106.66 17.81 Favored 'General case' 0 N--CA 1.461 0.11 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.363 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 89.9 m -90.21 105.64 17.95 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.898 0.38 . . . . 0.0 110.304 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 80.3 mt -109.82 118.03 35.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.732 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.544 ' ND1' ' N ' ' A' ' 67' ' ' LYS . 24.9 t-80 -77.75 -136.39 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 120.549 -0.461 . . . . 0.0 110.63 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.544 ' N ' ' ND1' ' A' ' 66' ' ' HIS . 15.8 ptmt -53.3 96.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.209 0.528 . . . . 0.0 110.694 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.1 p -69.72 159.29 5.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.874 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 70.6 p -136.95 161.24 36.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.334 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.479 ' H ' HD23 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -59.56 -27.26 66.08 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.193 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -71.4 -32.83 68.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.157 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -62.45 -36.52 82.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.026 -178.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -47.43 143.8 3.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.841 0.353 . . . . 0.0 110.438 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 172.86 -175.14 45.91 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 98.1 m -106.81 126.18 51.96 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.654 0.264 . . . . 0.0 111.403 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.3 t -98.51 133.25 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.6 m -122.71 154.01 38.66 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.084 0.469 . . . . 0.0 111.186 -178.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -134.46 144.7 48.26 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.28 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 61.7 m80 -133.44 113.92 13.07 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.74 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.479 ' C ' ' H ' ' A' ' 82' ' ' THR . 2.1 t -122.1 133.76 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.53 -5.07 0.29 Allowed Glycine 0 CA--C 1.528 0.905 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.564 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.479 ' H ' ' C ' ' A' ' 80' ' ' VAL . 5.1 p -109.39 -43.71 4.06 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.854 0.327 . . . . 0.0 111.165 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.591 ' SG ' ' N ' ' A' ' 84' ' ' SER . 44.4 t -152.85 166.05 33.49 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.709 0.29 . . . . 0.0 111.259 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.591 ' N ' ' SG ' ' A' ' 83' ' ' CYS . 60.0 m -129.01 151.35 49.8 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.859 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 37.6 p -158.63 166.61 31.64 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.925 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.43 ' N ' ' CD ' ' A' ' 86' ' ' GLU . 2.4 pm0 -154.24 169.86 22.64 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.943 0.401 . . . . 0.0 110.743 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -154.37 151.62 29.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.976 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -115.29 123.88 49.89 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.025 0.441 . . . . 0.0 111.14 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.58 HD23 ' C ' ' A' ' 89' ' ' LEU . 5.8 tt -107.09 115.1 29.59 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.462 ' N ' HD23 ' A' ' 89' ' ' LEU . 68.6 mttm -111.85 153.69 26.25 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.54 0.686 . . . . 0.0 111.737 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 43.8 t -120.8 129.89 75.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.396 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 29.5 m -100.68 128.0 46.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.526 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.83 140.83 56.31 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.254 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.777 0 CA-C-O 118.076 -1.402 . . . . 0.0 110.876 -179.727 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.8 mtm . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.571 ' N ' ' CD ' ' A' ' 3' ' ' PRO . . . -179.53 -44.17 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.553 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 2' ' ' ALA . 6.1 Cg_exo -72.0 145.43 44.89 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.447 2.098 . . . . 0.0 111.747 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -92.19 -157.63 0.53 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.509 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 29' ' ' SER . 9.9 p -58.8 128.68 19.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.461 ' OG1' ' CB ' ' A' ' 29' ' ' SER . 53.8 p -86.6 131.17 34.23 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 119.719 -0.792 . . . . 0.0 110.2 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 24.9 mm -99.87 73.0 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.052 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 79.6 mt -112.36 81.36 1.46 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -118.15 88.0 30.89 Favored Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.986 -177.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -73.48 -5.0 16.38 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 121.999 1.799 . . . . 0.0 110.229 178.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.413 HD22 ' HA ' ' A' ' 11' ' ' LEU . 0.2 OUTLIER -64.25 90.62 0.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.668 -179.694 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -97.3 -124.15 0.13 Allowed 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.404 ' O ' ' OD2' ' A' ' 13' ' ' ASP . 47.5 p-10 -109.01 137.5 46.83 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.798 0.333 . . . . 0.0 110.959 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.6 m -130.8 156.71 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -121.38 134.86 55.12 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.866 0.365 . . . . 0.0 110.782 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.9 pp -147.71 135.73 21.24 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.736 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.6 p -75.73 158.21 32.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.497 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -65.64 142.28 58.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.887 0.375 . . . . 0.0 110.022 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.3 -6.67 78.35 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -97.79 156.85 16.39 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 51.1 p30 -78.43 162.32 26.49 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.908 0.385 . . . . 0.0 110.964 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -147.2 150.74 35.49 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.52 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.4 p -160.04 159.07 31.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.346 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.411 ' O ' HD12 ' A' ' 62' ' ' LEU . 57.8 m-85 -131.8 152.42 50.99 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.951 0.405 . . . . 0.0 110.694 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -142.43 128.33 19.47 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 50.6 m -131.6 155.38 47.63 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.183 0.516 . . . . 0.0 111.577 -179.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -121.85 94.6 4.36 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.68 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 85.5 mt -127.15 112.53 15.26 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.745 -0.207 . . . . 0.0 110.691 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.467 ' O ' HG23 ' A' ' 5' ' ' VAL . 46.0 t -62.54 158.02 19.04 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 53.0 ptt85 -55.3 158.46 3.12 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.723 -177.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -86.28 -179.13 6.64 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.84 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 30.9 t -157.77 -49.61 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.141 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -86.15 -75.17 1.26 Allowed Glycine 0 CA--C 1.52 0.366 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -122.84 142.81 50.36 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.103 0.477 . . . . 0.0 111.051 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -75.02 144.02 43.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.768 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -81.54 170.28 16.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.666 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.6 mtm180 -132.46 137.28 47.19 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.355 0.598 . . . . 0.0 111.916 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 76.5 t-105 -117.93 137.49 52.79 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -169.96 165.96 9.44 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 119.474 -0.89 . . . . 0.0 112.484 -177.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.626 ' C ' HD23 ' A' ' 40' ' ' LEU . 7.0 tt -136.79 122.5 19.83 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.227 178.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.546 ' N ' HD23 ' A' ' 40' ' ' LEU . . . 78.27 14.6 82.04 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.98 4.17 87.23 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 111.62 -0.592 . . . . 0.0 111.62 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.1 t -113.27 130.26 23.8 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-O 119.491 -0.29 . . . . 0.0 110.467 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -58.34 144.94 95.48 Favored 'Trans proline' 0 N--CA 1.491 1.35 0 C-N-CA 120.919 1.08 . . . . 0.0 110.34 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.2 mt -77.53 150.76 34.78 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.681 -179.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -129.01 153.91 47.12 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.382 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.24 80.88 0.35 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.474 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -77.7 169.08 18.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.716 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -66.79 -37.17 84.04 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.137 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 25.8 ptt? -86.83 -21.23 26.56 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.651 0.262 . . . . 0.0 111.266 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.464 ' OD1' ' N ' ' A' ' 52' ' ' ASP . 58.9 t-20 -103.1 146.33 28.54 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.417 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.464 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 98.3 m-20 -138.84 115.18 10.41 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.414 HG21 HD13 ' A' ' 53' ' ' ILE . 48.1 mt -107.95 125.9 64.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.2 t -144.75 153.15 41.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.049 0.452 . . . . 0.0 110.912 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.423 ' O ' HG13 ' A' ' 55' ' ' VAL . 14.6 p -104.15 130.89 54.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.501 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -111.77 -179.19 3.63 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.485 -179.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -63.38 152.07 39.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.533 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.14 9.32 86.85 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 -179.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.3 m 67.27 38.75 3.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.866 0.365 . . . . 0.0 110.646 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.9 mp -94.39 130.59 40.66 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.674 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 64.0 m80 -91.38 158.0 16.77 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.411 HD12 ' O ' ' A' ' 24' ' ' PHE . 48.2 tp -156.77 111.24 2.75 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 120.247 -0.581 . . . . 0.0 111.623 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.44 ' CD1' ' N ' ' A' ' 63' ' ' LEU . 6.5 mp -96.73 115.7 27.88 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.816 178.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 63.7 m -109.94 95.47 5.61 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.551 HD23 ' N ' ' A' ' 66' ' ' HIS . 5.4 tt -107.53 121.5 44.76 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.551 ' N ' HD23 ' A' ' 65' ' ' LEU . 79.3 t60 -80.34 -86.05 0.09 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -178.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? -76.05 106.88 7.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.91 0.386 . . . . 0.0 110.428 -178.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.9 p -88.59 155.11 3.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.906 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 72.8 p -130.95 156.69 44.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.324 -0.398 . . . . 0.0 109.948 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 93.4 mt -59.54 -29.8 68.16 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -67.58 -35.36 78.85 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.959 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -61.72 -32.16 72.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.575 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.27 140.23 39.86 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.625 -0.43 . . . . 0.0 109.893 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 172.55 -171.64 44.44 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 87.8 m -101.53 120.87 40.97 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.735 0.303 . . . . 0.0 111.281 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 10.6 t -86.4 130.91 35.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.2 m -118.2 148.83 41.99 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.109 0.48 . . . . 0.0 110.918 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -136.95 124.96 22.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.453 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 63.4 t-80 -137.62 125.45 22.55 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.831 0.348 . . . . 0.0 111.568 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.411 ' O ' ' C ' ' A' ' 81' ' ' GLY . 5.8 p -141.47 134.3 29.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.579 178.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.411 ' C ' ' O ' ' A' ' 80' ' ' VAL . . . -26.36 -51.94 0.06 OUTLIER Glycine 0 CA--C 1.53 0.977 0 CA-C-N 115.573 -0.739 . . . . 0.0 113.248 -178.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 68.3 p -61.52 -77.27 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 7.3 m -125.56 -166.7 1.59 Allowed 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.06 0.457 . . . . 0.0 111.136 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 28.6 m -149.93 147.06 27.44 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.308 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 50.0 m -126.99 155.42 43.21 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.745 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -129.65 147.2 51.42 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.103 0.478 . . . . 0.0 111.126 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.63 151.92 30.26 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.762 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -130.96 138.51 49.75 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.982 0.42 . . . . 0.0 111.301 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.51 HD23 ' N ' ' A' ' 90' ' ' LYS . 2.2 tt -112.49 111.31 22.06 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.51 ' N ' HD23 ' A' ' 89' ' ' LEU . 57.3 mtpt -117.71 155.1 30.54 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.996 0.427 . . . . 0.0 111.391 -178.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 34.4 m -113.48 133.26 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.461 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 81.2 m -105.27 130.65 53.36 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.525 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.2 169.7 6.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.162 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.729 0 CA-C-O 118.015 -1.436 . . . . 0.0 110.981 179.862 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 82.0 mtp . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.558 ' H ' ' CD ' ' A' ' 3' ' ' PRO . . . -174.41 -44.44 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.703 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.558 ' CD ' ' H ' ' A' ' 2' ' ' ALA . 6.2 Cg_exo -71.04 145.43 49.77 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 122.379 2.053 . . . . 0.0 112.744 -178.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -81.57 153.75 26.57 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.213 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.522 HG22 ' HA ' ' A' ' 31' ' ' ALA . 2.4 t -67.54 133.2 31.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.584 HG23 ' OG ' ' A' ' 29' ' ' SER . 71.0 p -90.14 127.16 36.03 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 118.633 -1.227 . . . . 0.0 110.42 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 20.7 mm -104.81 49.46 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.811 -178.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 89.5 mt -88.07 81.02 7.52 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.532 ' C ' ' H ' ' A' ' 11' ' ' LEU . 27.8 mt-10 -111.9 97.07 36.51 Favored Pre-proline 0 CA--C 1.536 0.413 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.695 -179.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -68.9 25.82 0.15 Allowed 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.656 1.571 . . . . 0.0 111.53 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.532 ' H ' ' C ' ' A' ' 9' ' ' GLU . 3.8 mm? -72.82 125.76 28.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.244 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -133.38 -152.65 0.5 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.22 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.417 ' OD2' ' N ' ' A' ' 13' ' ' ASP . 23.0 p-10 -106.32 131.4 53.58 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.796 0.331 . . . . 0.0 110.238 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 26.9 m -133.07 154.74 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-O 121.052 0.453 . . . . 0.0 110.904 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -126.86 112.99 15.98 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 58.3 mt -110.69 132.9 53.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.444 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 55.7 p -73.05 161.86 30.15 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -63.64 142.94 58.21 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.352 -0.539 . . . . 0.0 110.308 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.93 -3.32 77.23 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 111.119 -0.793 . . . . 0.0 111.119 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -103.4 140.8 36.97 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.028 0.442 . . . . 0.0 110.911 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -78.25 173.76 11.93 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.399 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.85 149.9 36.18 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.722 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 41.8 t -162.78 155.36 19.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.027 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.416 ' HB3' HD11 ' A' ' 11' ' ' LEU . 70.6 m-85 -135.83 155.01 51.0 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.075 -0.512 . . . . 0.0 109.643 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -139.37 114.18 9.35 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 179.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.455 ' HG ' ' HZ2' ' A' ' 38' ' ' TRP . 1.0 OUTLIER -110.91 150.2 29.55 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.181 -178.762 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 96.3 mtt-85 -114.32 93.37 4.31 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.406 HD21 ' CG ' ' A' ' 9' ' ' GLU . 85.8 mt -119.35 118.65 31.75 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -178.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.584 ' OG ' HG23 ' A' ' 6' ' ' THR . 88.3 p -76.41 161.11 28.95 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 177.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 12.0 ptp85 -50.64 163.54 0.18 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -176.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.522 ' HA ' HG22 ' A' ' 5' ' ' VAL . . . -83.32 167.53 17.51 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 113.635 -1.62 . . . . 0.0 110.777 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.2 p -152.22 -59.75 0.15 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -90.99 -70.99 1.21 Allowed Glycine 0 CA--C 1.524 0.621 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 178.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 10.6 tp-100 -122.08 136.27 54.9 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -83.5 148.66 27.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.863 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.49 152.88 39.33 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.91 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 15.4 tpt180 -123.19 123.5 40.94 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.057 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.57 ' CZ2' ' CE1' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -83.59 157.93 22.11 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.151 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -166.78 146.12 5.49 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 119.028 -1.069 . . . . 0.0 112.674 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.521 ' C ' HD23 ' A' ' 40' ' ' LEU . 8.7 tt -142.26 128.13 19.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.631 178.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.456 ' N ' HD23 ' A' ' 40' ' ' LEU . . . 80.11 4.27 89.7 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -178.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.56 -24.92 29.9 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 111.941 -0.464 . . . . 0.0 111.941 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 16.7 m -109.41 148.58 38.36 Favored Pre-proline 0 N--CA 1.471 0.607 0 CA-C-N 117.048 0.424 . . . . 0.0 111.37 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -54.97 137.78 76.78 Favored 'Trans proline' 0 N--CA 1.487 1.132 0 C-N-CA 121.449 1.432 . . . . 0.0 110.752 178.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.54 -176.83 3.74 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.03 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -140.52 161.26 38.16 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.648 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.83 81.69 0.89 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.959 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.45 ' O ' ' O ' ' A' ' 51' ' ' ASN . 65.0 t30 -82.0 171.97 13.79 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.984 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -63.82 -35.7 81.49 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.934 0.397 . . . . 0.0 110.108 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 3.2 ppp? -86.96 -3.18 59.06 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.329 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.45 ' O ' ' O ' ' A' ' 48' ' ' ASN . 56.4 t30 -138.51 109.08 6.56 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.554 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -109.67 124.12 50.66 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.121 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.2 mt -110.78 132.15 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.228 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.4 t -144.42 150.5 37.78 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.154 0.502 . . . . 0.0 111.122 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 46.2 t -100.76 116.39 44.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.276 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -88.76 172.73 9.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.309 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -63.15 158.68 19.24 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.784 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.35 17.73 76.31 Favored Glycine 0 CA--C 1.518 0.276 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 66.66 27.9 9.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.95 0.405 . . . . 0.0 110.794 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.7 mp -85.37 131.09 34.45 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.893 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 75.5 m80 -94.49 163.62 13.33 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.468 HD13 ' N ' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -155.23 113.17 3.42 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.717 -179.425 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.468 ' N ' HD13 ' A' ' 62' ' ' LEU . 4.3 mm? -94.01 114.61 26.82 Favored 'General case' 0 C--N 1.341 0.215 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 63.9 m -102.2 103.88 14.42 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 38.4 tp -110.58 126.88 54.9 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.724 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -127.94 162.49 26.63 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.596 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt 53.57 72.49 0.43 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.085 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.6 p -91.27 140.92 15.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.067 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.455 ' O ' ' N ' ' A' ' 71' ' ' GLU . 26.9 m -125.39 131.03 53.02 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.4 pp -45.04 -19.22 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.88 0.371 . . . . 0.0 110.757 -178.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.455 ' N ' ' O ' ' A' ' 69' ' ' THR . 98.6 mt-10 -70.66 -32.91 70.36 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.948 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.433 ' O ' ' O ' ' A' ' 73' ' ' ALA . 51.5 t0 -54.16 -70.28 0.1 Allowed 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.373 -178.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.433 ' O ' ' O ' ' A' ' 72' ' ' ASP . . . 33.66 94.19 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.785 0.326 . . . . 0.0 111.019 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -136.73 170.83 23.25 Favored Glycine 0 N--CA 1.463 0.463 0 N-CA-C 111.389 -0.685 . . . . 0.0 111.389 -179.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 28.6 m -117.96 117.49 29.39 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.632 -0.284 . . . . 0.0 110.273 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 11.1 t -93.49 132.99 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 11.3 p -138.17 158.18 44.82 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.012 0.434 . . . . 0.0 111.299 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.57 ' CE1' ' CZ2' ' A' ' 38' ' ' TRP . 4.7 m-85 -130.85 144.95 51.83 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 62.7 t-80 -138.8 115.38 10.59 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.842 0.353 . . . . 0.0 111.601 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.536 ' O ' ' N ' ' A' ' 82' ' ' THR . 2.0 t -123.41 129.88 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -39.2 -20.84 0.01 OUTLIER Glycine 0 CA--C 1.527 0.838 0 CA-C-N 116.339 -0.391 . . . . 0.0 112.214 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.536 ' N ' ' O ' ' A' ' 80' ' ' VAL . 18.4 p -83.5 -74.81 0.35 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.996 0.427 . . . . 0.0 110.162 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 36.6 m -125.53 162.53 24.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.287 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 62.3 m -129.95 155.37 46.19 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.783 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 96.0 p -156.8 162.54 39.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.329 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.51 ' N ' ' OE2' ' A' ' 86' ' ' GLU . 56.7 mp0 -138.14 152.9 49.16 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.111 0.482 . . . . 0.0 111.061 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -139.19 149.58 44.58 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.388 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -119.84 126.57 51.3 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.992 0.425 . . . . 0.0 111.647 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 59.5 tp -113.56 116.13 29.05 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -127.89 147.52 50.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.383 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.7 t -106.52 125.72 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 120.91 0.386 . . . . 0.0 110.029 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.0 t -96.97 164.9 12.34 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.85 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.07 -5.93 58.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.106 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.717 0 CA-C-O 117.912 -1.493 . . . . 0.0 110.99 179.883 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.2 mtt . . . . . 0 N--CA 1.487 1.404 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.441 ' O ' ' OE2' ' A' ' 4' ' ' GLU . . . -159.37 73.26 3.38 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.75 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -63.09 148.78 92.99 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 121.935 1.757 . . . . 0.0 111.902 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.444 ' N ' ' CD ' ' A' ' 4' ' ' GLU . 2.6 pm0 -145.72 -146.92 0.2 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.235 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.47 ' O ' HG13 ' A' ' 5' ' ' VAL . 9.3 p -74.65 131.69 34.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.836 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 95.6 m -119.73 128.51 53.84 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.881 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.2 mp -121.62 112.72 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-O 121.121 0.486 . . . . 0.0 111.531 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.6 mt -105.25 93.72 4.84 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 177.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.422 ' OE2' ' CE1' ' A' ' 78' ' ' PHE . 3.4 pt-20 -116.94 89.99 31.31 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.321 -178.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -70.43 -12.59 31.87 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 122.296 1.997 . . . . 0.0 111.792 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.1 68.6 2.7 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.09 0.472 . . . . 0.0 109.737 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -77.99 -2.36 36.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.152 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 39.9 p-10 -172.89 143.36 1.2 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.189 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.8 m -134.93 155.93 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 120.891 0.377 . . . . 0.0 111.338 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -137.25 120.43 16.74 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.189 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 pp -152.14 138.56 18.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.947 0.403 . . . . 0.0 110.828 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.6 m -74.74 150.32 39.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.235 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -56.97 147.49 23.79 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.36 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.92 -9.17 78.55 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.769 -0.533 . . . . 0.0 111.769 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -97.09 156.23 16.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.853 0.358 . . . . 0.0 110.719 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.433 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 19.6 p-10 -75.33 148.91 38.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.495 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -134.54 149.51 50.66 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.814 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 38.2 t -163.17 159.88 23.5 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.567 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -129.47 143.11 50.7 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.383 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -142.39 119.93 11.73 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.905 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 1.2 p -149.6 157.67 43.47 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.078 0.466 . . . . 0.0 111.028 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 96.3 mtt-85 -99.68 143.34 30.03 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.564 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.463 ' O ' ' OG1' ' A' ' 59' ' ' THR . 2.1 tt -145.55 96.41 2.82 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.602 -179.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.7 p -59.97 159.72 8.89 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.805 0.336 . . . . 0.0 110.24 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -57.37 156.3 7.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.868 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -100.05 -173.28 2.4 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.646 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.3 t -141.68 -58.25 0.48 Allowed 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -82.96 -77.07 1.11 Allowed Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -123.91 143.28 50.46 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.797 0.332 . . . . 0.0 110.802 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -92.1 146.21 23.91 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.121 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.479 ' CB ' HG22 ' A' ' 80' ' ' VAL . . . -71.86 151.81 43.11 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.373 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 -130.99 151.89 50.9 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.236 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -74.49 178.33 5.37 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.85 125.65 3.66 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.402 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 58.1 tp -129.8 115.91 17.95 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.8 16.67 72.51 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.1 -24.29 25.5 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.5 m -103.4 150.47 38.04 Favored Pre-proline 0 N--CA 1.468 0.448 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -53.93 143.17 61.83 Favored 'Trans proline' 0 C--N 1.315 -1.201 0 C-N-CA 121.455 1.437 . . . . 0.0 110.757 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.476 ' H ' ' CD2' ' A' ' 45' ' ' LEU . 0.8 OUTLIER -89.08 175.72 7.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.484 179.867 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.442 HE21 ' H ' ' A' ' 47' ' ' ALA . 67.6 tp60 -144.89 153.76 41.91 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.442 ' H ' HE21 ' A' ' 46' ' ' GLN . . . -73.23 72.85 1.26 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.829 0.347 . . . . 0.0 111.539 -178.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' A' ' 51' ' ' ASN . 70.8 m-20 -64.9 -177.16 0.32 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 56.2 mp0 -68.29 -46.17 71.04 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.469 -0.493 . . . . 0.0 110.685 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 76.6 mtm -67.61 -39.32 84.76 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.943 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' A' ' 48' ' ' ASN . 1.9 m-80 -93.56 143.03 26.68 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.733 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.462 ' O ' HD12 ' A' ' 63' ' ' LEU . 97.8 m-20 -135.89 136.83 40.84 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.0 mm -107.39 122.5 61.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 95.3 m -129.85 129.49 44.03 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.073 0.463 . . . . 0.0 111.31 -178.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.5 m -121.3 136.88 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.425 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -137.56 -177.26 4.71 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.823 0.344 . . . . 0.0 110.521 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -51.23 157.58 0.92 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.575 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.08 30.29 77.35 Favored Glycine 0 CA--C 1.519 0.322 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.463 ' OG1' ' O ' ' A' ' 28' ' ' LEU . 65.3 p 41.63 39.64 1.19 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.095 0.474 . . . . 0.0 110.263 -179.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 55.5 mt -71.28 131.86 44.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.013 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -107.11 135.71 48.19 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.963 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.443 HD13 ' C ' ' A' ' 62' ' ' LEU . 0.3 OUTLIER -146.52 97.32 2.9 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.462 HD12 ' O ' ' A' ' 52' ' ' ASP . 27.9 tp -96.61 106.97 19.33 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.113 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 26.5 m -89.7 114.59 26.26 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.109 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.586 HD13 ' N ' ' A' ' 66' ' ' HIS . 0.3 OUTLIER -105.47 118.37 36.39 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.457 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.586 ' N ' HD13 ' A' ' 65' ' ' LEU . 85.5 m-70 -110.77 147.02 35.33 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.261 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 65.5 mttm 54.82 58.58 4.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.97 179.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.1 p -56.57 149.02 3.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.343 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 79.6 p -133.13 155.48 49.19 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.457 179.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 90.4 mt -60.32 -24.72 65.24 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -68.66 -36.12 78.13 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.145 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -62.01 -41.24 97.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.043 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.24 141.54 50.44 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 172.01 -99.28 0.14 Allowed Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.245 -0.979 . . . . 0.0 111.737 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 31.7 m -159.11 117.06 2.82 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.826 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 82.0 t -107.39 129.47 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 57.7 m -138.42 178.77 6.89 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.906 0.384 . . . . 0.0 111.236 -178.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.422 ' CE1' ' OE2' ' A' ' 9' ' ' GLU . 97.4 m-85 -128.53 141.02 51.51 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.101 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -116.99 102.53 9.42 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.479 HG22 ' CB ' ' A' ' 36' ' ' ALA . 2.1 t -118.9 134.38 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.241 -179.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.52 -23.91 61.13 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 121.159 -0.544 . . . . 0.0 111.885 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 43.2 p -98.8 -21.79 16.17 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 117.188 0.494 . . . . 0.0 112.124 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.451 ' O ' ' O ' ' A' ' 80' ' ' VAL . 27.6 p -154.17 -177.83 6.7 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.057 0.456 . . . . 0.0 111.205 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 31.4 t -148.79 150.51 33.2 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 49.2 m -154.13 168.11 27.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.923 0.392 . . . . 0.0 110.871 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -151.14 157.71 43.07 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.645 -179.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.88 146.44 25.66 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.274 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.482 ' C ' HD12 ' A' ' 89' ' ' LEU . 87.6 mt-30 -116.85 131.39 56.96 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.28 0.562 . . . . 0.0 111.605 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.54 HD12 ' N ' ' A' ' 89' ' ' LEU . 9.4 mp -101.74 115.81 31.35 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.34 -0.846 . . . . 0.0 108.969 178.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -120.5 152.88 37.45 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.63 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.5 m -113.72 135.62 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 39.9 m -76.98 132.63 39.11 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.037 0.446 . . . . 0.0 111.29 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.4 144.88 51.41 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.105 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.713 0 CA-C-O 118.063 -1.41 . . . . 0.0 110.604 179.713 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.4 mtt . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.401 ' N ' ' CD ' ' A' ' 3' ' ' PRO . . . -175.76 55.08 0.13 Allowed Pre-proline 0 C--N 1.326 -0.422 0 C-N-CA 120.566 -0.454 . . . . 0.0 111.188 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.401 ' CD ' ' N ' ' A' ' 2' ' ' ALA . 5.4 Cg_exo -53.33 134.6 57.68 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 121.788 1.659 . . . . 0.0 111.107 179.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -176.87 146.32 0.54 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.269 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.528 ' O ' HG13 ' A' ' 5' ' ' VAL . 5.6 p -61.88 122.01 11.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.512 ' HB ' ' H ' ' A' ' 29' ' ' SER . 38.2 m -67.82 131.55 45.74 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 119.284 -0.966 . . . . 0.0 109.091 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.645 HG23 ' O ' ' A' ' 7' ' ' ILE . 9.7 tp -110.47 101.22 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-O 122.057 0.932 . . . . 0.0 112.072 -178.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.6 mt -129.99 82.06 2.05 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.44 -1.254 . . . . 0.0 109.581 178.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 49.0 tt0 -119.71 86.2 34.79 Favored Pre-proline 0 N--CA 1.468 0.448 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.561 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.454 ' O ' ' N ' ' A' ' 12' ' ' GLN . 3.4 Cg_exo -71.55 -7.68 21.71 Favored 'Trans proline' 0 C--N 1.314 -1.273 0 C-N-CA 122.279 1.986 . . . . 0.0 111.409 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 29.3 mt -64.4 75.2 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.853 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.454 ' N ' ' O ' ' A' ' 10' ' ' PRO . 87.6 mt-30 -76.65 -67.63 0.68 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.119 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.444 ' OD2' ' O ' ' A' ' 12' ' ' GLN . 63.6 m-20 -157.42 127.3 6.18 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.514 -178.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.3 m -129.24 156.9 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 121.362 0.601 . . . . 0.0 111.305 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -120.71 129.33 53.61 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.136 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 74.8 mt -118.88 129.27 55.11 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.053 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.6 m -78.76 148.35 33.02 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 177.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -63.81 134.16 54.73 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.953 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.79 -2.09 64.08 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -112.24 134.5 53.75 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.006 0.431 . . . . 0.0 110.717 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -83.21 167.66 17.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.122 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -159.73 174.87 13.87 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.226 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.434 ' OG ' HD11 ' A' ' 62' ' ' LEU . 29.9 t -156.87 148.62 22.62 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.071 0.463 . . . . 0.0 110.915 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -103.0 141.09 36.39 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -129.39 119.1 23.27 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.118 0.485 . . . . 0.0 110.384 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 2.7 m -126.56 163.95 22.27 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.581 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 77.5 ttt-85 -142.65 115.76 8.87 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.9 mt -127.69 100.91 6.15 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 121.095 -0.242 . . . . 0.0 110.995 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.512 ' H ' ' HB ' ' A' ' 6' ' ' THR . 14.2 t -60.05 177.61 0.23 Allowed 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 119.991 -0.684 . . . . 0.0 109.5 179.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -54.41 136.95 43.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.481 0.658 . . . . 0.0 111.866 -178.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.05 -172.86 3.28 Favored 'General case' 0 CA--C 1.521 -0.136 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.937 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.2 t -147.53 -65.34 0.26 Allowed 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.493 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.84 -88.46 0.22 Allowed Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 178.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -124.13 141.0 52.43 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.234 0.54 . . . . 0.0 111.368 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.4 tp10 -83.63 152.91 24.55 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.246 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.41 ' CB ' HG22 ' A' ' 80' ' ' VAL . . . -70.38 139.34 51.88 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.197 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 86.2 mtm-85 -115.97 138.59 51.06 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.763 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 80.8 m95 -76.21 169.16 18.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.008 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -165.1 119.83 1.31 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.809 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.638 ' C ' HD23 ' A' ' 40' ' ' LEU . 6.7 tt -118.96 114.75 23.04 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.432 ' N ' HD23 ' A' ' 40' ' ' LEU . . . 74.97 14.7 81.51 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.64 -23.57 35.37 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 16.7 m -104.94 146.52 32.82 Favored Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -54.62 142.12 73.0 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 121.547 1.498 . . . . 0.0 111.892 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.489 ' H ' ' CD2' ' A' ' 45' ' ' LEU . 1.0 OUTLIER -82.4 171.54 14.06 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.279 179.154 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 71.3 tp60 -144.92 142.01 29.51 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.187 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.38 141.57 58.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.82 0.343 . . . . 0.0 110.274 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.456 ' O ' ' O ' ' A' ' 51' ' ' ASN . 45.4 t30 -155.66 -164.89 1.84 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 53.8 mp0 -66.03 -48.49 70.92 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 119.924 -0.71 . . . . 0.0 110.167 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 66.4 ttp -68.35 -43.43 77.47 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.466 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.456 ' O ' ' O ' ' A' ' 48' ' ' ASN . 99.1 m-20 -107.39 137.84 44.7 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.892 0.377 . . . . 0.0 110.84 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 48' ' ' ASN . 96.7 m-20 -139.31 146.74 40.69 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 98.6 mt -124.06 127.05 73.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 88.5 m -125.43 131.47 52.9 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.886 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.6 t -87.69 128.06 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.209 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -116.1 154.26 30.28 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.545 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -56.36 155.73 6.67 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.583 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.85 12.39 84.48 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 68.77 22.92 7.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.619 -0.291 . . . . 0.0 111.758 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.9 mp -79.28 144.28 34.45 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 178.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 66.1 m170 -110.96 156.18 21.59 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.461 HD13 ' C ' ' A' ' 62' ' ' LEU . 0.4 OUTLIER -153.22 108.9 3.28 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.385 -179.208 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.427 ' N ' HD13 ' A' ' 62' ' ' LEU . 7.3 mp -95.94 109.58 21.92 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 95.3 m -87.44 113.87 23.54 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.432 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 74.8 mt -99.63 104.13 15.87 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.718 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -97.96 134.79 40.59 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.037 0.446 . . . . 0.0 111.579 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt 52.79 65.68 1.45 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.991 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.1 p -61.84 153.04 6.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.389 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.2 t -135.77 163.34 30.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.735 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 62.8 mt -60.31 -29.01 68.57 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.256 0.551 . . . . 0.0 109.867 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -66.69 -24.11 66.22 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.587 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.4 ' O ' ' C ' ' A' ' 73' ' ' ALA . 55.7 t0 -61.99 -40.76 96.73 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.36 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 72' ' ' ASP . . . -38.9 122.08 1.14 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.518 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -174.97 177.25 47.08 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 52.9 m -103.93 127.61 51.45 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.033 0.444 . . . . 0.0 111.436 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 74.0 t -117.15 129.42 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.242 178.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 36.2 t -144.5 171.68 14.01 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -150.96 150.51 30.89 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.047 0.451 . . . . 0.0 110.996 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -117.26 127.86 54.5 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.62 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.427 ' O ' ' O ' ' A' ' 83' ' ' CYS . 2.5 t -118.36 130.14 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.03 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -48.0 -19.26 0.95 Allowed Glycine 0 CA--C 1.53 1.006 0 CA-C-N 115.962 -0.563 . . . . 0.0 113.061 -178.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.01 -33.63 7.43 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 117.725 0.762 . . . . 0.0 111.549 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.427 ' O ' ' O ' ' A' ' 80' ' ' VAL . 33.1 m -144.93 -175.56 4.73 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 96.0 p -159.38 157.95 31.28 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.778 0.323 . . . . 0.0 110.912 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 48.2 t -167.27 168.33 13.41 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.085 0.469 . . . . 0.0 111.022 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -133.95 163.27 29.92 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.956 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -149.15 154.04 38.6 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -124.72 132.84 53.35 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.262 0.553 . . . . 0.0 111.512 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 60.7 tp -116.92 103.69 10.55 Favored 'General case' 0 C--N 1.334 -0.094 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.691 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -103.98 147.39 27.41 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 13.2 t -120.01 99.26 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.4 t -139.38 146.26 39.98 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.4 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -92.19 -7.35 48.57 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.155 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.684 0 CA-C-O 118.015 -1.436 . . . . 0.0 111.004 179.867 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.4 mmm . . . . . 0 N--CA 1.488 1.474 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -168.46 77.34 0.81 Allowed Pre-proline 0 C--N 1.329 -0.322 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.652 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -69.04 147.89 68.48 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.602 2.202 . . . . 0.0 112.535 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -65.86 -166.33 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.32 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.6 t -64.32 135.95 27.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.742 ' C ' HD12 ' A' ' 7' ' ' ILE . 20.4 m -104.14 135.8 44.95 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.767 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.742 HD12 ' C ' ' A' ' 6' ' ' THR . 1.8 mp -121.25 116.25 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 121.379 0.609 . . . . 0.0 111.222 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 96.5 mt -128.35 98.11 4.96 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.073 -0.967 . . . . 0.0 108.581 177.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -122.59 90.14 49.7 Favored Pre-proline 0 N--CA 1.468 0.449 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -178.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -74.23 -5.06 16.41 Favored 'Trans proline' 0 N--CA 1.489 1.231 0 C-N-CA 122.024 1.816 . . . . 0.0 110.068 178.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 65.7 mt -66.45 74.85 0.1 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.353 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -71.6 -49.61 38.67 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.957 0.408 . . . . 0.0 111.775 -179.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -173.7 137.76 0.62 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.989 -178.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 53.0 t -125.11 133.48 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 120.84 0.352 . . . . 0.0 110.578 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -134.24 99.68 4.47 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.126 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 87.4 mt -124.9 139.92 53.39 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.939 0.399 . . . . 0.0 111.309 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.3 t -68.32 141.92 55.66 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.447 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -51.21 149.16 4.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.306 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.95 16.98 78.03 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -115.58 147.48 40.69 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.96 136.59 50.68 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.331 -0.548 . . . . 0.0 109.593 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -132.23 154.92 49.13 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.234 -179.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.9 m -158.63 159.62 35.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.981 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -136.99 148.65 47.02 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.225 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -145.15 122.82 11.82 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.042 0.449 . . . . 0.0 110.935 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 5.9 t -135.56 139.59 44.01 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.248 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 64.6 ttp85 -122.71 127.98 49.96 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.111 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.6 pp -143.69 133.46 23.83 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.22 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.514 ' H ' ' HB ' ' A' ' 6' ' ' THR . 44.7 t -66.22 158.85 27.77 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 38.4 ptt-85 -51.48 163.93 0.24 Allowed 'General case' 0 C--N 1.32 -0.716 0 O-C-N 123.665 0.603 . . . . 0.0 111.972 -177.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.56 174.8 2.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.322 -178.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.462 ' OG ' ' N ' ' A' ' 33' ' ' GLY . 18.4 p -138.46 -56.82 0.64 Allowed 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.462 ' N ' ' OG ' ' A' ' 32' ' ' SER . . . -104.89 -66.85 0.69 Allowed Glycine 0 CA--C 1.523 0.592 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 178.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.549 HE21 ' H ' ' A' ' 81' ' ' GLY . 14.1 pt20 -122.7 143.08 50.03 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.783 0.325 . . . . 0.0 110.315 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.632 ' CD ' ' H ' ' A' ' 35' ' ' GLU . 1.2 pm0 -70.57 146.46 50.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.528 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.89 157.05 38.21 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -123.97 133.86 53.61 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.337 0.589 . . . . 0.0 111.683 -178.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 22.0 t-105 -99.02 147.87 24.59 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.084 -0.962 . . . . 0.0 108.919 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -172.68 147.6 1.81 Allowed 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 119.883 -0.727 . . . . 0.0 112.419 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.59 ' N ' HD11 ' A' ' 45' ' ' LEU . 15.6 tp -124.96 119.03 27.59 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.89 8.52 84.78 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.42 -1.36 58.69 Favored Glycine 0 CA--C 1.531 1.066 0 N-CA-C 111.954 -0.458 . . . . 0.0 111.954 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.9 m -115.87 147.25 38.7 Favored Pre-proline 0 CA--C 1.549 0.93 0 CA-C-N 117.384 0.592 . . . . 0.0 111.618 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -58.45 145.82 92.82 Favored 'Trans proline' 0 N--CA 1.502 2.022 0 C-N-CA 122.008 1.806 . . . . 0.0 112.359 178.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.59 HD11 ' N ' ' A' ' 40' ' ' LEU . 9.0 mp -90.29 144.84 25.47 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.084 178.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.437 ' O ' ' N ' ' A' ' 48' ' ' ASN . 1.0 OUTLIER -122.89 153.14 40.05 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.396 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.64 76.57 0.02 OUTLIER 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.489 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.463 ' OD1' ' N ' ' A' ' 49' ' ' GLU . 24.3 t-20 -74.25 165.7 24.72 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.607 179.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.463 ' N ' ' OD1' ' A' ' 48' ' ' ASN . 97.5 mt-10 -62.12 -40.34 95.59 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.616 -0.433 . . . . 0.0 110.885 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 12.4 ptt? -85.6 -15.33 42.9 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 121.032 -0.267 . . . . 0.0 111.173 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.461 ' O ' ' O ' ' A' ' 48' ' ' ASN . 35.1 t-20 -126.11 122.45 35.79 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.594 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -124.5 128.1 48.46 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 75.5 mt -107.1 129.56 60.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.951 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.9 t -143.93 147.98 34.73 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.853 -179.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.9 m -110.92 131.32 62.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.371 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.446 ' O ' ' C ' ' A' ' 57' ' ' GLN . 98.8 mt-10 -112.11 -173.51 2.26 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.382 -179.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.446 ' C ' ' O ' ' A' ' 56' ' ' GLU . 45.6 tp60 -25.62 144.07 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 O-C-N 123.834 0.709 . . . . 0.0 111.854 -179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 58.12 -97.31 0.07 OUTLIER Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 17.9 m -162.5 62.31 0.21 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.991 0.424 . . . . 0.0 110.364 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 8.3 tt -104.31 120.66 41.67 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.915 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -90.8 148.53 22.47 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.202 -0.453 . . . . 0.0 109.833 178.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.468 ' C ' HD23 ' A' ' 62' ' ' LEU . 8.3 tt -151.57 114.66 4.73 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.86 0.362 . . . . 0.0 110.409 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.6 mp -97.0 114.94 26.59 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.882 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.6 m -94.11 109.37 21.15 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 62.3 mt -101.06 132.31 46.56 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.545 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 49.7 p-80 -153.25 155.46 36.63 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.76 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt 50.97 55.49 9.48 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 120.889 0.376 . . . . 0.0 110.091 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.5 m -110.49 130.1 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.777 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 64.1 p -86.35 -157.49 0.36 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.052 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 40.5 tp -59.88 -15.96 25.42 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.876 0.369 . . . . 0.0 110.442 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -67.6 -5.45 15.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.966 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.427 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 25.2 p-10 -53.37 -30.0 37.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.394 -179.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.1 135.02 56.96 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.101 -0.64 . . . . 0.0 109.667 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -174.54 166.83 38.89 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.427 ' O ' HD12 ' A' ' 40' ' ' LEU . 1.0 OUTLIER -122.95 108.6 13.14 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.57 0.224 . . . . 0.0 110.707 -179.954 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 8.6 t -101.15 120.6 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 33.9 t -137.13 152.09 49.57 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.334 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -135.73 147.8 48.58 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.86 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.52 ' ND1' ' OG ' ' A' ' 84' ' ' SER . 93.7 m-70 -125.22 123.83 40.42 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.209 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.508 ' O ' ' N ' ' A' ' 82' ' ' THR . 2.9 p -128.41 130.35 69.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.549 ' H ' HE21 ' A' ' 34' ' ' GLN . . . -31.7 -31.39 0.01 OUTLIER Glycine 0 CA--C 1.529 0.913 0 CA-C-N 115.671 -0.695 . . . . 0.0 113.1 -178.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.508 ' N ' ' O ' ' A' ' 80' ' ' VAL . 82.5 p -79.04 -75.68 0.23 Allowed 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.659 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.449 ' SG ' ' N ' ' A' ' 84' ' ' SER . 46.2 t -111.56 163.81 13.67 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 120.829 0.347 . . . . 0.0 111.315 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.52 ' OG ' ' ND1' ' A' ' 79' ' ' HIS . 23.3 t -140.74 134.36 30.15 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 13.9 m -160.27 167.91 26.49 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.272 0.558 . . . . 0.0 111.999 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -140.22 164.11 30.96 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.963 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -134.33 148.36 50.72 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -113.61 127.49 56.08 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.267 -179.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.56 HD23 ' C ' ' A' ' 89' ' ' LEU . 4.2 tt -112.02 112.34 23.9 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.52 ' N ' HD23 ' A' ' 89' ' ' LEU . 17.7 ttpt -113.29 170.12 8.46 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.078 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.0 t -111.0 125.58 68.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.476 -179.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.705 HG22 ' H ' ' A' ' 94' ' ' GLY . 97.8 m -79.98 129.77 34.75 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.999 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -88.96 -5.23 58.11 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.39 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.705 ' H ' HG22 ' A' ' 92' ' ' THR . . . . . . . . 0 C--O 1.22 -0.778 0 CA-C-O 117.939 -1.478 . . . . 0.0 110.834 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.5 mtt . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 45.3 70.7 1.85 Allowed Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.078 -179.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -73.92 158.48 46.17 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 122.803 2.335 . . . . 0.0 111.139 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.514 ' HG2' ' H ' ' A' ' 5' ' ' VAL . 39.3 tt0 73.3 176.43 0.26 Allowed 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.514 ' H ' ' HG2' ' A' ' 4' ' ' GLU . 9.8 p -52.65 136.49 13.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 110.431 -0.211 . . . . 0.0 110.431 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.559 HG22 ' CD1' ' A' ' 8' ' ' LEU . 7.1 m -115.96 125.3 52.36 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.42 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.791 ' N ' HD12 ' A' ' 7' ' ' ILE . 3.0 mp -108.41 111.43 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 121.144 0.497 . . . . 0.0 111.046 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.559 ' CD1' HG22 ' A' ' 6' ' ' THR . 8.8 mp -122.31 84.27 2.23 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.44 ' CG ' ' O ' ' A' ' 9' ' ' GLU . 0.2 OUTLIER -110.74 98.93 39.84 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.806 -178.246 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -73.9 -7.16 19.65 Favored 'Trans proline' 0 N--CA 1.489 1.238 0 C-N-CA 121.454 1.436 . . . . 0.0 110.136 178.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 52.3 mt -61.17 80.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.425 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -79.32 -67.15 0.78 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.422 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -171.78 128.26 0.63 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.651 -0.25 . . . . 0.0 110.37 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.8 m -126.15 162.1 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-O 120.926 0.394 . . . . 0.0 110.978 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -116.95 128.74 55.5 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.127 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 74.6 mt -123.01 129.34 51.39 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.058 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.4 p -76.55 164.18 26.19 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -61.83 128.68 37.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.828 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 77.34 19.53 76.48 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.068 178.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -103.41 138.47 40.1 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.85 0.357 . . . . 0.0 110.963 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 49.5 p30 -82.39 164.89 20.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.044 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -161.89 168.98 22.05 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.914 0.388 . . . . 0.0 110.213 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 73.1 m -147.76 140.85 25.01 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.961 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -111.8 129.85 56.0 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 23.8 tm0? -132.11 127.09 35.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.201 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -149.47 163.94 36.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.333 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -120.28 120.89 37.38 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.09 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.475 ' C ' HD23 ' A' ' 28' ' ' LEU . 3.7 tt -132.14 104.78 6.98 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.445 ' O ' HD23 ' A' ' 28' ' ' LEU . 10.1 p -62.68 153.12 33.45 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.167 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -53.31 153.25 4.0 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.592 -177.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.78 -175.17 3.66 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.848 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 44.9 t -142.44 -49.62 0.36 Allowed 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -91.77 -76.2 1.32 Allowed Glycine 0 CA--C 1.52 0.353 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -124.91 135.49 52.9 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.075 0.464 . . . . 0.0 111.864 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.461 ' O ' ' NH1' ' A' ' 37' ' ' ARG . 22.5 pt-20 -83.6 154.61 23.67 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.978 179.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.59 151.97 42.06 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.783 0.325 . . . . 0.0 110.692 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.461 ' NH1' ' O ' ' A' ' 35' ' ' GLU . 87.4 mmt-85 -106.72 148.24 28.64 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.068 0.461 . . . . 0.0 111.277 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 2.9 t-105 -107.71 148.52 29.31 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 179.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -173.31 155.26 2.85 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 119.864 -0.734 . . . . 0.0 111.73 -178.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 32.9 tp -134.22 124.72 26.42 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.707 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.51 6.14 88.06 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.653 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.73 -16.09 57.87 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 121.278 -0.487 . . . . 0.0 112.068 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.8 m -112.21 141.82 25.74 Favored Pre-proline 0 N--CA 1.472 0.671 0 CA-C-N 117.134 0.467 . . . . 0.0 110.43 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -56.87 143.12 92.43 Favored 'Trans proline' 0 N--CA 1.488 1.202 0 C-N-CA 120.826 1.018 . . . . 0.0 110.873 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.17 -166.69 1.33 Allowed 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.537 ' O ' ' N ' ' A' ' 48' ' ' ASN . 2.3 pm0 -153.28 153.99 33.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.927 0.394 . . . . 0.0 111.02 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -55.4 76.31 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.318 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.537 ' N ' ' O ' ' A' ' 46' ' ' GLN . 10.3 t-20 -75.04 171.37 14.23 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.884 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -62.13 -33.98 75.49 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.883 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 14.8 ptp -94.02 -19.63 20.7 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.772 0.32 . . . . 0.0 110.986 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -120.29 118.98 31.82 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.152 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -121.26 142.42 49.95 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.77 0.319 . . . . 0.0 110.63 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 15.5 mm -115.6 118.35 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.4 p -138.85 159.61 41.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.934 0.397 . . . . 0.0 111.183 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 55.8 t -117.51 129.04 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.659 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -107.4 167.46 9.91 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.547 ' NE2' ' H ' ' A' ' 58' ' ' GLY . 71.1 tp60 -58.42 152.77 17.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.947 0.403 . . . . 0.0 110.5 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.547 ' H ' ' NE2' ' A' ' 57' ' ' GLN . . . 79.5 11.29 85.0 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 69.15 27.37 5.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.402 -0.399 . . . . 0.0 110.809 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.521 ' N ' HD12 ' A' ' 60' ' ' LEU . 10.6 mp -87.09 129.69 34.81 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.32 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -97.51 131.12 44.43 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.556 HD13 ' N ' ' A' ' 63' ' ' LEU . 0.5 OUTLIER -123.48 115.57 21.79 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.875 -179.481 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.556 ' N ' HD13 ' A' ' 62' ' ' LEU . 6.8 mp -103.01 114.04 28.01 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 25.9 m -88.8 117.01 27.48 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.179 0.514 . . . . 0.0 110.387 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.563 HD11 HG11 ' A' ' 68' ' ' VAL . 36.9 tp -107.31 127.13 53.27 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.253 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -85.23 -170.1 2.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.888 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -72.36 71.31 0.9 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.672 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.563 HG11 HD11 ' A' ' 65' ' ' LEU . 23.9 m -69.21 -172.54 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.488 0.661 . . . . 0.0 112.069 -179.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 69.8 p -130.6 -165.31 1.53 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.764 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 53.6 mt -64.23 -15.94 61.02 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.738 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.25 -38.11 89.31 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -66.63 -36.29 82.22 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.744 0.307 . . . . 0.0 111.316 -179.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -40.28 112.79 0.3 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.17 0.51 . . . . 0.0 111.268 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -168.83 -179.65 41.1 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 109.704 -1.359 . . . . 0.0 109.704 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 99.0 m -105.19 120.54 41.79 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.907 0.354 . . . . 0.0 111.413 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 12.0 t -93.59 134.55 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.9 p -140.9 146.62 37.7 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.132 0.491 . . . . 0.0 110.916 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -150.95 147.59 27.36 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.483 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 53.5 p-80 -159.78 163.4 34.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.58 0.705 . . . . 0.0 111.96 -178.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.561 HG22 ' H ' ' A' ' 82' ' ' THR . 2.5 p -131.59 140.4 48.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.254 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -35.54 -24.5 0.01 OUTLIER Glycine 0 CA--C 1.528 0.897 0 CA-C-N 115.67 -0.695 . . . . 0.0 112.604 -178.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.561 ' H ' HG22 ' A' ' 80' ' ' VAL . 43.9 p -85.97 -72.73 0.48 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.058 0.456 . . . . 0.0 110.864 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.513 ' N ' ' OG1' ' A' ' 82' ' ' THR . 35.3 m -108.55 -171.56 1.88 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.794 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 83.2 p -156.85 153.95 29.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.896 0.379 . . . . 0.0 111.097 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 47.8 t -152.89 153.79 33.74 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.342 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -134.54 150.96 50.81 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.51 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -139.85 148.37 42.0 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -124.13 125.6 44.75 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.996 0.426 . . . . 0.0 111.793 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.8 tp -113.28 100.84 8.87 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.678 178.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 13.4 ptpt -107.91 172.07 7.04 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 179.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.4 m -128.77 158.6 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 121.328 0.585 . . . . 0.0 111.478 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.8 t -113.73 130.52 56.42 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.745 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.67 140.74 57.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.366 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.217 -0.907 0 CA-C-O 118.066 -1.408 . . . . 0.0 111.14 179.392 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.496 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 50.57 77.74 0.44 Allowed Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.449 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -69.88 -21.75 32.48 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.81 2.34 . . . . 0.0 111.799 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.468 ' O ' ' OG ' ' A' ' 29' ' ' SER . 88.5 tt0 -57.81 150.26 20.43 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.444 ' O ' HG23 ' A' ' 5' ' ' VAL . 18.6 m -58.28 122.22 7.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.545 ' OG1' ' N ' ' A' ' 29' ' ' SER . 41.7 p -88.5 138.73 31.17 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 118.81 -1.156 . . . . 0.0 110.189 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 18.8 mm -110.55 62.4 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.643 -179.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.404 HD22 ' HA ' ' A' ' 8' ' ' LEU . 0.3 OUTLIER -102.09 74.2 1.43 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.346 0.593 . . . . 0.0 109.948 -179.798 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -122.99 84.32 50.72 Favored Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.921 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -70.9 50.83 1.16 Allowed 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 122.275 1.983 . . . . 0.0 112.25 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.455 HD11 ' SG ' ' A' ' 26' ' ' CYS . 96.6 mt -79.93 127.39 32.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.169 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 27.3 pt20 -118.81 -145.05 0.37 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.342 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -104.36 130.88 52.19 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.949 0.404 . . . . 0.0 110.426 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.4 m -123.41 138.1 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.2 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -113.32 115.31 27.93 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.264 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 73.3 mt -119.35 135.08 54.89 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.04 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.0 t -63.6 151.39 41.74 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -55.55 144.42 26.35 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.052 0.453 . . . . 0.0 111.504 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.18 19.2 75.09 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -114.68 144.97 42.59 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.281 0.563 . . . . 0.0 111.152 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 51.3 p-10 -75.5 168.24 20.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.305 -0.862 . . . . 0.0 110.028 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -140.79 142.65 34.65 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.69 0.281 . . . . 0.0 110.913 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 60.6 m -136.25 152.54 50.84 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.857 0.361 . . . . 0.0 111.087 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -135.4 152.24 51.23 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.379 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.422 ' C ' ' SG ' ' A' ' 26' ' ' CYS . 58.4 tt0 -134.33 143.49 47.72 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.698 0.285 . . . . 0.0 110.364 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.455 ' SG ' HD11 ' A' ' 11' ' ' LEU . 30.0 m -150.34 164.34 36.05 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.254 0.55 . . . . 0.0 111.506 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -134.4 99.8 4.48 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 115.427 -0.806 . . . . 0.0 108.859 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.417 ' O ' ' OG1' ' A' ' 59' ' ' THR . 50.1 mt -118.91 128.79 54.76 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.205 -178.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.545 ' N ' ' OG1' ' A' ' 6' ' ' THR . 24.1 p -73.65 158.66 34.32 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 51.7 ptt85 -58.11 169.47 0.81 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 -176.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.8 151.08 45.2 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 113.826 -1.534 . . . . 0.0 111.56 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 73.4 m -139.48 -54.95 0.57 Allowed 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.037 179.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -100.49 -65.81 0.81 Allowed Glycine 0 CA--C 1.52 0.372 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 178.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -123.39 145.27 48.9 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 178.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.696 ' CD ' ' H ' ' A' ' 35' ' ' GLU . 1.7 pm0 -76.17 143.73 40.95 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.092 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.52 152.71 37.78 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.536 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 84.2 mtm180 -128.56 139.74 52.14 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.236 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.532 ' CZ2' ' CE2' ' A' ' 78' ' ' PHE . 10.6 t-105 -101.46 150.96 22.51 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -171.37 157.33 4.89 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 119.498 -0.881 . . . . 0.0 111.914 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.564 ' C ' HD23 ' A' ' 40' ' ' LEU . 7.2 tt -123.72 124.94 43.84 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.415 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.477 ' N ' HD23 ' A' ' 40' ' ' LEU . . . 69.27 21.99 76.04 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.98 7.72 88.27 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 71.7 t -113.69 128.77 25.36 Favored Pre-proline 0 N--CA 1.47 0.537 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -57.34 143.56 93.56 Favored 'Trans proline' 0 N--CA 1.488 1.203 0 CA-C-N 120.004 1.037 . . . . 0.0 111.03 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -106.73 179.66 4.2 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.035 0.445 . . . . 0.0 111.245 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -145.86 150.63 36.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.988 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.99 139.26 48.51 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.035 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.431 ' OD1' ' O ' ' A' ' 51' ' ' ASN . 32.8 p-10 -166.54 -175.01 3.02 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.884 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -66.45 -41.79 88.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.576 -0.283 . . . . 0.0 111.66 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 54.4 ttp -67.95 -42.7 80.52 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.431 ' O ' ' OD1' ' A' ' 48' ' ' ASN . 86.7 m-20 -135.31 115.41 13.23 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.392 178.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.481 ' OD1' ' O ' ' A' ' 64' ' ' THR . 12.2 p-10 -111.63 147.41 35.57 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 178.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.1 mm -113.26 126.25 70.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 98.4 m -127.82 134.31 49.44 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.757 0.313 . . . . 0.0 110.9 -178.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.6 p -111.17 133.86 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 57' ' ' GLN . 95.9 mt-10 -116.09 -177.33 3.14 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.035 0.445 . . . . 0.0 111.766 -178.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.449 ' O ' ' N ' ' A' ' 59' ' ' THR . 77.8 mt-30 -24.92 144.11 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.069 -0.969 . . . . 0.0 112.784 -179.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.576 ' O ' HG23 ' A' ' 59' ' ' THR . . . 52.91 -89.44 0.01 OUTLIER Glycine 0 CA--C 1.519 0.284 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.576 HG23 ' O ' ' A' ' 58' ' ' GLY . 19.7 p -160.33 42.82 0.19 Allowed 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.484 -179.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.447 ' N ' HD12 ' A' ' 60' ' ' LEU . 10.6 mp -86.01 112.66 21.43 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 179.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 49.1 m170 -86.49 150.93 23.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.874 -179.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.2 tp -149.41 105.91 3.53 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.537 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.469 ' CD2' ' N ' ' A' ' 63' ' ' LEU . 1.3 mm? -83.15 111.41 18.89 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.481 ' O ' ' OD1' ' A' ' 52' ' ' ASP . 70.9 m -101.79 94.82 6.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.108 0.48 . . . . 0.0 111.206 -178.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.511 ' N ' HD12 ' A' ' 65' ' ' LEU . 10.5 mp -95.65 136.37 36.14 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.613 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.59 ' CG ' ' H ' ' A' ' 67' ' ' LYS . 45.7 t60 -70.93 -176.07 1.27 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.587 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.59 ' H ' ' CG ' ' A' ' 66' ' ' HIS . 97.7 mttt -63.47 100.39 0.26 Allowed 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.3 m -100.02 134.36 39.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.258 -178.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 30.9 p -79.28 -148.54 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.247 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.494 ' C ' ' H ' ' A' ' 72' ' ' ASP . 88.4 mt -54.48 -37.31 65.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.598 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -50.25 -8.38 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.661 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.494 ' H ' ' C ' ' A' ' 70' ' ' LEU . 37.1 p-10 -65.64 -35.73 81.66 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.821 0.343 . . . . 0.0 110.839 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -47.45 111.43 0.41 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -173.84 166.55 38.78 Favored Glycine 0 CA--C 1.522 0.496 0 C-N-CA 120.638 -0.792 . . . . 0.0 111.388 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 10.3 m -118.84 126.43 51.82 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.723 -0.239 . . . . 0.0 110.448 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.5 t -103.88 130.76 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 93.9 p -121.92 160.43 24.82 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.171 0.51 . . . . 0.0 110.43 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.532 ' CE2' ' CZ2' ' A' ' 38' ' ' TRP . 12.0 m-85 -135.32 138.31 43.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.172 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 72.6 t60 -127.89 127.52 43.53 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.184 0.516 . . . . 0.0 111.225 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.48 ' O ' ' C ' ' A' ' 81' ' ' GLY . 2.6 p -148.7 116.63 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.337 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.48 ' C ' ' O ' ' A' ' 80' ' ' VAL . . . -5.75 -67.34 0.01 OUTLIER Glycine 0 N--CA 1.473 1.116 0 O-C-N 123.927 0.767 . . . . 0.0 113.877 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.446 ' OG1' ' N ' ' A' ' 83' ' ' CYS . 65.1 p -48.6 -86.59 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -178.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.446 ' N ' ' OG1' ' A' ' 82' ' ' THR . 92.5 m -125.48 -168.71 1.88 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.384 -179.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 51.6 p -153.79 168.71 25.4 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.709 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 39.1 t -152.11 169.99 21.06 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.723 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -150.19 164.11 36.51 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 120.973 0.416 . . . . 0.0 111.184 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.0 152.1 38.05 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.114 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -119.5 129.96 54.97 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.215 0.531 . . . . 0.0 111.066 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 8.2 tt -117.53 122.68 44.35 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.399 -0.818 . . . . 0.0 109.684 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -120.23 159.51 24.79 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.015 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.466 ' O ' HG13 ' A' ' 91' ' ' VAL . 7.7 p -109.56 126.91 66.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-O 120.889 0.375 . . . . 0.0 110.154 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 31.6 m -66.02 131.27 45.83 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.539 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -100.12 -7.59 24.7 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.469 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.754 0 CA-C-O 117.934 -1.481 . . . . 0.0 110.882 -179.79 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.3 ttp . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -162.22 74.11 2.24 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.275 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -65.5 143.82 77.03 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.646 2.231 . . . . 0.0 111.457 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.406 ' HG2' ' H ' ' A' ' 4' ' ' GLU . 7.4 pt-20 -92.33 -114.18 0.09 Allowed 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -178.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.479 ' O ' HG13 ' A' ' 5' ' ' VAL . 9.6 p -72.09 127.22 33.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.599 HG23 ' OG ' ' A' ' 29' ' ' SER . 26.2 p -101.0 135.56 42.25 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.721 -179.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.74 ' N ' HD12 ' A' ' 7' ' ' ILE . 1.9 mp -107.78 115.16 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 121.492 0.663 . . . . 0.0 111.687 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.455 ' CD2' ' NH1' ' A' ' 27' ' ' ARG . 49.2 tp -126.95 110.77 13.35 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 114.537 -1.211 . . . . 0.0 109.141 178.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.498 ' OE1' ' SG ' ' A' ' 26' ' ' CYS . 24.9 mm-40 -125.15 91.8 48.52 Favored Pre-proline 0 N--CA 1.471 0.598 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -178.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -71.69 -9.32 24.76 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 C-N-CA 121.747 1.632 . . . . 0.0 111.619 177.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.84 87.75 3.43 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.613 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 95.9 mm-40 -69.61 -32.79 71.71 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.097 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 43.6 p-10 -176.96 142.58 0.38 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.904 0.383 . . . . 0.0 110.576 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 51.8 t -119.72 133.1 67.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.557 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.483 ' C ' HD22 ' A' ' 16' ' ' LEU . 98.1 mt-30 -135.85 108.61 7.53 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.483 HD22 ' C ' ' A' ' 15' ' ' GLN . 3.9 mm? -115.13 133.22 56.23 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 120.563 0.221 . . . . 0.0 110.427 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.9 t -68.1 149.52 49.52 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.877 0.37 . . . . 0.0 110.732 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -52.3 132.28 33.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.779 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.94 16.48 56.1 Favored Glycine 0 CA--C 1.534 1.256 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.972 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -125.06 155.87 39.1 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.913 0.387 . . . . 0.0 110.273 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 43.9 p-10 -85.72 169.36 13.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.555 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -134.44 147.36 50.41 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.042 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 44.5 t -134.87 141.21 46.29 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.884 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -119.96 146.38 45.88 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.127 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -128.71 104.89 7.9 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.224 179.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.498 ' SG ' ' OE1' ' A' ' 9' ' ' GLU . 6.6 t -124.45 141.81 51.79 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.455 ' NH1' ' CD2' ' A' ' 8' ' ' LEU . 60.1 ttp180 -124.99 119.52 28.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.922 0.391 . . . . 0.0 110.634 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 84.0 mt -123.4 121.01 34.67 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.383 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.599 ' OG ' HG23 ' A' ' 6' ' ' THR . 66.3 p -71.6 161.33 31.17 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 18.5 ptp180 -53.9 147.74 11.66 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.377 0.608 . . . . 0.0 112.329 -178.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.29 -173.78 3.33 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.611 -178.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.7 t -163.68 -43.67 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.933 -1.03 . . . . 0.0 109.166 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -98.23 -71.41 1.02 Allowed Glycine 0 CA--C 1.521 0.409 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 179.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 -124.93 135.78 53.15 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.109 0.481 . . . . 0.0 111.926 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -90.12 151.98 21.34 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.211 178.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.2 167.62 15.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.358 -179.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -149.65 159.51 44.28 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.195 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.5 ' CB ' HD11 ' A' ' 45' ' ' LEU . 92.7 m95 -84.63 176.56 8.51 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.922 0.391 . . . . 0.0 110.222 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -166.12 106.32 0.69 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.676 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.449 ' C ' HD23 ' A' ' 40' ' ' LEU . 7.1 tt -114.88 118.0 32.26 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.59 21.37 68.87 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.7 -9.29 74.49 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 47.2 t -115.1 134.94 22.45 Favored Pre-proline 0 N--CA 1.471 0.618 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -56.71 142.21 91.55 Favored 'Trans proline' 0 N--CA 1.489 1.227 0 C-N-CA 121.378 1.386 . . . . 0.0 111.589 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.58 ' O ' HD12 ' A' ' 45' ' ' LEU . 0.4 OUTLIER -88.53 159.64 17.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.199 179.809 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -139.93 162.22 35.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.011 0.434 . . . . 0.0 110.389 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.99 76.3 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.362 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.468 ' CG ' ' H ' ' A' ' 49' ' ' GLU . 47.9 t30 -71.03 -174.89 1.03 Allowed 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.468 ' H ' ' CG ' ' A' ' 48' ' ' ASN . 86.5 tt0 -62.85 -44.63 95.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.153 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.9 ptt? -90.13 -16.24 29.98 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.02 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -105.32 142.2 35.5 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.092 0.472 . . . . 0.0 111.353 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.487 ' OD2' ' N ' ' A' ' 53' ' ' ILE . 63.3 t0 -148.03 146.47 28.9 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.429 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.487 ' N ' ' OD2' ' A' ' 52' ' ' ASP . 97.9 mt -125.25 130.77 72.93 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 CA-C-O 120.727 0.298 . . . . 0.0 110.616 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.3 p -135.47 157.91 45.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.11 0.481 . . . . 0.0 110.966 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 50.6 t -117.63 131.63 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.221 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.448 ' O ' ' O ' ' A' ' 57' ' ' GLN . 97.1 mt-10 -108.31 177.63 4.74 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.448 ' O ' ' O ' ' A' ' 56' ' ' GLU . 55.5 tt0 -28.15 148.77 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 O-C-N 123.795 0.684 . . . . 0.0 112.137 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 60.6 -98.14 0.14 Allowed Glycine 0 C--N 1.329 0.178 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.2 m -163.27 48.19 0.14 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.327 0.584 . . . . 0.0 110.535 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 8.2 tt -92.19 116.77 29.24 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.264 0.554 . . . . 0.0 110.339 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 -79.07 146.64 33.15 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.264 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.624 ' C ' HD23 ' A' ' 62' ' ' LEU . 6.3 tt -143.38 114.57 7.87 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.442 ' N ' HD23 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -90.62 106.17 18.32 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.511 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 90.9 m -92.45 107.78 19.47 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.695 -178.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 83.2 mt -103.28 124.08 47.98 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.276 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.522 ' O ' HG13 ' A' ' 68' ' ' VAL . 13.2 t60 -72.72 156.7 38.66 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 66' ' ' HIS . 15.8 ptpt -27.45 89.15 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.599 0.714 . . . . 0.0 112.495 -179.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.522 HG13 ' O ' ' A' ' 66' ' ' HIS . 28.0 m -82.33 167.45 2.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.031 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.521 HG23 ' H ' ' A' ' 71' ' ' GLU . 6.7 t -130.77 -149.68 0.4 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.335 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.501 ' C ' ' H ' ' A' ' 72' ' ' ASP . 3.3 mm? -51.24 -36.35 41.38 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.293 -0.563 . . . . 0.0 109.684 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.521 ' H ' HG23 ' A' ' 69' ' ' THR . 98.3 mt-10 -60.96 -0.39 0.3 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.481 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.501 ' H ' ' C ' ' A' ' 70' ' ' LEU . 42.8 t0 -63.53 -36.97 85.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.913 -179.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.93 141.25 40.12 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.211 0.529 . . . . 0.0 111.324 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 173.52 153.49 9.71 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.523 -1.031 . . . . 0.0 110.523 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 16.0 p -97.25 111.35 23.63 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.954 0.407 . . . . 0.0 110.91 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 25.2 t -107.59 128.28 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.884 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.5 t -144.29 175.8 9.82 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.28 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.409 ' CZ ' ' CZ3' ' A' ' 38' ' ' TRP . 57.9 m-85 -127.07 144.27 51.07 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -131.57 115.3 15.93 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.968 0.413 . . . . 0.0 110.84 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.486 ' O ' ' N ' ' A' ' 82' ' ' THR . 6.0 p -141.23 125.49 17.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.404 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -39.85 -20.38 0.02 OUTLIER Glycine 0 CA--C 1.531 1.068 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.863 -178.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.486 ' N ' ' O ' ' A' ' 80' ' ' VAL . 68.3 p -80.65 -75.19 0.28 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.054 0.454 . . . . 0.0 111.084 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.417 ' N ' ' OG1' ' A' ' 82' ' ' THR . 61.8 m -121.0 179.6 4.33 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.427 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 73.5 m -131.57 151.81 51.3 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 11.4 t -153.07 164.39 38.09 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -148.37 162.07 40.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.065 0.46 . . . . 0.0 111.214 -178.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.2 155.69 34.34 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.933 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -122.45 128.59 51.07 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.424 -179.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.548 HD23 ' N ' ' A' ' 90' ' ' LYS . 2.3 tt -121.1 117.55 27.47 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.548 ' N ' HD23 ' A' ' 89' ' ' LEU . 20.5 pttp -144.57 166.38 25.34 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 120.904 0.383 . . . . 0.0 111.679 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.6 p -104.08 133.22 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.184 0.516 . . . . 0.0 110.137 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.0 t -102.82 141.9 34.85 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.994 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -88.33 -9.12 53.81 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.64 -0.255 . . . . 0.0 111.042 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.724 0 CA-C-O 117.959 -1.467 . . . . 0.0 111.071 -179.94 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ttm . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -159.72 154.83 21.58 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.114 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -55.47 143.63 76.88 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 121.692 1.595 . . . . 0.0 111.648 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -175.92 139.01 0.37 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.519 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.477 ' O ' HG13 ' A' ' 5' ' ' VAL . 10.0 p -54.37 130.22 16.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.402 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.504 ' HG1' ' CB ' ' A' ' 29' ' ' SER . 16.6 p -101.23 124.95 47.74 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 22.9 mm -100.8 111.17 29.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.102 0.477 . . . . 0.0 110.948 -178.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.435 ' O ' ' O ' ' A' ' 27' ' ' ARG . 91.6 mt -120.02 106.07 11.65 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.501 178.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.47 ' OE1' ' SG ' ' A' ' 26' ' ' CYS . 34.0 mm-40 -124.81 89.39 52.54 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.957 -179.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -71.79 -3.51 13.29 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 121.622 1.548 . . . . 0.0 110.694 178.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 67.4 mt -69.24 141.5 54.41 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.982 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -124.77 -46.84 1.84 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.174 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 37.3 p30 -176.72 146.43 0.57 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.136 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 65.1 t -125.28 129.31 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.043 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -137.66 135.93 36.97 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.023 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -160.87 160.56 31.15 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.995 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.0 p -74.69 156.53 36.56 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.978 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -67.91 138.59 56.12 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.21 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.45 -3.38 65.92 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -103.33 151.52 22.64 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.871 0.367 . . . . 0.0 110.878 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -76.07 155.23 34.99 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.97 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -135.39 146.29 48.17 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.523 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.5 m -133.43 148.8 51.79 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.31 0.576 . . . . 0.0 111.112 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -128.19 147.35 50.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.608 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -136.38 116.09 13.02 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.452 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.47 ' SG ' ' OE1' ' A' ' 9' ' ' GLU . 3.0 t -131.48 127.99 38.49 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.398 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.435 ' O ' ' O ' ' A' ' 8' ' ' LEU . 99.6 mtt180 -96.76 125.81 41.48 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 178.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.442 HD12 ' O ' ' A' ' 6' ' ' THR . 18.8 tp -145.34 112.24 5.96 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -178.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.504 ' CB ' ' HG1' ' A' ' 6' ' ' THR . 6.6 p -79.08 155.24 28.86 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 18.1 ptp180 -54.22 157.96 2.46 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -177.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.69 -173.86 2.46 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 114.649 -1.16 . . . . 0.0 111.374 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.8 t -154.85 -44.93 0.09 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.231 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -86.51 -72.12 1.29 Allowed Glycine 0 CA--C 1.522 0.482 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 178.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -122.41 143.39 49.7 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.833 0.349 . . . . 0.0 110.632 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.515 ' N ' ' OE1' ' A' ' 35' ' ' GLU . 56.4 mp0 -91.72 129.64 37.66 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.463 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.412 ' CB ' HG22 ' A' ' 80' ' ' VAL . . . -71.48 145.98 48.88 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -129.92 151.86 50.02 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.747 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.445 ' CZ2' HD23 ' A' ' 63' ' ' LEU . 62.5 m95 -74.38 176.32 6.85 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -163.24 114.5 1.44 Allowed 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.896 178.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 41.1 tp -124.25 121.27 34.59 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.18 3.21 64.51 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.94 -17.21 58.51 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.9 m -107.08 149.68 38.93 Favored Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -58.76 145.11 97.33 Favored 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 120.885 1.056 . . . . 0.0 111.641 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.475 ' H ' ' CD2' ' A' ' 45' ' ' LEU . 0.9 OUTLIER -89.13 178.25 6.42 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.687 179.967 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -151.22 140.42 21.26 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.007 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.35 142.65 58.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.625 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.429 ' CG ' ' H ' ' A' ' 49' ' ' GLU . 48.4 t30 -169.01 -173.5 1.81 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.798 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.429 ' H ' ' CG ' ' A' ' 48' ' ' ASN . 82.4 tt0 -64.0 -42.25 97.24 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.526 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 97.2 mmm -66.28 -40.18 89.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.513 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.477 ' OD1' ' CD1' ' A' ' 63' ' ' LEU . 46.5 t30 -120.81 119.83 33.83 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.71 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -113.79 136.77 52.49 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 70.9 mt -120.07 129.87 74.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 110.11 -0.329 . . . . 0.0 110.11 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 86.8 m -132.5 142.04 49.04 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.203 0.525 . . . . 0.0 111.182 -178.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 42.1 t -110.58 132.9 57.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.438 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -124.6 -174.66 3.07 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.204 0.526 . . . . 0.0 110.543 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -28.41 137.99 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.466 -179.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.536 ' O ' HG23 ' A' ' 59' ' ' THR . . . 69.7 -99.63 0.69 Allowed Glycine 0 CA--C 1.52 0.367 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.536 HG23 ' O ' ' A' ' 58' ' ' GLY . 25.3 p -159.94 51.51 0.32 Allowed 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 52.1 tp -87.22 119.14 27.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.467 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 53.6 m170 -100.97 124.84 47.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.673 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 76.2 mt -119.01 123.81 45.44 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.173 0.511 . . . . 0.0 111.18 -179.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.477 ' CD1' ' OD1' ' A' ' 51' ' ' ASN . 0.3 OUTLIER -97.89 105.69 17.87 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 177.954 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 58.7 m -104.97 105.2 15.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.173 0.511 . . . . 0.0 111.297 -177.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.6 mt -96.42 131.17 43.26 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.019 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -112.84 144.62 42.08 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.986 0.422 . . . . 0.0 111.114 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 74.7 tttt 50.92 57.04 7.08 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.475 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -44.98 152.08 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.087 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 43.7 p -134.5 164.4 27.56 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.628 HD13 ' O ' ' A' ' 70' ' ' LEU . 0.3 OUTLIER -60.9 -33.93 73.88 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.301 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -65.06 -22.22 66.94 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.592 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -60.3 -34.6 74.0 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -44.63 118.33 1.55 Allowed 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.594 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -170.74 -179.34 41.98 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 52.6 m -108.63 122.99 48.24 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.833 0.349 . . . . 0.0 110.781 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.14 131.46 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 29.0 t -144.18 175.15 10.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.885 0.374 . . . . 0.0 110.584 -179.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -127.34 138.16 52.97 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.904 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 -120.72 112.0 18.31 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.504 ' HB ' ' H ' ' A' ' 83' ' ' CYS . 2.4 t -126.67 129.66 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 120.966 0.412 . . . . 0.0 110.336 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -57.18 -7.48 2.66 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.421 ' H ' ' C ' ' A' ' 80' ' ' VAL . 16.4 p -108.7 -40.53 5.04 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.656 0.265 . . . . 0.0 110.963 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.504 ' H ' ' HB ' ' A' ' 80' ' ' VAL . 26.2 m -148.04 -166.37 2.51 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.328 -179.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 91.0 p -160.04 167.02 28.8 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.046 0.45 . . . . 0.0 111.229 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 31.5 t -158.87 166.8 31.04 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.331 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -134.63 153.53 51.93 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.21 0.528 . . . . 0.0 110.969 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.93 151.31 23.41 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.489 -0.778 . . . . 0.0 108.917 178.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -133.66 132.57 40.86 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.846 0.355 . . . . 0.0 111.693 -178.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.595 HD23 ' N ' ' A' ' 90' ' ' LYS . 5.3 tt -114.57 118.46 33.8 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.595 ' N ' HD23 ' A' ' 89' ' ' LEU . 32.3 ttmt -128.17 134.84 49.11 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.912 0.387 . . . . 0.0 110.677 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.2 p -114.94 108.24 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 27.4 m -116.52 118.52 32.89 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.324 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.34 146.36 50.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.823 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.803 0 CA-C-O 118.004 -1.442 . . . . 0.0 110.744 179.79 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.6 ttm . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -165.32 78.38 1.28 Allowed Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.902 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -67.53 146.67 74.87 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 122.545 2.164 . . . . 0.0 111.573 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -87.89 156.95 19.11 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.994 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.643 HG22 ' HA ' ' A' ' 31' ' ' ALA . 3.2 t -59.99 132.73 25.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.338 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.596 ' HB ' ' H ' ' A' ' 29' ' ' SER . 89.6 m -87.15 121.13 29.19 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 119.032 -1.067 . . . . 0.0 110.486 -179.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 18.2 mm -105.2 100.5 10.69 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.926 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 60.6 mt -128.41 90.26 3.04 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.494 ' OE2' ' CE2' ' A' ' 78' ' ' PHE . 7.6 pt-20 -120.14 84.27 33.38 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.933 -178.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.402 ' O ' ' N ' ' A' ' 12' ' ' GLN . 3.1 Cg_exo -71.23 11.67 0.55 Allowed 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 122.204 1.936 . . . . 0.0 111.491 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.615 HD12 ' N ' ' A' ' 11' ' ' LEU . 8.4 mp -70.54 67.07 0.34 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.402 ' N ' ' O ' ' A' ' 10' ' ' PRO . 99.4 mm-40 -69.94 -43.17 72.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.365 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.593 ' CG ' HE21 ' A' ' 15' ' ' GLN . 54.9 t0 -175.04 138.64 0.45 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.916 0.389 . . . . 0.0 110.992 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.424 ' N ' ' OD2' ' A' ' 13' ' ' ASP . 54.7 t -127.0 131.69 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.626 ' C ' HD22 ' A' ' 16' ' ' LEU . 7.9 mp0 -136.43 102.64 5.02 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.734 0.302 . . . . 0.0 111.035 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.626 HD22 ' C ' ' A' ' 15' ' ' GLN . 4.4 mm? -119.68 146.36 45.66 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.239 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 45.0 t -82.06 162.91 22.4 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.14 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -61.61 137.68 58.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.162 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.21 2.29 85.74 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 111.761 -0.535 . . . . 0.0 111.761 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -96.73 166.79 11.48 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.87 0.367 . . . . 0.0 110.72 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 21' ' ' ASP . 39.9 p30 -79.46 151.56 30.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.625 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.07 142.19 29.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.271 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 96.5 p -162.48 161.17 26.96 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.943 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -132.59 150.69 52.12 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.944 0.402 . . . . 0.0 110.644 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -136.45 123.85 22.03 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 8.5 t -134.38 132.9 39.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.277 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 90.6 mtm-85 -104.44 104.72 14.63 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.763 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 85.7 mt -123.81 121.05 34.4 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.0 0.428 . . . . 0.0 111.682 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.596 ' H ' ' HB ' ' A' ' 6' ' ' THR . 85.2 p -75.33 163.68 27.21 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 177.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 35.5 ptt-85 -50.87 149.02 3.68 Favored 'General case' 0 C--N 1.322 -0.618 0 O-C-N 124.181 0.926 . . . . 0.0 113.331 -177.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.643 ' HA ' HG22 ' A' ' 5' ' ' VAL . . . -75.46 176.43 7.54 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 114.177 -1.374 . . . . 0.0 111.135 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 50.0 m -151.25 -63.51 0.19 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.695 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -88.44 -75.36 1.29 Allowed Glycine 0 CA--C 1.521 0.409 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 178.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -122.43 129.96 52.59 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.711 0.291 . . . . 0.0 110.332 178.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -73.35 145.46 45.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.712 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.47 ' CB ' HG22 ' A' ' 80' ' ' VAL . . . -71.34 146.83 48.57 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.587 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 24.2 mmt85 -104.85 132.74 50.72 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.908 179.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -113.0 138.62 49.59 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.46 ' HB1' ' O ' ' A' ' 43' ' ' VAL . . . -176.43 155.53 1.43 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 119.727 -0.789 . . . . 0.0 111.52 -178.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.623 HD23 ' N ' ' A' ' 41' ' ' GLY . 6.5 tt -123.06 121.85 37.04 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.623 ' N ' HD23 ' A' ' 40' ' ' LEU . . . 86.05 6.04 82.49 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -178.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.33 0.84 79.42 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 112.028 -0.429 . . . . 0.0 112.028 179.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.46 ' O ' ' HB1' ' A' ' 39' ' ' ALA . 23.1 m -113.13 143.98 30.26 Favored Pre-proline 0 N--CA 1.47 0.551 0 CA-C-N 116.777 0.289 . . . . 0.0 110.884 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -56.41 144.87 81.88 Favored 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 121.411 1.407 . . . . 0.0 110.449 178.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.557 HD21 ' N ' ' A' ' 40' ' ' LEU . 14.2 mt -80.87 156.97 25.82 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.034 0.445 . . . . 0.0 111.384 -179.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.465 ' O ' ' N ' ' A' ' 48' ' ' ASN . 89.9 mt-30 -126.6 131.48 51.49 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.21 179.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.01 70.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.943 0.401 . . . . 0.0 111.566 -178.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.465 ' N ' ' O ' ' A' ' 46' ' ' GLN . 87.4 m-20 -76.93 163.21 26.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.645 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -59.26 -46.57 88.15 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 95.2 mtp -66.91 -40.24 87.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.236 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.425 ' O ' ' O ' ' A' ' 48' ' ' ASN . 66.0 m-20 -117.6 107.77 14.65 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.769 179.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -109.82 158.51 18.08 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.7 mt -122.09 130.25 74.71 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-O 120.916 0.389 . . . . 0.0 110.084 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 97.1 m -128.27 129.38 46.27 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.905 -178.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.425 ' O ' HG13 ' A' ' 55' ' ' VAL . 7.4 p -111.03 129.25 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.879 179.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.411 ' O ' ' C ' ' A' ' 57' ' ' GLN . 98.0 mt-10 -112.38 -174.57 2.49 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.144 0.497 . . . . 0.0 111.114 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.411 ' C ' ' O ' ' A' ' 56' ' ' GLU . 63.1 tp60 -24.78 144.56 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 114.791 -1.095 . . . . 0.0 112.462 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 58.52 -94.48 0.05 OUTLIER Glycine 0 CA--C 1.522 0.512 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.672 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 37.5 m -163.7 65.06 0.17 Allowed 'General case' 0 C--O 1.239 0.516 0 CA-C-O 121.324 0.583 . . . . 0.0 110.635 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 91.4 mt -95.8 126.3 40.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.426 178.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 48.7 m170 -107.84 120.61 42.77 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.22 118.39 14.49 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.083 0.468 . . . . 0.0 110.8 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -86.58 118.05 25.75 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 94.9 m -105.64 95.94 6.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.278 -179.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.481 ' N ' HD23 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -106.88 140.84 39.06 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.593 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 21.3 p80 -139.19 159.02 43.14 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.575 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 79.2 tttt 47.74 73.17 0.21 Allowed 'General case' 0 C--O 1.231 0.109 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -179.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.425 HG13 ' O ' ' A' ' 68' ' ' VAL . 11.7 p -116.47 131.83 67.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.959 -179.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.6 p -79.08 -157.41 0.12 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.523 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.577 ' C ' ' H ' ' A' ' 72' ' ' ASP . 55.4 tp -57.72 -33.74 68.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.421 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -51.28 -2.33 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.235 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.577 ' H ' ' C ' ' A' ' 70' ' ' LEU . 29.1 t0 -53.57 -39.24 64.64 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.697 0.284 . . . . 0.0 110.474 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.65 137.89 57.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.181 0.515 . . . . 0.0 111.068 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 179.99 176.8 47.65 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 110.076 -1.209 . . . . 0.0 110.076 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 94.4 m -126.15 117.26 22.76 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 117.088 0.444 . . . . 0.0 111.003 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.1 t -89.63 131.64 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.1 p -132.04 149.5 52.4 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.149 0.5 . . . . 0.0 110.891 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.494 ' CE2' ' OE2' ' A' ' 9' ' ' GLU . 0.2 OUTLIER -153.52 150.24 28.52 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.826 179.911 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -145.07 141.43 28.84 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.222 0.534 . . . . 0.0 111.112 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.498 ' O ' ' N ' ' A' ' 82' ' ' THR . 2.3 t -130.07 131.53 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.893 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -46.76 -11.89 0.06 OUTLIER Glycine 0 CA--C 1.528 0.896 0 C-N-CA 121.067 -0.587 . . . . 0.0 111.693 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.498 ' N ' ' O ' ' A' ' 80' ' ' VAL . 22.7 p -99.92 -54.01 3.01 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 122.722 -0.281 . . . . 0.0 110.696 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 38.8 t -139.58 162.5 34.93 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.115 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 30.9 p -134.68 155.13 51.06 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.964 0.412 . . . . 0.0 111.254 -179.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.0 t -162.87 166.87 23.53 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.948 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -142.34 165.06 28.44 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.66 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.82 155.69 41.93 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.139 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -125.25 135.89 52.99 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.344 0.592 . . . . 0.0 111.773 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 48.2 tp -109.66 97.68 7.18 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.783 179.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -94.62 166.82 11.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.312 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 53.1 t -119.51 128.37 75.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.61 162.17 24.37 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.63 -179.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.74 139.92 58.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.225 -179.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.794 0 CA-C-O 118.025 -1.431 . . . . 0.0 111.125 -179.879 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.61 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.416 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.65 ' HB3' ' HD3' ' A' ' 3' ' ' PRO . . . -49.72 -66.43 0.62 Allowed Pre-proline 0 CA--C 1.536 0.427 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.495 -179.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.65 ' HD3' ' HB3' ' A' ' 2' ' ' ALA . 3.9 Cg_exo -50.68 140.32 37.31 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 121.672 1.581 . . . . 0.0 111.467 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -97.92 -158.56 0.68 Allowed 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 179.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.521 HG22 ' HA ' ' A' ' 31' ' ' ALA . 2.7 t -61.28 130.53 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 C-N-CA 120.221 -0.591 . . . . 0.0 109.413 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.607 ' HB ' ' H ' ' A' ' 29' ' ' SER . 72.4 m -91.94 130.21 37.74 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 119.962 -0.695 . . . . 0.0 111.457 -178.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 33.8 mm -111.86 102.52 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-O 121.275 0.559 . . . . 0.0 111.017 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 39.4 tp -126.3 87.51 2.68 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.08 -0.963 . . . . 0.0 108.768 178.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.513 ' OE2' ' CE2' ' A' ' 78' ' ' PHE . 28.9 mt-10 -120.61 85.03 37.73 Favored Pre-proline 0 N--CA 1.464 0.267 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.354 -179.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -72.2 8.85 1.29 Allowed 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 121.819 1.679 . . . . 0.0 111.557 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 65.2 mt -61.56 84.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.903 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 40.5 tp60 -72.86 -133.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -109.02 138.3 45.58 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.5 m -127.95 156.16 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -136.61 104.51 5.57 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.546 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 78.4 mt -118.45 139.97 50.58 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.249 -178.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 91.5 p -69.26 153.81 43.04 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.996 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -65.94 146.6 54.53 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.085 0.469 . . . . 0.0 111.065 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.43 8.82 65.63 Favored Glycine 0 CA--C 1.53 0.976 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.526 HE21 ' C ' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -112.29 156.78 21.84 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 120.976 0.417 . . . . 0.0 110.366 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.526 ' C ' HE21 ' A' ' 20' ' ' GLN . 87.1 m-20 -78.05 144.81 36.29 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.063 178.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -126.07 146.74 49.79 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.072 0.463 . . . . 0.0 110.594 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 41.5 t -156.77 154.74 30.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.927 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -132.81 152.13 51.87 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.809 0.337 . . . . 0.0 110.641 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.405 ' CD ' ' N ' ' A' ' 25' ' ' GLN . 0.5 OUTLIER -124.9 111.25 15.24 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.125 -0.488 . . . . 0.0 109.755 179.48 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 6.7 t -115.84 137.7 51.84 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 82.1 mtm180 -123.47 125.1 44.3 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.8 pp -147.98 141.17 25.07 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 119.974 -0.691 . . . . 0.0 111.438 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.607 ' H ' ' HB ' ' A' ' 6' ' ' THR . 98.5 p -74.31 162.65 28.68 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 178.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -52.24 162.53 0.49 Allowed 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -177.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.521 ' HA ' HG22 ' A' ' 5' ' ' VAL . . . -70.14 157.07 38.28 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 114.018 -1.447 . . . . 0.0 111.401 -179.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.5 t -141.44 -61.34 0.47 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.399 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -101.27 -67.24 0.81 Allowed Glycine 0 N--CA 1.459 0.22 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -123.55 137.72 54.7 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 179.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -79.8 147.58 31.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.589 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.44 152.21 40.85 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.188 179.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 61.3 mtp85 -126.09 147.04 49.68 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.292 -179.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 2.3 t-105 -104.45 151.29 23.72 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.597 -179.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -165.62 148.47 7.72 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.066 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.548 ' C ' HD23 ' A' ' 40' ' ' LEU . 8.0 tt -124.99 126.27 45.18 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.474 ' N ' HD23 ' A' ' 40' ' ' LEU . . . 80.65 7.69 88.3 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.87 -12.74 62.5 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.4 m -112.17 150.76 42.96 Favored Pre-proline 0 N--CA 1.468 0.466 0 C-N-CA 121.975 0.11 . . . . 0.0 110.756 -179.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -57.71 144.33 93.31 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 121.39 1.393 . . . . 0.0 110.666 178.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.476 ' H ' HD23 ' A' ' 45' ' ' LEU . 0.9 OUTLIER -114.66 171.78 7.43 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.691 0.281 . . . . 0.0 111.069 179.756 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -130.58 134.24 46.84 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.952 0.406 . . . . 0.0 110.247 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.01 96.29 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.273 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -75.17 169.67 17.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.997 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -58.43 -45.21 88.96 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 20.6 mmt -67.58 -38.83 84.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.639 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 62.8 t-20 -98.89 106.9 19.21 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.765 -178.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.431 ' O ' ' OG1' ' A' ' 64' ' ' THR . 67.0 m-20 -109.0 108.29 18.97 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.4 HG21 HD13 ' A' ' 53' ' ' ILE . 38.4 mt -100.74 133.74 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -179.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.9 t -146.11 159.17 43.65 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -179.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.0 t -109.25 137.44 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.268 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 57' ' ' GLN . 79.4 mm-40 -116.11 -178.6 3.44 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.438 ' C ' ' O ' ' A' ' 56' ' ' GLU . 56.1 tt0 -26.19 144.98 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 O-C-N 123.889 0.743 . . . . 0.0 112.102 -179.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 59.05 -94.7 0.06 OUTLIER Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.446 ' O ' ' OG1' ' A' ' 59' ' ' THR . 0.0 OUTLIER -166.75 59.49 0.09 Allowed 'General case' 0 C--O 1.24 0.594 0 CA-C-O 121.541 0.686 . . . . 0.0 110.962 -179.797 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.47 ' CD2' ' N ' ' A' ' 60' ' ' LEU . 3.1 mm? -99.55 130.56 45.81 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.099 179.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -107.27 142.96 36.2 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 120.869 0.366 . . . . 0.0 110.261 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.2 mp -137.89 118.92 14.37 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.293 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.33 108.2 19.89 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 52' ' ' ASP . 82.1 p -102.75 96.93 7.18 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 121.138 0.494 . . . . 0.0 109.908 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 36.6 tp -103.34 124.65 49.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.513 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.613 ' CG ' ' H ' ' A' ' 67' ' ' LYS . 1.0 OUTLIER -71.13 -152.71 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.41 -179.465 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.613 ' H ' ' CG ' ' A' ' 66' ' ' HIS . 5.4 mtmp? -53.99 97.09 0.02 OUTLIER 'General case' 0 CA--C 1.522 -0.108 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.376 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.498 HG22 ' H ' ' A' ' 69' ' ' THR . 3.0 p -58.19 168.35 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.819 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.498 ' H ' HG22 ' A' ' 68' ' ' VAL . 58.2 p -134.41 159.79 39.96 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 47.2 tp -58.54 -40.81 84.02 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -69.9 -33.02 71.64 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.677 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.45 ' HB2' ' H ' ' A' ' 69' ' ' THR . 55.3 m-20 -64.27 -40.27 95.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.86 -178.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.74 140.05 57.68 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.649 -0.421 . . . . 0.0 110.24 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -175.39 -108.02 0.22 Allowed Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 -179.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 97.0 m -156.5 109.69 2.63 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.412 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.5 t -89.07 127.9 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 31.9 t -133.03 146.23 51.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.283 0.563 . . . . 0.0 111.542 -178.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.513 ' CE2' ' OE2' ' A' ' 9' ' ' GLU . 0.1 OUTLIER -140.7 159.2 42.73 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.476 179.585 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.433 ' CD2' ' N ' ' A' ' 79' ' ' HIS . 5.3 p80 -143.41 146.39 33.44 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.973 -179.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.48 ' O ' ' N ' ' A' ' 82' ' ' THR . 2.2 t -134.32 134.46 54.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.557 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -43.06 -20.32 0.09 OUTLIER Glycine 0 CA--C 1.533 1.165 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.517 ' OG1' ' N ' ' A' ' 83' ' ' CYS . 33.1 p -82.6 -72.38 0.45 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.839 0.352 . . . . 0.0 110.657 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.517 ' N ' ' OG1' ' A' ' 82' ' ' THR . 7.8 t -128.02 -178.26 4.45 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.699 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.413 ' N ' ' SG ' ' A' ' 83' ' ' CYS . 35.5 m -127.74 149.69 50.12 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.244 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 52.9 p -156.63 162.85 39.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.611 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -160.06 168.14 26.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.983 0.42 . . . . 0.0 111.024 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.78 140.11 28.26 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.865 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 25.1 mp0 -109.7 122.04 46.59 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.098 0.475 . . . . 0.0 111.005 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 53.6 tp -108.54 106.29 16.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.929 179.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -110.02 171.03 7.69 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.458 ' O ' HG23 ' A' ' 91' ' ' VAL . 24.3 m -113.8 128.7 70.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 120.77 0.319 . . . . 0.0 110.242 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.9 m -66.66 136.5 55.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.247 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -148.4 40.37 0.93 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.152 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.816 0 CA-C-O 118.031 -1.427 . . . . 0.0 111.198 179.909 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.1 mtm . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 55.38 77.42 0.43 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.869 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -67.93 146.75 72.67 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.53 2.153 . . . . 0.0 112.434 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.0 tp10 -78.66 152.52 31.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.411 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.47 HG22 ' HA ' ' A' ' 31' ' ' ALA . 4.8 t -58.76 132.89 23.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.487 ' OG1' ' N ' ' A' ' 29' ' ' SER . 51.8 p -94.55 133.91 37.66 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 119.177 -1.009 . . . . 0.0 110.936 -179.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.3 mm -112.45 56.93 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.181 -178.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 48.0 tp -90.1 78.03 6.71 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.537 ' OE1' ' CZ ' ' A' ' 78' ' ' PHE . 16.3 tt0 -121.7 83.82 42.66 Favored Pre-proline 0 N--CA 1.466 0.369 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.286 -179.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -71.46 47.14 0.83 Allowed 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.447 2.098 . . . . 0.0 112.067 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.444 HD11 ' CD2' ' A' ' 24' ' ' PHE . 2.3 mm? -81.69 82.47 7.4 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.418 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -74.12 -86.08 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.811 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.431 ' O ' ' OD2' ' A' ' 13' ' ' ASP . 44.0 p-10 -172.7 133.83 0.6 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.328 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.0 m -131.03 156.5 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-O 120.975 0.417 . . . . 0.0 110.697 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.87 121.66 30.6 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.33 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 53.4 mt -124.66 141.02 52.4 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.319 -179.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.2 t -83.92 155.55 22.8 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 -52.27 143.33 14.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.015 0.436 . . . . 0.0 111.426 -179.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.42 2.1 85.42 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.844 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -101.08 146.76 27.04 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.003 0.43 . . . . 0.0 111.219 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -73.79 153.87 39.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.588 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -134.8 138.92 44.7 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.986 0.422 . . . . 0.0 110.049 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 71.0 m -161.51 158.05 25.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.235 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.444 ' CD2' HD11 ' A' ' 11' ' ' LEU . 67.9 m-85 -135.41 151.08 50.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.158 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -124.09 135.31 53.46 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.532 ' SG ' ' N ' ' A' ' 27' ' ' ARG . 53.8 t -149.8 163.62 37.5 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.043 0.449 . . . . 0.0 111.441 -179.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.532 ' N ' ' SG ' ' A' ' 26' ' ' CYS . 80.2 mtp85 -129.91 96.52 4.23 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.085 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.426 ' O ' ' CG2' ' A' ' 59' ' ' THR . 76.2 mt -113.32 113.66 25.57 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.728 -0.214 . . . . 0.0 111.384 -179.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.487 ' N ' ' OG1' ' A' ' 6' ' ' THR . 44.2 t -68.04 156.2 37.87 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 178.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -53.33 167.03 0.22 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -177.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.47 ' HA ' HG22 ' A' ' 5' ' ' VAL . . . -63.24 159.88 16.87 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 113.691 -1.595 . . . . 0.0 111.799 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.7 t -140.87 -58.19 0.51 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.49 -69.71 0.7 Allowed Glycine 0 CA--C 1.521 0.437 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 177.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -121.75 144.48 48.77 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.05 0.452 . . . . 0.0 110.652 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -83.85 142.12 30.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.57 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.29 152.68 41.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.443 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -124.15 126.72 46.64 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.199 0.523 . . . . 0.0 110.683 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 40.8 t-105 -93.73 148.05 22.47 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.951 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -167.37 154.99 8.96 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 119.632 -0.827 . . . . 0.0 112.123 -179.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 67.2 tp -118.17 117.03 28.05 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.74 8.7 82.38 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.9 3.93 79.39 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.5 t -113.48 134.8 21.9 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-O 119.224 -0.417 . . . . 0.0 110.357 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -50.83 138.49 41.88 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 121.022 1.148 . . . . 0.0 110.57 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -114.25 174.16 6.09 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.923 0.392 . . . . 0.0 111.792 -178.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -136.98 150.25 48.03 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.294 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.19 78.43 0.05 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.624 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.427 ' O ' ' O ' ' A' ' 51' ' ' ASN . 7.9 m120 -71.41 178.89 3.19 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.021 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 56.8 mp0 -61.31 -44.88 96.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.228 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 25.9 ptm -83.69 -17.15 42.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.074 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.427 ' O ' ' O ' ' A' ' 48' ' ' ASN . 77.1 m-20 -114.16 105.07 12.75 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.29 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -115.12 130.41 56.92 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 42.7 mt -123.78 133.99 67.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.2 t -137.61 153.23 49.92 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.024 0.44 . . . . 0.0 110.781 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 53.4 t -111.85 131.87 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.254 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -108.12 162.0 14.45 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.932 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -49.87 150.76 2.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.787 -179.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.31 13.09 82.35 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.426 ' CG2' ' O ' ' A' ' 28' ' ' LEU . 1.0 OUTLIER 67.38 26.68 8.35 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.835 0.35 . . . . 0.0 110.629 -179.76 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.6 mp -77.47 136.36 38.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.14 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 5.6 t-160 -104.97 153.39 21.49 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.213 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.1 tp -152.77 110.68 3.63 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 121.01 0.434 . . . . 0.0 109.969 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.416 ' C ' ' CD1' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -86.14 107.54 17.91 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.517 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 60.3 m -99.93 99.93 10.76 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.262 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 41.0 tp -110.94 120.66 43.14 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.452 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.484 ' CG ' ' H ' ' A' ' 67' ' ' LYS . 26.8 t60 -138.55 175.46 9.55 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.215 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.484 ' H ' ' CG ' ' A' ' 66' ' ' HIS . 64.1 mttp 55.18 57.09 5.8 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -179.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 28.2 m -108.28 156.3 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-O 121.448 0.642 . . . . 0.0 111.5 -179.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 36.5 p -135.69 -149.6 0.34 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.69 178.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 16.7 mt -56.52 -23.68 41.44 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -71.45 -1.15 12.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.693 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -56.89 -39.74 74.94 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.711 -0.395 . . . . 0.0 109.945 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.61 147.45 18.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.653 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 171.38 -161.14 33.51 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 87.5 m -153.5 109.28 3.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.719 0.295 . . . . 0.0 110.31 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.0 m -80.3 136.29 23.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.577 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.9 t -144.8 145.82 31.82 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.029 0.442 . . . . 0.0 110.904 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.537 ' CZ ' ' OE1' ' A' ' 9' ' ' GLU . 38.9 p90 -150.07 151.7 33.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.07 179.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.513 ' CE1' ' HG ' ' A' ' 84' ' ' SER . 64.9 t60 -134.86 131.22 37.12 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.906 -179.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.529 ' O ' ' N ' ' A' ' 82' ' ' THR . 2.4 t -127.87 130.89 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.22 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -39.91 -21.33 0.03 OUTLIER Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.775 -0.53 . . . . 0.0 111.775 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.529 ' N ' ' O ' ' A' ' 80' ' ' VAL . 19.0 p -88.54 -71.93 0.56 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.87 0.367 . . . . 0.0 110.233 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 4.1 t -132.04 160.1 36.88 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.939 179.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.513 ' HG ' ' CE1' ' A' ' 79' ' ' HIS . 20.4 m -133.91 154.88 50.77 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.157 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.5 m -160.28 161.65 33.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.116 0.484 . . . . 0.0 111.26 -179.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -143.05 150.13 39.15 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.424 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -135.01 153.24 52.16 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.303 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -108.43 135.74 49.22 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 121.365 0.603 . . . . 0.0 111.412 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 50.0 tp -115.59 96.42 5.62 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.103 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.5 ttmt -94.28 169.74 10.01 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.536 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.8 t -118.38 131.37 71.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -108.92 134.61 51.36 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.719 0.295 . . . . 0.0 110.798 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.22 137.77 57.84 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.422 -0.511 . . . . 0.0 109.838 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.701 0 CA-C-O 117.915 -1.492 . . . . 0.0 111.34 -179.115 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 ptm . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.31 149.84 30.16 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.158 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -56.69 -25.11 58.4 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 121.711 1.607 . . . . 0.0 111.383 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -38.0 142.5 0.16 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.479 0.657 . . . . 0.0 111.71 -179.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.41 HG13 ' O ' ' A' ' 5' ' ' VAL . 8.7 p -65.1 133.85 30.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.401 179.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.476 ' N ' ' OG ' ' A' ' 29' ' ' SER . 59.7 p -92.77 136.48 33.21 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.337 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.547 HG23 ' O ' ' A' ' 7' ' ' ILE . 2.4 tp -118.21 107.0 20.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-O 122.487 1.137 . . . . 0.0 111.455 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.544 HD12 ' C ' ' A' ' 7' ' ' ILE . 9.7 mp -126.14 79.94 1.88 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 113.996 -1.456 . . . . 0.0 108.418 178.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -120.62 87.8 42.27 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.652 -178.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.45 ' O ' ' N ' ' A' ' 12' ' ' GLN . 2.5 Cg_endo -73.75 -7.0 19.54 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 C-N-CA 122.109 1.873 . . . . 0.0 110.727 178.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 98.2 mt -56.23 83.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.233 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.45 ' N ' ' O ' ' A' ' 10' ' ' PRO . 59.5 tt0 -85.64 -64.76 1.1 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.594 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 14' ' ' VAL . 60.1 t0 -170.64 142.88 2.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.721 -178.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.545 ' N ' ' OD1' ' A' ' 13' ' ' ASP . 29.3 m -132.82 161.68 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.984 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.422 ' CD ' ' N ' ' A' ' 15' ' ' GLN . 0.6 OUTLIER -128.47 115.71 18.59 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.883 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 60.4 mt -122.16 143.78 49.35 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.949 0.404 . . . . 0.0 111.465 -179.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.7 m -80.74 157.86 25.7 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.003 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -65.9 148.53 51.65 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.585 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.8 10.16 84.53 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 111.071 -0.811 . . . . 0.0 111.071 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -121.16 145.14 48.13 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -74.29 162.25 29.09 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.403 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -131.22 162.24 30.42 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 28.1 p -159.39 158.51 32.32 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.196 -0.602 . . . . 0.0 111.476 -179.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -139.75 148.22 41.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.294 179.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -136.33 126.99 27.14 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.595 ' SG ' ' N ' ' A' ' 27' ' ' ARG . 8.2 t -130.13 162.47 28.76 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.472 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.595 ' N ' ' SG ' ' A' ' 26' ' ' CYS . 79.4 ttt180 -143.41 116.01 8.65 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.471 ' O ' HG21 ' A' ' 59' ' ' THR . 2.4 pp -146.06 123.47 11.67 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 119.846 -0.742 . . . . 0.0 111.71 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.476 ' OG ' ' N ' ' A' ' 6' ' ' THR . 92.4 p -62.25 160.23 13.49 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -53.52 155.84 2.81 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 122.015 0.912 . . . . 0.0 113.388 -177.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -53.47 179.57 0.02 OUTLIER 'General case' 0 C--O 1.232 0.163 0 CA-C-N 113.875 -1.511 . . . . 0.0 112.044 -179.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.4 p -156.56 -50.39 0.08 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.406 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -101.69 -66.87 0.79 Allowed Glycine 0 CA--C 1.522 0.507 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 178.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -122.69 157.46 32.21 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.726 0.298 . . . . 0.0 110.34 179.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -79.85 141.64 35.98 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.798 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.42 145.84 36.93 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.332 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -128.95 144.27 51.13 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.268 0.556 . . . . 0.0 111.062 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 18.8 t-105 -100.67 155.7 17.74 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.797 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -164.56 151.3 11.07 Favored 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 119.774 -0.77 . . . . 0.0 111.913 -179.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.559 HD13 ' N ' ' A' ' 41' ' ' GLY . 0.5 OUTLIER -129.32 116.63 19.37 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.057 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.559 ' N ' HD13 ' A' ' 40' ' ' LEU . . . 66.85 19.07 69.23 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -178.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.13 4.11 84.43 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.966 -0.853 . . . . 0.0 110.966 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.2 t -111.02 128.38 25.41 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-O 119.491 -0.29 . . . . 0.0 110.478 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -57.76 144.96 92.26 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 121.094 1.196 . . . . 0.0 111.284 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.821 ' H ' HD23 ' A' ' 45' ' ' LEU . 1.1 pt? -130.42 149.69 51.99 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.527 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -128.03 166.18 18.89 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.639 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.6 141.76 19.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.099 0.476 . . . . 0.0 111.377 -178.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.432 ' O ' ' O ' ' A' ' 51' ' ' ASN . 36.3 p-10 -163.3 -171.53 2.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.653 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -65.08 -46.72 79.97 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.169 -179.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 65.6 mtt -67.92 -42.91 80.36 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -179.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.432 ' O ' ' O ' ' A' ' 48' ' ' ASN . 17.5 m-20 -118.23 145.71 44.8 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 120.784 0.326 . . . . 0.0 111.458 -179.033 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 48' ' ' ASN . 98.2 m-20 -138.47 108.94 6.52 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.088 178.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.8 pt -101.23 134.61 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.472 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.7 t -139.11 155.46 47.87 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.872 0.368 . . . . 0.0 111.176 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.417 ' O ' HG23 ' A' ' 55' ' ' VAL . 35.5 m -120.14 129.14 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.158 -179.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.435 ' N ' ' OE2' ' A' ' 56' ' ' GLU . 56.7 mp0 -124.62 179.53 4.92 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.332 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 58.9 tp60 -48.93 147.52 2.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.199 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.48 14.72 80.79 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 111.542 -0.623 . . . . 0.0 111.542 179.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.471 HG21 ' O ' ' A' ' 28' ' ' LEU . 2.2 m 61.96 38.33 14.38 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 120.989 0.423 . . . . 0.0 110.266 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 49.3 mt -83.18 129.62 35.03 Favored 'General case' 0 CA--C 1.527 0.064 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.434 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 59.6 m170 -108.68 153.48 23.37 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.0 tp -154.83 116.77 4.17 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.225 -178.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.458 ' CD1' ' N ' ' A' ' 63' ' ' LEU . 7.2 mp -97.43 121.01 38.83 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 23.6 m -108.33 107.11 17.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.396 0.617 . . . . 0.0 109.665 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.423 ' CD2' ' N ' ' A' ' 65' ' ' LEU . 1.5 mm? -92.78 130.53 38.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.873 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.569 ' CG ' ' H ' ' A' ' 67' ' ' LYS . 1.5 t-80 -83.25 -150.9 0.1 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.406 -179.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.569 ' H ' ' CG ' ' A' ' 66' ' ' HIS . 13.9 ptpt -60.38 95.92 0.04 OUTLIER 'General case' 0 N--CA 1.461 0.102 0 CA-C-O 121.253 0.549 . . . . 0.0 110.337 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.5 m -96.78 133.98 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 121.302 0.572 . . . . 0.0 110.939 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 27.5 p -88.35 -152.89 0.23 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.202 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.4 mp -61.97 -23.56 66.46 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.7 tp10 -66.58 -1.72 3.99 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.098 -0.956 . . . . 0.0 110.142 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -54.74 -44.35 73.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.112 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.48 129.83 40.33 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -175.6 143.82 6.84 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.402 HG23 ' NE2' ' A' ' 88' ' ' GLN . 53.1 m -97.01 125.6 41.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.755 0.312 . . . . 0.0 110.873 -179.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.6 t -101.61 126.49 55.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 47.5 t -124.27 140.91 52.51 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.963 0.411 . . . . 0.0 110.485 -179.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -146.9 154.59 41.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.023 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 19.6 p80 -150.69 149.19 29.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.071 0.463 . . . . 0.0 110.55 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.541 ' O ' ' N ' ' A' ' 82' ' ' THR . 4.0 p -146.38 88.16 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.089 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 80' ' ' VAL . . . 30.75 -85.93 0.01 OUTLIER Glycine 0 CA--C 1.53 1.001 0 CA-C-N 115.487 -0.778 . . . . 0.0 112.462 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.541 ' N ' ' O ' ' A' ' 80' ' ' VAL . 25.3 p -39.11 -85.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -179.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.459 ' SG ' ' N ' ' A' ' 84' ' ' SER . 33.1 t -105.65 167.69 9.6 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.043 0.449 . . . . 0.0 111.862 -178.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.459 ' N ' ' SG ' ' A' ' 83' ' ' CYS . 35.3 t -151.11 145.81 25.72 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.265 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 46.9 t -158.09 172.13 18.98 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.072 0.463 . . . . 0.0 111.151 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -144.2 162.76 35.51 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.492 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -134.08 156.3 48.51 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.079 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.444 ' O ' ' OD1' ' A' ' 13' ' ' ASP . 98.9 mm-40 -118.59 135.97 54.13 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.823 0.344 . . . . 0.0 111.367 -179.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.497 HD23 ' C ' ' A' ' 89' ' ' LEU . 2.2 tt -115.27 109.64 18.24 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.495 ' N ' HD23 ' A' ' 89' ' ' LEU . 32.5 mmtp -105.66 160.76 14.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.005 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.4 m -117.89 127.35 75.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 120.934 0.397 . . . . 0.0 110.231 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.656 HG22 ' H ' ' A' ' 94' ' ' GLY . 85.9 m -123.3 127.68 48.88 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.101 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -89.64 -6.04 56.56 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.006 0.431 . . . . 0.0 109.964 179.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.656 ' H ' HG22 ' A' ' 92' ' ' THR . . . . . . . . 0 C--O 1.22 -0.75 0 CA-C-O 117.936 -1.48 . . . . 0.0 111.202 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.0 mtm . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -169.42 79.74 0.68 Allowed Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.97 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -69.54 -22.05 33.63 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.368 2.045 . . . . 0.0 111.945 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -74.23 154.94 38.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.048 0.452 . . . . 0.0 110.514 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.465 ' O ' HG13 ' A' ' 5' ' ' VAL . 8.7 p -62.04 132.46 27.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.796 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -111.54 122.04 46.77 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 179.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 76.9 mt -105.1 118.57 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-O 121.755 0.788 . . . . 0.0 111.804 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.9 mt -127.3 75.77 1.61 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.485 -1.234 . . . . 0.0 108.049 178.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.505 ' OE1' ' CE2' ' A' ' 78' ' ' PHE . 35.7 tt0 -114.97 92.83 32.28 Favored Pre-proline 0 N--CA 1.467 0.4 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.984 -177.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.53 ' O ' ' N ' ' A' ' 12' ' ' GLN . 2.6 Cg_endo -75.29 -6.59 18.04 Favored 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 122.042 1.828 . . . . 0.0 111.035 178.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 63.6 mt -60.91 72.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.191 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.53 ' N ' ' O ' ' A' ' 10' ' ' PRO . 70.9 tp60 -74.9 -64.1 1.12 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.124 -179.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.7 p-10 -170.29 133.87 1.13 Allowed 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 120.446 -0.501 . . . . 0.0 111.486 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.5 m -134.65 159.73 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.793 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -135.58 117.14 14.85 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.386 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 81.2 mt -121.2 132.64 54.95 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.439 -179.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.7 m -69.68 158.69 34.87 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.817 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.42 ' OE2' ' O ' ' A' ' 68' ' ' VAL . 52.5 tp10 -58.31 146.37 34.59 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.612 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.7 1.13 80.85 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.497 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -110.23 146.55 35.42 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.893 0.378 . . . . 0.0 110.562 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 52.6 p-10 -82.33 170.53 15.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.053 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -148.12 152.39 37.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.173 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 95.9 p -152.01 123.13 7.63 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.072 0.463 . . . . 0.0 111.048 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -103.82 119.51 39.06 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.453 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -131.52 133.44 45.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.948 0.404 . . . . 0.0 109.958 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 8.4 p -151.59 151.7 31.9 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.107 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 85.2 mtt85 -96.68 132.34 42.44 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.875 179.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.516 ' C ' HD23 ' A' ' 28' ' ' LEU . 2.9 tt -144.88 106.02 4.19 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.692 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.6 m -62.04 150.83 37.05 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.804 0.335 . . . . 0.0 110.432 179.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -56.33 156.13 6.19 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.528 0.68 . . . . 0.0 112.581 -178.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.78 -174.71 3.53 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.705 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 27.0 m -154.21 -43.93 0.09 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -86.76 -74.16 1.28 Allowed Glycine 0 CA--C 1.521 0.463 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 178.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.454 ' CD ' ' N ' ' A' ' 34' ' ' GLN . 25.4 mp0 -121.98 132.29 54.45 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.924 0.392 . . . . 0.0 110.994 179.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -77.28 150.41 35.3 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.835 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.14 147.31 38.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.643 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 45.8 mmm-85 -115.12 137.16 52.33 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.771 0.32 . . . . 0.0 111.225 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 1.8 t-105 -101.79 140.51 35.98 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.013 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -176.38 163.88 2.55 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.119 -179.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.62 HD23 ' H ' ' A' ' 40' ' ' LEU . 1.6 pt? -139.66 129.52 24.76 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.246 0.546 . . . . 0.0 110.467 178.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.58 7.03 78.65 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.84 -17.04 58.82 Favored Glycine 0 CA--C 1.529 0.969 0 N-CA-C 111.937 -0.465 . . . . 0.0 111.937 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.1 t -101.55 123.07 45.62 Favored Pre-proline 0 CA--C 1.541 0.633 0 CA-C-N 116.905 0.352 . . . . 0.0 110.37 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -58.69 138.01 83.33 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 CA-C-N 119.875 0.991 . . . . 0.0 111.204 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.0 -174.96 4.18 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.095 0.474 . . . . 0.0 110.551 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.492 ' O ' ' N ' ' A' ' 48' ' ' ASN . 2.6 pm0 -139.06 154.92 48.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.185 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.95 70.33 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.616 -0.433 . . . . 0.0 110.389 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.492 ' N ' ' O ' ' A' ' 46' ' ' GLN . 18.4 t-20 -68.84 157.73 35.9 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.748 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.467 ' N ' ' OD1' ' A' ' 48' ' ' ASN . 86.1 tt0 -55.74 -44.6 77.72 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.246 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 5.4 ptt? -69.31 -35.54 76.08 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 120.907 0.384 . . . . 0.0 110.18 179.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.446 ' O ' ' O ' ' A' ' 48' ' ' ASN . 41.7 m-20 -116.47 104.64 11.64 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.136 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.419 ' OD2' ' O ' ' A' ' 48' ' ' ASN . 96.7 m-20 -107.97 138.1 44.82 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.704 0.288 . . . . 0.0 110.46 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.3 mt -117.98 129.81 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.312 -0.404 . . . . 0.0 109.995 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.1 t -142.38 146.78 35.29 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.02 0.438 . . . . 0.0 111.137 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 51.5 t -122.48 132.17 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.417 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -121.94 177.08 5.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.292 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -42.84 151.45 0.13 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.343 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.12 20.6 80.01 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.454 ' OG1' ' O ' ' A' ' 28' ' ' LEU . 62.8 p 47.62 38.3 8.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.086 0.47 . . . . 0.0 110.444 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 94.6 mt -75.73 138.72 41.45 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.31 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -108.18 148.31 30.09 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.032 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 53.9 tp -160.49 101.19 1.35 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.043 0.449 . . . . 0.0 110.501 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.439 HD12 ' N ' ' A' ' 64' ' ' THR . 4.8 tp -100.24 109.78 22.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.591 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.439 ' N ' HD12 ' A' ' 63' ' ' LEU . 2.9 p -86.14 112.08 20.96 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.238 0.542 . . . . 0.0 110.715 -179.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 55.5 tp -111.58 123.71 50.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.183 179.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.519 ' CG ' ' N ' ' A' ' 67' ' ' LYS . 78.3 t60 -145.67 167.94 21.9 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.993 0.425 . . . . 0.0 111.043 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.519 ' N ' ' CG ' ' A' ' 66' ' ' HIS . 72.0 tttt 56.77 57.06 4.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.443 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.42 ' O ' ' OE2' ' A' ' 18' ' ' GLU . 5.7 m -93.7 174.28 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 121.838 0.828 . . . . 0.0 111.544 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.491 ' C ' ' H ' ' A' ' 71' ' ' GLU . 4.4 t -137.89 157.22 46.85 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.121 -1.399 . . . . 0.0 108.216 178.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 67.8 mt -52.55 -5.96 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.521 -0.472 . . . . 0.0 111.202 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.491 ' H ' ' C ' ' A' ' 69' ' ' THR . 80.2 mm-40 -113.82 2.41 15.12 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.437 ' O ' ' O ' ' A' ' 73' ' ' ALA . 24.9 t70 -63.14 -52.71 61.41 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.673 -179.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.437 ' O ' ' O ' ' A' ' 72' ' ' ASP . . . 42.96 -167.81 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 -179.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 157.34 95.01 0.1 Allowed Glycine 0 CA--C 1.524 0.645 0 C-N-CA 120.404 -0.903 . . . . 0.0 112.351 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 40.6 p -90.74 94.54 9.72 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 178.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.0 t -76.87 152.09 5.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.18 0.514 . . . . 0.0 111.128 -179.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 33.9 t -153.64 151.63 29.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.3 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.505 ' CE2' ' OE1' ' A' ' 9' ' ' GLU . 64.6 m-85 -131.62 144.59 51.16 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.029 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -143.47 116.0 8.61 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.582 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.535 ' O ' ' N ' ' A' ' 82' ' ' THR . 5.6 p -129.38 135.0 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.739 178.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -38.01 -21.4 0.01 OUTLIER Glycine 0 CA--C 1.527 0.79 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.674 -178.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.535 ' N ' ' O ' ' A' ' 80' ' ' VAL . 82.7 p -85.19 -74.5 0.4 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.891 0.377 . . . . 0.0 111.14 -179.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.505 ' H ' HG13 ' A' ' 80' ' ' VAL . 60.4 m -128.08 -166.6 1.64 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.416 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 87.8 p -157.1 162.78 39.44 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.761 0.315 . . . . 0.0 110.93 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.9 p -152.9 166.99 30.6 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.904 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -141.97 155.98 45.46 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.147 0.499 . . . . 0.0 111.945 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.99 153.58 33.21 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.413 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -133.93 137.27 44.78 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.585 0.707 . . . . 0.0 112.328 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.7 tp -111.03 116.61 31.46 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.551 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -118.85 164.03 16.02 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.001 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.6 m -123.9 128.25 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 120.997 0.427 . . . . 0.0 110.386 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 23.3 m -73.3 134.19 44.11 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.82 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.74 148.95 51.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.444 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.666 0 CA-C-O 117.994 -1.448 . . . . 0.0 111.066 -179.875 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.7 mtt . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.584 ' N ' ' CD ' ' A' ' 3' ' ' PRO . . . -67.43 -39.47 20.35 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.783 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 2' ' ' ALA . 3.2 Cg_exo -75.43 -172.23 1.24 Allowed 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 122.298 1.999 . . . . 0.0 111.866 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -52.79 -171.74 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.297 0.57 . . . . 0.0 110.967 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.738 HG23 ' O ' ' A' ' 29' ' ' SER . 8.9 p -55.18 131.7 18.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.368 -0.833 . . . . 0.0 108.757 178.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 13.6 m -81.56 123.53 28.73 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 119.482 -0.887 . . . . 0.0 109.442 -179.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.8 mt -108.84 118.26 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 121.582 0.706 . . . . 0.0 112.673 -178.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 85.2 mt -126.31 111.11 14.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.466 -1.243 . . . . 0.0 107.947 177.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.537 ' N ' ' OE1' ' A' ' 9' ' ' GLU . 1.6 pm0 -122.96 88.5 50.76 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.318 -178.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -74.58 -8.51 20.6 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 122.068 1.846 . . . . 0.0 110.677 178.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.406 HD21 ' H ' ' A' ' 25' ' ' GLN . 67.3 mt -68.83 81.75 0.29 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.692 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -71.89 -58.79 3.15 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.786 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 14' ' ' VAL . 62.4 t0 -175.27 137.63 0.4 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.065 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.529 ' N ' ' OD1' ' A' ' 13' ' ' ASP . 28.4 m -137.54 156.52 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-O 121.11 0.481 . . . . 0.0 111.48 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -123.0 132.22 54.04 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.884 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.422 HD22 ' HB2' ' A' ' 22' ' ' ALA . 59.6 mt -120.54 123.73 43.61 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.476 -178.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.8 t -74.84 145.34 42.9 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 177.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -59.38 137.8 57.87 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.348 -179.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.98 -0.47 72.8 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -114.62 133.14 56.06 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.85 0.357 . . . . 0.0 110.763 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.409 ' C ' ' OD2' ' A' ' 21' ' ' ASP . 54.9 p30 -78.86 172.06 14.29 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.434 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.422 ' HB2' HD22 ' A' ' 16' ' ' LEU . . . -159.92 173.18 16.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.023 0.44 . . . . 0.0 111.263 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 29.0 p -154.67 162.29 41.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.502 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -127.93 152.55 47.74 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.022 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.406 ' H ' HD21 ' A' ' 11' ' ' LEU . 61.8 tt0 -130.58 130.06 43.56 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.473 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.466 ' SG ' ' N ' ' A' ' 27' ' ' ARG . 48.5 t -141.89 164.6 29.74 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.412 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.466 ' N ' ' SG ' ' A' ' 26' ' ' CYS . 95.7 mtt180 -140.95 121.19 13.86 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.951 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 86.0 mt -126.39 103.05 7.42 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.842 179.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.738 ' O ' HG23 ' A' ' 5' ' ' VAL . 25.1 t -63.52 170.03 3.44 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -52.62 140.21 23.85 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.378 0.609 . . . . 0.0 111.689 -178.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -91.42 -172.66 3.34 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.21 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 38.0 t -150.58 -60.26 0.19 Allowed 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -72.69 -90.13 0.13 Allowed Glycine 0 CA--C 1.521 0.45 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -123.56 143.33 50.27 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.935 0.397 . . . . 0.0 110.963 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -79.35 151.32 31.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.328 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.416 ' CB ' HG22 ' A' ' 80' ' ' VAL . . . -72.74 155.69 39.71 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.427 179.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -125.45 133.57 52.4 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.19 0.519 . . . . 0.0 111.306 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 1.5 t-105 -76.8 156.86 31.98 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.813 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -169.61 152.64 4.74 Favored 'General case' 0 N--CA 1.461 0.119 0 C-N-CA 119.716 -0.794 . . . . 0.0 111.959 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.61 HD13 ' C ' ' A' ' 40' ' ' LEU . 2.4 tm? -125.5 117.32 23.37 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.572 ' N ' HD13 ' A' ' 40' ' ' LEU . . . 82.2 4.1 90.33 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 -179.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 102.62 -9.88 55.8 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.803 -0.519 . . . . 0.0 111.803 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.5 m -107.82 155.3 40.13 Favored Pre-proline 0 N--CA 1.47 0.562 0 CA-C-N 117.08 0.44 . . . . 0.0 110.545 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -68.45 154.77 71.13 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 121.392 1.394 . . . . 0.0 112.258 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.475 HD12 ' C ' ' A' ' 45' ' ' LEU . 0.4 OUTLIER -130.48 -175.87 3.78 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.163 179.419 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.561 ' O ' ' N ' ' A' ' 48' ' ' ASN . 50.1 tt0 -141.95 149.74 40.51 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 179.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -50.14 82.64 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.947 0.404 . . . . 0.0 111.204 -179.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.561 ' N ' ' O ' ' A' ' 46' ' ' GLN . 52.3 t30 -81.03 162.17 23.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.372 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -57.77 -45.53 85.82 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.211 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 66.6 mtt -66.13 -38.35 87.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.819 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.452 ' O ' ' O ' ' A' ' 48' ' ' ASN . 79.4 m-20 -108.91 111.27 22.88 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.522 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -105.26 145.42 30.69 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 33.1 mt -125.0 129.85 73.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 90.2 m -124.69 131.74 53.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.601 -179.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 63.8 t -111.99 131.9 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.166 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.436 ' O ' ' O ' ' A' ' 57' ' ' GLN . 75.6 tt0 -137.09 156.77 47.97 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.911 -179.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.436 ' O ' ' O ' ' A' ' 56' ' ' GLU . 6.8 pt20 -41.58 165.87 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.952 0.406 . . . . 0.0 111.201 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.23 16.75 71.43 Favored Glycine 0 CA--C 1.517 0.16 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 70.7 p 52.23 31.31 9.0 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.26 -0.47 . . . . 0.0 110.048 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 22.9 mt -72.96 129.69 38.68 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.608 179.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 81.0 m80 -112.85 149.5 33.02 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.819 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 54.1 tp -151.16 106.49 3.34 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 120.809 -0.357 . . . . 0.0 111.126 -179.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -87.44 105.7 17.46 Favored 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.1 m -91.99 107.35 19.15 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.297 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 39.5 tp -97.77 110.42 22.99 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.503 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.426 ' O ' ' O ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -91.85 144.11 25.82 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.817 -179.828 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.426 ' O ' ' O ' ' A' ' 66' ' ' HIS . 99.2 mttt 41.76 96.85 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.09 179.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.9 p -75.28 156.12 6.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.073 0.464 . . . . 0.0 110.905 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.7 m -134.61 156.64 48.36 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.095 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 70.6 mt -56.56 -24.65 48.59 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -74.27 -6.32 47.28 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.044 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -60.48 -39.11 86.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.815 0.34 . . . . 0.0 110.754 -179.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -44.27 126.25 5.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.71 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -178.75 -150.52 8.89 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.459 HG23 ' O ' ' A' ' 87' ' ' ALA . 10.0 m -150.46 106.52 3.45 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 110.336 -0.246 . . . . 0.0 110.336 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.8 t -83.06 133.27 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.1 p -151.62 164.13 37.56 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.16 0.505 . . . . 0.0 111.338 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -141.9 146.53 35.84 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.517 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -119.28 129.29 54.82 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.192 0.52 . . . . 0.0 111.526 -179.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.531 ' C ' ' H ' ' A' ' 82' ' ' THR . 2.0 t -120.68 132.24 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.032 179.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -50.32 -6.72 0.11 Allowed Glycine 0 CA--C 1.529 0.925 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.408 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.531 ' H ' ' C ' ' A' ' 80' ' ' VAL . 6.4 p -102.8 -52.0 3.17 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.737 0.303 . . . . 0.0 110.194 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -152.8 161.6 42.35 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.946 179.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 40.1 t -135.54 143.19 45.58 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.935 0.398 . . . . 0.0 111.001 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 67.1 m -134.13 160.16 38.64 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.46 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.491 ' N ' ' OE2' ' A' ' 86' ' ' GLU . 57.9 mp0 -130.88 156.14 45.55 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.785 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.459 ' O ' HG23 ' A' ' 75' ' ' THR . . . -134.53 142.65 47.07 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.203 179.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.484 ' CD ' ' N ' ' A' ' 88' ' ' GLN . 14.7 mp0 -106.93 127.29 53.3 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.434 0.635 . . . . 0.0 111.955 -178.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.582 HD23 ' C ' ' A' ' 89' ' ' LEU . 4.6 tt -119.69 114.15 21.74 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.164 179.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.54 ' N ' HD23 ' A' ' 89' ' ' LEU . 23.2 mtmm -109.93 154.03 23.68 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.528 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.8 t -119.42 131.34 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.9 m -84.8 131.57 34.52 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.64 3.13 3.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.009 -179.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.693 0 CA-C-O 118.052 -1.416 . . . . 0.0 110.926 179.895 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.3 mmm . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -172.26 71.57 0.44 Allowed Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.54 -179.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -70.67 -18.77 32.47 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.474 2.116 . . . . 0.0 111.781 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -81.77 155.99 25.17 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.72 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.61 HG22 ' HA ' ' A' ' 31' ' ' ALA . 2.8 t -61.01 133.14 26.8 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.455 ' H ' ' HB2' ' A' ' 29' ' ' SER . 9.0 m -111.94 131.46 55.37 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.842 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.407 HD11 HG11 ' A' ' 80' ' ' VAL . 2.4 mt -120.41 124.08 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 120.959 0.409 . . . . 0.0 111.905 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.431 ' HA ' HD22 ' A' ' 8' ' ' LEU . 0.2 OUTLIER -130.46 89.93 2.85 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.271 177.845 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -121.53 83.3 41.02 Favored Pre-proline 0 N--CA 1.469 0.524 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.221 -179.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -73.92 -10.48 23.08 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.215 1.943 . . . . 0.0 111.57 179.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.472 ' CD2' ' H ' ' A' ' 25' ' ' GLN . 0.3 OUTLIER -91.75 55.14 2.63 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.194 0.521 . . . . 0.0 109.908 179.759 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -80.48 -1.19 40.62 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.418 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -151.67 109.39 3.65 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 43.0 t -120.41 133.87 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.017 -178.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -135.07 100.32 4.53 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.961 0.41 . . . . 0.0 110.961 179.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 66.2 mt -115.78 139.98 49.65 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.458 -179.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 85.3 p -74.58 165.68 24.81 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.767 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -69.23 146.41 52.37 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.011 0.434 . . . . 0.0 110.523 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.08 1.33 89.67 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 70.7 tp60 -105.34 148.34 27.17 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.614 0.245 . . . . 0.0 110.48 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 21' ' ' ASP . 54.8 p30 -76.29 153.82 35.61 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.79 147.58 37.52 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.97 -179.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.4 m -163.09 171.23 16.71 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.715 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -128.36 143.7 51.04 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.472 ' H ' ' CD2' ' A' ' 11' ' ' LEU . 88.0 mt-30 -139.19 119.7 13.97 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.723 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 9.7 p -152.04 163.89 38.37 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.418 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -102.05 137.06 40.82 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.419 ' C ' HD13 ' A' ' 28' ' ' LEU . 0.3 OUTLIER -140.52 95.68 2.91 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.978 -179.774 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.455 ' HB2' ' H ' ' A' ' 6' ' ' THR . 69.1 m -59.25 152.27 21.17 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.006 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -54.41 156.02 3.57 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -177.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.61 ' HA ' HG22 ' A' ' 5' ' ' VAL . . . -73.29 -178.71 3.06 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 114.606 -1.179 . . . . 0.0 112.123 -179.233 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 89.6 p -156.71 -52.05 0.08 Allowed 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.223 -0.898 . . . . 0.0 109.713 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -97.29 -65.4 0.9 Allowed Glycine 0 CA--C 1.524 0.648 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 179.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.446 ' HB2' ' H ' ' A' ' 81' ' ' GLY . 87.1 mt-30 -124.03 152.11 42.99 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -86.18 135.91 33.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.952 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.2 152.71 34.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.513 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -147.05 146.93 30.16 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.163 0.506 . . . . 0.0 111.739 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -81.48 179.64 7.76 Favored 'General case' 0 CA--C 1.521 -0.139 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.607 179.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.649 ' HB3' ' O ' ' A' ' 77' ' ' SER . . . -165.74 131.6 2.56 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.202 179.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 53.1 tp -133.89 123.35 24.58 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.012 179.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.31 8.83 80.53 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.08 -17.31 58.87 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.4 m -112.16 147.48 37.05 Favored Pre-proline 0 CA--C 1.535 0.381 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -52.39 140.7 52.79 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 121.301 1.334 . . . . 0.0 111.042 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.432 ' H ' ' CD2' ' A' ' 45' ' ' LEU . 0.9 OUTLIER -78.44 168.69 19.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.909 0.385 . . . . 0.0 110.874 -179.546 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -131.38 142.11 49.99 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.716 -179.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.42 62.89 1.02 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.796 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.459 ' O ' ' O ' ' A' ' 51' ' ' ASN . 97.3 m-20 -74.69 159.53 31.94 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -40.86 -36.49 0.64 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 120.681 -0.407 . . . . 0.0 111.359 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 94.4 mtp -64.55 -43.57 93.54 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.782 0.325 . . . . 0.0 111.117 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.463 ' O ' ' OD2' ' A' ' 52' ' ' ASP . 70.9 m-80 -100.26 149.97 23.04 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.469 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.463 ' OD2' ' O ' ' A' ' 51' ' ' ASN . 84.4 m-20 -140.21 98.51 3.45 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.888 0.375 . . . . 0.0 110.634 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.7 mt -85.72 128.1 39.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.516 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.3 t -140.03 152.22 46.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.987 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.1 t -119.88 130.12 74.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.05 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -126.18 -174.95 3.23 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.405 -179.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -54.3 152.06 6.74 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.858 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.65 26.47 74.42 Favored Glycine 0 CA--C 1.52 0.394 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.414 ' OG1' ' O ' ' A' ' 28' ' ' LEU . 17.8 p 48.33 29.07 1.81 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.762 0.315 . . . . 0.0 110.681 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 23.5 mt -69.32 131.9 45.57 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.278 0.561 . . . . 0.0 111.006 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 64.2 m80 -110.34 149.29 30.43 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.721 178.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.552 ' C ' HD23 ' A' ' 62' ' ' LEU . 7.0 tt -156.53 102.72 2.08 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.196 -178.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.35 106.97 19.07 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 177.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.454 ' OG1' ' CD2' ' A' ' 62' ' ' LEU . 15.9 m -88.31 113.11 23.59 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.023 0.439 . . . . 0.0 111.36 -178.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.0 tt -101.67 122.1 43.26 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.658 ' NE2' ' NZ ' ' A' ' 67' ' ' LYS . 56.0 t60 -85.28 132.26 34.29 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.263 0.554 . . . . 0.0 112.228 -178.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.658 ' NZ ' ' NE2' ' A' ' 66' ' ' HIS . 52.5 mttp 39.62 83.44 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.039 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.7 p -54.29 162.08 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.014 0.435 . . . . 0.0 110.649 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.45 ' H ' ' HB2' ' A' ' 72' ' ' ASP . 28.5 p -137.26 165.27 26.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.447 179.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.468 HD22 ' N ' ' A' ' 70' ' ' LEU . 4.1 mm? -60.95 -38.14 84.82 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -67.54 -36.62 81.34 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.896 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.45 ' HB2' ' H ' ' A' ' 69' ' ' THR . 44.3 m-20 -63.98 -36.81 85.19 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.789 -178.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.28 141.65 55.8 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.559 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -176.39 -165.02 31.41 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 57.7 m -98.93 123.39 43.18 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.627 0.251 . . . . 0.0 110.509 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.1 m -105.37 149.74 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.623 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.649 ' O ' ' HB3' ' A' ' 39' ' ' ALA . 51.7 p -159.47 158.23 31.59 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.678 0.275 . . . . 0.0 110.738 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.406 ' CD1' ' C ' ' A' ' 78' ' ' PHE . 45.3 p90 -143.16 157.35 44.59 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 69.8 m80 -142.87 139.66 30.93 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.245 0.545 . . . . 0.0 111.827 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.534 ' O ' ' N ' ' A' ' 82' ' ' THR . 3.2 p -144.12 143.12 23.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.17 178.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.446 ' H ' ' HB2' ' A' ' 34' ' ' GLN . . . -42.21 -14.39 0.01 OUTLIER Glycine 0 CA--C 1.526 0.748 0 CA-C-N 116.471 -0.331 . . . . 0.0 112.854 -178.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.534 ' N ' ' O ' ' A' ' 80' ' ' VAL . 45.6 p -89.3 -72.91 0.53 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 117.081 0.441 . . . . 0.0 110.152 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.443 ' H ' HG13 ' A' ' 80' ' ' VAL . 6.7 t -139.45 -172.37 3.35 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.633 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 41.6 p -158.56 163.08 37.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.051 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 31.0 m -162.31 173.83 13.65 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.546 -0.462 . . . . 0.0 111.054 179.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.467 ' N ' ' CD ' ' A' ' 86' ' ' GLU . 1.3 pm0 -137.04 152.66 50.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.823 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -143.79 151.68 40.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.269 -0.878 . . . . 0.0 108.922 178.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -110.86 128.6 55.84 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.527 0.679 . . . . 0.0 111.933 -178.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 51.4 tp -101.02 81.69 2.28 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 114.944 -1.025 . . . . 0.0 108.765 178.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -94.55 172.35 8.24 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.3 m -116.02 141.46 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 29.0 m -64.14 135.37 56.28 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.0 140.55 58.88 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.894 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.764 0 CA-C-O 117.754 -1.581 . . . . 0.0 111.588 179.958 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.9 ptm . . . . . 0 N--CA 1.492 1.65 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.48 150.79 82.64 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -53.68 144.51 53.11 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 121.257 1.304 . . . . 0.0 111.723 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.408 ' HG3' ' N ' ' A' ' 5' ' ' VAL . 35.5 tp10 -72.52 162.54 29.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.735 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.491 ' H ' HG13 ' A' ' 5' ' ' VAL . 1.0 OUTLIER -52.34 137.79 11.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 179.919 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.537 ' N ' ' OG ' ' A' ' 29' ' ' SER . 39.2 m -95.87 123.56 39.51 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 120.04 -0.664 . . . . 0.0 111.074 -178.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.3 mm -109.9 88.9 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.762 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.474 ' O ' ' SG ' ' A' ' 26' ' ' CYS . 55.4 mt -112.81 112.05 23.27 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 177.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -123.95 92.67 48.14 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.57 -178.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -69.25 -11.22 30.99 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 C-N-CA 121.259 1.306 . . . . 0.0 109.334 178.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.432 HD21 ' H ' ' A' ' 25' ' ' GLN . 63.7 mt -68.09 77.29 0.23 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.502 -1.226 . . . . 0.0 110.575 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 54.1 tp60 -70.66 -41.17 72.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.735 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -176.38 145.54 0.59 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.02 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.476 HG21 ' CE2' ' A' ' 24' ' ' PHE . 70.0 t -121.45 134.72 63.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.314 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -143.16 127.18 17.38 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.229 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.5 pp -162.75 144.3 10.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.861 -179.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.4 m -64.68 146.13 55.18 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -64.48 147.92 51.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.971 0.891 . . . . 0.0 112.218 -178.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.626 ' H ' ' CG1' ' A' ' 68' ' ' VAL . . . 92.75 -8.13 76.75 Favored Glycine 0 CA--C 1.521 0.466 0 CA-C-N 113.906 -1.497 . . . . 0.0 110.427 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -93.05 161.55 14.39 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 179.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -76.41 161.28 28.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.932 0.396 . . . . 0.0 110.588 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -149.39 156.89 42.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.389 -179.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.2 p -160.36 162.53 33.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.951 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.476 ' CE2' HG21 ' A' ' 14' ' ' VAL . 96.1 m-85 -133.41 147.31 51.74 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.146 0.498 . . . . 0.0 111.099 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.432 ' H ' HD21 ' A' ' 11' ' ' LEU . 89.0 mt-30 -139.0 125.48 20.5 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.424 178.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.61 ' SG ' ' N ' ' A' ' 27' ' ' ARG . 8.9 t -146.73 163.31 36.36 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.036 0.446 . . . . 0.0 110.453 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.61 ' N ' ' SG ' ' A' ' 26' ' ' CYS . 78.4 ttt-85 -120.61 119.48 33.01 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.449 ' C ' HD23 ' A' ' 28' ' ' LEU . 2.6 tt -136.15 105.76 6.14 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.551 -0.459 . . . . 0.0 110.541 -179.026 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.537 ' OG ' ' N ' ' A' ' 6' ' ' THR . 86.6 p -62.4 156.27 23.02 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 37.7 ptt-85 -50.84 160.68 0.43 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.223 -177.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.429 ' HA ' HG12 ' A' ' 5' ' ' VAL . . . -71.02 174.39 6.31 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.196 -178.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.3 t -120.35 1.94 10.77 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 151.65 -24.23 0.94 Allowed Glycine 0 N--CA 1.453 -0.184 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -121.07 119.16 31.67 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 115.416 -0.392 . . . . 0.0 110.449 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -93.71 149.99 20.78 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.123 -179.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.494 ' CB ' HG22 ' A' ' 80' ' ' VAL . . . -80.63 169.25 17.89 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.298 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.456 ' NH2' ' O ' ' A' ' 38' ' ' TRP . 9.5 ptm180 -144.21 146.06 32.46 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.42 179.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.458 ' CB ' HD11 ' A' ' 45' ' ' LEU . 81.4 m95 -78.16 176.54 9.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.813 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 77' ' ' SER . . . -164.55 107.21 0.88 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.598 179.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.532 HD13 ' N ' ' A' ' 41' ' ' GLY . 0.7 OUTLIER -116.19 114.1 23.98 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.532 ' N ' HD13 ' A' ' 40' ' ' LEU . . . 70.87 17.38 75.26 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.18 -22.19 42.17 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 18.8 m -111.94 148.73 39.62 Favored Pre-proline 0 CA--C 1.539 0.554 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -59.25 144.55 99.35 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 121.253 1.302 . . . . 0.0 111.625 -179.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.486 ' O ' HD12 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -89.69 164.77 14.57 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.085 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.436 ' O ' ' N ' ' A' ' 48' ' ' ASN . 78.3 mt-30 -135.91 155.44 50.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.978 0.418 . . . . 0.0 110.298 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.89 74.44 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.576 -179.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' A' ' 46' ' ' GLN . 98.5 m-20 -73.01 160.3 32.31 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.048 179.113 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -54.7 -49.16 71.38 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.326 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 78.4 mtm -69.38 -39.87 77.75 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.74 179.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.435 ' O ' ' O ' ' A' ' 48' ' ' ASN . 64.3 t30 -107.53 112.2 24.83 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.936 0.398 . . . . 0.0 110.975 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 53' ' ' ILE . 66.7 t0 -109.93 143.76 39.41 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.673 179.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.518 ' N ' ' OD1' ' A' ' 52' ' ' ASP . 20.6 tt -127.63 136.24 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.5 p -140.73 158.38 44.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.081 0.467 . . . . 0.0 111.551 -178.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.6 m -120.58 130.14 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.405 178.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -121.29 165.36 15.59 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.163 0.506 . . . . 0.0 111.009 -178.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -42.14 152.69 0.08 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.977 179.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.3 19.07 78.54 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' A' ' 28' ' ' LEU . 51.0 p 50.33 33.35 7.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.931 0.396 . . . . 0.0 110.376 -179.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 76.7 mt -79.32 120.56 23.96 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.714 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -83.69 142.63 30.61 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 56.1 tp -145.66 93.96 2.43 Favored 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 34.4 tp -92.91 106.97 18.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.606 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.537 ' CG2' ' NE2' ' A' ' 66' ' ' HIS . 78.0 m -96.85 98.41 10.1 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.184 -178.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.557 HD23 ' N ' ' A' ' 66' ' ' HIS . 4.0 tt -101.27 119.44 38.75 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.104 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.557 ' N ' HD23 ' A' ' 65' ' ' LEU . 54.1 m170 -112.43 154.22 26.15 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 120.772 0.32 . . . . 0.0 110.513 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 64.3 mttp 53.5 59.16 4.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.262 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.626 ' CG1' ' H ' ' A' ' 19' ' ' GLY . 1.0 OUTLIER -50.7 159.01 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.963 0.411 . . . . 0.0 110.782 -179.682 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.42 ' H ' ' HB2' ' A' ' 72' ' ' ASP . 55.0 p -133.97 167.04 21.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.313 179.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.445 HD12 ' N ' ' A' ' 70' ' ' LEU . 11.0 mp -61.78 -39.32 91.25 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -67.78 -35.55 78.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.158 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.42 ' HB2' ' H ' ' A' ' 69' ' ' THR . 98.9 m-20 -61.74 -43.03 99.65 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.197 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.27 141.15 51.75 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.374 -0.53 . . . . 0.0 109.73 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 168.28 -148.67 12.89 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.596 -0.811 . . . . 0.0 111.15 -179.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 43.6 m -110.1 125.16 52.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.709 -0.246 . . . . 0.0 110.715 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.0 t -111.76 130.58 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.52 ' O ' ' HB3' ' A' ' 39' ' ' ALA . 24.9 t -153.4 167.48 29.28 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.127 0.489 . . . . 0.0 110.764 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -146.68 150.33 35.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.066 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -128.62 140.37 51.8 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.092 0.472 . . . . 0.0 111.584 -178.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.509 ' C ' ' H ' ' A' ' 82' ' ' THR . 2.2 t -129.49 133.84 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.974 179.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -49.18 -7.48 0.07 OUTLIER Glycine 0 CA--C 1.529 0.928 0 C-N-CA 121.158 -0.544 . . . . 0.0 111.854 -179.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.509 ' H ' ' C ' ' A' ' 80' ' ' VAL . 31.0 p -107.72 -43.53 4.46 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.978 0.389 . . . . 0.0 110.932 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 14.1 t -154.2 154.62 33.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.336 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.1 m -130.61 157.1 43.66 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.984 0.421 . . . . 0.0 111.569 -179.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.404 ' O ' ' OG ' ' A' ' 77' ' ' SER . 15.8 t -154.68 157.2 37.74 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.848 -179.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -127.4 159.95 32.92 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.368 0.604 . . . . 0.0 111.706 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.49 147.57 27.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.425 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -117.66 139.6 50.78 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.346 0.593 . . . . 0.0 112.522 -178.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.512 HD23 ' C ' ' A' ' 89' ' ' LEU . 3.5 tt -119.81 106.78 12.42 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.182 -0.917 . . . . 0.0 108.597 178.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.414 ' N ' HD23 ' A' ' 89' ' ' LEU . 61.5 pttt -110.96 160.24 16.99 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.706 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.421 ' O ' HG23 ' A' ' 91' ' ' VAL . 23.7 m -110.66 131.47 61.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.886 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 98.1 m -112.65 127.32 56.08 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.271 -179.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -82.96 -78.63 0.21 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.087 -179.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.827 0 CA-C-O 117.838 -1.534 . . . . 0.0 111.332 -179.724 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 80.8 mtp . . . . . 0 N--CA 1.493 1.689 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.33 151.63 75.91 Favored Pre-proline 0 CA--C 1.532 0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.83 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.459 ' O ' ' O ' ' A' ' 4' ' ' GLU . 2.1 Cg_endo -46.85 -76.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.316 -1.163 0 C-N-CA 121.426 1.418 . . . . 0.0 110.485 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.459 ' O ' ' O ' ' A' ' 3' ' ' PRO . 80.9 mm-40 41.19 -165.64 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.741 179.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 29' ' ' SER . 0.2 OUTLIER -58.8 157.71 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 177.351 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.5 ' HB ' ' H ' ' A' ' 29' ' ' SER . 93.8 m -85.53 86.31 7.38 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 118.262 -1.375 . . . . 0.0 108.407 179.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.67 HG23 ' O ' ' A' ' 7' ' ' ILE . 10.6 tt -83.92 90.9 2.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 122.371 1.081 . . . . 0.0 112.52 -177.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 96.8 mt -127.33 83.51 2.17 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 113.457 -1.702 . . . . 0.0 109.056 178.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.446 ' C ' ' H ' ' A' ' 11' ' ' LEU . 4.8 pt-20 -122.93 83.9 50.3 Favored Pre-proline 0 N--CA 1.468 0.464 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.177 -178.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -71.93 17.51 0.32 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.189 1.926 . . . . 0.0 111.577 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.478 HD21 ' O ' ' A' ' 25' ' ' GLN . 76.6 mt -66.92 77.45 0.12 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.542 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -71.7 -70.47 0.32 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.345 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.417 ' OD2' ' N ' ' A' ' 13' ' ' ASP . 31.7 p-10 -176.72 152.41 0.99 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.336 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.9 m -135.57 161.3 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.068 -179.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -133.45 139.51 46.75 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.383 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -156.64 151.52 26.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.033 0.445 . . . . 0.0 111.417 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.8 p -80.66 168.04 19.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.639 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -64.83 141.68 58.69 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.831 0.348 . . . . 0.0 110.515 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.61 8.2 87.22 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.689 -0.564 . . . . 0.0 111.689 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 93.5 mm-40 -96.48 158.66 15.33 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.846 0.355 . . . . 0.0 110.153 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -86.04 167.54 14.92 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.05 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.493 ' HB3' HD22 ' A' ' 65' ' ' LEU . . . -161.54 157.08 24.29 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.916 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 73.6 m -163.93 159.47 20.94 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.148 -0.315 . . . . 0.0 110.148 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -128.78 147.91 50.82 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.087 0.47 . . . . 0.0 110.617 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.485 ' OE1' ' CD2' ' A' ' 62' ' ' LEU . 62.6 mm-40 -124.43 125.69 44.69 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.874 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 6.7 t -137.53 146.13 43.78 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.171 0.51 . . . . 0.0 110.701 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -125.99 100.42 6.35 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.244 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.478 ' O ' ' CG2' ' A' ' 59' ' ' THR . 91.0 mt -121.6 110.31 15.84 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.255 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.5 ' H ' ' HB ' ' A' ' 6' ' ' THR . 34.7 t -69.62 172.9 6.7 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.45 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 11.6 ptp85 -50.12 151.28 2.05 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 122.038 0.923 . . . . 0.0 113.03 -177.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.6 160.04 20.53 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 113.831 -1.531 . . . . 0.0 112.213 -178.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.9 m -138.77 -82.96 0.29 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.647 179.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -65.58 -85.9 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 178.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -123.56 155.68 37.16 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.303 0.573 . . . . 0.0 110.193 178.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 74.9 tt0 -72.99 153.47 40.92 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.239 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.72 143.6 26.81 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.075 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -108.08 141.74 39.33 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.52 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 8.7 t-105 -111.11 138.87 47.01 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -165.41 155.98 13.6 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 119.45 -0.9 . . . . 0.0 111.762 -178.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.633 ' C ' HD23 ' A' ' 40' ' ' LEU . 6.9 tt -131.27 123.57 28.65 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.941 179.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.564 ' N ' HD23 ' A' ' 40' ' ' LEU . . . 82.89 6.31 88.52 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.752 -0.539 . . . . 0.0 111.752 179.159 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 102.04 -20.34 45.84 Favored Glycine 0 N--CA 1.467 0.704 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.4 m -109.35 151.56 42.17 Favored Pre-proline 0 N--CA 1.467 0.401 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -56.79 141.78 92.34 Favored 'Trans proline' 0 C--N 1.316 -1.171 0 C-N-CA 120.939 1.092 . . . . 0.0 111.048 179.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.563 ' H ' ' CD2' ' A' ' 45' ' ' LEU . 0.8 OUTLIER -93.15 -172.46 2.97 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.14 -179.89 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 61.8 tp60 -144.93 155.7 43.57 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.262 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.14 63.7 1.33 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.44 ' O ' ' O ' ' A' ' 51' ' ' ASN . 13.3 t-20 -65.55 175.87 1.67 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.136 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -66.01 -39.72 90.48 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 78.1 mtm -67.65 -39.35 84.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.164 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.44 ' O ' ' O ' ' A' ' 48' ' ' ASN . 55.6 t30 -126.02 131.95 52.09 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.039 0.447 . . . . 0.0 111.073 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -120.02 140.57 50.77 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.551 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.4 mm -110.69 127.32 67.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.451 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.441 HG22 ' O ' ' A' ' 62' ' ' LEU . 5.0 t -145.86 156.55 43.63 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.099 0.476 . . . . 0.0 111.432 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.2 m -115.31 133.65 60.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.029 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -116.91 -177.48 3.21 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.101 0.477 . . . . 0.0 110.669 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.426 ' CD ' ' N ' ' A' ' 58' ' ' GLY . 9.8 tm0? -64.6 147.31 53.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.269 -179.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.426 ' N ' ' CD ' ' A' ' 57' ' ' GLN . . . 80.55 13.04 82.24 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.478 ' CG2' ' O ' ' A' ' 28' ' ' LEU . 1.6 m 70.4 24.53 4.63 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 121.418 0.628 . . . . 0.0 110.385 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.6 mp -79.76 138.85 37.4 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.879 179.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 58.4 m170 -111.18 130.29 55.68 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.628 HD13 ' N ' ' A' ' 63' ' ' LEU . 1.1 tm? -125.13 119.58 28.99 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 111.494 0.183 . . . . 0.0 111.494 -178.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.628 ' N ' HD13 ' A' ' 62' ' ' LEU . 6.3 mp -103.36 114.14 28.18 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 177.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 93.1 m -99.61 110.6 23.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.112 0.482 . . . . 0.0 110.746 -179.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.709 ' C ' HD23 ' A' ' 65' ' ' LEU . 7.0 tt -110.88 129.28 55.91 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.869 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.505 ' N ' HD23 ' A' ' 65' ' ' LEU . 0.8 OUTLIER -153.34 165.11 36.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.414 -179.602 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.5 mttp 42.58 86.78 0.02 OUTLIER 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.313 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.482 HG11 HD21 ' A' ' 65' ' ' LEU . 21.4 m -137.65 163.94 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.588 -178.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 33.2 p -117.77 -151.86 0.49 Allowed 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.669 179.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.506 ' C ' ' H ' ' A' ' 72' ' ' ASP . 87.1 mt -63.01 -23.71 67.58 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.675 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -56.92 -1.07 0.05 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.349 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.506 ' H ' ' C ' ' A' ' 70' ' ' LEU . 18.6 m-20 -62.73 -36.19 82.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.281 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.3 127.92 31.66 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.473 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 172.48 153.18 9.12 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.776 -0.929 . . . . 0.0 110.776 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 85.4 m -111.59 116.69 31.24 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.558 0.218 . . . . 0.0 110.958 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.2 t -91.93 128.2 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.2 p -128.24 145.45 51.04 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.043 0.449 . . . . 0.0 110.835 -179.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -156.87 155.49 31.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.421 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 40.8 p-80 -159.37 151.46 20.88 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.315 0.578 . . . . 0.0 111.911 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.544 ' O ' ' N ' ' A' ' 82' ' ' THR . 12.3 p -124.06 134.22 67.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 115.285 -0.87 . . . . 0.0 108.982 178.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -31.23 -30.01 0.01 OUTLIER Glycine 0 CA--C 1.529 0.958 0 CA-C-N 116.058 -0.519 . . . . 0.0 113.096 -178.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.544 ' N ' ' O ' ' A' ' 80' ' ' VAL . 4.5 m -76.61 -74.3 0.24 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.006 0.431 . . . . 0.0 110.92 -179.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.41 ' O ' ' O ' ' A' ' 80' ' ' VAL . 7.6 t -119.76 -170.04 1.88 Allowed 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 31.4 p -151.74 157.49 42.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.204 0.526 . . . . 0.0 110.718 179.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.4 t -167.06 151.35 6.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.827 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -146.1 156.26 43.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.054 0.454 . . . . 0.0 110.729 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -129.82 152.97 48.72 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.448 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -124.99 137.95 54.24 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.279 0.561 . . . . 0.0 111.459 -179.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.598 HD23 ' C ' ' A' ' 89' ' ' LEU . 6.3 tt -110.15 121.97 46.53 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.22 -0.9 . . . . 0.0 108.978 178.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.58 ' N ' HD23 ' A' ' 89' ' ' LEU . 17.7 ptpt -123.61 157.93 32.63 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.934 0.397 . . . . 0.0 111.367 -179.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 18.6 m -116.06 136.24 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.873 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 46.5 p -99.06 134.73 41.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.573 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -164.96 -19.25 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.263 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.768 0 CA-C-O 118.143 -1.365 . . . . 0.0 111.647 -179.16 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.9 mpp? . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.569 ' N ' ' CD ' ' A' ' 3' ' ' PRO . . . -176.16 44.79 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.427 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.569 ' CD ' ' N ' ' A' ' 2' ' ' ALA . 2.3 Cg_endo -42.66 -55.55 2.61 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.733 2.288 . . . . 0.0 112.112 -179.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.471 ' OE2' ' N ' ' A' ' 5' ' ' VAL . 1.3 tm-20 -70.96 161.03 31.81 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 29' ' ' SER . 1.9 p -59.23 130.31 22.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.545 HG22 ' H ' ' A' ' 8' ' ' LEU . 12.1 m -66.61 134.31 52.07 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 118.739 -1.184 . . . . 0.0 108.304 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.58 HG23 ' O ' ' A' ' 7' ' ' ILE . 2.4 tp -111.81 31.49 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -177.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.545 ' H ' HG22 ' A' ' 6' ' ' THR . 7.7 mp -81.98 90.1 6.46 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.502 ' C ' ' H ' ' A' ' 11' ' ' LEU . 1.8 pt-20 -121.3 90.5 47.6 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.032 -179.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -68.32 24.93 0.14 Allowed 'Trans proline' 0 C--N 1.314 -1.289 0 C-N-CA 121.861 1.707 . . . . 0.0 112.141 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.502 ' H ' ' C ' ' A' ' 9' ' ' GLU . 71.2 mt -81.01 72.9 8.06 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.104 0.478 . . . . 0.0 110.467 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -74.58 -67.78 0.6 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.446 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -172.26 133.57 0.67 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.357 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.1 m -123.99 142.38 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 120.924 0.392 . . . . 0.0 110.768 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.533 ' C ' HD22 ' A' ' 16' ' ' LEU . 89.5 mt-30 -129.71 112.97 14.17 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.518 -179.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.56 ' O ' HG23 ' A' ' 91' ' ' VAL . 4.5 mm? -122.92 151.32 41.89 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.36 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.2 m -72.85 155.09 40.26 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 178.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.2 tm-20 -59.5 139.43 57.13 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.832 0.348 . . . . 0.0 110.728 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.59 -1.41 87.17 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.891 179.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 23.0 mm100 -91.83 168.55 11.36 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.91 0.386 . . . . 0.0 110.725 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -84.3 164.15 19.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.255 179.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -153.27 153.27 32.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.785 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 28.2 p -156.43 159.13 38.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.921 0.391 . . . . 0.0 110.552 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -132.3 147.1 52.39 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.292 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.404 ' O ' HD21 ' A' ' 11' ' ' LEU . 52.5 tt0 -137.37 121.75 18.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.09 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 37.3 t -129.63 129.82 44.82 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.98 0.419 . . . . 0.0 111.053 -179.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.01 108.38 21.05 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.044 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.447 ' O ' ' OG1' ' A' ' 59' ' ' THR . 74.3 mt -122.38 129.81 52.48 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.537 178.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.568 ' O ' HG23 ' A' ' 5' ' ' VAL . 68.6 m -94.32 175.86 6.53 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 -56.67 138.56 52.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.361 0.6 . . . . 0.0 111.208 -179.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -79.27 -176.1 5.01 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.415 -179.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.42 ' OG ' ' N ' ' A' ' 33' ' ' GLY . 82.5 p -146.23 -62.04 0.31 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.711 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.42 ' N ' ' OG ' ' A' ' 32' ' ' SER . . . -93.82 -71.08 1.14 Allowed Glycine 0 CA--C 1.522 0.506 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 179.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 96.5 mm-40 -122.75 135.15 54.47 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.386 0.612 . . . . 0.0 111.78 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -86.75 145.41 26.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.072 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.477 ' CB ' HG22 ' A' ' 80' ' ' VAL . . . -70.45 147.63 49.24 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.5 mmt85 -102.52 143.68 31.92 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 20.9 t-105 -102.3 131.43 48.9 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.414 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -172.7 152.81 2.6 Favored 'General case' 0 C--O 1.226 -0.179 0 C-N-CA 119.608 -0.837 . . . . 0.0 112.447 -179.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.62 ' C ' HD23 ' A' ' 40' ' ' LEU . 6.7 tt -125.87 121.16 32.42 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.046 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.525 ' N ' HD23 ' A' ' 40' ' ' LEU . . . 88.23 -2.99 85.58 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -178.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.28 1.07 58.15 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 112.167 -0.373 . . . . 0.0 112.167 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.7 m -111.59 148.28 38.52 Favored Pre-proline 0 N--CA 1.471 0.603 0 CA-C-N 117.146 0.473 . . . . 0.0 110.709 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -49.85 138.72 33.75 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 121.631 1.554 . . . . 0.0 111.308 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.8 tp -86.62 163.19 17.55 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.899 -178.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -140.41 147.76 40.2 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.62 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.13 62.98 0.67 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.866 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.522 ' OD1' ' N ' ' A' ' 49' ' ' GLU . 60.1 t-20 -66.62 142.62 57.4 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.043 0.449 . . . . 0.0 111.033 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.522 ' N ' ' OD1' ' A' ' 48' ' ' ASN . 74.9 mm-40 -40.07 -42.05 1.35 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.093 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 74.1 mtm -65.99 -39.28 90.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.636 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.514 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 0.6 OUTLIER -112.27 125.88 54.64 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.123 -178.805 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.49 ' OD2' ' N ' ' A' ' 53' ' ' ILE . 56.5 t0 -109.28 154.09 22.95 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.49 ' N ' ' OD2' ' A' ' 52' ' ' ASP . 64.4 mt -137.11 129.22 43.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.9 p -130.86 148.87 52.69 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.035 0.445 . . . . 0.0 110.755 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.0 p -125.34 128.44 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.348 -179.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.454 ' O ' ' O ' ' A' ' 57' ' ' GLN . 96.3 mt-10 -126.82 -173.12 2.8 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.841 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.454 ' O ' ' O ' ' A' ' 56' ' ' GLU . 97.8 mm-40 -28.24 152.12 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.368 -179.123 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.427 ' C ' ' OG1' ' A' ' 59' ' ' THR . . . 58.8 -82.75 0.01 OUTLIER Glycine 0 CA--C 1.521 0.454 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 179.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER 175.68 51.29 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.83 0.824 . . . . 0.0 109.134 179.912 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 42.8 mt -80.16 135.93 36.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.95 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -113.76 145.74 40.94 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.522 ' C ' HD23 ' A' ' 62' ' ' LEU . 3.2 tt -153.59 110.94 3.48 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.643 -179.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.486 ' N ' HD23 ' A' ' 62' ' ' LEU . 7.8 mp -97.02 128.86 44.4 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 120.969 0.414 . . . . 0.0 110.804 179.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.9 m -108.71 103.22 12.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.544 179.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.431 ' CD2' ' N ' ' A' ' 65' ' ' LEU . 3.1 mm? -96.06 126.68 41.46 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.132 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.478 ' ND1' ' N ' ' A' ' 67' ' ' LYS . 12.0 t-80 -138.61 160.49 39.47 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.235 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.478 ' N ' ' ND1' ' A' ' 66' ' ' HIS . 70.9 mmtt 57.21 41.54 26.8 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.4 p -94.88 134.95 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.106 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.431 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 44.7 p -122.27 -151.01 0.46 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.102 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.589 ' C ' ' H ' ' A' ' 72' ' ' ASP . 86.0 mt -45.9 -27.4 0.87 Allowed 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.34 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -64.28 13.07 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.725 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.589 ' H ' ' C ' ' A' ' 70' ' ' LEU . 5.1 m-20 -60.34 -35.77 76.42 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.048 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -52.31 138.3 26.97 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.148 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -171.53 173.66 44.95 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 17.1 p -154.43 104.39 2.57 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 110.453 -0.203 . . . . 0.0 110.453 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.2 t -94.89 132.68 38.22 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 CA-C-O 121.147 0.499 . . . . 0.0 110.125 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 11.0 t -132.85 152.47 51.83 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.356 -179.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -127.25 133.67 50.17 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.515 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -114.88 109.86 18.78 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.464 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.477 HG22 ' CB ' ' A' ' 36' ' ' ALA . 1.4 t -115.89 129.35 72.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -57.07 -7.08 2.25 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.922 -178.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.15 -43.65 4.12 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 117.064 0.432 . . . . 0.0 110.915 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 59.7 m -137.38 172.69 12.61 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.9 0.381 . . . . 0.0 111.387 -179.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 87.7 p -133.93 156.42 48.16 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.392 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.8 p -156.73 160.06 38.93 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.989 0.424 . . . . 0.0 111.065 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -143.95 157.7 44.18 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.747 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -142.85 146.82 34.5 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.828 179.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -120.63 130.15 54.03 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.382 0.61 . . . . 0.0 112.255 -178.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 48.0 tp -114.89 119.2 35.76 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 114.992 -1.003 . . . . 0.0 108.822 178.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -133.25 156.64 47.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.216 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 16' ' ' LEU . 8.6 p -117.16 133.39 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.499 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 3.0 t -85.71 166.0 16.49 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.068 -179.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' A' ' 92' ' ' THR . . . 73.15 20.13 3.44 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.173 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.72 0 CA-C-O 117.951 -1.472 . . . . 0.0 110.476 179.641 . . . . . . . . 0 0 . 1 stop_ save_